Citrus Sinensis ID: 043262

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510--
Protein Sequence
LLQSSSAAAKLDSNYLYHFCVRESNTSSLFMYNVGTLFYGKLYNEGGRYLYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEPTAPISPPNKKSGSSNDSGKKKTKESRTWIAIGAAASSIIVLALSCFLLWCMKRRKERVKEEKANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccEEEccccccccEEEEEEccccccHHHHHHHHHHHHHHHHHccccccEEEEEccEEEEEEcccccccccccccEEEEccccccccHHHHHHHHHHHHHHHHHHHHcccccccccEEEEEccccccccEEEEEEccccccHHHHHHHHHHHHHHcccccccccccEEcccccEEEEccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHcccccccccccccHHccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEcccccccEEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEcccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccHHHHHcccccccccccccccccccHHHHHHHHHHHHcccccccccccEcccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHHcccccEEEEEEccEEEEEccccHcccccccccEEEEccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHcccccccEEEEccEEEEEEEEccccccccccccccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHcccccccccHHccccccccccccEEEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHEEcccccEEEEEEEcccccccEEEEcHHHcccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEEccccccccccEEEcc
Coil and Loop (DISEMBL)
LLQSSSAaakldsnyLYHFCVRESNTSSLFMYNVGTLFYgklyneggrylyynategddpnkvyglYHCYFGVSIEVCQNCIKALINTLVtnctgskgaiIWYDQcmlrfsnisfvstlglapYVILSqvtnftdpdkvTNILVQSINDLIQNvtsrdsnsKYAAAAQMVNASSIDKIWTLVQcipylsksdcniclrQTVSRISsryygrqsvralspsciiryemypffeeptapisppnkksgssndsgkkktkesRTWIAIGAAASSIIVLALSCFLLWCMKRRKERVKEEKANSQETRSLhladgrigndysydvlrgqkqeesqefplfplHLAVEAtqhfsdenklgeggfgpvykgkladgkEIAVKRLsrtsgqglqEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIyeympnkslnvflfdstrsvqlDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSnvlldhemnpkisdfgmarifggnqseantkrivgt
Flexible Loop (DISEMBL)
llqsssaaakldsnyLYHFCVRESNTSSLFMYNVGTLFYGKLYNEGGRYLYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSrissryygrqsvralSPSCIIRYEMYPFFEEptapisppnkksgssndsgkkktKESRTWIAIGAAASSIIVLALSCFLLWCMKRRKErvkeekansqetrslhladgrigNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLsrtsgqglqeFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARifggnqseantkrivgt
Low Complexity Region (SEG)
LLQSSSAAAKLDSNYLYHFCVRESNTSSLFMYNVGTLFYGKLYNEGGRYLYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEPTAPIsppnkksgssndsgkkkTKESRTWiaigaaassiiVLALSCFLLWCMkrrkervkeekANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT
Disordered region (IsUnstruct)
***********DSNYLYHFCVRESNTSSLFMYNVGTLFYGKLYNEGGRYLYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQVTNFTDPDKVTNILVQSINDLIQNVTS*****KYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFE****************************TWIAIGAAASSIIVLALSCFLLWCMK*************************IGNDYSYDVL**********FPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLS***GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF***************
Disordered Region (DISOPRED)
LLQSSSAAAKLDSNYLYHFCVRESNTSSLFMYNVGTLFYGKLYNEGGRYLYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEPTA*************************WIAIGAAASSIIVLALSCFLLWCMKRR****************************************SQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT
Disordered Region (DISEMBL)
LLQSSSAAAKLDSNYLYHFCVRESNTSSLFMYNVGTLFYGKLYNEGGRYLYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEPTAPI*********************RTWIAIGAAASSIIVLALSCFLLWCMKRRK*************RSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT
Disordered Region (DISPRO)
LLQSSSAAAKLDSNYLYHFCVRESNTSSLFMYNVGTLFYGKLYNEGGRYLYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEPT**********************ESRTWIAIGAAASSIIVLALSCFLLWCMKRRKER*********************************KQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS****K*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LLQSSSAAAKLDSNYLYHFCVRESNTSSLFMYNVGTLFYGKLYNEGGRYLYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEPTAPISPPNKKSGSSNDSGKKKTKESRTWIAIGAAASSIIVLALSCFLLWCMKRRKERVKEEKANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	512	2.2.26 [Sep-21-2011]
Q9M0X5	675	Cysteine-rich receptor-li	yes	no	0.914	0.693	0.409	1e-100
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.896	0.686	0.403	1e-96
O65479	666	Putative cysteine-rich re	no	no	0.929	0.714	0.385	8e-92
Q8GWJ7	645	Cysteine-rich receptor-li	no	no	0.927	0.736	0.399	1e-90
Q8H199	658	Cysteine-rich receptor-li	no	no	0.873	0.679	0.393	2e-90
O65468	676	Cysteine-rich receptor-li	no	no	0.916	0.693	0.383	2e-90
Q9LDQ3	669	Putative cysteine-rich re	no	no	0.833	0.638	0.375	2e-89
Q9C5S9	674	Cysteine-rich receptor-li	no	no	0.906	0.688	0.373	5e-89
O65472	690	Putative cysteine-rich re	no	no	0.890	0.660	0.403	2e-86
Q9ZP16	667	Cysteine-rich receptor-li	no	no	0.857	0.658	0.386	2e-86

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  366 bits (939), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 213/520 (40%), Positives = 300/520 (57%), Gaps = 52/520 (10%)

Query: 12  DSNYLYHFCVRESNTS--SLFMYNVGTLFYGKLYNEGGRY--LYYNATEGD--DPNKVYG 65
           D  YLYH C   +  S  S ++ N+ T+    L +    Y  L+ NA  G+  D N+VYG
Sbjct: 26  DPTYLYHICPNTTTYSRNSSYLTNLRTVL-SSLSSPNAAYASLFDNAAAGEENDSNRVYG 84

Query: 66  LYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYV 125
           ++ C   VS E+C++C+    N  +  C   K A+IWYD+CM+R+SN S V  + + P V
Sbjct: 85  VFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYSNQSIVGQMRIRPGV 144

Query: 126 ILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCI 185
            L+   N T+ ++V+    +S+  L+ +V  + + S    A +  N +    I++LVQC 
Sbjct: 145 FLTNKQNITE-NQVSR-FNESLPALLIDVAVKAALSSRKFATEKANFTVFQTIYSLVQCT 202

Query: 186 PYLSKSDCNICLRQTVS---RISSRYYGRQSVRALSPSCIIRYEMYPFFEEP-------- 234
           P L+  DC  CLRQ ++   R   R  G    R ++PSC  RYE+YPF+ E         
Sbjct: 203 PDLTNQDCESCLRQVINYLPRCCDRSVGG---RVIAPSCSFRYELYPFYNETIAAAPMAP 259

Query: 235 --TAPISPPNKKSGSSNDSGKKKTKESRTWIAIGAAASSIIVLALSCFLLWCMKRRKERV 292
             ++ ++ P     S    GK  T    T IA+  +   +++L   C+LL   +RR  ++
Sbjct: 260 PPSSTVTAPPLNIPSEKGKGKNLTVIV-TAIAVPVSVC-VLLLGAMCWLL--ARRRNNKL 315

Query: 293 KEEKANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENK 352
             E  +  E                     G    E+ +F    +     AT  FS+ NK
Sbjct: 316 SAETEDLDED--------------------GITSTETLQFQFSAIE---AATNKFSESNK 352

Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ 412
           LG GGFG VYKG+L  G+ +A+KRLS+ S QG +EFKNEV ++AKLQH+NL +LLG CL 
Sbjct: 353 LGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLD 412

Query: 413 ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRD 472
             E +L+YE++PNKSL+ FLFD+ +   LDW+RR  II GIARG+LYLH DSRL IIHRD
Sbjct: 413 GEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRD 472

Query: 473 LKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           LK SN+LLD +M+PKISDFGMARIFG +Q++ANTKRIVGT
Sbjct: 473 LKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGT 512

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  353 bits (907), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 210/520 (40%), Positives = 297/520 (57%), Gaps = 61/520 (11%)

Query: 12  DSNYLYHFCVRESNTSSLFMYN--VGTLFYGKLYNEGGRYL--YYNATEGDDPNKVYGLY 67
           D  Y+YH C   +N +S   YN  + TL    L +    Y   + NAT G  P++V GL+
Sbjct: 36  DPTYVYHTCQNTANYTSNSTYNNNLKTLL-ASLSSRNASYSTGFQNATVGQAPDRVTGLF 94

Query: 68  HCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVIL 127
           +C   VS EVC+ C+   +N  +T C   K A ++YD+C+LR+SN + +STL     VIL
Sbjct: 95  NCRGDVSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITTGGVIL 154

Query: 128 SQVTNFTDP--DKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCI 185
               N T    D ++++++ ++N       + +S+ K+       N +++   + LVQC 
Sbjct: 155 VNTRNVTSNQLDLLSDLVLPTLNQAA--TVALNSSKKFGTRKN--NFTALQSFYGLVQCT 210

Query: 186 PYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEPTA--------- 236
           P L++ DC+ CL+  +++I +   G    R ++PSC  RYE+Y F+ E            
Sbjct: 211 PDLTRQDCSRCLQLVINQIPTDRIG---ARIINPSCTSRYEIYAFYTESAVPPPPPPPSI 267

Query: 237 ----PISPPNKKSGSSNDSGKKKTKESRTWIAIGAAASSIIVLALSCFLLWCMKRRKERV 292
                 +PP  +SG   +S     K     I +    + ++ +A  CFL      R+ R 
Sbjct: 268 STPPVSAPP--RSGKDGNS-----KVLVIAIVVPIIVAVLLFIAGYCFLT-----RRAR- 314

Query: 293 KEEKANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENK 352
                     +S +      G+D +          +S +     +     AT  F + NK
Sbjct: 315 ----------KSYYTPSAFAGDDIT--------TADSLQLDYRTIQ---TATDDFVESNK 353

Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ 412
           +G+GGFG VYKG L+DG E+AVKRLS++SGQG  EFKNEV L+AKLQH+NLVRLLG CL 
Sbjct: 354 IGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLD 413

Query: 413 ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRD 472
             E +L+YEY+PNKSL+ FLFD  +  QLDW RR  II G+ARG+LYLH+DSRL IIHRD
Sbjct: 414 GEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRD 473

Query: 473 LKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           LK SN+LLD +MNPKI+DFGMARIFG +Q+E NT RIVGT
Sbjct: 474 LKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGT 513

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2

 Score =  338 bits (866), Expect = 8e-92,   Method: Compositional matrix adjust.
 Identities = 203/526 (38%), Positives = 291/526 (55%), Gaps = 50/526 (9%)

Query: 4   SSSAAAKLDSNYLYHFCVRESNTSSLFMY--NVGTLFYGKL-----YNEGGRYLYYNATE 56
           +S  A+  +  YLYH C   +  SS   Y  N+ TL          Y+ G    + NAT 
Sbjct: 17  TSFTASAQNPFYLYHNCSITTTYSSNSTYSTNLKTLLSSLSSRNASYSTG----FQNATA 72

Query: 57  GDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFV 116
           G  P+ V GL+ C   VS EVC++CI   +N  ++ C   + A+ +Y+QCMLR+SN + +
Sbjct: 73  GQAPDMVTGLFLCRGNVSPEVCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNIL 132

Query: 117 STLGLAPYVILSQVTN--FTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASS 174
           STL     V +    N      D+  ++++  +N  +  + +  S  ++A     +NA  
Sbjct: 133 STLNTDGGVFMQNARNPISVKQDRFRDLVLNPMN--LAAIEAARSIKRFAVTKFDLNA-- 188

Query: 175 IDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEP 234
           +  ++ +VQC P L++ DC  CL+Q++++++   Y +   R   PSC  RY+ Y F+ E 
Sbjct: 189 LQSLYGMVQCTPDLTEQDCLDCLQQSINQVT---YDKIGGRTFLPSCTSRYDNYEFYNEF 245

Query: 235 TAPI----SPPNKKSGSSNDSGKKKTKESRTWIAIGAAASSIIVL----ALSCFLLWCMK 286
                   SP   K G+S+               +  A  S+        +    L+ +K
Sbjct: 246 NVGTPQDSSPRPGKGGNSSVIVIAVVVPITVLFLLFVAFFSVRRAKRKKTIGAIPLFKVK 305

Query: 287 RRKERVKEEKANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQH 346
           R++  V E  A + +   +  A              G  Q        F     V AT  
Sbjct: 306 RKETEVTEPPAETTDGDDITTA--------------GSLQ--------FDFKAIVAATDI 343

Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           F   NKLG+GGFG VYKG    G ++AVKRLS+ SGQG +EF+NEV ++AKLQH+NLV+L
Sbjct: 344 FLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKL 403

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
           LG CL+  E +L+YE++PNKSL+ FLFD T   QLDW RR  II GIARG+LYLH+DSRL
Sbjct: 404 LGYCLEGEEKILVYEFVPNKSLDYFLFDPTMQGQLDWSRRYKIIGGIARGILYLHQDSRL 463

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            IIHRDLK  N+LLD +MNPK++DFGMARIFG +Q+EANT+R+VGT
Sbjct: 464 TIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVGT 509

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2

 Score =  334 bits (856), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 207/518 (39%), Positives = 293/518 (56%), Gaps = 43/518 (8%)

Query: 1   LLQSSSAAAKLDSNYLYHFCVRESNTSSLFMY--NVGTLFYGKLYNEGGRYL--YYNATE 56
            L SS  A+  ++ YLYH C   +  SS   Y  N+ TL           Y   +  AT 
Sbjct: 11  FLFSSITASAQNTFYLYHNCSVTTTFSSNSTYSTNLKTLLSSLSSLNASSYSTGFQTATA 70

Query: 57  GDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFV 116
           G  P++V GL+ C   VS EVC++C+   +N  +T C   K  + +Y+QC+LR+SN + V
Sbjct: 71  GQAPDRVTGLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEGVFYYEQCLLRYSNRNIV 130

Query: 117 STLGLAPYVILSQVTN--FTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASS 174
           +TL     + +    N      D+  ++++  +N  +  V +  S  K+A     +NAS 
Sbjct: 131 ATLNTDGGMFMQSARNPLSVKQDQFRDLVLTPMN--LAAVEAARSFKKWAVRKIDLNASQ 188

Query: 175 IDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEP 234
              ++ +V+C P L + DC  CL+  +++++   Y +   R L PSC  RY+ Y F+ E 
Sbjct: 189 --SLYGMVRCTPDLREQDCLDCLKIGINQVT---YDKIGGRILLPSCASRYDNYAFYNES 243

Query: 235 TAPISPPNKKSGSSNDSGKKKTKESRTWIAIGAAASSIIVLALSCFLLWCMKRRKERVKE 294
                      G+  DS  +  K   + + I A    I VL L    ++ ++ + +R   
Sbjct: 244 NV---------GTPQDSSPRPGKGGNSSVIIIAVVVPITVLFLLLVAVFSVRAKNKRTLN 294

Query: 295 EKANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLG 354
           EK    E           GND +     G  Q        F       AT  F   NKLG
Sbjct: 295 EKEPVAED----------GNDIT---TAGSLQ--------FDFKAIEAATNCFLPINKLG 333

Query: 355 EGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN 414
           +GGFG VYKG L+ G ++AVKRLS+TSGQG +EF+NEV ++AKLQH+NLV+LLG CL+  
Sbjct: 334 QGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGE 393

Query: 415 ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 474
           E +L+YE++PNKSL+ FLFDST  ++LDW RR  II GIARG+LYLH+DSRL IIHRDLK
Sbjct: 394 EKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLK 453

Query: 475 TSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             N+LLD +MNPKI+DFGMARIFG +Q+EA T+R+VGT
Sbjct: 454 AGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGT 491

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2

 Score =  333 bits (854), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 195/495 (39%), Positives = 275/495 (55%), Gaps = 48/495 (9%)

Query: 33  NVGTLFYGKLYNEGGRYLYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTN 92
           N G L      N   R  +YN++ G  P++VY L  C  G   +VC +CI+   N L+  
Sbjct: 40  NRGLLLSSLPSNVSARGGFYNSSIGQGPDRVYALGMCIEGAEPDVCSDCIEYASNLLLDT 99

Query: 93  CTGSKGAIIWYDQ---CMLRFSNISFVSTLGLAPYVILSQV----TNFTDPDKVTNILVQ 145
           C      + W ++   CM+R+SN SF  +L   P+  +  V    +N T+ D+V   L +
Sbjct: 100 CLNQTEGLAWPEKRILCMVRYSNSSFFGSLKAEPHFYIHNVDDITSNLTEFDQVWEELAR 159

Query: 146 SINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRIS 205
               +I + TS  S  KY AA  +   ++   I+ L+QC P LS  DC+ICLRQ+V    
Sbjct: 160 R---MIASTTSPSSKRKYYAA-DVAALTAFQIIYALMQCTPDLSLEDCHICLRQSVGDYE 215

Query: 206 SRYYGRQSVRALSPSCIIRYEMYPFFEEPT-APISPPNKKSGSSNDSG--KKKTKESRTW 262
           +   G+Q       SC+ R+E++PF E  +   ++PP +              TK+    
Sbjct: 216 TCCNGKQGGIVYRASCVFRWELFPFSEAFSRISLAPPPQSPAFPTLPAVTNTATKKGSIT 275

Query: 263 IAIGAAASSIIVLALSCFLL-----WCMKRRKERVKEEKANSQETRSLHLADGRIGNDYS 317
           I+IG   + II   +  FL+     + + RR++  +    +   T SL            
Sbjct: 276 ISIGIVWAIIIPTVIVVFLVLLALGFVVYRRRKSYQGSSTDITITHSLQ----------- 324

Query: 318 YDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRL 377
                            F      +AT  FS+ N +G GGFG V+ G L +G E+A+KRL
Sbjct: 325 -----------------FDFKAIEDATNKFSESNIIGRGGFGEVFMGVL-NGTEVAIKRL 366

Query: 378 SRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR 437
           S+ S QG +EFKNEV ++AKL H+NLV+LLG CL+  E +L+YE++PNKSL+ FLFD T+
Sbjct: 367 SKASRQGAREFKNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFVPNKSLDYFLFDPTK 426

Query: 438 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
             QLDW +R +II GI RG+LYLH+DSRL IIHRDLK SN+LLD +MNPKI+DFGMARIF
Sbjct: 427 QGQLDWTKRYNIIRGITRGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIF 486

Query: 498 GGNQSEANTKRIVGT 512
           G +QS ANTK+I GT
Sbjct: 487 GIDQSGANTKKIAGT 501

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2

 Score =  333 bits (853), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 195/509 (38%), Positives = 275/509 (54%), Gaps = 40/509 (7%)

Query: 15  YLYHFCVRESNTSSLFMY--NVGTLFYGKLYNEGGRYL--YYNATEGDDPNKVYGLYHCY 70
           YL H C   +  SS   Y  N+ TL      +    Y   + N   G  P++V GL+ C 
Sbjct: 39  YLNHDCPNRTTYSSNSTYSTNLKTLL-SSFASRNASYSTGFQNIRAGQTPDRVTGLFLCR 97

Query: 71  FGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQV 130
             +S EVC NC+   +N  +T C   + A+ +Y++C+LR+S+ +F+ST+     +I+   
Sbjct: 98  GDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMRNP 157

Query: 131 TNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSK 190
            N +      +  +  +   +    +  +NS    +      +S+  ++ LVQC P L++
Sbjct: 158 NNISSIQNQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDLAR 217

Query: 191 SDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEPT-APISPPNKKSGSSN 249
            DC  CL  +++R+   +  R   R   PSC  RYE+Y F+ E      SPP    GS+ 
Sbjct: 218 QDCFSCLTSSINRMMPLF--RIGARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTP 275

Query: 250 D------SGKKKTKESRTWIAIGAAASSIIVLALSCFLLWCMKRRKERVKEEKANSQETR 303
                   GK           +  A    I L   CFL     +R ++  +  + S+   
Sbjct: 276 PLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVGYCFL----AQRTKKTFDTASASEVGD 331

Query: 304 SLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYK 363
            +  AD  +  DY                          AT  F++ NK+G GGFG VYK
Sbjct: 332 DMATADS-LQLDY---------------------RTIQTATNDFAESNKIGRGGFGEVYK 369

Query: 364 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM 423
           G  ++GKE+AVKRLS+ S QG  EFK EV ++AKLQH+NLVRLLG  LQ  E +L+YEYM
Sbjct: 370 GTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYM 429

Query: 424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE 483
           PNKSL+  LFD T+  QLDW +R +II GIARG+LYLH+DSRL IIHRDLK SN+LLD +
Sbjct: 430 PNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 489

Query: 484 MNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +NPKI+DFGMARIFG +Q++ NT RIVGT
Sbjct: 490 INPKIADFGMARIFGLDQTQDNTSRIVGT 518

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3

 Score =  330 bits (846), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 183/487 (37%), Positives = 270/487 (55%), Gaps = 60/487 (12%)

Query: 51  YYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRF 110
           ++N+  G  PN+V+    C  G   E C +CIK   + +  +C     A  W D CM+R+
Sbjct: 59  FFNSKFGQAPNRVFINGMCIPGTKPETCSDCIKGASDKISESCPNKTDAYTWPDCCMVRY 118

Query: 111 SNISFVSTLGLAPYVILSQV-------TNFTDPDKV-TNILVQSINDLIQNVTSRDSNSK 162
           SN+SF  +L + P   L          TN T  D++   +++++I     + ++  S  +
Sbjct: 119 SNVSFSGSLVMEPSETLYHTGDIEDTGTNLTVFDRIWEELMLRTITAASLSSSNGSSFGQ 178

Query: 163 YAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCI 222
              AA++ + ++   ++ ++QC P +S  DC  CL+ +V    S   G+Q    + PSC 
Sbjct: 179 KYFAAEVASLTTFQTMYAMMQCTPDVSSKDCEFCLKTSVGDYESCCRGKQGGAVIRPSCF 238

Query: 223 IRYEMYPF---FEEPT--------------APISPPNKKSGSSNDSGKKKTKESRTWIAI 265
           +R+++YP+   FE  T              + I PP     ++   G          + +
Sbjct: 239 VRWDLYPYAGAFENVTFPPPPPQSLPQPPVSLIPPPVSDRANTTIKGIIVAIVVPIIVIL 298

Query: 266 GAAASSIIVLALSCFLLWCMKRRKERVKEEKANSQETRSLHLADGRIGNDYSYDVLRGQK 325
            +    ++V         C +++  +  E +A  + T +  L        +S+  +    
Sbjct: 299 VSLVVLLVV---------CRRKKSYKTTEVQATDEITTTHSL-------QFSFKTIEA-- 340

Query: 326 QEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGL 385
                            AT  FSD N +G GGFG VY+GKL+ G E+AVKRLS+TSGQG 
Sbjct: 341 -----------------ATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGA 383

Query: 386 QEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKR 445
           +EFKNE  L++KLQHKNLVRLLG CL+  E +L+YE++PNKSL+ FLFD  +  +LDW R
Sbjct: 384 EEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTR 443

Query: 446 RISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           R +II GIARG+LYLH+DSRL IIHRDLK SN+LLD +MNPKI+DFGMARIFG +QS+AN
Sbjct: 444 RYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQAN 503

Query: 506 TKRIVGT 512
           T+RI GT
Sbjct: 504 TRRIAGT 510

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1

 Score =  328 bits (842), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 200/536 (37%), Positives = 280/536 (52%), Gaps = 72/536 (13%)

Query: 8   AAKLDSNYLYHFCVRESNTSSLFMYNVGTLFYGKLY---NEGGRYLYYNATEGDDPNKVY 64
           A+  D  YL H+C   +  SS   Y+             N      + NAT G  P++V 
Sbjct: 22  ASAQDPFYLNHYCPNTTTYSSNSTYSTNLRTLLSSLSSRNASYSTGFQNATAGKAPDRVT 81

Query: 65  GLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVST-LGLAP 123
           GL+ C   VS EVC+NC+   +N  +  C   + A+ +Y+QC+LR+S+ + +ST +    
Sbjct: 82  GLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYEQCILRYSHKNILSTAITNEG 141

Query: 124 YVILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQ 183
             ILS     +   K  +     ++  +     + +NS           ++   ++ L+Q
Sbjct: 142 EFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLYTVNTELTAYQNLYGLLQ 201

Query: 184 CIPYLSKSDCNICLRQTV-----SRISSRYYGRQSVRALSPSCIIRYEMYPFFEE----- 233
           C P L+++DC  CL+ ++     SRI +R Y         PSC  RYE+YPF+ E     
Sbjct: 202 CTPDLTRADCLSCLQSSINGMALSRIGARLYW--------PSCTARYELYPFYNESAIET 253

Query: 234 -----------------PTAPISPPNKKSGSSNDSGKKKTKESRTWIAIGAAASSIIVLA 276
                             T PIS       SS+  GK           +  A    I L 
Sbjct: 254 PPLPPPPPPPPPRESLVSTPPIS-------SSSLPGKSGNSTVLVVAVVVLAVLLFIALV 306

Query: 277 LSCFLLWCMKRRKERVKEEKANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFP 336
             CFL     ++K++  +  + S+    +  AD  +  DY                    
Sbjct: 307 GYCFL----AKKKKKTFDTASASEVGDDMATADS-LQLDY-------------------- 341

Query: 337 LHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIA 396
                 AT  F++ NK+G GGFG VYKG  ++GKE+AVKRLS+ S QG  EFK EV ++A
Sbjct: 342 -RTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVA 400

Query: 397 KLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARG 456
           KLQH+NLVRLLG  LQ  E +L+YEYMPNKSL+  LFD T+ +QLDW +R +II GIARG
Sbjct: 401 KLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQIQLDWMQRYNIIGGIARG 460

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +LYLH+DSRL IIHRDLK SN+LLD ++NPKI+DFGMARIFG +Q++ NT RIVGT
Sbjct: 461 ILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGT 516

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65472|CRK12_ARATH Putative cysteine-rich receptor-like protein kinase 12 OS=Arabidopsis thaliana GN=CRK12 PE=3 SV=2

 Score =  320 bits (820), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 200/496 (40%), Positives = 276/496 (55%), Gaps = 40/496 (8%)

Query: 44  NEGGRYLYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWY 103
           N    + ++N + G  PN+VY +  C  G   E C  C+ +  NTL+  C   + A+IW 
Sbjct: 50  NVTSHFGFFNGSIGQAPNRVYAVGMCLPGTEEESCIGCLLSASNTLLETCLTEENALIWI 109

Query: 104 DQ---CMLRFSNISFVSTLGLAPY----VILSQVTNFTDPDKVTNILVQSINDLIQNVTS 156
                CM+R+S+ SFV +  L P+     I    TN T+ + V + L Q    ++Q  +S
Sbjct: 110 ANRTICMIRYSDTSFVGSFELEPHREFLSIHGYKTNETEFNTVWSRLTQR---MVQEASS 166

Query: 157 RD----SNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQ 212
                 S +KY  A       S   ++ ++QC P LS ++CN+CL ++V    S   GRQ
Sbjct: 167 STDATWSGAKYYTADVAALPDS-QTLYAMMQCTPDLSPAECNLCLTESVVNYQSCCLGRQ 225

Query: 213 SVRALSPSCIIRYEMYPF---FEEPTA-PISPPNKKSGSSNDSGKKKTKESRTWIAIGAA 268
               +  SC  R E+YPF   F   TA P+S P        +   K    S+  + +   
Sbjct: 226 GGSIVRLSCAFRAELYPFGGAFTVMTARPLSQPPPSLIKKGEFFAKFMSNSQEPVKM--- 282

Query: 269 ASSIIVLALSCFLLWCMKRRKERVKEEKANSQETRSLHLADGRIGNDYSYDVLRGQKQEE 328
             ++ V+ L  + L   K   E +            + L    +        L  ++++ 
Sbjct: 283 IQNLYVVVLIFYFLDSGKFSTETIAAIVVPIIVVAIIFLVLLVLSR------LFARRRKS 336

Query: 329 SQEFPL-----FPLHL------AVE-ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKR 376
            QE  L       LH        +E AT++F+  NKLG+GGFG VYKG L +G E+AVKR
Sbjct: 337 YQEIDLDQSGITTLHFQQLDFKTIEVATENFAKTNKLGQGGFGEVYKGTLVNGTEVAVKR 396

Query: 377 LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDST 436
           LS+TS QG QEFKNEV L+AKLQH+NLV+LLG CL+  E +L+YE++PNKSL+ FLFD T
Sbjct: 397 LSKTSEQGAQEFKNEVVLVAKLQHRNLVKLLGYCLEPEEKILVYEFVPNKSLDYFLFDPT 456

Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
           +  QLDW +R +II GI RG+LYLH+DSRL IIHRDLK SN+LLD +M PKI+DFGMARI
Sbjct: 457 KQGQLDWTKRYNIIGGITRGILYLHQDSRLTIIHRDLKASNILLDADMIPKIADFGMARI 516

Query: 497 FGGNQSEANTKRIVGT 512
            G +QS ANTKRI GT
Sbjct: 517 SGIDQSVANTKRIAGT 532

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2

 Score =  320 bits (820), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 185/479 (38%), Positives = 260/479 (54%), Gaps = 40/479 (8%)

Query: 50  LYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQ---C 106
           LYYN + G  PN+VY +  C  G + E C +CIK      + NC     A  W  +   C
Sbjct: 61  LYYNGSIGQQPNRVYAIGMCIPGSTSEDCSDCIKKESEFFLKNCPNQTEAYSWPGEPTLC 120

Query: 107 MLRFSNISFVSTLGLAPYVILSQV----TNFTDPDKVTNILVQSINDLIQNVTSRDSNSK 162
            +R+SN SF  +  L P   L+      +N T+  K+   L+  +        S  S+S 
Sbjct: 121 YVRYSNTSFSGSADLNPRNWLTNTGDLDSNLTEFTKIWEGLMGRMISAASTAKSTPSSSD 180

Query: 163 YAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCI 222
              +A     + +  I+ L+QC P LS  DC  CLRQ+     S    ++    + PSC 
Sbjct: 181 NHYSADSAVLTPLLNIYALMQCTPDLSSGDCENCLRQSAIDYQSCCSQKRGGVVMRPSCF 240

Query: 223 IRYEMYPF---FEEPTAP------ISPPNKKSGSSNDSGKKKTKESRTWIAIGAAASSII 273
           +R+++Y +   F+  T             + +G  ++     +K     + +     ++I
Sbjct: 241 LRWDLYTYSNAFDNLTVASPPPEPPVTVPQPAGDQDNPTNNDSKGISAGVVVAITVPTVI 300

Query: 274 VLALSCFLLWCMKRRKERVKEEKANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFP 333
            + +   L + + RR++  +  K  S+       +D    +   YD     K  E+    
Sbjct: 301 AILILLVLGFVLFRRRKSYQRTKTESE-------SDISTTDSLVYDF----KTIEA---- 345

Query: 334 LFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVT 393
                    AT  FS  NKLGEGGFG VYKGKL++G ++AVKRLS+ SGQG +EF+NE  
Sbjct: 346 ---------ATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAV 396

Query: 394 LIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           L+ KLQH+NLVRLLG CL+  E +LIYE++ NKSL+ FLFD  +  QLDW RR  II GI
Sbjct: 397 LVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGI 456

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           ARG+LYLH+DSRLKIIHRDLK SN+LLD +MNPKI+DFG+A IFG  Q++ NT RI GT
Sbjct: 457 ARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGNTNRIAGT 515

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	512
359477817	670	PREDICTED: cysteine-rich receptor-like p	0.974	0.744	0.506	1e-134
147776074	815	hypothetical protein VITISV_005300 [Viti	0.914	0.574	0.519	1e-131
255555021	686	ATP binding protein, putative [Ricinus c	0.943	0.704	0.441	1e-118
224076400	666	predicted protein [Populus trichocarpa]	0.919	0.707	0.471	1e-116
359496581	666	PREDICTED: cysteine-rich receptor-like p	0.917	0.705	0.449	1e-109
359496705	1453	PREDICTED: uncharacterized protein LOC10	0.937	0.330	0.437	1e-108
359474717	663	PREDICTED: cysteine-rich receptor-like p	0.931	0.719	0.429	1e-107
255555035	671	ATP binding protein, putative [Ricinus c	0.917	0.700	0.436	1e-107
296088180	699	unnamed protein product [Vitis vinifera]	0.958	0.702	0.441	1e-106
359484020	662	PREDICTED: cysteine-rich receptor-like p	0.853	0.660	0.467	1e-106

>gi|359477817|ref|XP_003632027.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera]

 Score =  485 bits (1249), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 261/515 (50%), Positives = 332/515 (64%), Gaps = 16/515 (3%)

Query: 2   LQSSSAAAKLDSNYLYHFCVRESNTSSL-FMYNVGTLFYGKLYNEGGRYLYYNATEGDDP 60
           L  S   A     +LY FC   S+  S  F  N+G L    L NEGG   +    EG+DP
Sbjct: 17  LAWSQTPANYQPGFLYTFCNNNSHAGSTKFQSNLGALLSRSLNNEGGISSFSMVYEGEDP 76

Query: 61  NKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLG 120
           +KVYGL+ C   VS  +CQ+CI A    +V  C   K AIIWY++C LR+SN SF S L 
Sbjct: 77  DKVYGLFLCRPDVSKHICQSCIDAATLKIVQVCQHKKEAIIWYNECFLRYSNRSFFSNLE 136

Query: 121 LAPYVILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWT 180
           + P + +    N + PDK      Q + ++ QN+T++ ++S    A   V  S+   ++ 
Sbjct: 137 MKPTLYMWNTQNASAPDKFD----QKLGEMFQNLTAQATSSDDMYAIGQVEVSNFLNLYG 192

Query: 181 LVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPF--FEEPTAPI 238
           +VQC   L  S C  CL + V  I +   G+Q  R L+PSC IRYE+YPF   E+P    
Sbjct: 193 IVQCTRDLRMSYCRRCLDEVVGYIPNFMEGKQGGRVLAPSCYIRYEVYPFAAVEDPVVEA 252

Query: 239 SPPNKKSGSSNDSGKKKTKESRTWIAIGAAASSIIVLALSCFLLWCMKRRKERVKEEKAN 298
             P+  S S      +KTK    WIA G + S I+V+A   +  + ++RRK    EEK +
Sbjct: 253 QVPS--SISPRGRKGRKTK----WIATGTSLSGIVVVAFCVY--YVIRRRKGADPEEKES 304

Query: 299 SQETRSLHLADGRI-GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGG 357
             +   L L  GR+   DYS + L+G    +S+EFP+    +  EATQHFS++NKLGEGG
Sbjct: 305 KGDLCLLDLGGGRLDAEDYSSETLQGDMLAKSKEFPVIGFDIVYEATQHFSNDNKLGEGG 364

Query: 358 FGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL 417
           FGPVYKG L+DGKEIAVKRLS TSGQGLQEFKNEV LIAKLQH+NLVRLLGCCL+ NE L
Sbjct: 365 FGPVYKGTLSDGKEIAVKRLSSTSGQGLQEFKNEVILIAKLQHRNLVRLLGCCLEGNELL 424

Query: 418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
           LIYEYMPNKSL+ FLFDSTR ++LDWK R SIINGIARG+ YLHEDSRL+IIHRDLK SN
Sbjct: 425 LIYEYMPNKSLDFFLFDSTRGLELDWKTRFSIINGIARGISYLHEDSRLRIIHRDLKPSN 484

Query: 478 VLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +LLD +MNPKISDFG+ARIF G+++  NT +IVG+
Sbjct: 485 ILLDGDMNPKISDFGLARIFAGSENGTNTAKIVGS 519

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776074|emb|CAN65425.1| hypothetical protein VITISV_005300 [Vitis vinifera]

 Score =  475 bits (1223), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 251/483 (51%), Positives = 321/483 (66%), Gaps = 15/483 (3%)

Query: 33  NVGTLFYGKLYNEGGRYLYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTN 92
           N+G L    L NEGG   +    EG+DP+KVYGL+ C   VS  +CQ+CI A    +V  
Sbjct: 194 NLGALLSRSLNNEGGISSFSMVYEGEDPDKVYGLFLCRPDVSKHICQSCIDAATLKIVQV 253

Query: 93  CTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQVTNFTDPDKVTNILVQSINDLIQ 152
           C   K AIIWY++C LR+SN SF S L + P + +    N + PDK      Q + ++ Q
Sbjct: 254 CQHKKEAIIWYNECFLRYSNRSFFSNLEMKPTLYMWNRQNASAPDKFD----QKLGEMFQ 309

Query: 153 NVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQ 212
           N+T++ ++S    A   V  S+   ++ +VQC   L  S C  CL + V  I +   G++
Sbjct: 310 NLTAKATSSDGMYAIGQVEVSNFLNLYGIVQCTRDLRMSYCRQCLDEVVGYIPNFMEGKE 369

Query: 213 SVRALSPSCIIRYEMYPF--FEEPTAPISPPNKKSGSSNDSGKKKTKESRTWIAIGAAAS 270
             R L+PSC IRYE+YPF   E+P      P+  S S      +KTK    WIA G + S
Sbjct: 370 GGRVLAPSCYIRYEIYPFAAVEDPIVEAQVPS--SISPRGRKGRKTK----WIATGTSLS 423

Query: 271 SIIVLALSCFLLWCMKRRKERVKEEKANSQETRSLHLADGRI-GNDYSYDVLRGQKQEES 329
            I+V+A   +  + ++RRK    EEK +  +   L L  GR+   DYS + L+G    +S
Sbjct: 424 GIVVVAFCVY--YVIRRRKGADPEEKESKGDLCLLDLGGGRLDAEDYSSETLQGDMLAKS 481

Query: 330 QEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFK 389
           +EFP+    +  EATQHFS++NKLGEGGFGPVYKG L+DGKEIAVKRLSRTSGQGLQEFK
Sbjct: 482 KEFPVIGFDIVYEATQHFSNDNKLGEGGFGPVYKGTLSDGKEIAVKRLSRTSGQGLQEFK 541

Query: 390 NEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI 449
           NEV LIAKLQH+NLVRLLGCCL+ NE LLIYEYMPNKSL+ FLFDSTR ++LDWK R SI
Sbjct: 542 NEVILIAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDFFLFDSTRGLELDWKTRFSI 601

Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRI 509
           INGIARG+ YLHEDSRL+IIHRDLK SN+LLD +MNPKISDFG+ARIF G+++  NT +I
Sbjct: 602 INGIARGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISDFGLARIFAGSENGTNTAKI 661

Query: 510 VGT 512
           VG+
Sbjct: 662 VGS 664

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555021|ref|XP_002518548.1| ATP binding protein, putative [Ricinus communis] gi|223542393|gb|EEF43935.1| ATP binding protein, putative [Ricinus communis]

 Score =  432 bits (1112), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 237/537 (44%), Positives = 322/537 (59%), Gaps = 54/537 (10%)

Query: 8   AAKLDSNYLYHFCVRES--NTSSLFMYNVGTLFYGKLYNEGGR-YLYYNATEGDDPNKVY 64
           A++ + NY+YH C   +    +S +  N+  L      N   R   +Y+ +EG+  ++VY
Sbjct: 19  ASESEPNYIYHVCSNSTAFTRNSTYQNNLNRLLLSIRTNAINRPNGFYDTSEGEGEDRVY 78

Query: 65  GLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPY 124
           GL+ C   +S EVCQ+C+ +    +V  C   K AI+WYD+C+LR+SN +  S L L+P 
Sbjct: 79  GLFFCTADLSTEVCQDCVISATRDIVGRCPIEKTAIVWYDECILRYSNQTIYSILALSPG 138

Query: 125 VILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQC 184
           + +    N +D +  + +L  ++        +     K+A       AS   K++TL QC
Sbjct: 139 LYMWNAQNVSDQEGFSELLATTMIKTANQAAAPLGAIKFATLVANFTAS--QKLYTLAQC 196

Query: 185 IPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEPT--APISPPN 242
            P LS SD   CL   +S +     G++  R L PSC IRYE YPF+ E      +SP N
Sbjct: 197 TPDLSYSDSAQCLHTAISNLPLCCDGKRGGRILYPSCNIRYEFYPFYNETGFHREVSPFN 256

Query: 243 KKSGSSN---------------------------DSGKKKTKESRTWIAIGAAASSIIVL 275
             +                               + G + +K +RT +     A+ + +L
Sbjct: 257 NTTVVEGNPHSPILPPPPPPPIHPPAPMEKLGKVEKGGEGSKPTRTKVIASVTAAIVGIL 316

Query: 276 ALSCFLLWCMKRRKERVKEEKANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLF 335
             S F     +R+ ++                 +GR  ++YS + + G+   ++Q+FP+ 
Sbjct: 317 LFSSFFYITWRRKIQK-----------------EGRTRDEYSCENITGEM--DAQDFPMI 357

Query: 336 PLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLI 395
           P  +  EAT+HFSD+ KLGEGGFGPVYKG L DGKEIAVKRLSRTSGQGL EF NEVTLI
Sbjct: 358 PFDIIEEATEHFSDDAKLGEGGFGPVYKGTLPDGKEIAVKRLSRTSGQGLPEFMNEVTLI 417

Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
            KLQH+NLVRLLGCCL+++E LLIYEYMPNKSL+VFLFDS   V+LDW+RR+SII+GIAR
Sbjct: 418 FKLQHRNLVRLLGCCLEKSEKLLIYEYMPNKSLDVFLFDSHMGVRLDWQRRLSIISGIAR 477

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           GLLYLHEDSRL+IIHRDLK SN+LLD++MNPKISDFGMARIFGGN S++ T RIVGT
Sbjct: 478 GLLYLHEDSRLRIIHRDLKASNILLDYDMNPKISDFGMARIFGGNDSKS-TNRIVGT 533

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa]

 Score =  425 bits (1092), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 241/511 (47%), Positives = 314/511 (61%), Gaps = 40/511 (7%)

Query: 12  DSNYLYHFCVRESNTSSLFMYNVGTLFYGKLYNEGGRYL-YYNATEGDDPNKVYGLYHCY 70
           + NYL+HFC   + +++ +  N+ TL      N     + ++NA+ G +P+ VYGL+ C 
Sbjct: 34  NPNYLHHFCDDTTTSTTTYKDNLNTLLSSLASNATSNSIGFFNASAGLEPDDVYGLFFCR 93

Query: 71  FGVSIEVCQNCIKALINTLVTN-CTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQ 129
             +S +VCQNC+      +V   C   K A IWYD+C LR+SN    ST+   P   L  
Sbjct: 94  GDLSTDVCQNCVANATKDIVQRRCPTQKVAFIWYDECFLRYSNKIMFSTMERDPNYTLWN 153

Query: 130 VTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLS 189
             N          L+ +I   +    +  + +K   A +  N ++   ++ LVQC P LS
Sbjct: 154 PENVAVHADFNRELLNTIFTAVNRAANMPAGAKKFRATK-ANYTTEHYLYVLVQCTPDLS 212

Query: 190 KSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEE------PTAPISPPNK 243
             DC  CL    S +      ++  R L PSCI+ +E Y  + E        AP   P +
Sbjct: 213 SGDCEQCLLAAYSGLEICCNEKRGGRILFPSCIVNFETYINYNETYVESAALAPSPVPQE 272

Query: 244 KSGS-SNDSGKKKTKESRTWIAIGAAASSII-VLALSCFLLWCMKRRKERVKEEKANSQE 301
           K    + D G  K    +TWI IGA  S+I+ VL LS F  + M RRK+R          
Sbjct: 273 KHFCYAGDKGSSK----KTWIIIGATLSTIVGVLLLSSFA-YTMWRRKKR---------- 317

Query: 302 TRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPV 361
                       +D S +++ G+ +  SQ+  L  L + ++AT  +S+ENKLG+GGFGPV
Sbjct: 318 ------------DDCSNEIMYGEVK--SQDSFLIQLDIVLKATNQYSNENKLGQGGFGPV 363

Query: 362 YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE 421
           YKG + DGKEIAVKRLSRTSGQGL+EF NEV LIA+LQH+NLV+LLGCCL++NE LL+YE
Sbjct: 364 YKGVMEDGKEIAVKRLSRTSGQGLREFMNEVNLIARLQHRNLVKLLGCCLEKNEKLLVYE 423

Query: 422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD 481
           YMPNKSL+VFLFDS   VQLDW+RR+SIINGIARGLLYLHEDSRL+IIHRDLK SN+LLD
Sbjct: 424 YMPNKSLDVFLFDSAMRVQLDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKASNILLD 483

Query: 482 HEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +EMNPKISDFGMARIFGGN SEANT RIVGT
Sbjct: 484 YEMNPKISDFGMARIFGGNHSEANTNRIVGT 514

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496581|ref|XP_002270035.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera]

 Score =  401 bits (1031), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 227/505 (44%), Positives = 301/505 (59%), Gaps = 35/505 (6%)

Query: 16  LYHFCVRESN--TSSLFMYNVGTLFYGKLYNE---GGRYLYYNATEGDDPNKVYGLYHCY 70
           LY FC   SN   +S +  ++  L      +     GR  ++N T G  P+ VYGLY C 
Sbjct: 29  LYSFCTENSNYVPNSTYQSSLNVLLTSLSSDATILNGRK-FHNTTAGQAPDMVYGLYLCR 87

Query: 71  FGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQV 130
             V+  VCQ+C++     ++T C   K A+ WYDQCMLR+SN S  S +   P + +S  
Sbjct: 88  GDVTDAVCQDCVQTASQEILTKCPNRKEALSWYDQCMLRYSNRSIFSIMEERPMLTMSNS 147

Query: 131 TNFTDPDKVTNILVQSINDLIQNVTSRDSN-SKYAAAAQMVNASSIDKIWTLVQCIPYLS 189
            +  DPD+   I+ +++  LI+  T   S    +       NAS+  KI+ LVQC P LS
Sbjct: 148 LDMDDPDRFDQIVNKTMVGLIEKATHNSSERDMFETGEANFNAST--KIYGLVQCTPDLS 205

Query: 190 KSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFF-EEPTAPISPPNKKSGSS 248
            S+C+ CL    SRI++   G+Q  R L PSC  RYE+YPF+ +   A    P     S 
Sbjct: 206 GSNCSTCLENIFSRITNCCLGKQGARILVPSCNFRYELYPFYGDLAAATPPAPAPSPLSL 265

Query: 249 NDSGKKKTKESRTWIAI-GAAASSIIVLALSCFLLWCMKRRKERVKEEKANSQETRSLHL 307
                KK   S+  IAI    A S+++ ++ C+   C K +K+    E+           
Sbjct: 266 LSPPGKKGNSSQLLIAIIVPVAVSVVIFSILCYCFICRKAKKKYSSTEEE---------- 315

Query: 308 ADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLA 367
              ++ ND +          +S +F    L     AT +FSD+NK+GEGGFG VYKG L+
Sbjct: 316 ---KVENDIT--------TVQSLQFDFGTLE---AATNNFSDDNKIGEGGFGDVYKGTLS 361

Query: 368 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKS 427
            GKEIA+KRLSR+S QG  EFKNEV L+AKLQH+NLVRLLG CL+  E +L+YEY+PNKS
Sbjct: 362 SGKEIAIKRLSRSSAQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKS 421

Query: 428 LNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPK 487
           L+ FLFD  +  QLDW RR  II GIARG+LYLHEDS+LK+IHRDLK SNVLLD +MNPK
Sbjct: 422 LDCFLFDPDKQGQLDWSRRYKIIGGIARGILYLHEDSQLKVIHRDLKASNVLLDGDMNPK 481

Query: 488 ISDFGMARIFGGNQSEANTKRIVGT 512
           ISDFGMARIFGG+Q+  +TKR+VGT
Sbjct: 482 ISDFGMARIFGGDQTRGSTKRVVGT 506

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496705|ref|XP_003635307.1| PREDICTED: uncharacterized protein LOC100265431, partial [Vitis vinifera]

 Score =  399 bits (1025), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 222/508 (43%), Positives = 293/508 (57%), Gaps = 28/508 (5%)

Query: 18   HFCVRESNTSSLFMYNVG-----TLFYGKLYNEGGRYLYYNATEGDDPNKVYGLYHCYFG 72
            HF   +S+T+     N       T     L ++   Y +YN    D  N++Y LY C   
Sbjct: 662  HFMSDQSSTTGTSTDNANYENNLTALLDSLSSKASLYSFYN----DSANQIYSLYLCRGD 717

Query: 73   VSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQVTN 132
            V+   CQNC++     +   C  ++ AIIWYD+C LR+S+ +F      +PY +L    N
Sbjct: 718  VNATTCQNCVRTASQEVQQQCQSNRTAIIWYDECKLRYSSENFFGIAATSPYFLLWNTRN 777

Query: 133  FTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSD 192
             + PD+     +  I  L+    + ++      A  + NAS    I+  VQC   +S  +
Sbjct: 778  NSSPDERDVGGLAFIYTLVSKAPNSENMFGTDVAEAVNNASQ--NIYGSVQCTRDISNDE 835

Query: 193  CNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEPTAPISPPNKKSGSSN--- 249
            C  CL Q +  I     G+     + PSC +RYE Y F+++P AP +P ++     N   
Sbjct: 836  CRSCLLQQIEEIEGCCQGKIGWNIMGPSCNMRYEQYLFYQQPLAPSTPASQPMPDDNPVY 895

Query: 250  DSGKKKTKESRTWIAIGAAASSIIVLALSCFLLWCMKRRKERVKEEKANSQ-----ETRS 304
            +    K  ++ T IAI   ++      L  F L+C   R++R  EE  + +      T +
Sbjct: 896  NIVAGKGGKNTTDIAIITVSTVTGAAVLLGFYLYCSIFRRKREPEEHVSEEILLHYSTAA 955

Query: 305  LHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG 364
             H  +G I           + Q+ S E   F L   + AT +FSD NKLGEGGFGPVYKG
Sbjct: 956  THFMEGHI---------HARDQDNSGELHCFNLTTILTATNNFSDANKLGEGGFGPVYKG 1006

Query: 365  KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP 424
            KL +GKEIAVKRLSR SGQGL+EFKNEV LI KLQHKNLVRLLGCC++  E LL+YEYM 
Sbjct: 1007 KLLNGKEIAVKRLSRKSGQGLEEFKNEVMLIVKLQHKNLVRLLGCCIEREEKLLVYEYMA 1066

Query: 425  NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM 484
            N SL+ FLFD  +S QLDW +R +I+ GIARG+LYLHEDSRLKIIHRDLK SNVLLD EM
Sbjct: 1067 NTSLDAFLFDPIKSRQLDWAKRAAIVGGIARGILYLHEDSRLKIIHRDLKASNVLLDEEM 1126

Query: 485  NPKISDFGMARIFGGNQSEANTKRIVGT 512
            NPKISDFG ARIFG NQ +ANT ++VGT
Sbjct: 1127 NPKISDFGTARIFGSNQIDANTNKVVGT 1154

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359474717|ref|XP_002267916.2| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Vitis vinifera]

 Score =  395 bits (1014), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 221/514 (42%), Positives = 302/514 (58%), Gaps = 37/514 (7%)

Query: 8   AAKLDSNYLYHFCVRES--NTSSLFMYNVGTLFYGKLYNEGGRYLYYNATEGDDPNKV-Y 64
           A +    YLYH C   +  N +S +  N+         N      +YN T G  P  V Y
Sbjct: 17  ATESAPGYLYHICPNTTTFNPNSSYETNLNFALSSLSSNATRDTGFYNVTAGRTPPDVAY 76

Query: 65  GLYHCYFGVSIEVCQNCIKALIN-TLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAP 123
           GL+ C   V+ +VCQ+C+   +N T+   C G K AIIWYD+CMLR+SN SF S +  +P
Sbjct: 77  GLFLCRGDVTSQVCQDCVATAVNETVRQRCRGFKQAIIWYDECMLRYSNESFFSQVSESP 136

Query: 124 YVILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQ 183
            V +    N T+PD+   +L  +++ +     +  S  K+A   +  N +   ++++LVQ
Sbjct: 137 RVSMWNTQNITEPDQFNQVLGDTLDSIRTQAVNDQSGKKFATKEE--NFTGFQRVYSLVQ 194

Query: 184 CIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEPTAPISPPNK 243
           C P LS   C+ CL  T++ +     G+Q  R L PSC +RYE+YPF++   AP SPP  
Sbjct: 195 CTPDLSPDQCDRCLIGTIAILPDCCGGKQGARVLFPSCNVRYELYPFYQSVAAPPSPPPA 254

Query: 244 KSGSSNDSGKKKTKESRTWIAIGAAASSIIVLAL--SCFLLWCMKRRKERVKEEKANSQE 301
           +    +  GK         I +     S+++ ++   CF+  C K+R + ++ E      
Sbjct: 255 RPSEPSTEGKGGISSKTIVIIVVPTFVSVVIFSILCYCFIRRCAKKRYDTLEAENVEFNI 314

Query: 302 TRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPV 361
           T                        E+S +F L  +     AT +FSD NK+GEGGFG V
Sbjct: 315 T-----------------------TEQSLQFDLATIQ---AATNNFSDHNKIGEGGFGAV 348

Query: 362 YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE 421
           YKG L+ G+EIA+KRLS++SGQG  EFKNEV L+AKLQH+NLVRLLG CL+  E +L+YE
Sbjct: 349 YKGTLSSGQEIAIKRLSKSSGQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 408

Query: 422 YMPNKSLNVFLF---DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNV 478
           Y+PNKSL+ FLF     T+  QLDW RR  II GIARG+LYLHEDSRL++IHRDLK SNV
Sbjct: 409 YVPNKSLDYFLFGLAQPTKRGQLDWSRRYKIIGGIARGILYLHEDSRLRVIHRDLKASNV 468

Query: 479 LLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           LLD +MNPKISDFGMARIFG +Q++ NT R+VGT
Sbjct: 469 LLDGDMNPKISDFGMARIFGVDQTQGNTNRVVGT 502

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555035|ref|XP_002518555.1| ATP binding protein, putative [Ricinus communis] gi|223542400|gb|EEF43942.1| ATP binding protein, putative [Ricinus communis]

 Score =  394 bits (1011), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 223/511 (43%), Positives = 297/511 (58%), Gaps = 41/511 (8%)

Query: 15  YLYHFCVRESNTS-----SLFMYNVGTLFYGKLYNEGGRYLYYNATEGDDPNKVYGLYHC 69
           Y YHFC   SNT+     S +  N+  +      N      ++N   G  P+ VYG + C
Sbjct: 28  YRYHFC---SNTTTFTPNSTYQTNLNQVLSSLSNNANNSIGFFNIPSGQQPDDVYGSFLC 84

Query: 70  YFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQ 129
              VS +VCQ+C+      +V  C   K AI+WYDQC+LR+ N SF+ST+   P V LS 
Sbjct: 85  RGDVSTDVCQDCVTFATQDIVKRCPIEKVAIVWYDQCLLRYENQSFISTMDQTPGVFLSN 144

Query: 130 VTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLS 189
             + +DPD+  N+L  ++ +L  + +S  S  K  AA    N ++  K+++LVQC P LS
Sbjct: 145 TQDISDPDRFDNLLATTMENLATDASSAASGEKKFAATDD-NFTAFQKLYSLVQCTPDLS 203

Query: 190 KSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFFEEPTAPISPPNKKSGSS- 248
              C  CLR  +S + S   G++    L PSC +RYE+YPFF        PP+       
Sbjct: 204 NPGCRQCLRGAISNLPSCCGGKRGANVLYPSCNVRYEVYPFFNATAVEPPPPSPSPAVPP 263

Query: 249 ---NDSGKKKTKESRTWIA--IGAAASSIIVLALSCF-LLWCMKRRKERVKEEKANSQET 302
                SG +   E ++ I+  I  A  + + +A+  F L +C  RR+ R K         
Sbjct: 264 PPPTGSGTRPETEGQSGISTVIIVAIVAPVAIAIVLFSLAYCYLRRRPRKK--------- 314

Query: 303 RSLHLADGRIGNDYSYDVLRGQKQE-ESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPV 361
                          YD ++    E  + E     L+    AT  FS +NKLGEGGFG V
Sbjct: 315 ---------------YDAVQEDGNEITTVESLQIDLNTVEAATNKFSADNKLGEGGFGEV 359

Query: 362 YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE 421
           YKG L +G+EIAVK+LSR+SGQG QEFKNEV L+AKLQH+NLVRLLG CL+  E +L+YE
Sbjct: 360 YKGILPNGQEIAVKKLSRSSGQGAQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEKILVYE 419

Query: 422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD 481
           ++ NKSL+ FLFD  +  QLDW  R  I+ GIARG+LYLHEDS+L+I+HRDLK SN+LLD
Sbjct: 420 FVSNKSLDYFLFDPEKQRQLDWSTRYKIVGGIARGILYLHEDSQLRIVHRDLKVSNILLD 479

Query: 482 HEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             MNPKISDFG ARIFG +QS+ NTKRIVGT
Sbjct: 480 RNMNPKISDFGTARIFGVDQSQGNTKRIVGT 510

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296088180|emb|CBI35672.3| unnamed protein product [Vitis vinifera]

 Score =  392 bits (1008), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 228/517 (44%), Positives = 306/517 (59%), Gaps = 26/517 (5%)

Query: 16  LYHFCVRESN--TSSLFMYNVGTLFYGKLYNE---GGRYLYYNATEGDDPNKVYGLYHCY 70
           LY FC   SN   +S +  ++  L      +     GR  ++N T G  P+ VYGLY C 
Sbjct: 29  LYSFCTENSNYVPNSTYQSSLNVLLTSLSSDATILNGRK-FHNTTAGQAPDMVYGLYLCR 87

Query: 71  FGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISFVSTLGLAPYVILSQV 130
             V+  VCQ+C++     ++T C   K A+ WYDQCMLR+SN S  S +   P + +S  
Sbjct: 88  GDVTDAVCQDCVQTASQEILTKCPNRKEALSWYDQCMLRYSNRSIFSIMEERPMLTMSNS 147

Query: 131 TNFTDPDKVTNILVQSINDLIQNVTSRDSN-SKYAAAAQMVNASSIDKIWTLVQCIPYLS 189
            +  DPD+   I+ +++  LI+  T   S    +       NAS+  KI+ LVQC P LS
Sbjct: 148 LDMDDPDRFDQIVNKTMVGLIEKATHNSSERDMFETGEANFNAST--KIYGLVQCTPDLS 205

Query: 190 KSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYPFF-EEPTAPISPPNKKSGSS 248
            S+C+ CL    SRI++   G+Q  R L PSC  RYE+YPF+ +   A    P     S 
Sbjct: 206 GSNCSTCLENIFSRITNCCLGKQGARILVPSCNFRYELYPFYGDLAAATPPAPAPSPLSL 265

Query: 249 NDSGKKKTKESRTWIAIGAAASSIIVLALSCFLLWC-MKRRKERVKEEKANSQETRSLHL 307
                KK   S+  IAI    +  +++  S FL +C + R++  +     +   + +L +
Sbjct: 266 LSPPGKKGNSSQLLIAIIVPVAGTLII--SGFLCYCWLNRKRWNIFTNNYHHSYSNNLSV 323

Query: 308 ADGRIGNDYSYDVLRGQK-----QEESQEFPL-------FPLHLAVEATQHFSDENKLGE 355
               I   Y +   + +K     +EE  E  +       F       AT +FSD+NK+GE
Sbjct: 324 VIFSILC-YCFICRKAKKKYSSTEEEKVENDITTVQSLQFDFGTLEAATNNFSDDNKIGE 382

Query: 356 GGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE 415
           GGFG VYKG L+ GKEIA+KRLSR+S QG  EFKNEV L+AKLQH+NLVRLLG CL+  E
Sbjct: 383 GGFGDVYKGTLSSGKEIAIKRLSRSSAQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 442

Query: 416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKT 475
            +L+YEY+PNKSL+ FLFD  +  QLDW RR  II GIARG+LYLHEDS+LK+IHRDLK 
Sbjct: 443 KILVYEYVPNKSLDCFLFDPDKQGQLDWSRRYKIIGGIARGILYLHEDSQLKVIHRDLKA 502

Query: 476 SNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           SNVLLD +MNPKISDFGMARIFGG+Q+  +TKR+VGT
Sbjct: 503 SNVLLDGDMNPKISDFGMARIFGGDQTRGSTKRVVGT 539

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484020|ref|XP_002273323.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera]

 Score =  391 bits (1005), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 219/468 (46%), Positives = 279/468 (59%), Gaps = 31/468 (6%)

Query: 51  YYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRF 110
           ++N T G  P+ VYGLY C   V+  VCQNC++     ++T C   K  I WYDQCM R+
Sbjct: 68  FHNQTAGQAPDMVYGLYLCRGDVTDAVCQNCVQTASQEILTKCPNRKEVISWYDQCMFRY 127

Query: 111 SNISFVSTLGLAPYVILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSN-SKYAAAAQM 169
           SN S  S +   P V  S      DPD+   I+ +++  +I+  T   S    +      
Sbjct: 128 SNRSIFSIMEERPSVTGSNELEMEDPDRFDQIVNETMVGMIEKATYNSSERDMFETGEAK 187

Query: 170 VNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQSVRALSPSCIIRYEMYP 229
            NAS+  KI+ L QC P LS SDC  CL    SRI +  YG+Q  R L PSC  RYE+YP
Sbjct: 188 FNAST--KIYGLAQCTPDLSGSDCRRCLENIFSRIPNCCYGKQGARILGPSCNFRYEVYP 245

Query: 230 FFEE-----PTAPISPPNKKSGSSNDSGKKKTKESRTWIAIGAAASSIIVLALSCFLLWC 284
           F+ +     P AP       + ++++S  KK   SR  I I       +++    FL  C
Sbjct: 246 FYGDFAAAAPLAPSPLSPPGNNTASESKGKKGNSSRLLIVIIVPVVGTVIIF--GFLYSC 303

Query: 285 MKRRKERVKEEKANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEAT 344
              RK R     A  ++++S+         D + D L            LF L     AT
Sbjct: 304 WLNRKMRKSTPSAFGEDSQSM---------DSTMDSL------------LFDLKTLRAAT 342

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
            +FSD NK+GEGGFG VYKG L+ G EIA+KRLSR SGQG +EFKNE+ L+AKLQH+NLV
Sbjct: 343 NNFSDANKIGEGGFGAVYKGLLSSGLEIAIKRLSRNSGQGTEEFKNEIALLAKLQHRNLV 402

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           RLLG CL+  E +L+YE++PNKSL+ FLFD+ +  QLDW  R  II GIARGLLYLHE+S
Sbjct: 403 RLLGFCLEAKEKILVYEFVPNKSLDYFLFDTDKQSQLDWPTRHKIIVGIARGLLYLHEES 462

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RLKIIHRDLK SN+LLD ++NPKISDFGMARIF   QS+ANT RIVGT
Sbjct: 463 RLKIIHRDLKASNILLDSKLNPKISDFGMARIFFMEQSQANTTRIVGT 510

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	512
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.332	0.254	0.694	6.1e-95
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.337	0.256	0.660	2.1e-94
TAIR|locus:2121626	830	CRK23 "cysteine-rich RLK (RECE	0.347	0.214	0.646	3.9e-89
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.337	0.268	0.666	1.5e-87
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.332	0.254	0.688	8.1e-87
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.332	0.251	0.664	2.1e-86
TAIR|locus:2121636	659	CRK7 "cysteine-rich RLK (RECEP	0.332	0.257	0.641	1.1e-82
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.337	0.255	0.660	7.4e-82
TAIR|locus:2121691	667	CRK11 "cysteine-rich RLK (RECE	0.332	0.254	0.670	3.2e-81
TAIR|locus:2141762	665	CRK26 "cysteine-rich RLK (RECE	0.347	0.267	0.603	3.2e-81

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 626 (225.4 bits), Expect = 6.1e-95, Sum P(2) = 6.1e-95
 Identities = 118/170 (69%), Positives = 140/170 (82%)

Query:   343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
             AT  F + NK+G+GGFG VYKG L+DG E+AVKRLS++SGQG  EFKNEV L+AKLQH+N
Sbjct:   344 ATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRN 403

Query:   403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
             LVRLLG CL   E +L+YEY+PNKSL+ FLFD  +  QLDW RR  II G+ARG+LYLH+
Sbjct:   404 LVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQ 463

Query:   463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             DSRL IIHRDLK SN+LLD +MNPKI+DFGMARIFG +Q+E NT RIVGT
Sbjct:   464 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGT 513

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 604 (217.7 bits), Expect = 2.1e-94, Sum P(2) = 2.1e-94
 Identities = 115/174 (66%), Positives = 142/174 (81%)

Query:   340 AVEA-TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL 398
             A+EA T  FS+ NKLG GGFG VYKG+L  G+ +A+KRLS+ S QG +EFKNEV ++AKL
Sbjct:   339 AIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKL 398

Query:   399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
             QH+NL +LLG CL   E +L+YE++PNKSL+ FLFD+ +   LDW+RR  II GIARG+L
Sbjct:   399 QHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGIL 458

Query:   459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             YLH DSRL IIHRDLK SN+LLD +M+PKISDFGMARIFG +Q++ANTKRIVGT
Sbjct:   459 YLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGT 512

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 611 (220.1 bits), Expect = 3.9e-89, Sum P(2) = 3.9e-89
 Identities = 115/178 (64%), Positives = 142/178 (79%)

Query:   335 FPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTL 394
             F     V AT +F   NKLG+GGFG VYKG    G ++AVKRLS+TSGQG +EF+NEV +
Sbjct:   496 FDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGEREFENEVVV 555

Query:   395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIA 454
             +AKLQH+NLVRLLG CL+  E +L+YE++ NKSL+ FLFD+T   QLDW RR  II GIA
Sbjct:   556 VAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRRYKIIGGIA 615

Query:   455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             RG+LYLH+DSRL IIHRDLK  N+LLD +MNPK++DFGMARIFG +Q+EANT+R+VGT
Sbjct:   616 RGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVGT 673

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 612 (220.5 bits), Expect = 1.5e-87, Sum P(2) = 1.5e-87
 Identities = 116/174 (66%), Positives = 145/174 (83%)

Query:   340 AVEA-TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL 398
             A+EA T  F   NKLG+GGFG VYKG L+ G ++AVKRLS+TSGQG +EF+NEV ++AKL
Sbjct:   318 AIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKL 377

Query:   399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
             QH+NLV+LLG CL+  E +L+YE++PNKSL+ FLFDST  ++LDW RR  II GIARG+L
Sbjct:   378 QHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGIL 437

Query:   459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             YLH+DSRL IIHRDLK  N+LLD +MNPKI+DFGMARIFG +Q+EA T+R+VGT
Sbjct:   438 YLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGT 491

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 634 (228.2 bits), Expect = 8.1e-87, Sum P(2) = 8.1e-87
 Identities = 117/170 (68%), Positives = 142/170 (83%)

Query:   343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
             AT  FSD N +G GGFG VY+GKL+ G E+AVKRLS+TSGQG +EFKNE  L++KLQHKN
Sbjct:   341 ATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKN 400

Query:   403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
             LVRLLG CL+  E +L+YE++PNKSL+ FLFD  +  +LDW RR +II GIARG+LYLH+
Sbjct:   401 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQ 460

Query:   463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             DSRL IIHRDLK SN+LLD +MNPKI+DFGMARIFG +QS+ANT+RI GT
Sbjct:   461 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGT 510

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 599 (215.9 bits), Expect = 2.1e-86, Sum P(2) = 2.1e-86
 Identities = 113/170 (66%), Positives = 138/170 (81%)

Query:   343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
             AT  F++ NK+G GGFG VYKG  ++GKE+AVKRLS+ S QG  EFK EV ++AKLQH+N
Sbjct:   349 ATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRN 408

Query:   403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
             LVRLLG  LQ  E +L+YEYMPNKSL+  LFD T+  QLDW +R +II GIARG+LYLH+
Sbjct:   409 LVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQ 468

Query:   463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             DSRL IIHRDLK SN+LLD ++NPKI+DFGMARIFG +Q++ NT RIVGT
Sbjct:   469 DSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGT 518

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 574 (207.1 bits), Expect = 1.1e-82, Sum P(2) = 1.1e-82
 Identities = 109/170 (64%), Positives = 135/170 (79%)

Query:   343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
             AT  FS+ NK+G GGFG VYKG  ++G E+AVKRLS+TS QG  EFKNEV ++A L+HKN
Sbjct:   332 ATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKN 391

Query:   403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
             LVR+LG  ++  E +L+YEY+ NKSL+ FLFD  +  QL W +R  II GIARG+LYLH+
Sbjct:   392 LVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQ 451

Query:   463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             DSRL IIHRDLK SN+LLD +MNPKI+DFGMARIFG +Q++ NT RIVGT
Sbjct:   452 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIVGT 501

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 602 (217.0 bits), Expect = 7.4e-82, Sum P(2) = 7.4e-82
 Identities = 115/174 (66%), Positives = 141/174 (81%)

Query:   340 AVEA-TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL 398
             A+EA T  F + NKLG+GGFG VYKG    G ++AVKRLS+TSGQG +EF NEV ++AKL
Sbjct:   343 AIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKL 402

Query:   399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
             QH+NLVRLLG CL+ +E +L+YE++PNKSL+ F+FDST    LDW RR  II GIARG+L
Sbjct:   403 QHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGIL 462

Query:   459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             YLH+DSRL IIHRDLK  N+LL  +MN KI+DFGMARIFG +Q+EANT+RIVGT
Sbjct:   463 YLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGT 516

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 610 (219.8 bits), Expect = 3.2e-81, Sum P(2) = 3.2e-81
 Identities = 114/170 (67%), Positives = 137/170 (80%)

Query:   343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
             AT  FS  NKLGEGGFG VYKGKL++G ++AVKRLS+ SGQG +EF+NE  L+ KLQH+N
Sbjct:   346 ATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRN 405

Query:   403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
             LVRLLG CL+  E +LIYE++ NKSL+ FLFD  +  QLDW RR  II GIARG+LYLH+
Sbjct:   406 LVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQ 465

Query:   463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             DSRLKIIHRDLK SN+LLD +MNPKI+DFG+A IFG  Q++ NT RI GT
Sbjct:   466 DSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGNTNRIAGT 515

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEP;RCA

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IEP

GO:0016020 "membrane" evidence=ISS

GO:0009611 "response to wounding" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 560 (202.2 bits), Expect = 3.2e-81, Sum P(2) = 3.2e-81
 Identities = 108/179 (60%), Positives = 139/179 (77%)

Query:   335 FPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTL 394
             F   +  +AT HFS ENKLGEGGFG VYKG L+DG++IAVKRLS+ + QG  EFKNE  L
Sbjct:   332 FDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQGETEFKNEFLL 391

Query:   395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIA 454
             +AKLQH+NLV+LLG  ++  E LL+YE++P+ SL+ F+FD  +  +L+W+ R  II G+A
Sbjct:   392 VAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEIRYKIIGGVA 451

Query:   455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSEANTKRIVGT 512
             RGLLYLH+DSRL+IIHRDLK SN+LLD EM PKI+DFGMAR+F   + ++  T RIVGT
Sbjct:   452 RGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQRYTNRIVGT 510

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00020409001 SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (654 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	512
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-41
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-41
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-39
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-38
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-34
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-21
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-20
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-20
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-20
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-20
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	9e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-18
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-17
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-15
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-14
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	8e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-11
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-10
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	3e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	9e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	0.001
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	0.001
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	0.001
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.002
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	0.002
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.004
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.004
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	0.004

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  149 bits (379), Expect = 1e-41
 Identities = 61/152 (40%), Positives = 80/152 (52%), Gaps = 10/152 (6%)

Query: 350 ENKLGEGGFGPVYKGKLADGK-----EIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNL 403
             KLGEG FG VYKG L         E+AVK L    S Q ++EF  E  ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           V+LLG C +E   +++ EYMP   L  +L    R  +L     +S    IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                IHRDL   N L+   +  KISDFG++R
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  149 bits (378), Expect = 2e-41
 Identities = 60/152 (39%), Positives = 78/152 (51%), Gaps = 11/152 (7%)

Query: 350 ENKLGEGGFGPVYKGKLADGK-----EIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNL 403
             KLGEG FG VYKGKL         E+AVK L    S Q ++EF  E  ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           V+LLG C +E    ++ EYM    L  +L       +L     +S    IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                IHRDL   N L+   +  KISDFG++R
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  142 bits (360), Expect = 1e-39
 Identities = 61/163 (37%), Positives = 87/163 (53%), Gaps = 10/163 (6%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           LGEGGFG VY  +    GK++A+K + +  S   L+E   E+ ++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
             EN   L+ EY    SL   L +     +L     + I+  I  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 471 RDLKTSNVLLDH-EMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RDLK  N+LLD      K++DFG++++   ++S   T  IVGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGT 156

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  142 bits (361), Expect = 3e-39
 Identities = 60/164 (36%), Positives = 78/164 (47%), Gaps = 11/164 (6%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           KLG G FG VYK K    GK +AVK L       +  Q  + E+ ++ +L H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
               ++   L+ EY     L  +L        L       I   I RGL YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHS---NGI 119

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           IHRDLK  N+LLD     KI+DFG+A+    + S   T   VGT
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGT 161

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  142 bits (360), Expect = 6e-39
 Identities = 62/156 (39%), Positives = 81/156 (51%), Gaps = 14/156 (8%)

Query: 351 NKLGEGGFGPVYKGKLADGK----EIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
            KLGEG FG VYKGKL        E+AVK L    S +  ++F  E  ++ KL H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFL------FDSTRSVQLDWKRRISIINGIARGLLY 459
           LLG C +E    L+ EYM    L  +L      F S     L  K  +S    IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L      K +HRDL   N L+  ++  KISDFG++R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  140 bits (356), Expect = 2e-38
 Identities = 58/150 (38%), Positives = 77/150 (51%), Gaps = 11/150 (7%)

Query: 352 KLGEGGFGPVYKGKLADGKE-----IAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVR 405
           KLGEG FG VYKG L    E     +AVK L    S +  +EF  E +++ KL H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           LLG C Q     ++ EYMP   L  FL      + L     + +   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDL--LQMALQIAKGMEYLES--- 120

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +HRDL   N L+   +  KISDFG++R
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR 150

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  129 bits (327), Expect = 2e-34
 Identities = 54/168 (32%), Positives = 80/168 (47%), Gaps = 11/168 (6%)

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLV 404
           +    KLGEG FG VY  +    GK +A+K + +   +  +E    E+ ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           RL      E++  L+ EY     L   L      +  D  R    +  I   L YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEAR--FYLRQILSALEYLHS-- 115

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
              I+HRDLK  N+LLD + + K++DFG+AR     +        VGT
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGT 159

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  118 bits (297), Expect = 4e-30
 Identities = 58/178 (32%), Positives = 84/178 (47%), Gaps = 33/178 (18%)

Query: 351 NKLGEGGFGPVYKGKLAD-GKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
             LG G FG VY     D G+ +AVK   LS  S + L+  + E+ +++ LQH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 408 GCCLQ-ENESLLIY-EYMPNKSLNVFL--FDS---------TRSVQLDWKRRISIINGIA 454
           G     E  +L I+ EY+   SL+  L  F           TR               I 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--------------IL 111

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            GL YLH      I+HRD+K +N+L+D +   K++DFG A+  G  ++   T  + GT
Sbjct: 112 EGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  112 bits (281), Expect = 9e-28
 Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 13/154 (8%)

Query: 351 NKLGEGGFGPVYKGKL-----ADGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLV 404
            +LGEG FG V   +        G+++AVK L+ +   Q   +F+ E+ ++  L H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 405 RLLGCC--LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           +  G C         LI EY+P+ SL  +L       Q++ KR +   + I +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
               + IHRDL   N+L++ E   KISDFG+A++
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  110 bits (278), Expect = 1e-27
 Identities = 51/169 (30%), Positives = 88/169 (52%), Gaps = 11/169 (6%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
            F    K+G+GGFG VYK +    GKE+A+K +   S +  ++  NE+ ++ K +H N+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS-IINGIARGLLYLHED 463
           +  G  L+++E  ++ E+    SL   L  + +++       I+ +   + +GL YLH  
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ---IAYVCKELLKGLEYLHS- 116

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
               IIHRD+K +N+LL  +   K+ DFG++              +VGT
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGT 160

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  104 bits (262), Expect = 4e-25
 Identities = 52/175 (29%), Positives = 86/175 (49%), Gaps = 19/175 (10%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
            + + +  K+GEG  G VYK    A GKE+A+K++ R   Q  +   NE+ ++   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPN 76

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSL----NVFLFDSTRSVQLDWKRRIS-IINGIARGL 457
           +V      L  +E  ++ EYM   SL                     +I+ +   + +GL
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-------QIAYVCREVLQGL 129

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            YLH      +IHRD+K+ N+LL  + + K++DFG A      +S+ N+  +VGT
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  104 bits (260), Expect = 5e-25
 Identities = 51/161 (31%), Positives = 83/161 (51%), Gaps = 21/161 (13%)

Query: 353 LGEGGFGPVYKGKLADGKE------IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVR 405
           LGEG FG V+ G+    +       +AVK L  T+    ++ F+ E  L+   QH+N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLF----DSTRSV-------QLDWKRRISIINGIA 454
             G C + +  ++++EYM +  LN FL     D+           +L   + + I   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            G++YL   +    +HRDL T N L+ +++  KI DFGM+R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 1e-24
 Identities = 51/143 (35%), Positives = 78/143 (54%), Gaps = 6/143 (4%)

Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ 412
           +G+G FG V  G    G+++AVK L   S    Q F  E +++  L+H NLV+LLG  LQ
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 413 ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRD 472
            N   ++ EYM   SL  +L    R+V +   +++     +  G+ YL E      +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 473 LKTSNVLLDHEMNPKISDFGMAR 495
           L   NVL+  ++  K+SDFG+A+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 1e-24
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 27/178 (15%)

Query: 346 HFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKN 402
           ++   + +G G FG VYKG  L  G  +A+K++S      + L+    E+ L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR--------ISIINGIA 454
           +V+ +G     +   +I EY  N SL        R +    K+            +  + 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSL--------RQII---KKFGPFPESLVAVYVYQVL 109

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +GL YLHE     +IHRD+K +N+L   +   K++DFG+A        +  +  +VGT
Sbjct: 110 QGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  102 bits (257), Expect = 1e-24
 Identities = 63/185 (34%), Positives = 90/185 (48%), Gaps = 33/185 (17%)

Query: 331 EFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKE------IAVKRLSRT-SGQ 383
           E PL        +   F +E  LGEG FG VYKG+L    E      +A+K L      +
Sbjct: 1   EIPL--------SAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK 50

Query: 384 GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLF---------- 433
             QEF+ E  L++ LQH N+V LLG C +E  + +++EY+ +  L+ FL           
Sbjct: 51  VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGA 110

Query: 434 -DSTRSVQ--LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD 490
                +V+  LD    + I   IA G+ YL   S    +HRDL   N L+   +  KISD
Sbjct: 111 ESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISD 167

Query: 491 FGMAR 495
           FG++R
Sbjct: 168 FGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  101 bits (253), Expect = 4e-24
 Identities = 51/150 (34%), Positives = 76/150 (50%), Gaps = 4/150 (2%)

Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           F+ E KLG G FG V++G   +   +A+K L        Q+F+ EV  + +L+HK+L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
              C       +I E M   SL  FL      V L     I +   +A G+ YL E    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
             IHRDL   N+L+  ++  K++DFG+AR+
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL 153

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 8e-24
 Identities = 50/164 (30%), Positives = 87/164 (53%), Gaps = 27/164 (16%)

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKR---------LSRTSGQGLQEFKNEVTLIA 396
           +    KLGEG +G VYK +    G+ +A+K+         +  T+   L+E    ++L+ 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA---LRE----ISLLK 53

Query: 397 KLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS--IINGIA 454
           +L+H N+V+LL     E +  L++EY  +  L  +L      +  +  + I   ++ G+A
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
               Y H  S  +I+HRDLK  N+L++ +   K++DFG+AR FG
Sbjct: 113 ----YCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFG 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.7 bits (244), Expect = 6e-23
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 10/167 (5%)

Query: 347 FSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           F    KLGEG +G VYK      G+ +A+K +       LQE   E++++ +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
             G   +  +  ++ EY    S++  +     +  L  +   +I+    +GL YLH    
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLH---S 117

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            K IHRD+K  N+LL+ E   K++DFG++       ++ NT  ++GT
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 95.3 bits (238), Expect = 4e-22
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 23/173 (13%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
            ++G+G FG VY  +  +DGK   +K   LS  S +  ++  NEV ++ KL H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 408 GCCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQ-------LDWKRRISIINGIARGLLY 459
               +E   L I  EY     L+  +    +  +       LDW  ++ +       L Y
Sbjct: 66  ES-FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL------ALKY 118

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           LH     KI+HRD+K  N+ L      K+ DFG++++       A T  +VGT
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 95.3 bits (238), Expect = 6e-22
 Identities = 49/167 (29%), Positives = 87/167 (52%), Gaps = 15/167 (8%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEF----KNEVTLIAKLQHKNLVR 405
            ++GEG +G VYK +    G+ +A+K++ R      + F      E+ L+ KL+H N+VR
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI-RME-NEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 406 LLGCCL--QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           L        +    +++EYM +  L   L   +  V+    +    +  +  GL YLH +
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH-DLTGLL--DSPEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIV 510
               I+HRD+K SN+L++++   K++DFG+AR +    S   T R++
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 56/164 (34%), Positives = 78/164 (47%), Gaps = 24/164 (14%)

Query: 351 NKLGEGGFGPVYKG--KLADGKEI--AVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVR 405
            +LG G FG V KG   +  GKE+  AVK L +     G +EF  E +++A+L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIIN------GIARGLLY 459
           L+G C  E   +L+ E  P   L  +L           +R I + +       +A G+ Y
Sbjct: 61  LIGVCKGE-PLMLVMELAPLGPLLKYLKK---------RREIPVSDLKELAHQVAMGMAY 110

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           L        +HRDL   NVLL +    KISDFGM+R  G     
Sbjct: 111 LESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 53/163 (32%), Positives = 86/163 (52%), Gaps = 10/163 (6%)

Query: 350 ENKLGEGGFGPVYKG--KLADGKEI--AVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLV 404
           E  +G G FG V +G  KL   KEI  A+K L   S    + +F  E +++ +  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           RL G   +    ++I EYM N SL+ FL       +    + + ++ GIA G+ YL   S
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---S 123

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            +  +HRDL   N+L++  +  K+SDFG++R    +++   TK
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 53/145 (36%), Positives = 79/145 (54%), Gaps = 6/145 (4%)

Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+G+G FG VYKG L    E+AVK    T    L ++F  E  ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           +Q+    ++ E +P  SL  FL    +  +L  K+ + +    A G+ YL  +S+   IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 471 RDLKTSNVLLDHEMNPKISDFGMAR 495
           RDL   N L+      KISDFGM+R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 51/155 (32%), Positives = 76/155 (49%), Gaps = 5/155 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG G FG V+ G      ++AVK L +      + F  E  ++ KL+H  LV+L   
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
           C +E    ++ EYM   SL  FL       +L   + + +   IA G+ YL        I
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           HRDL   N+L+   +  KI+DFG+AR+   ++  A
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 93.1 bits (231), Expect = 4e-21
 Identities = 56/162 (34%), Positives = 82/162 (50%), Gaps = 21/162 (12%)

Query: 352 KLGEGGFGPVYKGKLA------DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           +LGEG FG V+  +        D   +AVK L   S    Q+F+ E  L+  LQH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFL---------FDSTRSV---QLDWKRRISIINGI 453
             G C +    L+++EYM +  LN FL               V   QL   + ++I + I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           A G++YL   + L  +HRDL T N L+   +  KI DFGM+R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 51/160 (31%), Positives = 89/160 (55%), Gaps = 16/160 (10%)

Query: 346 HFSDENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQH 400
           H + +  +G G FG V++G  K+   KE+AV   +   G   +  Q+F +E +++ +  H
Sbjct: 6   HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDST---RSVQLDWKRRISIINGIARGL 457
            N++RL G   +   +++I EYM N +L+ +L D      S QL     + ++ GIA G+
Sbjct: 66  HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGM 120

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            YL   S +  +HRDL   N+L++  +  K+SDFG++R+ 
Sbjct: 121 KYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 55/155 (35%), Positives = 81/155 (52%), Gaps = 6/155 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
             KLG G FG V+ G      ++A+K L + S    + F  E  L+ +LQH  LVRL   
Sbjct: 11  VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
             QE    +I EYM N SL  FL  +   ++L   + I +   IA G+ ++    R   I
Sbjct: 70  VTQE-PIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYI 124

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           HRDL+ +N+L+   +  KI+DFG+AR+   N+  A
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 53/161 (32%), Positives = 88/161 (54%), Gaps = 20/161 (12%)

Query: 353 LGEGGFGPVYKGK-LADGK----EIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRL 406
           LG G FG VYKG  + +G+     +A+K L   +  +  +E  +E  ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARGLLYLHE 462
           LG CL   +  LI + MP   L  ++ +   ++     L+W  +I      A+G+ YL E
Sbjct: 75  LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL-E 126

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + RL  +HRDL   NVL+    + KI+DFG+A++   ++ E
Sbjct: 127 EKRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 92.5 bits (228), Expect = 2e-20
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 10/166 (6%)

Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQH-KNLVRLL 407
           KLGEG FG VY  +  D K +A+K L++      + ++ F  E+ ++A L H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
                E    L+ EY+   SL   L    R   L     + I+  I   L YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121

Query: 468 IIHRDLKTSNVLLDHEMN-PKISDFGMARIFGGNQSEANTKRIVGT 512
           IIHRD+K  N+LLD +    K+ DFG+A++     S ++   +  T
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167

Length = 384

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 54/156 (34%), Positives = 94/156 (60%), Gaps = 9/156 (5%)

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTS-GQGLQEFK-NEVTLIAKLQHKNL 403
           ++   K+GEG +G VYKG+    G+ +A+K++   S  +G+      E++L+ +LQH N+
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHE 462
           V L    +QE+   LI+E++ +  L  +L DS    Q +D +   S +  I +G+L+ H 
Sbjct: 62  VCLQDVLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCH- 118

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
               +++HRDLK  N+L+D++   K++DFG+AR FG
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 53/150 (35%), Positives = 89/150 (59%), Gaps = 8/150 (5%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHKNLVRLLG 408
           K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H N+VRLL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
               EN+  L++E++ +  L  ++ DS+    LD     S +  + +G+ Y H  S  ++
Sbjct: 66  VVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-RV 120

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +HRDLK  N+L+D E   K++DFG+AR FG
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 89.7 bits (222), Expect = 8e-20
 Identities = 57/163 (34%), Positives = 90/163 (55%), Gaps = 20/163 (12%)

Query: 353 LGEGGFGPVYKGKLADGKE-----IAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRL 406
           LG G FG VYKG      E     +A+K L+ T+G +   EF +E  ++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARGLLYLHE 462
           LG CL     L + + MP+  L  ++ +   ++     L+W  +I      A+G++YL E
Sbjct: 75  LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
               +++HRDL   NVL+    + KI+DFG+AR+  G++ E N
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 84.0 bits (208), Expect = 9e-20
 Identities = 30/107 (28%), Positives = 46/107 (42%), Gaps = 9/107 (8%)

Query: 17  YHFCVRESNTS-----SLFMYNVGTLFYGKLYNE---GGRYLYYNATEGDDPNKVYGLYH 68
           +H C   ++ +     S F  N+  L    L +         +   T G  P+ VYGL  
Sbjct: 1   FHLCSSNTSGNYTTANSTFESNLNALL-SSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQ 59

Query: 69  CYFGVSIEVCQNCIKALINTLVTNCTGSKGAIIWYDQCMLRFSNISF 115
           C   +S   C++C+   ++ L   C   KG  IWYD C LR+ +  F
Sbjct: 60  CRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 55/152 (36%), Positives = 84/152 (55%), Gaps = 18/152 (11%)

Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLS-----RTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG G FG VY+G  L DG   AVK +S     +T  + +++ + E+ L++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 407 LGCCLQENESLLIY-EYMPNKSLNVFL--FDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           LG   +E ++L I+ E +P  SL   L  + S     +    R      I  GL YLH+ 
Sbjct: 68  LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLHDR 121

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                +HRD+K +N+L+D     K++DFGMA+
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 46/152 (30%), Positives = 82/152 (53%), Gaps = 6/152 (3%)

Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L +     ++EF  E  ++ +++H NLV+LLG
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 125

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
           IHRDL   N L+      K++DFG++R+  G+
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 57/172 (33%), Positives = 90/172 (52%), Gaps = 15/172 (8%)

Query: 347 FSDENKLGEGGFGPVYKG-KLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           F   NK+G+G FG V+K  + AD +  A+K+  LS+ + +  +E  +E  ++AKL    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFL---FDSTRSVQLDWKRRISIINGIARGLLYL 460
           +R     L + +  ++ EY  N  L+  L             W+  I I+ G+A    +L
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----HL 117

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           H     KI+HRD+K+ N+ LD   N KI D G+A++   N + ANT  IVGT
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 56/153 (36%), Positives = 78/153 (50%), Gaps = 5/153 (3%)

Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           KLG G FG V+ G   +  ++AVK L +     +Q F  E  L+  LQH  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           +E    +I EYM   SL  FL  S    ++   + I     IA G+ Y+    R   IHR
Sbjct: 72  KEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 127

Query: 472 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           DL+ +NVL+   +  KI+DFG+AR+   N+  A
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 87.6 bits (218), Expect = 2e-19
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 17/169 (10%)

Query: 347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFK-----NEVTLIAKL-Q 399
           F     +GEG F  V   K     KE A+K L +   Q ++E K      E  ++ +L  
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNG 60

Query: 400 HKNLVRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           H  +++L     Q+ E+L  + EY PN  L  ++    +   LD K        I   L 
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
           YLH      IIHRDLK  N+LLD +M+ KI+DFG A++   N S  + K
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 20/153 (13%)

Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKR-----LSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG+G FG VY     D G+E+AVK+      S  + + +   + E+ L+  LQH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 407 LGCCLQENESLLIY-EYMPNKSLNVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHE 462
            GC L+++E+L I+ EYMP  S+   L      T +V   + R+I        G+ YLH 
Sbjct: 70  YGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVEYLHS 122

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +    I+HRD+K +N+L D   N K+ DFG ++
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.9 bits (215), Expect = 3e-19
 Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 6/155 (3%)

Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           ++G G FG V+ G   + +++A+K + R      ++F  E  ++ KL H  LV+L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           + +   L++E+M +  L+ +L    +  +   +  + +   +  G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 472 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           DL   N L+      K+SDFGM R    +Q  ++T
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 54/174 (31%), Positives = 78/174 (44%), Gaps = 18/174 (10%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLLG 408
            +LG G  G V K      GK +AVK +     + +Q +   E+ ++ K     +V   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI--SIINGIARGLLYLHEDSRL 466
                 +  +  EYM   SL+  L    + VQ     RI   I   + +GL YLHE    
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHEK--H 120

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
           KIIHRD+K SN+L++     K+ DFG        +A+ F G  S    +RI G 
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGN 174

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 5/155 (3%)

Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           KLG G FG V++G   +   +AVK L   +    ++F  E  ++ KL+H  L++L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
            E    ++ E M   SL  +L        L   + I +   +A G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 472 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           DL   NVL+      K++DFG+AR+   +  EA  
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 49/151 (32%), Positives = 83/151 (54%), Gaps = 12/151 (7%)

Query: 353 LGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 408 GCCLQ--ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           G C         L+ EY+P  SL  +L       +LD ++ +   + I +G+ YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GS 126

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
            + +HRDL T N+L++ E   KI DFG+ ++
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKV 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 29/172 (16%)

Query: 350 ENKLGEGGFGPVYKGK---LADGKE---IAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKN 402
              +G+G FG V++ +   L   +    +AVK L    S     +F+ E  L+A+  H N
Sbjct: 10  VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDST-------------------RSVQLDW 443
           +V+LLG C       L++EYM    LN FL   +                     + L  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 444 KRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             ++ I   +A G+ YL E    K +HRDL T N L+   M  KI+DFG++R
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 9/153 (5%)

Query: 352 KLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKN--EVTLIAKLQHKNLVRLLG 408
           K+GEG +G VYK +     EI A+K++               E+ L+ +L H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
               + +  L++E+M     +++     R   L      S +  + +GL + H      I
Sbjct: 66  VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
           +HRDLK  N+L++ E   K++DFG+AR FG   
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 56/179 (31%), Positives = 77/179 (43%), Gaps = 29/179 (16%)

Query: 343 ATQHFSDENKLGEGGFGPVY--------KGKLADGKE---------IAVKRLSRT-SGQG 384
             Q  +   KLGEG FG V+                E         +AVK L    S   
Sbjct: 3   PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA 62

Query: 385 LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFL--------FDST 436
            ++F  EV ++++L   N+ RLLG C  +    +I EYM N  LN FL          + 
Sbjct: 63  REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122

Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            S  L +   + +   IA G+ YL     L  +HRDL T N L+      KI+DFGM+R
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 85.0 bits (210), Expect = 3e-18
 Identities = 57/172 (33%), Positives = 88/172 (51%), Gaps = 34/172 (19%)

Query: 352 KLGEGGFGPVYKGKLADGKE----------------IAVKRL-SRTSGQGLQEFKNEVTL 394
           KLGEG FG V+  + A+G                  +AVK L +  +     +F  E+ +
Sbjct: 12  KLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR-----ISI 449
           +++L++ N++RLLG C+ ++   +I EYM N  LN FL  S R ++  +        +SI
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL--SQREIESTFTHANNIPSVSI 128

Query: 450 IN------GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            N       IA G+ YL   + L  +HRDL T N L+ +    KI+DFGM+R
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 17/167 (10%)

Query: 352 KLGEGGFGPVYKGKL-ADGKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
            LG+G  G VYK +    GK  A+K++        +  ++   E+  +   +   +V+  
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESPYVVKCY 65

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI--SIINGIARGLLYLHEDSR 465
           G   +E E  ++ EYM   SL                  +   I   I +GL YLH  ++
Sbjct: 66  GAFYKEGEISIVLEYMDGGSL-----ADLLKKVGKIPEPVLAYIARQILKGLDYLH--TK 118

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             IIHRD+K SN+L++ +   KI+DFG++++      + NT   VGT
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGT 163

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.5 bits (210), Expect = 4e-18
 Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 26/162 (16%)

Query: 350 ENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN-----------EVTLIAK 397
             KLGEG +  VYK +    G+ +A+K++       L E K            E+ L+ +
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQE 58

Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFD-STRSVQLDWKRRISIINGIARG 456
           L+H N++ LL     ++   L++E+M    L   + D S      D K   S +    RG
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIK---SYMLMTLRG 114

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           L YLH      I+HRDLK +N+L+  +   K++DFG+AR FG
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 84.0 bits (208), Expect = 4e-18
 Identities = 50/150 (33%), Positives = 84/150 (56%), Gaps = 9/150 (6%)

Query: 352 KLGEGGFGPVYKGKLADGKEI-AVKRLSRTS-GQGLQEFK-NEVTLIAKLQHKNLVRLLG 408
           K+GEG +G V+K K  +  EI A+KR+      +G+      E+ L+ +L+HKN+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
               + +  L++EY  ++ L  + FDS     +D +   S +  + +GL + H      +
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNG-DIDPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +HRDLK  N+L++     K++DFG+AR FG
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 48/175 (27%), Positives = 83/175 (47%), Gaps = 35/175 (20%)

Query: 346 HFSDENKLGEGGFGPVYKG-KLADGKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHK 401
            +    KLGEG FG VYK  ++  G+ +A+K++   +   G  +   + E+ ++ KL+H 
Sbjct: 9   DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHP 67

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKS----------------LNVFLFDSTRSVQLDWKR 445
           N+V L+          +  E                      L+  L     SV+L   +
Sbjct: 68  NVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLL--ENPSVKLTESQ 116

Query: 446 RISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
               +  +  G+ YLHE+    I+HRD+K +N+L+D++   KI+DFG+AR + G 
Sbjct: 117 IKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 83.6 bits (206), Expect = 7e-18
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 19/162 (11%)

Query: 350 ENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           + +LGEG FG V+  +        D   +AVK L   S    ++F  E  L+  LQH+++
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFL----------FDSTRSVQLDWKRRISIINGI 453
           V+  G C++ +  ++++EYM +  LN FL           +  R  +L   + + I   I
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           A G++YL   +    +HRDL T N L+   +  KI DFGM+R
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 83.3 bits (206), Expect = 8e-18
 Identities = 52/161 (32%), Positives = 79/161 (49%), Gaps = 17/161 (10%)

Query: 349 DENK----LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           DEN     LG+G +G VY  + L+    IA+K +     + +Q    E+ L + L+H+N+
Sbjct: 8   DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIIN----GIARGLLY 459
           V+ LG   +     +  E +P  SL+  L    RS     K     I      I  GL Y
Sbjct: 68  VQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQILEGLKY 123

Query: 460 LHEDSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGG 499
           LH+    +I+HRD+K  NVL++ +    KISDFG ++   G
Sbjct: 124 LHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 83.3 bits (206), Expect = 8e-18
 Identities = 51/160 (31%), Positives = 73/160 (45%), Gaps = 19/160 (11%)

Query: 351 NKLGEGGFGPVYKGKL----ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNL 403
             LG G FG VY+G       D  E+ V   +     S Q   +F  E  +++K  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLY 459
           VRL+G   +     ++ E M    L  FL ++     R   L  K  +     +A+G  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           L E+     IHRD+   N LL  +  P    KI+DFGMAR
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 9/162 (5%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++GEG  G V+K K    G+ +A+K+  L R  G    +   E+  +   QH  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
                +  +L+ EYMP+  L+  L D  R +     +    +  + +G+ Y+H      I
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NGI 120

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIV 510
           +HRDLK +N+L+  +   KI+DFG+AR+F   +    + ++ 
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 45/143 (31%), Positives = 72/143 (50%), Gaps = 6/143 (4%)

Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ 412
           LG G FG V+ GK     ++A+K + R       +F  E  ++ KL H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 413 ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRD 472
           +    ++ EYM N  L  +L +    +  +W   + + + +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 473 LKTSNVLLDHEMNPKISDFGMAR 495
           L   N L+  +   K+SDFG+AR
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 21/159 (13%)

Query: 353 LGEGGFGPVYKGKLAD------GKEIAVKRLSR--TSGQGLQEFKNEVTLIAKLQHKNLV 404
           LG+G FG VY+G             +A+K ++   +  + + EF NE +++ +    ++V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ-----LDWKRRISIIN---GIARG 456
           RLLG       +L++ E M    L  +L  S R        L        I     IA G
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + YL      K +HRDL   N ++  ++  KI DFGM R
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 21/168 (12%)

Query: 346 HFSDEN-----KLGEGGFGPVYKGKLA----DGKE--IAVKRLSRTSGQGLQ-EFKNEVT 393
            F   N      LG G FG V+  K      +G E  + VK L +T  + LQ EF+ E+ 
Sbjct: 1   AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60

Query: 394 LIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFL------FDSTRSVQLDWKRRI 447
           +  KL HKN+VRLLG C +     +I EY     L  FL       +  +   L  K+++
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120

Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           ++   IA G+ +L   S  + +HRDL   N L+  +   K+S   +++
Sbjct: 121 ALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 49/164 (29%), Positives = 83/164 (50%), Gaps = 16/164 (9%)

Query: 347 FSDENKLGEGGFGPVYKGKL---ADGKEIAVKRL--SRTSGQGL-QEFKNEVTLIAKLQH 400
           +  E  +G G +G VYK K     DGKE A+K+    +    G+ Q    E+ L+ +L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 401 KNLVRLLGCCLQENESL--LIYEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGL 457
           +N+V L+   L+  +    L+++Y  +    +  F    + V +      S++  I  G+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIF 497
            YLH +    ++HRDLK +N+L+  E       KI D G+AR+F
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 49/155 (31%), Positives = 89/155 (57%), Gaps = 8/155 (5%)

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHKNL 403
           F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H  
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
              +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 56/151 (37%), Positives = 78/151 (51%), Gaps = 15/151 (9%)

Query: 353 LGEGGFGPV--YKGKLAD---GKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRL 406
           LGEG FG V  Y    A+   G+ +AVK L R  GQ     +K E+ ++  L H+N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 407 LGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            GCC ++      LI EY+P  SL  +L      + L   + +     I  G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNL--AQLLLFAQQICEGMAYLHSQ- 126

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               IHRDL   NVLLD++   KI DFG+A+
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 9/153 (5%)

Query: 351 NKLGEGGFGPVYKG-KLADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           NK+G G FG VY    L  G+ +AVK  R+     + ++E  +E+ ++  L+H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  +   +  +  EY    +L   L +  R +     R  +    +  GL YLH      
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYT--LQLLEGLAYLHSH---G 119

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
           I+HRD+K +N+ LDH    K+ DFG A     N
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 16/153 (10%)

Query: 353 LGEGGFGPVYKGKLA-DGKEIAVKR--LSRTSGQG-------LQEFKNEVTLIAKLQHKN 402
           +G G FG VY G  A  G+ +AVK+  L   S          L     E+ L+ +LQH+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           +V+ LG  L  +   +  EY+P  S+   L ++  + +    R  + +  I +GL YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVR--NFVRQILKGLNYLH- 123

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +R  IIHRD+K +N+L+D++   KISDFG+++
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISK 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 48/159 (30%), Positives = 86/159 (54%), Gaps = 10/159 (6%)

Query: 350 ENKLGEGGFGPVYKGKL-ADGKE---IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G FG V +G+L   GK    +A+K L S  + +  ++F +E +++ +  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L G   +    ++I E+M N +L+ FL       Q    + + ++ GIA G+ YL E  
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE-- 124

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
            +  +HRDL   N+L++  +  K+SDFG++R    + S+
Sbjct: 125 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 53/149 (35%), Positives = 81/149 (54%), Gaps = 11/149 (7%)

Query: 353 LGEGGFGPVYKGKL--ADGKEI--AVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           +G+G FG VY G L  +DG++I  AVK L+R T  + +++F  E  ++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 408 GCCL-QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
           G CL  E   L++  YM +  L  F+   T +  +  K  I     +A+G+ YL      
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASK--- 117

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           K +HRDL   N +LD     K++DFG+AR
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 81.0 bits (201), Expect = 3e-17
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 14/165 (8%)

Query: 353 LGEGGFGPVYK-GKLADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+G FG V    K   GK  A+K L +      + ++    E  +++++ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
              Q  E L L+ EY P   L             +  R       I   L YLH    L 
Sbjct: 60  YAFQTEEKLYLVLEYAPGGEL-FSHLSKEGRFSEERARFY--AAEIVLALEYLH---SLG 113

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           II+RDLK  N+LLD + + K++DFG+A+      S  NT    GT
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 60/173 (34%), Positives = 90/173 (52%), Gaps = 25/173 (14%)

Query: 343 ATQHFSDENKLGEGGFGPVYKGKL---ADGKE---IAVKRLS-RTSGQGLQEFKNEVTLI 395
           +T  F +E  LGE  FG VYKG L   A G++   +A+K L  +  G   +EFK+E  + 
Sbjct: 5   STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62

Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLF-------------DSTRSVQLD 442
           ++LQH N+V LLG   +E    +I+ Y  +  L+ FL              D T    L+
Sbjct: 63  SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122

Query: 443 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               + I+  IA G+ +L   S   ++H+DL T NVL+  ++N KISD G+ R
Sbjct: 123 PADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 49/164 (29%), Positives = 85/164 (51%), Gaps = 19/164 (11%)

Query: 353 LGEGGFGPVYKGKLA--DGK--EIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LGEG FG V +G+L+  DG   ++AVK  +L   +   ++EF +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 407 LGCCLQENES------LLIYEYMPNKSLNVFLFDS---TRSVQLDWKRRISIINGIARGL 457
           +G C + +        ++I  +M +  L+ FL  S       +L  +  +  +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGN 500
            YL   S    IHRDL   N +L  +M   ++DFG+++ I+ G+
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 80.3 bits (198), Expect = 6e-17
 Identities = 50/164 (30%), Positives = 85/164 (51%), Gaps = 10/164 (6%)

Query: 350 ENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G FG V  G  KL   +EI V   +  +G   +  ++F +E +++ +  H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L G   +    +++ EYM N SL+ FL       Q    + + ++ GIA G+ YL   S
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYL---S 123

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
            +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 81.1 bits (200), Expect = 6e-17
 Identities = 55/187 (29%), Positives = 87/187 (46%), Gaps = 41/187 (21%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKE-----------------IAVKRL-SRTSGQGLQ 386
            H   + KLGEG FG V+  ++ + ++                 +AVK L    +     
Sbjct: 5   GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64

Query: 387 EFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ------ 440
           +F  EV ++++L+  N++RLLG C+ E+   +I EYM N  LN FL  S+  +       
Sbjct: 65  DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL--SSHHLDDKEENG 122

Query: 441 ------------LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI 488
                       + +   + +   IA G+ YL   S L  +HRDL T N L+   +  KI
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKI 179

Query: 489 SDFGMAR 495
           +DFGM+R
Sbjct: 180 ADFGMSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 57/171 (33%), Positives = 82/171 (47%), Gaps = 38/171 (22%)

Query: 353 LGEGGFGPVYKGKLADGKEI---------AVKRLSRTSGQGLQEFKNEVTLIAKL----Q 399
           LGEG FG V K   A+   +         AVK L   + +  ++  + V+ +  +    +
Sbjct: 20  LGEGAFGQVVK---AEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGK 74

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTRSV--QLDWKRR 446
           HKN++ LLG C QE    ++ EY  + +L  FL            D  R     L  K  
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL--DHEMNPKISDFGMAR 495
           +S    +ARG+ +L   S+ K IHRDL   NVL+  DH M  KI+DFG+AR
Sbjct: 135 VSFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVM--KIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 80.6 bits (199), Expect = 7e-17
 Identities = 51/149 (34%), Positives = 85/149 (57%), Gaps = 6/149 (4%)

Query: 352 KLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFK-NEVTLIAKLQHKNLVRLLGC 409
           KLGEG +  VYKG+     EI A+K +   + +G       E++L+ +L+H+N+VRL   
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
              EN+ +L++EYM +K L  ++        LD     S    + +G+ + HE+   +++
Sbjct: 67  IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVL 122

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           HRDLK  N+L++     K++DFG+AR FG
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFG 151

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 80.3 bits (198), Expect = 8e-17
 Identities = 55/160 (34%), Positives = 75/160 (46%), Gaps = 20/160 (12%)

Query: 353 LGEGGFGPVYKGK----LADGKE---IAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLV 404
           LG G FG VY+G     L  G     +AVK L + +  Q  +EF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFD----STRSVQLDWKRRISIINGIARGLLYL 460
           +LLG CL      +I E M    L  +L D          L  K  + I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 461 HEDSRLKIIHRDLKTSNVLL-----DHEMNPKISDFGMAR 495
               ++  IHRDL   N L+     D +   KI DFG+AR
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 54/153 (35%), Positives = 81/153 (52%), Gaps = 10/153 (6%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           Q  +    +GEG FG V +G+   G+++AVK +        Q F  E  ++ KL HKNLV
Sbjct: 6   QKLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLV 62

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRS-VQLDWKRRISIINGIARGLLYLHED 463
           RLLG  L  N   ++ E M   +L  FL    R+ V +    + S+   +A G+ YL   
Sbjct: 63  RLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK 119

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
              K++HRDL   N+L+  +   K+SDFG+AR+
Sbjct: 120 ---KLVHRDLAARNILVSEDGVAKVSDFGLARV 149

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 48/159 (30%), Positives = 86/159 (54%), Gaps = 16/159 (10%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGL-QEFKNEVTLIAKLQ---HKNLV 404
            ++GEG +G VYK + L  G+ +A+K++    S +G+      E+ L+ +L+   H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 405 RLLGCCL-QENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           RLL  C     +      L++E++ ++ L  +L        L  +    ++  + RG+ +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           LH     +I+HRDLK  N+L+  +   KI+DFG+ARI+ 
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 47/152 (30%), Positives = 80/152 (52%), Gaps = 14/152 (9%)

Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLS------RTSGQGLQEFKNEVTLIAKLQHKNLV 404
             LG+G +G VY G    G+ IAVK++         + +  ++ + EV L+  L+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI-SIINGIARGLLYLHED 463
           + LG CL +N   +  E++P  S++  L       +  + +    I++G+A    YLH +
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNN 121

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               ++HRD+K +NV+L      K+ DFG AR
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 54/164 (32%), Positives = 81/164 (49%), Gaps = 23/164 (14%)

Query: 352 KLGEGGFGPVYKGKL-----ADGKEIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVR 405
           +LGE  FG +YKG L        + +A+K L    + Q   EF+ E +L+A+L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLF--------------DSTRSVQLDWKRRISIIN 451
           LLG   QE    +++EY+    L+ FL               D T    LD    + I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            IA G+ YL   S    +H+DL   N+L+  +++ KISD G++R
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 8/153 (5%)

Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ 412
           +G+G FG V  G    G ++AVK +   +    Q F  E +++ +L+H NLV+LLG  ++
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 413 ENESLLIY-EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           E   L I  EYM   SL  +L    RSV L     +     +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 472 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           DL   NVL+  +   K+SDFG+ +     Q   
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 46/168 (27%), Positives = 83/168 (49%), Gaps = 11/168 (6%)

Query: 347 FSDENKLGEGGFGPVYKG-KLADGKEIAVKRLS-RTSGQGLQEFKNEVTLIAKLQHKNLV 404
           F+    +G+G FG VYK       + +A+K +    +   +++ + E+  +++ +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           +  G  L+ ++  +I EY    S      D  +  +LD      I+  +  GL YLHE+ 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
               IHRD+K +N+LL  E + K++DFG++       S+ NT   VGT
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGT 161

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 54/179 (30%), Positives = 77/179 (43%), Gaps = 26/179 (14%)

Query: 351 NKLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLLG 408
           ++LGEG  G V K +L +   I A+K ++      LQ +   E+ +    +   +V+  G
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 409 CCLQENESLL--IYEYMPNKSLNVFLFDSTRSVQLDWKRRIS------IINGIARGLLYL 460
             L E+ S +    EY    SL     DS          RI       I   + +GL YL
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVG 511
           H     KIIHRD+K SN+LL  +   K+ DFG        +A  F G       +RI G
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQG 177

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 49/144 (34%), Positives = 72/144 (50%), Gaps = 6/144 (4%)

Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCL 411
           LG+G FG V+KG L D   +AVK       Q L+ +F +E  ++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           Q     ++ E +P      FL    +  +L  K+ +      A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 472 DLKTSNVLLDHEMNPKISDFGMAR 495
           DL   N L+      KISDFGM+R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 54/172 (31%), Positives = 74/172 (43%), Gaps = 28/172 (16%)

Query: 352 KLGEGGFGPVYKG--KLADGKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRL 406
           KLG+G FG V +G    + GK I  AVK L        + +F  E  ++  L H+NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD-------WKRRISIINGIARGLLY 459
            G  L     +++ E  P  SL     D  R   L            + I NG+     Y
Sbjct: 62  YGVVLTH-PLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMR----Y 112

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ----SEANTK 507
           L      + IHRDL   N+LL  +   KI DFG+ R    N+     E + K
Sbjct: 113 LESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 54/167 (32%), Positives = 89/167 (53%), Gaps = 17/167 (10%)

Query: 353 LGEGGFGPVY------KGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           +G G FG V+        KL   K+I V+++++      Q   NE  ++  L H N++  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
               L++   +++ EY P  +L  ++     S+ LD     +I++   + LL LH     
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDED---TILHFFVQILLALHHVHTK 120

Query: 467 KIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            I+HRDLKT N+LLD H+M  KI DFG+++I   ++S+A T  +VGT
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT--VVGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 51/156 (32%), Positives = 82/156 (52%), Gaps = 8/156 (5%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
             KLG G FG V+ G      ++AVK L +      + F  E  ++ KL+H  LV+L   
Sbjct: 11  IKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            + E    ++ EYM   SL  FL D   R+++L     + +   +A G+ Y+    R+  
Sbjct: 70  -VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNY 123

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           IHRDL+++N+L+   +  KI+DFG+AR+   N+  A
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 31/171 (18%)

Query: 352 KLGEGGFGPVYKGKLADGKE------------------IAVKRLSRTSGQGLQ-EFKNEV 392
           KLGEG FG V+  + A+G E                  +AVK L   + +  + +F  E+
Sbjct: 12  KLGEGQFGEVHLCE-AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70

Query: 393 TLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFL--------FDSTRSVQLDWK 444
            ++++L+  N++RLL  C+  +   +I EYM N  LN FL         +    V + + 
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             I +   IA G+ YL   S L  +HRDL T N L+      KI+DFGM+R
Sbjct: 131 TLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 22/165 (13%)

Query: 350 ENKLGEGGFGPVYKGK------LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           + +LGEG FG V+  +        D   +AVK L   +    ++F+ E  L+  LQH+++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLF----DSTRSV---------QLDWKRRISII 450
           V+  G C   +  ++++EYM +  LN FL     D+   V         +L   + + I 
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + IA G++YL   +    +HRDL T N L+   +  KI DFGM+R
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 59/169 (34%), Positives = 84/169 (49%), Gaps = 32/169 (18%)

Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVT------LIAKLQ------- 399
           LGEG FG V +   A+   I   R  +T    ++  K+  T      LI++++       
Sbjct: 20  LGEGCFGQVVR---AEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTRSV--QLDWKRR 446
           HKN++ LLG C QE    +I EY    +L  FL           FD T+    QL +K  
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +S    +ARG+ YL  +SR + IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 137 VSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 52/163 (31%), Positives = 86/163 (52%), Gaps = 18/163 (11%)

Query: 353 LGEGGFGPVYKGKLADGKEI---AVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           LGEG FG V +G+L     I   AVK  +++  +   +++F +E   + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 408 GCCLQ--ENES----LLIYEYMPNKSLNVFLFDS---TRSVQLDWKRRISIINGIARGLL 458
           G CLQ  E+E     ++I  +M +  L+ FL  S        L  +  +  +  IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGN 500
           YL   S    IHRDL   N +L+  MN  ++DFG++ +I+ G+
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 55/171 (32%), Positives = 81/171 (47%), Gaps = 31/171 (18%)

Query: 353 LGEGGFGPVYKGK------LADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVR 405
           LGEG FG V K         A    +AVK L   +    L++  +E  L+ ++ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTR----SVQLDWKRRISIING--------- 452
           L G C Q+   LLI EY    SL  FL +S +     +  D  R  S ++          
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 453 --------IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                   I+RG+ YL E   +K++HRDL   NVL+      KISDFG++R
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 58/174 (33%), Positives = 82/174 (47%), Gaps = 45/174 (25%)

Query: 347 FSDENKLGEGGFGPVYKGKLADGKEI-AVK--RLSRTSG----QGLQEFKNEVTLIAKLQ 399
           F   N++GEG +G VY+ +     EI A+K  R+           L+    E+TL+  L+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR----EITLLLNLR 64

Query: 400 HKNLVRLL---------------GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWK 444
           H N+V L                  C Q+  SLL  + MP      F   S   V+    
Sbjct: 65  HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTP----F---SESQVK---- 111

Query: 445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
               ++  + RGL YLHE+    IIHRDLK SN+LL  +   KI+DFG+AR +G
Sbjct: 112 ---CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 46/145 (31%), Positives = 81/145 (55%), Gaps = 8/145 (5%)

Query: 352 KLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           +LG+G FG VYK K  + G   A K +   S + L+++  E+ ++A   H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKII 469
             + +  ++ E+ P  +++  + +  R +    + +I +I   +   L YLH    +KII
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKII 132

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMA 494
           HRDLK  NVLL  + + K++DFG++
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 6/155 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 11  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 70  -VSEEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 50/146 (34%), Positives = 73/146 (50%), Gaps = 7/146 (4%)

Query: 352 KLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGC 409
           ++G G FG V+ G+L AD   +AVK    T    L+ +F  E  ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
           C Q+    ++ E +       FL   T   +L  K  I ++   A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMAR 495
           HRDL   N L+  +   KISDFGM+R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 47/144 (32%), Positives = 71/144 (49%), Gaps = 6/144 (4%)

Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           +LG G FG V+ GK     ++A+K +        ++F  E  ++ KL H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           Q+    ++ E+M N  L  +L    R  +L     +S+   +  G+ YL  +S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 472 DLKTSNVLLDHEMNPKISDFGMAR 495
           DL   N L+      K+SDFGM R
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 54/166 (32%), Positives = 90/166 (54%), Gaps = 18/166 (10%)

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIIN---GIARGL 457
            ++ RLLG CL     L I + MP   L  ++ +   ++   +     ++N    IA+G+
Sbjct: 69  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY-----LLNWCVQIAKGM 122

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
            YL E+ RL  +HRDL   NVL+    + KI+DFG+A++ G ++ E
Sbjct: 123 NYL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 77.1 bits (189), Expect = 2e-15
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 16/170 (9%)

Query: 347 FSDENKLGEGGFGPVYKGKLADGKEI-AVKRLS---RTSGQGLQEFKNEVTLIAKLQHKN 402
           F+D  ++G G FG VY  +     E+ A+K++S   + S +  Q+   EV  + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
            +   GC L+E+ + L+ EY    + ++          L      +I +G  +GL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            +   +IHRD+K  N+LL      K++DFG A I     S AN+   VGT
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS--FVGT 184

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 54/170 (31%), Positives = 85/170 (50%), Gaps = 16/170 (9%)

Query: 347 FSDENKLGEGGFGPVYKGKLADGKEI-AVKRLS---RTSGQGLQEFKNEVTLIAKLQHKN 402
           FSD  ++G G FG VY  +     E+ A+K++S   + S +  Q+   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
            ++  GC L+E+ + L+ EY    + ++          L      ++ +G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            +   +IHRD+K  N+LL      K+ DFG A I     + AN    VGT
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANX--FVGT 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 10/170 (5%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
             +G+G FG V K +  +DGK +  K +     + +  Q+  +EV ++ +L+H N+VR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 408 G-CCLQENESLLIY-EYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLH--E 462
                + N++L I  EY     L   +    +  + ++ +    I+  +   L   H   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           D    ++HRDLK +N+ LD   N K+ DFG+A+I G + S A T   VGT
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGT 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 52/158 (32%), Positives = 83/158 (52%), Gaps = 9/158 (5%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKE-IAVK--RLSRTSGQGLQEFKNEVTLIAKLQHK 401
             +    K+GEG +G VYK +     E IA+K  RL +           E++L+ ++QH 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+VRL      E    L++EY+ +  L   + DS+     + +   + +  I RG+ Y H
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYL-DLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYCH 119

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFG 498
             S  +++HRDLK  N+L+D   N  K++DFG+AR FG
Sbjct: 120 --SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154

Length = 294

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 15/157 (9%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           KLG+G +G VYK K L+D +  A+K   L   S +  ++  NE+ ++A + H N++    
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSV-----QLDWKRRISIINGIARGLLYLHED 463
             L  N+  ++ EY P   L+  +    +       Q  W+  I +     RGL  LHE 
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL----LRGLQALHE- 121

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
              KI+HRDLK++N+LL      KI D G++++   N
Sbjct: 122 --QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 74.4 bits (183), Expect = 7e-15
 Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 17/154 (11%)

Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKR--LSRTSGQGLQE--------FKNEVTLIAKLQHK 401
           +G+G +G VY       G+ +AVK+  L  T                ++E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+ LG    E    +  EY+P  S+   L       + + +        +  GL YLH
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                 I+HRDLK  N+L+D +   KISDFG+++
Sbjct: 126 SKG---ILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 44/169 (26%), Positives = 83/169 (49%), Gaps = 14/169 (8%)

Query: 347 FSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
             +  K+GEG  G V      + G+++AVK++     Q  +   NEV ++   QH N+V 
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           +    L  +E  ++ E++   +L     D     +++ ++  ++   + + L +LH    
Sbjct: 81  MYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ-- 134

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR--IVGT 512
             +IHRD+K+ ++LL  +   K+SDFG    F    S+   +R  +VGT
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 6/144 (4%)

Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           +LG G FG V  GK     ++A+K +   S     EF  E  ++ KL H+ LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           ++    ++ EYM N  L  +L +  +  Q    + + +   +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 472 DLKTSNVLLDHEMNPKISDFGMAR 495
           DL   N L+D +   K+SDFG++R
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 55/151 (36%), Positives = 80/151 (52%), Gaps = 16/151 (10%)

Query: 351 NKLGEGGFGPVYKG--KLADG----KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           +KLGEG +  VYKG  KL D     KEI   RL    G      + EV+L+  L+H N+V
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      E    L++EY+ +K L  +L D   S+ +   +    +  + RGL Y H   
Sbjct: 68  TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH--- 121

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           R K++HRDLK  N+L++     K++DFG+AR
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 8/156 (5%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG G FG V+        ++AVK + +     ++ F  E  ++  LQH  LV+L   
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 410 CLQENESLLIYEYMPNKSLNVFL-FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
             +E    +I E+M   SL  FL  D      L   + I     IA G+ ++ + +    
Sbjct: 70  VTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---Y 123

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           IHRDL+ +N+L+   +  KI+DFG+AR+   N+  A
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 51/168 (30%), Positives = 88/168 (52%), Gaps = 11/168 (6%)

Query: 347 FSDENKLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLV 404
           F+   ++G+G FG VYKG     KE+ A+K +     +  +++ + E+T++++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           R  G  L+  +  +I EY+   S      D  +   L+     +I+  I +GL YLH + 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSER 121

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +   IHRD+K +NVLL  + + K++DFG+A      Q + NT   VGT
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 48/149 (32%), Positives = 77/149 (51%), Gaps = 12/149 (8%)

Query: 352 KLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKN--EVTLIAKLQ-HKNLVRLL 407
           +LG+G FG VY  +  +  E+ A+K++ +      +E  N  EV  + KL  H N+V+L 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI-SIINGIARGLLYLHEDSRL 466
               + +E   ++EYM     N++     R  +   +  I SII  I +GL ++H   + 
Sbjct: 65  EVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KH 118

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              HRDLK  N+L+      KI+DFG+AR
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 47/152 (30%), Positives = 82/152 (53%), Gaps = 18/152 (11%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLS---RTSGQG---LQEFKNEVTLIAKLQHKNLVR 405
           LG G F   Y+ + +  G  +AVK+++    TS +    ++  + E+ L+A+L H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI--INGIARGLLYLHED 463
           +LG   +++   L  E+M   S++  L          +K  + I     + RGL YLHE+
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN 122

Query: 464 SRLKIIHRDLKTSNVLLDHE-MNPKISDFGMA 494
              +IIHRD+K +N+L+D      +I+DFG A
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 53/170 (31%), Positives = 83/170 (48%), Gaps = 16/170 (9%)

Query: 347 FSDENKLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQ---GLQEFKNEVTLIAKLQHKN 402
           F   +++G G FG VY    +   E+ AVK++S +  Q     Q+   EV  + +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
            +   GC L+E+ + L+ EY    + ++          L      +I +G  +GL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            +   +IHRD+K  N+LL      K++DFG A       S AN+   VGT
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGT 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 72.9 bits (180), Expect = 4e-14
 Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 35/178 (19%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN---------EVTLI 395
            +     +G G +G V        G+++A+K++S         F +         E+ L+
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLL 53

Query: 396 AKLQHKNLVRLLGCCLQENESL-------LIYEYMPNKSLNVFLFDSTRSVQ-LDWKRRI 447
             L+H+N++ LL   +    S        ++ E M      V      +S Q L      
Sbjct: 54  RHLRHENIIGLLD--ILRPPSPEDFNDVYIVTELMETDLHKVI-----KSPQPLTDDHIQ 106

Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
             +  I RGL YLH      +IHRDLK SN+L++   + KI DFG+AR    ++ E  
Sbjct: 107 YFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 41/143 (28%), Positives = 75/143 (52%), Gaps = 6/143 (4%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           LG+G FG VYK +  +     A K +   S + L++F  E+ ++++ +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
            EN+  ++ E+    +L+  + +  R +     R +     +   L +LH     K+IHR
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVC--RQMLEALNFLHSH---KVIHR 127

Query: 472 DLKTSNVLLDHEMNPKISDFGMA 494
           DLK  N+LL  + + K++DFG++
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 14/165 (8%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFKNEVTLIAKLQH---KNLVRLL 407
           +G G +G VY+GK +  G+ +A+K ++  T    + + + EV L+++L+     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  L+     +I EY    S+   +    ++  +  K    II  +   L Y+H+     
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +IHRD+K +N+L+ +  N K+ DFG+A +   N S+ +T   VGT
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGT 164

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 27/159 (16%)

Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCC 410
           +GEG +G VYK +    G+ +A+K +        +E K E  ++ K   H N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 411 LQEN------ESLLIYEYMPNKSLNVFLFDSTRSVQ--LDWKRRIS------IINGIARG 456
           +++N      +  L+ E     S+       T  V+      +R+       I+    RG
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSV-------TDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L YLHE+   K+IHRD+K  N+LL      K+ DFG++ 
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 43/145 (29%), Positives = 80/145 (55%), Gaps = 8/145 (5%)

Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           +LG+G FG VYK +  +   +A  ++  T S + L+++  E+ ++A   H N+V+LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKII 469
             EN   ++ E+    +++  + +  R +    + +I ++       L YLHE+   KII
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN---KII 125

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMA 494
           HRDLK  N+L   + + K++DFG++
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 67.1 bits (164), Expect = 8e-14
 Identities = 27/86 (31%), Positives = 44/86 (51%)

Query: 145 QSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRI 204
            ++N L+ +++S  ++S     A   + ++ D ++ L QC   LS SDC  CL   VS +
Sbjct: 21  SNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRSCLATAVSEL 80

Query: 205 SSRYYGRQSVRALSPSCIIRYEMYPF 230
                 ++  R    SC +RYE YPF
Sbjct: 81  RRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 6/155 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           + KLG+G FG V+ G      ++A+K L +      + F  E  ++ KL+H  LV L   
Sbjct: 11  DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ E+M   SL  FL +      L   + + +   IA G+ Y+    R+  I
Sbjct: 70  -VSEEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIE---RMNYI 124

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           HRDL+ +N+L+   +  KI+DFG+AR+   N+  A
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 52/174 (29%), Positives = 91/174 (52%), Gaps = 20/174 (11%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKN---EVTLIAKLQH 400
           + F+D  ++G G FG VY  +     E+ A+K++S +  Q  +++++   EV  + +L+H
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVF--LFDSTRSVQLDWKRRISIINGIARGLL 458
            N +   GC L+E+ + L+ EY    + ++        + V++      +I +G  +GL 
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEI-----AAICHGALQGLA 129

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH     + IHRD+K  N+LL      K++DFG A +     S AN+   VGT
Sbjct: 130 YLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS--FVGT 174

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 21/164 (12%)

Query: 350 ENKLGEGGFGPVYKGKL-ADG--KEIAVKRLSRTSGQG-LQEFKNEVTLIAKL-QHKNLV 404
           ++ +GEG FG V K ++  DG   + A+KR+   + +   ++F  E+ ++ KL  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDS-------------TRSVQLDWKRRISIIN 451
            LLG C       L  EY P+ +L  FL  S             + +  L  ++ +    
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +ARG+ YL   S+ + IHRDL   N+L+      KI+DFG++R
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 17/151 (11%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN----EVTLIAKLQHKNLVRL 406
            +GEG +G V K +  A G+ +A+K+   +     ++ K     EV ++ +L+H+N+V L
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS--IINGIARGLLYLHEDS 464
                ++    L++EY+    L + L  S   +  D  R     ++  IA    Y H   
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIA----YCH--- 117

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              IIHRD+K  N+L+      K+ DFG AR
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)

Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRLS-RTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 26/166 (15%)

Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRLSR-TSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K      +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    ++ EY    +L  +L           FD+ +    QL +K  +S 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 43/149 (28%), Positives = 83/149 (55%), Gaps = 14/149 (9%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
            ++G G +G VYK + +A G+ +A+K +    G   +  + E++++ + +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSR 465
            L+ ++  ++ EY    SL   ++  TR     +Q+ +  R ++     +GL YLHE   
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETL-----KGLAYLHE--- 119

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
              IHRD+K +N+LL  + + K++DFG++
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 48/151 (31%), Positives = 82/151 (54%), Gaps = 13/151 (8%)

Query: 353 LGEGGFGPVYKGKL-----ADGKEIAVKRLS-RTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LGEG FG V   +        G+++AVK L   + G  + + K E+ ++  L H+N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 407 LGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            G C ++  +   LI E++P+ SL  +L  +   + L  + + ++   I +G+ YL   S
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--GS 127

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           R + +HRDL   NVL++ E   KI DFG+ +
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 46/171 (26%), Positives = 83/171 (48%), Gaps = 10/171 (5%)

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQHKN 402
           F  E K+G+G F  VYK   L DG+ +A+K++        +  Q+   E+ L+ +L H N
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI-SIINGIARGLLYLH 461
           +++ L   ++ NE  ++ E      L+  +    +  +L  +R I      +   L ++H
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
                +I+HRD+K +NV +      K+ D G+ R F    + A++   VGT
Sbjct: 124 SK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 16/158 (10%)

Query: 346 HFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQH-KN 402
              D  ++G G FG V K      G  +AVKR+  T  +  Q     ++ ++ +      
Sbjct: 5   DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPY 64

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI--SIINGIA----RG 456
           +V+  G   +E +  +  E M + SL+ F     + V    K  I   I+  IA    + 
Sbjct: 65  IVKFYGALFREGDCWICMELM-DISLDKF----YKYVYEVLKSVIPEEILGKIAVATVKA 119

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           L YL E+  LKIIHRD+K SN+LLD   N K+ DFG++
Sbjct: 120 LNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 53/156 (33%), Positives = 80/156 (51%), Gaps = 26/156 (16%)

Query: 351 NKLGEGGFGPVYKG--KLADG----KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
            KLGEG +  V+KG  KL +     KEI   RL    G      + EV+L+  L+H N+V
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFD-----STRSVQLDWKRRISIINGIARGLLY 459
            L      +    L++EY+ +K L  ++ D     S  +V++        +  I RGL Y
Sbjct: 68  TLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI-------FLYQILRGLAY 119

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            H   R K++HRDLK  N+L++     K++DFG+AR
Sbjct: 120 CH---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 51/162 (31%), Positives = 81/162 (50%), Gaps = 25/162 (15%)

Query: 352 KLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLV 404
           +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD-----------WKRRISIINGI 453
           RLLG   Q   +L+I E M    L  +L    RS++ +            K+ I +   I
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           A G+ YL+ +   K +HRDL   N ++  +   KI DFGM R
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 16/159 (10%)

Query: 353 LGEGGFGPVYKGKLA-DGKEI----AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG G FG VYKG    DG+ +    A+K L   TS +  +E  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ--LDWKRRISIINGIARGLLYLHEDS 464
           LG CL     L + + MP   L     D  R  +  +  +  ++    IA+G+ YL E  
Sbjct: 75  LGICLTSTVQL-VTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-- 127

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
            ++++HRDL   NVL+    + KI+DFG+AR+   +++E
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 58/172 (33%), Positives = 88/172 (51%), Gaps = 21/172 (12%)

Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKRL-----SRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG G FG VY    AD G+E+AVK++     S+ + + +   + E+ L+  L+H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 407 LGCCLQ-ENESLLIY-EYMPNKSLNVFLFDS---TRSVQLDWKRRISIINGIARGLLYLH 461
            GC    E + L I+ EYMP  S+   L      T +V   + R+I       +G+ YLH
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGVSYLH 123

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSEANTKRIVGT 512
            +    I+HRD+K +N+L D   N K+ DFG + RI     S    K + GT
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.4 bits (169), Expect = 5e-13
 Identities = 46/172 (26%), Positives = 90/172 (52%), Gaps = 10/172 (5%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH 400
           +  + ++   K+G+G  G V+    +A G+E+A+K+++       +   NE+ ++ +L++
Sbjct: 16  DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKN 75

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
            N+V  L   L  +E  ++ EY+   SL     D      +D  +  ++     + L +L
Sbjct: 76  PNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFL 131

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           H +   ++IHRD+K+ NVLL  + + K++DFG        QS+ +T  +VGT
Sbjct: 132 HAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 49/182 (26%), Positives = 90/182 (49%), Gaps = 25/182 (13%)

Query: 328 ESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL---SRTSGQ 383
           +  EFP        +    +    K+G+G FG V+K +    K+I A+K++   +   G 
Sbjct: 1   DQYEFPF------CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF 54

Query: 384 GLQEFKNEVTLIAKLQHKNLVRLLGCC----LQENES----LLIYEYMPNKSLNVFLFDS 435
            +   + E+ ++  L+H+N+V L+  C       N       L++E+  +  L   L  S
Sbjct: 55  PITALR-EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL--S 110

Query: 436 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            ++V+        ++  +  GL Y+H   R KI+HRD+K +N+L+  +   K++DFG+AR
Sbjct: 111 NKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167

Query: 496 IF 497
            F
Sbjct: 168 AF 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 16/157 (10%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQ-GLQ-EFKNEVTLIAKLQ---HKNLVR 405
           ++G G +G VYK +    G  +A+K +   + + GL      EV L+ +L+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 406 LLGCCL-----QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
           L+  C      +E +  L++E++ ++ L  +L D      L  +    ++    RGL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
           H +    I+HRDLK  N+L+      K++DFG+ARI+
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 49/151 (32%), Positives = 79/151 (52%), Gaps = 14/151 (9%)

Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKRL-----SRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG+G FG VY    AD G+E+AVK++     S  + + +   + E+ L+  L H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 407 LGCCLQENESLL--IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            GC     E  L    E+MP  S+   L  S  ++  +  R+ +    I  G+ YLH + 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYT--RQILEGVSYLHSN- 125

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              I+HRD+K +N+L D   N K+ DFG ++
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.6 bits (167), Expect = 8e-13
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 15/170 (8%)

Query: 347 FSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLV 404
           F+   K+G+G FG V+KG      K +A+K +     +  +++ + E+T++++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           +  G  L++ +  +I EY+   S      D      LD  +  +I+  I +GL YLH + 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR--IVGT 512
           +   IHRD+K +NVLL      K++DFG+A    G  ++   KR   VGT
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 68.8 bits (168), Expect = 8e-13
 Identities = 46/162 (28%), Positives = 85/162 (52%), Gaps = 10/162 (6%)

Query: 352 KLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+G+G  G VY    +A G+E+A+K+++       +   NE+ ++ + +H N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ EY+   SL     D      +D  +  ++     + L +LH +   ++IH
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 138

Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RD+K+ N+LL  + + K++DFG        QS+ +T  +VGT
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 10/160 (6%)

Query: 352 KLGEGGFGPVY--KGKLADGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLL 407
           K+GEG FG +Y  K K +D +   +K +  T    +  +  K EV L+AK++H N+V   
Sbjct: 7   KIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
               +     ++ EY     L +   +  R V     + +S    I+ GL ++H+    K
Sbjct: 66  ASFQENGRLFIVMEYCDGGDL-MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---K 121

Query: 468 IIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSEANT 506
           I+HRD+K+ N+ L    M  K+ DFG+AR    +   A T
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 20/154 (12%)

Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKRL-----SRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG+G FG VY     D G+E+A K++     S  + + +   + E+ L+  LQH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 407 LGCCLQENE-SLLIY-EYMPNKSLNVFLFDS---TRSVQLDWKRRISIINGIARGLLYLH 461
            GC     E +L I+ EYMP  S+   L      T SV   + R+I        G+ YLH
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSYLH 123

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +    I+HRD+K +N+L D   N K+ DFG ++
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 9/150 (6%)

Query: 351 NKLGEGGFGPVYKGKLADGKEIA---VKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRL 406
           +++G G FG V  G+   G   A   VK L  ++    Q  F  EV    +L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI--SIINGIARGLLYLHEDS 464
           LG C++    LL+ E+ P   L  +L  +   V    ++ +   +   +A GLL+LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           +   IH DL   N  L  +++ KI D+G+A
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 54/166 (32%), Positives = 80/166 (48%), Gaps = 26/166 (15%)

Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K     ++AVK L S  + + L +  +E+ ++  + +HKN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLF-------------DSTRSVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L                    QL +K  +S 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 53/170 (31%), Positives = 89/170 (52%), Gaps = 41/170 (24%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQG-----LQEFKNEVTLIAKLQHKNL 403
           N++ EG +G VY+ +    G+ +A+K+L      +G     L+E      ++ KLQH N+
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREIN----ILLKLQHPNI 66

Query: 404 VRL----LGCCLQENESLLIYEYMPN--KSL-----NVFLFDSTRS--VQLDWKRRISII 450
           V +    +G  L  ++  ++ EY+ +  KSL       FL    +   +QL        +
Sbjct: 67  VTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQL--------L 116

Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
           +G+A    +LH++    I+HRDLKTSN+LL++    KI DFG+AR +G  
Sbjct: 117 SGVA----HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 49/170 (28%), Positives = 89/170 (52%), Gaps = 15/170 (8%)

Query: 347 FSDENKLGEGGFGPVYKGKLADGKE---IAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKN 402
           F+   ++G+G FG V+KG   D +    +A+K +     +  +++ + E+T++++     
Sbjct: 6   FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           + +  G  L+  +  +I EY+   S      D  R+   D  +  +++  I +GL YLH 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +   K IHRD+K +NVLL  + + K++DFG+A      Q + NT   VGT
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 47/179 (26%), Positives = 92/179 (51%), Gaps = 21/179 (11%)

Query: 346 HFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHK 401
            F    ++GEG +G VYK +  D G+ +A+K++   +   G  +   + E+ ++ +L H+
Sbjct: 8   KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHR 66

Query: 402 NLVRLLGCCLQENESL----------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIIN 451
           N+V L      + ++L          L++EYM +  + +     +  V        S + 
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL---ESGLVHFSEDHIKSFMK 123

Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIV 510
            +  GL Y H+ + L   HRD+K SN+LL+++   K++DFG+AR++   +S   T +++
Sbjct: 124 QLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 31/185 (16%)

Query: 340 AVEATQHFSD---ENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQ-EFKNEVTL 394
           A  A +  S+    N++G G  G VYK      G+  A+K +       ++ +   E+ +
Sbjct: 66  APSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEI 125

Query: 395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN-------VFLFDSTRSVQLDWKRRI 447
           +  + H N+V+         E  ++ E+M   SL         FL D  R          
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ--------- 176

Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            I++GIA    YLH   R  I+HRD+K SN+L++   N KI+DFG++RI        N+ 
Sbjct: 177 -ILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228

Query: 508 RIVGT 512
             VGT
Sbjct: 229 --VGT 231

Length = 353

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 55/157 (35%), Positives = 77/157 (49%), Gaps = 19/157 (12%)

Query: 353 LGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAK------LQHKNLVR 405
           LG+G FG V   +L   G+  AVK L +     LQ+   E T+  K        H  L +
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 406 LLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           L  CC Q  + L  + E++    L   +F   +S + D  R       I   L++LH+  
Sbjct: 61  LY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGG 499
              II+RDLK  NVLLDHE + K++DFGM +  IF G
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 25/162 (15%)

Query: 352 KLGEGGFGPVYKGKLAD------GKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLV 404
           +LG+G FG VY+G   D         +AVK ++ + S +   EF NE +++      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD-----------WKRRISIINGI 453
           RLLG   +   +L++ E M +  L  +L    RS++ +            +  I +   I
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           A G+ YL+     K +HRDL   N ++ H+   KI DFGM R
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 10/155 (6%)

Query: 352 KLGEGGFGPVYKGKLADGK---EIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLL 407
           +LG G FG V KG     K   ++A+K L   + + ++ E   E  ++ +L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G C  E   +L+ E      LN FL  S +  ++     + +++ ++ G+ YL   +   
Sbjct: 62  GVCEAEA-LMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
            +HRDL   NVLL ++   KISDFG+++  G + S
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 52/151 (34%), Positives = 79/151 (52%), Gaps = 18/151 (11%)

Query: 353 LGEGGFGPVYKGK-LADGKEI----AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG G FG V+KG  + +G  I    A+K +  R+  Q  QE  + +  +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 407 LGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQ--LDWKRRISIINGIARGLLYLHED 463
           LG C     SL L+ +  P  SL     D  R  +  LD +R ++    IA+G+ YL E 
Sbjct: 75  LGIC--PGASLQLVTQLSPLGSL----LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
              +++HR+L   N+LL  +   +I+DFG+A
Sbjct: 129 ---RMVHRNLAARNILLKSDSIVQIADFGVA 156

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 38/161 (23%)

Query: 352 KLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFK--NEVTLIAKLQHKNLVRLLG 408
           KLGEG +  VYKG    +G+ +A+K +S  + +G+  F    E +L+  L+H N+V LL 
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIV-LLH 69

Query: 409 CCLQENESL-LIYEYMPNK-------------SLNVFLFDSTRSVQLDWKRRISIINGIA 454
             +   E+L  ++EYM                  NV LF      QL             
Sbjct: 70  DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLF----MFQL------------L 113

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           RGL Y+H      I+HRDLK  N+L+ +    K++DFG+AR
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 47/148 (31%), Positives = 80/148 (54%), Gaps = 12/148 (8%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           KLGEG +  VYKG+    G+ +A+K  RL    G      + E +L+  L+H N+V  L 
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TLH 69

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
             +   ++L L++EY+ +  L  ++ D    + +    R+ +   + RGL Y H   + +
Sbjct: 70  DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMH-NVRLFLFQ-LLRGLAYCH---QRR 123

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           ++HRDLK  N+L+      K++DFG+AR
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 65.7 bits (160), Expect = 6e-12
 Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 19/164 (11%)

Query: 353 LGEGGFGPVYKG--KLADG--KEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG+G FG V +   K  DG  +++AVK L     S   ++EF  E   + +  H N+++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 407 LGCCLQENES------LLIYEYMPNKSLNVFLFDS---TRSVQLDWKRRISIINGIARGL 457
           +G  L+          ++I  +M +  L+ FL  S        L  +  +  +  IA G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGN 500
            YL   S    IHRDL   N +L+  M   ++DFG+++ I+ G+
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 11/149 (7%)

Query: 352 KLGEGGFGPVYKGKLADGK----EIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRL 406
            +GEG FG VY+G     +     +AVK     +   ++E F  E  ++ +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
           +G    EN   ++ E  P   L  +L        LD    I     ++  L YL      
Sbjct: 73  IGVI-TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + +HRD+   NVL+      K+ DFG++R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 67.6 bits (165), Expect = 7e-12
 Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 41/250 (16%)

Query: 246 GSSNDSG----KKKTKESRTWIAIGAAASSIIVLALSCFLLWCMKRRKERVKEEKANSQE 301
           G    SG    K+  K    W  I     + +VLAL  F    ++ R     E K    E
Sbjct: 609 GGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGR--NNLELKRVENE 666

Query: 302 --TRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFG 359
             T  L   D ++    + + +    +E                      EN +  G  G
Sbjct: 667 DGTWELQFFDSKVSKSITINDILSSLKE----------------------ENVISRGKKG 704

Query: 360 PVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL 418
             YKGK + +G +  VK ++  +        +E+  + KLQH N+V+L+G C  E  + L
Sbjct: 705 ASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYL 760

Query: 419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNV 478
           I+EY+  K+L+  L +      L W+RR  I  GIA+ L +LH      ++  +L    +
Sbjct: 761 IHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKI 814

Query: 479 LLDHEMNPKI 488
           ++D +  P +
Sbjct: 815 IIDGKDEPHL 824

Length = 968

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 12/154 (7%)

Query: 346 HFSDENKLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFK---NEVTLIAKLQHK 401
            F    ++G+GG+G V+  K  D  EI A+KR+ ++    L E +    E  ++   + +
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 402 NLVRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
            LV+LL    Q++E L L  EY+P       L ++   +  D  R       +A     +
Sbjct: 62  WLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFY-----MAEMFEAV 114

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
                L  IHRDLK  N L+D   + K++DFG++
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.2 bits (159), Expect = 8e-12
 Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 11/164 (6%)

Query: 353 LGEGGFGP--VYKGKLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+G FG   +Y+ +  D   +  K   L+R S +  ++  NE+ +++ LQH N++    
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
             + +N  L+  EY    +L   +    +    + +  +  +  I   + Y+H+     I
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG---I 122

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +HRD+KT N+ L      K+ DFG+++I G   S A T  +VGT
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 12/159 (7%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAK 397
           E T  + D   +G G FG V   +    G+ +A+K++ +   T     + ++ E+ L+  
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKH 65

Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           L+H+N++ L    +   E +     +    L+  L  ++R ++  + +    +  I RGL
Sbjct: 66  LRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL--TSRPLEKQFIQ--YFLYQILRGL 121

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
            Y+H      ++HRDLK SN+L++   + KI DFG+ARI
Sbjct: 122 KYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 60/191 (31%), Positives = 83/191 (43%), Gaps = 22/191 (11%)

Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYK------GKL 366
           GN+Y Y        +   EFP   L               LG G FG V +       K 
Sbjct: 13  GNEYVYIDPTQLPYDLKWEFPRNNLSFG----------KTLGAGAFGKVVEATAYGLSKS 62

Query: 367 ADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
               ++AVK L  T+    +E   +E+ +++ L  H+N+V LLG C      L+I EY  
Sbjct: 63  DAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCC 122

Query: 425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM 484
              L  FL    R   L  +  +S    +A+G+ +L   +    IHRDL   NVLL H  
Sbjct: 123 YGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGK 178

Query: 485 NPKISDFGMAR 495
             KI DFG+AR
Sbjct: 179 IVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 51/151 (33%), Positives = 80/151 (52%), Gaps = 16/151 (10%)

Query: 351 NKLGEGGFGPVYKGK------LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           +KLGEG +  V+KG+      L   KEI   RL    G      + EV+L+  L+H N+V
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKNLKHANIV 66

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      E    L++EY+ +  L  +L D+  ++      +I +   + RGL Y H   
Sbjct: 67  TLHDIIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH--- 120

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + KI+HRDLK  N+L++ +   K++DFG+AR
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 61/170 (35%), Positives = 79/170 (46%), Gaps = 23/170 (13%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVTLIAKL------QHKNLVR 405
           LG+G FG V   +L    E+ AVK L +     LQ+   E T+  K       +H  L +
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKK--DVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 406 LLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           L   C Q  + L  + EY+    L   +F   RS + D  R       I  GL +LHE  
Sbjct: 61  LH-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLHER- 115

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSEANTKRIVGT 512
              II+RDLK  NVLLD E + KI+DFGM +  I GG      T    GT
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGT 159

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 11/149 (7%)

Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCL 411
           +G G +G VYKG+     ++A  ++   +G   +E K E+ ++ K   H+N+    G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 412 QEN------ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           ++N      +  L+ E+    S+   L  +T+   L  +    I   I RGL +LH+   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
            K+IHRD+K  NVLL      K+ DFG++
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVS 158

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 19/167 (11%)

Query: 353 LGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQE-FKNEVTLIAKLQHKNLVRLLG 408
           LG GGFG V   K+    +  A+K + +      G QE   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQL--DWKRRISIINGIARGLLYLHEDSR 465
              ++ + + ++ EY     L    +   R   L  ++  R   I  +     YLH    
Sbjct: 60  RTFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYLH---N 111

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             II+RDLK  N+LLD     K+ DFG A+     Q    T    GT
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGT 155

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 45/162 (27%), Positives = 85/162 (52%), Gaps = 10/162 (6%)

Query: 352 KLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+G+G  G VY    +A G+E+A+K+++       +   NE+ ++ + ++ N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ EY+   SL     D      +D  +  ++     + L +LH +   ++IH
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138

Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RD+K+ N+LL  + + K++DFG        QS+ +T  +VGT
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 21/164 (12%)

Query: 350 ENKLGEGGFGPVYKGKLA-DGKEI--AVKRLSR-TSGQGLQEFKNEVTLIAKL-QHKNLV 404
           E+ +GEG FG V +  +  DG ++  A+K L    S    ++F  E+ ++ KL  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDST-------------RSVQLDWKRRISIIN 451
            LLG C       +  EY P  +L  FL  S               +  L  ++ +   +
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +A G+ YL E    + IHRDL   NVL+   +  KI+DFG++R
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 48/165 (29%), Positives = 90/165 (54%), Gaps = 17/165 (10%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADG-KEIAVKRLS-RTSGQGLQ-EFKNEVTLIAKLQ- 399
           Q +    ++GEG +G V+K + L +G + +A+KR+  +T  +G+      EV ++  L+ 
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 400 --HKNLVRLLGCCL-----QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING 452
             H N+VRL   C      +E +  L++E++ ++ L  +L D      +  +    ++  
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQ 118

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
           + RGL +LH     +++HRDLK  N+L+      K++DFG+ARI+
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 12/149 (8%)

Query: 350 ENKLGEGGFGPVYKG--KLADGKE--IAVKRLSRTSGQGLQE--FKNEVTLIAKLQHKNL 403
           E  LG G FG + +G  KL   +E  +A+  L R      Q   F  E   + +  H N+
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           VRL G   + N  +++ EYM N +L+ FL       QL   + + ++ G+A G+ YL E 
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE- 125

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
             +  +H+ L    VL++ ++  KIS F 
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 26/167 (15%)

Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           + D   LG G  G V+    +D  K +AVK++  T  Q ++    E+ +I +L H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ--LDWKRRISIING----------- 452
           +          L           ++   +S   VQ  ++      +  G           
Sbjct: 67  VYEVLGPSGSDL------TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM 120

Query: 453 --IARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARI 496
             + RGL Y+H  +   ++HRDLK +NV ++ E +  KI DFG+ARI
Sbjct: 121 YQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 45/163 (27%), Positives = 84/163 (51%), Gaps = 12/163 (7%)

Query: 352 KLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+GEG  G V    + + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ E++   +L     D     +++ ++  ++   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 471 RDLKTSNVLLDHEMNPKISDFGM-ARIFGGNQSEANTKRIVGT 512
           RD+K+ ++LL H+   K+SDFG  A++   ++     K +VGT
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 11/148 (7%)

Query: 352 KLGEGGFGPVYKGKLAD-GKEIAVKR-LSRTSGQGLQEFK-NEVTLIAKLQHKNLVRLLG 408
            +GEG +G V K K  + G+ +A+K+ L     + +++    E+ ++ +L+H+NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHEDSRLK 467
              ++    L++E++ +  L+    D  +    LD  R    +  I RG+ + H  +   
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           IIHRD+K  N+L+      K+ DFG AR
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 17/159 (10%)

Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFK-NEVTLIAKLQHKNLVRLLGCC 410
           K+G G +G VYK K  DGK+     L +  G G+      E+ L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 411 LQ--ENESLLIYEYMPNKSLNVFLFD-----STRSVQLDWKRRISIINGIARGLLYLHED 463
           L   + +  L+++Y  +   ++  F      + + VQL      S++  I  G+ YLH +
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 464 SRLKIIHRDLKTSNVLLDHEMNP-----KISDFGMARIF 497
               ++HRDLK +N+L+  E  P     KI+D G AR+F
Sbjct: 128 W---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 32/175 (18%)

Query: 356 GGFGPVYKG-KLADGKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           G +G V+   K + G   A+K + +        + +   E  ++++ Q   +V+L     
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62

Query: 412 QENESL-LIYEYMPN-------KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           Q  ++L L+ EY+P        +++     D  R            I  I   L YLH  
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI----------YIAEIVLALEYLH-- 110

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFG------MARIFGGNQSEANTKRIVGT 512
               IIHRDLK  N+L+D   + K++DFG      + R    N  E   KRIVGT
Sbjct: 111 -SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 63.6 bits (154), Expect = 5e-11
 Identities = 50/148 (33%), Positives = 80/148 (54%), Gaps = 12/148 (8%)

Query: 352 KLGEGGFGPVYKGKL-ADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           KLGEG +  VYKGK   +GK +A+K  RL    G      + E +L+  L+H N+V LL 
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIV-LLH 69

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
             +   E+L L++EY+ +  L  ++      +  +  +    +  + RGL Y+H+     
Sbjct: 70  DIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIHQRY--- 123

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           I+HRDLK  N+L+      K++DFG+AR
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 15/150 (10%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFK---NEVTLIAKLQH-KNLVRLL 407
           LG G +G V K + +  G  +AVKR+  T     QE K    ++ +  +       V   
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 408 GCCLQENESLLIYEYMPNKSLNVF---LFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           G   +E +  +  E M + SL+ F   ++D   ++  D   +I++   I + L YLH   
Sbjct: 67  GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAV--SIVKALEYLHS-- 121

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           +L +IHRD+K SNVL++     K+ DFG++
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 17/154 (11%)

Query: 355 EGGFGPVYKGKLADGK-----EIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLG 408
           EG FG ++ G L D K     E+ VK +   + +  +     E  L+  L H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 409 CCLQENES-LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIIN------GIARGLLYLH 461
            C+++ E   ++Y YM   +L +FL    R  + +  + +S          IA G+ YLH
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQC-RLGEANNPQALSTQQLVHMAIQIACGMSYLH 134

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +  +IH+D+   N ++D E+  KI+D  ++R
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 54/174 (31%), Positives = 77/174 (44%), Gaps = 35/174 (20%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRT----SGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           LG G FG V   +     +  A+K LS+       Q ++   NE  ++  ++H  LV L 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67

Query: 408 GCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLL 458
           G   Q++ +L L+ EY+P   L    F   R        R      +AR         L 
Sbjct: 68  GS-FQDDSNLYLVMEYVPGGEL----FSHLRKS-----GRFP--EPVARFYAAQVVLALE 115

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH    L I++RDLK  N+LLD +   KI+DFG A+   G      T  + GT
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGT 161

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 32/160 (20%)

Query: 351 NKLGEGGFGPVYKGKLADGKEI-AVKRL-----SRTSGQG-------LQEFKNEVTLIAK 397
            KLG+G +G V+K      KE+ A+K++     + T  Q        LQE  +       
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD------- 65

Query: 398 LQHKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
             H N+V+LL     EN+    L++EYM      V   +    V    KR   I+  + +
Sbjct: 66  --HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH---KR--YIMYQLLK 118

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            L Y+H  S   +IHRDLK SN+LL+ +   K++DFG+AR
Sbjct: 119 ALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 7/166 (4%)

Query: 351 NKLGEGGFGPVYKGKLADGKE-IAVKRLS-RTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
             +G G    VY        E +A+KR+        + E + EV  +++  H N+V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
             +  +E  L+  Y+   SL   +  S     LD     +++  + +GL YLH + +   
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGM-ARIF-GGNQSEANTKRIVGT 512
           IHRD+K  N+LL  + + KI+DFG+ A +  GG+++    K  VGT
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 25/177 (14%)

Query: 346 HFSDENKLGEGGFGPVYKGKLADGKEI-AVKRLSRT---SGQGLQEFKNEVTLIAKLQHK 401
           HF     +G+G FG V   +  D K++ A+K +++        ++   NE  ++ +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 402 NLVRLLGCCLQENESL-LIYEYMPNKSLNVFL-----FDSTRSVQLDWKRRISIINGIAR 455
            LV L     Q+ E++ L+ + +    L   L     F   + V+         I  I  
Sbjct: 61  FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ-VKF-------WICEIVL 111

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            L YLH      IIHRD+K  N+LLD + +  I+DF +A     +     T    GT
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 47/156 (30%), Positives = 78/156 (50%), Gaps = 12/156 (7%)

Query: 352 KLGEGGFGPVYKG---KLADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLVRL 406
           +LG G FG V KG        K +AVK L   +       E   E  ++ +L +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
           +G C  E+  +L+ E      LN FL    ++  +  K    +++ ++ G+ YL E +  
Sbjct: 62  IGICEAES-WMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
             +HRDL   NVLL  +   KISDFG+++  G +++
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 45/160 (28%), Positives = 82/160 (51%), Gaps = 23/160 (14%)

Query: 353 LGEGGFGPVYKGKL---------ADGKEIAVKR-LSRTSGQGLQEFKNEVTLIAKLQHKN 402
           LG+G F  +YKG L           G+E++V   +  +  +    F    +L+++L HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           LV+L G C+++ E++++ EY+    L+VFL     +V L WK  + +   +A  L YL +
Sbjct: 63  LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119

Query: 463 DSRLKIIHRDLKTSNVLL----DHEMNP---KISDFGMAR 495
               K++H ++   N+L+     +E      K+SD G+  
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 17/159 (10%)

Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFK-NEVTLIAKLQHKNLVRLLGCC 410
           K+G G +G VYK K  DGK+     L +  G G+      E+ L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 411 LQENES--LLIYEYMPNKSLNVFLFD-----STRSVQLDWKRRISIINGIARGLLYLHED 463
           L  ++    L+++Y  +   ++  F      + + +QL      S++  I  G+ YLH +
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 464 SRLKIIHRDLKTSNVLLDHEMNP-----KISDFGMARIF 497
               ++HRDLK +N+L+  E  P     KI+D G AR+F
Sbjct: 128 W---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 12/163 (7%)

Query: 352 KLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+GEG  G V   +    G+++AVK +     Q  +   NEV ++   QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L   E  ++ E++   +L     D     +L+ ++  ++   + + L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 471 RDLKTSNVLLDHEMNPKISDFGM-ARIFGGNQSEANTKRIVGT 512
           RD+K+ ++LL  +   K+SDFG  A+I   ++     K +VGT
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGT 180

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 21/161 (13%)

Query: 353 LGEGGFGPVYKGKLA-DGKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKL-QHKNLVRLL 407
           +GEG FG V K ++  DG  +  A+KR+   + +   ++F  E+ ++ KL  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDST-------------RSVQLDWKRRISIINGIA 454
           G C       L  EY P+ +L  FL  S               +  L  ++ +     +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           RG+ YL +    + IHRDL   N+L+      KI+DFG++R
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 54/168 (32%), Positives = 78/168 (46%), Gaps = 16/168 (9%)

Query: 353 LGEGGFGPVY------KGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG+GGFG V        GKL   K++  KRL +   +G +    E  ++AK+ H   +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKV-HSRFIVS 57

Query: 407 LGCCLQENESL-LIYEYMPNKSLNVFLFD-STRSVQLDWKRRISIINGIARGLLYLHEDS 464
           L    Q    L L+   M    L   +++    +      R       I  GL +LH+  
Sbjct: 58  LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             +II+RDLK  NVLLD++ N +ISD G+A      QS+  TK   GT
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGT 160

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 15/159 (9%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKN 402
             + + + +GEG +G V        G ++A+K++S    Q   Q    E+ ++ + +H+N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 403 LVRLLGCCLQE-----NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           ++ +L           N+  ++ E M        L+   ++  L        +  I RGL
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQILRGL 119

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+ARI
Sbjct: 120 KYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 14/164 (8%)

Query: 352 KLGEGGFGPV-YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+GEG  G V    +   GK++AVK++     Q  +   NEV ++    H+N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ E++   +L     D     +++ ++  ++   + R L YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR--IVGT 512
           RD+K+ ++LL  +   K+SDFG    F    S+   KR  +VGT
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLVGT 181

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 61.7 bits (149), Expect = 2e-10
 Identities = 43/162 (26%), Positives = 84/162 (51%), Gaps = 10/162 (6%)

Query: 352 KLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+G+G  G VY    +A G+E+A+++++       +   NE+ ++ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ EY+   SL     D      +D  +  ++     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RD+K+ N+LL  + + K++DFG        QS+ +   +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 50/175 (28%), Positives = 86/175 (49%), Gaps = 21/175 (12%)

Query: 353 LGEGGFGPVYKGKLADG-------KEIAVKRLS-----RTSGQGLQEFKNEVTLIAK-LQ 399
           LG G FG VYK +  +        KEI V   +     R   + + +  +EVT+I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDW--KRRISIINGIARGL 457
           H N+VR     L+ +   ++ + +    L    F+S +  +  +  +R  +I   +   L
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            YLH++ R  I+HRDL  +N++L  +    I+DFG+A+     Q E+    +VGT
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGT 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 12/148 (8%)

Query: 353 LGEGGFGPV------YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG+GGFG V        GK+   K++  KRL + SG+ +   + E+  + K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
                 +    L+   M    L   +++      L+ +R I     I  G+L+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---M 114

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMA 494
            I++RD+K  NVLLD + N ++SD G+A
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.5 bits (150), Expect = 3e-10
 Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 27/168 (16%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGKLADGKE-IAVKRLSRTSGQGLQEFKNEVTLIAKLQH 400
           E    + + + +G G +G V           +A+K+LSR        F++ +   AK  +
Sbjct: 12  EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-------FQSAIH--AKRTY 62

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVF-------------LFDSTRSVQLDWKRRI 447
           + L RLL     EN   L+  + P  SL  F             L +  +  +L      
Sbjct: 63  REL-RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQ 121

Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            ++  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 122 FLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 49/150 (32%), Positives = 75/150 (50%), Gaps = 11/150 (7%)

Query: 352 KLGEGGFGPVYKGKLADG---KEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLL 407
           ++G G FG V  G++  G    ++ VK L  ++  Q   +F  E      LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQL---DWKRRISIINGIARGLLYLHEDS 464
           G C +    LL+ E+ P   L  +L  S R  +L   D      +   IA GLL+LH+++
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
               IH DL   N LL  ++  KI D+G++
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 11/164 (6%)

Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+GGFG V   ++   GK  A K+L +      +G Q   NE  ++ K+  + +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
               +++  L+   M    L   +++          R I     I  GL +LH   + +I
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH---QRRI 116

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           ++RDLK  NVLLD   N +ISD G+A    G +     K   GT
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGT 157

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 45/175 (25%), Positives = 85/175 (48%), Gaps = 18/175 (10%)

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQHKN 402
           F  E K+G G F  VY+   L D K +A+K++        +  Q+   E+ L+ +L H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLN--VFLFDSTRSV---QLDWKRRISIINGIARGL 457
           +++ L   +++NE  ++ E      L+  +  F   + +   +  WK  + + + +    
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE--- 120

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
              H  SR +++HRD+K +NV +      K+ D G+ R F    + A++  +VGT
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 18/159 (11%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKR-LSRTSGQGLQEFK-NEVTLIAKLQHKN-LVRLL 407
           K+GEG +G VYK +    GK +A+K+       +G+      E++L+  L     +VRLL
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 408 GCCLQENES-----LLIYEYMPNKSLNVFLFDSTR---SVQLDWKRRISIINGIARGLLY 459
                E ++      L++EY+ +  L  F+ DS        L  K   S +  + +G+ +
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIF 497
            H   +  ++HRDLK  N+L+D +    KI+D G+ R F
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.1 bits (143), Expect = 8e-10
 Identities = 42/158 (26%), Positives = 79/158 (50%), Gaps = 21/158 (13%)

Query: 353 LGEGGFGPVYKGK---LADGK-----EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           LG+G F  ++KG    + D       E+ +K L ++     + F    +++++L HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
              G C+  +ES+++ EY+   SL+ +L  +   + + WK  + +   +A  L +L +  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLEDK- 119

Query: 465 RLKIIHRDLKTSNVLLDHEM-----NP---KISDFGMA 494
              + H ++   NVLL  E      NP   K+SD G++
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 17/151 (11%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVTLIAK------LQHKNLVR 405
           LG+G FG V   +L    E  A+K L +     L++   E T++ +       +H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 406 LLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           L  C  Q  E L  + EY+    L   +F    S + D  R       I  GL +LH+  
Sbjct: 61  LF-CTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              II+RDLK  NVLLD + + KI+DFGM +
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 43/176 (24%), Positives = 84/176 (47%), Gaps = 18/176 (10%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQHK 401
           +F  E K+G G F  VY+   L DG  +A+K++        +   +   E+ L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFL--FDSTRSV---QLDWKRRISIINGIARG 456
           N+++     +++NE  ++ E      L+  +  F   + +   +  WK  + + + +   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
               H  SR +++HRD+K +NV +      K+ D G+ R F    + A++  +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 41/150 (27%), Positives = 74/150 (49%), Gaps = 13/150 (8%)

Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCL 411
           +G G +G VYKG+     ++A  ++   +    +E K E+ ++ K   H+N+    G  +
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 412 ------QENESLLIYEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDS 464
                  +++  L+ E+    S+   + ++   +++ DW   I     I RGL +LH   
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC--REILRGLAHLHAH- 140

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
             K+IHRD+K  NVLL      K+ DFG++
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVS 168

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 13/153 (8%)

Query: 352 KLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN----EVTLIAKLQHKNLVRL 406
           K+GEG +G V+K +  + G+ +A+K+   +    +   K     E+ ++ +L+H NLV L
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV--IKKIALREIRMLKQLKHPNLVNL 65

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
           +    ++ +  L++EY  +  LN  L  + R V     ++I  I    + + + H   + 
Sbjct: 66  IEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKI--IWQTLQAVNFCH---KH 119

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG 499
             IHRD+K  N+L+  +   K+ DFG ARI  G
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 13/164 (7%)

Query: 352 KLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           ++G G +G VYK   L  G+  AVK +    G      + E+ ++ + +H N+V   G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 411 LQENESLLIYEYMPNKSL-NVFLFDSTRS-VQLDWKRRISIINGIARGLLYLHEDSRLKI 468
           L   +  +  EY    SL +++      S +Q+ +  R ++     +GL YLH   ++  
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM-- 128

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            HRD+K +N+LL    + K++DFG+A       + A  K  +GT
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKSFIGT 169

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 44/165 (26%), Positives = 84/165 (50%), Gaps = 15/165 (9%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           ++G G +G VYK + +  G+  A+K +    G+     + E+ ++   +H N+V   G  
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75

Query: 411 LQENESLLIYEYMPNKSL-NVFLFDSTRS-VQLDWKRRISIINGIARGLLYLHEDSRLKI 468
           L+ ++  +  E+    SL +++      S  Q+ +  R ++     +GL YLH   +   
Sbjct: 76  LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK--- 127

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGM-ARIFGGNQSEANTKRIVGT 512
           +HRD+K +N+LL    + K++DFG+ A+I     + A  K  +GT
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGT 169

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 43/153 (28%)

Query: 369 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLLGCCLQENESLLI 419
           G+ +A+K+LSR        F+N         E+ L+  + HKN++ LL            
Sbjct: 41  GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83

Query: 420 YEYMPNKSLNVF--------LFDST--RSVQ--LDWKRRISIINGIARGLLYLHEDSRLK 467
             + P KSL  F        L D+   + +Q  LD +R   ++  +  G+ +LH      
Sbjct: 84  --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
           IIHRDLK SN+++  +   KI DFG+AR  G +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 17/151 (11%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVTLIAK------LQHKNLVR 405
           LG+G FG V   +L    E+ A+K L +     LQ+   + T+  K       +H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 406 LLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           L  CC Q  + L  + EY+    L   +F   RS + D  R       +   L++LH   
Sbjct: 61  LH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLH--- 113

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           R  +I+RDLK  N+LLD E + K++DFGM +
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 9/159 (5%)

Query: 352 KLGEGGFG-PVYKGKLADGKEIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           K+GEG FG  +      DGK+  +K +  S+ S +  +E + EV +++ ++H N+V+   
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
              +EN +L ++ +Y     L     ++ R V     + +     I   L ++H+    K
Sbjct: 67  S-FEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---K 121

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           I+HRD+K+ N+ L  +   K+ DFG+AR+       A T
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 28/105 (26%), Positives = 53/105 (50%), Gaps = 6/105 (5%)

Query: 391 EVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII 450
           E  L+  + H +++R+    +    + ++   +P+ S +++ + + RS  L   + + I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             I  GL YLH     +IIHRD+KT N+ ++      I D G A+
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 22/163 (13%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN--------------EVTLI 395
             LGEG +G V K      GK +A+K++                           E+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
            +++H+N++ L+   ++ +   L+ + M +    V      R ++L   +   I+  I  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVV----DRKIRLTESQVKCILLQILN 130

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           GL  LH+      +HRDL  +N+ ++ +   KI+DFG+AR +G
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170

Length = 335

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.5 bits (137), Expect = 9e-09
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 14/151 (9%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN--EVTLIAKLQ-HKNLVRL 406
            K+GEG F  V K +    GK  A+K + +   + L++  N  E+  + +L  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 407 LGCCL-QENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           +     ++   L L++E M    +N++     R   L  KR  S +  + + L ++H   
Sbjct: 64  IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--- 117

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           R  I HRD+K  N+L+  +   K++DFG  R
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 30/62 (48%), Positives = 37/62 (59%), Gaps = 9/62 (14%)

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSEANTKRIV 510
           IA GL +LH      II+RDLK  NV+LD E + KI+DFGM +  IFGG      T+   
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162

Query: 511 GT 512
           GT
Sbjct: 163 GT 164

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 26/155 (16%)

Query: 353 LGEGGFGPVYKGKLADGKE-IAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           +G G FG V+  +    +   A+K ++       +  Q   NE  ++ ++ H  ++RL  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLYL 460
               +    ++ EY+P   L  +L +S          R S  N             L YL
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNS---------GRFS--NSTGLFYASEIVCALEYL 117

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           H     +I++RDLK  N+LLD E + K++DFG A+
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 25/167 (14%)

Query: 342 EATQHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKN--EVTLIA 396
           E  + + +   +G G +G V   Y  +L   +++AVK+LSR     +   +   E+ L+ 
Sbjct: 12  EVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLK 69

Query: 397 KLQHKNLVRLL-----GCCLQE-NESLLIYEYMPNKSLNVFLFD--STRSVQLDWKRRIS 448
            ++H+N++ LL        ++  NE  L+   M     N+      S   VQ        
Sbjct: 70  HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF------- 122

Query: 449 IINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +I  + RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 47/139 (33%), Positives = 70/139 (50%), Gaps = 25/139 (17%)

Query: 369 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL 428
           G  +AVK+LSR        F+N+    AK  ++ LV LL C   +N   L+  + P KSL
Sbjct: 46  GINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSL 95

Query: 429 NVF--------LFDSTRS----VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTS 476
             F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK S
Sbjct: 96  EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 152

Query: 477 NVLLDHEMNPKISDFGMAR 495
           N+++  +   KI DFG+AR
Sbjct: 153 NIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 44/145 (30%), Positives = 71/145 (48%), Gaps = 12/145 (8%)

Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCC 410
           LG G  G VYK   L   + +AVK +       LQ +  +E+ ++ K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
             EN   +  E+M   SL+V+     R +      RI++   + +GL YL     LKI+H
Sbjct: 69  FVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAV--AVVKGLTYLWS---LKILH 118

Query: 471 RDLKTSNVLLDHEMNPKISDFGMAR 495
           RD+K SN+L++     K+ DFG++ 
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 47/151 (31%), Positives = 64/151 (42%), Gaps = 20/151 (13%)

Query: 353 LGEGGFGPV----YKGKLADGKEIAVKRL------SRTSGQGLQEFKNEVTLIAKLQHKN 402
           LG G FG V    YK     G+  A+K L      +R   + L   K         +H  
Sbjct: 7   LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           LV L  C   E+    + EY     L + +            R +     +  GL YLHE
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHE 119

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGM 493
           +   KI++RDLK  N+LLD E   KI+DFG+
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 17/163 (10%)

Query: 342 EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN---EVTLIAK 397
           E  + + + + +G G +G V        G  +AVK+LSR   Q +   K    E+ L+  
Sbjct: 14  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKH 72

Query: 398 LQHKNLVRLL-----GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING 452
           ++H+N++ LL        L+E   + +  ++    LN    +  +  +L       +I  
Sbjct: 73  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQ 128

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 129 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 53/159 (33%), Positives = 76/159 (47%), Gaps = 17/159 (10%)

Query: 353 LGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAK----LQHKN-LVRL 406
           LG+G FG V   +L   G+  AVK L +     L +   E T++ K    L  +N  +  
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 407 LGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L C  Q  E L  + E++    L   + D  R    D  R       I  GL +LH    
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG- 116

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQS 502
             II+RDLK  NV+LD + + KI+DFGM +  +FG N++
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 52/170 (30%), Positives = 77/170 (45%), Gaps = 23/170 (13%)

Query: 353 LGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAK------LQHKNLVR 405
           LG+G FG V+  +L    +  A+K L +     L +   E T++ K       +H  L  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 406 LLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           L  C  Q  E+L  + EY+    L   +F      + D  R       I  GL +LH   
Sbjct: 61  LY-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSEANTKRIVGT 512
              I++RDLK  N+LLD + + KI+DFGM +  + G    +A T    GT
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGT 159

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)

Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 50  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99

Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156

Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG 177

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + RGL Y+H      +IHRDLK SN+L++ +   +I DFGMAR
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 17/162 (10%)

Query: 356 GGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN---EVTLIAKLQHKNLVRLLGCCL 411
           G FG VY   K + G   A+K L ++      +  N   E  ++        V  L    
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 412 QENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           Q  + L L+ EY+        L  +   +  DW ++   I  +  G+  LH+     IIH
Sbjct: 67  QSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---IIH 120

Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RD+K  N+L+D   + K++DFG++R    N      K+ VGT
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLEN------KKFVGT 156

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 27/168 (16%)

Query: 342 EATQHFSDENKLGEGGFGPV-YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH 400
           E    + D  ++G G +G V        G ++A+K+L R        F++E  L AK  +
Sbjct: 12  EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-------FQSE--LFAKRAY 62

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFL-------FDSTRSVQLDWKRRIS----- 448
           + L RLL     EN   L+  + P+ SL+ F        F  T   +L    ++S     
Sbjct: 63  REL-RLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQ 121

Query: 449 -IINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR
Sbjct: 122 FLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)

Query: 350 ENKLGEGGFGPVY--KGKLADG-------KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH 400
           + +LG+G FG VY  K K A         KEI V  L+    + +Q    E  L++KL H
Sbjct: 5   QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN--PNETVQA-NQEAQLLSKLDH 61

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGIARGLLY 459
             +V+     L+ +   +I EY   + L+  L +   + + L   +       +  G+ Y
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           +H+    +I+HRDLK  N+ L + +  KI DFG++R+  G+   A T
Sbjct: 122 MHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 20/153 (13%)

Query: 352 KLGEGGFGPVYKGKLADGKEIA---VKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLL 407
           ++G G FG V   ++     +A   VK L   +    Q EF  +      LQH N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS-------IINGIARGLLYL 460
           G C++    LL++EY     L  +L       Q  W RR S       +   IA G+ ++
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM 493
           H   +   +H DL   N  L  ++  K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.6 bits (128), Expect = 1e-07
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)

Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 43  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLE 92

Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 93  EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 149

Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 150 IVVKSDCTLKILDFGLARTAG 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 12/150 (8%)

Query: 351 NKLGEGGFGPVYK------GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           ++LG+G +G VYK      G     KEI   RL     +   +   E+ ++ K     +V
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLELDESK-FNQIIMELDILHKAVSPYIV 62

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
              G    E    +  EYM   SL+        +  +       I   + +GL +L E+ 
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE- 121

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
              IIHRD+K +NVL++     K+ DFG++
Sbjct: 122 -HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 12/148 (8%)

Query: 353 LGEGGFGPV------YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG+GGFG V        GK+   K++  KR+ +  G+ +    NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
                 ++   L+   M    L   ++    +   +  R +     I  GL  LH++   
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQE--- 121

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           +I++RDLK  N+LLD   + +ISD G+A
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 12/160 (7%)

Query: 342 EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSR--TSGQGLQEFKNEVTLIAKL 398
           E  + ++   ++G G +G V        G+++A+K+LSR   S    +    E+TL+  +
Sbjct: 12  ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM 71

Query: 399 QHKNLVRLLGCCLQE---NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
           QH+N++ LL         +E    Y  MP    ++          L   +   ++  +  
Sbjct: 72  QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL---QKIMGHPLSEDKVQYLVYQMLC 128

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR
Sbjct: 129 GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 13/100 (13%)

Query: 421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL 480
           E+M   SL+  L      +  +   +ISI   + RGL YL E  + KI+HRD+K SN+L+
Sbjct: 79  EHMDGGSLDQVL-KKAGRIPENILGKISI--AVLRGLTYLRE--KHKIMHRDVKPSNILV 133

Query: 481 DHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
           +     K+ DFG        MA  F G +S  + +R+ GT
Sbjct: 134 NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 173

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 17/158 (10%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKN----EVTLIAKLQHKNLVRLL 407
           +GEG +G V K +  + KEI A+K+   +     +E K     E+ ++  L+ +N+V L 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
               +  +  L++EY+    L   L +   +     K R S I  + + + + H++    
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKN---D 120

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           I+HRD+K  N+L+ H    K+ DFG AR    N SE +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFAR----NLSEGS 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 43/148 (29%), Positives = 71/148 (47%), Gaps = 12/148 (8%)

Query: 353 LGEGGFGPV------YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG+GGFG V        GK+   K++  KR+ +  G+ +    NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
                 ++   L+   M    L   +++       D +R +     I  GL  LH   R 
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLH---RE 121

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           +I++RDLK  N+LLD   + +ISD G+A
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 56/193 (29%), Positives = 86/193 (44%), Gaps = 18/193 (9%)

Query: 332 FPLFPLHLAVEATQHFSDE----NKLGEGGFGPVYK-GKLADGKEIAVKRLSRTSGQGLQ 386
           FP     L +E+    +D       +G+G +G VYK     DG   AVK L   S    +
Sbjct: 5   FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-E 63

Query: 387 EFKNEVTLIAKL-QHKNLVRLLGCCLQENESL-----LIYEYMPNKSLNVFLFDSTRSVQ 440
           E + E  ++  L  H N+V+  G   + ++ +     L+ E     S+   +       Q
Sbjct: 64  EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123

Query: 441 -LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG 499
            LD      I+ G   GL +LH +   +IIHRD+K +N+LL  E   K+ DFG++     
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180

Query: 500 NQSEANTKRIVGT 512
            +   NT   VGT
Sbjct: 181 TRLRRNTS--VGT 191

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 12/148 (8%)

Query: 353 LGEGGFGPV------YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG+GGFG V        GK+   K++  KR+ +  G+ +    NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
                 ++   L+   M    L   +++       D +R I     +  GL  L    R 
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQ---RE 121

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           +I++RDLK  N+LLD   + +ISD G+A
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 52/166 (31%), Positives = 75/166 (45%), Gaps = 15/166 (9%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVT----LIAKLQHKNLVRLL 407
           +G+G FG V   K  ADGK  AVK L + +    +E K+ +     L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 408 GCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
               Q  + L  + +Y+    L    F   R       R       IA  L YLH    L
Sbjct: 62  HYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---L 115

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            II+RDLK  N+LLD + +  ++DFG+ +   G +    T    GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 42/174 (24%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN-----EVTLIAKLQH--KNLV 404
           +G G  G VYK +    G  +AVK++ RT  +  +E K      +V L     H    +V
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVL---KSHDCPYIV 77

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS----------IINGIA 454
           +  G  + +++  +  E M           ST   +L   +RI           +   I 
Sbjct: 78  KCYGYFITDSDVFICMELM-----------STCLDKL--LKRIQGPIPEDILGKMTVAIV 124

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSEANTK 507
           + L YL E     +IHRD+K SN+LLD   N K+ DFG++ R+     S+A T+
Sbjct: 125 KALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR 173

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 33/160 (20%)

Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKRLS----------RTSGQGLQEFKNEVTLIAKLQHK 401
           +G G +G V   K ++  +++A+K+++          RT    L+E K    L+  L H+
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT----LREIK----LLRHLDHE 64

Query: 402 NLVRLLGCCL-----QENESLLIYEYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGIAR 455
           N++ +            N+  ++YE M        L    RS Q L        +  + R
Sbjct: 65  NVIAIKDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLR 119

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           GL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 30/110 (27%), Positives = 54/110 (49%), Gaps = 19/110 (17%)

Query: 391 EVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII 450
           E  ++  + H ++++L G       + LI   +P    +++ +       L  KR I+I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCY-------LAAKRNIAIC 182

Query: 451 NGIA------RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           + +A      R + YLHE+    IIHRD+K  N+ ++H  +  + DFG A
Sbjct: 183 DILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 28/155 (18%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRT----SGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           +G G FG V+  +  D  ++ A+K L ++      Q +   + E  ++A      +V+L 
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKLY 67

Query: 408 GCCLQENESL-LIYEYMPNKSL-------NVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
               Q+ E L L+ EYMP   L       +VF  ++ R               IA  +L 
Sbjct: 68  -YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-------------IAELVLA 113

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           L    +L  IHRD+K  N+L+D + + K++DFG+ 
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 15/150 (10%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVTLIAK----LQHKN-LVRL 406
           LG+G FG V   +     E+ A+K L +     +Q+   E T++ K    LQ K   +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPFLTQ 65

Query: 407 LGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L  C Q  + L  + EY+    L   ++   +  +    + +     I+ GL +LH    
Sbjct: 66  LHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG- 121

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             II+RDLK  NV+LD E + KI+DFGM +
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 14/150 (9%)

Query: 353 LGEGGFGPVY-----KGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVR 405
           LG+G FG V+      G  A G+  A+K L + +   +     K E  ++A++ H  +V+
Sbjct: 4   LGQGSFGKVFLVRKITGPDA-GQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L      E +  LI +++    L   L       + D K  ++    +A  L +LH    
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDHLH---S 116

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L II+RDLK  N+LLD E + K++DFG+++
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 15/176 (8%)

Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           F   ++LG G  G V K +      I  ++L     +     +   E+ ++ +     +V
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
              G    + E  +  E+M   SL+  L ++ R +  +   ++SI   + RGL YL E  
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSI--AVLRGLAYLRE-- 121

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
           + +I+HRD+K SN+L++     K+ DFG        MA  F G +S  + +R+ GT
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 22/169 (13%)

Query: 353 LGEGGFGP--VYKGKLADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           +GEG FG   + +   +D K  A+K  RL ++S   +++ + E  L+AK++H N+V    
Sbjct: 8   VGEGSFGRALLVQHVNSDQK-YAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDS-----TRSVQLDWKRRISIINGIARGLLYLHED 463
               +    ++ EY     L   +             L W  ++ +      G+ ++HE 
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK 119

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
              +++HRD+K+ N+ L      K+ DFG AR+     + A T   VGT
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGT 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 12/148 (8%)

Query: 353 LGEGGFGPV------YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG+GGFG V        GK+   K +  KR+ +  G+ +    NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
                 ++   L+   M    L   +++       + +R +     I  GL  LH ++  
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHREN-- 122

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMA 494
             ++RDLK  N+LLD   + +ISD G+A
Sbjct: 123 -TVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 24/58 (41%), Positives = 36/58 (62%), Gaps = 3/58 (5%)

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIV 510
           I RGL YLH      I+HRD+K  N+L++     KI DFG+AR+   ++S+  T+ +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 30/164 (18%)

Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSR----TSGQGLQEFKNEVTLIAKLQHKNLV 404
           LG+GG+G V++ +   G +     A+K L +     + +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 405 RLLGCCLQENESLLIYEYMPNKSL-------NVFLFDSTRSVQLDWKRRISIINGIARGL 457
            L+       +  LI EY+    L        +F+ D+              ++ I+  L
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY----------LSEISLAL 113

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGG 499
            +LH   +  II+RDLK  N+LLD + + K++DFG+ +  I  G
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 43/163 (26%), Positives = 68/163 (41%), Gaps = 26/163 (15%)

Query: 345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQH 400
             F     LG G FG V   K    G+  A+K L +      + +Q    E +++ +L H
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR----- 455
             +V ++     EN    + E++    L    F   R             N +A+     
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGEL----FTHLRKAG-------RFPNDVAKFYHAE 126

Query: 456 ---GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                 YLH      II+RDLK  N+LLD++ + K++DFG A+
Sbjct: 127 LVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166

Length = 329

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 48.3 bits (115), Expect = 4e-06
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H  LV L  C   E+    + E++    L   +F   R  +L  +        I+  L +
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNF 111

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           LHE     II+RDLK  NVLLD E + K++D+GM +
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 34/128 (26%), Positives = 60/128 (46%), Gaps = 12/128 (9%)

Query: 367 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNK 426
              K++ VK     +  G +    E+ ++  + H+ ++ L+     ++   ++   MP  
Sbjct: 117 EQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKY 168

Query: 427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP 486
             ++F +   RS  L  ++ I+I   +   L YLH      IIHRD+KT N+ LD   N 
Sbjct: 169 KCDLFTY-VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENA 224

Query: 487 KISDFGMA 494
            + DFG A
Sbjct: 225 VLGDFGAA 232

Length = 392

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 36/177 (20%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQHKNLVR---- 405
           +G+G +G V   +   DGK+  +K+L+    S +  +  + E  L+++L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 406 ----------LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
                     ++G C    E   +Y  +  +   +       +  ++W  +I      A 
Sbjct: 68  WEGEDGLLYIVMGFC----EGGDLYHKLKEQKGKLLP----ENQVVEWFVQI------AM 113

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            L YLHE     I+HRDLKT NV L      K+ D G+AR+       A+T  ++GT
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 19/163 (11%)

Query: 352 KLGEGGFGPVYKGKLA---DGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQ-HKNLVR 405
           +LG+G +G V   + A   + + +A+K+++    + +  +    E+ L+   + HKN+  
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66

Query: 406 LLGCCL----QENESLLIYEYMPNKSLNVFLFDSTRS-VQLDWKRRISIINGIARGLLYL 460
           L    +      NE L +YE +    L+  +    RS   L      S I  I  GL Y+
Sbjct: 67  LYDMDIVFPGNFNE-LYLYEELMEADLHQII----RSGQPLTDAHFQSFIYQILCGLKYI 121

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           H  +   ++HRDLK  N+L++ +   KI DFG+AR F  N  E
Sbjct: 122 HSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 47.2 bits (112), Expect = 7e-06
 Identities = 40/161 (24%), Positives = 77/161 (47%), Gaps = 25/161 (15%)

Query: 353 LGEGGFGPVYKGKLAD---------GKEIAVKRLSRTSGQGLQE----FKNEVTLIAKLQ 399
           LG G    +Y G L             E  +K + +      ++    F    +++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           HK++V L G C+++ E++++ E++    L++F+   +  +   WK +++    +A  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVA--KQLASALSY 120

Query: 460 LHEDSRLKIIHRDLKTSNVLL-----DHEMNP--KISDFGM 493
           L ED  L  +H ++ T N+LL     D E  P  K+SD G+
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.4 bits (112), Expect = 9e-06
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H  LV L  C   E+    + EY+    L   +F   R  +L  +        I+  L Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           LHE     II+RDLK  NVLLD E + K++D+GM +
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)

Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           F   ++LG G  G V+K        I  ++L     +     +   E+ ++ +     +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHED 463
              G    + E  +  E+M   SL+  L  + R   Q+  K  I++I    +GL YL E 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 121

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
            + KI+HRD+K SN+L++     K+ DFG        MA  F G +S  + +R+ GT
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 44/180 (24%), Positives = 73/180 (40%), Gaps = 37/180 (20%)

Query: 353 LGEGGFGPVYKGK-------------LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           LG G  G V K K                 K    K++ R           E+ ++ + +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR-----------ELQIMHECR 61

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
              +V   G  L EN   +  E+M   SL+  ++     + ++   +I     +  GL Y
Sbjct: 62  SPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKI--AVAVVEGLTY 118

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVG 511
           L+   R  I+HRD+K SN+L++     K+ DFG        +A  F G  +  + +RI G
Sbjct: 119 LYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQG 176

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 23/43 (53%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           IA GL +LH      II+RDLK  NV+LD E + KI+DFGM +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 43/156 (27%), Positives = 66/156 (42%), Gaps = 24/156 (15%)

Query: 353 LGEGGFGPV-YKGKLADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           +G+G FG V    K   GK  A+K L ++       L   K E  ++A+     +V L  
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68

Query: 409 CCLQENESLLIYEYMPNKSL-------NVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
                    LI E++P   L       + F  D TR               +A  +L + 
Sbjct: 69  SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY-------------MAECVLAIE 115

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
              +L  IHRD+K  N+L+D   + K+SDFG++  F
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 50/166 (30%), Positives = 74/166 (44%), Gaps = 15/166 (9%)

Query: 353 LGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVT----LIAKLQHKNLVRLL 407
           +G+G FG V   K  +DG   AVK L + +    +E  + +     L+  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61

Query: 408 GCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
               Q  E L  + +Y+    L    F   R       R       +A  + YLH    L
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHS---L 115

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            II+RDLK  N+LLD + +  ++DFG+ +   G + E  T    GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 15/160 (9%)

Query: 353 LGEGGFGPVY----KGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLV 404
           LG G +G V+     G    GK  A+K L + +     +  +  + E  ++  ++    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 405 RLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
             L    Q +  L LI +Y+    L   L+                I  I   L +LH+ 
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALDHLHQ- 123

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
             L II+RD+K  N+LLD E +  ++DFG+++ F   + E
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 28/154 (18%)

Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLL 407
           +G G FG V   +  D G   A+K+L ++      Q +   + E  ++A+  +  +V+L 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKLY 67

Query: 408 GCCLQENESL-LIYEYMPNKSL-------NVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
               Q+   L LI EY+P   +       + F  + TR               IA  +L 
Sbjct: 68  -YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY-------------IAETILA 113

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM 493
           +    +L  IHRD+K  N+LLD + + K+SDFG+
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 20/150 (13%)

Query: 356 GGFGPVYKG-KLADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           G FG VY G K  + K  AVK + +    +   + + + E   +A  +   +V L     
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 412 QENESLLIYEYMPNKSLNVFL-----FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
             N   L+ EY+    +   L     FD   +V+         I+ +A  L YLH   R 
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--------ISEVALALDYLH---RH 123

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
            IIHRDLK  N+L+ +E + K++DFG++++
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 52/177 (29%), Positives = 79/177 (44%), Gaps = 46/177 (25%)

Query: 351 NKLGEGGFGPVYKGKLADGKE-IAVKRLSRTSGQGLQEFKNEVTLIAK-LQHKNLVRLLG 408
           N +G G FG VY+    D  E +A+K++ +       ++KN   LI K L H N++ L  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126

Query: 409 C----CLQENESLL----IYEYMP-------------NKSLNVFLFDSTRSVQLDWKRRI 447
                C ++NE  +    + E++P             N +L +FL     S QL      
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-KLYSYQL------ 179

Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR-IFGGNQS 502
                  R L Y+H      I HRDLK  N+L+D   +  K+ DFG A+ +  G +S
Sbjct: 180 ------CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS 227

Length = 440

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 13/149 (8%)

Query: 353 LGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVT----LIAKLQHKNLVRLL 407
           +G+G FG V   K   DGK  AVK L +      +E K+ +     L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 408 GCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
               Q  E L  + +++    L    F   R       R       IA  L YLH    +
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---I 115

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            I++RDLK  N+LLD + +  ++DFG+ +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.1 bits (106), Expect = 6e-05
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 16/149 (10%)

Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +  KR+   S   +Q  +NE+  + +L H+N++++     +E        YM  +  +
Sbjct: 193 ERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKI-----EEILRSEANTYMITQKYD 246

Query: 430 VFLFDSTRSVQLDWKRRI------SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE 483
             L+        DWK R       +I+  +   + Y+H+    K+IHRD+K  N+ L+ +
Sbjct: 247 FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303

Query: 484 MNPKISDFGMARIFGGNQSEANTKRIVGT 512
               + DFG A  F   + EA     VGT
Sbjct: 304 GKIVLGDFGTAMPF-EKEREAFDYGWVGT 331

Length = 501

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.8 bits (106), Expect = 8e-05
 Identities = 46/188 (24%), Positives = 67/188 (35%), Gaps = 58/188 (30%)

Query: 347 FSDENKLGEGGFGPVYKGKLAD-----GKEIAVK--------------RLSRTSGQGLQE 387
           F    KLGEG FG VYK  L +       +  +K              R+ R       +
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193

Query: 388 F------------KNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL--NV--F 431
           F            ++E  L+ +               E ES L  + M +K    NV  +
Sbjct: 194 FVYGFLEPVSSKKEDEYWLVWRY--------------EGESTL-ADLMQSKEFPYNVEPY 238

Query: 432 LFDSTRSVQLDWKRRISIINGIARGLLY----LHEDSRLKIIHRDLKTSNVLLDHEMNP- 486
           L    + +    +R   II  I R +L+    LH      I+HRD+K  N++        
Sbjct: 239 LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSF 295

Query: 487 KISDFGMA 494
           KI D G A
Sbjct: 296 KIIDLGAA 303

Length = 566

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 36/138 (26%), Positives = 61/138 (44%), Gaps = 13/138 (9%)

Query: 369 GKEIAVKRLSRTSGQGLQE---FKNEVTLIAKLQHKNLVRLLGCCLQENESLL-IYEYMP 424
           G E+A+K L   + +   +   F+ E  L A+L H N+V LL         L  ++EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---D 481
            ++L   L  +     L       ++  +   L   H      I+HRDLK  N+++    
Sbjct: 63  GRTLREVL--AADGA-LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116

Query: 482 HEMNPKISDFGMARIFGG 499
              + K+ DFG+  +  G
Sbjct: 117 VRPHAKVLDFGIGTLLPG 134

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 32/151 (21%), Positives = 53/151 (35%), Gaps = 15/151 (9%)

Query: 348 SDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV--R 405
           S    L  G    VY     D     +K           + + EV ++  L  K L   +
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDED-YVLKINPSREKG--ADREREVAILQLLARKGLPVPK 57

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           +L     +  S L+ E++  ++L     D     + +          +A  L  LH+   
Sbjct: 58  VLASGESDGWSYLLMEWIEGETL-----DEVSEEEKEDIAEQ-----LAELLAKLHQLPL 107

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
           L + H DL   N+L+D      I D+  A  
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 6/93 (6%)

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           LV L  C    +   L+ EY+    L   +F   R  +L  +        I   L +LHE
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                II+RDLK  NVLLD + + K++D+GM +
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 30/141 (21%), Positives = 56/141 (39%), Gaps = 7/141 (4%)

Query: 353 LGEGGFGPVYKGKLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
             +     + K K      +AVK+  L   S + L+  + E+    +LQH N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           + ++E  ++   M   S    L  +     L       I+  +   L Y+H       IH
Sbjct: 69  IVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIH 124

Query: 471 RDLKTSNVLLDHEMNPKISDF 491
           R +K S++LL  +    +S  
Sbjct: 125 RSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 26/93 (27%), Positives = 52/93 (55%), Gaps = 5/93 (5%)

Query: 388 FKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI 447
           F    +L++++ H +L  + G C++ +E++++ E++ +  L+V L      V + WK  I
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120

Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL 480
           ++   +A  L YL ED  L  +H ++   N+LL
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 12/164 (7%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVT---LIAKLQHKNLVRLLG 408
           LG+G FG V   +  A GK  A+K L +       E  + +T   ++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
               ++    + EY+    L    F  +R       R       I   L YLH     KI
Sbjct: 63  SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           ++RDLK  N++LD + + KI+DFG+ +   G    A  K   GT
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 28/175 (16%)

Query: 353 LGEGGFGPVYK-GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCC 410
           +G+G +G V+K     +G + AVK L        +E + E  ++  L  H N+V+  G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 411 LQEN-----ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKR--RIS------IINGIARGL 457
            +++     +  L+ E     S+       T  V+   KR  R+       I++    GL
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSV-------TDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            +LH +   K IHRD+K +N+LL  E   K+ DFG++      +   NT   VGT
Sbjct: 138 QHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGT 187

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 28/127 (22%), Positives = 47/127 (37%), Gaps = 34/127 (26%)

Query: 376 RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC------LQENESLLIYEYMPNKSLN 429
           R  RT        + E  ++AK       R  G        +  +  L++ EY+  + L 
Sbjct: 42  RRERT--------RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLK 87

Query: 430 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 489
             L           + R  ++  + R +  LH+     I+H DL TSN++L         
Sbjct: 88  DAL----------EEARPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFI 133

Query: 490 DFGMARI 496
           DFG+   
Sbjct: 134 DFGLGEF 140

Length = 204

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 17/152 (11%)

Query: 353 LGEGGFGPVYKGKLADGK--EIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLL 407
           LG G FG V      +     +A+KR  ++     + +    +E  ++  + H   V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTR---SVQLDWKRRISIINGIARGLLYLHEDS 464
           G    E+   L+ E++       FL  + R    V   +  +I +I        YL    
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI------FEYLQS-- 149

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
            L I++RDLK  N+LLD +   K++DFG A++
Sbjct: 150 -LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180

Length = 340

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 18/42 (42%), Positives = 26/42 (61%), Gaps = 3/42 (7%)

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
           R L Y+H  +   + HRDLK  N+L + +   KI DFG+AR+
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQE---FKNEVTLIAKLQHKNLVRLLG 408
           +G G FG V   +    +++ A+K LS+       +   F  E  ++A      +V+L  
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 109

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           C  Q+++ L ++ EYMP   L   +  S   V   W +  +     A  +L L     + 
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYT-----AEVVLALDAIHSMG 162

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFG 492
           +IHRD+K  N+LLD   + K++DFG
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 17/161 (10%)

Query: 353 LGEGGFGPVYKGKLADG----KEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLV 404
           LG G +G V+  +   G    K  A+K L + +     +  +  + E  ++  ++    +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 405 RLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING-IARGLLYLHE 462
             L    Q +  L LI +Y+    L   L    R  +    + + I +G I   L +LH 
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHLH- 122

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
             +L II+RD+K  N+LLD   +  ++DFG+++ F  ++ E
Sbjct: 123 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 42.4 bits (100), Expect = 5e-04
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 21/165 (12%)

Query: 345 QHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRT-SGQGL--QEFKNEVTLIAKLQH 400
           Q +     +G+GG G VY        + +A+K++    S   L  + F  E  + A L H
Sbjct: 2   QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61

Query: 401 KNLVRLLGCCLQENESLLIYEYMPN------KSL--NVFLFDSTRS---VQLDWKRRISI 449
             +V +   C   ++   +Y  MP       KSL  +V+  +S       +      +SI
Sbjct: 62  PGIVPVYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118

Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
            + I   + Y+H  S+  ++HRDLK  N+LL       I D+G A
Sbjct: 119 FHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAA 160

Length = 932

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.8 bits (98), Expect = 6e-04
 Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +ARG+ +L   SR K IHRDL   N+LL      KI DFG+AR
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.8 bits (98), Expect = 6e-04
 Identities = 39/128 (30%), Positives = 55/128 (42%), Gaps = 18/128 (14%)

Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYK------GKL 366
           GN+Y++         E  EFP   L               LG G FG V +      GK 
Sbjct: 16  GNNYTFIDPTQLPYNEKWEFPRDNLQFG----------KTLGAGAFGKVVEATAFGLGKE 65

Query: 367 ADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
            +   +AVK L  ++    +E   +E+ +++ L QHKN+V LLG C      L+I EY  
Sbjct: 66  DNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCC 125

Query: 425 NKSLNVFL 432
              L  FL
Sbjct: 126 YGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 41.3 bits (97), Expect = 7e-04
 Identities = 17/43 (39%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           I   L YLH      +++RDLK  N++LD + + KI+DFG+ +
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 41.3 bits (97), Expect = 9e-04
 Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 13/145 (8%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQE---FKNEVTLIAKLQHKNLVRLLG 408
           +G G FG V   +    K++ A+K LS+       +   F  E  ++A    + +V+L  
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH- 109

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
              Q+++ L ++ EYMP   L V L  S   +   W R        A  +L L     + 
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDIPEKWARFY-----TAEVVLALDAIHSMG 162

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFG 492
            IHRD+K  N+LLD   + K++DFG
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.4 bits (97), Expect = 9e-04
 Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 14/127 (11%)

Query: 390 NEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI 449
           +E  L+ +L H  ++ LL   +    + L+   +P    +++ +   R   L   +    
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261

Query: 450 INGIARGLL----YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           +  +AR LL    Y+H +    IIHRD+KT NVL++   +  + DFG A    G+ S   
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 506 TKRIVGT 512
              I GT
Sbjct: 319 HYGIAGT 325

Length = 461

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 41.6 bits (97), Expect = 9e-04
 Identities = 24/55 (43%), Positives = 33/55 (60%), Gaps = 7/55 (12%)

Query: 444 KRRISIINGIAR----GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           KR I++I G+ R    GL  LH   R+ I+HRD+K  N+L+  +   KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 11/148 (7%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVT----LIAKLQHKNLVRLL 407
           +G+G FG V   +  A+ K  AVK L + +    +E K+ ++    L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
                 ++   + +Y+    L  F         L+ + R      IA  L YLH    L 
Sbjct: 63  FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS---LN 116

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           I++RDLK  N+LLD + +  ++DFG+ +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 50/167 (29%), Positives = 79/167 (47%), Gaps = 17/167 (10%)

Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKRLSRTS---GQGLQEFKNE---VTLIAKLQHKNLVR 405
           +G GGFG VY  + AD GK  A+K L +      QG     NE   ++L++      +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           +       ++   I + M    L+  L  S   V  + + R      I  GL ++H  +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATE-IILGLEHMH--NR 116

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 48/164 (29%), Positives = 71/164 (43%), Gaps = 11/164 (6%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN--LVRLLGC 409
           LG+G FG V   K  A G+  A+K L +       E  + +T    LQ+     +  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 410 CLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
             Q ++ L  + EY     L    F  +R       R       I   L YLH  S   +
Sbjct: 63  SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEKNV 117

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           ++RDLK  N++LD + + KI+DFG+ +   G +  A  K   GT
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 21/60 (35%), Positives = 32/60 (53%), Gaps = 5/60 (8%)

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           I   L YLH      +++RD+K  N++LD + + KI+DFG+ +   G    A  K   GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +ARG+ +L   SR K IHRDL   N+LL      KI DFG+AR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 22/58 (37%), Positives = 32/58 (55%), Gaps = 3/58 (5%)

Query: 438 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            + LD +  +S    +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 262

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)

Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKN--LVRL 406
           +G GGFG VY  + AD GK  A+K L +      QG     NE  +++ +   +   +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 407 LGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           +       + L  I + M    L+  L  S   V  + + R      I  GL ++H  +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAE-IILGLEHMH--NR 116

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 17/54 (31%), Positives = 30/54 (55%)

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
            A  L  L    +  +I+RDLK  N+LLD++ +  + DFG+ ++   +  + NT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 39.2 bits (92), Expect = 0.004
 Identities = 46/160 (28%), Positives = 66/160 (41%), Gaps = 26/160 (16%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN---EVTLIAKLQH 400
           +HF     LG+G  G V+  +L   GK  A+K L +       + K    E  ++A L H
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 401 KNLVRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR---- 455
             L  L     Q    L L+ +Y P   L   L    +       + +S    +AR    
Sbjct: 61  PFLPTLY-ASFQTETYLCLVMDYCPGGELFRLL--QRQP-----GKCLSE--EVARFYAA 110

Query: 456 ----GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF 491
                L YLH    L I++RDLK  N+LL    +  +SDF
Sbjct: 111 EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDF 147

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 19/51 (37%), Positives = 32/51 (62%), Gaps = 3/51 (5%)

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           I   L +LH   +L I++RD+K  N+LLD E +  ++DFG+++ F   + E
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	512
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	99.98
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.96
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.96
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.96
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.96
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.95
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.95
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.95
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.95
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.94
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.94
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.94
KOG0198	313	consensus MEKK and related serine/threonine protei	99.94
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.94
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.94
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.93
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.93
KOG0578	550	consensus p21-activated serine/threonine protein k	99.93
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.93
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.93
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.93
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.93
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.93
KOG0605	550	consensus NDR and related serine/threonine kinases	99.93
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.93
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.92
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.92
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.92
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.92
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.92
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.91
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.91
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.91
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.91
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.91
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.91
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.91
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.91
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.91
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.91
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.91
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.91
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.91
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.91
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.91
PTZ00267	478	NIMA-related protein kinase; Provisional	99.91
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.91
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.91
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.91
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.91
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.91
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.91
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.91
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.91
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.91
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.91
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.91
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.91
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.91
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.9
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.9
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.9
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.9
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.9
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.9
KOG0589	426	consensus Serine/threonine protein kinase [General	99.9
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.9
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.9
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.9
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.9
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.9
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.9
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.9
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.9
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.9
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.9
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.9
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.9
PHA02988	283	hypothetical protein; Provisional	99.9
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.9
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.9
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.9
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.9
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.9
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.9
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.9
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.9
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.9
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.9
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.9
PTZ00283	496	serine/threonine protein kinase; Provisional	99.9
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.9
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.9
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.9
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.9
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.9
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.9
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.9
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.9
KOG0586	596	consensus Serine/threonine protein kinase [General	99.9
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.9
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.9
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.9
PHA03212	391	serine/threonine kinase US3; Provisional	99.9
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.9
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.89
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.89
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.89
PHA03211	461	serine/threonine kinase US3; Provisional	99.89
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.89
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.89
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.89
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.89
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.89
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.89
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.89
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.89
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.89
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.89
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.89
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.89
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.89
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.89
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.89
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.89
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.89
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.89
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.89
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.89
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.89
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.89
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.89
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.89
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.89
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.89
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.89
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.89
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.89
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.89
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.89
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.89
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.89
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.89
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.89
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.89
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.89
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.89
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.89
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.89
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.88
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.88
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.88
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.88
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.88
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.88
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.88
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.88
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.88
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.88
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.88
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.88
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.88
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.88
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.88
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.88
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.88
KOG0584	632	consensus Serine/threonine protein kinase [General	99.88
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.88
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.88
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.88
KOG0610	459	consensus Putative serine/threonine protein kinase	99.88
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.88
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.88
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.88
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.88
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.88
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.88
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.88
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.88
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.88
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.88
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.88
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.88
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.88
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.88
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.88
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.88
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.88
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.88
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.88
PHA03207	392	serine/threonine kinase US3; Provisional	99.88
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.88
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.88
PHA03209	357	serine/threonine kinase US3; Provisional	99.88
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.88
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.88
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.88
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.88
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.88
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.88
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.88
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.88
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.88
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.88
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.88
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.88
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.88
PTZ00036	440	glycogen synthase kinase; Provisional	99.88
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.88
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.87
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.87
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.87
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.87
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.87
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.87
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.87
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.87
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.87
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.87
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.87
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.87
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.87
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.87
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.87
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.87
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.87
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.87
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.87
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.87
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.87
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.87
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.87
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.87
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.87
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.87
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.87
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.87
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.87
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.87
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.87
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.87
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.87
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.87
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.86
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.86
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.86
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.86
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.86
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.86
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.86
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.86
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.86
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.86
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.86
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.86
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.86
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.86
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.86
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.86
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.86
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.86
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.86
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.86
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.86
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.86
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.86
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.86
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.86
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.86
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.86
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.86
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.86
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.86
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.86
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.86
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.86
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.86
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.86
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.86
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.86
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.86
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.86
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.86
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.86
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.85
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.85
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.85
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.85
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.85
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.85
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.85
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.85
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.85
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.85
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.85
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.85
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.85
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.85
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.85
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.85
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.85
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.85
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.85
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.85
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.85
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.85
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.85
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.85
PHA03210	501	serine/threonine kinase US3; Provisional	99.85
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.85
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.85
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.84
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.84
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.84
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.84
PLN00009	294	cyclin-dependent kinase A; Provisional	99.84
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.84
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.84
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.84
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.84
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.84
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.84
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.84
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.84
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.84
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.84
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.84
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.84
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.84
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.84
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.83
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.83
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.83
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.83
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.83
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.83
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.83
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.83
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.83
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.83
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.83
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.83
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.83
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.83
PTZ00284	467	protein kinase; Provisional	99.83
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.82
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.82
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.82
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.82
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.82
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.82
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.82
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.82
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.82
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.82
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.82
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.82
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.82
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.82
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.81
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.81
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.81
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.81
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.81
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.81
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.81
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.81
KOG1152	772	consensus Signal transduction serine/threonine kin	99.81
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.81
PHA02882	294	putative serine/threonine kinase; Provisional	99.81
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.81
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.8
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.8
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.8
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.79
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.79
PRK10345	210	hypothetical protein; Provisional	99.79
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.78
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.78
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.78
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.76
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.76
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.75
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.75
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.75
smart00090	237	RIO RIO-like kinase.	99.74
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.73
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.72
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.72
PRK12274	218	serine/threonine protein kinase; Provisional	99.71
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.68
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.66
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.66
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.63
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.62
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.62
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.59
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.58
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.57
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.51
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.36
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.33
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.28
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.24
PLN00181	793	protein SPA1-RELATED; Provisional	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.13
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.1
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.07
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.07
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.96
KOG3087	229	consensus Serine/threonine protein kinase [General	98.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	98.92
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	98.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	98.78
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.78
KOG1243	690	consensus Protein kinase [General function predict	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.67
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.63
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.53
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.47
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.45
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.4
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.39
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.37
PRK09902	216	hypothetical protein; Provisional	98.36
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.34
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.29
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.28
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.19
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.19
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.14
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.03
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.95
PF01636	239	APH: Phosphotransferase enzyme family This family	97.93
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.86
PLN02876	822	acyl-CoA dehydrogenase	97.8
PRK10593	297	hypothetical protein; Provisional	97.7
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.57
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.46
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.46
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.39
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.37
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.35
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.98
PRK05231	319	homoserine kinase; Provisional	96.97
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.66
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.51
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.48
KOG2270	520	consensus Serine/threonine protein kinase involved	96.37
PLN02236	344	choline kinase	96.29
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.05
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.02
KOG0576	829	consensus Mitogen-activated protein kinase kinase	95.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	95.76
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.71
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.65
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.61
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.42
PLN02756	418	S-methyl-5-thioribose kinase	95.4
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.21
COG2334	331	Putative homoserine kinase type II (protein kinase	94.94
PRK12396	409	5-methylribose kinase; Reviewed	94.67
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.66
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	94.47
PRK11768	325	serine/threonine protein kinase; Provisional	94.4
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.36
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	94.29
PRK06148	1013	hypothetical protein; Provisional	94.26
PF04478	154	Mid2: Mid2 like cell wall stress sensor; InterPro:	94.12
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.35
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	93.18
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	93.14
COG4248	637	Uncharacterized protein with protein kinase and he	92.86

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-38  Score=313.19  Aligned_cols=168  Identities=52%  Similarity=0.864  Sum_probs=154.9

Q ss_pred             CCCCcChhHHHHHhcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeE
Q 043262          331 EFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC  410 (512)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~  410 (512)
                      ....|++.++..+|++|+..+.||+|+||.||+|.+++|..||||++.....+..++|.+|++++.+++|||||+|+|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56678999999999999999999999999999999999999999988765543256699999999999999999999999


Q ss_pred             EeCC-eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEe
Q 043262          411 LQEN-ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  489 (512)
Q Consensus       411 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~  489 (512)
                      .+.+ +.+||||||++|+|.++|+..... +|+|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999875544 89999999999999999999999988899999999999999999999999


Q ss_pred             ccCcccccCC
Q 043262          490 DFGMARIFGG  499 (512)
Q Consensus       490 DFGla~~~~~  499 (512)
                      |||||+....
T Consensus       220 DFGLa~~~~~  229 (361)
T KOG1187|consen  220 DFGLAKLGPE  229 (361)
T ss_pred             CccCcccCCc
Confidence            9999976654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=7e-32  Score=262.26  Aligned_cols=158  Identities=32%  Similarity=0.545  Sum_probs=138.8

Q ss_pred             CccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhc--CCCCccccceeeEEeCC----eeEEEE
Q 043262          347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAK--LQHKNLVRLLGCCLQEN----ESLLIY  420 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~lv~  420 (512)
                      ....++||+|.||.||||.+. ++.||||++...+   .+.|++|-+++..  ++|+||++|++.-....    +.+||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            344578999999999999995 5999999997543   4567777777664  68999999999987766    789999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED------SRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                      ||.++|+|.+||..    ..++|....+|+..+++||+|||+.      .+++|+|||||++||||.+|+++.|+|||||
T Consensus       288 ~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999954    4589999999999999999999976      3568999999999999999999999999999


Q ss_pred             cccCCCCCCcCccccccC
Q 043262          495 RIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       495 ~~~~~~~~~~~~~~~~Gt  512 (512)
                      .++..+.....+...|||
T Consensus       364 l~~~p~~~~~d~~~qVGT  381 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGT  381 (534)
T ss_pred             EEecCCCCCcchhhhhhh
Confidence            999999888888888887

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=257.39  Aligned_cols=151  Identities=31%  Similarity=0.553  Sum_probs=135.4

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .+|...++||+|.|+.||+|++ .++.+||||.+...  .++..+.+..|+.+|++++|||||+|++++..++..+||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            4567777899999999999997 45889999999765  56667789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC------CceEEeccCccc
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE------MNPKISDFGMAR  495 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~------~~~kl~DFGla~  495 (512)
                      ||.+|+|.+|++..   ..+++.....++.|+|.||++||+++   ||||||||.||||+..      -.+||+|||+||
T Consensus        90 yC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999653   46999999999999999999999985   9999999999999765      458999999999


Q ss_pred             ccCCCC
Q 043262          496 IFGGNQ  501 (512)
Q Consensus       496 ~~~~~~  501 (512)
                      .+..+.
T Consensus       164 ~L~~~~  169 (429)
T KOG0595|consen  164 FLQPGS  169 (429)
T ss_pred             hCCchh
Confidence            987553

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=5.7e-31  Score=273.71  Aligned_cols=150  Identities=36%  Similarity=0.600  Sum_probs=132.8

Q ss_pred             cCCccccccccccceeEEEEEeC------CCCEEEEEEcccCCcc-cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      .+....+.||+|.||+||+|+..      +...||||.+++.... ..++|++|++++..++|||||+|+|+|.++++++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            34455678999999999999853      3457999999876555 7889999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCce
Q 043262          418 LIYEYMPNKSLNVFLFDSTR-----------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP  486 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~  486 (512)
                      ||+|||.+|+|.+||+....           ..+|+..+.+.|+.|||.||.||-++   ++|||||..+|+||.+++.+
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence            99999999999999974211           23489999999999999999999887   49999999999999999999


Q ss_pred             EEeccCccccc
Q 043262          487 KISDFGMARIF  497 (512)
Q Consensus       487 kl~DFGla~~~  497 (512)
                      ||+||||+|.+
T Consensus       643 KIsDfGLsRdi  653 (774)
T KOG1026|consen  643 KISDFGLSRDI  653 (774)
T ss_pred             Eecccccchhh
Confidence            99999999965

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5e-31  Score=261.77  Aligned_cols=151  Identities=34%  Similarity=0.611  Sum_probs=136.2

Q ss_pred             CccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCC
Q 043262          347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNK  426 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~g  426 (512)
                      +...+.||+|.||.||.|.+++...||||.++... ...+.|.+|+.+|++|+|+|||+++|+|..+++++||||||++|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            34467899999999999999888899999998653 33578999999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCC
Q 043262          427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  502 (512)
Q Consensus       427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~  502 (512)
                      +|.+||.. .....+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+||||||.+.++.-
T Consensus       287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            99999976 3345688999999999999999999987   599999999999999999999999999997776654

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-30  Score=256.90  Aligned_cols=152  Identities=36%  Similarity=0.568  Sum_probs=134.9

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ......++||+|.||+|.+++...+..||||+++.... ..+++|.+|+++|.+++|||||+|+|+|..++++++++|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            44556789999999999999998889999999986554 44689999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++|+|.+||..+.... +......+|+.||+.||+||.+-   ++|||||.++|||+|.++++||+||||+|-+-.+
T Consensus       618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999997654433 56667788999999999999874   6999999999999999999999999999965433

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.97  E-value=2e-30  Score=257.94  Aligned_cols=151  Identities=40%  Similarity=0.642  Sum_probs=133.1

Q ss_pred             CccccccccccceeEEEEEeCCCCEEEEEEcccCCcc--cHHHHHHHHHHHhcCCCCccccceeeEEeCC-eeEEEEEec
Q 043262          347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ--GLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN-ESLLIYEYM  423 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lv~E~~  423 (512)
                      +...+.||+|+||+||+|.+.....||||++......  ..++|.+|+.+|.+++|||||+|+|+|.+.. ...+|||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            3445669999999999999975555999999754322  2669999999999999999999999999988 799999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-ceEEeccCcccccCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGGN  500 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DFGla~~~~~~  500 (512)
                      ++|+|.++|+.. ....+++..++.|+.|||+||.|||++.  +||||||||+||||+.++ ++||+|||+++.....
T Consensus       123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~--~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEG--PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC--CeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            999999999764 4567999999999999999999999985  299999999999999997 9999999999987643

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-30  Score=261.89  Aligned_cols=151  Identities=30%  Similarity=0.578  Sum_probs=136.3

Q ss_pred             CCccccccccccceeEEEEEeC----CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA----DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~----~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ...++++||.|.||+|++|+++    ....||||.|+.. .++.+.+|+.|..+|.+++||||++|.|+.+...+.++|.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            4556789999999999999974    2357999999865 4566789999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |||+||+|+.||+..  ..++.+.++..+.++||.||.||-+.   ++|||||.++|||++.+..+||+||||+|.+.++
T Consensus       710 EyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            999999999999764  35699999999999999999999774   6999999999999999999999999999988776


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       785 ~  785 (996)
T KOG0196|consen  785 P  785 (996)
T ss_pred             C
Confidence            6

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=6e-30  Score=250.77  Aligned_cols=161  Identities=30%  Similarity=0.527  Sum_probs=140.1

Q ss_pred             hcCCccccccccccceeEEEEE-eCCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESLL  418 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~-~~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l  418 (512)
                      .+.|...++||+|+||.|||++ ..+|..||+|+++-..  .....-..+||.+|++|+||||++|.+..++.  ..+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            4567778899999999999998 4789999999997543  34456678999999999999999999999987  67999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+|||++ +|.-++..  ....++..++..++.|++.||+|+|+.+   |+|||||.+|||||.++.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999987 66666633  3456999999999999999999999986   9999999999999999999999999999998


Q ss_pred             CCCCCcCccccc
Q 043262          499 GNQSEANTKRIV  510 (512)
Q Consensus       499 ~~~~~~~~~~~~  510 (512)
                      .......|.+++
T Consensus       270 ~~~~~~~T~rVv  281 (560)
T KOG0600|consen  270 PSGSAPYTSRVV  281 (560)
T ss_pred             CCCCcccccceE
Confidence            888777777664

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=6.6e-30  Score=244.72  Aligned_cols=161  Identities=28%  Similarity=0.453  Sum_probs=136.0

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcc-------cHHHHHHHHHHHhcCCCCccccceeeEEeCC
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQ-------GLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN  414 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  414 (512)
                      ..+.|...+.||+|+||.|-+|.. ++|+.||||.+++....       ......+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            345567788999999999999975 67999999999753211       1234579999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC---CceEEecc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDF  491 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~---~~~kl~DF  491 (512)
                      ..||||||+++|+|.+++-.+   ..+.+..-..++.|++.|+.|||+.+   |+||||||+||||..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            999999999999999998543   34667777889999999999999986   9999999999999765   88999999


Q ss_pred             CcccccCCCCCCcCccccccC
Q 043262          492 GMARIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~Gt  512 (512)
                      |||+..+.+.   -++.++||
T Consensus       324 GlAK~~g~~s---fm~TlCGT  341 (475)
T KOG0615|consen  324 GLAKVSGEGS---FMKTLCGT  341 (475)
T ss_pred             chhhccccce---ehhhhcCC
Confidence            9999987443   45557776

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.4e-29  Score=254.00  Aligned_cols=160  Identities=31%  Similarity=0.477  Sum_probs=144.3

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      .+|...+.||+|+|..+|+++. ..|+.||+|++.+.   .....+...+||++.+.|+|||||+|++++.+.+..|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4678889999999999999997 88999999999753   3445678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+|++++|..++.   +..++++.+...+..||+.||.|||+++   |+|||||..|++|++++++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999984   4567999999999999999999999985   999999999999999999999999999999877


Q ss_pred             CCCcCccccccC
Q 043262          501 QSEANTKRIVGT  512 (512)
Q Consensus       501 ~~~~~~~~~~Gt  512 (512)
                      ...-.|  ++||
T Consensus       172 ~Erk~T--lCGT  181 (592)
T KOG0575|consen  172 GERKKT--LCGT  181 (592)
T ss_pred             ccccce--ecCC
Confidence            544443  7887

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.96  E-value=7.8e-29  Score=235.66  Aligned_cols=150  Identities=31%  Similarity=0.412  Sum_probs=132.6

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC-eeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN-ESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lv~E~  422 (512)
                      ++...+.||+|..|.|||++++ ++..+|+|.+... .....+++.+|++++.+.+||+||+++|.+.... ...++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3445678999999999999975 5788999999543 4445678999999999999999999999999999 59999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |.+|||++++...   +.+++...-+|+.+|++||.|||+.  .+||||||||+|||++..+++||+|||.++.+...
T Consensus       160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            9999999999543   5589999999999999999999974  26999999999999999999999999999988654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.95  E-value=5.3e-28  Score=219.43  Aligned_cols=151  Identities=33%  Similarity=0.600  Sum_probs=133.3

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcc-c-HHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQ-G-LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .+|...++||+|.||.||+|+. ..|+.||||+++..... + .....+||+.|++++|+||+.|++++...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            3566778999999999999985 67999999999755332 1 3467899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      ||+. +|+..+++.  ...+.......++.++.+||+|||++.   |+||||||.|+|+++++.+||+||||||.++...
T Consensus        82 fm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9965 899988764  356888999999999999999999986   9999999999999999999999999999997543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.4e-28  Score=233.11  Aligned_cols=160  Identities=26%  Similarity=0.435  Sum_probs=138.0

Q ss_pred             CCcChhHHHHHhcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHh--cCCCCccccceeeE
Q 043262          333 PLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIA--KLQHKNLVRLLGCC  410 (512)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~--~l~H~nIv~l~g~~  410 (512)
                      ...|+-..+.........+.||+|.||+||+|.++ |+.||||++...++   +.+.+|.+++.  .|+|+||+.|++.-
T Consensus       199 SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD  274 (513)
T KOG2052|consen  199 SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAAD  274 (513)
T ss_pred             CCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhcc
Confidence            45666677777888889999999999999999996 88999999976553   44566777766  46999999999987


Q ss_pred             EeCC----eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCcccCCCCCCCeeec
Q 043262          411 LQEN----ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-----SRLKIIHRDLKTSNVLLD  481 (512)
Q Consensus       411 ~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~dlk~~NiLl~  481 (512)
                      ..++    ++|||.+|.++|||.+||..    ..++....++++..+|.||++||-+     ++|.|.|||||++|||+.
T Consensus       275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK  350 (513)
T KOG2052|consen  275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  350 (513)
T ss_pred             ccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence            6553    47999999999999999944    5699999999999999999999954     678899999999999999


Q ss_pred             CCCceEEeccCcccccCCC
Q 043262          482 HEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       482 ~~~~~kl~DFGla~~~~~~  500 (512)
                      +++.+.|+|+|||-....+
T Consensus       351 kn~~C~IADLGLAv~h~~~  369 (513)
T KOG2052|consen  351 KNGTCCIADLGLAVRHDSD  369 (513)
T ss_pred             cCCcEEEeeceeeEEeccc
Confidence            9999999999999887665

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.95  E-value=5.8e-28  Score=229.69  Aligned_cols=161  Identities=29%  Similarity=0.438  Sum_probs=140.7

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .++|...++||+|+||+|+.++. +.++.+|+|.+++..   ....+...+|..+|.+++||.||+++-.+.+.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            36788899999999999999986 458889999997542   34467789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +||+.+|.|...|.   +...+++....-++.+|+.||.|||+++   ||||||||+|||||++|+++|+||||++..-.
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999984   3456899999999999999999999985   99999999999999999999999999997655


Q ss_pred             CCCCcCccccccC
Q 043262          500 NQSEANTKRIVGT  512 (512)
Q Consensus       500 ~~~~~~~~~~~Gt  512 (512)
                      +...  |..++||
T Consensus       178 ~~~~--t~tfcGT  188 (357)
T KOG0598|consen  178 DGDA--TRTFCGT  188 (357)
T ss_pred             CCCc--cccccCC
Confidence            5433  3347887

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.4e-28  Score=243.89  Aligned_cols=147  Identities=35%  Similarity=0.554  Sum_probs=130.0

Q ss_pred             CccccccccccceeEEEEEeCC--C---CEEEEEEccc---CCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          347 FSDENKLGEGGFGPVYKGKLAD--G---KEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~~--g---~~vaVK~l~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ....++||+|.||.||+|++..  +   ..||||..+.   .......+|++|.++|.+++|||||+|+|++....++++
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            3445899999999999998642  2   2389999885   345667899999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |||+|.+|+|+++|.....  .++..+++.++.+.|.||+|||++.   ++||||.++|||++.+..+||+||||++.-.
T Consensus       239 vmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            9999999999999965432  5999999999999999999999984   9999999999999999999999999988653

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=7.6e-29  Score=226.42  Aligned_cols=166  Identities=27%  Similarity=0.456  Sum_probs=140.4

Q ss_pred             cCCccccccccccceeEEEEE-eCCCCEEEEEEcc--cCCcccHHHHHHHHHHHhcCCCCccccceee-EEeCCe-eEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC-CLQENE-SLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~-~~~g~~vaVK~l~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~-~~~~~~-~~lv  419 (512)
                      .+|...++||+|.||+|||+. +.+|..||.|.+.  ..+.+..+....|+.+|++|+|||||+++++ +.++++ +.+|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            456778899999999999997 5789999999986  3355667889999999999999999999994 445555 7899


Q ss_pred             EEecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          420 YEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDS-RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |||+..|+|...+..-. ....++++.+++++.|++.||..+|++- +.-|.||||||.||+|+.++.+||+||||+|.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999986432 3456899999999999999999999942 123999999999999999999999999999999


Q ss_pred             CCCCCCcCccccccC
Q 043262          498 GGNQSEANTKRIVGT  512 (512)
Q Consensus       498 ~~~~~~~~~~~~~Gt  512 (512)
                      ....+...  ..|||
T Consensus       179 ~s~~tfA~--S~VGT  191 (375)
T KOG0591|consen  179 SSKTTFAH--SLVGT  191 (375)
T ss_pred             cchhHHHH--hhcCC
Confidence            88765443  36776

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.95  E-value=9.6e-28  Score=221.32  Aligned_cols=149  Identities=23%  Similarity=0.427  Sum_probs=129.7

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +.|+...++|+|+||.|||++.+ .|+.||||++.....  .-.+-.++|+++|++++|+|+|.|+.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            34666678999999999999975 599999999965433  334567999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |++..-|+++-+   ....++......++.|++.|+.|+|++.   +|||||||+||||+.++.+||+|||+||.+..
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            999877766543   2334889999999999999999999984   99999999999999999999999999999873

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=1.6e-27  Score=227.31  Aligned_cols=151  Identities=24%  Similarity=0.517  Sum_probs=136.4

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      .+|...+.||+|.||.|-++.. ..|++||||.+++.   +++++-.+.+||++|..|+||||+.++.++...+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4677778999999999999985 77999999999764   3445567899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||..+|.|.+|+..   ...|++....+++.||..|+.|+|.+.   ++|||||.+|||||.++++||+||||+-.+.++
T Consensus       133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            99999999999953   456999999999999999999999974   999999999999999999999999999988665


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       207 k  207 (668)
T KOG0611|consen  207 K  207 (668)
T ss_pred             c
Confidence            3

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.94  E-value=3.5e-27  Score=233.22  Aligned_cols=152  Identities=32%  Similarity=0.456  Sum_probs=133.4

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .++|...+.||+|.|++|++++. ..++++|||++.+.   .+...+-...|-+.|.+| .||.|++|+-.+.+...+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            36788899999999999999985 56899999998643   122233456778888888 89999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+||+++|+|.++|.+   .+.+++.....++.+|..||+|||+.+   ||||||||+|||||+||++||+|||-|++++
T Consensus       152 vLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            9999999999999954   456899999999999999999999986   9999999999999999999999999999996


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      +..
T Consensus       226 ~~~  228 (604)
T KOG0592|consen  226 PSQ  228 (604)
T ss_pred             hhh
Confidence            654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.94  E-value=8.9e-27  Score=230.62  Aligned_cols=159  Identities=30%  Similarity=0.507  Sum_probs=140.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...+.||+|.||.||||+- .+.+.||+|.+.+.  ..++.+.+.+|++++++++|||||.++.++....++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4677778999999999999985 45788999999653  45567889999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      |+.+ +|..+|.+   ...|++.....|+.++..||.|||+..   |+|||+||+||||+.++.+|++|||+||.++.+.
T Consensus        82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9977 99999954   456999999999999999999999974   9999999999999999999999999999988754


Q ss_pred             CCcCccccccC
Q 043262          502 SEANTKRIVGT  512 (512)
Q Consensus       502 ~~~~~~~~~Gt  512 (512)
                      .  ..++|-||
T Consensus       155 ~--vltsikGt  163 (808)
T KOG0597|consen  155 S--VLTSIKGT  163 (808)
T ss_pred             e--eeeeccCc
Confidence            3  33456665

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=5e-26  Score=219.94  Aligned_cols=150  Identities=29%  Similarity=0.495  Sum_probs=131.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCC--eeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN--ESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lv~E  421 (512)
                      .++...+.||+|.||.||++... +|...|||.+...+....+.+.+|+.+|.+++|||||+.+|......  ...+.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34566789999999999999975 48999999987654333677999999999999999999999855544  6899999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-CCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DFGla~~~~~  499 (512)
                      |+++|+|.+++.+...  .|++..+..+..||++||+|||+++   ||||||||+||||+. ++.+||+|||+++....
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            9999999999965432  6999999999999999999999985   999999999999999 79999999999998874

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-26  Score=247.71  Aligned_cols=150  Identities=37%  Similarity=0.654  Sum_probs=133.1

Q ss_pred             cCCccccccccccceeEEEEEeCC--CC----EEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD--GK----EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~--g~----~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ......+.||+|.||.||+|.+.+  |.    .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            345567789999999999998743  33    4899999765 4566789999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          418 LIYEYMPNKSLNVFLFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      +++|||++|+|..||++.+.    ...|...+++.|+.|||+|+.||+++   ++|||||.++||||++...+||+||||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999987532    34689999999999999999999987   599999999999999999999999999


Q ss_pred             cccc
Q 043262          494 ARIF  497 (512)
Q Consensus       494 a~~~  497 (512)
                      ||.+
T Consensus       849 ArDi  852 (1025)
T KOG1095|consen  849 ARDI  852 (1025)
T ss_pred             hHhh
Confidence            9954

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4e-27  Score=229.43  Aligned_cols=152  Identities=28%  Similarity=0.453  Sum_probs=133.2

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHH--HHHHHHHHhcCC-CCccccceeeEEeCC-eeE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQE--FKNEVTLIAKLQ-HKNLVRLLGCCLQEN-ESL  417 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~--~~~E~~~l~~l~-H~nIv~l~g~~~~~~-~~~  417 (512)
                      ..++|...++||.|+||.||+|+- ..+..||||++++.-.. +++  =.+|+..|.+|+ ||||++|..++.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            456788889999999999999984 67889999999765433 333  368999999998 999999999999998 899


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +|||||+. +|.+++.+.  +..+++..+..|+.||++||+|+|.++   +.||||||+|||+.....+||+||||||.+
T Consensus        87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            99999965 888888653  667999999999999999999999986   999999999999998889999999999988


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ....
T Consensus       161 ~Skp  164 (538)
T KOG0661|consen  161 RSKP  164 (538)
T ss_pred             ccCC
Confidence            6543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.93  E-value=3.1e-26  Score=210.94  Aligned_cols=157  Identities=32%  Similarity=0.445  Sum_probs=138.1

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||.|+||.|.+.+. .+|.-+|+|.+.+..   .+..+...+|..+|+.+.||.++++.+.+.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            4677788999999999999986 468889999997653   234566789999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|.|.++|++   .+.++++....++.||+.||+|||+..   |++|||||+|||||.+|.+||.|||+|+...+.
T Consensus       124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            99999999999954   446899999999999999999999975   999999999999999999999999999988754


Q ss_pred             CCCcCccccccC
Q 043262          501 QSEANTKRIVGT  512 (512)
Q Consensus       501 ~~~~~~~~~~Gt  512 (512)
                           |-.++||
T Consensus       198 -----T~TlCGT  204 (355)
T KOG0616|consen  198 -----TWTLCGT  204 (355)
T ss_pred             -----EEEecCC
Confidence                 3335665

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-25  Score=218.51  Aligned_cols=163  Identities=29%  Similarity=0.468  Sum_probs=134.1

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc--------------ccHHHHHHHHHHHhcCCCCccccce
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG--------------QGLQEFKNEVTLIAKLQHKNLVRLL  407 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv~l~  407 (512)
                      .-+.|...+.||+|.||.|-+++. .++..||||.+.+...              ...+...+||.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            347788899999999999999985 5689999999964311              1245789999999999999999999


Q ss_pred             eeEEeC--CeeEEEEEecCCCChhHHhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC
Q 043262          408 GCCLQE--NESLLIYEYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM  484 (512)
Q Consensus       408 g~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~  484 (512)
                      .+.-+.  +..|||+|||..|.+...-    ...+ |.+.+..+++.++..||+|||.++   ||||||||+|+||++++
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            998654  6689999999999875332    2233 899999999999999999999986   99999999999999999


Q ss_pred             ceEEeccCcccccCCCCC---CcCccccccC
Q 043262          485 NPKISDFGMARIFGGNQS---EANTKRIVGT  512 (512)
Q Consensus       485 ~~kl~DFGla~~~~~~~~---~~~~~~~~Gt  512 (512)
                      ++||+|||.+-.+..+..   .....+.+||
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGT  278 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGT  278 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCC
Confidence            999999999998844422   2234446776

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.2e-26  Score=226.72  Aligned_cols=160  Identities=31%  Similarity=0.534  Sum_probs=143.0

Q ss_pred             hcCCccccccccccceeEEEEE-eCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ...|....+||+|..|.||.+. ..++++||||++........+-+.+|+.+|+..+|+|||.++..+...+++|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            3457777899999999999997 467899999999876666667789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  502 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~  502 (512)
                      |++|+|.+.+..    ..+++.++..|+.+++.||+|||.++   |+|||||..||||+.++.+||+|||++..+...+.
T Consensus       352 m~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             cCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            999999988833    34899999999999999999999986   99999999999999999999999999999988776


Q ss_pred             CcCccccccC
Q 043262          503 EANTKRIVGT  512 (512)
Q Consensus       503 ~~~~~~~~Gt  512 (512)
                      ...|  .+||
T Consensus       425 KR~T--mVGT  432 (550)
T KOG0578|consen  425 KRST--MVGT  432 (550)
T ss_pred             cccc--ccCC
Confidence            5544  6776

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.93  E-value=8.9e-26  Score=214.63  Aligned_cols=150  Identities=31%  Similarity=0.526  Sum_probs=128.6

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCc-cccceeeEEeCC------
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKN-LVRLLGCCLQEN------  414 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~------  414 (512)
                      ..|...++||+|+||.||+|+. .+|+.||+|+++....  .--....+|+.++++++|+| ||+|++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3456667899999999999985 6789999999975433  22345689999999999999 999999999887      


Q ss_pred             eeEEEEEecCCCChhHHhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTRS-VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      ..+||+||+.. +|..++....+. ..++...+..++.||++||+|||+++   |+||||||.||||++++.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            78899999965 898888654322 45777889999999999999999985   99999999999999999999999999


Q ss_pred             ccccC
Q 043262          494 ARIFG  498 (512)
Q Consensus       494 a~~~~  498 (512)
                      ||.++
T Consensus       167 Ara~~  171 (323)
T KOG0594|consen  167 ARAFS  171 (323)
T ss_pred             HHHhc
Confidence            99876

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-25  Score=225.09  Aligned_cols=149  Identities=28%  Similarity=0.476  Sum_probs=132.1

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC----Cc-ccHHHHHHHHHHHhcCC-CCccccceeeEEeCCee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT----SG-QGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~  416 (512)
                      ..+|...+.||+|.||.|+.|.. .+++.||||.+.+.    .. ...+.+.+|+.+++.++ ||||++++.++......
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            45678889999999999999975 56899999976543    11 23456678999999999 99999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC-CceEEeccCccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMAR  495 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~-~~~kl~DFGla~  495 (512)
                      ++||||+.+|+|.+++.+   ...+.+.....++.|++.|++|+|+.+   |+||||||+||||+.+ +++||+|||++.
T Consensus        96 ~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            999999999999999965   456888999999999999999999985   9999999999999999 999999999999


Q ss_pred             ccC
Q 043262          496 IFG  498 (512)
Q Consensus       496 ~~~  498 (512)
                      ...
T Consensus       170 ~~~  172 (370)
T KOG0583|consen  170 ISP  172 (370)
T ss_pred             ccC
Confidence            884

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.93  E-value=4.4e-26  Score=213.02  Aligned_cols=151  Identities=30%  Similarity=0.493  Sum_probs=129.3

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcc-c-HHHHHHHHHHHhcCCCCccccceeeEEeC--CeeEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQ-G-LQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESLL  418 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l  418 (512)
                      .+.|...+.|++|+||.||+|+. ++++.||+|+++..... + --.-.+||.+|.+++|||||.+..+..-.  +..||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            35677789999999999999996 56889999999754322 1 22457899999999999999999888643  56899


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |||||++ +|...+..  ...++...+...+..|+++|++|||...   |+|||||++|+|+...|.+||+||||||.++
T Consensus       155 VMe~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999976 78888854  3356888999999999999999999986   9999999999999999999999999999998


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      ..
T Consensus       229 sp  230 (419)
T KOG0663|consen  229 SP  230 (419)
T ss_pred             CC
Confidence            76

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=5.2e-26  Score=233.54  Aligned_cols=153  Identities=33%  Similarity=0.566  Sum_probs=133.2

Q ss_pred             CccccccccccceeEEEEEe-CCC----CEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADG----KEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g----~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      +...++||+|+||+||||.+ +.|    -+||+|.+... ..+...++++|+.+|.+++||||++|+|+|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34467899999999999986 444    36899988644 4456789999999999999999999999998776 78999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +||+.|.|.+|++.++  ..+.-+..+.+..|||+||.|||++   ++|||||.++|||+.+-..+||.|||+++++..+
T Consensus       777 q~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999997644  3577889999999999999999987   4999999999999999999999999999999888


Q ss_pred             CCCcC
Q 043262          501 QSEAN  505 (512)
Q Consensus       501 ~~~~~  505 (512)
                      ..+-.
T Consensus       852 ~~ey~  856 (1177)
T KOG1025|consen  852 EKEYS  856 (1177)
T ss_pred             ccccc
Confidence            75533

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.93  E-value=4e-25  Score=218.84  Aligned_cols=152  Identities=34%  Similarity=0.551  Sum_probs=130.7

Q ss_pred             cCCccccccccccceeEEEEEeCC-----------------CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccc
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-----------------GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRL  406 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-----------------g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l  406 (512)
                      ++|...++||+|+||.||++.+++                 +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467778899999999999998532                 3369999987543 3345689999999999999999999


Q ss_pred             eeeEEeCCeeEEEEEecCCCChhHHhhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCccc
Q 043262          407 LGCCLQENESLLIYEYMPNKSLNVFLFDST----------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH  470 (512)
Q Consensus       407 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  470 (512)
                      ++++...+..++||||+++|+|.+++....                ....++|...+.++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999885421                1134788999999999999999999975   999


Q ss_pred             CCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          471 RDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       471 ~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||||+|||+++++.+||+|||+++.+..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~  190 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYA  190 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceeccc
Confidence            99999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.93  E-value=2.2e-25  Score=220.73  Aligned_cols=150  Identities=25%  Similarity=0.380  Sum_probs=135.0

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ..++|.....||+|+||+||+++. ..|..+|+|+|++..   ..+.+..+.|-.+|...++|+||+|+-.+.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            457888899999999999999986 458999999998754   3446678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++|++..+|.   +...|++.....++.+++.|+.-||..+   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999994   3456899989999999999999999985   9999999999999999999999999997654

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=5.7e-26  Score=203.41  Aligned_cols=154  Identities=32%  Similarity=0.474  Sum_probs=135.3

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      -++|..++.||+|.||.||.|+. +++-.||+|++.+..   .+-.+.+.+|+++-+.|+||||+++++++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            36788899999999999999986 567899999996542   23356789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +||.+.|+|...|.. .+...+++.....++.|+|.||.|+|..   +++||||||+|+|++.++..||+|||.+-.-..
T Consensus       101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            999999999999964 3445688888999999999999999987   599999999999999999999999999987654


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      +.
T Consensus       177 ~k  178 (281)
T KOG0580|consen  177 NK  178 (281)
T ss_pred             CC
Confidence            33

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.92  E-value=3.1e-25  Score=223.05  Aligned_cols=153  Identities=29%  Similarity=0.458  Sum_probs=129.3

Q ss_pred             hcCCccccccccccceeEEEEEe------CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeCC-
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQEN-  414 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~------~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~-  414 (512)
                      .++|...++||+|+||.||+|..      .++..||||++.... ....+.+.+|+.++..+ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            35788889999999999999974      235679999997543 23356799999999999 8999999999987654 


Q ss_pred             eeEEEEEecCCCChhHHhhcCCC---------------------------------------------------------
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTR---------------------------------------------------------  437 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------  437 (512)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999999864211                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          438 --SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       438 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                        ..++++..++.++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~  226 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK  226 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence              134788899999999999999999975   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-25  Score=224.08  Aligned_cols=149  Identities=34%  Similarity=0.621  Sum_probs=131.3

Q ss_pred             HHHHhcCCccccccccccceeEEEEEeCCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          340 AVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       340 ~~~~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++...+.+...+.||+|.||+||+|+|.  -.||||.+...  .....+.|++|+..+++-+|.||+-|.|+|..... .
T Consensus       387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  387 WEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            3334455566789999999999999996  36999999743  34468899999999999999999999999998877 9


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      +|.-+|++-+|..+|+..+  ..++..+.+.|+.|||+||.|||.+.   |||||||..||+|.+++.+||+||||+..
T Consensus       464 IiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             eeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence            9999999999999997643  56888999999999999999999985   99999999999999999999999999864

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.9e-25  Score=222.87  Aligned_cols=152  Identities=30%  Similarity=0.546  Sum_probs=135.9

Q ss_pred             cCCccccccccccceeEEEEEeCC-CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .++....+||-|.||.||.|.|+. ...||||.|+... -..++|+.|..+|+.++|||+|+|+|+|+.....|+|.|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            344556789999999999999854 5689999997654 45789999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      .+|+|.+||+...+ ..++--.++.++.||+.||+||..+   ++|||||.++|+|+.++..+||+||||+|++.++.
T Consensus       346 ~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             cCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            99999999976543 4577778899999999999999886   59999999999999999999999999999998775

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.92  E-value=5.2e-25  Score=224.43  Aligned_cols=160  Identities=30%  Similarity=0.514  Sum_probs=137.9

Q ss_pred             CccccccccccceeEEEEE-eCCCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeC------CeeEE
Q 043262          347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE------NESLL  418 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~-~~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~l  418 (512)
                      |...+.||+|+||.||+|+ -..|+.||||.+... .....+...+|+++|++++|+|||++++.-...      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3445789999999999999 467999999999764 344567789999999999999999999886544      45789


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec--CCC--ceEEeccCcc
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD--HEM--NPKISDFGMA  494 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~--~~~--~~kl~DFGla  494 (512)
                      |||||.+|||...|.++++...|++...+.+..++..||.|||+++   |+||||||.||++-  +++  --||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999999888889999999999999999999999875   99999999999993  333  4799999999


Q ss_pred             cccCCCCCCcCccccccC
Q 043262          495 RIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       495 ~~~~~~~~~~~~~~~~Gt  512 (512)
                      |-+.++.   ..+.++||
T Consensus       172 rel~d~s---~~~S~vGT  186 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGT  186 (732)
T ss_pred             ccCCCCC---eeeeecCc
Confidence            9999887   34447887

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-24  Score=209.05  Aligned_cols=152  Identities=22%  Similarity=0.394  Sum_probs=134.9

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +.|...+.||.|.-+.||+|+. +.+..||||++.-. .....+++.+|+..|+.++||||++.+..+..+..+|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            5678889999999999999984 56799999999632 333478999999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |.+||+.++++..-+. .+++..+..|.+++++||.|||.++   .||||||+.||||+++|.+||+|||.+-.+...
T Consensus       106 Ma~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999764333 3899999999999999999999986   999999999999999999999999998766443

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.91  E-value=2.9e-25  Score=210.96  Aligned_cols=150  Identities=31%  Similarity=0.501  Sum_probs=123.1

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCe-----eEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE-----SLLI  419 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-----~~lv  419 (512)
                      .|...+++|.|.||.||+|.+. ++.+||||++.......    .+|+.+|.+++|||||+|+-++....+     ..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4566789999999999999974 47899999986544321    468899999999999999998875433     3589


Q ss_pred             EEecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC-CceEEeccCccccc
Q 043262          420 YEYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIF  497 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~-~~~kl~DFGla~~~  497 (512)
                      ||||+. +|.++++.- ..+..++...+..+..||.+||.|||+.   +|+||||||.|+|+|.+ +.+||+|||.|+++
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 777777532 2244577778888999999999999996   49999999999999987 89999999999999


Q ss_pred             CCCCCC
Q 043262          498 GGNQSE  503 (512)
Q Consensus       498 ~~~~~~  503 (512)
                      ..++..
T Consensus       177 ~~~epn  182 (364)
T KOG0658|consen  177 VKGEPN  182 (364)
T ss_pred             ccCCCc
Confidence            777643

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.1e-24  Score=220.41  Aligned_cols=147  Identities=26%  Similarity=0.359  Sum_probs=130.3

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+++. .+++.||||.+...   .....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3577789999999999999986 56889999998643   2234567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      ||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999999999854   345888899999999999999999975   999999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.91  E-value=2e-24  Score=219.42  Aligned_cols=148  Identities=23%  Similarity=0.362  Sum_probs=131.4

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|+..+.||+|+||.||+++. .+++.+|||.++...   ......+..|+.++.+++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            3677889999999999999986 458899999996532   233457889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            99999999999854   346899999999999999999999975   9999999999999999999999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.91  E-value=3.4e-24  Score=214.13  Aligned_cols=141  Identities=27%  Similarity=0.325  Sum_probs=125.5

Q ss_pred             cccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCC
Q 043262          351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNK  426 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~g  426 (512)
                      +.||+|+||.||+++. .+|+.+|+|.++..   .......+.+|+.++.+++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999986 56889999998743   2233456889999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +|.+++..   ...+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            99998854   346899999999999999999999975   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.2e-24  Score=215.25  Aligned_cols=148  Identities=26%  Similarity=0.391  Sum_probs=131.7

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +|...++||+|+||.||+++.. +++.||||+++...   ....+.+..|+.++..++||||+++++.+...+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            5778899999999999999975 58899999987432   2345678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        82 ~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          82 YVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999953   345889999999999999999999975   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.91  E-value=2.9e-24  Score=215.17  Aligned_cols=149  Identities=27%  Similarity=0.396  Sum_probs=132.3

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++.. +++.||||.+...   .....+.+.+|+.++.+++||||+++++.+...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46777899999999999999974 5889999998643   2234567899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999854   245788899999999999999999975   99999999999999999999999999987754

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.91  E-value=2.7e-24  Score=219.78  Aligned_cols=146  Identities=23%  Similarity=0.351  Sum_probs=129.8

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .|...++||+|+||.||+++. .++..+|||++....   ......+.+|+.++..++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            467788999999999999986 568899999996532   2345678999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            9999999999854   235888899999999999999999875   999999999999999999999999998755

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.3e-24  Score=219.12  Aligned_cols=149  Identities=26%  Similarity=0.379  Sum_probs=132.3

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+++.. +++.||||++....   ......+.+|+.++..++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36788899999999999999874 68899999996432   233456889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999999854   235899999999999999999999975   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.2e-24  Score=212.26  Aligned_cols=148  Identities=26%  Similarity=0.376  Sum_probs=131.3

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +|...++||+|+||.||++... +++.||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            5777889999999999999874 68899999986432   2335678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        82 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          82 YVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999854   345889999999999999999999975   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.91  E-value=5.4e-24  Score=208.81  Aligned_cols=150  Identities=29%  Similarity=0.412  Sum_probs=130.5

Q ss_pred             CccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      |...+.||+|+||.||++.. .++..||||.+....   ......+.+|+.++..++|+||+++++.+.+.+..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            56678899999999999986 578999999986432   22345678999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++|+|..++... ....+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999998887542 2345899999999999999999999975   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.91  E-value=4.9e-24  Score=213.42  Aligned_cols=142  Identities=27%  Similarity=0.331  Sum_probs=126.1

Q ss_pred             cccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCC
Q 043262          351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNK  426 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~g  426 (512)
                      +.||+|+||.||+++. .++..||||.+...   .......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999986 46899999999753   2334567889999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            99988854   345899999999999999999999975   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.91  E-value=3.4e-24  Score=218.50  Aligned_cols=154  Identities=32%  Similarity=0.481  Sum_probs=131.9

Q ss_pred             hcCCccccccccccceeEEEEEe------CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENE  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~------~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  415 (512)
                      .++|...++||+|+||.||+++.      .++..||||+++... ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35678889999999999999963      245689999997432 33456789999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCC----------------------------------------------------------
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTR----------------------------------------------------------  437 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------------  437 (512)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999854211                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          438 --------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       438 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                                    ...++|..++.++.||+.||.|||+.+   |+||||||+|||++++..+||+|||+++.+...
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                          125789999999999999999999874   999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=1.1e-24  Score=219.99  Aligned_cols=149  Identities=30%  Similarity=0.437  Sum_probs=133.4

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      -|..++.||.|+.|.|-.|+. .+|+.+|||.+.+.   +......+.+||.+|+.+.||||++|++++....++|+|+|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            356678999999999999986 67999999999754   22335568899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+++|.|.++|.   ..++|++.+..+++.||..|+.|+|..   +|+||||||+|+|||...++||+|||||.+--++
T Consensus        93 yv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   93 YVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             ecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            999999999994   456799999999999999999999987   5999999999999999999999999999876544

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.8e-24  Score=211.44  Aligned_cols=140  Identities=24%  Similarity=0.315  Sum_probs=125.0

Q ss_pred             cccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          353 LGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       353 lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      ||+|+||.||+++.. ++..||+|.+...   .......+..|+.++.+++||||+++++.+...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999874 5789999998643   234456788999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          429 NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      .+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~  144 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM  144 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence            999854   345899999999999999999999975   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.91  E-value=3.8e-24  Score=215.09  Aligned_cols=149  Identities=25%  Similarity=0.359  Sum_probs=131.2

Q ss_pred             cCCccccccccccceeEEEEEeCC--CCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD--GKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~--g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...+.||+|+||.||++...+  +..||+|.+...   .....+.+.+|+.++..++||||+++++++...+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            467888999999999999998643  368999998643   233456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999854   235889999999999999999999975   99999999999999999999999999987654

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.91  E-value=5.6e-24  Score=223.48  Aligned_cols=153  Identities=18%  Similarity=0.249  Sum_probs=133.3

Q ss_pred             CCccccccccccceeEEEEEeC-C-CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-D-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~-g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .|...+.||+|+||.||++... + +..|++|.+..........+..|+.++..++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3777889999999999999753 3 6788888876555555567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      ++|+|.+++... ....++++.....++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999988643 23446889999999999999999999974   9999999999999999999999999999876543

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.91  E-value=1e-24  Score=179.70  Aligned_cols=99  Identities=30%  Similarity=0.714  Sum_probs=77.4

Q ss_pred             cccCC-CC-C-C--CCchHHHHHHHHHhhhhhhcCCC--CCccccccCCCCCcEEEEEeccCCCChhhhHHHHHHHHHHH
Q 043262           17 YHFCV-RE-S-N--TSSLFMYNVGTLFYGKLYNEGGR--YLYYNATEGDDPNKVYGLYHCYFGVSIEVCQNCIKALINTL   89 (512)
Q Consensus        17 ~~~c~-~~-~-~--~~~~f~~~l~~l~~~l~~~~~~~--~~~~~~~~g~~~~~vy~~~~C~~d~~~~~C~~C~~~a~~~~   89 (512)
                      |+.|+ +. . .  ++++|+++|+.||..|...++..  .+|++++.|.++++||||+||++|+++.+|..||+.|+..+
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~   80 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANI   80 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence            67898 32 2 2  57789999999999999997644  58999998999999999999999999999999999999999


Q ss_pred             HhhCCCCCcEEEEeceeEEEEccccc
Q 043262           90 VTNCTGSKGAIIWYDQCMLRFSNISF  115 (512)
Q Consensus        90 ~~~c~~~~~~~~~~~~C~~ry~~~~f  115 (512)
                      .+.|+++++|+||++.|+||||+++|
T Consensus        81 ~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   81 SSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHhCCCCceEEEECCCEEEEEECCCC
Confidence            99999999999999999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.91  E-value=4.8e-24  Score=213.04  Aligned_cols=141  Identities=26%  Similarity=0.333  Sum_probs=125.4

Q ss_pred             cccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCC
Q 043262          351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNK  426 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~g  426 (512)
                      +.||+|+||.||+++. .+|..||+|.++..   .......+.+|+.++..++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3689999999999986 46899999998753   2334567788999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            99988854   235899999999999999999999975   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.91  E-value=1.8e-24  Score=226.47  Aligned_cols=150  Identities=33%  Similarity=0.483  Sum_probs=132.8

Q ss_pred             cCCccccccccccceeEEEEEeCCC-CEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceee-EEe------CCe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADG-KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGC-CLQ------ENE  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g-~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~-~~~------~~~  415 (512)
                      .++.+++.|.+|||+.||.++...+ .++|+|++-..++..++...+|+++|+.|+ |+|||.+++. ...      .-+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4567788999999999999998766 999999998778888999999999999997 9999999993 322      135


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .+|+||||++|.|-+|+..... ..|.+.++++|+.|+++|+.+||.. ++||||||||.+||||+.+++.||||||-|.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            7899999999999999965433 3499999999999999999999997 4789999999999999999999999999986


Q ss_pred             c
Q 043262          496 I  496 (512)
Q Consensus       496 ~  496 (512)
                      -
T Consensus       195 t  195 (738)
T KOG1989|consen  195 T  195 (738)
T ss_pred             c
Confidence            4

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-24  Score=186.64  Aligned_cols=149  Identities=30%  Similarity=0.503  Sum_probs=128.1

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|...++||+|.||+|+|++. ..++.||+|+++..  ++.--....+|+-+++.++|.|||+++++...++.+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            355568999999999999985 45788999998643  333345678999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +.. +|..|.-.  -+..++......++.|+++||.|.|++   ++.||||||.|.||+.+++.|++||||+|-++-.
T Consensus        83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            965 67777633  235688999999999999999999998   4999999999999999999999999999988644

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.91  E-value=4.8e-24  Score=216.81  Aligned_cols=149  Identities=24%  Similarity=0.318  Sum_probs=131.4

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .++|...++||+|+||.||+++.. +++.+|+|.+...   .....+.+.+|+.++..++||||+++++.+..++..++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            467888899999999999999974 5788999998642   223345688999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++..    ..+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            999999999999853    24788889999999999999999975   99999999999999999999999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.91  E-value=4.5e-24  Score=218.31  Aligned_cols=146  Identities=23%  Similarity=0.373  Sum_probs=129.4

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +|...++||+|+||.||+++. .+++.+|+|.+....   ......+.+|+.++..++||||+++++.+...+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            577789999999999999986 568899999986432   2335678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+++|+|.+++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            99999999998542   35788888999999999999999975   999999999999999999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.91  E-value=8.9e-24  Score=216.46  Aligned_cols=154  Identities=32%  Similarity=0.445  Sum_probs=131.2

Q ss_pred             hcCCccccccccccceeEEEEEeC------CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCC-CCccccceeeEEeCCe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENE  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~  415 (512)
                      .++|...++||+|+||.||+|+..      .+..||||++.... ....+.|.+|+.++.++. ||||+++++++.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            457778899999999999999852      23479999997543 334567999999999996 9999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCC----------------------------------------------------------
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTR----------------------------------------------------------  437 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------------  437 (512)
                      .++||||+++|+|.++|.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999998864210                                                          


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC
Q 043262          438 -----------------------------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH  482 (512)
Q Consensus       438 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~  482 (512)
                                                         ...+++..++.++.||+.||.|||+.+   |+||||||+|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                               124788889999999999999999874   999999999999999


Q ss_pred             CCceEEeccCcccccCCC
Q 043262          483 EMNPKISDFGMARIFGGN  500 (512)
Q Consensus       483 ~~~~kl~DFGla~~~~~~  500 (512)
                      ++.+||+|||+++.+...
T Consensus       273 ~~~~kL~DfGla~~~~~~  290 (400)
T cd05105         273 GKIVKICDFGLARDIMHD  290 (400)
T ss_pred             CCEEEEEeCCcceecccc
Confidence            999999999999876443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.91  E-value=1.1e-24  Score=198.43  Aligned_cols=164  Identities=31%  Similarity=0.479  Sum_probs=139.0

Q ss_pred             HHHHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC----cc----cHHHHHHHHHHHhcC-CCCccccceee
Q 043262          340 AVEATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS----GQ----GLQEFKNEVTLIAKL-QHKNLVRLLGC  409 (512)
Q Consensus       340 ~~~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~----~~----~~~~~~~E~~~l~~l-~H~nIv~l~g~  409 (512)
                      .....+.|...+.||.|..+.|.++.. ..|.+.|+|++....    ..    -+++-..|+.+|+++ -||+|+.+.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            345567788888999999999988875 568899999985321    11    134567899999998 59999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEe
Q 043262          410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  489 (512)
Q Consensus       410 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~  489 (512)
                      +..+...++|+|.|+.|.|.++|   .....++++...+|+.|+.+|+.|||..   +||||||||+|||+|+++++||+
T Consensus        92 yes~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEe
Confidence            99999999999999999999999   4456799999999999999999999997   49999999999999999999999


Q ss_pred             ccCcccccCCCCCCcCccccccC
Q 043262          490 DFGMARIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       490 DFGla~~~~~~~~~~~~~~~~Gt  512 (512)
                      |||++..+.+++   ..+.++||
T Consensus       166 DFGFa~~l~~Ge---kLrelCGT  185 (411)
T KOG0599|consen  166 DFGFACQLEPGE---KLRELCGT  185 (411)
T ss_pred             ccceeeccCCch---hHHHhcCC
Confidence            999999998776   33345555

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.91  E-value=1.3e-23  Score=210.10  Aligned_cols=143  Identities=27%  Similarity=0.321  Sum_probs=125.1

Q ss_pred             cccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCC
Q 043262          351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNK  426 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~g  426 (512)
                      +.||+|+||.||+++. .++..||+|.++..   .......+..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999985 56889999999753   2234567788999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +|..++..   ...+++.....++.||+.||.|||+..  +|+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~--~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            99988853   345899999999999999999999731  59999999999999999999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.91  E-value=6.5e-24  Score=216.68  Aligned_cols=146  Identities=22%  Similarity=0.364  Sum_probs=129.3

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +|...++||+|+||.||+++. .+++.||||.+....   ......+.+|++++.+++|+||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            577889999999999999986 458899999986432   2335678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            9999999999854   345788888999999999999999975   999999999999999999999999998644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.91  E-value=6.3e-24  Score=216.33  Aligned_cols=154  Identities=32%  Similarity=0.485  Sum_probs=131.2

Q ss_pred             hcCCccccccccccceeEEEEEe------CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENE  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~------~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  415 (512)
                      .++|...+.||+|+||.||+++.      .++..||||+++... ......+.+|+.++..+ +|+||+++++.+...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            35688889999999999999874      234579999997543 33356788999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCC-----------------------------------------------------------
Q 043262          416 SLLIYEYMPNKSLNVFLFDST-----------------------------------------------------------  436 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~-----------------------------------------------------------  436 (512)
                      .++||||+++|+|.++++...                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999985321                                                           


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          437 --------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       437 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                              ....+++...+.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..+
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~  265 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMND  265 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence                    1124788999999999999999999975   999999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.91  E-value=1.2e-23  Score=209.52  Aligned_cols=150  Identities=32%  Similarity=0.579  Sum_probs=129.3

Q ss_pred             cCCccccccccccceeEEEEEeC-CCC----EEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGK----EIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~----~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|.++... ....+++.+|+.++..++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46788899999999999999863 333    38999987543 34467899999999999999999999999864 5679


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++||+++|+|.+++...  ...+++...+.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999998653  235889999999999999999999974   9999999999999999999999999999876


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      .+
T Consensus       161 ~~  162 (316)
T cd05108         161 AD  162 (316)
T ss_pred             CC
Confidence            44

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.91  E-value=1.2e-23  Score=210.83  Aligned_cols=151  Identities=24%  Similarity=0.340  Sum_probs=133.2

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++. .++..||+|.++...   ....+.+.+|+.++..++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            3577889999999999999986 468899999997532   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|.+++...  ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999999653  245899999999999999999999975   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.90  E-value=2.2e-23  Score=208.96  Aligned_cols=150  Identities=25%  Similarity=0.330  Sum_probs=132.6

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|+..+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++.+++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            57888899999999999999874 67889999887542 23456799999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +++|+|.+++..   ...+++..+..++.|++.||.|||+..  +|+||||||+|||+++++.+||+|||+++.+..
T Consensus        85 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          85 MDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            999999999854   235889999999999999999999853  599999999999999999999999999987643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.6e-23  Score=209.94  Aligned_cols=151  Identities=23%  Similarity=0.298  Sum_probs=132.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++. .++..||+|.+...   .....+.+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            3577789999999999999996 45889999998642   2233456889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999998542  235889999999999999999999975   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.1e-23  Score=212.70  Aligned_cols=151  Identities=25%  Similarity=0.391  Sum_probs=134.1

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+++.. +++.||||.++...   ......+..|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            35778899999999999999974 68999999986432   234567899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++++|.+++...   ..+++.....++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999999653   46899999999999999999999974   999999999999999999999999999877554


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       155 ~  155 (350)
T cd05573         155 K  155 (350)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=1.5e-23  Score=209.49  Aligned_cols=141  Identities=28%  Similarity=0.415  Sum_probs=124.0

Q ss_pred             cccccccceeEEEEEe----CCCCEEEEEEcccC----CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          351 NKLGEGGFGPVYKGKL----ADGKEIAVKRLSRT----SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~----~~g~~vaVK~l~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++||+|+||.||+++.    .+++.||||.++..    .......+.+|+.++..++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999985    35789999998643    223345678999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +++|+|.+++..   ...+.+.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            999999998854   345788888899999999999999975   999999999999999999999999999854

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.90  E-value=2e-23  Score=209.31  Aligned_cols=151  Identities=23%  Similarity=0.279  Sum_probs=131.8

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+++.. +++.||+|.+...   .......+.+|..++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46778899999999999999864 5788999998642   2223456888999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|.+++...  ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999642  235889999999999999999999875   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.90  E-value=1.6e-23  Score=213.11  Aligned_cols=150  Identities=25%  Similarity=0.325  Sum_probs=131.0

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .++|...++||+|+||.||+++.. ++..+|+|.+...   .......+.+|+.++..++||||+++++++...+..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            356888899999999999999864 6889999998642   223345678999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++..    ..+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999854    24778888889999999999999975   99999999999999999999999999987754


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       195 ~  195 (370)
T cd05596         195 N  195 (370)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=3.9e-24  Score=212.02  Aligned_cols=162  Identities=27%  Similarity=0.467  Sum_probs=140.9

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCe-eEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE-SLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~lv~  420 (512)
                      ++|...+++|+|+||.++..+. .++..+++|.+...  ....++....|+.++++++|||||.+.+.+.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            4567778999999999998875 45778999988643  44455678999999999999999999999999998 99999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|.+.+... +...++++++..++.|++.|+.|||++   +|+|||||+.||+++.+..+||+|||+||+++.+
T Consensus        84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            999999999998653 356789999999999999999999976   5999999999999999999999999999999988


Q ss_pred             CCCcCccccccC
Q 043262          501 QSEANTKRIVGT  512 (512)
Q Consensus       501 ~~~~~~~~~~Gt  512 (512)
                      .....|  ++||
T Consensus       160 ~~~a~t--vvGT  169 (426)
T KOG0589|consen  160 DSLAST--VVGT  169 (426)
T ss_pred             hhhhhe--ecCC
Confidence            754443  6776

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.90  E-value=1.9e-23  Score=202.71  Aligned_cols=148  Identities=28%  Similarity=0.448  Sum_probs=130.4

Q ss_pred             cCCccccccccccceeEEEEEeC----CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA----DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~----~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...+.||+|+||.||+|.+.    .+..||+|.++... ......|.+|+..+.+++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            45777889999999999999753    35689999997543 23356799999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||++...
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999999653  246899999999999999999999875   999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.90  E-value=2.8e-23  Score=204.05  Aligned_cols=148  Identities=29%  Similarity=0.481  Sum_probs=128.6

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|+||.||+|+.. ++..||+|.++... ......+.+|+.++..++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            45777889999999999999864 68899999986433 23345778999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++ |+|.+++...  ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        85 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          85 LD-SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             CC-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            97 4898888542  234788999999999999999999975   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.90  E-value=2.4e-23  Score=208.85  Aligned_cols=149  Identities=26%  Similarity=0.361  Sum_probs=129.1

Q ss_pred             CCccccccccccceeEEEEEe----CCCCEEEEEEcccC----CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCee
Q 043262          346 HFSDENKLGEGGFGPVYKGKL----ADGKEIAVKRLSRT----SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENES  416 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~----~~g~~vaVK~l~~~----~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  416 (512)
                      +|...++||+|+||.||+++.    .++..||+|.+...    .....+.+..|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            366788999999999999875    35789999998643    222345688899999999 599999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++||||+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999854   345899999999999999999999875   99999999999999999999999999987


Q ss_pred             cCCC
Q 043262          497 FGGN  500 (512)
Q Consensus       497 ~~~~  500 (512)
                      +...
T Consensus       155 ~~~~  158 (332)
T cd05614         155 FLSE  158 (332)
T ss_pred             cccc
Confidence            6443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.90  E-value=1.3e-23  Score=212.52  Aligned_cols=145  Identities=28%  Similarity=0.438  Sum_probs=126.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .+|...++||+|+||.||+++. .+++.||||.+.... ....+.+.+|++++..++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            3455678899999999999986 468999999986543 23356789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +++|+|....       .+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            9999986432       3567778899999999999999975   99999999999999999999999999987754

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=2.4e-23  Score=207.50  Aligned_cols=144  Identities=28%  Similarity=0.362  Sum_probs=126.4

Q ss_pred             cccccccceeEEEEEe----CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          351 NKLGEGGFGPVYKGKL----ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~----~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      +.||+|+||.||+++.    .+|..+|+|.+....  ......+..|++++.+++||||+++++.+...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    367899999997532  2234567889999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            9999999854   345899999999999999999999975   999999999999999999999999999876443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.90  E-value=2.7e-23  Score=208.50  Aligned_cols=149  Identities=25%  Similarity=0.339  Sum_probs=131.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|+..++||+|+||.||++... ++..+|+|.+.... ......+.+|++++..++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            57888899999999999999875 57888999886542 23346789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +++|+|.+++..   ...+++.....++.|++.||.|||+..  +|+||||||+|||+++++.+||+|||+++.+.
T Consensus        85 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          85 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            999999999854   235889999999999999999999753  59999999999999999999999999998664

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.90  E-value=1.7e-23  Score=212.87  Aligned_cols=151  Identities=24%  Similarity=0.303  Sum_probs=132.2

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ..++|...+.||+|+||.||+++.. +++.+|+|.+...   .....+.+.+|+.++..++||||+++++.+...+..++
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            4478888999999999999999874 5788999998642   22334568899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++|+|.+++..    ..++......++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus       121 v~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         121 VMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            9999999999999853    24788888899999999999999975   9999999999999999999999999998775


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      ..
T Consensus       194 ~~  195 (371)
T cd05622         194 KE  195 (371)
T ss_pred             cC
Confidence            43

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.7e-24  Score=201.29  Aligned_cols=149  Identities=30%  Similarity=0.497  Sum_probs=129.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEccc--CCcccHHHHHHHHHHHhcCCCCccccceeeEEe-----CCee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSR--TSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ-----ENES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~~~  416 (512)
                      ..|...+.||+|.||.|+.+.. .+|..||||++..  .+....++..+|+++++.++|+||+.+.+....     -+..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            3455567899999999999986 5789999999973  455567888999999999999999999998875     3568


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++|+|+| ..+|...++.   ...|+......++.|+++||+|+|+..   ++||||||+|+|++.+...||+||||||.
T Consensus       102 YiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             EEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence            9999999 5688888843   334889999999999999999999974   99999999999999999999999999999


Q ss_pred             cCCC
Q 043262          497 FGGN  500 (512)
Q Consensus       497 ~~~~  500 (512)
                      ....
T Consensus       175 ~~~~  178 (359)
T KOG0660|consen  175 LDKF  178 (359)
T ss_pred             cccc
Confidence            8654

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.90  E-value=3.4e-23  Score=202.86  Aligned_cols=151  Identities=32%  Similarity=0.618  Sum_probs=132.3

Q ss_pred             cCCccccccccccceeEEEEEe-----CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-----ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~  417 (512)
                      ++|...+.||+|+||.||++..     .++..|++|.+........+.|.+|++++..++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4677788999999999999974     35789999999876666677899999999999999999999987643  4578


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +|+||+++|+|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998543  235899999999999999999999875   999999999999999999999999999977


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      ..+
T Consensus       159 ~~~  161 (284)
T cd05081         159 PQD  161 (284)
T ss_pred             cCC
Confidence            543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.90  E-value=1.4e-23  Score=202.95  Aligned_cols=146  Identities=38%  Similarity=0.655  Sum_probs=126.5

Q ss_pred             cccccccccceeEEEEEeC-----CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          349 DENKLGEGGFGPVYKGKLA-----DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       349 ~~~~lg~G~fG~Vy~~~~~-----~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ..+.||+|.||.||+|.+.     .+..|+||.+... .....++|.+|++.+.+++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3568999999999999986     3568999999653 334478999999999999999999999999988889999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +++|+|.++|... ....+++..++.|+.||++||.|||+..   ++|+||+++|||+++++.+||+|||+++...
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            9999999999764 2356899999999999999999999974   9999999999999999999999999999873

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.90  E-value=3.1e-23  Score=207.75  Aligned_cols=141  Identities=28%  Similarity=0.393  Sum_probs=123.7

Q ss_pred             cccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      +.||+|+||.||+++.. +++.+|+|.++..   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999864 5789999999753   223455678898888776 899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            999988843   245899999999999999999999975   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.90  E-value=3.6e-23  Score=202.59  Aligned_cols=152  Identities=34%  Similarity=0.551  Sum_probs=130.9

Q ss_pred             cCCccccccccccceeEEEEEe-----CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-----ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      +.|+..++||+|+||.||+|..     .++..|++|.+.... .....+|.+|+.++..++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3466678999999999999984     346789999997533 3345679999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC
Q 043262          419 IYEYMPNKSLNVFLFDST--------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM  484 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~  484 (512)
                      ||||+++++|.+++....              ....+++...+.++.|++.||.|||+.+   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999985321              1235889999999999999999999975   99999999999999999


Q ss_pred             ceEEeccCcccccCC
Q 043262          485 NPKISDFGMARIFGG  499 (512)
Q Consensus       485 ~~kl~DFGla~~~~~  499 (512)
                      .+||+|||+++.+..
T Consensus       162 ~~kl~dfg~~~~~~~  176 (283)
T cd05090         162 HVKISDLGLSREIYS  176 (283)
T ss_pred             cEEeccccccccccC
Confidence            999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PHA02988 hypothetical protein; Provisional

Probab=99.90  E-value=3.9e-23  Score=202.48  Aligned_cols=143  Identities=19%  Similarity=0.341  Sum_probs=125.4

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCccc---HHHHHHHHHHHhcCCCCccccceeeEEe----CCeeEEEEEec
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQHKNLVRLLGCCLQ----ENESLLIYEYM  423 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~E~~  423 (512)
                      ..|++|++|.||+|.+ +|+.||||.++......   .+.|.+|+.++.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 68899999997643333   5678899999999999999999999977    34678999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++|+|.+++..   ...++|...+.++.+++.||.|||+..  +++||||||+|||+++++.+||+|||+++.+..
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            99999999954   346899999999999999999999752  478999999999999999999999999987644

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.90  E-value=3.8e-23  Score=199.34  Aligned_cols=148  Identities=31%  Similarity=0.501  Sum_probs=131.7

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...+.||+|+||.||++.+.++..+|+|.+.... ....+|.+|+.++.+++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            3466778899999999999999888899999886432 335678999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +|+|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            999999986432  35899999999999999999999875   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.90  E-value=2.3e-23  Score=211.42  Aligned_cols=147  Identities=23%  Similarity=0.365  Sum_probs=130.7

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +|...+.||+|+||.||+++.. ++..||+|.+...   .......+..|+.++..++||||+++++.+...+..++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            5777889999999999999864 5889999998643   23345678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          82 FLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             CCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            9999999999854   345899999999999999999999875   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.90  E-value=4.9e-23  Score=203.85  Aligned_cols=148  Identities=30%  Similarity=0.471  Sum_probs=128.7

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|+||.||+++.. ++..||||.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            57888899999999999999974 688999999875432 2334678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++ ++|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        85 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          85 VH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             CC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            95 6787777542  345888999999999999999999985   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.90  E-value=3.4e-23  Score=207.42  Aligned_cols=140  Identities=26%  Similarity=0.392  Sum_probs=124.0

Q ss_pred             cccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      +.||+|+||.||+++. .++..||||.++..   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3689999999999986 46889999999753   223345688999999888 799999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      |+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence            999988843   346899999999999999999999975   99999999999999999999999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.90  E-value=4.3e-23  Score=199.12  Aligned_cols=149  Identities=30%  Similarity=0.520  Sum_probs=132.1

Q ss_pred             CCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          346 HFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      +|...+.||+|+||.||++...++..+|||.+.... ....+|.+|+.++.+++||||+++++++...+..+++|||+++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            466678899999999999998877789999987543 3356799999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+|.+++....  ..+++..++.++.||+.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+..+
T Consensus        84 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          84 GCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            99999986532  25899999999999999999999875   999999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.90  E-value=4.4e-23  Score=200.38  Aligned_cols=143  Identities=29%  Similarity=0.451  Sum_probs=122.7

Q ss_pred             ccccccceeEEEEEeCC---CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCC
Q 043262          352 KLGEGGFGPVYKGKLAD---GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKS  427 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~---g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gs  427 (512)
                      +||+|+||.||+|...+   ...+++|.+.... ......|.+|+.+++.++|+||+++++.+...+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   3468888876443 2334578899999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          428 LNVFLFDSTR--SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       428 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |.+++.....  ....++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence            9999965432  233567888999999999999999974   999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.90  E-value=3.6e-23  Score=206.56  Aligned_cols=141  Identities=28%  Similarity=0.422  Sum_probs=123.6

Q ss_pred             cccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ++||+|+||.||+|+.. +++.||||.+...   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999874 5789999998753   223455678888888866 799999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence            999988854   345889999999999999999999975   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=4.3e-23  Score=202.39  Aligned_cols=150  Identities=29%  Similarity=0.409  Sum_probs=130.4

Q ss_pred             CccccccccccceeEEEEEe-CCCCEEEEEEcccCCc---ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      |+..++||+|+||.||++.. .++..||||.+.....   .....+.+|+.++..++||||+++++.+..++..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            56678899999999999986 4688999999864321   2234578899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++|+|.+++... ....+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+..+
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          82 MNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             cCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999888542 2346899999999999999999999975   999999999999999999999999999876433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.90  E-value=4.3e-23  Score=202.45  Aligned_cols=149  Identities=23%  Similarity=0.416  Sum_probs=129.7

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...+.||+|+||.||+++.. +++.+|||++....  ....+.+.+|+.++..++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            35778899999999999999975 57889999986432  2335678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |++++.+..+..   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            999987766542   2345899999999999999999999874   99999999999999999999999999988754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.90  E-value=4.4e-23  Score=206.33  Aligned_cols=141  Identities=28%  Similarity=0.376  Sum_probs=121.5

Q ss_pred             cccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHH-HHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVT-LIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ++||+|+||.||+++. .+|+.+|+|.+...   ......++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3689999999999986 56899999998643   2223345566655 56789999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            999988843   346899999999999999999999875   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.90  E-value=4e-23  Score=207.20  Aligned_cols=150  Identities=22%  Similarity=0.280  Sum_probs=130.4

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+++.. +++.+|+|.+.+.   .......+..|+.++..++|++|+++++.+...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            35777899999999999999975 4778999998642   2223445888999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++|+|.+++...  ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            999999999999642  235899999999999999999999975   99999999999999999999999999986643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=2.9e-23  Score=218.48  Aligned_cols=156  Identities=21%  Similarity=0.293  Sum_probs=132.9

Q ss_pred             HHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC----
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN----  414 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----  414 (512)
                      ...++|...++||+|+||.||+++. .+++.||||.+...  +......+.+|+..+..++|+||++++..+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3456899999999999999999985 57899999998643  3344567889999999999999999988775432    


Q ss_pred             ----eeEEEEEecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEe
Q 043262          415 ----ESLLIYEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  489 (512)
Q Consensus       415 ----~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~  489 (512)
                          ..++||||+++|+|.+++.... ....+++.....++.|++.||.|||+.+   |+||||||+||||++++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence                3679999999999999986432 2356899999999999999999999974   9999999999999999999999


Q ss_pred             ccCcccccCCC
Q 043262          490 DFGMARIFGGN  500 (512)
Q Consensus       490 DFGla~~~~~~  500 (512)
                      |||+++.+...
T Consensus       186 DFGls~~~~~~  196 (496)
T PTZ00283        186 DFGFSKMYAAT  196 (496)
T ss_pred             ecccCeecccc
Confidence            99999987544

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=5.8e-23  Score=198.63  Aligned_cols=150  Identities=31%  Similarity=0.503  Sum_probs=134.4

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...+.||+|++|.||++...++..||+|.++... ...+++.+|+.++.+++||||+++++++...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            5577789999999999999998888899999987543 345779999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+..
T Consensus        85 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          85 YGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             CCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            999999986532 346899999999999999999999875   99999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.90  E-value=7.2e-23  Score=198.55  Aligned_cols=149  Identities=32%  Similarity=0.570  Sum_probs=131.9

Q ss_pred             cCCccccccccccceeEEEEEeCC----CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD----GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~----g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...+.||+|+||.||+|.+..    ...|+||.++... .....+|.+|+.++.+++||||+++++.+...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            467788999999999999998742    4579999987543 33456799999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+|+||||+|||+++++.+||+|||+++.+.
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999986532  36899999999999999999999874   9999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.90  E-value=4.9e-23  Score=205.75  Aligned_cols=141  Identities=30%  Similarity=0.395  Sum_probs=121.2

Q ss_pred             cccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHH-HHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVT-LIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      +.||+|+||.||+++. .+++.||||.+....   ....+++..|.. ++..++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            3689999999999997 468999999986432   222345555554 56789999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            999998854   345889999999999999999999975   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.5e-23  Score=211.62  Aligned_cols=162  Identities=28%  Similarity=0.415  Sum_probs=136.8

Q ss_pred             HHhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCee
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENES  416 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  416 (512)
                      ...++|...++||+|.||+|+++.++ +++.+|||.+++..   ..+.+..+.|-+++... +||.|+.|+..+...+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34578888999999999999999975 57788999998764   34456677888877766 599999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++||||+.+|++..+.    ....+++.+...++..|+.||.|||+++   ||+||||.+|||||.+|.+||+||||+|.
T Consensus       445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999954433    3356999999999999999999999986   99999999999999999999999999997


Q ss_pred             cCCCCCCcCccccccC
Q 043262          497 FGGNQSEANTKRIVGT  512 (512)
Q Consensus       497 ~~~~~~~~~~~~~~Gt  512 (512)
                      --....  .|+.+.||
T Consensus       518 ~m~~g~--~TsTfCGT  531 (694)
T KOG0694|consen  518 GMGQGD--RTSTFCGT  531 (694)
T ss_pred             cCCCCC--ccccccCC
Confidence            543332  45568887

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.90  E-value=3e-23  Score=200.46  Aligned_cols=152  Identities=33%  Similarity=0.540  Sum_probs=137.6

Q ss_pred             hcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ..+|...++||+|+||.||+|...++..+++|.+..........+..|+.++..++|+||+++++++...+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            35577788999999999999999889999999998766656778999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++++|.+++.+. ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+..
T Consensus        85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            999999999653 3356899999999999999999999875   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.90  E-value=5.3e-23  Score=210.68  Aligned_cols=152  Identities=30%  Similarity=0.452  Sum_probs=130.0

Q ss_pred             cCCccccccccccceeEEEEEeC------CCCEEEEEEcccCCc-ccHHHHHHHHHHHhcCC-CCccccceeeEEeCCee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~  416 (512)
                      ++|...++||+|+||.||++++.      .+.+||||+++.... ...+.+.+|+.++.++. ||||+++++.+...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            45677889999999999999863      346899999975432 33457899999999997 99999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCC-----------------------------------------------------------
Q 043262          417 LLIYEYMPNKSLNVFLFDSTR-----------------------------------------------------------  437 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~-----------------------------------------------------------  437 (512)
                      ++|+||+++|+|.++++....                                                           
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999999999999864311                                                           


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec
Q 043262          438 ------------------------------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD  481 (512)
Q Consensus       438 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~  481 (512)
                                                          ...+++...+.++.||+.||.|||+.   +++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence                                                12467888999999999999999986   499999999999999


Q ss_pred             CCCceEEeccCcccccCC
Q 043262          482 HEMNPKISDFGMARIFGG  499 (512)
Q Consensus       482 ~~~~~kl~DFGla~~~~~  499 (512)
                      +++.+||+|||+++.+..
T Consensus       274 ~~~~~kL~DfGla~~~~~  291 (401)
T cd05107         274 EGKLVKICDFGLARDIMR  291 (401)
T ss_pred             CCCEEEEEecCcceeccc
Confidence            999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.90  E-value=5.9e-23  Score=200.90  Aligned_cols=145  Identities=31%  Similarity=0.438  Sum_probs=126.3

Q ss_pred             cccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          353 LGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       353 lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      ||+|+||.||++.. .+++.+|+|.+....   ....+.+..|+.++..++|+||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999986 468899999986432   22345678899999999999999999999999999999999999999


Q ss_pred             hHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          429 NVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       429 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ..++... .....+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            9887542 23456899999999999999999999975   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.90  E-value=4.5e-23  Score=207.24  Aligned_cols=146  Identities=24%  Similarity=0.447  Sum_probs=125.2

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC-----eeE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN-----ESL  417 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~  417 (512)
                      +|...++||+|+||.||+|+. .++..||||++...  .......+.+|+.++..++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            466778999999999999986 46899999998643  2233457889999999999999999999886543     479


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +||||+. ++|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 689888843   335899999999999999999999975   999999999999999999999999999865


Q ss_pred             C
Q 043262          498 G  498 (512)
Q Consensus       498 ~  498 (512)
                      .
T Consensus       154 ~  154 (338)
T cd07859         154 F  154 (338)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=2.6e-23  Score=209.29  Aligned_cols=151  Identities=30%  Similarity=0.484  Sum_probs=133.9

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ...|....+||+|.|+.|..++. ..+.+||+|.+.+..  ...++.+.+|+++|..|+|||||+++.+......+++||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            35677789999999999999986 468999999997653  334566899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+.+|.+.++|..+.   .+.+.....++.|+.++++|||++.   |||||||++||||+.++++||+|||++..+..+
T Consensus       135 eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence            9999999999996543   3556788889999999999999985   999999999999999999999999999988754

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.90  E-value=4.9e-23  Score=199.06  Aligned_cols=151  Identities=35%  Similarity=0.555  Sum_probs=134.5

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|+..++||+|+||.||+|...++..|++|.+.... ...+.+.+|+.++..++|+||+++++.+...+..++++||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            5677889999999999999998888899999986533 235789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+...
T Consensus        85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            99999998653 2345889999999999999999999874   999999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.90  E-value=5.2e-23  Score=205.71  Aligned_cols=144  Identities=30%  Similarity=0.445  Sum_probs=123.5

Q ss_pred             CccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHH---hcCCCCccccceeeEEeCCeeEEE
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLI---AKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      |...+.||+|+||.||++.. .+++.||||.++...   ....+.+..|++++   ..++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            45567899999999999986 468899999997432   22345566666554   567899999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |||+++|+|..++..    ..+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            999999999888743    35899999999999999999999975   999999999999999999999999998864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.90  E-value=5.1e-23  Score=204.95  Aligned_cols=142  Identities=30%  Similarity=0.414  Sum_probs=121.4

Q ss_pred             cccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhc-CCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAK-LQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ++||+|+||.||+++.. ++..||||.++..   .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999874 5788999998743   22334556667776664 4899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            999998854   235889999999999999999999975   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=6.6e-23  Score=209.73  Aligned_cols=141  Identities=22%  Similarity=0.328  Sum_probs=125.2

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ..+|...++||+|+||.||++.. ..++.||+|...      ...+.+|+.++++++||||+++++++...+..++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            35799999999999999999986 568899999753      24578899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +. ++|..++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            85 688888743   245899999999999999999999975   999999999999999999999999999764

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.90  E-value=5e-23  Score=205.84  Aligned_cols=146  Identities=28%  Similarity=0.371  Sum_probs=126.2

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCC-ccccceeeEEeCCeeEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHK-NLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lv~  420 (512)
                      +|...+.||+|+||.||+|+.. +++.||||.+...   .....+.+..|..++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            3667789999999999999864 5778999998743   233456788899999999765 5888999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      ||+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            99999999998854   345889999999999999999999975   999999999999999999999999998753

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.89  E-value=8e-23  Score=200.76  Aligned_cols=152  Identities=34%  Similarity=0.601  Sum_probs=133.2

Q ss_pred             cCCccccccccccceeEEEEEeC------CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ++|...+.||+|+||.||++...      ++..+++|.+........+.+.+|++++.+++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            45777889999999999999742      345689999987666667789999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          419 IYEYMPNKSLNVFLFDST----------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                      |+||+++++|.+++....          ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999986432          2235899999999999999999999875   999999999999999999999


Q ss_pred             eccCcccccCC
Q 043262          489 SDFGMARIFGG  499 (512)
Q Consensus       489 ~DFGla~~~~~  499 (512)
                      +|||+++.+..
T Consensus       162 ~dfg~~~~~~~  172 (288)
T cd05093         162 GDFGMSRDVYS  172 (288)
T ss_pred             ccCCccccccC
Confidence            99999987643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.89  E-value=5.5e-23  Score=205.14  Aligned_cols=141  Identities=31%  Similarity=0.477  Sum_probs=123.6

Q ss_pred             cccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ++||+|+||.||+++.. +++.||||.+...   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999874 5889999998643   223456678888888876 699999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+|.+++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            9999888542   45899999999999999999999875   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.89  E-value=7.4e-23  Score=199.75  Aligned_cols=153  Identities=30%  Similarity=0.516  Sum_probs=131.3

Q ss_pred             HhcCCccccccccccceeEEEEEeC------CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCe
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE  415 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  415 (512)
                      ..++|+..+.||+|+||.||+|...      .+..||||++.... .....+|.+|+.++..++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3567888899999999999998753      24679999986433 2345678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTR-------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                      .++||||+++|+|.+++.....       ...+++..++.++.|++.||.|||+.+   ++|+||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999864221       234688899999999999999999874   999999999999999999999


Q ss_pred             eccCcccccC
Q 043262          489 SDFGMARIFG  498 (512)
Q Consensus       489 ~DFGla~~~~  498 (512)
                      +|||+++.+.
T Consensus       161 ~dfg~~~~~~  170 (277)
T cd05062         161 GDFGMTRDIY  170 (277)
T ss_pred             CCCCCccccC
Confidence            9999998654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=6.3e-23  Score=212.87  Aligned_cols=145  Identities=23%  Similarity=0.315  Sum_probs=126.6

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ..|...+.||+|+||.||++... .++.||||...      ...+.+|++++++++|+|||++++++...+..++|||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            46888899999999999999975 47889999643      234678999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      . ++|..++...  ...++|..++.|+.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus       243 ~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        243 R-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             C-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            5 7888887542  236999999999999999999999975   9999999999999999999999999998875443

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.89  E-value=5e-23  Score=206.75  Aligned_cols=160  Identities=28%  Similarity=0.460  Sum_probs=138.9

Q ss_pred             HhcCCccccccccccceeEEEEEeCC-CCEEEEEEcccCCc---ccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESL  417 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~---~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~  417 (512)
                      ....|...+.||+|.||.||+++.+. |+.+|+|.+.+...   .....+.+|+.+|.++. |||||.+.+++...+..+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34567777899999999999999754 99999999975433   24568999999999998 999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC----CceEEeccCc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE----MNPKISDFGM  493 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~----~~~kl~DFGl  493 (512)
                      +|||++.+|.|.+.+...    .+++.....++.||+.++.|||+.+   ++||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999998654    3899999999999999999999975   9999999999999643    4799999999


Q ss_pred             ccccCCCCCCcCccccccC
Q 043262          494 ARIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       494 a~~~~~~~~~~~~~~~~Gt  512 (512)
                      ++.+..+.   ....++||
T Consensus       186 a~~~~~~~---~~~~~~Gt  201 (382)
T KOG0032|consen  186 AKFIKPGE---RLHTIVGT  201 (382)
T ss_pred             ceEccCCc---eEeeecCC
Confidence            99998732   44557776

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.89  E-value=6.6e-23  Score=204.66  Aligned_cols=141  Identities=28%  Similarity=0.366  Sum_probs=120.5

Q ss_pred             cccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHH-HHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVT-LIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ++||+|+||.||+++. .++..+|+|.+....   .....++..|.. ++..++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999997 468899999986432   222345556654 67889999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            999888843   345788888999999999999999875   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.89  E-value=2.9e-22  Score=228.78  Aligned_cols=143  Identities=30%  Similarity=0.568  Sum_probs=124.1

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ...+...+.||+|+||.||+|+. .++..||||++.......    ..|++.+.+++|||||+++|++.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            34577788999999999999986 578999999987543322    3468889999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +++|+|.++++      .++|..+..|+.||++||+|||+...++|+||||||+||+++.+..+++. ||+.+..
T Consensus       765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            99999999994      28999999999999999999997766789999999999999999988886 6666543

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.89  E-value=7e-23  Score=204.66  Aligned_cols=147  Identities=28%  Similarity=0.356  Sum_probs=126.2

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      +|...+.||+|+||.||+++.. ++..||||.+....   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            3667789999999999999864 57899999987532   22345567788888777 5899999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            99999999988854   245889999999999999999999875   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.89  E-value=1.2e-22  Score=197.02  Aligned_cols=148  Identities=26%  Similarity=0.442  Sum_probs=133.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .+|...++||+|+||.||+|+. .++..||+|++..........+.+|+.++.+++||||+++++.+...+..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4678889999999999999996 568899999997655555667889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            99999998853   245899999999999999999999874   9999999999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.89  E-value=5.7e-24  Score=210.74  Aligned_cols=139  Identities=32%  Similarity=0.524  Sum_probs=124.5

Q ss_pred             ccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCC
Q 043262          348 SDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKS  427 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gs  427 (512)
                      ...+.||.|+-|.||+|++. +++||||+++...       ..+|+-|++|+||||+.|.|+|....-.++|||||..|-
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            34678999999999999996 6899999986433       357888999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          428 LNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |...|+.   ..++.......+..+||.||.|||.+   .|||||||+-||||..+-.+||+|||-++.+...
T Consensus       199 L~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  199 LYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             HHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence            9999954   34578888999999999999999998   4999999999999999999999999999988765

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.89  E-value=9.5e-23  Score=221.41  Aligned_cols=150  Identities=24%  Similarity=0.351  Sum_probs=131.2

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+|+.. +++.||+|++....   ....++|.+|+.++.+++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46788899999999999999864 58999999997532   223567999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccC
Q 043262          421 EYMPNKSLNVFLFDST--------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  492 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFG  492 (512)
                      ||+++|+|.+++....        ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886421        1234677888999999999999999975   9999999999999999999999999


Q ss_pred             ccccc
Q 043262          493 MARIF  497 (512)
Q Consensus       493 la~~~  497 (512)
                      +++..
T Consensus       159 LAk~i  163 (932)
T PRK13184        159 AAIFK  163 (932)
T ss_pred             cceec
Confidence            99977

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.89  E-value=1.1e-22  Score=197.53  Aligned_cols=145  Identities=31%  Similarity=0.467  Sum_probs=124.4

Q ss_pred             cccccccceeEEEEEeCC---CCEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCC
Q 043262          351 NKLGEGGFGPVYKGKLAD---GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNK  426 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~---g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~g  426 (512)
                      +.||+|+||.||+|...+   +..+++|.++.... .....+.+|+.++..++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998643   45789998875432 33457899999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          427 SLNVFLFDST--RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       427 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +|.+++....  ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++++||+|||+++...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999996532  2235678888899999999999999875   9999999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.89  E-value=2.4e-23  Score=208.36  Aligned_cols=151  Identities=26%  Similarity=0.526  Sum_probs=131.2

Q ss_pred             cCCccccccccccceeEEEEEeCC---C--CEEEEEEccc-CCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD---G--KEIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~---g--~~vaVK~l~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      +.....++||+|-||.||+|.+-+   |  -.||||..+. ......+.|+.|..+|++++||||++|+|+|.+ .+.|+
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            334556789999999999998632   2  3589999886 445557889999999999999999999999986 47899


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |||.++.|.|..||...  ...|+......++.||+.+|.|||+.   ++|||||.++|||+...--+||+||||+|.+.
T Consensus       468 vmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            99999999999999653  34588899999999999999999997   59999999999999999999999999999987


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      ++.
T Consensus       543 d~~  545 (974)
T KOG4257|consen  543 DDA  545 (974)
T ss_pred             ccc
Confidence            664

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.89  E-value=7.9e-23  Score=201.55  Aligned_cols=151  Identities=33%  Similarity=0.527  Sum_probs=129.5

Q ss_pred             cCCccccccccccceeEEEEEeCC---------------CCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCcccccee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD---------------GKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLG  408 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~---------------g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g  408 (512)
                      ++|...++||+|+||.||+++..+               ...||+|.++.. .......|.+|++++.+++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            467788999999999999987532               224899998754 3334567999999999999999999999


Q ss_pred             eEEeCCeeEEEEEecCCCChhHHhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCee
Q 043262          409 CCLQENESLLIYEYMPNKSLNVFLFDST---------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVL  479 (512)
Q Consensus       409 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiL  479 (512)
                      ++...+..++||||+++++|.+++....         ....+++..++.++.|++.||.|||+.+   ++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999985432         1124789999999999999999999875   999999999999


Q ss_pred             ecCCCceEEeccCcccccC
Q 043262          480 LDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       480 l~~~~~~kl~DFGla~~~~  498 (512)
                      +++++.+||+|||+++.+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~  180 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLY  180 (295)
T ss_pred             EcCCCcEEecccccccccc
Confidence            9999999999999998764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.89  E-value=1.3e-22  Score=198.29  Aligned_cols=150  Identities=32%  Similarity=0.511  Sum_probs=126.3

Q ss_pred             cCCccccccccccceeEEEEEeC-CCC----EEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGK----EIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~----~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .+|...+.||+|+||.||+|.+. +++    .+++|.+..... ....++..|+..+.+++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            35667789999999999999863 344    477888754332 33567888999999999999999999875 455788


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++||+++|+|.+++...  ...++|.....++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999999643  245899999999999999999999875   9999999999999999999999999998775


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      .+
T Consensus       161 ~~  162 (279)
T cd05111         161 PD  162 (279)
T ss_pred             CC
Confidence            43

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.89  E-value=7.8e-23  Score=204.29  Aligned_cols=146  Identities=27%  Similarity=0.374  Sum_probs=126.0

Q ss_pred             CccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEE
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      |...+.||+|+||.||+++. .+++.||+|.+...   .....+.+..|..++..+. |++|+++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            56678899999999999986 46889999998743   2233456788999988886 5678889999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        82 y~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          82 YVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            9999999998854   245899999999999999999999875   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.89  E-value=9.3e-23  Score=198.89  Aligned_cols=141  Identities=23%  Similarity=0.399  Sum_probs=120.6

Q ss_pred             ccccccceeEEEEEeCC-------------------------CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccc
Q 043262          352 KLGEGGFGPVYKGKLAD-------------------------GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL  406 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~-------------------------g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l  406 (512)
                      +||+|+||.||+|.+..                         ...|++|.+.........+|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         13588998876544445678999999999999999999


Q ss_pred             eeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC--
Q 043262          407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM--  484 (512)
Q Consensus       407 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~--  484 (512)
                      ++++...+..++||||+++|+|..++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||+++.+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999998543  345889999999999999999999874   99999999999997643  


Q ss_pred             -----ceEEeccCccccc
Q 043262          485 -----NPKISDFGMARIF  497 (512)
Q Consensus       485 -----~~kl~DFGla~~~  497 (512)
                           .+||+|||+++..
T Consensus       157 ~~~~~~~kl~d~g~~~~~  174 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTA  174 (274)
T ss_pred             cCccceeeecCCcccccc
Confidence                 3899999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.89  E-value=1.4e-22  Score=197.12  Aligned_cols=149  Identities=32%  Similarity=0.581  Sum_probs=125.2

Q ss_pred             ccccccccccceeEEEEEeCCCC---EEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC------Cee
Q 043262          348 SDENKLGEGGFGPVYKGKLADGK---EIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE------NES  416 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~~~g~---~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~  416 (512)
                      ...++||+|+||.||+|+..+..   .+|+|.++..  +....+.+..|+.++..++|+||+++++.+...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            44678999999999999975432   5899988643  334467899999999999999999999988543      246


Q ss_pred             EEEEEecCCCChhHHhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          417 LLIYEYMPNKSLNVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      ++++||+++|+|.+++...   .....+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999987432   12345899999999999999999999874   99999999999999999999999999


Q ss_pred             ccccCC
Q 043262          494 ARIFGG  499 (512)
Q Consensus       494 a~~~~~  499 (512)
                      ++.+..
T Consensus       159 ~~~~~~  164 (272)
T cd05075         159 SKKIYN  164 (272)
T ss_pred             ccccCc
Confidence            998754

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.89  E-value=4.1e-23  Score=203.00  Aligned_cols=155  Identities=32%  Similarity=0.520  Sum_probs=129.5

Q ss_pred             ccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCC
Q 043262          350 ENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNK  426 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~g  426 (512)
                      .+.||+|.||.||-|+. ++|+.||||.+.+.  ..+....+++|+.+|.+++||.||.|...+...+..++|||-+.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            47899999999999986 57999999999643  4455578999999999999999999999999999999999999554


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC---CceEEeccCcccccCCCCCC
Q 043262          427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFGMARIFGGNQSE  503 (512)
Q Consensus       427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~---~~~kl~DFGla~~~~~~~~~  503 (512)
                      -|+-+| .. ....|++..-..++.||+.||.|||.+   +|+|.||||+||||.+.   -.+||+|||.||+++...-.
T Consensus       649 MLEMIL-Ss-EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMIL-SS-EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHH-Hh-hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            444444 33 335688888888999999999999998   49999999999999653   46999999999999876543


Q ss_pred             cCccccccC
Q 043262          504 ANTKRIVGT  512 (512)
Q Consensus       504 ~~~~~~~Gt  512 (512)
                      .   .++||
T Consensus       724 r---sVVGT  729 (888)
T KOG4236|consen  724 R---SVVGT  729 (888)
T ss_pred             h---hhcCC
Confidence            2   25666

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.89  E-value=2.2e-24  Score=198.63  Aligned_cols=158  Identities=30%  Similarity=0.518  Sum_probs=139.2

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      -|...++||+|.||.|||+.+ ..|+.||||.+.-.  .+++++..|+.+|.+.+.|+||+.+|.+.....+|+|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            466778999999999999986 46999999998744  357899999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCCCc
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA  504 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~  504 (512)
                      .|+..+.++.  ++.+|.+..+..+....++||+|||.-   +-+|||||+.||||+-++.+||+|||.|..+.+-....
T Consensus       112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence            9999999864  446799999999999999999999985   58999999999999999999999999999887654444


Q ss_pred             CccccccC
Q 043262          505 NTKRIVGT  512 (512)
Q Consensus       505 ~~~~~~Gt  512 (512)
                      +|  ++||
T Consensus       187 NT--VIGT  192 (502)
T KOG0574|consen  187 NT--VIGT  192 (502)
T ss_pred             Cc--cccC
Confidence            43  5665

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.89  E-value=1e-22  Score=202.73  Aligned_cols=141  Identities=28%  Similarity=0.433  Sum_probs=122.2

Q ss_pred             cccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhc-CCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAK-LQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      +.||+|+||.||+|+.. ++..||||.++...   ......+..|..++.. ++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999975 57899999987532   2334556777777775 5899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            999999854   245889999999999999999999975   999999999999999999999999999854

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.2e-22  Score=196.00  Aligned_cols=148  Identities=30%  Similarity=0.500  Sum_probs=131.2

Q ss_pred             CCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          346 HFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      +|...+.||+|+||.||++...++..+++|.+..... ...+|.+|+.++..++||||+++++++...+..++|+||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            4667789999999999999988777899998864332 345788999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++|.+++....  ..+++...+.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence            99999986432  36899999999999999999999975   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.89  E-value=9.7e-23  Score=203.97  Aligned_cols=141  Identities=26%  Similarity=0.366  Sum_probs=124.1

Q ss_pred             cccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ++||+|+||.||+++. .+++.+|+|.++...   ....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999986 457899999997532   23356688999999888 699999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            999988843   245899999999999999999999975   999999999999999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.89  E-value=1.5e-22  Score=198.14  Aligned_cols=151  Identities=36%  Similarity=0.624  Sum_probs=130.4

Q ss_pred             cCCccccccccccceeEEEEEeCC------CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD------GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~------g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++|+..+.||+|+||.||+|....      ...|++|.+.... .....+|.+|+.++..++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            356778899999999999998643      2579999987443 334567999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC
Q 043262          418 LIYEYMPNKSLNVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM  484 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~  484 (512)
                      ++|||+++|+|.+++.....             ...+++...+.++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999865321             145889999999999999999999975   99999999999999999


Q ss_pred             ceEEeccCcccccC
Q 043262          485 NPKISDFGMARIFG  498 (512)
Q Consensus       485 ~~kl~DFGla~~~~  498 (512)
                      .+||+|||+++...
T Consensus       162 ~~~L~dfg~~~~~~  175 (283)
T cd05048         162 TVKISDFGLSRDIY  175 (283)
T ss_pred             cEEECCCcceeecc
Confidence            99999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.89  E-value=1.2e-22  Score=198.34  Aligned_cols=151  Identities=33%  Similarity=0.593  Sum_probs=132.1

Q ss_pred             cCCccccccccccceeEEEEEeCC------CCEEEEEEcccCCcc-cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD------GKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      .+|...+.||+|+||.||+|...+      +..||||.++..... ..+.|.+|++++..++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            346677899999999999998633      478999999765443 4578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCce
Q 043262          418 LIYEYMPNKSLNVFLFDST-----------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP  486 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~  486 (512)
                      +||||+++++|.+++....           ....+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999996432           2345889999999999999999999875   9999999999999999999


Q ss_pred             EEeccCcccccC
Q 043262          487 KISDFGMARIFG  498 (512)
Q Consensus       487 kl~DFGla~~~~  498 (512)
                      ||+|||+++.+.
T Consensus       162 kl~d~g~~~~~~  173 (280)
T cd05049         162 KIGDFGMSRDVY  173 (280)
T ss_pred             EECCcccceecc
Confidence            999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.89  E-value=1.3e-22  Score=206.69  Aligned_cols=148  Identities=27%  Similarity=0.455  Sum_probs=127.9

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC-----eeE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN-----ESL  417 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~  417 (512)
                      +|+..++||+|+||.||++.. .+++.||||++...  .....+++.+|++++..++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            366788999999999999986 57899999998643  2234567899999999999999999999998776     789


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +|+||+. ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 578777743   346899999999999999999999975   999999999999999999999999999876


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      ...
T Consensus       154 ~~~  156 (372)
T cd07853         154 EPD  156 (372)
T ss_pred             ccC
Confidence            543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.89  E-value=1e-22  Score=205.12  Aligned_cols=151  Identities=28%  Similarity=0.451  Sum_probs=127.7

Q ss_pred             cCCccccccccccceeEEEEEe------CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeC-Ce
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQE-NE  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~------~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~  415 (512)
                      ++|...++||+|+||.||+|..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5688889999999999999973      356789999997543 23356788999999999 689999999988754 45


Q ss_pred             eEEEEEecCCCChhHHhhcCCC----------------------------------------------------------
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTR----------------------------------------------------------  437 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------------  437 (512)
                      .+++|||+++|+|.+++.....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999999864210                                                          


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          438 ------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       438 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                            ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  230 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY  230 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence                  123688889999999999999999875   9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.89  E-value=1.2e-22  Score=203.11  Aligned_cols=141  Identities=27%  Similarity=0.347  Sum_probs=119.4

Q ss_pred             cccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHH-HHHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEV-TLIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~-~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      +.||+|+||.||+++.. +++.+|+|.+....   .....++..|. .++..++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999864 57789999986432   22233444454 456789999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+|.+++..   ...+.+.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            999999854   235778888889999999999999975   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.89  E-value=1.4e-22  Score=199.36  Aligned_cols=152  Identities=32%  Similarity=0.556  Sum_probs=132.7

Q ss_pred             cCCccccccccccceeEEEEEeC------CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .+|...+.||+|+||.||+++..      ++..+++|.+........+.+.+|+.++.+++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            34666789999999999999742      345689999877666666789999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc
Q 043262          419 IYEYMPNKSLNVFLFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN  485 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~  485 (512)
                      ||||+++++|.+++....             ....++|..++.++.||+.||.|||+++   |+||||||+|||+++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999986432             1235899999999999999999999885   999999999999999999


Q ss_pred             eEEeccCcccccCC
Q 043262          486 PKISDFGMARIFGG  499 (512)
Q Consensus       486 ~kl~DFGla~~~~~  499 (512)
                      +||+|||+++....
T Consensus       162 ~~l~dfg~a~~~~~  175 (291)
T cd05094         162 VKIGDFGMSRDVYS  175 (291)
T ss_pred             EEECCCCcccccCC
Confidence            99999999986644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.89  E-value=1.8e-22  Score=198.40  Aligned_cols=151  Identities=35%  Similarity=0.519  Sum_probs=129.1

Q ss_pred             CCccccccccccceeEEEEEeC------CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      +|...+.||+|+||.||+|+..      ....+++|.+.... .....++.+|+.++..++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3566789999999999999853      23578888887543 3345679999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCC
Q 043262          419 IYEYMPNKSLNVFLFDST---------------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN  477 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N  477 (512)
                      ++||+.+|+|.+++....                     ....+++...+.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999985421                     1235889999999999999999999874   9999999999


Q ss_pred             eeecCCCceEEeccCcccccCC
Q 043262          478 VLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       478 iLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++++.+||+|||+++.+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~  179 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYE  179 (290)
T ss_pred             EEEcCCCcEEeccccccccccC
Confidence            9999999999999999987643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.89  E-value=1.8e-22  Score=194.00  Aligned_cols=143  Identities=34%  Similarity=0.557  Sum_probs=126.8

Q ss_pred             cccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      +.||+|+||.||+++. .++..+|+|.+.... ......|.+|++++..++||||+++++++...+..++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3699999999999987 468899999886433 33456799999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          429 NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      .+++...  ...+++...+.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence            9998542  235899999999999999999999875   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.89  E-value=1.4e-22  Score=198.99  Aligned_cols=153  Identities=29%  Similarity=0.496  Sum_probs=130.2

Q ss_pred             HhcCCccccccccccceeEEEEEeC------CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCe
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE  415 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  415 (512)
                      ..++|...++||+|+||.||+|...      .+..||+|.+.... ......+.+|+.++..++||||+++++.+...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3467888899999999999999753      24579999886443 2334568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTR-------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                      .++||||+++|+|.+++.....       ...+.+..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999964221       234577888999999999999999874   999999999999999999999


Q ss_pred             eccCcccccC
Q 043262          489 SDFGMARIFG  498 (512)
Q Consensus       489 ~DFGla~~~~  498 (512)
                      +|||+++.+.
T Consensus       161 ~Dfg~~~~~~  170 (288)
T cd05061         161 GDFGMTRDIY  170 (288)
T ss_pred             CcCCcccccc
Confidence            9999998653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.89  E-value=1.2e-22  Score=202.21  Aligned_cols=141  Identities=30%  Similarity=0.431  Sum_probs=122.1

Q ss_pred             cccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhc-CCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAK-LQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ++||+|+||.||+++.. ++..||+|.++...   ....+.+..|..++.. ++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999974 58899999987532   2334566778877765 4899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            999998854   245889999999999999999999975   999999999999999999999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-23  Score=212.35  Aligned_cols=151  Identities=34%  Similarity=0.514  Sum_probs=133.2

Q ss_pred             ccccccccccceeEEEEEeC--CCC--EEEEEEcccCCcc-cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          348 SDENKLGEGGFGPVYKGKLA--DGK--EIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~~--~g~--~vaVK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ...++||+|.||.|++|.|.  +|.  .||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....||+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            44578999999999999874  344  5899999876554 67899999999999999999999999987 778899999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  502 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~  502 (512)
                      ++.|+|.+.|++ .....|--..+..++.|||.||.||.++.   +|||||.++|+||-..-.+||+||||.|-++.++.
T Consensus       192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            999999999987 44456778888999999999999999874   99999999999999999999999999999987764


Q ss_pred             C
Q 043262          503 E  503 (512)
Q Consensus       503 ~  503 (512)
                      .
T Consensus       268 ~  268 (1039)
T KOG0199|consen  268 M  268 (1039)
T ss_pred             c
Confidence            3

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.89  E-value=1.9e-22  Score=198.85  Aligned_cols=152  Identities=33%  Similarity=0.539  Sum_probs=130.8

Q ss_pred             cCCccccccccccceeEEEEEeC-----------------CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccc
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-----------------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRL  406 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-----------------~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l  406 (512)
                      ++|+..++||+|+||.||++...                 +...+|+|.+... .......|.+|+.++..++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46788899999999999998532                 2346899998754 33445789999999999999999999


Q ss_pred             eeeEEeCCeeEEEEEecCCCChhHHhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCe
Q 043262          407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTR--------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNV  478 (512)
Q Consensus       407 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~Ni  478 (512)
                      ++++...+..+++|||+++|+|.+++.....        ...+++.....++.|++.||.|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999865321        134788899999999999999999975   99999999999


Q ss_pred             eecCCCceEEeccCcccccCC
Q 043262          479 LLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       479 Ll~~~~~~kl~DFGla~~~~~  499 (512)
                      |+++++.+||+|||+++.+..
T Consensus       162 li~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             EEcCCCCEEeccCcccccccC
Confidence            999999999999999987643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.89  E-value=2.2e-22  Score=197.71  Aligned_cols=150  Identities=29%  Similarity=0.509  Sum_probs=122.7

Q ss_pred             CCccccccccccceeEEEEEe--CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcC---CCCccccceeeEEe-----C
Q 043262          346 HFSDENKLGEGGFGPVYKGKL--ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKL---QHKNLVRLLGCCLQ-----E  413 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~--~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~-----~  413 (512)
                      +|...+.||+|+||.||+++.  .++..||||.++...  ......+.+|+.++..+   +||||+++++++..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            577788999999999999986  346889999886432  22234566777766655   69999999999863     3


Q ss_pred             CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          414 NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      ...++|+||+. ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence            45899999996 6898888543 2345899999999999999999999975   99999999999999999999999999


Q ss_pred             ccccCCC
Q 043262          494 ARIFGGN  500 (512)
Q Consensus       494 a~~~~~~  500 (512)
                      ++.....
T Consensus       157 ~~~~~~~  163 (290)
T cd07862         157 ARIYSFQ  163 (290)
T ss_pred             eEeccCC
Confidence            9876543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.89  E-value=1.4e-22  Score=203.66  Aligned_cols=153  Identities=29%  Similarity=0.465  Sum_probs=128.5

Q ss_pred             cCCccccccccccceeEEEEEeC------CCCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeC-Ce
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQE-NE  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~  415 (512)
                      ++|...++||+|+||.||+|...      .++.||+|+++... ....+.+..|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            46788899999999999999642      34789999987543 23345788999999999 899999999988754 56


Q ss_pred             eEEEEEecCCCChhHHhhcCCC----------------------------------------------------------
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTR----------------------------------------------------------  437 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------------  437 (512)
                      .++++||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999999853211                                                          


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          438 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       438 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ...++|..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..+
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~  226 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD  226 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccC
Confidence            126899999999999999999999874   999999999999999999999999999976443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.89  E-value=2.1e-22  Score=199.83  Aligned_cols=149  Identities=26%  Similarity=0.320  Sum_probs=130.6

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|+||.||++... ++..+++|.+.... ......+.+|++++.+++||||+++++.+..++..++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            35778899999999999999864 57888999886442 23345688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +++++|.+++...   ..+++.....++.|++.||.|||+..  +++|+||||+|||+++++.+||+|||+++.+.
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            9999999999543   45889999999999999999999742  59999999999999999999999999998653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.89  E-value=2.7e-22  Score=197.68  Aligned_cols=152  Identities=35%  Similarity=0.528  Sum_probs=131.5

Q ss_pred             cCCccccccccccceeEEEEEeCC-----------------CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccc
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-----------------GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRL  406 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-----------------g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l  406 (512)
                      .+|...++||+|+||.||++...+                 +..||+|.+.... ....+.+.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            467788999999999999987642                 2458999987543 3446789999999999999999999


Q ss_pred             eeeEEeCCeeEEEEEecCCCChhHHhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCe
Q 043262          407 LGCCLQENESLLIYEYMPNKSLNVFLFDST--------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNV  478 (512)
Q Consensus       407 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~Ni  478 (512)
                      ++++...+..++++||+++++|.+++....        ....+++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence            999999999999999999999999986532        1236899999999999999999999875   99999999999


Q ss_pred             eecCCCceEEeccCcccccCC
Q 043262          479 LLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       479 Ll~~~~~~kl~DFGla~~~~~  499 (512)
                      ++++++.+||+|||+++.+..
T Consensus       162 li~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             eecCCCceEEccccceeeccc
Confidence            999999999999999987643

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.89  E-value=1.8e-22  Score=196.15  Aligned_cols=142  Identities=25%  Similarity=0.428  Sum_probs=120.6

Q ss_pred             ccccccceeEEEEEeCCCC---EEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCC
Q 043262          352 KLGEGGFGPVYKGKLADGK---EIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKS  427 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~g~---~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gs  427 (512)
                      .||+|+||.||++...++.   .+++|.+.... ....+.|.+|+.++..++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5999999999999754433   45667665433 3346789999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          428 LNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       428 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      |.+++..... ...+++.....++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence            9999965322 234677778899999999999999874   99999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.89  E-value=1.9e-22  Score=194.45  Aligned_cols=142  Identities=27%  Similarity=0.495  Sum_probs=122.7

Q ss_pred             cccccccceeEEEEEeCCCC-----------EEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          351 NKLGEGGFGPVYKGKLADGK-----------EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~-----------~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      +.||+|+||.||+|...+..           .+++|.+...... ...|.+|+.+++.++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999975433           4777877644333 6789999999999999999999999988 788999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-------ceEEeccC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-------NPKISDFG  492 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-------~~kl~DFG  492 (512)
                      +||+++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999996533  26899999999999999999999874   99999999999999888       79999999


Q ss_pred             cccccCC
Q 043262          493 MARIFGG  499 (512)
Q Consensus       493 la~~~~~  499 (512)
                      +++....
T Consensus       154 ~a~~~~~  160 (259)
T cd05037         154 IPITVLS  160 (259)
T ss_pred             ccccccc
Confidence            9987543

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.89  E-value=2.1e-22  Score=199.38  Aligned_cols=152  Identities=32%  Similarity=0.539  Sum_probs=131.0

Q ss_pred             cCCccccccccccceeEEEEEe--------CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL--------ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQEN  414 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~--------~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  414 (512)
                      ++|...+.||+|+||.||+++.        .++..|++|.+... .....+++.+|+.++..+ +||||+++++.+...+
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            5677788999999999999974        12457999988743 234467899999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD  481 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~  481 (512)
                      ..+++|||+++|+|.+++.....             ...+++..++.++.||+.||.|||+.+   ++||||||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~  171 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVT  171 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEc
Confidence            99999999999999999965321             235889999999999999999999975   99999999999999


Q ss_pred             CCCceEEeccCcccccCC
Q 043262          482 HEMNPKISDFGMARIFGG  499 (512)
Q Consensus       482 ~~~~~kl~DFGla~~~~~  499 (512)
                      +++.+||+|||+++.+..
T Consensus       172 ~~~~~kl~D~g~~~~~~~  189 (304)
T cd05101         172 ENNVMKIADFGLARDVNN  189 (304)
T ss_pred             CCCcEEECCCccceeccc
Confidence            999999999999987753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.89  E-value=2.9e-22  Score=194.73  Aligned_cols=150  Identities=29%  Similarity=0.551  Sum_probs=127.6

Q ss_pred             CccccccccccceeEEEEEeCC----CCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCe-----
Q 043262          347 FSDENKLGEGGFGPVYKGKLAD----GKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE-----  415 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~~----g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-----  415 (512)
                      |...+.||+|+||.||+|.+..    +..||+|+++..  .......+.+|++.+..++||||+++++.+...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            3456789999999999998642    367999998743  23345689999999999999999999999876654     


Q ss_pred             -eEEEEEecCCCChhHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEecc
Q 043262          416 -SLLIYEYMPNKSLNVFLFDST---RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  491 (512)
Q Consensus       416 -~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DF  491 (512)
                       .++++||+++|+|..++....   ....+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999999885432   2346899999999999999999999874   999999999999999999999999


Q ss_pred             CcccccCC
Q 043262          492 GMARIFGG  499 (512)
Q Consensus       492 Gla~~~~~  499 (512)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05035         158 GLSKKIYS  165 (273)
T ss_pred             cceeeccc
Confidence            99987643

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.89  E-value=2.1e-22  Score=195.39  Aligned_cols=151  Identities=29%  Similarity=0.559  Sum_probs=131.2

Q ss_pred             cCCccccccccccceeEEEEEeC-C---CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-D---GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~---g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .+|...+.||+|+||.||+|... +   +..+++|.++... ....+.|.+|+.++.+++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            45677889999999999999863 2   3378999987533 33456899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++++|.+++...  ...+++...+.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999999643  245899999999999999999999875   99999999999999999999999999987754


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       159 ~  159 (267)
T cd05066         159 D  159 (267)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.88  E-value=2e-22  Score=200.98  Aligned_cols=141  Identities=33%  Similarity=0.452  Sum_probs=123.8

Q ss_pred             cccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      +.||+|+||.||+++.. ++..||||.++..   .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875 5789999999753   233456678888888887 799999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            999988854   235899999999999999999999875   999999999999999999999999999753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.88  E-value=2.5e-22  Score=194.46  Aligned_cols=150  Identities=30%  Similarity=0.542  Sum_probs=132.3

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      +|...++||+|+||.||++... .+..|++|.+... .....++.+|++++..++|+||+++++++...+..+++|||++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            4667789999999999999864 5788999998754 3345789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.....
T Consensus        86 ~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          86 YGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             CCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            99999998543 2346899999999999999999999875   999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.88  E-value=2.3e-22  Score=196.48  Aligned_cols=154  Identities=27%  Similarity=0.470  Sum_probs=132.8

Q ss_pred             hcCCccccccccccceeEEEEEeCC-----CCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEe-CCee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLAD-----GKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ-ENES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~-----g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~  416 (512)
                      .++|...+.||+|+||.||+|...+     +..|++|++... .....+.+.+|+.++.+++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            3567888999999999999999765     678999998754 33446678999999999999999999999876 4678


Q ss_pred             EEEEEecCCCChhHHhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEecc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRS-----VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  491 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DF  491 (512)
                      ++++||+++++|.+++......     ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998653322     46899999999999999999999874   999999999999999999999999


Q ss_pred             CcccccCCC
Q 043262          492 GMARIFGGN  500 (512)
Q Consensus       492 Gla~~~~~~  500 (512)
                      |+++.+..+
T Consensus       162 g~~~~~~~~  170 (280)
T cd05043         162 ALSRDLFPM  170 (280)
T ss_pred             CCcccccCC
Confidence            999876443

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.88  E-value=2.7e-22  Score=194.29  Aligned_cols=144  Identities=24%  Similarity=0.417  Sum_probs=123.5

Q ss_pred             cccccccceeEEEEEeCC-------------CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          351 NKLGEGGFGPVYKGKLAD-------------GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~-------------g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      +.||+|+||.||+|.+.+             ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998632             2258889887655555668899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc-------eEEec
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN-------PKISD  490 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~-------~kl~D  490 (512)
                      +||||+++|+|..++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999988542  345899999999999999999999874   999999999999987664       89999


Q ss_pred             cCcccccCC
Q 043262          491 FGMARIFGG  499 (512)
Q Consensus       491 FGla~~~~~  499 (512)
                      ||++..+..
T Consensus       156 ~g~~~~~~~  164 (262)
T cd05077         156 PGIPITVLS  164 (262)
T ss_pred             CCCCccccC
Confidence            999976643

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.88  E-value=3e-22  Score=196.42  Aligned_cols=148  Identities=29%  Similarity=0.411  Sum_probs=129.0

Q ss_pred             CccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      |...+.||+|+||.||++.. .+++.+|+|.+....   ......+.+|++++..++|+||+.+.+.+..++..++++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            45567899999999999986 468899999986432   22234578899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +++++|.+++... ....+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            9999999888643 2346999999999999999999999875   9999999999999999999999999997764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.88  E-value=2e-22  Score=219.36  Aligned_cols=149  Identities=28%  Similarity=0.415  Sum_probs=132.2

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+|... +++.||||+++...   ....+.+..|+.++..++||||+++++.+...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56788899999999999999975 68899999987532   223467889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++++|.+++...   ..+++...+.|+.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++....
T Consensus        84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~  156 (669)
T cd05610          84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN  156 (669)
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence            999999999998542   35888999999999999999999874   99999999999999999999999999997653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.88  E-value=1.6e-22  Score=197.89  Aligned_cols=151  Identities=34%  Similarity=0.519  Sum_probs=129.1

Q ss_pred             CCccccccccccceeEEEEEeC------CCCEEEEEEcccCCcc-cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      +|...++||+|+||.||+|...      ++..||+|+++..... ..+.|.+|+.++..++||||+++++.+...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            3556678999999999999863      2468999999754332 34678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc
Q 043262          419 IYEYMPNKSLNVFLFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN  485 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~  485 (512)
                      ++||+++++|.+++....             ....+++..+..++.|++.||.|||+.+   |+||||||.|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            999999999999985211             1235889999999999999999999875   999999999999999999


Q ss_pred             eEEeccCcccccCC
Q 043262          486 PKISDFGMARIFGG  499 (512)
Q Consensus       486 ~kl~DFGla~~~~~  499 (512)
                      +||+|||+++.+..
T Consensus       163 ~kl~Dfg~~~~~~~  176 (283)
T cd05091         163 VKISDLGLFREVYA  176 (283)
T ss_pred             eEeccccccccccc
Confidence            99999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=2.8e-22  Score=193.23  Aligned_cols=148  Identities=33%  Similarity=0.565  Sum_probs=133.1

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...+.||+|+||.||++... ++.|++|.+..... ..+++.+|+.++.+++|+||+++++++...+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            46777889999999999999875 78999999976554 56789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +++|.+++.... ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence            999999985432 236899999999999999999999975   9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.88  E-value=3.1e-22  Score=193.80  Aligned_cols=150  Identities=31%  Similarity=0.517  Sum_probs=130.1

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      .+|...++||+|+||.||+|+..+...|++|.++.... ..+.|.+|+.++..++||||+++++.+. .+..++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            45778889999999999999987777899999975332 3467899999999999999999999874 456799999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +|+|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+...
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            99999999643 2345799999999999999999999875   999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.88  E-value=2.7e-22  Score=199.15  Aligned_cols=148  Identities=28%  Similarity=0.492  Sum_probs=128.2

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|+||.||+++.. ++..||+|.++... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            45778889999999999999864 57889999987443 23345678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +++ +|.+++...  ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence            975 788877543  234788999999999999999999975   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.88  E-value=2.6e-22  Score=196.25  Aligned_cols=151  Identities=36%  Similarity=0.572  Sum_probs=132.3

Q ss_pred             cCCccccccccccceeEEEEEeC------CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .++...++||+|+||.||++...      ++..+++|.+........+.|.+|++++..++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45666789999999999999742      356789999887666667789999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCce
Q 043262          419 IYEYMPNKSLNVFLFDSTR------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP  486 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~  486 (512)
                      ++||+++++|.+++.....            ...+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999865321            135899999999999999999999875   9999999999999999999


Q ss_pred             EEeccCcccccC
Q 043262          487 KISDFGMARIFG  498 (512)
Q Consensus       487 kl~DFGla~~~~  498 (512)
                      ||+|||+++.+.
T Consensus       162 kL~dfg~~~~~~  173 (280)
T cd05092         162 KIGDFGMSRDIY  173 (280)
T ss_pred             EECCCCceeEcC
Confidence            999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.88  E-value=2.5e-22  Score=195.80  Aligned_cols=152  Identities=28%  Similarity=0.477  Sum_probs=131.4

Q ss_pred             cCCccccccccccceeEEEEEeCC------CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD------GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~------g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++|...+.||+|+||.||++...+      +..|++|.+.... ......+.+|+.++..++||||+++++++...+..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            567778899999999999998642      3689999987543 234567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEec
Q 043262          418 LIYEYMPNKSLNVFLFDSTR-------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD  490 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~D  490 (512)
                      +||||+++|+|.+++.....       ...++|..++.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence            99999999999999864321       234789999999999999999999874   99999999999999999999999


Q ss_pred             cCcccccCC
Q 043262          491 FGMARIFGG  499 (512)
Q Consensus       491 FGla~~~~~  499 (512)
                      ||+++.+..
T Consensus       163 fg~~~~~~~  171 (277)
T cd05032         163 FGMTRDIYE  171 (277)
T ss_pred             cccchhhcc
Confidence            999987643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.88  E-value=2.8e-22  Score=197.33  Aligned_cols=153  Identities=33%  Similarity=0.534  Sum_probs=131.9

Q ss_pred             hcCCccccccccccceeEEEEEeC------CCCEEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENE  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  415 (512)
                      .++|...+.||+|+||.||++...      +...+++|.+... ......++.+|+.++.++ +|+||+++++++...+.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            356777889999999999999863      2357899998753 333456789999999999 79999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC
Q 043262          416 SLLIYEYMPNKSLNVFLFDS-------------TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH  482 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~  482 (512)
                      .+++|||+++|+|..++...             .....+++..++.++.|++.||.|||+.+   |+||||||+|||+++
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence            99999999999999998542             22346899999999999999999999874   999999999999999


Q ss_pred             CCceEEeccCcccccCC
Q 043262          483 EMNPKISDFGMARIFGG  499 (512)
Q Consensus       483 ~~~~kl~DFGla~~~~~  499 (512)
                      ++.+||+|||+++.+..
T Consensus       168 ~~~~kL~Dfg~~~~~~~  184 (293)
T cd05053         168 DHVMKIADFGLARDIHH  184 (293)
T ss_pred             CCeEEeCcccccccccc
Confidence            99999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.88  E-value=4.7e-23  Score=185.56  Aligned_cols=154  Identities=30%  Similarity=0.379  Sum_probs=137.2

Q ss_pred             HhcCCccccccccccceeEEEEE-eCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeC-----Cee
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE-----NES  416 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~  416 (512)
                      ..++|...++||+|||.-||.++ +.++..+|+|++.-.+.++.+..++|++..++++||||++++++...+     .+.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34678889999999999999998 678899999999887778889999999999999999999999987654     348


Q ss_pred             EEEEEecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          417 LLIYEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      |+++.|...|+|.+.+.... +...+++.+.+.|+.+|++||++||+.. +++.||||||.|||+.+.+.++|.|||.++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999886533 3347999999999999999999999986 579999999999999999999999999987


Q ss_pred             cc
Q 043262          496 IF  497 (512)
Q Consensus       496 ~~  497 (512)
                      ..
T Consensus       178 ~a  179 (302)
T KOG2345|consen  178 QA  179 (302)
T ss_pred             cc
Confidence            54

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.88  E-value=2.7e-22  Score=194.80  Aligned_cols=153  Identities=29%  Similarity=0.446  Sum_probs=132.4

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +++++.....||+|+||.||+|.. .++..|++|.+........+.+.+|+.++..++|+||+++++++...+..++++|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            445666667899999999999985 4678899999887666667789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-CCceEEeccCcccccC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFG  498 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DFGla~~~~  498 (512)
                      |+++++|.+++.........++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|||++..+.
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            9999999999965332222378888999999999999999874   999999999999976 6789999999998764

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.88  E-value=2.9e-22  Score=194.59  Aligned_cols=149  Identities=30%  Similarity=0.566  Sum_probs=130.6

Q ss_pred             CCccccccccccceeEEEEEeCC-C---CEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLAD-G---KEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~-g---~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      .|...+.||+|+||.||+|.... +   ..|+||.+... .....++|..|+.++..++||||+++++++...+..++|+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46677899999999999998643 3   36999998754 3444678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999998643  345899999999999999999999875   99999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.88  E-value=4.2e-22  Score=191.17  Aligned_cols=144  Identities=33%  Similarity=0.526  Sum_probs=127.9

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCChh
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN  429 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~  429 (512)
                      ++||+|+||.||+|...++..+|+|.+..... .....|.+|++++..++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999999875543 33457899999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          430 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       430 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +++...  ...+++..++.++.|++.+|.|||+.+   ++|+||||+||++++++.+||+|||+++....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccc
Confidence            998543  245899999999999999999999875   99999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.88  E-value=3.4e-23  Score=208.76  Aligned_cols=156  Identities=29%  Similarity=0.494  Sum_probs=130.3

Q ss_pred             cccccccccceeEEEEEeC-CCCEEEEEE--cc--cCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCe--eEEEEE
Q 043262          349 DENKLGEGGFGPVYKGKLA-DGKEIAVKR--LS--RTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE--SLLIYE  421 (512)
Q Consensus       349 ~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~--l~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~--~~lv~E  421 (512)
                      ...+||+|.|-+||||... +|-+||=--  +.  ..++..+++|..|+.+|+.|+||||++++..|.+.+.  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3568999999999999873 466776222  22  2344557899999999999999999999999988765  789999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC-CceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~-~~~kl~DFGla~~~~~~  500 (512)
                      .+..|+|..|+.+.   +.++.+....+++||++||.|||++. |||||||||..||+|+.+ |.+||+|+|||++....
T Consensus       124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            99999999999654   45888899999999999999999985 799999999999999764 78999999999998765


Q ss_pred             CCCcCccccccC
Q 043262          501 QSEANTKRIVGT  512 (512)
Q Consensus       501 ~~~~~~~~~~Gt  512 (512)
                      ..    +.++||
T Consensus       200 ~a----ksvIGT  207 (632)
T KOG0584|consen  200 HA----KSVIGT  207 (632)
T ss_pred             cc----ceeccC
Confidence            52    236776

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.88  E-value=4.4e-22  Score=194.45  Aligned_cols=144  Identities=29%  Similarity=0.419  Sum_probs=124.4

Q ss_pred             cccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          353 LGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       353 lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      ||+|+||.||+++. .+|+.+|+|.+....   ......+..|++++.+++||||+++++.+......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999986 468999999986422   12234566799999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          429 NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      .+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++..+...
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            9888543 2345899999999999999999999875   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.88  E-value=4e-22  Score=192.46  Aligned_cols=143  Identities=29%  Similarity=0.546  Sum_probs=123.4

Q ss_pred             ccccccceeEEEEEeC---CCCEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCC
Q 043262          352 KLGEGGFGPVYKGKLA---DGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKS  427 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gs  427 (512)
                      .||+|+||.||+|.+.   .+..||+|.+..... ...++|.+|+.++.+++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999763   355799999875533 33567999999999999999999999875 457899999999999


Q ss_pred             hhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          428 LNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.+..+||+|||+++.+..+
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  148 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence            99998542  346899999999999999999999975   999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=2.7e-22  Score=201.07  Aligned_cols=140  Identities=25%  Similarity=0.341  Sum_probs=119.5

Q ss_pred             cccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcC---CCCccccceeeEEeCCeeEEEEEecCC
Q 043262          353 LGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL---QHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       353 lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ||+|+||.||+++. .++..||||++....   ......+..|..++...   +||||+++++.+...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999986 458999999986432   12233455666666655   699999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~  147 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL  147 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence            999988853   345899999999999999999999975   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.88  E-value=1.5e-22  Score=194.61  Aligned_cols=149  Identities=26%  Similarity=0.338  Sum_probs=133.2

Q ss_pred             cCCccccccccccceeEEEEEeCC-CCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||.|.-|+||++++.+ +...|+|++.+..   .+...+.+.|-++|+.++||.+..|++.+..++..+++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456667899999999999999865 5889999997643   344567888999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |||++|+|...+++ +....+++.....++.+|.-||+|||-.+   ||.|||||+||||-++|++-|+||.|+...
T Consensus       157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            99999999998754 55667999999999999999999999865   999999999999999999999999999876

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=4.7e-22  Score=192.12  Aligned_cols=151  Identities=33%  Similarity=0.566  Sum_probs=134.9

Q ss_pred             hcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .++|...++||+|+||.||++...++..++||.+.... ...+++.+|+.++.+++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            35778889999999999999998888899999987543 34578999999999999999999999999889999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence            999999999653 2346899999999999999999999875   99999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=2.8e-22  Score=196.61  Aligned_cols=151  Identities=25%  Similarity=0.409  Sum_probs=132.4

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      +|+..+.||+|+||.||++... ++..+|+|.++.. .......+.+|+.++.+++||||+++++.+...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            4667789999999999999975 6899999988643 3333567899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++++|..++........+++..+..++.|++.||.|||+..  +|+|+||||+||+++.++.+||+|||+++.+.
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999999865433446899999999999999999999742  59999999999999999999999999998663

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.88  E-value=2.5e-23  Score=192.79  Aligned_cols=154  Identities=30%  Similarity=0.502  Sum_probs=126.9

Q ss_pred             HhcCCccccccccccceeEEEEEeC---C--CCEEEEEEcccCCcc-c-HHHHHHHHHHHhcCCCCccccceeeEEe-CC
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA---D--GKEIAVKRLSRTSGQ-G-LQEFKNEVTLIAKLQHKNLVRLLGCCLQ-EN  414 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~---~--g~~vaVK~l~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~  414 (512)
                      ....|.....||+|.||.|||+.-.   +  ..++|+|+++..... + .....+|+.++++++||||+.|..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3456777889999999999999642   2  237899999754321 1 2457899999999999999999999988 77


Q ss_pred             eeEEEEEecCCCChhHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC----CceEE
Q 043262          415 ESLLIYEYMPNKSLNVFLFDS--TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE----MNPKI  488 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~----~~~kl  488 (512)
                      ..+|++||.+. +|...++.+  .+...++......|..||+.|+.|||++=   |+||||||.|||+..+    +.+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence            78999999987 566665432  33457899999999999999999999985   9999999999999877    89999


Q ss_pred             eccCcccccCCC
Q 043262          489 SDFGMARIFGGN  500 (512)
Q Consensus       489 ~DFGla~~~~~~  500 (512)
                      +|||++|++...
T Consensus       178 aDlGlaR~~~~p  189 (438)
T KOG0666|consen  178 ADLGLARLFNNP  189 (438)
T ss_pred             ecccHHHHhhcc
Confidence            999999998654

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.88  E-value=2.7e-22  Score=194.53  Aligned_cols=148  Identities=25%  Similarity=0.460  Sum_probs=132.4

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ++|...++||+|+||.||+++. .++..+++|.++.........+.+|+.++..++||||+++++.+...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4667778999999999999986 468899999987655555567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+.
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            99999998853   345899999999999999999999975   9999999999999999999999999998664

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.88  E-value=4.3e-22  Score=195.02  Aligned_cols=149  Identities=34%  Similarity=0.578  Sum_probs=130.3

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|...+.||+|++|.||+|+.. ++..|++|.++...  ....+.+.+|+.++..++||||+++++++..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            3566788999999999999874 68899999986432  23356788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++ ++|.+++........+++..+..++.|++.||.|||+.+   ++|+||||+|||+++++.+||+|||+++.+.
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            97 688888865444467899999999999999999999874   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.88  E-value=4.7e-22  Score=194.87  Aligned_cols=150  Identities=32%  Similarity=0.593  Sum_probs=129.9

Q ss_pred             CCccccccccccceeEEEEEe-----CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-----ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESL  417 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~  417 (512)
                      .|...++||+|+||.||++.+     .++..|++|.++... ......+.+|+.+++.++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            456778999999999999974     357889999987543 33456799999999999999999999998875  5688


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +||||+++++|.+++...  ...++|..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+
T Consensus        85 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence            999999999999998543  235899999999999999999999975   999999999999999999999999999877


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      ...
T Consensus       160 ~~~  162 (284)
T cd05079         160 ETD  162 (284)
T ss_pred             ccC
Confidence            543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.88  E-value=3.8e-22  Score=196.91  Aligned_cols=150  Identities=33%  Similarity=0.563  Sum_probs=128.4

Q ss_pred             cCCccccccccccceeEEEEEeCC-CC--EEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-GK--EIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g~--~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|+..+.||+|+||.||+|...+ +.  .+++|.++.. .....+.|.+|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            467778899999999999998743 33  4788888743 334456799999999999 799999999999999999999


Q ss_pred             EEecCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCce
Q 043262          420 YEYMPNKSLNVFLFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP  486 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~  486 (512)
                      +||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999986422             1135889999999999999999999874   9999999999999999999


Q ss_pred             EEeccCccccc
Q 043262          487 KISDFGMARIF  497 (512)
Q Consensus       487 kl~DFGla~~~  497 (512)
                      ||+|||+++..
T Consensus       159 kl~dfg~~~~~  169 (297)
T cd05089         159 KIADFGLSRGE  169 (297)
T ss_pred             EECCcCCCccc
Confidence            99999998643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.88  E-value=4.2e-22  Score=191.98  Aligned_cols=144  Identities=33%  Similarity=0.493  Sum_probs=127.8

Q ss_pred             cccccccceeEEEEEeCC--C--CEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLAD--G--KEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~--g--~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ++||+|++|.||++.+.+  +  ..||||.+..... ...+.+..|+.++.+++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998743  3  3689999987655 556789999999999999999999999988 889999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++|.+++.+... ..++|...+.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence            999999865432 56899999999999999999999874   99999999999999999999999999998755

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.88  E-value=3.6e-22  Score=198.06  Aligned_cols=151  Identities=33%  Similarity=0.530  Sum_probs=130.6

Q ss_pred             cCCccccccccccceeEEEEEeC--------CCCEEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA--------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQEN  414 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~--------~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  414 (512)
                      ++|...+.||+|+||.||++...        +...+|+|.+... ......++..|+.++..+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            46788899999999999999752        2356999999754 234456788999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD  481 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~  481 (512)
                      ..++||||+++|+|.+++.....             ...++|..++.++.|++.||+|||+.+   ++||||||+|||++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence            99999999999999999965321             235899999999999999999999874   99999999999999


Q ss_pred             CCCceEEeccCcccccC
Q 043262          482 HEMNPKISDFGMARIFG  498 (512)
Q Consensus       482 ~~~~~kl~DFGla~~~~  498 (512)
                      +++.+||+|||+++.+.
T Consensus       175 ~~~~~kL~dfg~a~~~~  191 (307)
T cd05098         175 EDNVMKIADFGLARDIH  191 (307)
T ss_pred             CCCcEEECCCccccccc
Confidence            99999999999998664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.88  E-value=4.6e-22  Score=192.21  Aligned_cols=150  Identities=32%  Similarity=0.537  Sum_probs=131.1

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...++||+|+||.||++...++..+++|.+..... ..+.|.+|+.++.+++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            45677889999999999999988888999999875433 3567999999999999999999999874 556899999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+..+
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            99999998653 2345899999999999999999999975   999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.88  E-value=3.5e-22  Score=197.68  Aligned_cols=152  Identities=33%  Similarity=0.482  Sum_probs=131.7

Q ss_pred             cCCccccccccccceeEEEEEe------CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~------~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  416 (512)
                      ++|...+.||+|+||.||++..      ..+..||||.++... ....+.+.+|+.++.++ +||||+++++.+...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            5688889999999999999974      134579999987543 33356799999999999 799999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      +++|||+++|+|.+++.... ...+++.....++.|++.||.|||+.+   |+|+||||+|||++.+..+||+|||+++.
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence            99999999999999986422 234899999999999999999999875   99999999999999999999999999987


Q ss_pred             cCCC
Q 043262          497 FGGN  500 (512)
Q Consensus       497 ~~~~  500 (512)
                      +...
T Consensus       191 ~~~~  194 (302)
T cd05055         191 IMND  194 (302)
T ss_pred             ccCC
Confidence            6543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.88  E-value=7.6e-22  Score=190.16  Aligned_cols=147  Identities=40%  Similarity=0.641  Sum_probs=130.9

Q ss_pred             cccccccceeEEEEEeCC----CCEEEEEEcccCCcc-cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLAD----GKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ++||+|+||.||++....    +..+++|.+...... ..+.+.+|++.+..++|+||+++++++...+..++++||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999754    788999999765433 367899999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          426 KSLNVFLFDSTR------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       426 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++|.+++.....      ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+..
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965421      356999999999999999999999975   99999999999999999999999999998765


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       158 ~  158 (262)
T cd00192         158 D  158 (262)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.88  E-value=4.5e-22  Score=192.96  Aligned_cols=152  Identities=23%  Similarity=0.421  Sum_probs=132.2

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+|+. .++..||||.+...   .......+.+|+++++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4677889999999999999986 47899999987542   2333457899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++|+|.+++.... ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885422 2345788999999999999999999874   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.88  E-value=7.2e-22  Score=190.10  Aligned_cols=151  Identities=31%  Similarity=0.453  Sum_probs=133.3

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|...+.||+|++|.||++.. .++..|++|.+...  ......++.+|+++++.++||||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            356678899999999999987 46889999988643  344567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++++|.+++... ....+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999998653 2356899999999999999999999874   999999999999999999999999999977554

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.5e-23  Score=206.99  Aligned_cols=154  Identities=32%  Similarity=0.518  Sum_probs=132.7

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ..|.+.+.||.|+||-||-++. .+...||||++.-..   ...++++..|+..|..++|||++.+-|++......||||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            4577778899999999999985 567889999997443   334778999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |||- |+-.++|.-.  ..+|.+-.+..|..+.+.||+|||++.   .||||||+.||||++.+.+||+|||.|.+..+.
T Consensus       106 EYCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HHHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            9995 5666666332  245888889999999999999999985   999999999999999999999999999998876


Q ss_pred             CCCc
Q 043262          501 QSEA  504 (512)
Q Consensus       501 ~~~~  504 (512)
                      .+..
T Consensus       180 nsFv  183 (948)
T KOG0577|consen  180 NSFV  183 (948)
T ss_pred             hccc
Confidence            6443

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.88  E-value=3.3e-22  Score=197.96  Aligned_cols=150  Identities=33%  Similarity=0.593  Sum_probs=128.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCC--EEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGK--EIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~--~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|+..+.||+|+||.||+|... ++.  .+++|.++.. .......+.+|++++.++ +||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46777889999999999999864 444  4578877643 334456789999999999 899999999999999999999


Q ss_pred             EEecCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCce
Q 043262          420 YEYMPNKSLNVFLFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP  486 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~  486 (512)
                      +||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999986432             1235889999999999999999999875   9999999999999999999


Q ss_pred             EEeccCccccc
Q 043262          487 KISDFGMARIF  497 (512)
Q Consensus       487 kl~DFGla~~~  497 (512)
                      ||+|||+++..
T Consensus       164 kl~dfg~~~~~  174 (303)
T cd05088         164 KIADFGLSRGQ  174 (303)
T ss_pred             EeCccccCccc
Confidence            99999999743

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.88  E-value=6.7e-22  Score=193.51  Aligned_cols=147  Identities=29%  Similarity=0.485  Sum_probs=131.0

Q ss_pred             CccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          347 FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      |+..+.||+|+||.||++... ++..+++|.+........+.+.+|++++..++||||+++++.+...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            455678999999999999975 4778899988766666677899999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++|..++...  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence            9999887542  346899999999999999999999975   9999999999999999999999999997654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.88  E-value=5e-22  Score=194.11  Aligned_cols=150  Identities=32%  Similarity=0.540  Sum_probs=128.4

Q ss_pred             cCCccccccccccceeEEEEEe-CCCC----EEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGK----EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~----~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ++|...++||+|+||.||+|++ .++.    .||+|.++.. .....+++.+|+.++..++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            5677788999999999999985 3444    4799998754 33345678999999999999999999999875 45789


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++||+++|+|.+++...  ...+++...+.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            99999999999998643  235899999999999999999999974   9999999999999999999999999999775


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      ..
T Consensus       161 ~~  162 (279)
T cd05109         161 ID  162 (279)
T ss_pred             cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=3.8e-22  Score=194.96  Aligned_cols=150  Identities=27%  Similarity=0.448  Sum_probs=134.7

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .++|...+.||+|+||.||++... ++..+++|.+........+.|..|++++.+++||||+++++.+...+..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356778889999999999999874 6889999999766666677899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +++++|.+++....  ..+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus        84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            99999999985432  35899999999999999999999975   9999999999999999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.88  E-value=3.2e-22  Score=205.25  Aligned_cols=146  Identities=24%  Similarity=0.381  Sum_probs=126.9

Q ss_pred             hcCCccccccccccceeEEEEEeC---CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA---DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ..+|...++||+|+||.||++...   .+..|+||.+...     +.+.+|++++..++||||+++++++...+..+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457888999999999999999753   3578999988643     23568999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |++. ++|..++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9986 68888883   3356899999999999999999999975   999999999999999999999999999877554


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       239 ~  239 (392)
T PHA03207        239 P  239 (392)
T ss_pred             c
Confidence            3

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.88  E-value=5.3e-22  Score=195.91  Aligned_cols=150  Identities=25%  Similarity=0.447  Sum_probs=134.5

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ..+|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++..++|+||+++++.+...+..++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            35778889999999999999986 57899999999765555567789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++....+
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            999999999843    34789999999999999999999874   999999999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.88  E-value=4.8e-22  Score=193.70  Aligned_cols=150  Identities=30%  Similarity=0.491  Sum_probs=131.0

Q ss_pred             cCCccccccccccceeEEEEEeC------CCCEEEEEEcccCCcc-cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++|.....||+|+||.||+++..      +...|++|.+...... ..+++.+|+.++.+++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46777889999999999999863      3457899988654433 4578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEecc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRS------VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  491 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DF  491 (512)
                      +||||+++|+|.+++......      ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999654321      25899999999999999999999875   999999999999999999999999


Q ss_pred             Cccccc
Q 043262          492 GMARIF  497 (512)
Q Consensus       492 Gla~~~  497 (512)
                      |+++..
T Consensus       162 ~~~~~~  167 (275)
T cd05046         162 SLSKDV  167 (275)
T ss_pred             cccccc
Confidence            998754

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.88  E-value=1e-21  Score=199.04  Aligned_cols=143  Identities=24%  Similarity=0.349  Sum_probs=124.6

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ...+|...+.||+|+||.||+|+.. ++..||+|.....      ....|+.++.+++||||+++++++...+..++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3467999999999999999999975 4678999975432      23568999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+. ++|.+++..  ....+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            995 688888754  2346899999999999999999999975   999999999999999999999999999854

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.88  E-value=5.6e-22  Score=194.52  Aligned_cols=150  Identities=29%  Similarity=0.415  Sum_probs=129.4

Q ss_pred             CccccccccccceeEEEEEe-CCCCEEEEEEcccCCc---ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      |+..+.||+|+||.||++.. .+++.+|||.+.....   .....+..|+.++.+++|++|+.+++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            55667899999999999986 4688999999864322   2234578899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++.....+
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999988542 234589999999999999999999987   4999999999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.88  E-value=7.2e-22  Score=193.08  Aligned_cols=144  Identities=26%  Similarity=0.386  Sum_probs=127.2

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      +|...++||+|+||.||++.. .++..+|+|.+... .....+++.+|+.++.+++||||+++++.+...+..++|+||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            466678999999999999985 56889999998654 2334567999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++++|..+.       .+++.....++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++..+..
T Consensus        82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            999997653       3678889999999999999999975   99999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.88  E-value=6.1e-22  Score=195.39  Aligned_cols=149  Identities=25%  Similarity=0.453  Sum_probs=133.4

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .+|...+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++..+.|+||+++++.+...+..++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4677788999999999999985 568899999997655555678899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            99999999843    34789999999999999999999875   999999999999999999999999999876443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.88  E-value=6.9e-22  Score=191.03  Aligned_cols=150  Identities=31%  Similarity=0.515  Sum_probs=129.7

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...++||+|++|.||++...++..+++|.+.... ...+.+.+|+.++..++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            3466778899999999999998777789999886543 23567899999999999999999998874 566899999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+..+
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            99999999653 2345899999999999999999999874   999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.88  E-value=7.4e-22  Score=190.15  Aligned_cols=148  Identities=33%  Similarity=0.515  Sum_probs=130.9

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-----cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-----GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      +|...+.||+|+||.||+|... ++..|++|.+....     ....+.+.+|+.++..++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3566788999999999999975 78999999886432     23456799999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +||+++++|.+++.+.   ..+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++....
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999998542   35889999999999999999999875   99999999999999999999999999987644

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.88  E-value=5.5e-22  Score=194.76  Aligned_cols=152  Identities=32%  Similarity=0.576  Sum_probs=131.8

Q ss_pred             hcCCccccccccccceeEEEEEeC------CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      .++|...+.||+|+||.||++...      ++..||+|.+.... ....++|.+|+.++.+++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            356788899999999999999863      46789999987543 33456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCC
Q 043262          417 LLIYEYMPNKSLNVFLFDST-------------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN  477 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N  477 (512)
                      ++++||+++|+|.+++....                   ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986321                   1235789999999999999999999875   9999999999


Q ss_pred             eeecCCCceEEeccCcccccC
Q 043262          478 VLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       478 iLl~~~~~~kl~DFGla~~~~  498 (512)
                      |++++++.+||+|||+++.+.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~  181 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIY  181 (288)
T ss_pred             eEecCCCceEECccccceecc
Confidence            999999999999999998654

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.88  E-value=6e-22  Score=191.39  Aligned_cols=148  Identities=34%  Similarity=0.565  Sum_probs=131.0

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      +.|...++||+|+||.||++...++..+|+|.+..... ....+.+|+.++.+++|+||++++++. ..+..++++||++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCC
Confidence            56777889999999999999998899999999875443 356899999999999999999999886 4567899999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++.+.
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          84 NGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            99999998653 3346899999999999999999999874   9999999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.88  E-value=9e-22  Score=190.66  Aligned_cols=152  Identities=25%  Similarity=0.437  Sum_probs=133.9

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+|... +++++++|.++..   .....+.+.+|++++.+++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            56788899999999999999975 7899999988632   2233568999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++|+|..++.+.. ....+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999986432 2345899999999999999999999875   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.88  E-value=6.4e-22  Score=192.05  Aligned_cols=150  Identities=31%  Similarity=0.628  Sum_probs=131.4

Q ss_pred             cCCccccccccccceeEEEEEeC-CC---CEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DG---KEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g---~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|+..+.||+|+||.||+++.. ++   ..+++|.++.. .....+++..|++++.+++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46777889999999999999874 23   36899998754 233456799999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            9999999999998643  246899999999999999999999874   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.88  E-value=6.6e-22  Score=195.09  Aligned_cols=149  Identities=32%  Similarity=0.515  Sum_probs=130.5

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcc-----cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQ-----GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      +|...++||+|+||.||+|... +++.|+||.++.....     ....+..|++++.+++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3666788999999999999864 6899999999754322     245678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+ +|+|.+++....  ..+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.+..
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 999999985432  36899999999999999999999975   99999999999999999999999999987754


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       155 ~  155 (298)
T cd07841         155 P  155 (298)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.88  E-value=4.8e-22  Score=192.76  Aligned_cols=152  Identities=23%  Similarity=0.423  Sum_probs=132.8

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||++.. .++..++||.+...   ......++.+|+.++..++||||+++++.+...+..++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3566778999999999999995 57899999988643   2334568899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++++|.+++... .....+++...+.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988642 22346899999999999999999999875   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.88  E-value=9.1e-22  Score=193.62  Aligned_cols=149  Identities=30%  Similarity=0.485  Sum_probs=133.4

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      +.|+..++||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++..++||||+++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            55777889999999999999874 48899999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++++|..++...  ...+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            999998887543  245899999999999999999999874   9999999999999999999999999987653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.88  E-value=8.3e-22  Score=192.98  Aligned_cols=150  Identities=27%  Similarity=0.449  Sum_probs=131.0

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|+..+.||+|+||.||+++.. +++.||+|++....  ....+.+.+|+.++..++|+||+++++.+...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            35777789999999999999975 58899999886432  2234568899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |++++.|..++..   ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+...
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999998887643   235899999999999999999999974   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.88  E-value=5.2e-22  Score=206.31  Aligned_cols=149  Identities=25%  Similarity=0.406  Sum_probs=122.0

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeC--------C
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--------N  414 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--------~  414 (512)
                      ..+|...++||+|+||.||+|.. .+++.||||++....    ....+|+.++..++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            45788899999999999999987 468899999886432    2345799999999999999999887532        2


Q ss_pred             eeEEEEEecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-ceEEeccC
Q 043262          415 ESLLIYEYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFG  492 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DFG  492 (512)
                      ..++||||+++ +|.+++... .....+++.....++.||+.||.|||+.+   |+||||||+||||+.+. .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            35789999985 676665432 23456899999999999999999999975   99999999999998664 79999999


Q ss_pred             cccccCCC
Q 043262          493 MARIFGGN  500 (512)
Q Consensus       493 la~~~~~~  500 (512)
                      +++.+...
T Consensus       217 la~~~~~~  224 (440)
T PTZ00036        217 SAKNLLAG  224 (440)
T ss_pred             cchhccCC
Confidence            99977543

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.88  E-value=7.4e-22  Score=194.11  Aligned_cols=150  Identities=31%  Similarity=0.425  Sum_probs=132.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|++++.+++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            35777889999999999999864 58899999986432   233567899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+|||+++++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999998543   46899999999999999999999974   999999999999999999999999999887544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.87  E-value=7.7e-22  Score=190.35  Aligned_cols=143  Identities=32%  Similarity=0.547  Sum_probs=123.8

Q ss_pred             ccccccceeEEEEEe---CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCC
Q 043262          352 KLGEGGFGPVYKGKL---ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNK  426 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~---~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~g  426 (512)
                      +||+|+||.||+|.+   .++..+|+|+++...  ....+++.+|+.++..++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999975   357889999986443  234568999999999999999999999875 45678999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +|.+++..   ...+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            99999853   235899999999999999999999875   9999999999999999999999999998875443

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.87  E-value=8.7e-22  Score=197.72  Aligned_cols=152  Identities=32%  Similarity=0.527  Sum_probs=130.1

Q ss_pred             cCCccccccccccceeEEEEEeC--------CCCEEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA--------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQEN  414 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~--------~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  414 (512)
                      .+|...+.||+|+||.||+++..        ....||+|.++.. .....+++.+|+.++.++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            35677889999999999999742        1236899988743 233467899999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec
Q 043262          415 ESLLIYEYMPNKSLNVFLFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD  481 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~  481 (512)
                      ..++++||+++|+|.+++....             ....++|..++.++.|++.||.|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986421             2235889999999999999999999875   99999999999999


Q ss_pred             CCCceEEeccCcccccCC
Q 043262          482 HEMNPKISDFGMARIFGG  499 (512)
Q Consensus       482 ~~~~~kl~DFGla~~~~~  499 (512)
                      +++.+||+|||+++.+..
T Consensus       169 ~~~~~kL~Dfg~~~~~~~  186 (334)
T cd05100         169 EDNVMKIADFGLARDVHN  186 (334)
T ss_pred             CCCcEEECCcccceeccc
Confidence            999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.87  E-value=9e-22  Score=195.84  Aligned_cols=151  Identities=35%  Similarity=0.540  Sum_probs=130.0

Q ss_pred             cCCccccccccccceeEEEEEeC--------CCCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeCC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA--------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQEN  414 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~--------~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  414 (512)
                      ++|...++||+|+||.||+++..        ....+|+|.++... .....++..|+.++.++ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46777899999999999999742        24568999887543 33456789999999999 6999999999999999


Q ss_pred             eeEEEEEecCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec
Q 043262          415 ESLLIYEYMPNKSLNVFLFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD  481 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~  481 (512)
                      ..++++||+++|+|.+++....             ....++|.....++.||+.||.|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999996532             1245899999999999999999999875   99999999999999


Q ss_pred             CCCceEEeccCcccccC
Q 043262          482 HEMNPKISDFGMARIFG  498 (512)
Q Consensus       482 ~~~~~kl~DFGla~~~~  498 (512)
                      +++.+||+|||+++.+.
T Consensus       169 ~~~~~kL~Dfg~~~~~~  185 (314)
T cd05099         169 EDNVMKIADFGLARGVH  185 (314)
T ss_pred             CCCcEEEcccccccccc
Confidence            99999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.87  E-value=1.1e-21  Score=191.72  Aligned_cols=150  Identities=32%  Similarity=0.565  Sum_probs=129.4

Q ss_pred             cCCccccccccccceeEEEEEeCC-CC----EEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-GK----EIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g~----~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .+|...+.||+|+||.||+|...+ +.    .+++|.+.... .....++.+|+.++.+++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            456777899999999999998642 33    58999887554 3345688999999999999999999999987 78899


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+||+++|+|.+++...  ...+++...+.++.||+.||+|||+.   +++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999998653  23489999999999999999999996   49999999999999999999999999998775


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      ..
T Consensus       161 ~~  162 (279)
T cd05057         161 VD  162 (279)
T ss_pred             Cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.87  E-value=1.1e-21  Score=195.45  Aligned_cols=145  Identities=31%  Similarity=0.514  Sum_probs=119.5

Q ss_pred             ccccccccceeEEEEEeC---CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEe--CCeeEEEEEecC
Q 043262          350 ENKLGEGGFGPVYKGKLA---DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ--ENESLLIYEYMP  424 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~E~~~  424 (512)
                      .++||+|+||.||+|+..   ++..+|+|.+....  ....+.+|+.++.+++||||+++++++..  ....++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   46789999986542  23467889999999999999999999864  355789999986


Q ss_pred             CCChhHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee----cCCCceEEeccCcc
Q 043262          425 NKSLNVFLFDS------TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMA  494 (512)
Q Consensus       425 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl----~~~~~~kl~DFGla  494 (512)
                       ++|.+++...      .....+++.....++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             4787776432      12235889999999999999999999975   9999999999999    45678999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +.+...
T Consensus       160 ~~~~~~  165 (317)
T cd07868         160 RLFNSP  165 (317)
T ss_pred             eccCCC
Confidence            987544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.87  E-value=8e-22  Score=191.03  Aligned_cols=146  Identities=32%  Similarity=0.547  Sum_probs=129.3

Q ss_pred             CccccccccccceeEEEEEeCCCCEEEEEEcccCC------cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS------GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      |...+.||+|+||.||+|...+++.+|||.+....      ......+.+|+++++.++|+||+++++++.+.+..++++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            56678899999999999998889999999886432      122356889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||+++++|.+++.+.   ..+++.....++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||+++.+.
T Consensus        82 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          82 EFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            999999999998542   35889999999999999999999875   9999999999999999999999999998653

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.87  E-value=9.5e-22  Score=192.54  Aligned_cols=145  Identities=37%  Similarity=0.591  Sum_probs=126.1

Q ss_pred             ccccccccccceeEEEEEe-----CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeEEE
Q 043262          348 SDENKLGEGGFGPVYKGKL-----ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESLLI  419 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv  419 (512)
                      ...+.||+|+||.||++..     .++..||+|.++... ......|.+|++++.+++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6678999999999988653     457889999987543 23456789999999999999999999988764  357899


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence            999999999999854    24899999999999999999999975   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.87  E-value=4.4e-22  Score=191.93  Aligned_cols=145  Identities=34%  Similarity=0.579  Sum_probs=127.7

Q ss_pred             CccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccH--HHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          347 FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~--~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      |+..+.||+|+||.||++... +++.+|+|.+........  .....|+.++.+++||||+++++++...+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            345688999999999999975 456899999986654332  23456999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      ++++|.+++.   +...+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||++..+
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            9999999996   3356899999999999999999999985   999999999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.87  E-value=1.6e-21  Score=187.90  Aligned_cols=152  Identities=25%  Similarity=0.408  Sum_probs=133.2

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|+..+.||+|+||.||.++. .++..+++|.+...  +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            467788999999999998885 56889999987643  344567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999986532 346899999999999999999999874   9999999999999999999999999998775443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1e-21  Score=189.95  Aligned_cols=149  Identities=30%  Similarity=0.496  Sum_probs=130.8

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-----cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-----GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ++|...+.||+|++|.||++.. .+++++++|.+....     ....+.+.+|+.++.+++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4678889999999999999986 468999999886432     1234578899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+.
T Consensus        82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            99999999999988542   35888999999999999999999875   9999999999999999999999999998764


Q ss_pred             C
Q 043262          499 G  499 (512)
Q Consensus       499 ~  499 (512)
                      .
T Consensus       156 ~  156 (263)
T cd06625         156 T  156 (263)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.87  E-value=1.2e-21  Score=189.43  Aligned_cols=150  Identities=31%  Similarity=0.520  Sum_probs=132.0

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...++||+|+||.||++...++..+++|.+.... ...+.|.+|+.+++.++|+||+++++.+.. ...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            5677889999999999999998888889999887543 335678999999999999999999999887 77899999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+...
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          84 KGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             CCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            99999998653 3346889999999999999999999874   999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.87  E-value=9.8e-22  Score=191.87  Aligned_cols=152  Identities=32%  Similarity=0.522  Sum_probs=130.5

Q ss_pred             hcCCccccccccccceeEEEEEeCC------CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLAD------GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~------g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      .++|...+.||+|+||.||++.+.+      +..|++|.+.... ......|..|+.++..++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            3567888999999999999998753      5678999886443 33346799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC---ceEEe
Q 043262          417 LLIYEYMPNKSLNVFLFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKIS  489 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~---~~kl~  489 (512)
                      ++||||+++++|.+++.....    ...++|..++.++.||+.||.|||+.+   ++||||||+|||++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865321    235899999999999999999999975   99999999999998754   59999


Q ss_pred             ccCcccccC
Q 043262          490 DFGMARIFG  498 (512)
Q Consensus       490 DFGla~~~~  498 (512)
                      |||+++.+.
T Consensus       162 dfg~~~~~~  170 (277)
T cd05036         162 DFGMARDIY  170 (277)
T ss_pred             cCccccccC
Confidence            999998763

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.87  E-value=1.3e-21  Score=193.11  Aligned_cols=149  Identities=26%  Similarity=0.477  Sum_probs=133.9

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .+|...+.||.|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4577888999999999999985 578999999997655555678899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++++|..++..    ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+...
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            99999998843    34899999999999999999999975   999999999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.87  E-value=1.4e-21  Score=190.11  Aligned_cols=143  Identities=34%  Similarity=0.620  Sum_probs=123.3

Q ss_pred             cccccccceeEEEEEeCC-CC--EEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLAD-GK--EIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~-g~--~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      +.||+|+||.||+|+..+ +.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999753 43  4688888743 334456889999999999 799999999999999999999999999


Q ss_pred             CChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccC
Q 043262          426 KSLNVFLFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  492 (512)
Q Consensus       426 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFG  492 (512)
                      |+|.+++....             ....+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986432             1235889999999999999999999874   9999999999999999999999999


Q ss_pred             cccc
Q 043262          493 MARI  496 (512)
Q Consensus       493 la~~  496 (512)
                      +++.
T Consensus       158 l~~~  161 (270)
T cd05047         158 LSRG  161 (270)
T ss_pred             Cccc
Confidence            9863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.7e-21  Score=188.22  Aligned_cols=150  Identities=26%  Similarity=0.488  Sum_probs=134.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ++|...+.||+|+||.||++... ++..+++|.+........+.+.+|+.++.+++||||+++++.+...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            56778889999999999999864 57889999998665556788999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++++|.+++...  ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+..
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999988543  245889999999999999999999874   99999999999999999999999999987653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.87  E-value=9.6e-22  Score=199.43  Aligned_cols=148  Identities=30%  Similarity=0.451  Sum_probs=125.2

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC-----
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN-----  414 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----  414 (512)
                      ..++|...+.||+|+||.||+++. .++..||||.+...  .......+.+|+.++..++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            347788899999999999999986 45889999998643  2334567889999999999999999999986543     


Q ss_pred             -eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          415 -ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       415 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                       ..++||||+++ +|...+.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             46999999975 5555552     23788889999999999999999985   99999999999999999999999999


Q ss_pred             ccccCC
Q 043262          494 ARIFGG  499 (512)
Q Consensus       494 a~~~~~  499 (512)
                      ++....
T Consensus       170 a~~~~~  175 (359)
T cd07876         170 ARTACT  175 (359)
T ss_pred             cccccc
Confidence            987543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5e-23  Score=199.36  Aligned_cols=159  Identities=27%  Similarity=0.459  Sum_probs=138.8

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEccc-CCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .|...+.||+|.||.||||.. ..++.||+|.+.. ..+...++++.|+.++..++++||.+.+|.+..+..+|++|||+
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            455668899999999999996 4588899999974 44556788999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE  503 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~  503 (512)
                      .+|++.+.|..   ...+++....-|.+++..||.|||.+.   .+|||||+.|||+.+++.+||+|||.+..+......
T Consensus        94 ~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   94 GGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             cCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            99999998843   334577778889999999999999985   999999999999999999999999999998877655


Q ss_pred             cCccccccC
Q 043262          504 ANTKRIVGT  512 (512)
Q Consensus       504 ~~~~~~~Gt  512 (512)
                      ..  .++||
T Consensus       168 r~--tfvGT  174 (467)
T KOG0201|consen  168 RK--TFVGT  174 (467)
T ss_pred             cc--ccccc
Confidence            43  47887

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.87  E-value=1.7e-21  Score=188.93  Aligned_cols=147  Identities=33%  Similarity=0.569  Sum_probs=128.8

Q ss_pred             CccccccccccceeEEEEEe-CCCCEEEEEEcccCCcc---------cHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQ---------GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      |.....||+|+||.||+|.. .++..+++|.+......         ..+.+.+|+.++.+++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            55667899999999999986 45789999988643221         135688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++++||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            999999999999999954   245889999999999999999999875   99999999999999999999999999988


Q ss_pred             cCC
Q 043262          497 FGG  499 (512)
Q Consensus       497 ~~~  499 (512)
                      +..
T Consensus       156 ~~~  158 (267)
T cd06628         156 LEA  158 (267)
T ss_pred             ccc
Confidence            763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.87  E-value=2.6e-21  Score=186.28  Aligned_cols=150  Identities=23%  Similarity=0.389  Sum_probs=131.3

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      +|...++||+|+||.||++.. .++..+++|.++.. .....+.+.+|+.++..++|+||+++++.+...+..++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            356678999999999999986 46889999988643 3344567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++|+|.+++... ....+++...+.++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||+++.+..
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            999999988542 3345789999999999999999999875   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.87  E-value=1.4e-21  Score=191.16  Aligned_cols=149  Identities=34%  Similarity=0.589  Sum_probs=130.4

Q ss_pred             CCccccccccccceeEEEEEeC-----CCCEEEEEEcccCCcc-cHHHHHHHHHHHhcCCCCccccceeeEEe--CCeeE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-----DGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLQ--ENESL  417 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-----~g~~vaVK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~  417 (512)
                      .|...+.||+|+||.||++++.     .+..+|||.+...... ..+.|.+|+++++.++|+||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4566788999999999999863     3678999999755443 46789999999999999999999999887  55789


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      ++|||+++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+
T Consensus        85 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            9999999999999996432  25899999999999999999999875   999999999999999999999999999987


Q ss_pred             CC
Q 043262          498 GG  499 (512)
Q Consensus       498 ~~  499 (512)
                      ..
T Consensus       160 ~~  161 (284)
T cd05038         160 PE  161 (284)
T ss_pred             cc
Confidence            63

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.87  E-value=1.1e-21  Score=190.69  Aligned_cols=152  Identities=28%  Similarity=0.491  Sum_probs=130.6

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeC------C
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQE------N  414 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~------~  414 (512)
                      ++..|...+.||+|+||.||+|... +++.||+|.+.... ....++..|+.++.++ +|+||+++++.+...      +
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4566777889999999999999864 57889999986543 3456788999999998 699999999998753      4


Q ss_pred             eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                      ..+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            578999999999999998653 2346899999999999999999999974   999999999999999999999999999


Q ss_pred             cccCC
Q 043262          495 RIFGG  499 (512)
Q Consensus       495 ~~~~~  499 (512)
                      +.+..
T Consensus       159 ~~~~~  163 (272)
T cd06637         159 AQLDR  163 (272)
T ss_pred             eeccc
Confidence            87643

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.87  E-value=1.4e-21  Score=190.02  Aligned_cols=148  Identities=28%  Similarity=0.466  Sum_probs=128.4

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc----------ccHHHHHHHHHHHhcCCCCccccceeeEEeCC
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG----------QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN  414 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~----------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  414 (512)
                      +|...+.||+|+||.||+|.. .+++.+|+|.++....          ...+.+..|+.++..++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            355678999999999999985 4688999998753211          11346888999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                      ..++|+||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++||||+|+||++++++.+||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998543   46899999999999999999999874   999999999999999999999999999


Q ss_pred             cccCC
Q 043262          495 RIFGG  499 (512)
Q Consensus       495 ~~~~~  499 (512)
                      +....
T Consensus       156 ~~~~~  160 (272)
T cd06629         156 KKSDD  160 (272)
T ss_pred             ccccc
Confidence            87643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=8.9e-22  Score=196.04  Aligned_cols=142  Identities=21%  Similarity=0.265  Sum_probs=114.1

Q ss_pred             HhcCCccccccccccceeEEEEEeC--CCCEEEEEEcccC-----CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCe
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA--DGKEIAVKRLSRT-----SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE  415 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~--~g~~vaVK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  415 (512)
                      ...+|...+.||+|+||+||+|...  +++.||||++...     .....+.|.+|++++.+++|+|++..+..   .+.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            4567888999999999999999864  5777899987533     12235679999999999999999853322   256


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCC-CCCCeeecCCCceEEeccCcc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDL-KTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dl-k~~NiLl~~~~~~kl~DFGla  494 (512)
                      .++||||+++++|....    .   ..   ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||+|||+|
T Consensus        93 ~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         93 DGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             cEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            79999999999996321    1   11   1457889999999999975   999999 999999999999999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +.+...
T Consensus       160 ~~~~~~  165 (365)
T PRK09188        160 SVFRRR  165 (365)
T ss_pred             eecccC
Confidence            987543

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.87  E-value=1.5e-21  Score=192.98  Aligned_cols=148  Identities=30%  Similarity=0.508  Sum_probs=129.0

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|+||.||++... ++..||+|.++... ......+.+|+.++..++||||+++++++...+..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46778889999999999999864 57899999986433 33345678999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++ ++|..++...  ...+++.....++.||+.||.|||+.+   |+|+||||+|||+++++.+||+|||+++...
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            97 5898888543  235889999999999999999999975   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.87  E-value=1.5e-21  Score=189.11  Aligned_cols=148  Identities=29%  Similarity=0.459  Sum_probs=127.2

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-----cccHHHHHHHHHHHhcCCCCccccceeeEEeC--Cee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-----GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  416 (512)
                      ++|...++||+|+||.||++.. .++..|+||.+....     ....+.+.+|+.++.+++||||+++++.+.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4677789999999999999986 458899999885321     22346788999999999999999999988764  457


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++++||+++++|.+++...   ..+++...+.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999998542   34788889999999999999999875   99999999999999999999999999986


Q ss_pred             cC
Q 043262          497 FG  498 (512)
Q Consensus       497 ~~  498 (512)
                      +.
T Consensus       156 ~~  157 (265)
T cd06652         156 LQ  157 (265)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.87  E-value=1.4e-21  Score=193.66  Aligned_cols=145  Identities=21%  Similarity=0.358  Sum_probs=128.9

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +|...+.||+|+||.||++... .++.|++|.+....   ....+.+.+|+.++..++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            5777889999999999999864 57899999986543   2335678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      |+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        82 ~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          82 YVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            99999999999542   45899999999999999999999874   99999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.87  E-value=2.3e-21  Score=186.18  Aligned_cols=143  Identities=36%  Similarity=0.568  Sum_probs=128.4

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCcc-cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCChh
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN  429 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~  429 (512)
                      ++||+|+||.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++...+..++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999877999999998754433 4568999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          430 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       430 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +++...  ...+++...+.++.+++.+|.|||+++   ++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            998543  235889999999999999999999875   9999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.87  E-value=1.5e-21  Score=193.30  Aligned_cols=150  Identities=35%  Similarity=0.651  Sum_probs=126.6

Q ss_pred             cCCccccccccccceeEEEEEeC-CCC----EEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGK----EIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~----~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ++|...+.||+|+||.||++... ++.    .||+|.+..... ....++.+|+.++..++||||++++|++... ...+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45677789999999999999863 444    478888865432 3345789999999999999999999998754 4679


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999998543  235889999999999999999999874   9999999999999999999999999999775


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      ..
T Consensus       161 ~~  162 (303)
T cd05110         161 GD  162 (303)
T ss_pred             Cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.87  E-value=1.2e-21  Score=213.87  Aligned_cols=158  Identities=23%  Similarity=0.370  Sum_probs=130.3

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESL  417 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~  417 (512)
                      ..++|...++||+|+||.||+++.. .+..+|+|.+...  .......|..|+.++..|+|||||++++++...  ...+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3467888999999999999999864 5678899988643  333456789999999999999999999988654  5689


Q ss_pred             EEEEecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCcccCCCCCCCeeecCC---------
Q 043262          418 LIYEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSR----LKIIHRDLKTSNVLLDHE---------  483 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~dlk~~NiLl~~~---------  483 (512)
                      |||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.+         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999986432 23469999999999999999999998531    259999999999999643         


Q ss_pred             --------CceEEeccCcccccCCC
Q 043262          484 --------MNPKISDFGMARIFGGN  500 (512)
Q Consensus       484 --------~~~kl~DFGla~~~~~~  500 (512)
                              ..+||+|||+++.+...
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~  195 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIE  195 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccc
Confidence                    34899999999877543

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.87  E-value=2.3e-21  Score=187.50  Aligned_cols=149  Identities=31%  Similarity=0.508  Sum_probs=132.5

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|...+.||+|+||.||++.. .++..+++|.++....  ...+.+.+|+.++..++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            466778999999999999986 4688999999875544  3567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+...
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            9999999998542   34788999999999999999999975   999999999999999999999999999887543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.87  E-value=1e-21  Score=193.35  Aligned_cols=145  Identities=27%  Similarity=0.452  Sum_probs=128.8

Q ss_pred             ccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCC
Q 043262          348 SDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNK  426 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~g  426 (512)
                      .....||+|+||.||++.. .++..||||.+........+.+.+|+.++..++|+||+++++.+...+..++||||++++
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            3346799999999999986 468899999987655555677999999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +|.+++..    ..+++.....++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++..+..
T Consensus       105 ~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         105 ALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             cHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            99998843    34889999999999999999999974   99999999999999999999999999986643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.87  E-value=2.5e-21  Score=186.59  Aligned_cols=148  Identities=28%  Similarity=0.491  Sum_probs=128.1

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEe-CCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ-ENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lv~E~~  423 (512)
                      ++|...+.||+|+||.||++... +..+++|.++...  ..+.|.+|+.++.+++|+|++++++++.. .+..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            45777889999999999999875 7889999886433  34678999999999999999999998754 45689999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence            999999998643 2335899999999999999999999875   99999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.87  E-value=1.2e-21  Score=191.91  Aligned_cols=149  Identities=28%  Similarity=0.467  Sum_probs=130.3

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|+..++||+|+||.||++... +++.+|+|++.....  ...+.+.+|++++..++||||+++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            35777889999999999999975 588999999864322  235678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |+++++|..+...   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            9999999887643   234899999999999999999999874   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.87  E-value=1.4e-21  Score=196.95  Aligned_cols=149  Identities=30%  Similarity=0.450  Sum_probs=126.7

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeC------
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE------  413 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------  413 (512)
                      ..++|...+.||+|+||.||++.. .++..||||.+....  ....+.+.+|+.++..++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            346788889999999999999986 567899999986532  23345678999999999999999999987543      


Q ss_pred             CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          414 NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      ...++++|++ +++|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence            3468999987 7889887732    35899999999999999999999975   99999999999999999999999999


Q ss_pred             ccccCC
Q 043262          494 ARIFGG  499 (512)
Q Consensus       494 a~~~~~  499 (512)
                      ++....
T Consensus       165 ~~~~~~  170 (343)
T cd07878         165 ARQADD  170 (343)
T ss_pred             ceecCC
Confidence            987654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.87  E-value=2.4e-21  Score=187.33  Aligned_cols=143  Identities=34%  Similarity=0.568  Sum_probs=121.5

Q ss_pred             cccccccceeEEEEEeC----CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEe-CCeeEEEEEecC
Q 043262          351 NKLGEGGFGPVYKGKLA----DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ-ENESLLIYEYMP  424 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~----~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lv~E~~~  424 (512)
                      +.||+|+||.||+|...    +...+|+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2457999998643 33446788999999999999999999998764 455789999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +|+|.+++...  ...+.+...+.++.|++.||.|||+.   +++||||||+|||+++++.+||+|||+++.+.
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999998643  23467888899999999999999987   49999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.86  E-value=2.9e-21  Score=186.02  Aligned_cols=149  Identities=27%  Similarity=0.519  Sum_probs=131.4

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      .+|...+.||+|+||.||++.+.++..+++|.+..... ...+|.+|++++..++||||+++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            35666789999999999999987788999998875432 34678999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +++|.+++...  ...+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            99999998542  235889999999999999999999875   99999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=3.7e-21  Score=191.53  Aligned_cols=150  Identities=27%  Similarity=0.343  Sum_probs=132.5

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc---ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +|...+.||+|+||.||++... ++..+|+|.+.....   ...+.+..|++++..++|+||+++++.+...+..++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            5777889999999999999875 489999999975432   245678999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |+.+++|.+++... ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          82 YCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             ecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999998542 3356899999999999999999999875   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.86  E-value=1.5e-21  Score=190.61  Aligned_cols=147  Identities=29%  Similarity=0.499  Sum_probs=129.6

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            355667899999999999986 457889999887433 344567999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence            99999998843    35899999999999999999999874   99999999999999999999999999987654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.86  E-value=1.9e-21  Score=188.97  Aligned_cols=150  Identities=26%  Similarity=0.449  Sum_probs=128.5

Q ss_pred             cCCccccccccccceeEEEEEeCC----CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD----GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~----g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...++||+|+||.||+|...+    ...|+||...... ....+.+.+|+.++..++||||+++++++.. +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            456778899999999999998643    2468999887554 4456789999999999999999999998865 567899


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999543  235899999999999999999999874   99999999999999999999999999987644


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       160 ~  160 (270)
T cd05056         160 E  160 (270)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.86  E-value=1.7e-21  Score=192.36  Aligned_cols=144  Identities=27%  Similarity=0.460  Sum_probs=128.3

Q ss_pred             ccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          350 ENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      ..+||+|+||.||++.. .++..|++|.+........+.+.+|+.++..++||||+++++.+..++..++++||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            45799999999999986 46889999998765555567789999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          429 NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ..++..    ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+..+
T Consensus       106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659         106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            988743    35899999999999999999999875   999999999999999999999999999866443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.86  E-value=1.8e-21  Score=191.40  Aligned_cols=147  Identities=29%  Similarity=0.504  Sum_probs=128.3

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|++|.||++... +++.|+||.+..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56778889999999999999875 688999999864332 2234577899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +.+ +|.+++.+..  ..+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            984 8998886432  36889999999999999999999874   999999999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.86  E-value=3.1e-21  Score=186.08  Aligned_cols=143  Identities=36%  Similarity=0.581  Sum_probs=123.9

Q ss_pred             cccccccceeEEEEEeCC----CCEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLAD----GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ++||+|+||.||+|.+..    +..+++|.+..... ...+++.+|+.++..+.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999997532    26899999875543 34567999999999999999999999875 5568999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+|.+++...   ..+++..+..++.|++.||.|||..+   ++|+||||+|||++.++.+||+|||+++.+..+
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            9999999643   26899999999999999999999874   999999999999999999999999999877544

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.86  E-value=7.8e-22  Score=190.51  Aligned_cols=144  Identities=26%  Similarity=0.454  Sum_probs=123.8

Q ss_pred             cccccccceeEEEEEeCC--------CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          351 NKLGEGGFGPVYKGKLAD--------GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~--------g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +.||+|+||.||+|....        ..++++|.+........+++.+|+.++..++||||+++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998632        234888888665555567889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc--------eEEeccCcc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN--------PKISDFGMA  494 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~--------~kl~DFGla  494 (512)
                      +++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.+..        +|++|||++
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999996532  35899999999999999999999874   999999999999987765        699999998


Q ss_pred             cccCC
Q 043262          495 RIFGG  499 (512)
Q Consensus       495 ~~~~~  499 (512)
                      .....
T Consensus       156 ~~~~~  160 (258)
T cd05078         156 ITVLP  160 (258)
T ss_pred             cccCC
Confidence            76543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.86  E-value=2.9e-21  Score=185.85  Aligned_cols=149  Identities=38%  Similarity=0.636  Sum_probs=130.6

Q ss_pred             ccccccccccceeEEEEEeCC-----CCEEEEEEcccCCcc-cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          348 SDENKLGEGGFGPVYKGKLAD-----GKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~~~-----g~~vaVK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ...+.||.|+||.||+++..+     +..||+|.+...... ..+.+..|+..+..++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            446789999999999998754     478999999755433 56789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.....
T Consensus        82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999854221 22899999999999999999999975   999999999999999999999999999877544

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.86  E-value=3.5e-21  Score=185.32  Aligned_cols=149  Identities=28%  Similarity=0.503  Sum_probs=133.6

Q ss_pred             cCCccccccccccceeEEEEEeCC-CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ++|...++||+|+||.||++...+ +..+++|.+.....  .+++.+|++++++++||||+++++.+...+..++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            567788899999999999999764 78999999875433  678999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++++|.+++...  ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+...
T Consensus        81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            999999998542  346899999999999999999999874   999999999999999999999999999877543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.86  E-value=1.7e-21  Score=190.85  Aligned_cols=149  Identities=25%  Similarity=0.345  Sum_probs=130.7

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|+..++||+|+||.||++.. .++..+|+|.+.... ....+.+.+|++++..++||||+++++.+...+..++|+||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            4566778999999999999986 468899999886443 33467899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +++++|.+++..   ...+++.....++.+++.+|.|||+..  +++||||||+||++++++.++|+|||+++.+.
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            999999998854   245899999999999999999999742  59999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.86  E-value=2.3e-21  Score=189.57  Aligned_cols=152  Identities=26%  Similarity=0.409  Sum_probs=126.7

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHH-HhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTL-IAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...+.||+|+||.||+++.. +|..||+|+++... .....++..|+.. ++.++||||+++++++...+..++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            35777889999999999999874 68999999987542 2233455666664 666789999999999999999999999


Q ss_pred             ecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |++ |+|.+++... .....+++..++.++.||+.||.|||++.  +++||||||+|||+++++.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6888877542 23356899999999999999999999862  599999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.86  E-value=3.4e-21  Score=191.79  Aligned_cols=145  Identities=32%  Similarity=0.514  Sum_probs=119.2

Q ss_pred             ccccccccceeEEEEEeC---CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEe--CCeeEEEEEecC
Q 043262          350 ENKLGEGGFGPVYKGKLA---DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ--ENESLLIYEYMP  424 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~E~~~  424 (512)
                      ..+||+|+||.||+++..   ++..||+|.+....  ....+.+|+.++.+++||||+++++++..  ....++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999864   35689999986543  23467899999999999999999999864  456789999987


Q ss_pred             CCChhHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee----cCCCceEEeccCcc
Q 043262          425 NKSLNVFLFDS------TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMA  494 (512)
Q Consensus       425 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl----~~~~~~kl~DFGla  494 (512)
                      + +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    ++++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 676665321      12345889999999999999999999975   9999999999999    56678999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +.+...
T Consensus       160 ~~~~~~  165 (317)
T cd07867         160 RLFNSP  165 (317)
T ss_pred             eccCCC
Confidence            987543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.86  E-value=3.8e-21  Score=187.05  Aligned_cols=150  Identities=29%  Similarity=0.542  Sum_probs=125.5

Q ss_pred             CccccccccccceeEEEEEeC----CCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC------
Q 043262          347 FSDENKLGEGGFGPVYKGKLA----DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN------  414 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~----~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------  414 (512)
                      |...+.||+|+||.||+|.+.    .+..||||.+...  .....+++.+|+.+++.++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            445678999999999999853    3678999998653  3334667899999999999999999999887543      


Q ss_pred             eeEEEEEecCCCChhHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEecc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDST---RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  491 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DF  491 (512)
                      ..++++||+++|+|..++....   ....+++.....++.||+.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2378899999999998875321   2235889999999999999999999875   999999999999999999999999


Q ss_pred             CcccccCC
Q 043262          492 GMARIFGG  499 (512)
Q Consensus       492 Gla~~~~~  499 (512)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05074         158 GLSKKIYS  165 (273)
T ss_pred             cccccccC
Confidence            99997643

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.86  E-value=3.5e-21  Score=189.35  Aligned_cols=148  Identities=30%  Similarity=0.457  Sum_probs=127.6

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +++|...+.||+|+||.||+|.. .++..|++|.+.... ......+.+|+.++..++|+||+++++++...+..++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            46788889999999999999986 468899999986443 2333467899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+. ++|.+++...  ...+++.....++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||+++..
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          84 YMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             ccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence            996 6777776432  235788888999999999999999875   999999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.86  E-value=3.7e-21  Score=188.42  Aligned_cols=149  Identities=30%  Similarity=0.497  Sum_probs=132.0

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|...+.||+|+||.||+|.. .++..|++|++....  ......+.+|+.++.+++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            356678899999999999986 468999999987543  33356899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      + +++|.+++....  ..+++..+..++.||+.||.|||+.+   ++|+||||+||++++++.++|+|||+++.+...
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9 999999986533  46899999999999999999999875   999999999999999999999999999987544

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.86  E-value=2.2e-21  Score=190.16  Aligned_cols=155  Identities=25%  Similarity=0.381  Sum_probs=130.7

Q ss_pred             HHHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEe-----C
Q 043262          341 VEATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQ-----E  413 (512)
Q Consensus       341 ~~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~-----~  413 (512)
                      ..+.++|...+.||+|+||.||++.. .++..+++|.+.... ....++.+|+.++.++ +||||+++++++..     +
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   92 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG   92 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence            34567888899999999999999986 457889999876432 2235688899999999 69999999998853     3


Q ss_pred             CeeEEEEEecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccC
Q 043262          414 NESLLIYEYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  492 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFG  492 (512)
                      +..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCC
Confidence            5689999999999999987532 22346889999999999999999999874   9999999999999999999999999


Q ss_pred             cccccCC
Q 043262          493 MARIFGG  499 (512)
Q Consensus       493 la~~~~~  499 (512)
                      +++.+..
T Consensus       170 ~~~~~~~  176 (286)
T cd06638         170 VSAQLTS  176 (286)
T ss_pred             ceeeccc
Confidence            9987643

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.86  E-value=2.9e-21  Score=188.99  Aligned_cols=150  Identities=33%  Similarity=0.567  Sum_probs=131.1

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      +|+..++||+|++|.||+|+.. ++..|+||.++.... .....+.+|+.++.+++|+||+++++.+...+..++|+||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4677889999999999999974 688999999875432 23467788999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+..
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            85 88888865444456899999999999999999999874   99999999999999999999999999986543

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.86  E-value=1.9e-21  Score=196.88  Aligned_cols=149  Identities=29%  Similarity=0.464  Sum_probs=125.7

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC------
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE------  413 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------  413 (512)
                      ..++|...+.||+|+||.||++.. ..+..||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            346888899999999999999986 45889999999753  223356788999999999999999999988644      


Q ss_pred             CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          414 NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      ...++||||+++ +|..++.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            346999999975 5666653     24788999999999999999999975   99999999999999999999999999


Q ss_pred             ccccCCC
Q 043262          494 ARIFGGN  500 (512)
Q Consensus       494 a~~~~~~  500 (512)
                      ++.....
T Consensus       166 ~~~~~~~  172 (355)
T cd07874         166 ARTAGTS  172 (355)
T ss_pred             cccCCCc
Confidence            9876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.86  E-value=5.7e-21  Score=184.95  Aligned_cols=153  Identities=25%  Similarity=0.436  Sum_probs=134.8

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|+..+.||.|+||.||++.. .++..+++|++.... ....+.+.+|++.++.++|+||+++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            3577788999999999999986 467889999986432 33567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++++|.+++........+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            999999999965433356899999999999999999999875   999999999999999999999999999877554

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.86  E-value=2.4e-21  Score=187.86  Aligned_cols=149  Identities=30%  Similarity=0.525  Sum_probs=129.9

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCC------cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS------GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      +|+..+.||+|+||.||++.. .++..+++|.+....      ....+.+..|+.++++++|+||+++++.+.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            366778999999999999985 678999999986432      1134678999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-ceEEeccCccccc
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIF  497 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DFGla~~~  497 (512)
                      |+||+++++|.+++.+   ..++++.....++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||+++.+
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999854   235889999999999999999999975   99999999999998775 5999999999877


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      ...
T Consensus       155 ~~~  157 (268)
T cd06630         155 AAK  157 (268)
T ss_pred             ccc
Confidence            543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=4.6e-21  Score=186.70  Aligned_cols=148  Identities=27%  Similarity=0.455  Sum_probs=132.2

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      +|...+.||.|++|.||+++.. ++..|++|.+.... ......+.+|+.+++.++|+||+++++.+......++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5677788999999999999864 68899999986543 344567899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++++|.+++...    .+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+...
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999998542    6899999999999999999999875   999999999999999999999999999887644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.86  E-value=3.7e-21  Score=191.25  Aligned_cols=150  Identities=31%  Similarity=0.507  Sum_probs=127.1

Q ss_pred             CCccccccccccceeEEEEEeC---CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA---DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESL  417 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~---~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~  417 (512)
                      +|...++||+|+||.||+|...   ++..+|+|.+....   ....+.+.+|+.++..++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3666788999999999999974   47899999997633   33356788999999999999999999999988  7899


Q ss_pred             EEEEecCCCChhHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC----CCceEEecc
Q 043262          418 LIYEYMPNKSLNVFLFDST--RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH----EMNPKISDF  491 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~----~~~~kl~DF  491 (512)
                      +||||+++ +|.+++....  ....+++.....++.||+.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6666654322  2236889999999999999999999875   999999999999999    999999999


Q ss_pred             CcccccCC
Q 043262          492 GMARIFGG  499 (512)
Q Consensus       492 Gla~~~~~  499 (512)
                      |+++.+..
T Consensus       157 g~~~~~~~  164 (316)
T cd07842         157 GLARLFNA  164 (316)
T ss_pred             ccccccCC
Confidence            99987644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=5.4e-21  Score=186.49  Aligned_cols=148  Identities=28%  Similarity=0.518  Sum_probs=130.9

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcCC---CCccccceeeEEeCCeeEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      .|+..+.||+|+||.||+|.. .++..+++|.+... ......++.+|+.++++++   |||++++++++...+..++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            456678899999999999996 56889999998644 3344667889999999986   999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++++|.+++..    ..+++...+.++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++..+..+
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998843    26899999999999999999999875   999999999999999999999999999877544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.86  E-value=3e-23  Score=186.26  Aligned_cols=151  Identities=28%  Similarity=0.426  Sum_probs=128.0

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcc--cCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++.|+..+.||+|.|+.|+++.. ..|+.+|+|.+.  +-+..+.+++.+|+.+-..|+||||++|.....+....+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            35667778999999999999975 568889988874  334457889999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC---CCceEEeccCccccc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGMARIF  497 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~---~~~~kl~DFGla~~~  497 (512)
                      |+|.+++|..-+-.   ..-.++....+.+.||+++|.|+|.++   |||||+||+|+||..   .--+||+|||+|..+
T Consensus        90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999654422   234677788899999999999999985   999999999999954   345899999999999


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      +++
T Consensus       164 ~~g  166 (355)
T KOG0033|consen  164 NDG  166 (355)
T ss_pred             CCc
Confidence            843

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.86  E-value=4.3e-21  Score=188.31  Aligned_cols=149  Identities=30%  Similarity=0.532  Sum_probs=121.8

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcC---CCCccccceeeEEeC-----C
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKL---QHKNLVRLLGCCLQE-----N  414 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~-----~  414 (512)
                      +|...+.||+|+||.||+++.. +++.||+|.++...  ......+.+|+.++..+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            3667789999999999999864 68899999986432  12234556677766655   799999999988642     4


Q ss_pred             eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                      ..++++||+. ++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            5789999997 4888887542 2345899999999999999999999975   999999999999999999999999999


Q ss_pred             cccCC
Q 043262          495 RIFGG  499 (512)
Q Consensus       495 ~~~~~  499 (512)
                      +.+..
T Consensus       156 ~~~~~  160 (288)
T cd07863         156 RIYSC  160 (288)
T ss_pred             ccccC
Confidence            87754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.86  E-value=4e-21  Score=189.27  Aligned_cols=149  Identities=26%  Similarity=0.463  Sum_probs=132.7

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .+|...+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++..++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5677788999999999999985 468899999987555555678899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+...
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            99999999853    24789999999999999999999875   999999999999999999999999998766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.86  E-value=3.4e-21  Score=189.31  Aligned_cols=148  Identities=26%  Similarity=0.357  Sum_probs=128.8

Q ss_pred             CccccccccccceeEEEEEe----CCCCEEEEEEcccCC----cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeE
Q 043262          347 FSDENKLGEGGFGPVYKGKL----ADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~----~~g~~vaVK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  417 (512)
                      |+..+.||+|+||.||+++.    .+|..||+|++....    ....+.+.+|+.++..+ +|+||+++++.+..++..+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            56678899999999999985    468899999987532    22346788999999999 5999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +|+||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++||||+|+|||+++++.+||+|||+++.+
T Consensus        82 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          82 LILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            99999999999999854   245888999999999999999999875   999999999999999999999999999877


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      ..+
T Consensus       156 ~~~  158 (290)
T cd05613         156 HED  158 (290)
T ss_pred             ccc
Confidence            543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.3e-22  Score=203.07  Aligned_cols=149  Identities=26%  Similarity=0.447  Sum_probs=131.5

Q ss_pred             CCccccccccccceeEEEEEeCC-CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          346 HFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      .|.+...||.|+||.||++..++ +...|.|.+...+...+++|+-||++|+..+||+||+|++.++..+.+|++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            34556679999999999998764 34457788887788889999999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +|-.+..+..  -...|.+.++.-++.|++.||.|||++   +|||||||+.|||++-+|.++|+|||.+.....
T Consensus       113 GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  113 GGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             CchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence            9999888754  235689999999999999999999998   599999999999999999999999999876543

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.86  E-value=4.4e-21  Score=186.06  Aligned_cols=148  Identities=30%  Similarity=0.492  Sum_probs=127.4

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-----cccHHHHHHHHHHHhcCCCCccccceeeEEeC--Cee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-----GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  416 (512)
                      .+|...+.||+|+||.||++.. .++..|++|.+....     ......+.+|+.++..++||||+++++.+...  +..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3677889999999999999986 458899999886432     12345688999999999999999999988753  567


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++++||+++++|.+++...   ..+++...+.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            8999999999999998542   34889999999999999999999874   99999999999999999999999999986


Q ss_pred             cC
Q 043262          497 FG  498 (512)
Q Consensus       497 ~~  498 (512)
                      +.
T Consensus       156 ~~  157 (266)
T cd06651         156 LQ  157 (266)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.86  E-value=4.5e-21  Score=191.96  Aligned_cols=143  Identities=17%  Similarity=0.285  Sum_probs=123.9

Q ss_pred             ccccccc--cceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          350 ENKLGEG--GFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       350 ~~~lg~G--~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      .++||+|  +|++||++.. .+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4679999  6899999986 568999999996532  2334567889999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      +|+|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|++||+....
T Consensus        83 ~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~  150 (327)
T cd08227          83 YGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS  150 (327)
T ss_pred             CCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhc
Confidence            999999985432 235899999999999999999999875   99999999999999999999999986544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.86  E-value=6.9e-21  Score=185.89  Aligned_cols=148  Identities=27%  Similarity=0.484  Sum_probs=130.8

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .|+..++||.|+||.||+|... ++..||+|.+.... ......+.+|+.++..++||||+++++.+...+..++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4566788999999999999874 58899999887443 344678999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++|+|.+++..    ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+...
T Consensus        85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            99999998843    35888999999999999999999874   999999999999999999999999999877543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.86  E-value=3.8e-21  Score=195.39  Aligned_cols=148  Identities=28%  Similarity=0.458  Sum_probs=125.6

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC------C
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE------N  414 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~  414 (512)
                      .++|...+.||+|+||.||++.. ..++.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            46788899999999999999986 45889999999743  233456788999999999999999999987643      3


Q ss_pred             eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                      ..++||||+++ +|..++.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            47999999975 6766663     23788999999999999999999975   999999999999999999999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +.....
T Consensus       174 ~~~~~~  179 (364)
T cd07875         174 RTAGTS  179 (364)
T ss_pred             cccCCC
Confidence            876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.9e-21  Score=200.56  Aligned_cols=154  Identities=24%  Similarity=0.359  Sum_probs=121.4

Q ss_pred             HhcCCccccccccccceeEEEEEe-----------------CCCCEEEEEEcccCCcccHHH--------------HHHH
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-----------------ADGKEIAVKRLSRTSGQGLQE--------------FKNE  391 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-----------------~~g~~vaVK~l~~~~~~~~~~--------------~~~E  391 (512)
                      ..++|...++||+|+||.||+|.+                 .+++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                 235689999986543322333              3446


Q ss_pred             HHHHhcCCCCcc-----ccceeeEEe--------CCeeEEEEEecCCCChhHHhhcCCC---------------------
Q 043262          392 VTLIAKLQHKNL-----VRLLGCCLQ--------ENESLLIYEYMPNKSLNVFLFDSTR---------------------  437 (512)
Q Consensus       392 ~~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~---------------------  437 (512)
                      +..+.+++|.++     ++++++|..        .+..+|||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            667777766654     678888753        3568999999999999999864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          438 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       438 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ...++|..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  361 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT  361 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCcccccc
Confidence            123578888999999999999999874   99999999999999999999999999987643

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.86  E-value=7.1e-21  Score=183.94  Aligned_cols=150  Identities=29%  Similarity=0.435  Sum_probs=134.5

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      +|...+.||+|++|.||+++.. ++..|+||++..... ...+.+.+|+..+.+++|+||+++++.+...+..++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            5777889999999999999976 489999999876543 44678999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      ++++|.+++...   ..+++...+.++.|+++||.|||+ .+   ++|+||+|+||+++.++.+||+|||+++.+....
T Consensus        82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999543   568999999999999999999998 64   9999999999999999999999999999875443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.86  E-value=2.5e-21  Score=186.74  Aligned_cols=149  Identities=28%  Similarity=0.398  Sum_probs=132.5

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +|...+.||.|+||.||++... ++..+++|.+....   ....+.+.+|+.++++++||||+++++.+...+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4677889999999999999975 58899999986432   2446789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+++++|..++...   .++++.....++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999998542   46899999999999999999999874   999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.86  E-value=4.3e-21  Score=184.74  Aligned_cols=146  Identities=34%  Similarity=0.560  Sum_probs=126.9

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...+.||+|+||.||++.. ++..|++|.++...  ..+.+.+|+.++..++||||+++++.+... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4577788999999999999986 57889999986532  346789999999999999999999998654 5799999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +++|.+++.... ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            999999986532 345899999999999999999999874   9999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.86  E-value=9.1e-22  Score=210.79  Aligned_cols=150  Identities=32%  Similarity=0.512  Sum_probs=121.7

Q ss_pred             HHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC-----
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN-----  414 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----  414 (512)
                      .-.++|...+.||+|+||.|||++. -||+.+|||+|... +........+|+.++++|+|||||+++..|.+..     
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4556788889999999999999985 48999999999754 3444567889999999999999999876653200     


Q ss_pred             --------------------------------------------------------------------------------
Q 043262          415 --------------------------------------------------------------------------------  414 (512)
Q Consensus       415 --------------------------------------------------------------------------------  414 (512)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 043262          415 ----------------------------------ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL  460 (512)
Q Consensus       415 ----------------------------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL  460 (512)
                                                        .+|+-||||+...|.+++.+..-..  .....++++.+|++||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                              1356678888777777764422110  3566789999999999999


Q ss_pred             HcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       461 H~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      |+.+   ||||||||.||+||++..+||+|||||..
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence            9986   99999999999999999999999999987

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.86  E-value=5.1e-21  Score=188.15  Aligned_cols=158  Identities=29%  Similarity=0.403  Sum_probs=133.1

Q ss_pred             hHHHHHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeCC-
Q 043262          338 HLAVEATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQEN-  414 (512)
Q Consensus       338 ~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~-  414 (512)
                      ..+..++++|...+.||+|+||.||++.. .++..+|+|.+.... .....+.+|+.++.++ +||||+++++++...+ 
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            33444578899999999999999999986 568899999986532 2245678899999998 8999999999987543 


Q ss_pred             ----eeEEEEEecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEe
Q 043262          415 ----ESLLIYEYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  489 (512)
Q Consensus       415 ----~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~  489 (512)
                          ..++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence                579999999999999988532 22346899999999999999999999874   9999999999999999999999


Q ss_pred             ccCcccccCC
Q 043262          490 DFGMARIFGG  499 (512)
Q Consensus       490 DFGla~~~~~  499 (512)
                      |||+++.+..
T Consensus       171 dfg~~~~~~~  180 (291)
T cd06639         171 DFGVSAQLTS  180 (291)
T ss_pred             ecccchhccc
Confidence            9999987643

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.86  E-value=4.4e-21  Score=187.78  Aligned_cols=149  Identities=32%  Similarity=0.548  Sum_probs=129.4

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|+..+.||+|++|.||+++. .++..|+||.+....  ......+.+|++++.+++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            367778999999999999986 468899999886432  22345789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +. ++|..++... ....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            96 6888888543 2356899999999999999999999874   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.86  E-value=7.3e-21  Score=185.73  Aligned_cols=147  Identities=30%  Similarity=0.505  Sum_probs=129.7

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      -|+..++||+|+||.||+|.. .++..+|+|.+.... ......+.+|+.++.+++||||+++++.+..++..++|+||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            355677899999999999986 468899999886433 334567899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++++|..++..    ..+++.....++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            99999999843    35899999999999999999999875   99999999999999999999999999987643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.85  E-value=6.9e-21  Score=183.39  Aligned_cols=150  Identities=25%  Similarity=0.456  Sum_probs=131.5

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|+..++||+|+||.+|++.. .+++.+++|.+...  .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            467788999999999999986 46889999998643  334456899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +++++|.+++... ....+++...+.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..+..
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            9999999988542 2335789999999999999999999875   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.85  E-value=4.2e-21  Score=186.36  Aligned_cols=145  Identities=37%  Similarity=0.589  Sum_probs=124.7

Q ss_pred             cccccccceeEEEEEeCC-------CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          351 NKLGEGGFGPVYKGKLAD-------GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~-------g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +.||+|+||.||+|+..+       +..++||.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998643       2578999886543 23466899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-----ceEEeccCc
Q 043262          423 MPNKSLNVFLFDST----RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-----NPKISDFGM  493 (512)
Q Consensus       423 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-----~~kl~DFGl  493 (512)
                      +++++|.+++.+..    ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996532    2234789999999999999999999874   99999999999999877     899999999


Q ss_pred             ccccC
Q 043262          494 ARIFG  498 (512)
Q Consensus       494 a~~~~  498 (512)
                      ++.+.
T Consensus       158 ~~~~~  162 (269)
T cd05044         158 ARDIY  162 (269)
T ss_pred             ccccc
Confidence            98664

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.85  E-value=3.3e-21  Score=188.71  Aligned_cols=148  Identities=30%  Similarity=0.525  Sum_probs=127.7

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|...+.||+|+||.||+++. .+|..+++|.++...  ......+.+|+.++.+++||||+++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            366678899999999999987 468899999986432  22235678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++ ++|.+++...  ...+++.....++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            97 5787777542  245899999999999999999999875   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.85  E-value=7.2e-21  Score=184.77  Aligned_cols=152  Identities=26%  Similarity=0.472  Sum_probs=128.1

Q ss_pred             CccccccccccceeEEEEEeCC--CCEEEEEEcccC----------CcccHHHHHHHHHHHhc-CCCCccccceeeEEeC
Q 043262          347 FSDENKLGEGGFGPVYKGKLAD--GKEIAVKRLSRT----------SGQGLQEFKNEVTLIAK-LQHKNLVRLLGCCLQE  413 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~~--g~~vaVK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~  413 (512)
                      |+..+.||+|+||.||++....  +..+++|.+...          ......++..|+.++.+ ++||||+++++++.+.
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            6667889999999999999754  678999987532          12234567788888765 7999999999999999


Q ss_pred             CeeEEEEEecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccC
Q 043262          414 NESLLIYEYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  492 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFG  492 (512)
                      +..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+..  +++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEeccc
Confidence            9999999999999999887432 23346899999999999999999999642  59999999999999999999999999


Q ss_pred             cccccCCC
Q 043262          493 MARIFGGN  500 (512)
Q Consensus       493 la~~~~~~  500 (512)
                      ++......
T Consensus       160 ~~~~~~~~  167 (269)
T cd08528         160 LAKQKQPE  167 (269)
T ss_pred             ceeecccc
Confidence            99876544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.85  E-value=2e-21  Score=160.15  Aligned_cols=93  Identities=35%  Similarity=0.586  Sum_probs=75.5

Q ss_pred             CChHHHHHHHHHHHHHHHHHhhccCccccceeeeeeccCCCcceEEEEeeccCCCCHHhHHHHHHHHHHhhhhcccCCCC
Q 043262          134 TDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSRISSRYYGRQS  213 (512)
Q Consensus       134 ~~~~~f~~~~~~l~~~l~~~a~~~~~~~~~a~~~~~~~~~~~~~vy~laQC~~dls~~~C~~CL~~~~~~~~~~~~~~~g  213 (512)
                      +++..|...+..+|..|.+.++... ..+|++++  . ..+.++||||+||++||++++|..||+.++..++.+|+++.|
T Consensus        14 ~~~~~f~~~l~~ll~~l~~~a~~~~-~~~f~~~~--~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g   89 (106)
T PF01657_consen   14 TDNSTFEQNLNSLLSSLVSNAASSS-SKGFATGS--A-GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRG   89 (106)
T ss_dssp             -TT-THHHHHHHHHHHHHHHGGGTT--TEEEEEE-----ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSS
T ss_pred             CCCchHHHHHHHHHHHHHHHHhhcc-ccCcEEee--c-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCce
Confidence            4555699999999999999988653 47899997  3 346689999999999999999999999999999999999999


Q ss_pred             ceeeccccceeeecCCC
Q 043262          214 VRALSPSCIIRYEMYPF  230 (512)
Q Consensus       214 ~~~~~~~C~lrye~~pf  230 (512)
                      |+|++++|+||||.++|
T Consensus        90 ~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   90 GRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             EEEEESSEEEEEESS--
T ss_pred             EEEECCCEEEEEECCCC
Confidence            99999999999999997

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.85  E-value=2.3e-21  Score=197.22  Aligned_cols=149  Identities=28%  Similarity=0.412  Sum_probs=127.9

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-C-----CccccceeeEEeCCeeEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-H-----KNLVRLLGCCLQENESLL  418 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~g~~~~~~~~~l  418 (512)
                      +|...+.||+|.||+|.|+.. .+++.||||+++..... ..+-..|+.+|..|+ |     -|+|++++++...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            678889999999999999985 56999999999865433 455678999999987 4     479999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC--CceEEeccCcccc
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE--MNPKISDFGMARI  496 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~--~~~kl~DFGla~~  496 (512)
                      |+|.++ -+|.++|+. ++...++......|+.||+.||.+||+.+   |||+||||+||||.+-  ..+||+|||.+..
T Consensus       266 VfELL~-~NLYellK~-n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKN-NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhhh-hhHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            999985 499999965 34456999999999999999999999874   9999999999999753  4799999999987


Q ss_pred             cCCC
Q 043262          497 FGGN  500 (512)
Q Consensus       497 ~~~~  500 (512)
                      ..+.
T Consensus       341 ~~q~  344 (586)
T KOG0667|consen  341 ESQR  344 (586)
T ss_pred             cCCc
Confidence            6543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=3.7e-21  Score=176.20  Aligned_cols=142  Identities=15%  Similarity=0.156  Sum_probs=109.6

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEEcccCCcc--c-------HHH-----------------HHHHHHHHhcCCCCcc
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ--G-------LQE-----------------FKNEVTLIAKLQHKNL  403 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~nI  403 (512)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ...                 ...|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999999888999999999653211  1       112                 2348999999988887


Q ss_pred             ccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCcccCCCCCCCeeecC
Q 043262          404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL-HEDSRLKIIHRDLKTSNVLLDH  482 (512)
Q Consensus       404 v~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dlk~~NiLl~~  482 (512)
                      .......  ....+|||||++++++.....   ....+++.....++.|++.+|.|| |+.   +|+||||||+|||+++
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~  153 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD  153 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC
Confidence            5444332  223489999999887765432   224588999999999999999999 565   4999999999999984


Q ss_pred             CCceEEeccCcccccCCC
Q 043262          483 EMNPKISDFGMARIFGGN  500 (512)
Q Consensus       483 ~~~~kl~DFGla~~~~~~  500 (512)
                       +.++|+|||+|......
T Consensus       154 -~~v~LiDFG~a~~~~~~  170 (190)
T cd05147         154 -GKLYIIDVSQSVEHDHP  170 (190)
T ss_pred             -CcEEEEEccccccCCCc
Confidence             68999999999876443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.85  E-value=1.3e-20  Score=181.61  Aligned_cols=149  Identities=28%  Similarity=0.412  Sum_probs=128.3

Q ss_pred             CccccccccccceeEEEEEeC-CCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC-CeeEEEEEe
Q 043262          347 FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE-NESLLIYEY  422 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lv~E~  422 (512)
                      |...+.||+|++|.||++... +++.+++|.+...  .....+.+.+|++++++++|+|++++++.+... ...++++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            667789999999999999864 5788999998643  233456789999999999999999999887644 457899999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +++++|.+++... ....+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+..
T Consensus        82 ~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          82 CEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             cCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            9999999998652 3346899999999999999999999875   99999999999999999999999999987743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.4e-21  Score=196.11  Aligned_cols=144  Identities=33%  Similarity=0.505  Sum_probs=128.3

Q ss_pred             ccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCChhH
Q 043262          352 KLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNV  430 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~  430 (512)
                      +||+|.||.||-|+.. +...+|||-+........+.+..||.+-+.|+|.|||+.+|.+.+++..-+.||-+++|+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999964 456789999988877788899999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-CCceEEeccCcccccCCC
Q 043262          431 FLFDSTRSVQL--DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGGN  500 (512)
Q Consensus       431 ~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DFGla~~~~~~  500 (512)
                      +|+..  =++|  .+.+.-.+.+||++||.|||++.   |||||||-.|||++- .|.+||+|||-++++.+-
T Consensus       662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi  729 (1226)
T KOG4279|consen  662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI  729 (1226)
T ss_pred             HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC
Confidence            99653  2344  67788889999999999999984   999999999999964 688999999999988653

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.85  E-value=1.3e-20  Score=184.92  Aligned_cols=146  Identities=25%  Similarity=0.451  Sum_probs=130.3

Q ss_pred             CccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      |...++||+|++|.||++.. .++..+++|++........+.+.+|+.++..++||||+++++++...+..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44457899999999999985 56889999998765555566789999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||+++.+..
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            999999854    35899999999999999999999975   99999999999999999999999999886644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.85  E-value=5.7e-21  Score=184.52  Aligned_cols=141  Identities=28%  Similarity=0.438  Sum_probs=126.0

Q ss_pred             cccccceeEEEEEeC-CCCEEEEEEcccCCc---ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          353 LGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       353 lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      ||+|+||.||+++.. +++.+++|.+.....   ...+.+.+|++++.+++||||+++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999986 489999999865433   3456789999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          429 NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      .+++.+.   ..+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            9998643   26899999999999999999999875   99999999999999999999999999986543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.85  E-value=1.1e-21  Score=182.47  Aligned_cols=142  Identities=28%  Similarity=0.433  Sum_probs=128.1

Q ss_pred             ccccccccceeEEEEE-eCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEEecCCCC
Q 043262          350 ENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYEYMPNKS  427 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E~~~~gs  427 (512)
                      .+.||+|+|+.|-.++ +.+|.++|||++.+.....+.+..+|++++...+ |+||+.|+.++.++...|||||-|.+|+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            3679999999999887 6789999999999888888899999999999996 9999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC---ceEEeccCccccc
Q 043262          428 LNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKISDFGMARIF  497 (512)
Q Consensus       428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~---~~kl~DFGla~~~  497 (512)
                      |...+..   ...+++.+..++.++|+.||.|||.++   |.||||||+|||-.+-.   -+||+||.|+.-+
T Consensus       163 lLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  163 LLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             HHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence            9988843   456899999999999999999999986   99999999999996543   4899999998654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=8.9e-22  Score=190.05  Aligned_cols=153  Identities=29%  Similarity=0.389  Sum_probs=127.7

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-------cccHHHHHHHHHHHhcCCCCccccceeeEEe-CCe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-------GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ-ENE  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~  415 (512)
                      ++|-...+||+|+|+.|||+.. ...+-||||+-....       ....+..++|-++-+.|+||.||++++++.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            4566678899999999999984 556788888653211       1123457889999999999999999999865 466


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC---CceEEeccC
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFG  492 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~---~~~kl~DFG  492 (512)
                      .+-|+||+++.+|+.||..   ...++++....|+.||..||.||.+. .+||||-||||.||||.++   +.+||.|||
T Consensus       543 FCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            7899999999999999954   34589999999999999999999987 4799999999999999654   679999999


Q ss_pred             cccccCCCC
Q 043262          493 MARIFGGNQ  501 (512)
Q Consensus       493 la~~~~~~~  501 (512)
                      |++++.++.
T Consensus       619 LSKIMdddS  627 (775)
T KOG1151|consen  619 LSKIMDDDS  627 (775)
T ss_pred             hhhhccCCc
Confidence            999997664

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.85  E-value=6.6e-21  Score=187.56  Aligned_cols=150  Identities=28%  Similarity=0.460  Sum_probs=129.1

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv  419 (512)
                      ++|...+.||+|+||.||+|... ++..+++|.++....  .....+.+|+.++.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            45777889999999999999975 588999999864332  2234577899999999999999999999877  889999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +||+. ++|.+++....  ..+++.....++.||+.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+..
T Consensus        85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 58988885432  35899999999999999999999875   99999999999999999999999999997755


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       159 ~  159 (293)
T cd07843         159 P  159 (293)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.85  E-value=8.9e-21  Score=186.71  Aligned_cols=150  Identities=30%  Similarity=0.472  Sum_probs=127.0

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCC-CCccccceeeEEeCCe-----
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENE-----  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~-----  415 (512)
                      ++|+..+.||+|+||.||++... ++..||+|.++...  ......+.+|+.++..+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            35777889999999999999964 68899999886432  223467889999999995 6999999999987666     


Q ss_pred             eEEEEEecCCCChhHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-CCceEEeccC
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTR--SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFG  492 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DFG  492 (512)
                      .++||||+++ +|.+++.....  ...+++...+.++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 78888754322  346899999999999999999999875   999999999999998 8899999999


Q ss_pred             cccccC
Q 043262          493 MARIFG  498 (512)
Q Consensus       493 la~~~~  498 (512)
                      +++.+.
T Consensus       157 ~~~~~~  162 (295)
T cd07837         157 LGRAFS  162 (295)
T ss_pred             cceecC
Confidence            998764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=8.7e-21  Score=183.77  Aligned_cols=148  Identities=30%  Similarity=0.488  Sum_probs=127.7

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC-----CcccHHHHHHHHHHHhcCCCCccccceeeEEeC--Cee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT-----SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  416 (512)
                      .+|...+.||+|+||.||++.. .++..+++|.+...     .......+.+|+.++.+++|+||+++++.+.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4677889999999999999986 46899999987532     223456789999999999999999999998764  457


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++++||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999999853   234788999999999999999999875   99999999999999999999999999987


Q ss_pred             cC
Q 043262          497 FG  498 (512)
Q Consensus       497 ~~  498 (512)
                      +.
T Consensus       156 ~~  157 (264)
T cd06653         156 IQ  157 (264)
T ss_pred             cc
Confidence            63

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.85  E-value=7.1e-21  Score=186.60  Aligned_cols=149  Identities=26%  Similarity=0.426  Sum_probs=130.3

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|+..++||+|+||.||++... +++.|+||.++..  .....+.+.+|+++++.++|+||+++++.+...+..++++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5777889999999999999875 5789999988643  233457899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++++.+..++..   ...+++.....++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+...
T Consensus        82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          82 VERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            998877766532   344899999999999999999999975   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.85  E-value=1.3e-20  Score=186.97  Aligned_cols=149  Identities=32%  Similarity=0.526  Sum_probs=128.3

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc---ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ..|...+.||+|+||.||++... +++.|++|.+.....   ...+++.+|++++..++||||+++++++...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45777889999999999999864 688999998864332   33457899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+. |+|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++....
T Consensus        95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 5776766432  235899999999999999999999874   99999999999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.85  E-value=7.2e-21  Score=191.27  Aligned_cols=150  Identities=29%  Similarity=0.513  Sum_probs=127.9

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC--CcccHHHHHHHHHHHhcC-CCCccccceeeEEeC--Cee
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQE--NES  416 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~--~~~  416 (512)
                      ..++|...+.||+|+||.||+|... ++..++||++...  .......+.+|+.++.++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467888899999999999999975 5789999988542  233456688899999999 999999999998654  357


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++|+||++ ++|..++...    .++|..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 5898888432    6889999999999999999999874   99999999999999999999999999987


Q ss_pred             cCCC
Q 043262          497 FGGN  500 (512)
Q Consensus       497 ~~~~  500 (512)
                      +...
T Consensus       157 ~~~~  160 (337)
T cd07852         157 LSEL  160 (337)
T ss_pred             cccc
Confidence            6543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.85  E-value=1.1e-20  Score=184.47  Aligned_cols=143  Identities=33%  Similarity=0.455  Sum_probs=125.0

Q ss_pred             cccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          353 LGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       353 lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      ||+|+||+||++.. .+++.+++|.+....   ....+.+..|++++..++||||+++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999985 468899999986432   22345678899999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          429 NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      .+++.... ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~  147 (277)
T cd05577          81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG  147 (277)
T ss_pred             HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence            99986533 246899999999999999999999975   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=1.7e-20  Score=180.10  Aligned_cols=150  Identities=29%  Similarity=0.492  Sum_probs=133.2

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|...+.||+|.+|.||+++.. ++..+++|.+.....  .....+.+|++++.+++|+|++++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            3566789999999999999864 578999999976543  4567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999998543   46899999999999999999999875   9999999999999999999999999999875543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.85  E-value=8.4e-21  Score=183.72  Aligned_cols=148  Identities=28%  Similarity=0.387  Sum_probs=131.2

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      +|+..+.||+|+||.||++... +++.+++|.+.... ....+++.+|++++++++||||+++++.+...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            4666788999999999999875 68899999987543 344567899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++++|.+++....  ..+++.....++.|++.||.|||+ .   +++|+||||+||++++++.+||+|||++..+.
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            9999999986532  568899999999999999999998 5   59999999999999999999999999987664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.85  E-value=1.1e-20  Score=185.97  Aligned_cols=143  Identities=27%  Similarity=0.455  Sum_probs=127.9

Q ss_pred             ccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          350 ENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      ..+||+|+||.||++.. .++..|+||.+..........+.+|+.++..++|+||+++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            35799999999999987 56889999998755555566799999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          429 NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      .+++..    ..+++.....++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++..+..
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            998743    34889999999999999999999975   99999999999999999999999999876644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.85  E-value=1.6e-20  Score=184.21  Aligned_cols=151  Identities=29%  Similarity=0.507  Sum_probs=134.4

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ..+.|...+.||+|++|.||++... ++..+++|.+..... ..+.+.+|++++..++|+||+++++.+...+..++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3456777789999999999999975 688999999976544 56778999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |+++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            999999999996532  36999999999999999999999864   99999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.85  E-value=2.5e-20  Score=178.33  Aligned_cols=149  Identities=32%  Similarity=0.574  Sum_probs=134.3

Q ss_pred             CccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          347 FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      |...+.||+|++|.||++... ++..+++|++........+.+.+|++.+..++|+||+++++.+...+..++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            566788999999999999975 6889999999876555667899999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++|.+++....  ..+++..+..++.|++.+|.|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            99999985432  4689999999999999999999996   4999999999999999999999999999887654

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.9e-21  Score=188.78  Aligned_cols=151  Identities=26%  Similarity=0.360  Sum_probs=132.3

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcc--cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQ--GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      -|..++.||+|-|..|-++++ -.|..||||++.+..-.  ....++.|++.|+.++|||||+|+.+.-....+|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            456678899999999999874 57999999999765433  345688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-CCceEEeccCcccccCCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DFGla~~~~~~~  501 (512)
                      -.+|+|.+|+.++...  +.+....+++.||+.|+.|+|+.   ++|||||||+||.+-+ -+-+||.|||++-.|.+++
T Consensus        99 GD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             cCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            9999999999876543  88899999999999999999986   5999999999988755 5789999999999887765

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.85  E-value=6.1e-21  Score=201.40  Aligned_cols=155  Identities=23%  Similarity=0.408  Sum_probs=119.9

Q ss_pred             HHhcCCccccccccccceeEEEEEeCC--CCEEEEEE--------------cc---cCCcccHHHHHHHHHHHhcCCCCc
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKLAD--GKEIAVKR--------------LS---RTSGQGLQEFKNEVTLIAKLQHKN  402 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~~~--g~~vaVK~--------------l~---~~~~~~~~~~~~E~~~l~~l~H~n  402 (512)
                      ...++|...++||+|+||.||++.++.  +...++|.              +.   .........+.+|+.++.+++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999987532  22222221              10   111223456889999999999999


Q ss_pred             cccceeeEEeCCeeEEEEEecCCCChhHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee
Q 043262          403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR--SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL  480 (512)
Q Consensus       403 Iv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl  480 (512)
                      |+++++++...+..++|+|++. ++|..++.....  ...........|+.||+.||.|||+.+   |+||||||+||||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999985 567666643221  112335567789999999999999975   9999999999999


Q ss_pred             cCCCceEEeccCcccccCCC
Q 043262          481 DHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       481 ~~~~~~kl~DFGla~~~~~~  500 (512)
                      +.++.+||+|||+++.+...
T Consensus       301 ~~~~~vkL~DFGla~~~~~~  320 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKE  320 (501)
T ss_pred             CCCCCEEEEeCCCceecCcc
Confidence            99999999999999987654

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.85  E-value=1.8e-20  Score=180.36  Aligned_cols=151  Identities=28%  Similarity=0.460  Sum_probs=130.5

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|...+.||+|+||.||++.. .++..++||.+...  .....+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            466778999999999999986 46889999998643  233467899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC-CceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~-~~~kl~DFGla~~~~~~  500 (512)
                      +++++|.+++... ....+++..+..++.+++.+|.|||+.+   ++|+||+|+||+++++ ..+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999999642 2345899999999999999999999974   9999999999999865 46899999999877543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.85  E-value=1.3e-20  Score=186.22  Aligned_cols=152  Identities=28%  Similarity=0.505  Sum_probs=129.3

Q ss_pred             HHhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCC----
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN----  414 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----  414 (512)
                      ...++|+..+.||+|+||.||+|... +++.|++|.++...  ......+.+|+.++..++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34567888899999999999999974 58899999986433  233456788999999999999999999987655    


Q ss_pred             ------eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          415 ------ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       415 ------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                            ..++|+||+++ +|..++...  ...+++.....++.||+.||.|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 676666432  346899999999999999999999974   999999999999999999999


Q ss_pred             eccCcccccCC
Q 043262          489 SDFGMARIFGG  499 (512)
Q Consensus       489 ~DFGla~~~~~  499 (512)
                      +|||+++.+..
T Consensus       158 ~dfg~~~~~~~  168 (302)
T cd07864         158 ADFGLARLYNS  168 (302)
T ss_pred             CcccccccccC
Confidence            99999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.84  E-value=1.8e-20  Score=183.18  Aligned_cols=142  Identities=29%  Similarity=0.341  Sum_probs=118.2

Q ss_pred             ccccccceeEEEEEe-CCCCEEEEEEcccCCc---ccHHHHHHHHH---HHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          352 KLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG---QGLQEFKNEVT---LIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~---~~~~~~~~E~~---~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      .||+|+||.||++.. .+++.+|+|.+.....   .....+.+|..   ++...+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999986 4588999998864321   11233444443   3344579999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            9999998854   245899999999999999999999975   99999999999999999999999999976643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.84  E-value=2.8e-20  Score=178.74  Aligned_cols=150  Identities=32%  Similarity=0.519  Sum_probs=133.7

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESLLIY  420 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~  420 (512)
                      +|...+.||+|++|.||+|... ++..|++|.+.....  ...+.+.+|+.++++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3666789999999999999975 688999999875442  4567899999999999999999999999988  8899999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++++|.+++....   .+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999985432   6899999999999999999999974   999999999999999999999999999987655


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       155 ~  155 (260)
T cd06606         155 E  155 (260)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.84  E-value=8.5e-21  Score=203.62  Aligned_cols=153  Identities=34%  Similarity=0.473  Sum_probs=131.8

Q ss_pred             cCCccccccccccceeEEEEEeC--------CCCEEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA--------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQEN  414 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~--------~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  414 (512)
                      +++...+.||+|.||.|++|...        ....||||.++.. ...+.+.++.|+++|..+ +|+||+.++|+|...+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            44455569999999999999842        1457999999854 335678899999999998 6999999999999999


Q ss_pred             eeEEEEEecCCCChhHHhhcCC-----------CC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec
Q 043262          415 ESLLIYEYMPNKSLNVFLFDST-----------RS--VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD  481 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~  481 (512)
                      ..++|.||++.|+|.+||+..+           ..  ..|.....+.++.|||.||+||++.   ++|||||.+||||+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence            9999999999999999997654           00  1388999999999999999999987   599999999999999


Q ss_pred             CCCceEEeccCcccccCCC
Q 043262          482 HEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       482 ~~~~~kl~DFGla~~~~~~  500 (512)
                      ++..+||+||||||.....
T Consensus       453 ~~~~~kIaDFGlar~~~~~  471 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNK  471 (609)
T ss_pred             CCCEEEEccccceeccCCC
Confidence            9999999999999976444

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.84  E-value=1.8e-20  Score=183.96  Aligned_cols=150  Identities=28%  Similarity=0.410  Sum_probs=128.5

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~E  421 (512)
                      +|...+.||.|.+|.||++... ++..+++|.+..... ....++.+|++++..++||||+++++++...  +..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5677889999999999999974 578899998875432 3456799999999999999999999998654  46899999


Q ss_pred             ecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          422 YMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       422 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+++++|.+++... .....+++.....++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++....
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            99999999887532 23345889999999999999999999875   9999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=2.1e-20  Score=171.72  Aligned_cols=142  Identities=18%  Similarity=0.261  Sum_probs=112.5

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEEcccCCcc---------------------c-----HHHHHHHHHHHhcCCCCcc
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ---------------------G-----LQEFKNEVTLIAKLQHKNL  403 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~nI  403 (512)
                      ...||+|+||.||+|...+|+.||||.++.....                     .     ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3579999999999999878999999998754211                     0     1124578899999999988


Q ss_pred             ccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCCeeecC
Q 043262          404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKTSNVLLDH  482 (512)
Q Consensus       404 v~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlk~~NiLl~~  482 (512)
                      .....+...  ..+|||||++++++.....   ....++......++.|++.+|.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            655554433  3489999999886543321   12357788899999999999999999 64   99999999999999 


Q ss_pred             CCceEEeccCcccccCCC
Q 043262          483 EMNPKISDFGMARIFGGN  500 (512)
Q Consensus       483 ~~~~kl~DFGla~~~~~~  500 (512)
                      ++.++|+|||+++.+..+
T Consensus       153 ~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         153 DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             CCCEEEEEcccceecCCC
Confidence            789999999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.84  E-value=2.2e-20  Score=182.83  Aligned_cols=148  Identities=30%  Similarity=0.531  Sum_probs=128.8

Q ss_pred             CccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeEEEEE
Q 043262          347 FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESLLIYE  421 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~E  421 (512)
                      |...++||+|+||.||+++.. ++..+++|.+....  ......+.+|+.++..++|+||+++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            445678999999999999875 58899999997653  33456788999999999999999999999988  88999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+++ +|..++...  ...+++..++.++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.....
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 888887543  246899999999999999999999874   999999999999999999999999999877554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.84  E-value=3e-20  Score=182.93  Aligned_cols=150  Identities=31%  Similarity=0.521  Sum_probs=126.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...+.||+|.+|.||+|... +++.|++|.+.....  .....+.+|++++++++||||+++++++...+..++|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46778889999999999999874 688999999864322  334678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-CCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DFGla~~~~~  499 (512)
                      |++ ++|.+++... ....+++.....++.||+.||.|||+.+   ++|+||+|+||++++ +..+||+|||+++.+..
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 5777776432 2334678888899999999999999874   999999999999985 56799999999987643

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.84  E-value=2.2e-20  Score=180.58  Aligned_cols=142  Identities=27%  Similarity=0.367  Sum_probs=125.9

Q ss_pred             cccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          353 LGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       353 lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      ||.|+||.||+++.. ++..+++|.+....   ....+.+.+|+.++..++||||+++++.+.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999975 48899999986432   23356799999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          429 NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      .+++.+.   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            9999542   34889999999999999999999974   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.84  E-value=2e-20  Score=180.62  Aligned_cols=156  Identities=26%  Similarity=0.454  Sum_probs=130.8

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEe--CCeeEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ--ENESLLIY  420 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~  420 (512)
                      +|...+.||.|+||.||++.. .++..+++|.+...  .....+.+..|+.+++.++||||+++++.+..  ....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            356678899999999999985 46789999988643  33445678899999999999999999998764  34578999


Q ss_pred             EecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          421 EYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDS--RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       421 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      ||+++++|.+++... .....+++...+.++.|++.||.|||..+  ..+++|+||+|+||++++++.+||+|||+++.+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653 22456899999999999999999999432  346999999999999999999999999999987


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ....
T Consensus       161 ~~~~  164 (265)
T cd08217         161 GHDS  164 (265)
T ss_pred             cCCc
Confidence            6544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.84  E-value=9.7e-21  Score=184.64  Aligned_cols=150  Identities=33%  Similarity=0.492  Sum_probs=132.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...+.||+|+||.||++... ++..|++|.+...   .....+.+.+|..++.+++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            35777889999999999999874 6899999988652   2233467889999999998 99999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999999999543   36999999999999999999999875   99999999999999999999999999987754


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       155 ~  155 (280)
T cd05581         155 N  155 (280)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2.7e-20  Score=180.88  Aligned_cols=152  Identities=29%  Similarity=0.489  Sum_probs=131.5

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeCC------
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQEN------  414 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~------  414 (512)
                      .+++|...+.||+|++|.||++... +++.+++|.+..... ..+.+.+|+.++.++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4578888999999999999999974 578899998875443 346799999999999 6999999999997654      


Q ss_pred             eeEEEEEecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4899999999999999885422 2456899999999999999999999875   99999999999999999999999999


Q ss_pred             ccccC
Q 043262          494 ARIFG  498 (512)
Q Consensus       494 a~~~~  498 (512)
                      +....
T Consensus       160 ~~~~~  164 (275)
T cd06608         160 SAQLD  164 (275)
T ss_pred             ceecc
Confidence            87654

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.84  E-value=4.3e-20  Score=184.00  Aligned_cols=147  Identities=32%  Similarity=0.549  Sum_probs=127.0

Q ss_pred             CccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      |...+.||+|+||.||+++. .++..+++|.+....   ......+.+|+.+++.++|||++++++++...+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            66678899999999999986 468899999986432   22345788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +. |+|.+++...  ...++|..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++.....
T Consensus       107 ~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         107 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            97 5777776432  345899999999999999999999875   99999999999999999999999999886654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.84  E-value=2.6e-20  Score=182.19  Aligned_cols=147  Identities=33%  Similarity=0.581  Sum_probs=127.7

Q ss_pred             CccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      |+..++||+|++|.||++.. .+|..|++|++....  ......+.+|++++..++||||+++++++...+..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            44567899999999999986 479999999986433  223467889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      + ++|.+++.... ...+++..++.++.|+++||.|||+.   +++||||+|+||++++++.+||+|||+++.+.
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            5 68998885432 24689999999999999999999987   49999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.84  E-value=2.3e-20  Score=179.70  Aligned_cols=151  Identities=28%  Similarity=0.484  Sum_probs=130.4

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|...+.||+|+||.||++... +|..+++|.+...  .....+.+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4667789999999999999974 5788999998643  223456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-ceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DFGla~~~~~~  500 (512)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++++. .+||+|||++..+..+
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999998643 2335899999999999999999999875   99999999999999885 4699999999877543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=2.4e-21  Score=206.08  Aligned_cols=165  Identities=25%  Similarity=0.287  Sum_probs=139.3

Q ss_pred             HHHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          341 VEATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       341 ~~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      +-..++|.+.++||+|+||.|...+. ..++.+|.|++.+.   ......-|..|-++|..-+.+.|+.|+-.+.+.+++
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            34457889999999999999999997 45778899999762   223345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      |||||||+||+|..++.+..   .+++.-...++..|..||.-||+-   ++|||||||.|||||..|++||+|||-+-.
T Consensus       151 YlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             EEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHh
Confidence            99999999999999995433   588888888999999999999986   599999999999999999999999999988


Q ss_pred             cCCCCCCcCccccccC
Q 043262          497 FGGNQSEANTKRIVGT  512 (512)
Q Consensus       497 ~~~~~~~~~~~~~~Gt  512 (512)
                      +..+..-.. .-.|||
T Consensus       225 m~~dG~V~s-~~aVGT  239 (1317)
T KOG0612|consen  225 MDADGTVRS-SVAVGT  239 (1317)
T ss_pred             cCCCCcEEe-ccccCC
Confidence            876553322 235776

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.84  E-value=2.1e-20  Score=187.69  Aligned_cols=148  Identities=24%  Similarity=0.448  Sum_probs=127.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEe----CCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ----ENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~  417 (512)
                      .+|...+.||+|+||.||++.. .++..|++|++....  ....+.+.+|+.++..++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            5778888999999999999986 468999999987532  2345678889999999999999999998763    34679


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +|+||+. ++|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++.+
T Consensus        85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9999996 689888843   345899999999999999999999875   999999999999999999999999999876


Q ss_pred             CC
Q 043262          498 GG  499 (512)
Q Consensus       498 ~~  499 (512)
                      ..
T Consensus       158 ~~  159 (334)
T cd07855         158 SS  159 (334)
T ss_pred             cc
Confidence            43

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.84  E-value=2.9e-20  Score=181.85  Aligned_cols=155  Identities=28%  Similarity=0.469  Sum_probs=130.5

Q ss_pred             HHHHHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEe----
Q 043262          339 LAVEATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQ----  412 (512)
Q Consensus       339 ~~~~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----  412 (512)
                      .+......|+..+.||+|+||.||+|.. .+++.+++|.+.... ....++..|+.++.++ +|+||+++++++..    
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            3334556788889999999999999987 467889999886543 3345788899999998 69999999999863    


Q ss_pred             --CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEec
Q 043262          413 --ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD  490 (512)
Q Consensus       413 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~D  490 (512)
                        .+..+++|||+++|+|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~d  164 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVD  164 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEee
Confidence              45689999999999999988542 2345888889999999999999999975   99999999999999999999999


Q ss_pred             cCcccccC
Q 043262          491 FGMARIFG  498 (512)
Q Consensus       491 FGla~~~~  498 (512)
                      ||+++.+.
T Consensus       165 fg~~~~~~  172 (282)
T cd06636         165 FGVSAQLD  172 (282)
T ss_pred             Ccchhhhh
Confidence            99988654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.84  E-value=2.8e-20  Score=187.43  Aligned_cols=150  Identities=27%  Similarity=0.478  Sum_probs=128.0

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC-----
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN-----  414 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----  414 (512)
                      ..++|...+.||+|+||.||++.. .++..||||++...  .....+.+.+|+.++.+++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            456788899999999999999985 57899999998643  2223456889999999999999999999987654     


Q ss_pred             -eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          415 -ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       415 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                       ..++|+||+ +++|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence             358999998 6789888743    35899999999999999999999875   99999999999999999999999999


Q ss_pred             ccccCCC
Q 043262          494 ARIFGGN  500 (512)
Q Consensus       494 a~~~~~~  500 (512)
                      ++....+
T Consensus       165 ~~~~~~~  171 (343)
T cd07880         165 ARQTDSE  171 (343)
T ss_pred             ccccccC
Confidence            9876543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.84  E-value=3e-20  Score=184.36  Aligned_cols=151  Identities=33%  Similarity=0.530  Sum_probs=128.1

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESLL  418 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l  418 (512)
                      .++|...+.||+|+||.||++.. .+|..||+|.++....  .....+.+|+.++.+++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            35688889999999999999997 4589999999864322  2234567899999999999999999998765  46899


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+||+.+ +|.+++...  ...+++..+..++.||+.||.|||+.+   ++||||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999974 788887542  246899999999999999999999985   9999999999999999999999999998875


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      ..
T Consensus       160 ~~  161 (309)
T cd07845         160 LP  161 (309)
T ss_pred             Cc
Confidence            43

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.84  E-value=2.4e-20  Score=183.04  Aligned_cols=148  Identities=26%  Similarity=0.365  Sum_probs=127.9

Q ss_pred             CccccccccccceeEEEEEe----CCCCEEEEEEcccCC----cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeE
Q 043262          347 FSDENKLGEGGFGPVYKGKL----ADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~----~~g~~vaVK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  417 (512)
                      |...+.||+|++|.||+++.    .++..+|||.++...    ....+.+.+|+.++.++ +||||+++++.+..++..+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            56678899999999999874    357889999986432    22345688999999999 5999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +||||+++|+|.+++..   ...+++.....++.|++++|.|||+.+   ++||||+|+||++++++.+||+|||+++.+
T Consensus        82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            99999999999999853   245889999999999999999999874   999999999999999999999999999876


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      ..+
T Consensus       156 ~~~  158 (288)
T cd05583         156 LAE  158 (288)
T ss_pred             ccc
Confidence            443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.84  E-value=5.5e-20  Score=176.73  Aligned_cols=152  Identities=23%  Similarity=0.430  Sum_probs=134.0

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|...+.||+|+||.||++... ++..+++|++.....  ...+++.+|++++..++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4667788999999999999974 588999999875432  4567889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999999986532 2356899999999999999999999974   999999999999999999999999999876554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.83  E-value=2.7e-20  Score=187.10  Aligned_cols=148  Identities=28%  Similarity=0.489  Sum_probs=126.6

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeC-----Cee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE-----NES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~  416 (512)
                      .++|...++||+|+||.||+|+. .++..||||.+.... ......+.+|+.++.+++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46788889999999999999985 568999999986432 23456788999999999999999999987654     357


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++++||+.+ +|..++..    ..+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999974 77777632    35899999999999999999999975   99999999999999999999999999987


Q ss_pred             cCC
Q 043262          497 FGG  499 (512)
Q Consensus       497 ~~~  499 (512)
                      ...
T Consensus       156 ~~~  158 (336)
T cd07849         156 ADP  158 (336)
T ss_pred             ccc
Confidence            643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=8e-21  Score=177.09  Aligned_cols=161  Identities=28%  Similarity=0.313  Sum_probs=134.7

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCccc---HHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .++|...++||+|.||+|-+++- ..++.+|+|++++.-...   ...-..|-++|...+||.+..|--.+...+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46788889999999999999974 568899999998754333   34457788999999999999999889999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||..+|.|.-.|.+   ...+++.+...+...|..||.|||++.   ||.||||.+|.|||.|+++||+||||++.--.
T Consensus       247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence            999999999877743   345777888888999999999999974   99999999999999999999999999986433


Q ss_pred             CCCCcCccccccC
Q 043262          500 NQSEANTKRIVGT  512 (512)
Q Consensus       500 ~~~~~~~~~~~Gt  512 (512)
                      ...  .++.++||
T Consensus       321 ~g~--t~kTFCGT  331 (516)
T KOG0690|consen  321 YGD--TTKTFCGT  331 (516)
T ss_pred             ccc--eeccccCC
Confidence            322  34557776

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.83  E-value=3.7e-20  Score=183.51  Aligned_cols=149  Identities=26%  Similarity=0.518  Sum_probs=125.8

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCe------
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE------  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------  415 (512)
                      ++|...++||+|+||.||++... ++..||||.+....  ......+.+|+.++++++||||+++++++...+.      
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            56888899999999999999864 68899999886432  2223456789999999999999999999876543      


Q ss_pred             --eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          416 --SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       416 --~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                        .++|+||+.+ +|.+++..  ....+++.....++.||+.||.|||+++   ++|+||||+||++++++.+||+|||+
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence              4999999974 78777743  2235899999999999999999999874   99999999999999999999999999


Q ss_pred             ccccCC
Q 043262          494 ARIFGG  499 (512)
Q Consensus       494 a~~~~~  499 (512)
                      ++.+..
T Consensus       166 ~~~~~~  171 (310)
T cd07865         166 ARAFSL  171 (310)
T ss_pred             cccccC
Confidence            987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.83  E-value=6.7e-20  Score=179.08  Aligned_cols=142  Identities=28%  Similarity=0.332  Sum_probs=118.3

Q ss_pred             ccccccceeEEEEEe-CCCCEEEEEEcccCCc---ccHHHHHHHH---HHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          352 KLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG---QGLQEFKNEV---TLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~---~~~~~~~~E~---~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      .||+|+||.||++.. .+++.||+|.+.....   .....+..|.   ..+....||+|+++++.+...+..++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999986 4588999999865321   1122234443   34455689999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +|+|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+..
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence            9999998853   346999999999999999999999874   99999999999999999999999999986643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.83  E-value=5e-20  Score=186.42  Aligned_cols=149  Identities=30%  Similarity=0.467  Sum_probs=126.5

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC------
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE------  413 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------  413 (512)
                      ..++|...+.||+|+||.||++.. .++..||+|.+...  .......+.+|+.++..++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            346788889999999999999986 47899999998643  233345778899999999999999999988644      


Q ss_pred             CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          414 NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      ...++|+||+. ++|.+.+..     .+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            34699999996 578777732     2888899999999999999999975   99999999999999999999999999


Q ss_pred             ccccCCC
Q 043262          494 ARIFGGN  500 (512)
Q Consensus       494 a~~~~~~  500 (512)
                      ++.....
T Consensus       165 ~~~~~~~  171 (353)
T cd07850         165 ARTAGTS  171 (353)
T ss_pred             ceeCCCC
Confidence            9876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.83  E-value=7.8e-20  Score=178.61  Aligned_cols=146  Identities=27%  Similarity=0.392  Sum_probs=122.9

Q ss_pred             CccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCC-CCccccceeeEEeC--CeeEEEEE
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQE--NESLLIYE  421 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lv~E  421 (512)
                      |...++||+|+||.||++.. .++..+|+|.++... .........|+..+.++. |+||+++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            34567899999999999986 468899999987532 222334567888898885 99999999999987  88999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |++ |+|.+++...  ...++|..+..++.|++.||.|||+.+   ++||||+|+||+++. +.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            997 5787777542  246899999999999999999999975   999999999999999 9999999999987643

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.83  E-value=8.1e-20  Score=183.28  Aligned_cols=147  Identities=29%  Similarity=0.426  Sum_probs=122.6

Q ss_pred             CCccccccccccceeEEEEEeC-C--CCEEEEEEcccCC--cccHHHHHHHHHHHhcC-CCCccccceeeEEeC----Ce
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-D--GKEIAVKRLSRTS--GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQE----NE  415 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~--g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~----~~  415 (512)
                      +|...+.||+|+||.||+++.. .  +..+|+|++....  ....+.+.+|+.++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3566788999999999999964 3  6789999986432  22356788999999999 599999999976543    34


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++++||+. ++|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            688888886 689888843   345899999999999999999999875   9999999999999999999999999998


Q ss_pred             ccCC
Q 043262          496 IFGG  499 (512)
Q Consensus       496 ~~~~  499 (512)
                      .+..
T Consensus       154 ~~~~  157 (332)
T cd07857         154 GFSE  157 (332)
T ss_pred             eccc
Confidence            7654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.83  E-value=9.6e-21  Score=166.29  Aligned_cols=153  Identities=26%  Similarity=0.417  Sum_probs=127.2

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC-CcccHHHHHHHHHHHhc-CCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAK-LQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +.+.....||+|++|.|-+-++ .+|..+|||++... ..+..+...+|+++..+ ...|.+|+|+|........|+.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            3344456799999999988775 67999999999754 34556678888887555 579999999999999999999999


Q ss_pred             ecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      .|. .||+.|-... .+...+++..+-+|+..|.+||.|||++  +.++|||+||+||||+.++++||+|||++..+.+.
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            995 4887775432 3445688999999999999999999986  58999999999999999999999999999876543

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.83  E-value=5.1e-20  Score=177.11  Aligned_cols=152  Identities=30%  Similarity=0.466  Sum_probs=132.2

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|+..++||+|+||.||++.. .++..+++|.+...  ......++.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            366778999999999999975 46789999998643  233456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++++|.+++.+.. ....+++.....++.|++.||.|||+.+   ++|+||+|.||++++++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            99999999986522 2346899999999999999999999875   999999999999999999999999999887554

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.83  E-value=7.5e-21  Score=184.51  Aligned_cols=158  Identities=27%  Similarity=0.367  Sum_probs=137.9

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .+.|..-+.||+|+||.||-++.. .|..+|.|++.+.   ..++....++|-.++.+++.+.||.+--.+...+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356777889999999999999864 5888899888532   233455678999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +..|.+|+|...|.+... ..+++.+.+.++.+|+.||++||...   ||.|||||+|||||+.|+++|+|+|||..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999998876544 45899999999999999999999984   99999999999999999999999999999988


Q ss_pred             CCCCcC
Q 043262          500 NQSEAN  505 (512)
Q Consensus       500 ~~~~~~  505 (512)
                      ++.+..
T Consensus       340 g~~~~~  345 (591)
T KOG0986|consen  340 GKPIRG  345 (591)
T ss_pred             CCcccc
Confidence            876543

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.83  E-value=4.9e-20  Score=185.04  Aligned_cols=147  Identities=26%  Similarity=0.414  Sum_probs=125.8

Q ss_pred             cCCc-cccccccccceeEEEEEe-CCCCEEEEEEcccCCccc--------------HHHHHHHHHHHhcCCCCcccccee
Q 043262          345 QHFS-DENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQG--------------LQEFKNEVTLIAKLQHKNLVRLLG  408 (512)
Q Consensus       345 ~~~~-~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~g  408 (512)
                      ++|. ..+.||+|+||.||++.. .+++.||||.++......              ...+.+|++++..++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3444 346799999999999986 468999999986432211              125789999999999999999999


Q ss_pred             eEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       409 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                      ++...+..++||||+. |+|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 689888843   345889999999999999999999875   999999999999999999999


Q ss_pred             eccCcccccC
Q 043262          489 SDFGMARIFG  498 (512)
Q Consensus       489 ~DFGla~~~~  498 (512)
                      +|||+++.+.
T Consensus       161 ~dfg~~~~~~  170 (335)
T PTZ00024        161 ADFGLARRYG  170 (335)
T ss_pred             CCccceeecc
Confidence            9999998765

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.83  E-value=4.7e-20  Score=185.38  Aligned_cols=149  Identities=27%  Similarity=0.485  Sum_probs=127.5

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC-----Ce
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE-----NE  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~  415 (512)
                      .++|...+.||+|+||.||+++. .++..|+||.+...  .......+.+|+.++..++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35688889999999999999986 46899999998643  233355778899999999999999999988654     34


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++|+||+. ++|.+++..   ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 688888743   346899999999999999999999875   9999999999999999999999999998


Q ss_pred             ccCC
Q 043262          496 IFGG  499 (512)
Q Consensus       496 ~~~~  499 (512)
                      ....
T Consensus       157 ~~~~  160 (337)
T cd07858         157 TTSE  160 (337)
T ss_pred             ccCC
Confidence            7644

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=8.7e-20  Score=176.23  Aligned_cols=142  Identities=25%  Similarity=0.366  Sum_probs=119.6

Q ss_pred             cccccccceeEEEEEe-CCCCEEEEEEcccCCc---ccHHHHHHHHHH-HhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG---QGLQEFKNEVTL-IAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      +.||+|+||.||++.. .+++.||||.+.....   .....+..|..+ ....+|+||+++++.+...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999986 4588999999865432   222344555544 4456899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++...
T Consensus        82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence            9999998542   35889999999999999999999874   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.83  E-value=8e-20  Score=180.21  Aligned_cols=150  Identities=26%  Similarity=0.426  Sum_probs=125.9

Q ss_pred             cCCccccccccccceeEEEEEeCC-CCEEEEEEcccCC-cccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...+.||+|+||.||++...+ +..||||.++... .....++..|+.++.+.. ||||+++++++......+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            456778899999999999999864 8899999997543 233456777887777765 9999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |++ ++|.+++...  ...+++..+..++.|++.||.|||+..  +|+||||+|+||++++++.+||+|||+++.+..
T Consensus        95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            985 4777766432  236899999999999999999999742  599999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00284 protein kinase; Provisional

Probab=99.83  E-value=5e-20  Score=193.37  Aligned_cols=148  Identities=23%  Similarity=0.303  Sum_probs=118.4

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCC------CccccceeeEEeC-C
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH------KNLVRLLGCCLQE-N  414 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~g~~~~~-~  414 (512)
                      ..++|...++||+|+||.||++.. ..+..||||+++.... ..+++..|+.++..++|      ++|+++++++... +
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~  205 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG  205 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence            457899999999999999999986 4578899999965322 23455667777776654      4588888888754 5


Q ss_pred             eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC----------
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM----------  484 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~----------  484 (512)
                      ..++|||++ +++|.+++..   ...+++..+..|+.||+.||.|||++  .+||||||||+|||++.++          
T Consensus       206 ~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        206 HMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             eEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccc
Confidence            678999987 6788888754   24689999999999999999999974  2599999999999998765          


Q ss_pred             ------ceEEeccCccccc
Q 043262          485 ------NPKISDFGMARIF  497 (512)
Q Consensus       485 ------~~kl~DFGla~~~  497 (512)
                            .+||+|||++...
T Consensus       280 ~~~~~~~vkl~DfG~~~~~  298 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDE  298 (467)
T ss_pred             cCCCCceEEECCCCccccC
Confidence                  4999999988653

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.82  E-value=4.1e-20  Score=185.17  Aligned_cols=148  Identities=28%  Similarity=0.467  Sum_probs=129.5

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCC-----eeE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN-----ESL  417 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~  417 (512)
                      +|...+.||+|++|.||+++.. ++..++||++....  ....+.+.+|+.++..++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4667789999999999999975 48899999987543  344568999999999999999999999998875     789


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +++||++ ++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||.|||++.++.+||+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 4888888542   36999999999999999999999975   999999999999999999999999999987


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      ...
T Consensus       154 ~~~  156 (330)
T cd07834         154 DPD  156 (330)
T ss_pred             ccc
Confidence            554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.82  E-value=8e-20  Score=178.70  Aligned_cols=148  Identities=30%  Similarity=0.454  Sum_probs=126.9

Q ss_pred             CccccccccccceeEEEEEeC-CCCEEEEEEcccCCc-ccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEEec
Q 043262          347 FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      |...+.||+|++|.||+|+.. +++.|+||++..... .......+|+..+.+++ |+||+++++.+...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            455678999999999999975 478899999865432 22334567899999999 999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                       +|+|.+++.... ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||+++....
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence             889988885432 346899999999999999999999875   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.82  E-value=8e-20  Score=184.31  Aligned_cols=153  Identities=31%  Similarity=0.444  Sum_probs=128.4

Q ss_pred             HHHHHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeC--
Q 043262          339 LAVEATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--  413 (512)
Q Consensus       339 ~~~~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--  413 (512)
                      .+....++|...+.||+|+||.||++.. .++..||+|++....  ....+.+.+|+.++.+++||||+++++++...  
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            3345668899999999999999999985 568899999987532  22346788999999999999999999988643  


Q ss_pred             ----CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEe
Q 043262          414 ----NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  489 (512)
Q Consensus       414 ----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~  489 (512)
                          ...++++|++ +++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence                3367788876 7899887743    34899999999999999999999975   9999999999999999999999


Q ss_pred             ccCcccccCC
Q 043262          490 DFGMARIFGG  499 (512)
Q Consensus       490 DFGla~~~~~  499 (512)
                      |||+++....
T Consensus       163 dfg~~~~~~~  172 (345)
T cd07877         163 DFGLARHTDD  172 (345)
T ss_pred             cccccccccc
Confidence            9999987543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.82  E-value=8.2e-20  Score=181.61  Aligned_cols=143  Identities=20%  Similarity=0.231  Sum_probs=122.1

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      +.+|.|+++.|+++.. ++..||||++...  .....+.+..|+.++..++|+||+++++++...+..+++|||+++|+|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3455556666666655 6899999998754  344567899999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          429 NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      .+++.... ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+.
T Consensus        87 ~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          87 EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             HHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence            99986532 235888999999999999999999975   9999999999999999999999999987553

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.82  E-value=7.3e-20  Score=190.59  Aligned_cols=170  Identities=28%  Similarity=0.470  Sum_probs=142.1

Q ss_pred             ChhHHHHHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEe-
Q 043262          336 PLHLAVEATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQ-  412 (512)
Q Consensus       336 ~~~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~-  412 (512)
                      ++..+...++.|.+.+.||.|.+|.||+++. ++++.+|||++..... ..++...|.++++.. .|||++.++|++.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3444445567788899999999999999984 6788899998865432 346677888888877 69999999999975 


Q ss_pred             ----CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          413 ----ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       413 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                          ++.+|||||||.+|+..+++.... ...+.|..+.-|++.++.||.+||..   .++|||||-.||||+.++.+||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence                477999999999999999986644 67799999999999999999999987   4999999999999999999999


Q ss_pred             eccCcccccCCCCCCcCccccccC
Q 043262          489 SDFGMARIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       489 ~DFGla~~~~~~~~~~~~~~~~Gt  512 (512)
                      .|||++..+........|  .+||
T Consensus       165 vDFGvSaQldsT~grRnT--~iGt  186 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVGRRNT--FIGT  186 (953)
T ss_pred             eeeeeeeeeecccccccC--cCCC
Confidence            999999988766554444  4555

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.82  E-value=8.6e-20  Score=182.72  Aligned_cols=150  Identities=29%  Similarity=0.492  Sum_probs=128.1

Q ss_pred             HHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEe-CCeeE
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ-ENESL  417 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~  417 (512)
                      ..+++|...+.||+|+||.||++.. .++..||||++...  .....+.+..|++++..++||||+++++++.. .+..+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            3567899999999999999999985 47899999988542  22335678899999999999999999999876 45788


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +++||+ +++|..++..    ..+++.....++.|++.||.|||+.+   |+||||+|+|||+++++.+||+|||+++..
T Consensus        87 lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 5688888742    34788888899999999999999975   999999999999999999999999999865


Q ss_pred             CC
Q 043262          498 GG  499 (512)
Q Consensus       498 ~~  499 (512)
                      ..
T Consensus       159 ~~  160 (328)
T cd07856         159 DP  160 (328)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.82  E-value=2.1e-19  Score=174.57  Aligned_cols=148  Identities=24%  Similarity=0.315  Sum_probs=120.3

Q ss_pred             HHhcCCcccccc--ccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeE
Q 043262          342 EATQHFSDENKL--GEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       342 ~~~~~~~~~~~l--g~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  417 (512)
                      ...++|...+.+  |+|+||.||+++. .++..+++|.+........     |+.....+ +||||+++++.+...+..+
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            334555555555  9999999999986 4678899998864322111     22222212 7999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-ceEEeccCcccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARI  496 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DFGla~~  496 (512)
                      +||||+++++|.+++...   ..+++.....++.||++||.|||+.+   ++||||||+||+++.++ .+||+|||+++.
T Consensus        86 iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~  159 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI  159 (267)
T ss_pred             EEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence            999999999999998543   36999999999999999999999975   99999999999999998 999999999987


Q ss_pred             cCCC
Q 043262          497 FGGN  500 (512)
Q Consensus       497 ~~~~  500 (512)
                      ....
T Consensus       160 ~~~~  163 (267)
T PHA03390        160 IGTP  163 (267)
T ss_pred             cCCC
Confidence            7544

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.82  E-value=6.3e-20  Score=180.05  Aligned_cols=151  Identities=28%  Similarity=0.414  Sum_probs=124.6

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +|...++||+|+||.||++.. .++..+|+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            455567899999999999986 458899999987433 334567899999999996 99999999999999999999999


Q ss_pred             cCCCChhHHhhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFD--STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +.. +|.++...  ......+++.....++.|++.||+|||+..  +++||||||+||++++++.+||+|||+++.+..
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 55443321  122356899999999999999999999752  599999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=9.7e-22  Score=177.31  Aligned_cols=151  Identities=29%  Similarity=0.586  Sum_probs=122.6

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeC--------C
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--------N  414 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--------~  414 (512)
                      .|....+||+|.||+||+++.. .|+.||+|++.-..  ..--....+|++++..++|+|++.++..|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            3445678999999999999864 57788988774322  22234568899999999999999999988532        3


Q ss_pred             eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                      ..+|||++++. +|.-+|.+  ....++..++.+++.+++.||.|+|..   .|+|||+||.|+||+.++.+||+|||++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence            47999999976 66666643  335688889999999999999999986   5999999999999999999999999999


Q ss_pred             cccCCCCC
Q 043262          495 RIFGGNQS  502 (512)
Q Consensus       495 ~~~~~~~~  502 (512)
                      |.+.....
T Consensus       172 r~fs~~~n  179 (376)
T KOG0669|consen  172 RAFSTSKN  179 (376)
T ss_pred             cceecccc
Confidence            98865543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.2e-21  Score=178.46  Aligned_cols=152  Identities=28%  Similarity=0.460  Sum_probs=125.7

Q ss_pred             ccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC-----eeEEE
Q 043262          348 SDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN-----ESLLI  419 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lv  419 (512)
                      +..+.||-|.||.||..+. ++|+.|+.|++...  +-...+.+.+|++++..++|.|++..++.....+     ++|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3457799999999999985 68999999998643  2234578899999999999999999998776543     46788


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      .|.|. .+|.+++-   ....|+.....-+..||++||+|||+.+   |.||||||.|.|++.+...||+||||+|....
T Consensus       136 TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            88884 47877773   3456777788889999999999999974   99999999999999999999999999999887


Q ss_pred             CCCCcCc
Q 043262          500 NQSEANT  506 (512)
Q Consensus       500 ~~~~~~~  506 (512)
                      ++....|
T Consensus       209 d~~~hMT  215 (449)
T KOG0664|consen  209 RDRLNMT  215 (449)
T ss_pred             hhhhhhH
Confidence            7654433

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.82  E-value=1e-19  Score=177.68  Aligned_cols=147  Identities=34%  Similarity=0.551  Sum_probs=128.8

Q ss_pred             CccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          347 FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      |+..+.||+|.+|.||+|+.. +++.+++|.+....  ....+.+..|+.++..++|+||+++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            345678999999999999975 58999999997643  333567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      + ++|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            8 58999986532  45899999999999999999999975   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.82  E-value=1.5e-19  Score=179.26  Aligned_cols=148  Identities=34%  Similarity=0.556  Sum_probs=126.7

Q ss_pred             CCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .|...+.||+|+||.||+|+.. ++..+++|.+...   .....+++.+|+++++.++|+|++++++++...+..++|+|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999964 5788999988642   22334578899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |+. |+|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.+||+|||++.....
T Consensus        96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            996 6787776432  235889999999999999999999874   99999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.82  E-value=1.1e-19  Score=181.87  Aligned_cols=142  Identities=23%  Similarity=0.313  Sum_probs=122.5

Q ss_pred             cccccc--cceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEG--GFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G--~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ..||+|  +||+||+++. .+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  8999999986 478999999986432  23356789999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|++||+.+..
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            99999886532 235889999999999999999999874   99999999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.82  E-value=2.8e-21  Score=175.68  Aligned_cols=150  Identities=30%  Similarity=0.431  Sum_probs=124.2

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHh-cCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIA-KLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++++...||.|.||.|+|=.+ +.|+.+|||+++... ..+.++++.|.+... .-+.||||+++|.+...+..|+.||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            445567899999999999876 569999999998554 466778888987655 45799999999999999999999999


Q ss_pred             cCCCChhHHhhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFD--STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |. .||+.+-..  ..+...+++...-+|...+..||.||-.+  ++|||||+||+||||+..|.+||+|||++..+-
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            94 466655321  12345688888889999999999999876  489999999999999999999999999987654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.81  E-value=1.9e-19  Score=172.57  Aligned_cols=141  Identities=30%  Similarity=0.429  Sum_probs=125.6

Q ss_pred             cccccceeEEEEEeC-CCCEEEEEEcccCCc---ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          353 LGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       353 lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      ||+|+||.||++... ++..+++|.+.....   .....+..|+.+++.++||||+++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999875 588999999875432   2456789999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          429 NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      .+++...   ..+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            9998543   3589999999999999999999986   499999999999999999999999999987654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.81  E-value=3.6e-19  Score=177.10  Aligned_cols=145  Identities=32%  Similarity=0.525  Sum_probs=124.9

Q ss_pred             CccccccccccceeEEEEEe-CCCCEEEEEEcccCCc---ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      |...++||+|+||.||+|+. .++..|++|.+.....   ...+.+.+|++++..++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55567899999999999986 4688999999864322   3345788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +. |+|.+++...  ..++++..+..++.||+.+|.|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus       103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            96 5777776432  345899999999999999999999875   999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.81  E-value=8.2e-21  Score=204.52  Aligned_cols=151  Identities=32%  Similarity=0.468  Sum_probs=131.4

Q ss_pred             hcCCccccccccccceeEEEEE-eCCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~-~~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      +-++....+||.|.||.||.+. .++|...|+|-++-.  .........+|+.++..++|||+|+.+|+-.+++..++.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            4566777899999999999998 467888999987633  3445667889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |||++|+|.+.+...+   -+++.....+-.|++.|+.|||+++   ||||||||.||+|+.++.+|++|||-|+.+..+
T Consensus      1314 EyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            9999999999985432   3566666778899999999999986   999999999999999999999999999988665

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.81  E-value=1.3e-19  Score=177.18  Aligned_cols=149  Identities=30%  Similarity=0.518  Sum_probs=128.7

Q ss_pred             CccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          347 FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      |...+.||+|++|.||++... ++..+++|.+.....  .....+.+|+.++++++|+||+++++++...+..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            345578999999999999874 688999999865432  24567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      ++ +|.+++....  ..+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||.+..+....
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            75 8888775422  46899999999999999999999975   9999999999999999999999999998776543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.81  E-value=2.5e-19  Score=175.46  Aligned_cols=149  Identities=30%  Similarity=0.539  Sum_probs=123.8

Q ss_pred             CccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--ccHHHHHHHHHHHhcC---CCCccccceeeEEeCCe-----
Q 043262          347 FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKL---QHKNLVRLLGCCLQENE-----  415 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~-----  415 (512)
                      |+..+.||+|+||.||+++.. ++..+|+|+++....  .....+.+|+.++.++   +|+||+++++.+...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            455678999999999999986 489999999964322  2234566787776655   69999999999998876     


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .+++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            899999997 48888885432 235899999999999999999999974   9999999999999999999999999998


Q ss_pred             ccCCC
Q 043262          496 IFGGN  500 (512)
Q Consensus       496 ~~~~~  500 (512)
                      .+...
T Consensus       156 ~~~~~  160 (287)
T cd07838         156 IYSFE  160 (287)
T ss_pred             eccCC
Confidence            87543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.81  E-value=1.2e-19  Score=173.23  Aligned_cols=157  Identities=22%  Similarity=0.361  Sum_probs=134.8

Q ss_pred             HHHHHhcCCccccccccccceeEEEEEeC------CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEE
Q 043262          339 LAVEATQHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL  411 (512)
Q Consensus       339 ~~~~~~~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  411 (512)
                      ++.....++....++-+|.||.||+|.|.      +.++|-||.++.. +..+...+..|.-++..+.|||+..+.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            33344566777888999999999999764      3456788988754 4556778999999999999999999999998


Q ss_pred             eC-CeeEEEEEecCCCChhHHhh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc
Q 043262          412 QE-NESLLIYEYMPNKSLNVFLF-----DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN  485 (512)
Q Consensus       412 ~~-~~~~lv~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~  485 (512)
                      +. +..+++|.++.-|+|..||.     +......+...+...++.|++.||+|||.++   +||.||.++|++||+..+
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence            76 45788999999999999998     5556677889999999999999999999986   999999999999999999


Q ss_pred             eEEeccCcccccC
Q 043262          486 PKISDFGMARIFG  498 (512)
Q Consensus       486 ~kl~DFGla~~~~  498 (512)
                      +||+|=.|+|.+-
T Consensus       435 VkltDsaLSRDLF  447 (563)
T KOG1024|consen  435 VKLTDSALSRDLF  447 (563)
T ss_pred             EEeccchhccccC
Confidence            9999999999763

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=2.3e-20  Score=187.36  Aligned_cols=148  Identities=23%  Similarity=0.374  Sum_probs=127.9

Q ss_pred             hcCCccccccccccceeEEEEEeCC-CCEEEEEEcccCCc---ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ...|...+.||-|+||+|.++...| ...+|.|.|++.+-   ........|-++|++.+.+.||+|+-.+.+.+.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            4567778899999999999998644 55679999976542   3345678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |||+++|++..+|.+   -.-+++.....++.++..|+++.|.-   ++|||||||.|||||.++++||.||||+.-+
T Consensus       708 MdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccc
Confidence            999999999999854   33477788888899999999999975   5999999999999999999999999998644

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.81  E-value=1.3e-19  Score=182.59  Aligned_cols=146  Identities=31%  Similarity=0.495  Sum_probs=125.8

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeC----------
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE----------  413 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~----------  413 (512)
                      .+|...+.||+|+||.||+|.. .++..|++|.+........+.+.+|++++..++||||+++++.+...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            5788889999999999999986 46889999999766656677899999999999999999999776543          


Q ss_pred             ----CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec-CCCceEE
Q 043262          414 ----NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD-HEMNPKI  488 (512)
Q Consensus       414 ----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~-~~~~~kl  488 (512)
                          ...++|+||++ ++|.+++..    ..+++.....++.||+.||.|||+.+   |+||||||+||+++ ++..+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 588887742    35889999999999999999999875   99999999999997 4567999


Q ss_pred             eccCcccccC
Q 043262          489 SDFGMARIFG  498 (512)
Q Consensus       489 ~DFGla~~~~  498 (512)
                      +|||+++.+.
T Consensus       157 ~dfg~~~~~~  166 (342)
T cd07854         157 GDFGLARIVD  166 (342)
T ss_pred             CCcccceecC
Confidence            9999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.81  E-value=4.7e-20  Score=183.68  Aligned_cols=150  Identities=25%  Similarity=0.377  Sum_probs=127.2

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--------ccHHHHHHHHHHHhcCC---CCccccceeeEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--------QGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLQ  412 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--------~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~  412 (512)
                      ..|...+.||+|+||.|+.+.++ +..+|+||.+.+..-        ..+-..-.||.+|..++   |+||++++.++.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            34777889999999999999974 567899998865321        11223567999999997   9999999999999


Q ss_pred             CCeeEEEEEec-CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEecc
Q 043262          413 ENESLLIYEYM-PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  491 (512)
Q Consensus       413 ~~~~~lv~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DF  491 (512)
                      ++..+|++|-. ++-+|.+++..   ...++++....|++||+.|+++||+++   |||||||-+||.++.++-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            99999999986 45688888843   345899999999999999999999986   999999999999999999999999


Q ss_pred             CcccccCCC
Q 043262          492 GMARIFGGN  500 (512)
Q Consensus       492 Gla~~~~~~  500 (512)
                      |.+.....+
T Consensus       715 gsaa~~ksg  723 (772)
T KOG1152|consen  715 GSAAYTKSG  723 (772)
T ss_pred             cchhhhcCC
Confidence            999876544

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.81  E-value=1.5e-19  Score=179.23  Aligned_cols=150  Identities=32%  Similarity=0.539  Sum_probs=125.8

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeCC------
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN------  414 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------  414 (512)
                      .++|...++||+|+||.||+++.. +++.++||++.....  .....+.+|++++..++||||+++++.+....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467888899999999999999864 688999999864322  22346788999999999999999999876543      


Q ss_pred             --eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccC
Q 043262          415 --ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  492 (512)
Q Consensus       415 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFG  492 (512)
                        ..++|+||+.. +|...+..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              35999999875 67666643  2346899999999999999999999975   9999999999999999999999999


Q ss_pred             cccccCC
Q 043262          493 MARIFGG  499 (512)
Q Consensus       493 la~~~~~  499 (512)
                      +++....
T Consensus       161 ~~~~~~~  167 (311)
T cd07866         161 LARPYDG  167 (311)
T ss_pred             cchhccC
Confidence            9987644

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.81  E-value=3.3e-19  Score=175.72  Aligned_cols=148  Identities=21%  Similarity=0.294  Sum_probs=109.9

Q ss_pred             cCCccccccccccceeEEEEEeCCC----CEEEEEEcccCCcccH-----------HHHHHHHHHHhcCCCCccccceee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADG----KEIAVKRLSRTSGQGL-----------QEFKNEVTLIAKLQHKNLVRLLGC  409 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g----~~vaVK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l~g~  409 (512)
                      ++|...++||+|+||.||+|...+.    ..+++|..........           .....+...+..++|+||+++++.
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5788889999999999999997543    4556665432221110           112233445667899999999997


Q ss_pred             EEeCC----eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc
Q 043262          410 CLQEN----ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN  485 (512)
Q Consensus       410 ~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~  485 (512)
                      +....    ..++++|++.. ++.+.+..   ....++..+..|+.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence            76543    34677777643 55555532   123578888999999999999999874   999999999999999999


Q ss_pred             eEEeccCcccccCC
Q 043262          486 PKISDFGMARIFGG  499 (512)
Q Consensus       486 ~kl~DFGla~~~~~  499 (512)
                      +||+|||+++.+..
T Consensus       165 ~~l~DFGla~~~~~  178 (294)
T PHA02882        165 GYIIDYGIASHFII  178 (294)
T ss_pred             EEEEEcCCceeecc
Confidence            99999999988753

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.81  E-value=3.6e-19  Score=179.29  Aligned_cols=146  Identities=29%  Similarity=0.484  Sum_probs=124.0

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC------
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN------  414 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------  414 (512)
                      .++|...+.||+|+||.||+|+. .++..||||++...  .......+.+|+.++..++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            36788889999999999999986 46899999998643  2223456889999999999999999999987543      


Q ss_pred             eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                      ..++|+||+.. +|..++.     ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999964 6766551     24889999999999999999999975   999999999999999999999999999


Q ss_pred             cccC
Q 043262          495 RIFG  498 (512)
Q Consensus       495 ~~~~  498 (512)
                      +...
T Consensus       165 ~~~~  168 (342)
T cd07879         165 RHAD  168 (342)
T ss_pred             cCCC
Confidence            8754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.80  E-value=2.7e-19  Score=172.72  Aligned_cols=150  Identities=28%  Similarity=0.442  Sum_probs=123.3

Q ss_pred             CCccccccccccceeEEEEEeCC-CCEEEEEEcccC-----CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRT-----SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      +|...++||+|+||.||++.... +..+++|.++..     .......+..|+.++..++||||+++++.+.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            36667899999999999998643 444555555432     222344677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          420 YEYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++ ..+||+|||+++.+.
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642 23356899999999999999999999874   999999999999976 469999999998764


Q ss_pred             C
Q 043262          499 G  499 (512)
Q Consensus       499 ~  499 (512)
                      .
T Consensus       157 ~  157 (260)
T cd08222         157 G  157 (260)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.80  E-value=5.4e-20  Score=167.99  Aligned_cols=152  Identities=26%  Similarity=0.414  Sum_probs=126.1

Q ss_pred             ccccccccccceeEEEEEe-CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEEecC
Q 043262          348 SDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      .....||.|.-|.||+.+. +.|..+|||.+.+. .+...+++...++++..-+ .|.||+.+|++..+...++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            3456799999999999986 45889999999765 4455677888888776664 8999999999999999999999984


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCCCc
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA  504 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~  504 (512)
                      . -++.+|..  ...++++..+-++...+..||.||.++.  .|+|||+||+|||+|+.+++|++|||++.++-+..-+.
T Consensus       175 ~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht  249 (391)
T KOG0983|consen  175 T-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT  249 (391)
T ss_pred             H-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence            3 45555543  2345888888899999999999999876  79999999999999999999999999998886655443

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.80  E-value=2.4e-19  Score=180.64  Aligned_cols=150  Identities=29%  Similarity=0.478  Sum_probs=128.5

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCe----
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE----  415 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----  415 (512)
                      ..++|...+.||+|++|.||+++.. ++..||||++...  .....+.+.+|+.+++.++||||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3567888899999999999999974 5789999998643  22334667889999999999999999998876655    


Q ss_pred             --eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          416 --SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       416 --~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                        .++|+||+ +++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 5689888843    35899999999999999999999874   99999999999999999999999999


Q ss_pred             ccccCCC
Q 043262          494 ARIFGGN  500 (512)
Q Consensus       494 a~~~~~~  500 (512)
                      ++....+
T Consensus       165 ~~~~~~~  171 (343)
T cd07851         165 ARHTDDE  171 (343)
T ss_pred             ccccccc
Confidence            9876543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.79  E-value=3e-19  Score=185.20  Aligned_cols=159  Identities=33%  Similarity=0.471  Sum_probs=124.0

Q ss_pred             CCcccccccccccee-EEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEEec
Q 043262          346 HFSDENKLGEGGFGP-VYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~-Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      -|...+.+|.|.-|+ ||+|.+ +|++||||++-...   ..-..+|+..+..- +|||||++++.-.++...|+..|.|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            356677899999876 899999 58899999986432   23467899998887 5999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-----CCceEEeccCccccc
Q 043262          424 PNKSLNVFLFDSTRSV-QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-----EMNPKISDFGMARIF  497 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-----~~~~kl~DFGla~~~  497 (512)
                      . -+|.+++....... .......+.+..|+++||++||+-   +||||||||.||||+.     ...++|+|||+++.+
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            5 59999996531111 111134567889999999999995   5999999999999976     257999999999999


Q ss_pred             CCCCCC-cCccccccC
Q 043262          498 GGNQSE-ANTKRIVGT  512 (512)
Q Consensus       498 ~~~~~~-~~~~~~~Gt  512 (512)
                      ..+.+. .......||
T Consensus       662 ~~~~sS~~r~s~~sGt  677 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGT  677 (903)
T ss_pred             CCCcchhhcccCCCCc
Confidence            877643 223444554

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.79  E-value=6.7e-19  Score=167.84  Aligned_cols=133  Identities=20%  Similarity=0.188  Sum_probs=115.0

Q ss_pred             ccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCChhHHhhc
Q 043262          356 GGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFD  434 (512)
Q Consensus       356 G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~  434 (512)
                      |.||.||+++. .+++.+|+|++...+     .+..|...+....||||+++++++...+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            78999999986 568899999997543     234455556666799999999999999999999999999999999854


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          435 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       435 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      .   ..+++.....++.|++.||.|||+.+   |+||||||+||++++++.+|++|||+++.+..
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~  137 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED  137 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence            2   34899999999999999999999875   99999999999999999999999998876543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.2e-18  Score=161.26  Aligned_cols=140  Identities=21%  Similarity=0.361  Sum_probs=108.0

Q ss_pred             CccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-----CCCccccceeeEEeCC---e-eE
Q 043262          347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-----QHKNLVRLLGCCLQEN---E-SL  417 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~g~~~~~~---~-~~  417 (512)
                      +...++||+|+||.||. ...++.. +||++........+.+.+|+.++..+     +||||++++|++..+.   . ..
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567899999999996 3334444 78988765444567899999999999     5799999999998874   3 33


Q ss_pred             EEEEe--cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCcccCCCCCCCeeecC----CCceEEec
Q 043262          418 LIYEY--MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL-LYLHEDSRLKIIHRDLKTSNVLLDH----EMNPKISD  490 (512)
Q Consensus       418 lv~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~dlk~~NiLl~~----~~~~kl~D  490 (512)
                      +|+||  ++.|+|.+++.+.    .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  6689999999542    25554  35677888888 8999985   999999999999974    34799999


Q ss_pred             cCccccc
Q 043262          491 FGMARIF  497 (512)
Q Consensus       491 FGla~~~  497 (512)
                      |+-++.+
T Consensus       153 g~G~~~~  159 (210)
T PRK10345        153 NIGESTF  159 (210)
T ss_pred             CCCCcce
Confidence            5555444

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.78  E-value=2.3e-18  Score=161.86  Aligned_cols=149  Identities=34%  Similarity=0.519  Sum_probs=132.0

Q ss_pred             CccccccccccceeEEEEEeCC-CCEEEEEEcccCCcc-cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      |...+.||+|++|.||++...+ +..+++|.+...... ..+.+.+|++.+.+++|+|++++++.+...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            3456789999999999999865 889999999865544 57789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++|.+++.....  .+++.....++.+++.+|.|||..   +++|+||+|+||+++.+..++|+|||++..+...
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999999854321  178999999999999999999987   4999999999999999999999999999987654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=7.3e-19  Score=174.67  Aligned_cols=161  Identities=25%  Similarity=0.409  Sum_probs=136.4

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcc--cCCcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~--~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ..|+..++||+||-+.||++...+.+.+|+|++.  ..+.+....|.+|+.+|.+|+ |.+||.|++|-..++.+|||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            4577789999999999999999888999999875  456667889999999999996 9999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      |- ..+|..+|.... .....| .+..+-.||+.++.++|+++   |||.||||.|+|+-+ |.+||+|||+|..+..+.
T Consensus       441 ~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             cc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence            85 568999996532 223445 56678899999999999986   999999999999966 489999999999998887


Q ss_pred             CCcCccccccC
Q 043262          502 SEANTKRIVGT  512 (512)
Q Consensus       502 ~~~~~~~~~Gt  512 (512)
                      +...-...+||
T Consensus       514 TsI~kdsQvGT  524 (677)
T KOG0596|consen  514 TSIVKDSQVGT  524 (677)
T ss_pred             cceeeccccCc
Confidence            66555556776

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.78  E-value=1.1e-18  Score=185.75  Aligned_cols=150  Identities=25%  Similarity=0.340  Sum_probs=106.7

Q ss_pred             HhcCCccccccccccceeEEEEEeC-C----CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceee------EE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-D----GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC------CL  411 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~----g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~------~~  411 (512)
                      ..++|...++||+|+||.||+|++. +    +..||||++......  +.+..|  .+....+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            3467888999999999999999974 4    689999988643321  111221  1222223333332222      24


Q ss_pred             eCCeeEEEEEecCCCChhHHhhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCC
Q 043262          412 QENESLLIYEYMPNKSLNVFLFDSTRS-----------------VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK  474 (512)
Q Consensus       412 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk  474 (512)
                      ..++.++|+||+.+++|.+++......                 ....+..+..++.||+.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            566789999999999999988643210                 01122345679999999999999874   9999999


Q ss_pred             CCCeeecC-CCceEEeccCcccccCC
Q 043262          475 TSNVLLDH-EMNPKISDFGMARIFGG  499 (512)
Q Consensus       475 ~~NiLl~~-~~~~kl~DFGla~~~~~  499 (512)
                      |+|||+++ ++.+||+|||+++.+..
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~  308 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRV  308 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccc
Confidence            99999986 57999999999987643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.76  E-value=1.3e-17  Score=154.23  Aligned_cols=143  Identities=38%  Similarity=0.649  Sum_probs=127.2

Q ss_pred             cccccceeEEEEEeCC-CCEEEEEEcccCCcc-cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCChhH
Q 043262          353 LGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNV  430 (512)
Q Consensus       353 lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~  430 (512)
                      ||+|.+|.||++...+ ++++++|.+...... ..+.+.+|+..+..++|++|+++++++......++++||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999854 899999999765432 35689999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-CCceEEeccCcccccCCC
Q 043262          431 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGGN  500 (512)
Q Consensus       431 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DFGla~~~~~~  500 (512)
                      ++....  ..+++..+..++.+++++|.+||+.+   ++|+||+|.||+++. +..++|+|||++......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            985432  35899999999999999999999984   999999999999999 899999999999877544

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.76  E-value=6.7e-19  Score=162.83  Aligned_cols=147  Identities=26%  Similarity=0.317  Sum_probs=120.0

Q ss_pred             hcCCcc-ccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEe----CCee
Q 043262          344 TQHFSD-ENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQ----ENES  416 (512)
Q Consensus       344 ~~~~~~-~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~  416 (512)
                      +++|+. .++||-|-.|+|..+.. +.++..|+|.|.+..     ..++|+++--.. .|||||.+++++..    ..-+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            344433 36799999999999986 568899999987543     346778765544 69999999999864    3457


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC---CCceEEeccCc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGM  493 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~---~~~~kl~DFGl  493 (512)
                      ++|||.|++|.|.+.+.+ .....+++.+...|+.||+.|+.|||+.   +|.||||||+|+|...   +-.+||+|||+
T Consensus       135 LiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             EeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence            899999999999998855 3456799999999999999999999986   6999999999999964   45699999999


Q ss_pred             ccccCC
Q 043262          494 ARIFGG  499 (512)
Q Consensus       494 a~~~~~  499 (512)
                      |+.-..
T Consensus       211 AK~t~~  216 (400)
T KOG0604|consen  211 AKETQE  216 (400)
T ss_pred             ccccCC
Confidence            997653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.76  E-value=5.7e-19  Score=157.43  Aligned_cols=147  Identities=24%  Similarity=0.472  Sum_probs=125.6

Q ss_pred             hcCCccccccccccceeEEEEE-eCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceeeEEeCC--eeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQEN--ESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~~lv  419 (512)
                      .++|+..+++|+|.+++|+.|. ..+.+.++||.++...   .+.+.+|+.+|..|. ||||++|++...+..  ...|+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            3567888999999999999998 4677889999997543   356889999999998 999999999988654  46899


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC-CceEEeccCcccccC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFG  498 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~-~~~kl~DFGla~~~~  498 (512)
                      +||+.+.+...+-      ..|+...+...+.+++.||.|+|+.+   |.|||+||.|++||.. -..+|+|.|||-.+-
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998886654      24777888889999999999999975   9999999999999975 469999999999987


Q ss_pred             CCCC
Q 043262          499 GNQS  502 (512)
Q Consensus       499 ~~~~  502 (512)
                      ++..
T Consensus       185 p~~e  188 (338)
T KOG0668|consen  185 PGKE  188 (338)
T ss_pred             CCce
Confidence            7654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.4e-17  Score=155.68  Aligned_cols=136  Identities=19%  Similarity=0.295  Sum_probs=114.9

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCcc--------cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ--------GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +.||+|++|.||+|.. +|..|+||........        ....+.+|+.++..++|++|.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999988 6778999976532211        124578899999999999998888888888889999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +++++|.+++...      .+ .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||+++...
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence            9999999988431      22 78889999999999999975   99999999999999 7889999999998643

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=2.1e-19  Score=176.50  Aligned_cols=158  Identities=27%  Similarity=0.350  Sum_probs=134.9

Q ss_pred             CCccccccccccceeEEEEEeCCCC-EEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLADGK-EIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~g~-~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++.....||-|+||.|=+...+... ..|+|.+++.   +....+....|-.+|...+.|.||+|+-.+.+.+..||+||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3444567999999999988875433 3788877653   33445678889999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      -|-+|.|...|++   ...++..+...++..+.+|++|||.++   ||.|||||+|++||.++-+||.|||+|+.++.++
T Consensus       501 aClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  501 ACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            9999999999954   456888888899999999999999985   9999999999999999999999999999998877


Q ss_pred             CCcCccccccC
Q 043262          502 SEANTKRIVGT  512 (512)
Q Consensus       502 ~~~~~~~~~Gt  512 (512)
                         .|-.++||
T Consensus       575 ---KTwTFcGT  582 (732)
T KOG0614|consen  575 ---KTWTFCGT  582 (732)
T ss_pred             ---ceeeecCC
Confidence               44456776

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.75  E-value=1.3e-17  Score=158.19  Aligned_cols=138  Identities=33%  Similarity=0.501  Sum_probs=123.9

Q ss_pred             cceeEEEEEeC-CCCEEEEEEcccCCccc-HHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCChhHHhhc
Q 043262          357 GFGPVYKGKLA-DGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFD  434 (512)
Q Consensus       357 ~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~  434 (512)
                      +||.||+++.. +++.+++|.+....... .+.+.+|++.+.+++|+||+++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999986 48999999997655544 78999999999999999999999999999999999999999999999854


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          435 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       435 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ..   .+++..++.++.+++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  140 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG  140 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence            32   2889999999999999999999974   999999999999999999999999999987653

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.75  E-value=4.2e-19  Score=179.70  Aligned_cols=151  Identities=26%  Similarity=0.453  Sum_probs=135.5

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .++|.....+|.|.||.|||++. ..++..|||.++........-.+.|+-+++.-+||||+.++|.+...+..|++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            35677778999999999999995 56888999999877777778888999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +.+|+|.+.-+-   ..+|++.++..+++...+||+|||+.+   -+|||||-.|||+++.+.+|++|||.+..++.-
T Consensus        94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence            999999987643   356889999999999999999999986   799999999999999999999999999877643

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=1.3e-17  Score=158.07  Aligned_cols=146  Identities=16%  Similarity=0.191  Sum_probs=111.9

Q ss_pred             CCccccccccccceeEEEEE--eCCCCEEEEEEcccCCcc------------------------cHHHHHHHHHHHhcCC
Q 043262          346 HFSDENKLGEGGFGPVYKGK--LADGKEIAVKRLSRTSGQ------------------------GLQEFKNEVTLIAKLQ  399 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~--~~~g~~vaVK~l~~~~~~------------------------~~~~~~~E~~~l~~l~  399 (512)
                      .|...+.||+|+||.||+|.  ..+|+.||||.++.....                        ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46677899999999999998  578999999998643210                        0123568999999997


Q ss_pred             CCc--cccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCC
Q 043262          400 HKN--LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN  477 (512)
Q Consensus       400 H~n--Iv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N  477 (512)
                      +..  +.++++.    ...++||||+++++|..+...   ...+.......++.||+.+|.+||+.+  +|+||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence            643  3333332    235899999999888765422   223556667889999999999999874  39999999999


Q ss_pred             eeecCCCceEEeccCcccccCCCC
Q 043262          478 VLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       478 iLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      |+++ ++.++|+|||+++..+...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~~~~  202 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELDHPM  202 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccCCcc
Confidence            9999 8899999999999765543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=1e-18  Score=167.75  Aligned_cols=160  Identities=29%  Similarity=0.340  Sum_probs=128.7

Q ss_pred             cCCccccccccccceeEEEEEeCC-CCEEEEEEcccCCcc---cHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQ---GLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~---~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .+|....+||+|+||.|.++.-+. .+.+|||++++....   +.+--+.|-++|+.. +-|.++.|+..+..-+.+++|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            467778899999999999998654 456899999765322   233345666677666 567899999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+.+|+|...+..   -..+.++....++.+||-||-|||+++   |+.||||..|||||.++++||+||||++.---
T Consensus       429 MEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence            999999999888743   345788889999999999999999986   99999999999999999999999999985432


Q ss_pred             CCCCcCccccccC
Q 043262          500 NQSEANTKRIVGT  512 (512)
Q Consensus       500 ~~~~~~~~~~~Gt  512 (512)
                      +..  .|+.+.||
T Consensus       503 ~~~--TTkTFCGT  513 (683)
T KOG0696|consen  503 DGV--TTKTFCGT  513 (683)
T ss_pred             CCc--ceeeecCC
Confidence            221  24446665

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1.5e-17  Score=153.90  Aligned_cols=141  Identities=19%  Similarity=0.200  Sum_probs=110.5

Q ss_pred             CCccccccccccceeEEEEEeCCCCEEEEEEcccCCcc----------------------cHHHHHHHHHHHhcCCCCc-
Q 043262          346 HFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ----------------------GLQEFKNEVTLIAKLQHKN-  402 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~----------------------~~~~~~~E~~~l~~l~H~n-  402 (512)
                      .|...+.||+|+||.||++...+|+.||||++......                      ....+..|..++..+.|++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            36667899999999999999888999999987542210                      1123677888898888874 


Q ss_pred             -cccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec
Q 043262          403 -LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD  481 (512)
Q Consensus       403 -Iv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~  481 (512)
                       +...++    ....++||||+++++|......         .....++.+++.++.++|+.+   |+||||||+||+++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~  159 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVD  159 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEc
Confidence             334333    3456899999999998765420         234578899999999999974   99999999999999


Q ss_pred             CCCceEEeccCcccccCCCCC
Q 043262          482 HEMNPKISDFGMARIFGGNQS  502 (512)
Q Consensus       482 ~~~~~kl~DFGla~~~~~~~~  502 (512)
                      +++.++|+|||+++.+..+..
T Consensus       160 ~~~~~~liDfg~~~~~~~~~~  180 (198)
T cd05144         160 DDEKIYIIDWPQMVSTDHPNA  180 (198)
T ss_pred             CCCcEEEEECCccccCCCccH
Confidence            999999999999988776543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=1.8e-17  Score=176.43  Aligned_cols=140  Identities=18%  Similarity=0.294  Sum_probs=112.8

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccC-C------cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRT-S------GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~-~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ..|...++||+|+||.||+|.+.+...++.+++.+. .      ....+++.+|++++..++|++++....++...+..+
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            344567899999999999999865443332222221 1      112356889999999999999999888888888889


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +||||+++++|.+++.           ....++.+++++|.|||+.+   ++||||||+|||+ +++.++|+|||+++..
T Consensus       413 lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999999998873           35678999999999999975   9999999999999 5779999999999875


Q ss_pred             CC
Q 043262          498 GG  499 (512)
Q Consensus       498 ~~  499 (512)
                      ..
T Consensus       478 ~~  479 (535)
T PRK09605        478 DL  479 (535)
T ss_pred             Cc
Confidence            43

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.73  E-value=2e-17  Score=148.74  Aligned_cols=150  Identities=22%  Similarity=0.395  Sum_probs=123.9

Q ss_pred             cCCccccccccccceeEEEEE-eCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCC-CccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH-KNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ..|...++||.|+||.+|.|. ..+|.+||||.-+.....  -.+..|..+...|+| ..|..+..+..+.+.-.||||.
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL   92 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence            567888999999999999998 578999999986543322  346778889999975 5677788888888899999998


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC---CceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~---~~~kl~DFGla~~~~~  499 (512)
                      + +-+|+++..-..+  .++.++.+-++-|+..-++|+|.++   +|||||||+|+|..-+   ..+.++|||||+.+-+
T Consensus        93 L-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   93 L-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             c-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            7 6788887754333  4788899999999999999999986   9999999999999755   3588999999999866


Q ss_pred             CCC
Q 043262          500 NQS  502 (512)
Q Consensus       500 ~~~  502 (512)
                      ..+
T Consensus       167 ~~t  169 (341)
T KOG1163|consen  167 IRT  169 (341)
T ss_pred             ccc
Confidence            544

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=3.4e-17  Score=151.72  Aligned_cols=133  Identities=20%  Similarity=0.338  Sum_probs=109.5

Q ss_pred             ccccccceeEEEEEeCCCCEEEEEEcccCCc--------ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSG--------QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .||+|+||.||+|.+ ++..|++|.......        ....++.+|++++..++|+++.....+....+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 578899998653221        11356788999999999988777777777777789999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++++|.+++....       .   .++.+++.+|.+||+.+   ++|+|++|+||+++ ++.+++.|||+++....
T Consensus        80 ~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~  141 (199)
T TIGR03724        80 EGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE  141 (199)
T ss_pred             CCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence            9999998874311       0   78999999999999975   99999999999999 78999999999987543

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.73  E-value=2.8e-17  Score=152.58  Aligned_cols=141  Identities=13%  Similarity=0.144  Sum_probs=115.0

Q ss_pred             HhcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHH---H------HHHHHHHHhcCCCCccccceeeEEeC
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQ---E------FKNEVTLIAKLQHKNLVRLLGCCLQE  413 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~---~------~~~E~~~l~~l~H~nIv~l~g~~~~~  413 (512)
                      ..++|...++||.|+||.||.... ++..+|||.++........   .      +.+|+..+.+++|++|..+..+....
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            467899999999999999999766 5778999999754332222   2      67899999999999999999886643


Q ss_pred             --------CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc
Q 043262          414 --------NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN  485 (512)
Q Consensus       414 --------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~  485 (512)
                              +..+++|||+++.+|.++..       ++.    ....+++.+|..+|..+   ++||||||+||++++++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999987741       222    24568999999999985   99999999999999988 


Q ss_pred             eEEeccCcccccCC
Q 043262          486 PKISDFGMARIFGG  499 (512)
Q Consensus       486 ~kl~DFGla~~~~~  499 (512)
                      ++|+|||..+....
T Consensus       173 i~liDfg~~~~~~e  186 (232)
T PRK10359        173 LRIIDLSGKRCTAQ  186 (232)
T ss_pred             EEEEECCCcccccc
Confidence            99999999987643

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.3e-17  Score=152.29  Aligned_cols=148  Identities=20%  Similarity=0.402  Sum_probs=120.1

Q ss_pred             hcCCccccccccccceeEEEEEeCC-CCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeE-EeCCeeEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCC-LQENESLLIY  420 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~-~~~~~~~lv~  420 (512)
                      .+.|.+.+.||+|.||.+-+++++. ...+++|.+...- ...++|.+|...--.| .|.||+.-+.+. ...+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            3567888999999999999999854 6678888886532 3467899998876666 599999877654 4556778999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee--cCCCceEEeccCcccccC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL--DHEMNPKISDFGMARIFG  498 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl--~~~~~~kl~DFGla~~~~  498 (512)
                      ||++.|+|.+-+..    ..+.+....+++.|++.||.|+|++   ++||||||.+||||  .+..++||+|||+.+..+
T Consensus       102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999876633    3467777888999999999999998   59999999999999  345689999999998765


Q ss_pred             C
Q 043262          499 G  499 (512)
Q Consensus       499 ~  499 (512)
                      .
T Consensus       175 ~  175 (378)
T KOG1345|consen  175 T  175 (378)
T ss_pred             c
Confidence            3

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.2e-17  Score=156.40  Aligned_cols=160  Identities=28%  Similarity=0.380  Sum_probs=131.3

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|....+||+|+|.+|..+++ +..+.+|+|++++.   ......-.+.|-.++... +||.+|.|..++.....+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            5677889999999999999987 45678899988753   223344456666666665 799999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      .||+++|+|...+   .+...|+++....+...|..||.|||+.+   ||.||||..|+|||..+++||.|+||++.--.
T Consensus       330 ieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence            9999999997666   44556999999999999999999999986   99999999999999999999999999986432


Q ss_pred             CCCCcCccccccC
Q 043262          500 NQSEANTKRIVGT  512 (512)
Q Consensus       500 ~~~~~~~~~~~Gt  512 (512)
                      +..  .|+.+.||
T Consensus       404 ~gd--~tstfcgt  414 (593)
T KOG0695|consen  404 PGD--TTSTFCGT  414 (593)
T ss_pred             CCc--ccccccCC
Confidence            222  34446776

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=9.7e-17  Score=145.84  Aligned_cols=133  Identities=20%  Similarity=0.198  Sum_probs=105.5

Q ss_pred             cccccccccceeEEEEEeCCCCEEEEEEcccCCcc----cHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEEec
Q 043262          349 DENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ----GLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       349 ~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~----~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ....|++|+||+|+.+.- ++.+++.+.+.....-    ....|.+|+++|.+|+ |+++.+++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            456899999999996655 6778887777654321    1235889999999995 5789998886    4579999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCC-CCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDL-KTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dl-k~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      .+.+|...+..          ....++.|+..+|.++|..+   |+|||| ||.|||+++++.++|+|||++.....
T Consensus        81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            99888654310          11357789999999999985   999999 79999999999999999999986553

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.68  E-value=6.2e-17  Score=154.78  Aligned_cols=161  Identities=20%  Similarity=0.251  Sum_probs=131.2

Q ss_pred             hHHHHHhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCC--C----ccccceeeE
Q 043262          338 HLAVEATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH--K----NLVRLLGCC  410 (512)
Q Consensus       338 ~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H--~----nIv~l~g~~  410 (512)
                      ...+..+++|....++|+|.||.|.++... .+..||||+++.-.+ ..+..+-|++++.++.+  |    -+|.+.+|+
T Consensus        82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            333445788999999999999999999864 368899999875443 35667889999999942  2    278888999


Q ss_pred             EeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC--------
Q 043262          411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH--------  482 (512)
Q Consensus       411 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~--------  482 (512)
                      .-.++.++|+|.+ +-|+.+||.. ++..+++...+..|+.|++++++|||+.   .++|-||||+|||+.+        
T Consensus       161 dyrghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEec
Confidence            9999999999988 4589999954 4556789999999999999999999997   4999999999999931        


Q ss_pred             ------------CCceEEeccCcccccCCCCCCc
Q 043262          483 ------------EMNPKISDFGMARIFGGNQSEA  504 (512)
Q Consensus       483 ------------~~~~kl~DFGla~~~~~~~~~~  504 (512)
                                  ...+||.|||-|+.-....+..
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~i  269 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTI  269 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceeccCccee
Confidence                        3458999999999877666443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.66  E-value=9.7e-17  Score=163.02  Aligned_cols=146  Identities=23%  Similarity=0.336  Sum_probs=120.8

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++.|.....+|.|+|+.|-++.. .++++.+||++.+...    +-.+|+.++... +||||+++.+++.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            45666677799999999999985 5678899999976522    234566555554 79999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee-cCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL-DHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl-~~~~~~kl~DFGla~~~~~~  500 (512)
                      .+.++-|.+-+....    .....+..|+.+|+.++.|||+++   +|||||||+|||+ ++.++++|+|||.++....+
T Consensus       397 ~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999998877774322    222677789999999999999985   9999999999999 68999999999999987665

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.66  E-value=1.7e-16  Score=153.66  Aligned_cols=147  Identities=26%  Similarity=0.476  Sum_probs=127.6

Q ss_pred             HHHhcCCccccccccccceeEEEEEeC----CCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCe
Q 043262          341 VEATQHFSDENKLGEGGFGPVYKGKLA----DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENE  415 (512)
Q Consensus       341 ~~~~~~~~~~~~lg~G~fG~Vy~~~~~----~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~  415 (512)
                      ....+.|..+++||+|.|+.||++.+.    ..+.||+|.+...+.-  ....+|+++|..+. +.||+++.++....+.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            344567888999999999999999863    4678999999765443  56889999999995 9999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC-CceEEeccCcc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMA  494 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~-~~~kl~DFGla  494 (512)
                      ..+|+||+++....+++..      ++...+..++..+..||.++|.++   ||||||||+|+|.+.. +.-.|.|||||
T Consensus       110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence            9999999999999998843      677888899999999999999986   9999999999999865 56789999999


Q ss_pred             cccC
Q 043262          495 RIFG  498 (512)
Q Consensus       495 ~~~~  498 (512)
                      ....
T Consensus       181 ~~~d  184 (418)
T KOG1167|consen  181 QRYD  184 (418)
T ss_pred             HHHH
Confidence            8643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.65  E-value=6.1e-16  Score=154.20  Aligned_cols=145  Identities=27%  Similarity=0.382  Sum_probs=119.3

Q ss_pred             CCccccccccccceeEEEEEeCCC--CEEEEEEcccCCcccHHHHHHHHHHHhcCCC----CccccceeeE-EeCCeeEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLADG--KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH----KNLVRLLGCC-LQENESLL  418 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~g--~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~g~~-~~~~~~~l  418 (512)
                      +|...++||+|+||.||++.....  ..+|+|............+..|..++..+.+    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            788899999999999999996543  4778887765433332367888888888873    5788888888 46778899


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC-----CceEEeccCc
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-----MNPKISDFGM  493 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~-----~~~kl~DFGl  493 (512)
                      ||+.+ +-+|.++..... ...++..+.+.|+.|+..+|.+||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99976 778988774433 567999999999999999999999986   9999999999999765     4699999999


Q ss_pred             cc
Q 043262          494 AR  495 (512)
Q Consensus       494 a~  495 (512)
                      ++
T Consensus       174 ar  175 (322)
T KOG1164|consen  174 AR  175 (322)
T ss_pred             Cc
Confidence            99

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=1.2e-15  Score=133.91  Aligned_cols=136  Identities=21%  Similarity=0.210  Sum_probs=115.3

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCC--CccccceeeEEeCCeeEEEEEecCCCC
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH--KNLVRLLGCCLQENESLLIYEYMPNKS  427 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lv~E~~~~gs  427 (512)
                      .+.||+|.++.||++...+ ..+++|.......  ...+..|+..+..++|  .++.+++++....+..++++||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4679999999999999854 7899998865443  5678999999999976  588899888887788999999998877


Q ss_pred             hhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          428 LNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +..+          ++.....++.+++++|.+||.....+++|+||+|+||++++++.+++.|||+++...
T Consensus        80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~  140 (155)
T cd05120          80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP  140 (155)
T ss_pred             cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence            7533          556777889999999999998654569999999999999998999999999998644

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=1.8e-15  Score=138.63  Aligned_cols=139  Identities=19%  Similarity=0.250  Sum_probs=97.7

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEEcccCCcc--cHHHH----------------------HHHHHHHhcCCCCc--c
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ--GLQEF----------------------KNEVTLIAKLQHKN--L  403 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~--~~~~~----------------------~~E~~~l~~l~H~n--I  403 (512)
                      .+.||+|+||.||++...++++||||.+......  ....+                      ..|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3579999999999999888999999988643221  11111                      24455555554332  3


Q ss_pred             ccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCCeeecC
Q 043262          404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKTSNVLLDH  482 (512)
Q Consensus       404 v~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlk~~NiLl~~  482 (512)
                      .+.++.    ...++||||++++.+........   ... .....++.+++.++.++|. .   +|+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence            333332    34689999999965422111100   011 5567899999999999998 5   599999999999999 


Q ss_pred             CCceEEeccCcccccCCC
Q 043262          483 EMNPKISDFGMARIFGGN  500 (512)
Q Consensus       483 ~~~~kl~DFGla~~~~~~  500 (512)
                      ++.++|+|||+++.....
T Consensus       150 ~~~~~liDfg~a~~~~~~  167 (187)
T cd05119         150 DGKVYIIDVPQAVEIDHP  167 (187)
T ss_pred             CCcEEEEECcccccccCc
Confidence            889999999999877653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=1.1e-15  Score=150.28  Aligned_cols=134  Identities=25%  Similarity=0.348  Sum_probs=111.7

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-----C---CccccceeeEEe---
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-----H---KNLVRLLGCCLQ---  412 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~g~~~~---  412 (512)
                      .+|...++||-|-|++||++.. .+.+-||+|+.+... ...+..+.||++|..++     |   .+||+|++.+..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            6788899999999999999985 567889999987543 23456789999999884     3   359999999975   


Q ss_pred             -CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC
Q 043262          413 -ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE  483 (512)
Q Consensus       413 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~  483 (512)
                       +.+.+||+|++ +.+|..+|... ..+.++...+.+|+.||+.||.|||.++  +|||-||||+||||..+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence             45689999998 56788887654 3445899999999999999999999987  79999999999999654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.62  E-value=2.5e-15  Score=141.31  Aligned_cols=150  Identities=24%  Similarity=0.391  Sum_probs=121.1

Q ss_pred             cCCccccccccccceeEEEEE-eCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      -+|...++||+|.||.++.|+ +-+++.||||.-...++  .-.+..|-+..+.|. -++|...+-+-.++.+-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            368889999999999999998 56799999997654332  234567777777774 67888887777778888999998


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC-----CceEEeccCccccc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-----MNPKISDFGMARIF  497 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~-----~~~kl~DFGla~~~  497 (512)
                      + +-||+++.--.  ...++.++...|++|+..-++|+|++.   +|.|||||+|+||..-     ..+.|.|||||+.+
T Consensus       106 L-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            7 66888865322  235888999999999999999999985   9999999999999643     34899999999998


Q ss_pred             CCCCC
Q 043262          498 GGNQS  502 (512)
Q Consensus       498 ~~~~~  502 (512)
                      .+..+
T Consensus       180 rDp~T  184 (449)
T KOG1165|consen  180 RDPKT  184 (449)
T ss_pred             cCccc
Confidence            76654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.62  E-value=3.9e-16  Score=146.10  Aligned_cols=146  Identities=29%  Similarity=0.457  Sum_probs=117.2

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC------e
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN------E  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~  415 (512)
                      .+|.....++.|.- .|.-+.. -.++.||+|++...  .....++..+|..++..++|+||++++.+++-..      +
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            34555566777765 4444432 24788999988532  3344667889999999999999999999997543      4


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++|||+|. ++|...+.     ..++-.+...|..|++.|+.|||+.+   |+||||||+||++..+...||.|||+|+
T Consensus        96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            689999994 57877774     34788899999999999999999975   9999999999999999999999999999


Q ss_pred             ccCCC
Q 043262          496 IFGGN  500 (512)
Q Consensus       496 ~~~~~  500 (512)
                      .-+.+
T Consensus       167 ~e~~~  171 (369)
T KOG0665|consen  167 TEDTD  171 (369)
T ss_pred             ccCcc
Confidence            76655

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.59  E-value=1.3e-14  Score=137.85  Aligned_cols=137  Identities=20%  Similarity=0.283  Sum_probs=106.2

Q ss_pred             ccccc-cccceeEEEEEeCCCCEEEEEEcccCC-------------cccHHHHHHHHHHHhcCCCCcc--ccceeeEEeC
Q 043262          350 ENKLG-EGGFGPVYKGKLADGKEIAVKRLSRTS-------------GQGLQEFKNEVTLIAKLQHKNL--VRLLGCCLQE  413 (512)
Q Consensus       350 ~~~lg-~G~fG~Vy~~~~~~g~~vaVK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~g~~~~~  413 (512)
                      ...|| .|+.|+||+.... +..++||++....             ......+.+|+.++..++|++|  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8899999999885 6788998875321             1223568889999999998885  6677765443


Q ss_pred             Ce----eEEEEEecCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          414 NE----SLLIYEYMPN-KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       414 ~~----~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                      ..    .++|+|++++ .+|.+++..    ..++..    ...+|+.+|.+||+.+   |+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            22    3599999997 689888743    234443    3568999999999986   999999999999999889999


Q ss_pred             eccCcccccC
Q 043262          489 SDFGMARIFG  498 (512)
Q Consensus       489 ~DFGla~~~~  498 (512)
                      +|||.++...
T Consensus       184 IDfg~~~~~~  193 (239)
T PRK01723        184 IDFDRGELRT  193 (239)
T ss_pred             EECCCcccCC
Confidence            9999998765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.58  E-value=3.4e-15  Score=147.56  Aligned_cols=157  Identities=23%  Similarity=0.311  Sum_probs=132.1

Q ss_pred             HHHHhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCC------CCccccceeeEEe
Q 043262          340 AVEATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ------HKNLVRLLGCCLQ  412 (512)
Q Consensus       340 ~~~~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~g~~~~  412 (512)
                      .+....+|......|+|-|++|.+|... -|.+||||+|.....- .+.=+.|+++|.+|+      .-|+++|+-.+..
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            3444567877888999999999999864 4789999999765322 234467999999995      3579999999999


Q ss_pred             CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-ceEEecc
Q 043262          413 ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDF  491 (512)
Q Consensus       413 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DF  491 (512)
                      .++++||||-+ ..+|.+.|..-.....|.......++.|+.-||..|-.-   +|+|.||||.|||+++.- ..||+||
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccC
Confidence            99999999987 458999998777777899999999999999999999865   599999999999998864 5899999


Q ss_pred             CcccccCCCC
Q 043262          492 GMARIFGGNQ  501 (512)
Q Consensus       492 Gla~~~~~~~  501 (512)
                      |.|...+.++
T Consensus       582 GSA~~~~ene  591 (752)
T KOG0670|consen  582 GSASFASENE  591 (752)
T ss_pred             cccccccccc
Confidence            9999887765

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.57  E-value=5.1e-14  Score=139.22  Aligned_cols=150  Identities=34%  Similarity=0.529  Sum_probs=127.3

Q ss_pred             CccccccccccceeEEEEEeCCCCEEEEEEcccCCcc---cHHHHHHHHHHHhcCCCC-ccccceeeEEeCCeeEEEEEe
Q 043262          347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ---GLQEFKNEVTLIAKLQHK-NLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      |...+.||.|.||.||++...  ..+++|.+......   ....|.+|+.++..+.|+ +++++.+.+......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            445678999999999999987  78899998754332   367899999999999988 799999999777778999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-ceEEeccCcccccCCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGGNQ  501 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DFGla~~~~~~~  501 (512)
                      +.++++.+++........+.......+..|++.++.|+|..+   ++|||+||+||+++... .+|+.|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977643221135888999999999999999999985   99999999999999988 79999999999765544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=3e-14  Score=146.92  Aligned_cols=143  Identities=23%  Similarity=0.322  Sum_probs=100.1

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEEcccCCcccH----------------------------------------HHHH
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGL----------------------------------------QEFK  389 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~----------------------------------------~~~~  389 (512)
                      .+.||.|++|+||+|++.+|++||||+.+.......                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999865321100                                        0244


Q ss_pred             HHHHHHhcC----CCCccccceeeEE-eCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHcC
Q 043262          390 NEVTLIAKL----QHKNLVRLLGCCL-QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR-GLLYLHED  463 (512)
Q Consensus       390 ~E~~~l~~l----~H~nIv~l~g~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~  463 (512)
                      +|...+.++    +|.+-+.+-.++. .....+|||||+++++|.++......  ..+   +..++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhC
Confidence            455544444    2322233322332 24557999999999999887643211  122   3456666665 46788876


Q ss_pred             CCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       464 ~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +   ++|+|+||.||++++++.++|.|||+++.+.+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence            4   999999999999999999999999999988654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=3.6e-14  Score=154.10  Aligned_cols=144  Identities=24%  Similarity=0.338  Sum_probs=114.9

Q ss_pred             hcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC---CCccccceeeEEeCCeeEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      .+.|.+.+.||+|+||+||+|...+|+.||+|.-+....-.   |--=.+++.+|+   -+.|+.+.....-.+..+||+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            35577778999999999999999889999999876554321   222223344444   345666667777788899999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec-------CCCceEEeccCc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD-------HEMNPKISDFGM  493 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~-------~~~~~kl~DFGl  493 (512)
                      ||.+.|+|.+++.   ...-++|.....++.|+++.++.||..+   |||+||||+|+||.       +...++|+|||-
T Consensus       774 ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  774 EYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            9999999999994   4456999999999999999999999975   99999999999993       234599999998


Q ss_pred             ccc
Q 043262          494 ARI  496 (512)
Q Consensus       494 a~~  496 (512)
                      +--
T Consensus       848 siD  850 (974)
T KOG1166|consen  848 SID  850 (974)
T ss_pred             cee
Confidence            843

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.36  E-value=9.1e-13  Score=137.53  Aligned_cols=146  Identities=16%  Similarity=0.200  Sum_probs=93.2

Q ss_pred             hcCCccccccccccceeEEEEEeCC-CCEEEEEEcccCCcc----------------------------------cHHH-
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQ----------------------------------GLQE-  387 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~----------------------------------~~~~-  387 (512)
                      ...|+. +.||+|++|+||+|++.+ |++||||+++.....                                  ..+. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345665 689999999999999987 999999999743210                                  0111 


Q ss_pred             -----HHHHHHHHhcC----CCCccccceeeEEe-CCeeEEEEEecCCCChhHHhhcCCCC---CCCCHHHHHHHHHHHH
Q 043262          388 -----FKNEVTLIAKL----QHKNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRS---VQLDWKRRISIINGIA  454 (512)
Q Consensus       388 -----~~~E~~~l~~l----~H~nIv~l~g~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia  454 (512)
                           |.+|...+.++    .+.+.+.+-.++.+ ....+|||||+.++.+.++..-....   ..+.......++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                 33333333333    23333333333333 45578999999999997753111111   012222222233333 


Q ss_pred             HHHHHHHcCCCCCcccCCCCCCCeeecCCC----ceEEeccCcccccCCC
Q 043262          455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEM----NPKISDFGMARIFGGN  500 (512)
Q Consensus       455 ~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~----~~kl~DFGla~~~~~~  500 (512)
                            +..   +++|+|+||.||+++.++    .+++.|||++..++..
T Consensus       277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                  333   499999999999999988    9999999999988654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.33  E-value=7.2e-12  Score=112.69  Aligned_cols=131  Identities=22%  Similarity=0.196  Sum_probs=96.7

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccc-cceeeEEeCCeeEEEEEecCCCChh
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV-RLLGCCLQENESLLIYEYMPNKSLN  429 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~E~~~~gsL~  429 (512)
                      +.|+.|.++.||+.+.. +..+++|....... ....+..|...+..+.+.+++ +++..  ..+..++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence            56888999999999875 77899998765432 123467888888888765554 34433  334468999999998775


Q ss_pred             HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          430 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS--RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       430 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      ...        .   ....+..+++++|..||...  ...++|+|++|.||+++ +..+++.|||.+..-
T Consensus        80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            320        1   11235678999999999875  22369999999999999 568999999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.28  E-value=1e-12  Score=120.54  Aligned_cols=137  Identities=28%  Similarity=0.484  Sum_probs=113.8

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEEccc--CCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCC
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSR--TSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKS  427 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gs  427 (512)
                      ..+|.+...|+.|+|+++ |..+++|.+.-  ......++|..|.-.++.+.||||..++|.|.....+.++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            346888889999999997 45566677642  233334689999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEe
Q 043262          428 LNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  489 (512)
Q Consensus       428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~  489 (512)
                      |...|+.. .....+..+..+++.+||+||+|||+..+ -|.--.|.++.+++|++++++|+
T Consensus       274 lynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee
Confidence            99999764 34557888999999999999999999862 24445699999999999998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.24  E-value=6.1e-12  Score=134.00  Aligned_cols=157  Identities=27%  Similarity=0.368  Sum_probs=116.8

Q ss_pred             ccccccccccceeEEEEEeC-CCCEEEEEEcc-----cCCccc-HHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          348 SDENKLGEGGFGPVYKGKLA-DGKEIAVKRLS-----RTSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~-----~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      .....+|.|.+|.|+..... .....+.|...     ...... ...+..|..+-..+.|+|++..+....+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999977766532 22223333221     111111 122666777888899999998888888777777779


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||++. +|..++...   ..+....+-.++.|+..|+.|||+.+   |.|||||++|+++..++.+||+|||.+..+.-+
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 999888442   35777888899999999999999986   999999999999999999999999999887544


Q ss_pred             CCC--cCcccccc
Q 043262          501 QSE--ANTKRIVG  511 (512)
Q Consensus       501 ~~~--~~~~~~~G  511 (512)
                      ...  ....+++|
T Consensus       474 ~e~~~~~~~g~~g  486 (601)
T KOG0590|consen  474 WEKNIHESSGIVG  486 (601)
T ss_pred             cchhhhhhcCccc
Confidence            433  33445555

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.24  E-value=5.8e-12  Score=140.74  Aligned_cols=95  Identities=19%  Similarity=0.266  Sum_probs=73.7

Q ss_pred             cCCC-CccccceeeE-------EeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCc
Q 043262          397 KLQH-KNLVRLLGCC-------LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI  468 (512)
Q Consensus       397 ~l~H-~nIv~l~g~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  468 (512)
                      .++| +||.++++++       .+.+..++++||+ .++|.++|...  ...+++..++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4455 5788888877       3334567788887 56999999642  345999999999999999999999875   9


Q ss_pred             ccCCCCCCCeeecC-------------------CCceEEeccCccccc
Q 043262          469 IHRDLKTSNVLLDH-------------------EMNPKISDFGMARIF  497 (512)
Q Consensus       469 vH~dlk~~NiLl~~-------------------~~~~kl~DFGla~~~  497 (512)
                      +||||||+||||+.                   ++.+||+|||+++..
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~  149 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRRE  149 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccc
Confidence            99999999999954                   445666666766643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.13  E-value=4.3e-10  Score=105.67  Aligned_cols=143  Identities=18%  Similarity=0.278  Sum_probs=109.4

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCC--ccccceeeEEeCC---eeEEEEEecC
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHK--NLVRLLGCCLQEN---ESLLIYEYMP  424 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~--nIv~l~g~~~~~~---~~~lv~E~~~  424 (512)
                      +.|+.|..+.+|+.+..+|..+++|....... .....+..|.+++..+++.  ++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46889999999999987778999998764332 2345788999999998764  4566777766542   5689999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS----------------------------------------  464 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  464 (512)
                      +.++...+..    ..++...+..++.++++.|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888665421    24677777788888888888888531                                        


Q ss_pred             -------------CCCcccCCCCCCCeeecC--CCceEEeccCccccc
Q 043262          465 -------------RLKIIHRDLKTSNVLLDH--EMNPKISDFGMARIF  497 (512)
Q Consensus       465 -------------~~~ivH~dlk~~NiLl~~--~~~~kl~DFGla~~~  497 (512)
                                   ...++|+|+++.||+++.  +..+.|.||+.+..-
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                         134799999999999998  667899999988753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.10  E-value=1.2e-09  Score=99.50  Aligned_cols=137  Identities=14%  Similarity=0.116  Sum_probs=97.4

Q ss_pred             cccccccceeEEEEEeCC-------CCEEEEEEcccCC----------------------cccHHHHH----HHHHHHhc
Q 043262          351 NKLGEGGFGPVYKGKLAD-------GKEIAVKRLSRTS----------------------GQGLQEFK----NEVTLIAK  397 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~-------g~~vaVK~l~~~~----------------------~~~~~~~~----~E~~~l~~  397 (512)
                      ..||.|.-+.||.|.-.+       +..+|||..+...                      ....+.+.    +|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998643       4789999764210                      01122333    78888888


Q ss_pred             CCC--CccccceeeEEeCCeeEEEEEecCCCChhH-HhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCcccCCC
Q 043262          398 LQH--KNLVRLLGCCLQENESLLIYEYMPNKSLNV-FLFDSTRSVQLDWKRRISIINGIARGLLYL-HEDSRLKIIHRDL  473 (512)
Q Consensus       398 l~H--~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dl  473 (512)
                      +..  -++..++++    ...++||||+.++.+.. .+.    ...++......+..+++.+|..| |..   +|||+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            854  345555543    56789999997754422 121    12345556677889999999999 665   5999999


Q ss_pred             CCCCeeecCCCceEEeccCcccccCC
Q 043262          474 KTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       474 k~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++.|||+++ +.+.|+|||.+-....
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav~~~h  176 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCceeCCC
Confidence            999999974 5799999999877653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.07  E-value=2.1e-10  Score=117.03  Aligned_cols=100  Identities=33%  Similarity=0.574  Sum_probs=91.1

Q ss_pred             HhcCCCCccccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCC
Q 043262          395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK  474 (512)
Q Consensus       395 l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk  474 (512)
                      |+.+.|.|+.+|+|.+..+...++|.+|++.|+|.+.+..  ....++|.-...++++|+.||.|||...  -..|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            4578999999999999999999999999999999999965  4467999999999999999999999863  23999999


Q ss_pred             CCCeeecCCCceEEeccCcccccC
Q 043262          475 TSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       475 ~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++|+++|..+.+||+|||+..+..
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             cccceeeeeEEEEechhhhccccc
Confidence            999999999999999999998874

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=1.4e-09  Score=95.71  Aligned_cols=133  Identities=20%  Similarity=0.315  Sum_probs=102.0

Q ss_pred             ccccccceeEEEEEeCCCCEEEEEE-cccC---C----cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          352 KLGEGGFGPVYKGKLADGKEIAVKR-LSRT---S----GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~g~~vaVK~-l~~~---~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .+++|+-..+|.+.+.+ .++++|. +++.   .    .-..+.-.+|..++.+++--.|....-+..+.+...++|||.
T Consensus         3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            57789999999997753 3455552 3221   1    112345678999999988777777777888889999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++-.|.+++...          ...++..+-.-+.-||..+   |+|+||.++||++..+. +.++||||+..-..
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~  143 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE  143 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccccc
Confidence            999999888543          2456677777788899986   99999999999998775 99999999986443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.96  E-value=2.8e-09  Score=102.34  Aligned_cols=150  Identities=22%  Similarity=0.297  Sum_probs=98.1

Q ss_pred             CccccccccccceeEEEEEeC-CCCEEEEEEccc---CCcccHHHHHHHHHHHhcCCC----------CccccceeeEEe
Q 043262          347 FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQH----------KNLVRLLGCCLQ  412 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~---~~~~~~~~~~~E~~~l~~l~H----------~nIv~l~g~~~~  412 (512)
                      +...+.||.|+++.||.++.. .++++|||....   ......+++.+|......+.+          -.++..++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            344678999999999999985 489999998742   223446778888766666443          223333333221


Q ss_pred             C--------C---------eeEEEEEecCCCChhHHhh---cC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccC
Q 043262          413 E--------N---------ESLLIYEYMPNKSLNVFLF---DS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR  471 (512)
Q Consensus       413 ~--------~---------~~~lv~E~~~~gsL~~~l~---~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~  471 (512)
                      .        .         ..+++|+-+ .++|.+++.   .. .....+....++.+..|+.+.+++||+.+   +||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence            1        1         124566655 568877753   21 11223455566778899999999999986   9999


Q ss_pred             CCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          472 DLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       472 dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+|+|++++.+|.++|+||+.....+..
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~  198 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR  198 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEE
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCce
Confidence            99999999999999999999988776543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.94  E-value=1.1e-08  Score=89.79  Aligned_cols=146  Identities=21%  Similarity=0.301  Sum_probs=106.6

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEE-cccC-------CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKR-LSRT-------SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~-l~~~-------~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ...+.+|+-+.|+++.++ |+...||. ..+.       ..-..++..+|.+++.++.--.|.-..-++.+...-.++||
T Consensus        12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            457889999999999995 56655553 2211       12235677889999999876666666666777777889999


Q ss_pred             ecCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC---ceEEeccCccccc
Q 043262          422 YMPN-KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKISDFGMARIF  497 (512)
Q Consensus       422 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~---~~kl~DFGla~~~  497 (512)
                      |.++ -++.+|+...-... ........++..|-+.+.-||...   |+|+||..+||+|..++   .+.+.||||+..-
T Consensus        91 ~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             eccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9976 47788876533322 223334678889999999999985   99999999999996654   4689999999765


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      ...
T Consensus       167 ~~~  169 (229)
T KOG3087|consen  167 RLP  169 (229)
T ss_pred             cCc
Confidence            433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=98.92  E-value=2.2e-10  Score=117.20  Aligned_cols=143  Identities=27%  Similarity=0.300  Sum_probs=114.2

Q ss_pred             ccccccceeEEEEEe----CCCCEEEEEEcccCCcc--cHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEEecC
Q 043262          352 KLGEGGFGPVYKGKL----ADGKEIAVKRLSRTSGQ--GLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~----~~g~~vaVK~l~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      .+|+|.||.|+..+.    ..|.-.|.|.+++....  .......|..++..++ ||.+|++.-.+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999987653    34566777777543221  1224566778888887 9999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +|.|...+.+   ....+..........++-+++++|+.+   |+|||+|++||+++.+|.+|+.|||+++.+-..
T Consensus        81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~  150 (612)
T KOG0603|consen   81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE  150 (612)
T ss_pred             cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence            9999776633   334566666777888999999999975   999999999999999999999999999987443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.86  E-value=4e-08  Score=94.48  Aligned_cols=140  Identities=20%  Similarity=0.154  Sum_probs=99.1

Q ss_pred             ccccccceeEEEEEeCCCCEEEEEEcccCCcc-----------cHHHHHHHHHHHhcCCCCccc--cceeeEEe-----C
Q 043262          352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ-----------GLQEFKNEVTLIAKLQHKNLV--RLLGCCLQ-----E  413 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv--~l~g~~~~-----~  413 (512)
                      .+-+-....|.+..+ +|+.+.||+.......           ....+.+|...+.++...+|.  .++++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            333333345667766 5778999976433211           112477898888888544443  44555543     2


Q ss_pred             CeeEEEEEecCCC-ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-------CCc
Q 043262          414 NESLLIYEYMPNK-SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-------EMN  485 (512)
Q Consensus       414 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-------~~~  485 (512)
                      ...++|+|++++- +|.+++.+.. ..+.+...+..++.+++..+.-||..+   |+|+||+++|||++.       +..
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            3478999999986 8988874321 223455677789999999999999986   999999999999975       468


Q ss_pred             eEEeccCcccc
Q 043262          486 PKISDFGMARI  496 (512)
Q Consensus       486 ~kl~DFGla~~  496 (512)
                      +.|+||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999999964

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=98.86  E-value=4.7e-10  Score=120.77  Aligned_cols=143  Identities=20%  Similarity=0.230  Sum_probs=112.6

Q ss_pred             CCccccccccccceeEEEEEeCCCCEEEEEEcccC-CcccHHHHHHHHHH--HhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRT-SGQGLQEFKNEVTL--IAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~-~~~~~~~~~~E~~~--l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++...+.||++.|=+|.+++.++|. |+||++-+. ....++.|.++++-  ....+|||.+.+.-+-....-.+||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            4556788999999999999998887 888988544 35556666655543  4556899999988887767777888888


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      +.+ +|.+.|..   +.-|..-+..-|+.|++.||.-+|..+   |+|||||.+||||+.-.=+.|+||.--|.
T Consensus       103 vkh-nLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  103 VKH-NLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             Hhh-hhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence            854 67666621   223556667779999999999999875   99999999999999988899999987764

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=98.78  E-value=9.5e-09  Score=99.62  Aligned_cols=89  Identities=25%  Similarity=0.487  Sum_probs=69.2

Q ss_pred             CCCccccceeeEEe---------------------------CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHH
Q 043262          399 QHKNLVRLLGCCLQ---------------------------ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIIN  451 (512)
Q Consensus       399 ~H~nIv~l~g~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  451 (512)
                      +|||||++.+++.+                           ...+|+||.-.+. +|..|+...    ..+.....-|..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence            59999999988753                           2346788877644 788888532    355666777899


Q ss_pred             HHHHHHHHHHcCCCCCcccCCCCCCCeee--cCCC--ceEEeccCccc
Q 043262          452 GIARGLLYLHEDSRLKIIHRDLKTSNVLL--DHEM--NPKISDFGMAR  495 (512)
Q Consensus       452 ~ia~gL~yLH~~~~~~ivH~dlk~~NiLl--~~~~--~~kl~DFGla~  495 (512)
                      |+++|+.|||.++   +.|||||+.||||  |+|.  ...|+|||.+-
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL  393 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL  393 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence            9999999999986   9999999999999  4444  36789999764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=3.1e-08  Score=89.85  Aligned_cols=127  Identities=24%  Similarity=0.322  Sum_probs=81.9

Q ss_pred             eEEEEEeCCCCEEEEEEcccCC---------------------cc-----cHHHHHHHHHHHhcCCCCc--cccceeeEE
Q 043262          360 PVYKGKLADGKEIAVKRLSRTS---------------------GQ-----GLQEFKNEVTLIAKLQHKN--LVRLLGCCL  411 (512)
Q Consensus       360 ~Vy~~~~~~g~~vaVK~l~~~~---------------------~~-----~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~  411 (512)
                      .||.|...+|.++|||..+...                     ..     ......+|.+.|.++...+  +.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            3899999899999999764310                     00     1234678999999998664  4555533  


Q ss_pred             eCCeeEEEEEecC--CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          412 QENESLLIYEYMP--NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL-HEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       412 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                        +...+||||++  +..+..+. +..    ++......+..++...+..+ |..   +|+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence              24579999998  54444332 211    11234456777788866665 555   59999999999999988 9999


Q ss_pred             eccCcccccCC
Q 043262          489 SDFGMARIFGG  499 (512)
Q Consensus       489 ~DFGla~~~~~  499 (512)
                      +|||.+.....
T Consensus       148 IDf~qav~~~~  158 (188)
T PF01163_consen  148 IDFGQAVDSSH  158 (188)
T ss_dssp             --GTTEEETTS
T ss_pred             EecCcceecCC
Confidence            99999887653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.73  E-value=4.9e-08  Score=101.16  Aligned_cols=124  Identities=20%  Similarity=0.287  Sum_probs=101.8

Q ss_pred             EeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHH
Q 043262          365 KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWK  444 (512)
Q Consensus       365 ~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~  444 (512)
                      +..++.+|.|...+...........+-++.|+.++||||++++......+..|+|+|-+.  -|..++..      +...
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~  104 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKE  104 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHH
Confidence            345788999998887666444556777889999999999999999999999999999874  45555532      2344


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       445 ~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ...-.+.||+.||.|||+++  +++|++|.-..|++++.+..||++|-++....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence            45567889999999999887  79999999999999999999999998886543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.71  E-value=7.5e-08  Score=100.25  Aligned_cols=148  Identities=15%  Similarity=0.215  Sum_probs=95.8

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcc--------------------------cH----H--------
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ--------------------------GL----Q--------  386 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~--------------------------~~----~--------  386 (512)
                      ..|.. +.|+.++-|+||+|++++|++||||+.+..-..                          ..    +        
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            34443 578999999999999999999999987643111                          00    1        


Q ss_pred             --HHHHHHHHHhcC----C-CCccccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 043262          387 --EFKNEVTLIAKL----Q-HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY  459 (512)
Q Consensus       387 --~~~~E~~~l~~l----~-H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y  459 (512)
                        ++.+|..-+.++    + .++|.-..-++.-.....|+|||++|-.+.++..-..  ...+.+.......++.--.-+
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f~~q~~  282 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAFLRQLL  282 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence              133344434333    2 3333322222333567899999999999988753222  234544433333332222222


Q ss_pred             HHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       460 LH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      -|     +++|.|.+|.||+++.++.+-+.|||+...+++.
T Consensus       283 ~d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         283 RD-----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             hc-----CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            22     4999999999999999999999999999988764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.67  E-value=4.5e-09  Score=112.20  Aligned_cols=153  Identities=26%  Similarity=0.367  Sum_probs=118.0

Q ss_pred             CCccccccccccceeEEEEEeCC--CCEEEEEEcccCC--cccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLAD--GKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~--g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      .|...+.||+|.|+.|-......  ...+++|.+....  .........|..+-..+. |+|++++++.....+..++.+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            34555679999999998887643  4456666665432  222334455676666676 999999999999999999999


Q ss_pred             EecCCCChhHHhh-cCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCcccCCCCCCCeeecCCC-ceEEeccCccccc
Q 043262          421 EYMPNKSLNVFLF-DSTRSVQLDWKRRISIINGIARGLLYLH-EDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIF  497 (512)
Q Consensus       421 E~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DFGla~~~  497 (512)
                      ||..++++.+.+. ...  ...+....-.+..|+..++.|+| ..   .+.|+||||+|.+++..+ ..|++|||+|..+
T Consensus       101 ~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             CcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999987773 211  13455566778899999999999 65   499999999999999999 9999999999988


Q ss_pred             CC-CCCC
Q 043262          498 GG-NQSE  503 (512)
Q Consensus       498 ~~-~~~~  503 (512)
                      .. +..+
T Consensus       176 ~~~~g~~  182 (601)
T KOG0590|consen  176 RNKNGAE  182 (601)
T ss_pred             cccCCcc
Confidence            76 4433

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.63  E-value=2.3e-07  Score=93.36  Aligned_cols=140  Identities=22%  Similarity=0.348  Sum_probs=110.2

Q ss_pred             eeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEE----eCCeeEEEEEecCC-CChhHHh
Q 043262          359 GPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL----QENESLLIYEYMPN-KSLNVFL  432 (512)
Q Consensus       359 G~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~----~~~~~~lv~E~~~~-gsL~~~l  432 (512)
                      .+.||+.. .||..+++|+++.........-..-++.++++.|+|||+|..++.    .+..+++||+|.+. ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            46788875 589999999995433333223345577899999999999999887    34567899999985 5666655


Q ss_pred             hcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          433 FDST------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       433 ~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +...            .....++..+|.++.|+..||.++|+.+   +.-+-|.+++||++.+.+++|+..|+.-++..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            4321            2234778899999999999999999986   888999999999999999999999998887665


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       447 ~  447 (655)
T KOG3741|consen  447 P  447 (655)
T ss_pred             C
Confidence            5

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.53  E-value=7.7e-07  Score=83.32  Aligned_cols=136  Identities=21%  Similarity=0.254  Sum_probs=92.5

Q ss_pred             ccccccccccceeEEEEEeCCCCEEEEEEcccCC------------------c----ccHHHHHHHHHHHhcCCCC--cc
Q 043262          348 SDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS------------------G----QGLQEFKNEVTLIAKLQHK--NL  403 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~------------------~----~~~~~~~~E~~~l~~l~H~--nI  403 (512)
                      ...++||.|.-+.||.|..++|.+++||.-+...                  .    ..+....+|.+.|.+|.-.  .|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4457899999999999999999999999532110                  0    1133467888888888655  56


Q ss_pred             ccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC
Q 043262          404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE  483 (512)
Q Consensus       404 v~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~  483 (512)
                      .+.+++    +...+||||.++-.|...-        ++....-.|...|++-+.-+-..   ++||+|+.+-||+++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence            666654    4567999999886653321        11222222333333333333333   49999999999999999


Q ss_pred             CceEEeccCcccccC
Q 043262          484 MNPKISDFGMARIFG  498 (512)
Q Consensus       484 ~~~kl~DFGla~~~~  498 (512)
                      +.+.++||--+-..+
T Consensus       239 g~~~vIDwPQ~v~~~  253 (304)
T COG0478         239 GDIVVIDWPQAVPIS  253 (304)
T ss_pred             CCEEEEeCcccccCC
Confidence            999999997665443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.47  E-value=1.2e-06  Score=81.43  Aligned_cols=108  Identities=25%  Similarity=0.297  Sum_probs=84.4

Q ss_pred             HHHHHHHHHHHhcCCCC--ccccceeeEEeCC----eeEEEEEecCCC-ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 043262          385 LQEFKNEVTLIAKLQHK--NLVRLLGCCLQEN----ESLLIYEYMPNK-SLNVFLFDSTRSVQLDWKRRISIINGIARGL  457 (512)
Q Consensus       385 ~~~~~~E~~~l~~l~H~--nIv~l~g~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL  457 (512)
                      .....+|...+..+...  .+.+.+++.....    ..++|+|++++- +|.+++.....   ++......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            34677888887777543  3556666665532    358999999874 79998854222   55667788999999999


Q ss_pred             HHHHcCCCCCcccCCCCCCCeeecCCC---ceEEeccCcccccC
Q 043262          458 LYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKISDFGMARIFG  498 (512)
Q Consensus       458 ~yLH~~~~~~ivH~dlk~~NiLl~~~~---~~kl~DFGla~~~~  498 (512)
                      .-||..+   |+|+|++++|||++.+.   .+.++||+.++...
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            9999986   99999999999999887   89999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.45  E-value=1.7e-07  Score=96.18  Aligned_cols=151  Identities=22%  Similarity=0.271  Sum_probs=117.6

Q ss_pred             cCCcccccccc--ccceeEEEEEe---CCCCEEEEEEccc--CCcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCee
Q 043262          345 QHFSDENKLGE--GGFGPVYKGKL---ADGKEIAVKRLSR--TSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENES  416 (512)
Q Consensus       345 ~~~~~~~~lg~--G~fG~Vy~~~~---~~g~~vaVK~l~~--~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~  416 (512)
                      ..|.....+|+  |.+|.||.+..   .++..+|+|+-+.  ........=.+|+.....++ |+|.++....+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34555677899  99999999986   4577889987432  22222233355666666664 99999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCcccCCCCCCCeeecCC-CceEEecc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR----GLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDF  491 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~dlk~~NiLl~~~-~~~kl~DF  491 (512)
                      ++-+|++. .+|..+.+.  ....++....+.+..+...    ||.++|+.   +++|-|+||.||++.++ ...++.||
T Consensus       194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            99999885 677777643  2333666777777777778    99999997   49999999999999999 89999999


Q ss_pred             CcccccCCCC
Q 043262          492 GMARIFGGNQ  501 (512)
Q Consensus       492 Gla~~~~~~~  501 (512)
                      |+...++...
T Consensus       268 ~~v~~i~~~~  277 (524)
T KOG0601|consen  268 GLVSKISDGN  277 (524)
T ss_pred             ceeEEccCCc
Confidence            9999987664

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.40  E-value=2.2e-07  Score=95.39  Aligned_cols=149  Identities=24%  Similarity=0.261  Sum_probs=116.4

Q ss_pred             HhcCCccccccccccceeEEEEEe--CCCCEEEEEEcccCCcccHHH--HHHHHHHHhcC-CCCccccceeeEEeCCeeE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL--ADGKEIAVKRLSRTSGQGLQE--FKNEVTLIAKL-QHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~--~~g~~vaVK~l~~~~~~~~~~--~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  417 (512)
                      ...+|.....||.|.|+.|++...  .++..+++|.+.+.......+  -..|+.+...+ .|.++++....+......+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            345677888999999999998865  467788999886543322222  23445444444 5888999888888888888


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC-CceEEeccCcccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARI  496 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~-~~~kl~DFGla~~  496 (512)
                      +-.||++++++...+   .-...++...++++..|++.++.++|+.   .++|+|+||+||++..+ +..++.|||.+..
T Consensus       343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence            999999999987665   2234577788899999999999999976   49999999999999886 8899999999864


Q ss_pred             c
Q 043262          497 F  497 (512)
Q Consensus       497 ~  497 (512)
                      +
T Consensus       417 ~  417 (524)
T KOG0601|consen  417 L  417 (524)
T ss_pred             c
Confidence            3

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.39  E-value=2.7e-07  Score=87.69  Aligned_cols=95  Identities=28%  Similarity=0.361  Sum_probs=79.8

Q ss_pred             HHhcCCCCccccceeeEEeCC-----eeEEEEEecCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 043262          394 LIAKLQHKNLVRLLGCCLQEN-----ESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHEDSRLK  467 (512)
Q Consensus       394 ~l~~l~H~nIv~l~g~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  467 (512)
                      -+-.+.|.|||+++.++.+.+     ...++.|||+.|+|..||++..+ ...+......+++.||..||.|||+- .++
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence            455567999999999987643     46889999999999999976433 34577777788999999999999996 588


Q ss_pred             cccCCCCCCCeeecCCCceEEe
Q 043262          468 IIHRDLKTSNVLLDHEMNPKIS  489 (512)
Q Consensus       468 ivH~dlk~~NiLl~~~~~~kl~  489 (512)
                      |+|+++..+-|++..++-+||.
T Consensus       199 iihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             cccCCcchhheeecCCceEEec
Confidence            9999999999999999888885

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.37  E-value=7.8e-07  Score=80.19  Aligned_cols=62  Identities=23%  Similarity=0.139  Sum_probs=53.9

Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+|.+++...  ...++|..++.|+.||+.||.|||+++         ||+|||++.++.+|+  ||+++.....
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~   62 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE   62 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence            6899998642  345999999999999999999999863         999999999999999  9999877543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09902 hypothetical protein; Provisional

Probab=98.36  E-value=7.4e-06  Score=74.98  Aligned_cols=139  Identities=17%  Similarity=0.175  Sum_probs=101.0

Q ss_pred             cccccceeEEEEEeCCCCEEEEEEcccCC------cccHHHHHHHHHHHhcCCCCc--cccceeeEEeC----CeeEEEE
Q 043262          353 LGEGGFGPVYKGKLADGKEIAVKRLSRTS------GQGLQEFKNEVTLIAKLQHKN--LVRLLGCCLQE----NESLLIY  420 (512)
Q Consensus       353 lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~------~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~----~~~~lv~  420 (512)
                      -|+||-+.|++-.+. |..+-+|+-...-      +.....|.+|+..+..+...+  +.+++......    -.-+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            467888889987775 4478888765211      335678999999999986433  44444222221    2258999


Q ss_pred             EecC-CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc--eEEeccCcccc
Q 043262          421 EYMP-NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN--PKISDFGMARI  496 (512)
Q Consensus       421 E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~--~kl~DFGla~~  496 (512)
                      |-+. .-+|.+++.+.. ..+.+...+..+..+++..+.-||+.+   +.|+|+.++|||++.++.  ++++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9765 358888884422 224567778899999999999999985   999999999999986666  99999987664

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.34  E-value=1.3e-07  Score=95.29  Aligned_cols=81  Identities=23%  Similarity=0.361  Sum_probs=72.6

Q ss_pred             eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                      .+++.|+++...+|.+||.........+|...+.++.|++.|++|   +   ..+|+|+||.||....+..+||.||||.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            478999999999999999766666678999999999999999999   4   3999999999999999999999999999


Q ss_pred             cccCCCC
Q 043262          495 RIFGGNQ  501 (512)
Q Consensus       495 ~~~~~~~  501 (512)
                      .......
T Consensus       404 ts~~~~~  410 (516)
T KOG1033|consen  404 TSQDKDE  410 (516)
T ss_pred             eecccCC
Confidence            8776555

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.29  E-value=4.9e-06  Score=86.54  Aligned_cols=147  Identities=15%  Similarity=0.218  Sum_probs=93.1

Q ss_pred             CCccccccccccceeEEEEEeCCCCEEEEEEcccCCccc-------------------------------------HHHH
Q 043262          346 HFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQG-------------------------------------LQEF  388 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~-------------------------------------~~~~  388 (512)
                      .|+ .+.||..+.|+||++++++|+.||||+-+..-+..                                     .-+|
T Consensus       163 ~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF  241 (538)
T KOG1235|consen  163 EFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF  241 (538)
T ss_pred             hcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence            344 35799999999999999999999999875432110                                     0123


Q ss_pred             HHHHHHHhc----CCCCcc---ccceeeEEe-CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 043262          389 KNEVTLIAK----LQHKNL---VRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL  460 (512)
Q Consensus       389 ~~E~~~l~~----l~H~nI---v~l~g~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL  460 (512)
                      ..|.+-..+    +.|-++   |.+=.++++ .....|+||||+|..+.+...-  ....++...+..-+.+...-+-+-
T Consensus       242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFK  319 (538)
T ss_pred             HHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHh
Confidence            444443332    335551   112223332 3567999999999887665321  112244444444444433333333


Q ss_pred             HcCCCCCcccCCCCCCCeeecC----CCceEEeccCcccccCCC
Q 043262          461 HEDSRLKIIHRDLKTSNVLLDH----EMNPKISDFGMARIFGGN  500 (512)
Q Consensus       461 H~~~~~~ivH~dlk~~NiLl~~----~~~~kl~DFGla~~~~~~  500 (512)
                      |     +++|.|-+|.||++..    +..+.+-||||.+.+...
T Consensus       320 ~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  320 T-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             c-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            3     4999999999999984    678999999999877643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.28  E-value=1.3e-05  Score=75.47  Aligned_cols=139  Identities=16%  Similarity=0.171  Sum_probs=84.4

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCc--cccceeeEEeCCeeEEEEEecCCCC-
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN--LVRLLGCCLQENESLLIYEYMPNKS-  427 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lv~E~~~~gs-  427 (512)
                      .+||+|..+.||+.   .+..+++|......  ......+|.+++..+..-.  +.+.+++....+...+|||++++.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999983   24567778776433  2345688999998886444  3566777777777889999998863 


Q ss_pred             hhHHh---------------------hcCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHcC-CCCCcccCCC
Q 043262          428 LNVFL---------------------FDSTRSVQLDWKRRI-SIIN----------GIAR-GLLYLHED-SRLKIIHRDL  473 (512)
Q Consensus       428 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~ia~-gL~yLH~~-~~~~ivH~dl  473 (512)
                      +...+                     |.... ......... .+-.          .+.. ...+|... ....++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            22111                     11000 001111100 0000          0111 12222211 2235789999


Q ss_pred             CCCCeeecCCCceEEeccCcccc
Q 043262          474 KTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       474 k~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      .|.||++++++ +.|.||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.19  E-value=1.3e-06  Score=94.83  Aligned_cols=110  Identities=24%  Similarity=0.379  Sum_probs=72.9

Q ss_pred             cCCccccccccccceeEEEEEeCC-CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .+|...++|..|+||.||..+++. .+.+|.|.-+... .    .++   ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-i----lRn---ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-I----LRN---ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccch-h----hhc---cccccCCccee-------------------
Confidence            567888999999999999998753 4566763222110 0    000   12222233222                   


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                        |+-...+..   ..+++-        +++.+++|||+.+   |+|||+||.|.||+.-+++|+.||||.+..
T Consensus       136 --gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 --GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             --chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence              333333321   122322        2378899999985   999999999999999999999999999875

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.19  E-value=5.7e-06  Score=75.38  Aligned_cols=106  Identities=22%  Similarity=0.241  Sum_probs=83.2

Q ss_pred             HHHHHHHhcCCC-CccccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 043262          389 KNEVTLIAKLQH-KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK  467 (512)
Q Consensus       389 ~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  467 (512)
                      ..|..++..+++ +++.+++|.|    ..+++.||...+++...-..-..-..-+|..|.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457888888876 6899999999    34789999988766421000011124689999999999999999999865445


Q ss_pred             cccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       468 ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      +.-.|++++|+-+++++++|+.|...+-...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            7789999999999999999999998876553

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.14  E-value=5.6e-05  Score=69.54  Aligned_cols=139  Identities=17%  Similarity=0.173  Sum_probs=89.4

Q ss_pred             HhcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHH---------HHHHHHHhcCCCC---ccccceeeE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEF---------KNEVTLIAKLQHK---NLVRLLGCC  410 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~---------~~E~~~l~~l~H~---nIv~l~g~~  410 (512)
                      ...+|...+.+.......|.+-.. +|....+|.-+.......+.|         .+++..+.+++..   ..+.++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            345666667777666666776666 467788887765433322222         2333334444322   222323222


Q ss_pred             E-----eCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc
Q 043262          411 L-----QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN  485 (512)
Q Consensus       411 ~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~  485 (512)
                      .     .....+|+|||+++-.|.++..       ++.    .+...+.+.|.-||..+   ++|+|+.|.|+++.+++ 
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence            2     2244579999999988865431       222    24566778899999986   99999999999998664 


Q ss_pred             eEEeccCccccc
Q 043262          486 PKISDFGMARIF  497 (512)
Q Consensus       486 ~kl~DFGla~~~  497 (512)
                      +++.||+..+..
T Consensus       173 i~iID~~~k~~~  184 (229)
T PF06176_consen  173 IRIIDTQGKRMS  184 (229)
T ss_pred             EEEEECcccccc
Confidence            999999887754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.03  E-value=5.5e-05  Score=72.22  Aligned_cols=140  Identities=15%  Similarity=0.182  Sum_probs=84.5

Q ss_pred             cccccc-eeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEEecCCCChhH
Q 043262          353 LGEGGF-GPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYEYMPNKSLNV  430 (512)
Q Consensus       353 lg~G~f-G~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~  430 (512)
                      |..|.. ..||+.... +..+.||......   ...+.+|++++..+. +--+.+++++....+..++|||++++.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            445555 678988765 4678888876443   235667888887774 3345567777766667899999999887764


Q ss_pred             Hh-------------------hcCCC-CCCCCH--HHHHHHH-H-------------------HHHHHHHHHHc----CC
Q 043262          431 FL-------------------FDSTR-SVQLDW--KRRISII-N-------------------GIARGLLYLHE----DS  464 (512)
Q Consensus       431 ~l-------------------~~~~~-~~~l~~--~~~~~i~-~-------------------~ia~gL~yLH~----~~  464 (512)
                      ..                   +.... ..+...  ...+.-. .                   .+...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   11000 001110  0000000 0                   01112222211    12


Q ss_pred             CCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       465 ~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      .+.++|+|+.|.|||++++....|.||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            34589999999999999987789999998864

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.95  E-value=0.00012  Score=68.17  Aligned_cols=139  Identities=17%  Similarity=0.293  Sum_probs=87.7

Q ss_pred             ccccccceeEEEEEeCCCCEEEEEEcccCCcc-------------------cHHH-----HHHHHHHHhcCC--CCcccc
Q 043262          352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ-------------------GLQE-----FKNEVTLIAKLQ--HKNLVR  405 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~-------------------~~~~-----~~~E~~~l~~l~--H~nIv~  405 (512)
                      .|..|.-..||+|.-.++..+|||+.+.....                   ..+.     ...|..-|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            45567778899999888999999988643211                   1110     233444444442  222333


Q ss_pred             ceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc
Q 043262          406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN  485 (512)
Q Consensus       406 l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~  485 (512)
                      .+++    ..-.|||||+....+-   ....+..++.......+..++.+.|.-|-...  ++||+||..=|||+. ++.
T Consensus       135 Pi~~----~~nVLvMEfIg~~g~p---AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~  204 (268)
T COG1718         135 PIAF----RNNVLVMEFIGDDGLP---APRLKDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGE  204 (268)
T ss_pred             ceee----cCCeEEEEeccCCCCC---CCCcccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCe
Confidence            3322    2336999998654110   00011222333356667777888888777643  699999999999999 789


Q ss_pred             eEEeccCcccccCCC
Q 043262          486 PKISDFGMARIFGGN  500 (512)
Q Consensus       486 ~kl~DFGla~~~~~~  500 (512)
                      +.|+|||-|-....+
T Consensus       205 p~iID~~QaV~~~hp  219 (268)
T COG1718         205 PYIIDVSQAVTIDHP  219 (268)
T ss_pred             EEEEECccccccCCC
Confidence            999999988776533

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.93  E-value=5e-05  Score=71.55  Aligned_cols=144  Identities=21%  Similarity=0.228  Sum_probs=84.0

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCC--ccccceeeEEeC---CeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK--NLVRLLGCCLQE---NESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~~~~~---~~~~lv~E~~~~  425 (512)
                      +.|+.|..+.||+....+ ..+++|.....  .....+..|..++..+...  .+.+++......   ...+++||++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            468889999999999977 68999987654  3456777888888877533  345666644332   346899999999


Q ss_pred             CChhH----------------Hh---hcC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHc-
Q 043262          426 KSLNV----------------FL---FDS-TRSVQLDWKR---------RISI------------INGIAR-GLLYLHE-  462 (512)
Q Consensus       426 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~-  462 (512)
                      ..+..                .+   +.. .......+..         ....            ...+.. .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88877                11   111 0111111110         0000            111222 2333332 


Q ss_pred             ---CCCCCcccCCCCCCCeeec-CCCceEEeccCccccc
Q 043262          463 ---DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIF  497 (512)
Q Consensus       463 ---~~~~~ivH~dlk~~NiLl~-~~~~~kl~DFGla~~~  497 (512)
                         .....++|+|+.|.|||++ +++.+-|.||+.+..-
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence               1334599999999999999 5666689999987643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.86  E-value=0.00018  Score=65.85  Aligned_cols=134  Identities=18%  Similarity=0.299  Sum_probs=90.0

Q ss_pred             ccccccccccceeEEEEEeCCCCEEEEEEcccCC----------------cccHHHHHHHHHHHhcCC------CCcccc
Q 043262          348 SDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS----------------GQGLQEFKNEVTLIAKLQ------HKNLVR  405 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~nIv~  405 (512)
                      +....||+|+.-.||  .+++.....||+.....                ....++..+|+.....+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            345679999988888  45556677888886544                223456677776655555      888999


Q ss_pred             ceeeEEeCCeeEEEEEecCC--C----ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCee
Q 043262          406 LLGCCLQENESLLIYEYMPN--K----SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVL  479 (512)
Q Consensus       406 l~g~~~~~~~~~lv~E~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiL  479 (512)
                      ++|+...+...-+|+|.+.+  |    +|.+++.+    ..++. .....+.+.   ..||-++   .|+.+||+|.||+
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~~f---~~~l~~~---~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALDEF---KRYLLDH---HIVIRDLNPHNIV  150 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHHHH---HHHHHHc---CCeecCCCcccEE
Confidence            99999999999999998743  2    46677733    23444 333333333   3455554   4999999999999


Q ss_pred             ecCC---C-ceEEec-cCcc
Q 043262          480 LDHE---M-NPKISD-FGMA  494 (512)
Q Consensus       480 l~~~---~-~~kl~D-FGla  494 (512)
                      +...   . .+.|.| ||-.
T Consensus       151 ~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EEecCCCceEEEEEeCCCCc
Confidence            9543   2 466666 4433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.80  E-value=0.00026  Score=79.59  Aligned_cols=79  Identities=16%  Similarity=0.389  Sum_probs=56.6

Q ss_pred             ccccccccceeEEEEEeCCC---CEEEEEEcccCC-cccHHHHHHHHHHHhcCC-CCcc--ccceeeEEeC---CeeEEE
Q 043262          350 ENKLGEGGFGPVYKGKLADG---KEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQ-HKNL--VRLLGCCLQE---NESLLI  419 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g---~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nI--v~l~g~~~~~---~~~~lv  419 (512)
                      .++++.|.+..+|+....++   ..+++|+..... ......+.+|.+++..+. |.+|  .++++++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45688899999999887654   356777664332 223457889999999995 6665  6777777654   457899


Q ss_pred             EEecCCCCh
Q 043262          420 YEYMPNKSL  428 (512)
Q Consensus       420 ~E~~~~gsL  428 (512)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987643

>PRK10593 hypothetical protein; Provisional

Probab=97.70  E-value=0.00056  Score=67.26  Aligned_cols=78  Identities=12%  Similarity=0.089  Sum_probs=56.3

Q ss_pred             ccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCC---CccccceeeEEe---CCeeEEEEE
Q 043262          348 SDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH---KNLVRLLGCCLQ---ENESLLIYE  421 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~---~~~~~lv~E  421 (512)
                      ...+.||.|..+.||+....+++ +.+|..+..  .....|..|.+.++.|..   ..+.++++++..   .+..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            34567999999999998876664 566664331  123578899999888853   357788887754   356899999


Q ss_pred             ecCCCCh
Q 043262          422 YMPNKSL  428 (512)
Q Consensus       422 ~~~~gsL  428 (512)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.57  E-value=0.0006  Score=64.70  Aligned_cols=31  Identities=26%  Similarity=0.386  Sum_probs=26.2

Q ss_pred             CCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       466 ~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      +.++|+|+.+.|||++++...-|.||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3489999999999998776567999998764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.46  E-value=0.00093  Score=60.86  Aligned_cols=125  Identities=27%  Similarity=0.415  Sum_probs=88.4

Q ss_pred             cCCccccccccccc-eeEEEEEeCCCCEEEEEEccc---C---------Cc---------ccHHHHHHHHHHHhcCC---
Q 043262          345 QHFSDENKLGEGGF-GPVYKGKLADGKEIAVKRLSR---T---------SG---------QGLQEFKNEVTLIAKLQ---  399 (512)
Q Consensus       345 ~~~~~~~~lg~G~f-G~Vy~~~~~~g~~vaVK~l~~---~---------~~---------~~~~~~~~E~~~l~~l~---  399 (512)
                      .+++..+.||.|.- |.|||.+.. |..+|+|..+.   .         ..         .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67777889999999 999999994 77999999321   0         00         11235888998888775   


Q ss_pred             CCcc--ccceeeEEeCC------------------eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 043262          400 HKNL--VRLLGCCLQEN------------------ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY  459 (512)
Q Consensus       400 H~nI--v~l~g~~~~~~------------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y  459 (512)
                      +.++  |+.+||..-..                  ..-+|.||++...            .+.    ..-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            4566  89999985331                  1246777665432            122    2234567777888


Q ss_pred             HHcCCCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       460 LH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                      +|..+   |+-+|+++.|..     .-||.|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99875   999999999986     5689999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.46  E-value=0.0015  Score=57.74  Aligned_cols=130  Identities=23%  Similarity=0.307  Sum_probs=85.4

Q ss_pred             cccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          349 DENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       349 ~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      ..+.|++|.+|.||+|.+. |.++|+|.-+..+.  +..+..|.+++..++-.++-.=+   ..-+..++.|||..+-.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~v---y~yg~~~i~me~i~G~~L   99 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEV---YFYGEDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceE---EEechhhhhhhhhcCcch
Confidence            3567999999999999996 45888887665443  46788999999888766554321   122334566999988888


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCC-CCCeeecCCCceEEeccCccccc
Q 043262          429 NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK-TSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk-~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      .+.-..      .+.+....+    ++. +|.-+.  ++|-|+.|. |...+|..+..+.|+||--|+.-
T Consensus       100 ~~~~~~------~~rk~l~~v----lE~-a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112         100 GKLEIG------GDRKHLLRV----LEK-AYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhc------ccHHHHHHH----HHH-HHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            765421      122333333    333 333322  258888775 55555555669999999998843

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.39  E-value=0.0021  Score=65.33  Aligned_cols=75  Identities=15%  Similarity=0.246  Sum_probs=52.5

Q ss_pred             cccccccceeEEEEEeCCC-CEEEEEEcccC-----C--cccHHHHHHHHHHHhcCC---CCccccceeeEEeCCeeEEE
Q 043262          351 NKLGEGGFGPVYKGKLADG-KEIAVKRLSRT-----S--GQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g-~~vaVK~l~~~-----~--~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv  419 (512)
                      +.||.|.+..||+....+| +.|+||.-...     .  ....+.+..|.+.|..+.   ...+.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999999877 48999975311     1  123456777777777653   2345666655  44567899


Q ss_pred             EEecCCCC
Q 043262          420 YEYMPNKS  427 (512)
Q Consensus       420 ~E~~~~gs  427 (512)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.37  E-value=0.0016  Score=62.66  Aligned_cols=138  Identities=16%  Similarity=0.134  Sum_probs=76.9

Q ss_pred             cccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccc-cceeeEEeCCeeEEEEEecCCCChhHH
Q 043262          353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV-RLLGCCLQENESLLIYEYMPNKSLNVF  431 (512)
Q Consensus       353 lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~E~~~~gsL~~~  431 (512)
                      +..|-...+|+... ++..+++|........-.-+..+|..++..+....++ ++++..    ..++|+||+++..+..-
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence            45577788998874 5667888876543222112356788888887644343 333332    24789999988665321


Q ss_pred             -----------------hhcCC-CCCCCCHHHH-HHHH---------HHHHHHHHHHHcC-----CCCCcccCCCCCCCe
Q 043262          432 -----------------LFDST-RSVQLDWKRR-ISII---------NGIARGLLYLHED-----SRLKIIHRDLKTSNV  478 (512)
Q Consensus       432 -----------------l~~~~-~~~~l~~~~~-~~i~---------~~ia~gL~yLH~~-----~~~~ivH~dlk~~Ni  478 (512)
                                       ||... ...+++.... ....         ..+..-+..+-..     ....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             11111 1112222211 1111         1111112222211     123489999999999


Q ss_pred             eecCCCceEEeccCcccc
Q 043262          479 LLDHEMNPKISDFGMARI  496 (512)
Q Consensus       479 Ll~~~~~~kl~DFGla~~  496 (512)
                      ++++++ ++|.||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999876 78999988764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.35  E-value=0.0019  Score=61.11  Aligned_cols=141  Identities=18%  Similarity=0.287  Sum_probs=79.1

Q ss_pred             cccccccceeEEEEEeCC--CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccc-cceeeEEeCCeeEEEEEecCCCC
Q 043262          351 NKLGEGGFGPVYKGKLAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV-RLLGCCLQENESLLIYEYMPNKS  427 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~--g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~E~~~~gs  427 (512)
                      +.|..|-...+|+....+  +..+++|........ ..+-.+|+.++..+...+++ ++++..  .  ..++|||+++..
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~--~--~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATF--Q--NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEe--C--CcEEEEeeCCCc
Confidence            456667778999988764  678888876543221 12234688888877544443 333322  2  248999998876


Q ss_pred             hhHH-----------------hhcCCCCC--------CC-CHHHHHHHHH----------------------HHHHHHHH
Q 043262          428 LNVF-----------------LFDSTRSV--------QL-DWKRRISIIN----------------------GIARGLLY  459 (512)
Q Consensus       428 L~~~-----------------l~~~~~~~--------~l-~~~~~~~i~~----------------------~ia~gL~y  459 (512)
                      +...                 ++......        .. -|.....+..                      .+..-+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            5321                 01111110        11 1222111111                      11111122


Q ss_pred             H----HcC-CCCCcccCCCCCCCeeecC-CCceEEeccCcccc
Q 043262          460 L----HED-SRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARI  496 (512)
Q Consensus       460 L----H~~-~~~~ivH~dlk~~NiLl~~-~~~~kl~DFGla~~  496 (512)
                      |    -.. ....++|+|+.+.|||+++ +..+.|.||-.|..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            2    111 2345899999999999998 57899999987764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.98  E-value=0.0097  Score=58.45  Aligned_cols=143  Identities=18%  Similarity=0.193  Sum_probs=84.0

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCc--cccceee------EEeCCeeEEEEE
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN--LVRLLGC------CLQENESLLIYE  421 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~------~~~~~~~~lv~E  421 (512)
                      .+.|..|....+|+....+ ..+++|....   ........|+.++..+.+.+  +.+++..      ....+..++|+|
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4557777778899887654 4688887764   22345666777777774332  4444331      123455689999


Q ss_pred             ecCCCChhH----H----------hhcC----C----CCCCCCHHHHH----------HHHHHHHHHHHHHHc----CCC
Q 043262          422 YMPNKSLNV----F----------LFDS----T----RSVQLDWKRRI----------SIINGIARGLLYLHE----DSR  465 (512)
Q Consensus       422 ~~~~gsL~~----~----------l~~~----~----~~~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~  465 (512)
                      |+++..+..    .          ++..    .    ......|....          .....+...+.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998876532    0          0110    0    00112332221          011223444555543    122


Q ss_pred             CCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       466 ~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ..++|+|+.|.|||++++..+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3599999999999999987788999987653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=96.97  E-value=0.027  Score=55.98  Aligned_cols=141  Identities=18%  Similarity=0.225  Sum_probs=75.0

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCc--ccccee------eEEeCCeeEEEEEe
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN--LVRLLG------CCLQENESLLIYEY  422 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g------~~~~~~~~~lv~E~  422 (512)
                      +.|+.|....+|+....+| .+++|+.....   .+....|+.++..|...+  +.+.+.      +....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4566677778999887655 67888775222   233333444444442211  333332      11234567899999


Q ss_pred             cCCCChhH-----------Hh---hcCCC--------CCCCCH-HHHHHH------------H-HHHHHHHHHHHcC---
Q 043262          423 MPNKSLNV-----------FL---FDSTR--------SVQLDW-KRRISI------------I-NGIARGLLYLHED---  463 (512)
Q Consensus       423 ~~~gsL~~-----------~l---~~~~~--------~~~l~~-~~~~~i------------~-~~ia~gL~yLH~~---  463 (512)
                      +++..+..           .|   +....        ...+.| .....-            . ..+...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            98875421           11   11100        111222 111111            1 1111222333211   


Q ss_pred             -CCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          464 -SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       464 -~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                       -...++|+|+.+.|||++.+...-|.||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             23369999999999999977656899999874

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.66  E-value=0.035  Score=54.92  Aligned_cols=143  Identities=17%  Similarity=0.199  Sum_probs=80.0

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCc--cccceee------EEeCCeeEEEEE
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN--LVRLLGC------CLQENESLLIYE  421 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~------~~~~~~~~lv~E  421 (512)
                      .+.++.|....+|+....++ ..++|......  ...+...|++++..|....  +.+++..      ....+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            34566776778998876555 56678765422  1234455666666653222  3344332      112455789999


Q ss_pred             ecCCCChhH-----------H---hhcCCCC---------CCCCHHHHHH------------HHHHHHHHHHHHHc----
Q 043262          422 YMPNKSLNV-----------F---LFDSTRS---------VQLDWKRRIS------------IINGIARGLLYLHE----  462 (512)
Q Consensus       422 ~~~~gsL~~-----------~---l~~~~~~---------~~l~~~~~~~------------i~~~ia~gL~yLH~----  462 (512)
                      |+++..+..           .   ++.....         ..-.|.....            ....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            998754321           0   1110000         0112221110            11223345555542    


Q ss_pred             CCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       463 ~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .....++|+|+++.||+++++....|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223469999999999999998777899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.51  E-value=0.024  Score=55.14  Aligned_cols=32  Identities=22%  Similarity=0.463  Sum_probs=26.4

Q ss_pred             CCcccCCCCCCCeeecCCCc-eEEeccCccccc
Q 043262          466 LKIIHRDLKTSNVLLDHEMN-PKISDFGMARIF  497 (512)
Q Consensus       466 ~~ivH~dlk~~NiLl~~~~~-~kl~DFGla~~~  497 (512)
                      ..++|+|+++.|||+++++. .-|.||+.+.+-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            35899999999999997555 469999988754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.48  E-value=0.026  Score=55.62  Aligned_cols=141  Identities=26%  Similarity=0.346  Sum_probs=80.3

Q ss_pred             ccccccceeEEEEEeCC-------CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccc-cceeeEEeCCeeEEEEEec
Q 043262          352 KLGEGGFGPVYKGKLAD-------GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV-RLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~-------g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~E~~  423 (512)
                      .|..|-...+|+....+       +..+++|....... ...+..+|.+++..+....+. ++++...    -.+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhee
Confidence            34455566888887655       47788888654332 223456777777777543333 3444432    23689999


Q ss_pred             CCCChhHH-----------------hhcCCCC--------CCCCHHHHHH--------------------------HHHH
Q 043262          424 PNKSLNVF-----------------LFDSTRS--------VQLDWKRRIS--------------------------IING  452 (512)
Q Consensus       424 ~~gsL~~~-----------------l~~~~~~--------~~l~~~~~~~--------------------------i~~~  452 (512)
                      ++..+...                 +|.....        .+.-|.....                          +...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88766431                 1111100        0001111100                          1122


Q ss_pred             HHHHHHHHHc------CCCCCcccCCCCCCCeeecCC----CceEEeccCccccc
Q 043262          453 IARGLLYLHE------DSRLKIIHRDLKTSNVLLDHE----MNPKISDFGMARIF  497 (512)
Q Consensus       453 ia~gL~yLH~------~~~~~ivH~dlk~~NiLl~~~----~~~kl~DFGla~~~  497 (512)
                      +..-+.+|..      .....++|+|+.+.|||++++    ..++|+||..+..-
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            2333444532      234568999999999999985    78999999988753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.37  E-value=0.022  Score=56.20  Aligned_cols=138  Identities=17%  Similarity=0.211  Sum_probs=92.7

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCC-------c---------------ccHH----HHHHHHHHHhcCCCCccc
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTS-------G---------------QGLQ----EFKNEVTLIAKLQHKNLV  404 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~-------~---------------~~~~----~~~~E~~~l~~l~H~nIv  404 (512)
                      ..|..|.-..||.+.-.+|.++|||+++..-       .               ..++    -...|++-|.+++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            4577888899999999999999999875320       0               0011    123466666666544433


Q ss_pred             cceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC
Q 043262          405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM  484 (512)
Q Consensus       405 ~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~  484 (512)
                      ..--...  ....|||+|+....   |-....+...++...+..+-.+++.-|.-|.+.+  ++||.||.--|+|+-+ +
T Consensus       230 ~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G  301 (520)
T KOG2270|consen  230 CPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-G  301 (520)
T ss_pred             CCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-C
Confidence            2221111  12368999986432   2222234456777788888889999999998887  7999999999999854 5


Q ss_pred             ceEEeccCcccc
Q 043262          485 NPKISDFGMARI  496 (512)
Q Consensus       485 ~~kl~DFGla~~  496 (512)
                      .+.|+|.+-+-.
T Consensus       302 ~lyiIDVSQSVE  313 (520)
T KOG2270|consen  302 KLYIIDVSQSVE  313 (520)
T ss_pred             EEEEEEcccccc
Confidence            788999875543

>PLN02236 choline kinase

Probab=96.29  E-value=0.034  Score=55.94  Aligned_cols=141  Identities=18%  Similarity=0.261  Sum_probs=78.1

Q ss_pred             ccccccceeEEEEEeCC-----CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccc-cceeeEEeCCeeEEEEEecCC
Q 043262          352 KLGEGGFGPVYKGKLAD-----GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV-RLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~-----g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      .|-.|-.-.+|+....+     +..+++|........... -.+|..++..+...++. ++++...  +.  .|.||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~--~g--~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFP--NG--RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEEC--Cc--eEEEeeCC
Confidence            34446667888887532     357888877554332222 26788887777654444 3444442  22  58999977


Q ss_pred             CChhHH-----------------hhcCCC---CCCCCHHHHHHHHHH-----------------HHHHHHHH----Hc-C
Q 043262          426 KSLNVF-----------------LFDSTR---SVQLDWKRRISIING-----------------IARGLLYL----HE-D  463 (512)
Q Consensus       426 gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~~-----------------ia~gL~yL----H~-~  463 (512)
                      .+|..-                 +|....   .....|.+...+..+                 +..-+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            665321                 111110   011123322222211                 11122222    22 2


Q ss_pred             CCCCcccCCCCCCCeeecC-CCceEEeccCccccc
Q 043262          464 SRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIF  497 (512)
Q Consensus       464 ~~~~ivH~dlk~~NiLl~~-~~~~kl~DFGla~~~  497 (512)
                      ....++|+|+++.|||+++ +..+.|.||..+..-
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            2345899999999999986 468999999887653

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.05  E-value=0.027  Score=54.87  Aligned_cols=74  Identities=18%  Similarity=0.302  Sum_probs=47.3

Q ss_pred             cccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcC---CCCccccceeeEEeCCeeEEEEEecCC
Q 043262          349 DENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL---QHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       349 ~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ..+.++-|....+|+.. .++..+.||.-..   .....|..|.+-|+.|   .--.+.+.+++....+..+||+||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            34568888889999877 5678899998762   2235677888777776   345577889988888888999999987


Q ss_pred             C
Q 043262          426 K  426 (512)
Q Consensus       426 g  426 (512)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            7

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.02  E-value=0.079  Score=52.14  Aligned_cols=128  Identities=18%  Similarity=0.291  Sum_probs=74.1

Q ss_pred             CCEEEEEEccc--CCcccHHHHHHHHHHHhcCCC--CccccceeeEEeCC--eeEEEEEecCCCChh-------------
Q 043262          369 GKEIAVKRLSR--TSGQGLQEFKNEVTLIAKLQH--KNLVRLLGCCLQEN--ESLLIYEYMPNKSLN-------------  429 (512)
Q Consensus       369 g~~vaVK~l~~--~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~--~~~lv~E~~~~gsL~-------------  429 (512)
                      +++.++. ...  ..........+|..+|+.+.-  .-+...++.|.++.  ..+.||||+++..+.             
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~  126 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA  126 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence            5666666 321  222334556677777777643  23445667776666  669999999873221             


Q ss_pred             -----HHhh---cC--------C-----CCCC-CCHHHHHHHH--------HHHHHHHHHHHcCC-----CCCcccCCCC
Q 043262          430 -----VFLF---DS--------T-----RSVQ-LDWKRRISII--------NGIARGLLYLHEDS-----RLKIIHRDLK  474 (512)
Q Consensus       430 -----~~l~---~~--------~-----~~~~-l~~~~~~~i~--------~~ia~gL~yLH~~~-----~~~ivH~dlk  474 (512)
                           ++|.   .-        .     ...+ -.|......+        -....-..||+.+.     ...++|+|++
T Consensus       127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                 1111   00        0     0001 1122222111        12233355665542     3469999999


Q ss_pred             CCCeeecCCCceEEeccCccccc
Q 043262          475 TSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       475 ~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +.|++++.+.-+=|.||+++..-
T Consensus       207 ~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         207 PGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             cCCEEEeCCCeeEEEeccccccC
Confidence            99999999888999999998764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=95.85  E-value=0.0024  Score=66.77  Aligned_cols=135  Identities=19%  Similarity=0.193  Sum_probs=94.6

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCc-cccceeeEEeCCeeEEEEEecCCC-Ch
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN-LVRLLGCCLQENESLLIYEYMPNK-SL  428 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lv~E~~~~g-sL  428 (512)
                      .-++++++++++|.+....+...++.+...     .+..-++++|.+++||| .+..++-+..++..+++++++..+ +-
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence            457889999999988654445556655433     34567889999999999 777777777778889999999877 21


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          429 NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ..-.  ......+...+...+...-.++|+|||+..   -+|+|    |||..+ ...|..||+....+...
T Consensus       323 ~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  323 ALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             cccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence            1111  011122333444556666788999999853   58998    777766 57899999998877654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=95.76  E-value=0.0018  Score=71.09  Aligned_cols=146  Identities=18%  Similarity=0.196  Sum_probs=97.3

Q ss_pred             cCCccccccccccceeEEEEEeCC-CCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      +.|...+-+-+|.++.+....-.. |...++|......   ....+....+-.+.-..+||-+++..--+.......|++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            445555667788898888776432 3223333322111   111222233333333345677776666666778899999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      +|+.+++|...|+...   .++..-....+..+...++|||..   .+.|+|++|.|.|...++..+++|||+...
T Consensus       884 ~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             HHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence            9999999998886543   233333344556678899999985   389999999999999999999999995544

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.71  E-value=0.13  Score=50.79  Aligned_cols=29  Identities=24%  Similarity=0.347  Sum_probs=25.0

Q ss_pred             CCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          466 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       466 ~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      ..++|+|+.+.||+++. ..+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            46899999999999988 578999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.65  E-value=0.01  Score=57.62  Aligned_cols=131  Identities=17%  Similarity=0.190  Sum_probs=86.8

Q ss_pred             CccccccccccceeEEEEEeCCCCEEEEEEcccC------------------Cccc----HHHHHHHHHHHhcCCC--Cc
Q 043262          347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRT------------------SGQG----LQEFKNEVTLIAKLQH--KN  402 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~------------------~~~~----~~~~~~E~~~l~~l~H--~n  402 (512)
                      ++..++||-|.-+-||.+-..+|.+.++|.-+..                  +..+    +-...+|...|+.|..  --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            4567899999999999999999999888742110                  0111    2234667777777743  22


Q ss_pred             cccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC
Q 043262          403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH  482 (512)
Q Consensus       403 Iv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~  482 (512)
                      |.+.++    .+..++|||++.+-.|...-+      ..+.+++.   ..++.-+.-|..++   +||+|..-=||++++
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly---~~lm~~Iv~la~~G---lIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLY---DDLMGLIVRLANHG---LIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeeee------cCChHHHH---HHHHHHHHHHHHcC---ceecccchheeEEec
Confidence            334443    345689999988776643321      12233333   23333344555554   999999999999999


Q ss_pred             CCceEEeccCc
Q 043262          483 EMNPKISDFGM  493 (512)
Q Consensus       483 ~~~~kl~DFGl  493 (512)
                      +..++++||--
T Consensus       238 d~~i~vIDFPQ  248 (465)
T KOG2268|consen  238 DDKIVVIDFPQ  248 (465)
T ss_pred             CCCEEEeechH
Confidence            99999999953

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.61  E-value=0.11  Score=52.04  Aligned_cols=79  Identities=14%  Similarity=0.196  Sum_probs=47.7

Q ss_pred             ccccccceeEEEEEeCCC-CEEEEEEccc-------CCcccHHHHHHHHHHHhcCC--CC-ccccceeeEEeCCeeEEEE
Q 043262          352 KLGEGGFGPVYKGKLADG-KEIAVKRLSR-------TSGQGLQEFKNEVTLIAKLQ--HK-NLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~g-~~vaVK~l~~-------~~~~~~~~~~~E~~~l~~l~--H~-nIv~l~g~~~~~~~~~lv~  420 (512)
                      .||.|....||++..++| ..|+||.-..       .-+-...+..-|.+.|....  -| .+.+++  ..+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence            478999999999998755 5899986421       11233444556666665542  23 233333  33555667999


Q ss_pred             EecCCCC-hhHHh
Q 043262          421 EYMPNKS-LNVFL  432 (512)
Q Consensus       421 E~~~~gs-L~~~l  432 (512)
                      |+++... |...|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            9996533 33444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.42  E-value=0.27  Score=45.62  Aligned_cols=74  Identities=19%  Similarity=0.329  Sum_probs=49.7

Q ss_pred             ccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcC---CCCccccceeeEEeCCeeEEEEEecCCCCh
Q 043262          352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL---QHKNLVRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      .+.-|..-+-|.... +..++-||+-..   .....|..|+.-|..+   +--++.+.+.+-.+.++.++|+||++-|.+
T Consensus        23 ~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          23 EVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            344444333343332 456788886432   3356788887765555   456678888888899999999999998777


Q ss_pred             h
Q 043262          429 N  429 (512)
Q Consensus       429 ~  429 (512)
                      +
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            5

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.40  E-value=0.22  Score=50.70  Aligned_cols=73  Identities=12%  Similarity=0.109  Sum_probs=46.7

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEEcccC----Cc---ccHHHHHHHHHHHhcCC---CCccccceeeEEeCCeeEEE
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRT----SG---QGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~----~~---~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .+.||.|..-.||+.... +..++||.-...    ..   ....+-..|...|..+.   ...+.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            456899999999998764 556888875411    11   12233334455555442   346777777776  556889


Q ss_pred             EEecCC
Q 043262          420 YEYMPN  425 (512)
Q Consensus       420 ~E~~~~  425 (512)
                      ||+++.
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.21  E-value=0.082  Score=53.04  Aligned_cols=61  Identities=20%  Similarity=0.134  Sum_probs=42.0

Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH  482 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~  482 (512)
                      ..|+-+|+++-++..++...    ..++....+++.-.+.+|.-+-.-.  +++|.|+.|.||++-.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~----~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK----SQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhcc----cChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence            45777888888998888432    2344455666666666665443322  5999999999999943

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.94  E-value=0.26  Score=48.99  Aligned_cols=136  Identities=23%  Similarity=0.294  Sum_probs=79.3

Q ss_pred             cceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCc------cccceeeEE--eCC--eeEEEEEecCCC
Q 043262          357 GFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN------LVRLLGCCL--QEN--ESLLIYEYMPNK  426 (512)
Q Consensus       357 ~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~--~~~--~~~lv~E~~~~g  426 (512)
                      .--.+|+....+|+. ++|..+..  ....+...|+..+..|.-..      |..+=|-..  -..  ..+-+++|+++.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            345688888877777 77777655  33455666666666663221      222222221  123  678899999988


Q ss_pred             ChhH-Hh--------------hc---------CCCCCCCCHHH-------------HHHHHHHHHHHHHHHHcCC-----
Q 043262          427 SLNV-FL--------------FD---------STRSVQLDWKR-------------RISIINGIARGLLYLHEDS-----  464 (512)
Q Consensus       427 sL~~-~l--------------~~---------~~~~~~l~~~~-------------~~~i~~~ia~gL~yLH~~~-----  464 (512)
                      .+.. ..              +.         +.......|..             ......++...+..+.+.-     
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            8772 10              10         00111233431             0112334455555554431     


Q ss_pred             C--CCcccCCCCCCCeeecCCCc-eEEeccCccc
Q 043262          465 R--LKIIHRDLKTSNVLLDHEMN-PKISDFGMAR  495 (512)
Q Consensus       465 ~--~~ivH~dlk~~NiLl~~~~~-~kl~DFGla~  495 (512)
                      .  ..+||+|+.|.||+++.+.. +-+.||+-+.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            1  22899999999999999885 8899998664

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.67  E-value=0.14  Score=51.94  Aligned_cols=73  Identities=10%  Similarity=0.141  Sum_probs=46.5

Q ss_pred             cccccccceeEEEEEeCC-CCEEEEEEccc------CCcccHHHHHHHHHHHhcCC--CC-ccccceeeEEeCCeeEEEE
Q 043262          351 NKLGEGGFGPVYKGKLAD-GKEIAVKRLSR------TSGQGLQEFKNEVTLIAKLQ--HK-NLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~------~~~~~~~~~~~E~~~l~~l~--H~-nIv~l~g~~~~~~~~~lv~  420 (512)
                      +.||.|.-..||++...+ +..|+||.-..      .-+-..++..-|.+.|....  -| .+.+++.  .+.+...+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHHH
Confidence            568999999999999753 56799986421      11233555666666666542  23 3444443  3455567899


Q ss_pred             EecCC
Q 043262          421 EYMPN  425 (512)
Q Consensus       421 E~~~~  425 (512)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            99864

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.66  E-value=0.097  Score=51.79  Aligned_cols=71  Identities=21%  Similarity=0.294  Sum_probs=55.0

Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .+++|++. +++|...       ..-.|.+.+.|+.+.+.-++-|..+  .++=||||.-.||||+ +|++-|+||-++|
T Consensus       301 ~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         301 LYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             EEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeee
Confidence            45666654 4444221       2357889999999988888777765  4799999999999999 8999999999999


Q ss_pred             cc
Q 043262          496 IF  497 (512)
Q Consensus       496 ~~  497 (512)
                      .-
T Consensus       370 l~  371 (488)
T COG5072         370 LS  371 (488)
T ss_pred             cc
Confidence            53

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=94.47  E-value=0.026  Score=36.48  Aligned_cols=16  Identities=19%  Similarity=0.306  Sum_probs=6.8

Q ss_pred             CceeeeehhhHHHHHH
Q 043262          259 SRTWIAIGAAASSIIV  274 (512)
Q Consensus       259 ~~~~i~i~i~v~~vll  274 (512)
                      ....|++++++.++++
T Consensus         9 ~~vaIa~~VvVPV~vI   24 (40)
T PF08693_consen    9 NTVAIAVGVVVPVGVI   24 (40)
T ss_pred             ceEEEEEEEEechHHH
Confidence            3344544444443333

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.40  E-value=1.1  Score=44.77  Aligned_cols=69  Identities=13%  Similarity=0.107  Sum_probs=42.3

Q ss_pred             ceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCC--ccccc---ee--eEEeCCeeEEEEEecCCCC
Q 043262          358 FGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK--NLVRL---LG--CCLQENESLLIYEYMPNKS  427 (512)
Q Consensus       358 fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l---~g--~~~~~~~~~lv~E~~~~gs  427 (512)
                      -..||+....++..+++|..+.. .....+...|++.+..|...  .++..   -|  ....++..+.+++++++..
T Consensus        38 eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         38 ENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            35789988888888998887532 22345666777776665321  12222   22  1223456788999998754

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.36  E-value=0.47  Score=46.89  Aligned_cols=32  Identities=25%  Similarity=0.343  Sum_probs=28.0

Q ss_pred             CCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       465 ~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      +..++|+|+.+.|+|+++++.+.|.||-.+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34699999999999999998999999987754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=94.29  E-value=0.33  Score=48.56  Aligned_cols=140  Identities=16%  Similarity=0.264  Sum_probs=74.4

Q ss_pred             ccccccceeEEEEEeCC----CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccc-cceeeEEeCCeeEEEEEecCCC
Q 043262          352 KLGEGGFGPVYKGKLAD----GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV-RLLGCCLQENESLLIYEYMPNK  426 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~E~~~~g  426 (512)
                      .|..|=.-.+|+....+    +..+++|........ .-+-.+|..++..+...++. +++++. . +.  +|.||+++-
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~-~-~G--~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVF-G-NG--MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEe-C-Cc--EeehhhcCC
Confidence            34345556788876543    237888876544332 22235677777777655554 445444 2 22  588998765


Q ss_pred             ChhH-------H----------hhcCCC---CCCCCHHHHHHHHHH----------------------HHHHHH----HH
Q 043262          427 SLNV-------F----------LFDSTR---SVQLDWKRRISIING----------------------IARGLL----YL  460 (512)
Q Consensus       427 sL~~-------~----------l~~~~~---~~~l~~~~~~~i~~~----------------------ia~gL~----yL  460 (512)
                      .|..       .          +|....   ..+--|....++..+                      +..-+.    ++
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            5421       0          111110   011123322222111                      111111    22


Q ss_pred             Hc-CCCCCcccCCCCCCCeeecC-CCceEEeccCcccc
Q 043262          461 HE-DSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARI  496 (512)
Q Consensus       461 H~-~~~~~ivH~dlk~~NiLl~~-~~~~kl~DFGla~~  496 (512)
                      .. ....-+.|+||.+.|||+++ +..++++||..|..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11 11223789999999999975 57899999987764

>PRK06148 hypothetical protein; Provisional

Probab=94.26  E-value=0.59  Score=53.97  Aligned_cols=30  Identities=33%  Similarity=0.522  Sum_probs=25.2

Q ss_pred             CCcccCCCCCCCeeecCCC--ceE-EeccCccc
Q 043262          466 LKIIHRDLKTSNVLLDHEM--NPK-ISDFGMAR  495 (512)
Q Consensus       466 ~~ivH~dlk~~NiLl~~~~--~~k-l~DFGla~  495 (512)
                      ..+||+|+.+.|||++.+.  .+. |.|||-+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4599999999999999875  555 99999764

>PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region

Probab=94.12  E-value=0.044  Score=46.79  Aligned_cols=29  Identities=17%  Similarity=0.248  Sum_probs=13.6

Q ss_pred             ceeeeehhhHHHHHHHHHHHHHhhhhhhh
Q 043262          260 RTWIAIGAAASSIIVLALSCFLLWCMKRR  288 (512)
Q Consensus       260 ~~~i~i~i~v~~vlll~l~~~i~~~~rrr  288 (512)
                      .++|.+++.+++.++++++++++++++|+
T Consensus        49 nIVIGvVVGVGg~ill~il~lvf~~c~r~   77 (154)
T PF04478_consen   49 NIVIGVVVGVGGPILLGILALVFIFCIRR   77 (154)
T ss_pred             cEEEEEEecccHHHHHHHHHhheeEEEec
Confidence            44555544444555555444444443333

The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway [].

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.35  E-value=0.33  Score=44.85  Aligned_cols=100  Identities=16%  Similarity=0.173  Sum_probs=62.1

Q ss_pred             EEEEEcccCCcc-cHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHH
Q 043262          372 IAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII  450 (512)
Q Consensus       372 vaVK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~  450 (512)
                      ..+|+++...-. ...-|..+.++++++.  .|++|..-  .....-+++|+|-.-..            +.    ..++
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~----~N~i  147 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF----SNFI  147 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch----hHHH
Confidence            456666544333 3456778888887765  35555521  22234577888732111            00    1111


Q ss_pred             HHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccC
Q 043262          451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  492 (512)
Q Consensus       451 ~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFG  492 (512)
                      .-=...|.-.|+.. .+.+|+|-.|+||+-|..+.+||.|=+
T Consensus       148 ~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~  188 (308)
T PF07387_consen  148 TAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPV  188 (308)
T ss_pred             HHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChh
Confidence            11135677778643 579999999999999999999999965

The function of this family is unknown.

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=93.18  E-value=0.37  Score=45.98  Aligned_cols=75  Identities=21%  Similarity=0.244  Sum_probs=52.2

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHH---HHHhcCCCCccccceeeEEeCCeeEEEEEec-CCC
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEV---TLIAKLQHKNLVRLLGCCLQENESLLIYEYM-PNK  426 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~---~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~-~~g  426 (512)
                      ..+..|..+.|++++..+|.++++|.......     +..|.   ..|...+-...|+++..-.  +...|++|.+ ++-
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~g~   80 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAADP--ERGALLLERLDPGR   80 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeecccc--ccchhhhhhccCCC
Confidence            34567888999999999999999998864432     12232   4477777777888887643  3456788888 445


Q ss_pred             ChhHHh
Q 043262          427 SLNVFL  432 (512)
Q Consensus       427 sL~~~l  432 (512)
                      +|.+..
T Consensus        81 ~L~~~~   86 (253)
T PF04655_consen   81 SLASLP   86 (253)
T ss_pred             chhhcc
Confidence            665544

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=93.14  E-value=0.038  Score=46.20  Aligned_cols=47  Identities=21%  Similarity=0.425  Sum_probs=34.8

Q ss_pred             CCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHh
Q 043262          346 HFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIA  396 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~  396 (512)
                      .|+ .+.|+.|+.|+||+|++++|++||||..+..-.   +.+..++.+|.
T Consensus        13 ~fd-~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~---~~i~~Dl~~l~   59 (119)
T PF03109_consen   13 EFD-PEPLASASIAQVHRARLKDGEEVAVKVQRPGIE---EQIEADLRILR   59 (119)
T ss_pred             HCC-cchhhheehhhheeeeecccchhhhhhcchHHH---HHHHHHHHHHH
Confidence            344 357999999999999999999999999875433   33444454444

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=92.86  E-value=0.67  Score=46.82  Aligned_cols=135  Identities=13%  Similarity=0.161  Sum_probs=80.1

Q ss_pred             cccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeE----E--eCCe-eEEEE
Q 043262          349 DENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCC----L--QENE-SLLIY  420 (512)
Q Consensus       349 ~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~----~--~~~~-~~lv~  420 (512)
                      ....||+|+-+.+|----- +. -+.|+++..........   +..|... .||-+..=+.|=    +  .... .-++|
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh-hc-hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            3567999999998843211 11 23466654433222222   2223333 465443312111    1  1111 33455


Q ss_pred             EecCCCC-hhHHhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEecc
Q 043262          421 EYMPNKS-LNVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  491 (512)
Q Consensus       421 E~~~~gs-L~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DF  491 (512)
                      ..+++.. +..++...   +.....+|...++.+..+|.+.+-||..+   .+-+|+.++|+|++++..+.|.|=
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence            5554432 22222211   12235789999999999999999999986   889999999999999988888763

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	512
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-34
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-34
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-28
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-28
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-27
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-27
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-27
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		9e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-09
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		3e-05
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-05
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		9e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 75/157 (47%), Positives = 101/157 (64%), Gaps = 2/157 (1%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHK 401
           A+ +FS++N LG GGFG VYKG+LADG  +AVKRL     QG + +F+ EV +I+   H+
Sbjct: 36  ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHR 95
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRS-VQLDWKRRISIINGIARGLLYL 460
           NL+RL G C+   E LL+Y YM N S+   L +   S   LDW +R  I  G ARGL YL
Sbjct: 96  NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 155
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
           H+    KIIHRD+K +N+LLD E    + DFG+A++ 
Sbjct: 156 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 192

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 77/158 (48%), Positives = 101/158 (63%), Gaps = 4/158 (2%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRL--SRTSGQGLQEFKNEVTLIAKLQH 400
           A+ +F ++N LG GGFG VYKG+LADG  +AVKRL   RT G  LQ F+ EV +I+   H
Sbjct: 28  ASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 86
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRS-VQLDWKRRISIINGIARGLLY 459
           +NL+RL G C+   E LL+Y YM N S+   L +   S   LDW +R  I  G ARGL Y
Sbjct: 87  RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 146
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
           LH+    KIIHRD+K +N+LLD E    + DFG+A++ 
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 73/169 (43%), Positives = 108/169 (63%), Gaps = 7/169 (4%)
Query: 328 ESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQE 387
           ES   PL  L    EAT +F  +  +G G FG VYKG L DG ++A+KR +  S QG++E
Sbjct: 25  ESYRVPLVDLE---EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 388 FKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDST-RSVQLDWKRR 446
           F+ E+  ++  +H +LV L+G C + NE +LIY+YM N +L   L+ S   ++ + W++R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 73/169 (43%), Positives = 108/169 (63%), Gaps = 7/169 (4%)
Query: 328 ESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQE 387
           ES   PL  L    EAT +F  +  +G G FG VYKG L DG ++A+KR +  S QG++E
Sbjct: 25  ESYRVPLVDLE---EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 388 FKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDST-RSVQLDWKRR 446
           F+ E+  ++  +H +LV L+G C + NE +LIY+YM N +L   L+ S   ++ + W++R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 71/166 (42%), Positives = 96/166 (57%), Gaps = 8/166 (4%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSR----TSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           NK+GEGGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+ ++AK QH+NLV L
Sbjct: 31  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
           LG     ++  L+Y YMPN SL   L     +  L W  R  I  G A G+ +LHE+   
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 148
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             IHRD+K++N+LLD     KISDFG+AR            RIVGT
Sbjct: 149 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGT 192

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 71/166 (42%), Positives = 96/166 (57%), Gaps = 8/166 (4%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSR----TSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           NK+GEGGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+ ++AK QH+NLV L
Sbjct: 37  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
           LG     ++  L+Y YMPN SL   L     +  L W  R  I  G A G+ +LHE+   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             IHRD+K++N+LLD     KISDFG+AR            RIVGT
Sbjct: 155 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGT 198

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 71/166 (42%), Positives = 96/166 (57%), Gaps = 8/166 (4%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSR----TSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           NK+GEGGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+ ++AK QH+NLV L
Sbjct: 37  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
           LG     ++  L+Y YMPN SL   L     +  L W  R  I  G A G+ +LHE+   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             IHRD+K++N+LLD     KISDFG+AR            RIVGT
Sbjct: 155 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGT 198

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 70/166 (42%), Positives = 93/166 (56%), Gaps = 8/166 (4%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSR----TSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           NK GEGGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+ + AK QH+NLV L
Sbjct: 28  NKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL 86
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
           LG     ++  L+Y Y PN SL   L     +  L W  R  I  G A G+ +LHE+   
Sbjct: 87  LGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH- 145
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             IHRD+K++N+LLD     KISDFG+AR            RIVGT
Sbjct: 146 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGT 189

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 52/149 (34%), Positives = 86/149 (57%), Gaps = 4/149 (2%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLL 407
           + K+G G FG V++ +   G ++AVK L       + + EF  EV ++ +L+H N+V  +
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G   Q     ++ EY+   SL   L  S    QLD +RR+S+   +A+G+ YLH +    
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARI 496
           I+HRDLK+ N+L+D +   K+ DFG++R+
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 8/163 (4%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLL 407
           + K+G G FG V++ +   G ++AVK L       + + EF  EV ++ +L+H N+V  +
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G   Q     ++ EY+   SL   L  S    QLD +RR+S+   +A+G+ YLH +    
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARI----FGGNQSEANT 506
           I+HR+LK+ N+L+D +   K+ DFG++R+    F  ++S A T
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGT 202

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 89/164 (54%), Gaps = 20/164 (12%)
Query: 353 LGEGGFGPVYKGKLADGKE-----IAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRL 406
           LG G FG VYKG      E     +A+K L+ T+G     EF +E  ++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARGLLYLHE 462
           LG CL     L + + MP+  L  ++ +   ++     L+W  +I      A+G++YL E
Sbjct: 106 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 158
Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
               +++HRDL   NVL+    + KI+DFG+AR+  G++ E N 
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 199

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 89/164 (54%), Gaps = 20/164 (12%)
Query: 353 LGEGGFGPVYKGKLADGKE-----IAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRL 406
           LG G FG VYKG      E     +A+K L+ T+G     EF +E  ++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARGLLYLHE 462
           LG CL     L + + MP+  L  ++ +   ++     L+W  +I      A+G++YL E
Sbjct: 83  LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 135
Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
               +++HRDL   NVL+    + KI+DFG+AR+  G++ E N 
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 176

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 89/186 (47%), Gaps = 34/186 (18%)
Query: 341 VEATQHFSD-------------ENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRTS 381
           +E  Q+FSD             + +LGEG FG V+  +        D   +AVK L   S
Sbjct: 24  IENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS 83
Query: 382 GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ- 440
               Q+F+ E  L+  LQH+++VR  G C +    L+++EYM +  LN FL       + 
Sbjct: 84  ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 143
Query: 441 -----------LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 489
                      L   + +++ + +A G++YL   + L  +HRDL T N L+   +  KI 
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIG 200
Query: 490 DFGMAR 495
           DFGM+R
Sbjct: 201 DFGMSR 206

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G   +  ++AVK L +     +Q F  E  L+  LQH  LVRL    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            +E    +I EYM   SL  FL  S    ++   + I     IA G+ Y+    R   IH
Sbjct: 78  TREEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 133
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +NVL+   +  KI+DFG+AR+   N+  A
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 167

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 352 KLGEGGFGPVYKGKL------ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           +LGEG FG V+  +        D   +AVK L   S    Q+F+ E  L+  LQH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ------------LDWKRRISIINGI 453
             G C +    L+++EYM +  LN FL       +            L   + +++ + +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           A G++YL   + L  +HRDL T N L+   +  KI DFGM+R
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 352 KLGEGGFGPVYKGKL------ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           +LGEG FG V+  +        D   +AVK L   S    Q+F+ E  L+  LQH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ------------LDWKRRISIINGI 453
             G C +    L+++EYM +  LN FL       +            L   + +++ + +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           A G++YL   + L  +HRDL T N L+   +  KI DFGM+R
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            KLG G FG V+ G   +  ++AVK L +     +Q F  E  L+  LQH  LVRL    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            +E    +I E+M   SL  FL  S    ++   + I     IA G+ Y+    R   IH
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +NVL+   +  KI+DFG+AR+   N+  A
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 166

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 21/160 (13%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVR 405
           E  +G GGFG VY+     G E+AVK           Q ++  + E  L A L+H N++ 
Sbjct: 12  EEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS--TRSVQLDWKRRISIINGIARGLLYLHED 463
           L G CL+E    L+ E+     LN  L        + ++W  +I      ARG+ YLH++
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHDE 124
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP--------KISDFGMAR 495
           + + IIHRDLK+SN+L+  ++          KI+DFG+AR
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 346 HFSDENKLGEGGFGPVYKG--KLADGKEIAVK----RLSRTSGQGLQEFKNEVTLIAKLQ 399
           + S +  +G G FG V  G  KL   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N++RL G   +    +++ EYM N SL+ FL       Q    + + ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           L   S +  +HRDL   N+L++  +  K+SDFG+AR+   +   A T R
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR 208

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 83/173 (47%), Gaps = 24/173 (13%)
Query: 344 TQHFSDEN-----KLGEGGFGPVYKGKL------ADGKEIAVKRLSRTSGQGLQEFKNEV 392
            QH    N     +LGEG FG V+  +        D   +AVK L   S    ++F  E 
Sbjct: 7   VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREA 66
Query: 393 TLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFL----------FDSTRSVQLD 442
            L+  LQH+++V+  G C++ +  ++++EYM +  LN FL           +     +L 
Sbjct: 67  ELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELT 126
Query: 443 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             + + I   IA G++YL   +    +HRDL T N L+   +  KI DFGM+R
Sbjct: 127 QSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 301 ETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLH---LAVEATQHFSDENKLGEGG 357
           + + LH  +G +        LR      + E P   +H     ++AT + S +  +G G 
Sbjct: 1   DEKRLHFGNGHL----KLPGLRTYVDPHTYEDPTQTVHEFAKELDAT-NISIDKVVGAGE 55
Query: 358 FGPVYKG--KLADGKEIAVK----RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           FG V  G  KL   KEI+V     ++  T  Q  ++F  E +++ +  H N++RL G   
Sbjct: 56  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVT 114
Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           +    +++ EYM N SL+ FL       Q    + + ++ GIA G+ YL   S +  +HR
Sbjct: 115 KSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHR 169
Query: 472 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           DL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 170 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 346 HFSDENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQH 400
           + S +  +G G FG V  G  KL   KEI+V   +   G   +  ++F  E +++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
            N++RL G   +    +++ EYM N SL+ FL       Q    + + ++ GIA G+ YL
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
              S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 135 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 85/162 (52%), Gaps = 12/162 (7%)
Query: 353 LGEGGFGPVYKG--KLADGKEIAVK----RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           +G G FG V  G  KL   KEI+V     ++  T  Q  ++F  E +++ +  H N++RL
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNIIRL 111
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
            G   +    +++ EYM N SL+ FL       Q    + + ++ GIA G+ YL   S +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
             +HRDL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 301 ETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLH---LAVEATQHFSDENKLGEGG 357
           + + LH  +G +        LR      + E P   +H     ++AT + S +  +G G 
Sbjct: 3   DEKRLHFGNGHL----KLPGLRTYVDPHTYEDPTQTVHEFAKELDAT-NISIDKVVGAGE 57
Query: 358 FGPVYKG--KLADGKEIAVK----RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           FG V  G  KL   KEI+V     ++  T  Q  ++F  E +++ +  H N++RL G   
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVT 116
Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           +    +++ EYM N SL+ FL       Q    + + ++ GIA G+ YL   S +  +HR
Sbjct: 117 KSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHR 171
Query: 472 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           DL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/147 (37%), Positives = 83/147 (56%), Gaps = 10/147 (6%)
Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G 
Sbjct: 19  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
             +   + ++ ++    SL   L  S    + + K+ I I    ARG+ YLH  S   II
Sbjct: 77  STKPQLA-IVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARI 496
           HRDLK++N+ L  +   KI DFG+A +
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATV 157

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 78  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 166

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 79  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 133
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 167

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 346 HFSDENKLGEGGFGPVYKG--KLADGKEIAVK----RLSRTSGQGLQEFKNEVTLIAKLQ 399
           + S +  +G G FG V  G  KL   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 92
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N++RL G   +    +++ EYM N SL+ FL       Q    + + ++ GIA G+ Y
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 151 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 196

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 78  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 166

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 80  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 134
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 168

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 84  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 138
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 172

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 87  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 141
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 175

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 86  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 140
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 174

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 346 HFSDENKLGEGGFGPVYKG--KLADGKEIAVK----RLSRTSGQGLQEFKNEVTLIAKLQ 399
           + S +  +G G FG V  G  KL   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N++RL G   +    +++ EYM N SL+ FL       Q    + + ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 84  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 138
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 172

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 346 HFSDENKLGEGGFGPVYKG--KLADGKEIAVK----RLSRTSGQGLQEFKNEVTLIAKLQ 399
           + S +  +G G FG V  G  KL   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N++RL G   +    +++ EYM N SL+ FL       Q    + + ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 346 HFSDENKLGEGGFGPVYKG--KLADGKEIAVK----RLSRTSGQGLQEFKNEVTLIAKLQ 399
           + S +  +G G FG V  G  KL   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N++RL G   +    +++ EYM N SL+ FL       Q    + + ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 78  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 83  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 137
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 171

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 14  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 73  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 127
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 161

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 12/169 (7%)
Query: 346 HFSDENKLGEGGFGPVYKG--KLADGKEIAVK----RLSRTSGQGLQEFKNEVTLIAKLQ 399
           + S +  +G G FG V  G  KL   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N++RL G   +    +++ EYM N SL+ FL       Q    + + ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           L   S +  +HRDL   N+L++  +  K+SDFG+ R+   +   A T R
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/145 (37%), Positives = 82/145 (56%), Gaps = 10/145 (6%)
Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G 
Sbjct: 31  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
             +   + ++ ++    SL   L  S    + + K+ I I    ARG+ YLH  S   II
Sbjct: 89  STKPQLA-IVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMA 494
           HRDLK++N+ L  +   KI DFG+A
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 88  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 142
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 176

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/146 (37%), Positives = 81/146 (55%), Gaps = 10/146 (6%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
                  + ++ ++    SL   L  S    + + K+ I I    ARG+ YLH  S   I
Sbjct: 88  YSTAPQLA-IVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMA 494
           IHRDLK++N+ L  +   KI DFG+A
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 51  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ Y
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 166
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/165 (35%), Positives = 89/165 (53%), Gaps = 23/165 (13%)
Query: 351 NKLGEGGFGPVYKGKL---ADGKE---IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNL 403
            +LGE  FG VYKG L   A G++   +A+K L  +  G   +EF++E  L A+LQH N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLF-----------DSTRSVQ--LDWKRRISII 450
           V LLG   ++    +I+ Y  +  L+ FL            D  R+V+  L+    + ++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             IA G+ YL   S   ++H+DL T NVL+  ++N KISD G+ R
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 193

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 25  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ Y
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 140
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/165 (35%), Positives = 89/165 (53%), Gaps = 23/165 (13%)
Query: 351 NKLGEGGFGPVYKGKL---ADGKE---IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNL 403
            +LGE  FG VYKG L   A G++   +A+K L  +  G   +EF++E  L A+LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLF-----------DSTRSVQ--LDWKRRISII 450
           V LLG   ++    +I+ Y  +  L+ FL            D  R+V+  L+    + ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             IA G+ YL   S   ++H+DL T NVL+  ++N KISD G+ R
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ Y
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 146
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 350 ENKLGEGGFGPVYKGKL-ADGKE---IAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G FG V +G+L A GK+   +A+K L    + +  +EF +E +++ + +H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           RL G        +++ E+M N +L+ FL       Q    + + ++ GIA G+ YL E  
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVIQLVGMLRGIASGMRYLAE-- 136
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVG 511
            +  +HRDL   N+L++  +  K+SDFG++R    N S+      +G
Sbjct: 137 -MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG 182

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 28  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ Y
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 143
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 52  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ Y
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 167
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ Y
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 145
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 90/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 13  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 72
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L     + ++D  + +   + I +G+
Sbjct: 73  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGM 130
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 131 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 88/159 (55%), Gaps = 10/159 (6%)
Query: 350 ENKLGEGGFGPVYKGKL-ADGKE---IAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G FG V +G+L A GK+   +A+K L    + +  +EF +E +++ + +H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           RL G        +++ E+M N +L+ FL       Q    + + ++ GIA G+ YL E  
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVIQLVGMLRGIASGMRYLAE-- 134
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
            +  +HRDL   N+L++  +  K+SDFG++R    N S+
Sbjct: 135 -MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD 172

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 83/153 (54%), Gaps = 6/153 (3%)
Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL     
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IHR
Sbjct: 75  QE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 129
Query: 472 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           +L+ +N+L+   ++ KI+DFG+AR+   N+  A
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTA 162

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 93/178 (52%), Gaps = 20/178 (11%)
Query: 331 EFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKE-IAVKRLSRTSGQG----- 384
           EFP     L   A      E ++G+GGFG V+KG+L   K  +A+K L     +G     
Sbjct: 7   EFPKS--RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 385 --LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD 442
              QEF+ EV +++ L H N+V+L G  L  N   ++ E++P   L   L D    ++  
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIK-- 120
Query: 443 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD--HEMNP---KISDFGMAR 495
           W  ++ ++  IA G+ Y+ ++    I+HRDL++ N+ L    E  P   K++DFG+++
Sbjct: 121 WSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 301 ETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLH---LAVEATQHFSDENKLGEGG 357
           + + LH  +G +        LR      + E P   +H     ++AT + S +  +G G 
Sbjct: 3   DEKRLHFGNGHL----KLPGLRTYVDPHTYEDPTQTVHEFAKELDAT-NISIDKVVGAGE 57
Query: 358 FGPVYKG--KLADGKEIAVK----RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           FG V  G  KL   KEI+V     ++  T  Q  ++F  E +++ +  H N++RL G   
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVT 116
Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           +    +++ E M N SL+ FL       Q    + + ++ GIA G+ YL   S +  +HR
Sbjct: 117 KSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHR 171
Query: 472 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           DL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 86/168 (51%), Gaps = 10/168 (5%)
Query: 346 HFSDENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQH 400
           + S +  +G G FG V  G  KL   KEI+V   +   G   +  ++F  E +++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
            N++RL G   +    +++ E M N SL+ FL       Q    + + ++ GIA G+ YL
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
              S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 135 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 92  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 207
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 9   RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 68
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 69  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 126
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 127 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 173

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 205

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 8   RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 67
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 68  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 125
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 126 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 172

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 146
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 19/197 (9%)
Query: 305 LHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG 364
           LH+    +  D S   L  +  +  Q   + P  L V    HF++   +G G FG VY G
Sbjct: 3   LHMGSNTVHIDLS--ALNPELVQAVQHVVIGPSSLIV----HFNE--VIGRGHFGCVYHG 54
Query: 365 KLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLQ-ENESLL 418
            L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LLG CL+ E   L+
Sbjct: 55  TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 114
Query: 419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNV 478
           +  YM +  L  F+ + T +  +  K  I     +A+G+ +L   +  K +HRDL   N 
Sbjct: 115 VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNC 169
Query: 479 LLDHEMNPKISDFGMAR 495
           +LD +   K++DFG+AR
Sbjct: 170 MLDEKFTVKVADFGLAR 186

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 174

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 16  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 75
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 76  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 133
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 134 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 180

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 87/169 (51%), Gaps = 12/169 (7%)
Query: 346 HFSDENKLGEGGFGPVYKG--KLADGKEIAVK----RLSRTSGQGLQEFKNEVTLIAKLQ 399
           + S +  +G G FG V  G  KL   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N++RL G   +    +++ E M N SL+ FL       Q    + + ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 163 L---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 15  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 74
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 75  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 132
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 133 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 179

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 174

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 13  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 72
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 73  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 130
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 131 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 346 HFSDENKLGEGGFGPVYKGKLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF++   +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L   +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 17  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 76
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 77  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 134
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 135 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 181

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 14  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 73
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 74  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 131
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 132 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 178

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 28  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 87
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 88  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 145
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 146 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 92/178 (51%), Gaps = 20/178 (11%)
Query: 331 EFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKE-IAVKRLSRTSGQG----- 384
           EFP     L   A      E ++G+GGFG V+KG+L   K  +A+K L     +G     
Sbjct: 7   EFPKS--RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 385 --LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD 442
              QEF+ EV +++ L H N+V+L G  L  N   ++ E++P   L   L D    ++  
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIK-- 120
Query: 443 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD--HEMNP---KISDFGMAR 495
           W  ++ ++  IA G+ Y+ ++    I+HRDL++ N+ L    E  P   K++DFG ++
Sbjct: 121 WSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 28  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 87
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 88  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 145
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 146 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 86/160 (53%), Gaps = 12/160 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            YL      + IHRDL T N+L+++E   KI DFG+ ++ 
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 10/162 (6%)
Query: 350 ENKLGEGGFGPVYKGKL-ADGKE---IAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G  G V  G+L   G+    +A+K L    + +  ++F +E +++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           RL G   +   ++++ EYM N SL+ FL   T   Q    + + ++ G+  G+ YL   S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
            L  +HRDL   NVL+D  +  K+SDFG++R+   +   A T
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 13  RHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 72
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI E++P  SL  +L       ++D  + +   + I +G+
Sbjct: 73  HDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGM 130
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            YL      + IHRDL T N+L+++E   KI DFG+ ++   ++     K
Sbjct: 131 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 82/148 (55%), Gaps = 10/148 (6%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G
Sbjct: 16  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
              +   + ++ ++    SL   L       + +  + I I    A+G+ YLH  S   I
Sbjct: 74  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 127
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARI 496
           IHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATV 155

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 92/160 (57%), Gaps = 8/160 (5%)
Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKL 398
           E  ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
            H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL 
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 124
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 125 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 161

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 82/148 (55%), Gaps = 10/148 (6%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
              +   + ++ ++    SL   L       + +  + I I    A+G+ YLH  S   I
Sbjct: 77  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARI 496
           IHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATV 158

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 82/148 (55%), Gaps = 10/148 (6%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
              +   + ++ ++    SL   L       + +  + I I    A+G+ YLH  S   I
Sbjct: 72  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARI 496
           IHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 10/162 (6%)
Query: 350 ENKLGEGGFGPVYKGKL-ADGKE---IAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G  G V  G+L   G+    +A+K L    + +  ++F +E +++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           RL G   +   ++++ EYM N SL+ FL   T   Q    + + ++ G+  G+ YL   S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
            L  +HRDL   NVL+D  +  K+SDFG++R+   +   A T
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 92/160 (57%), Gaps = 8/160 (5%)
Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKL 398
           E  ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
            H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL 
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 124
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 125 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 161

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 82/148 (55%), Gaps = 10/148 (6%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
              +   + ++ ++    SL   L       + +  + I I    A+G+ YLH  S   I
Sbjct: 77  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARI 496
           IHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATV 158

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 13/152 (8%)
Query: 353 LGEGGFGPVYKG--KLADGKE---IAVKRLSR--TSGQGLQEFKNEVTLIAKLQHKNLVR 405
           +G G FG VYKG  K + GK+   +A+K L    T  Q + +F  E  ++ +  H N++R
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQFSHHNIIR 110
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L G   +    ++I EYM N +L+ FL +  +  +    + + ++ GIA G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---AN 165
Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
           +  +HRDL   N+L++  +  K+SDFG++R+ 
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 88/183 (48%), Gaps = 34/183 (18%)
Query: 353 LGEGGFGPVYKGKLADG-------KEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLV 404
           +GEG FG V++ + A G         +AVK L   +   +Q +F+ E  L+A+  + N+V
Sbjct: 55  IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFD--------------STRS-------VQLDW 443
           +LLG C       L++EYM    LN FL                STR+         L  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 444 KRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQS 502
             ++ I   +A G+ YL E    K +HRDL T N L+   M  KI+DFG++R I+  +  
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 503 EAN 505
           +A+
Sbjct: 231 KAD 233

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 92/178 (51%), Gaps = 20/178 (11%)
Query: 331 EFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKE-IAVKRLSRTSGQG----- 384
           EFP     L   A      E ++G+GGFG V+KG+L   K  +A+K L     +G     
Sbjct: 7   EFPKS--RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 385 --LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD 442
              QEF+ EV +++ L H N+V+L G  L  N   ++ E++P   L   L D    ++  
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIK-- 120
Query: 443 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD--HEMNP---KISDFGMAR 495
           W  ++ ++  IA G+ Y+ ++    I+HRDL++ N+ L    E  P   K++DF +++
Sbjct: 121 WSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 87/167 (52%), Gaps = 16/167 (9%)
Query: 350 ENKLGEGGFGPVYKGKL-ADGKE---IAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G FG V  G+L   GK    +A+K L    + +  ++F +E +++ +  H N++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRS---VQLDWKRRISIINGIARGLLYLH 461
            L G   +    ++I EYM N SL+ FL  +      +QL     + ++ GI  G+ YL 
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-----VGMLRGIGSGMKYL- 147
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
             S +  +HRDL   N+L++  +  K+SDFGM+R+   +   A T R
Sbjct: 148 --SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 192

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 156

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 86/159 (54%), Gaps = 14/159 (8%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
              +   + ++ ++    SL   L       + +  + I I    A+G+ YLH  S   I
Sbjct: 72  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMA----RIFGGNQSE 503
           IHRDLK++N+ L  ++  KI DFG+A    R  G +Q E
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 164

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 82/148 (55%), Gaps = 10/148 (6%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G
Sbjct: 41  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
              +   + ++ ++    SL   L       + +  + I I    A+G+ YLH  S   I
Sbjct: 99  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARI 496
           IHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATV 180

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 88/165 (53%), Gaps = 13/165 (7%)
Query: 341 VEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFK-NEVTLIAKL 398
           + ++  F    KLG G +  VYKG     G  +A+K +   S +G       E++L+ +L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDST-----RSVQLDWKRRISIINGI 453
           +H+N+VRL      EN+  L++E+M N  L  ++   T     R ++L+  +       +
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW--QL 117
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            +GL + HE+   KI+HRDLK  N+L++     K+ DFG+AR FG
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 155

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 82/148 (55%), Gaps = 10/148 (6%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
              +   + ++ ++    SL   L       + +  + I I    A+G+ YLH  S   I
Sbjct: 100 YSTKPQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARI 496
           IHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATV 181

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 158

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 91/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 81/148 (54%), Gaps = 10/148 (6%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
                  + ++ ++    SL   L       + +  + I I    A+G+ YLH  S   I
Sbjct: 72  YSTAPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARI 496
           IHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 91/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 91/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 87/167 (52%), Gaps = 16/167 (9%)
Query: 350 ENKLGEGGFGPVYKGKL-ADGKE---IAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G FG V  G+L   GK    +A+K L    + +  ++F +E +++ +  H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRS---VQLDWKRRISIINGIARGLLYLH 461
            L G   +    ++I EYM N SL+ FL  +      +QL     + ++ GI  G+ YL 
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-----VGMLRGIGSGMKYL- 132
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
             S +  +HRDL   N+L++  +  K+SDFGM+R+   +   A T R
Sbjct: 133 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 177

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 91/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 91/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 91/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 87/167 (52%), Gaps = 16/167 (9%)
Query: 350 ENKLGEGGFGPVYKGKL-ADGKE---IAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G FG V  G+L   GK    +A+K L    + +  ++F +E +++ +  H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRS---VQLDWKRRISIINGIARGLLYLH 461
            L G   +    ++I EYM N SL+ FL  +      +QL     + ++ GI  G+ YL 
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-----VGMLRGIGSGMKYL- 126
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
             S +  +HRDL   N+L++  +  K+SDFGM+R+   +   A T R
Sbjct: 127 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 171

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 91/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 85/164 (51%), Gaps = 10/164 (6%)
Query: 350 ENKLGEGGFGPVYKGKLA-DGKE---IAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G FG V  G+L   GK    +A+K L    + +  ++F  E +++ +  H N++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L G   +    +++ EYM N SL+ FL       Q    + + ++ GI+ G+ YL   S
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFL--KKNDGQFTVIQLVGMLRGISAGMKYL---S 141
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
            +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 185

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 154

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 91/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 86/159 (54%), Gaps = 14/159 (8%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G
Sbjct: 34  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
              +   + ++ ++    SL   L       + +  + I I    A+G+ YLH  S   I
Sbjct: 92  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMA----RIFGGNQSE 503
           IHRDLK++N+ L  ++  KI DFG+A    R  G +Q E
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 184

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 91/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 91/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 158

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/147 (34%), Positives = 79/147 (53%), Gaps = 6/147 (4%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G  G V+ G      ++AVK L + S      F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 78  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIF 497
           RDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 86/159 (54%), Gaps = 14/159 (8%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG VYKGK     ++AVK L+ T  + Q LQ FKNEV ++ K +H N++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
              +   + ++ ++    SL   L       + +  + I I    A+G+ YLH  S   I
Sbjct: 100 YSTKPQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMA----RIFGGNQSE 503
           IHRDLK++N+ L  ++  KI DFG+A    R  G +Q E
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 192

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            ++G G FG V+ G   +  ++A+K + R      ++F  E  ++ KL H  LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L++    L++E+M +  L+ +L   T+      +  + +   +  G+ YL E S   +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIH 126
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           RDL   N L+      K+SDFGM R    +Q  ++T
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 86/160 (53%), Gaps = 12/160 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H     +LG+G FG V   +   L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQ
Sbjct: 11  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 70
Query: 400 HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           H N+V+  G C         LI EY+P  SL  +L       ++D  + +   + I +G+
Sbjct: 71  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 128
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            YL      + IHR+L T N+L+++E   KI DFG+ ++ 
Sbjct: 129 EYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVL 165

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 87/150 (58%), Gaps = 8/150 (5%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHKNLVRLLG 408
            K+GEG +G VYK K + G+ +A+KR+      +G+      E++L+ +L H N+V L+ 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
               E    L++E+M  K L   L ++   +Q D + +I +   + RG+ + H+    +I
Sbjct: 87  VIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ-DSQIKIYLYQ-LLRGVAHCHQH---RI 140
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +HRDLK  N+L++ +   K++DFG+AR FG
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 87/150 (58%), Gaps = 8/150 (5%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHKNLVRLLG 408
            K+GEG +G VYK K + G+ +A+KR+      +G+      E++L+ +L H N+V L+ 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
               E    L++E+M  K L   L ++   +Q D + +I +   + RG+ + H+    +I
Sbjct: 87  VIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ-DSQIKIYLYQ-LLRGVAHCHQH---RI 140
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +HRDLK  N+L++ +   K++DFG+AR FG
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 91/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 92/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 347 FSDENKLGEGGFGPVYKGKLADGKEI-AVKRLS---RTSGQGLQEFKNEVTLIAKLQHKN 402
           FSD  ++G G FG VY  +     E+ A+K++S   + S +  Q+   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
            ++  GC L+E+ + L+ EY    + ++          L      ++ +G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            +   +IHRD+K  N+LL      K+ DFG A I  
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 91/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ +  L  F+ D++    +      S +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 155

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 91/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ +  L  F+ D++    +      S +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 122 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 157

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 347 FSDENKLGEGGFGPVYKGKLADGKEI-AVKRLS---RTSGQGLQEFKNEVTLIAKLQHKN 402
           FSD  ++G G FG VY  +     E+ A+K++S   + S +  Q+   EV  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
            ++  GC L+E+ + L+ EY    + ++          L      ++ +G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            +   +IHRD+K  N+LL      K+ DFG A I  
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 84/163 (51%), Gaps = 10/163 (6%)
Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           ++G G FG VYKGK      + + ++   + +  Q F+NEV ++ K +H N++  +G   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           ++N + ++ ++    SL   L       Q+   + I I    A+G+ YLH  +   IIHR
Sbjct: 103 KDNLA-IVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYLHAKN---IIHR 156
Query: 472 DLKTSNVLLDHEMNPKISDFGMA----RIFGGNQSEANTKRIV 510
           D+K++N+ L   +  KI DFG+A    R  G  Q E  T  ++
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 91/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ +  L  F+ D++    +      S +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 91/159 (57%), Gaps = 8/159 (5%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQ 399
           + ++F    K+GEG +G VYK +    G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+V+LL     EN+  L++E++ +  L  F+ D++    +      S +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 350 ENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G FG V  G  KL   +EI V   +  SG   +  ++F +E +++ +  H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L G   +    ++I E+M N SL+ FL       Q    + + ++ GIA G+ YL +  
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLAD-- 153
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVG 511
            +  +HRDL   N+L++  +  K+SDFG++R    + S+      +G
Sbjct: 154 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 199

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 22/165 (13%)
Query: 350 ENKLGEGGFGPVYKGK------LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           + +LGEG FG V+  +        D   +AVK L   +    ++F+ E  L+  LQH+++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLF----DSTRSV---------QLDWKRRISII 450
           V+  G C   +  ++++EYM +  LN FL     D+   V         +L   + + I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + IA G++YL   +    +HRDL T N L+   +  KI DFGM+R
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 13  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 72  -VSEEPIXIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYV 126
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTAR 162

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 6/155 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 248 -VSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 6/155 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 248 -VSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 6/156 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            ++G G FG V+ G   +  ++A+K + R      ++F  E  ++ KL H  LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L++    L++E+M +  L+ +L   T+      +  + +   +  G+ YL E     +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           RDL   N L+      K+SDFGM R    +Q  ++T
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 90/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+ ++   T  +G+      E++L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 90/157 (57%), Gaps = 8/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           ++F    K+GEG +G VYK +    G+ +A+ ++   T  +G+      E++L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 6/156 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            ++G G FG V+ G   +  ++A+K + R      ++F  E  ++ KL H  LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L++    L++E+M +  L+ +L   T+      +  + +   +  G+ YL E     +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           RDL   N L+      K+SDFGM R    +Q  ++T
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 9/157 (5%)
Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAK 397
           E  + F   N LG+G F  VY+ + +  G E+A+K + + +      +Q  +NEV +  +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           L+H +++ L       N   L+ E   N  +N +L +  +    +  R    ++ I  G+
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGM 125
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           LYLH      I+HRDL  SN+LL   MN KI+DFG+A
Sbjct: 126 LYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA 159

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 7/174 (4%)
Query: 333 PLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEV 392
           P   LH+ ++ ++  +   ++G G FG V+ G   +  ++A+K +   S     +F  E 
Sbjct: 16  PRGSLHMVIDPSE-LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEA 73
Query: 393 TLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING 452
            ++ KL H  LV+L G CL++    L++E+M +  L+ +L   T+      +  + +   
Sbjct: 74  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLD 131
Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           +  G+ YL E     +IHRDL   N L+      K+SDFGM R    +Q  ++T
Sbjct: 132 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 182

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 6/156 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            ++G G FG V+ G   +  ++A+K + R      ++F  E  ++ KL H  LV+L G C
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L++    L++E+M +  L+ +L   T+      +  + +   +  G+ YL E     +IH
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           RDL   N L+      K+SDFGM R    +Q  ++T
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 6/155 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 248 -VSEEPIYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 16  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 75  -VSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYV 129
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 165

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V+ G      ++A+K L +      + F  E  ++ KL+H  LV+L    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLY-AV 72
Query: 411 LQENESLLIYEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
           + E    ++ EYM   SL  FL D   R+++L     + +   +A G+ Y+    R+  I
Sbjct: 73  VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYI 127
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           HRDL+++N+L+ + +  KI+DFG+AR+   N+  A
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTA 162

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 6/155 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY-A 329
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 353 LGEGGFGPVYKGKLADGKEIAV-KRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           LG+G FG   K    +  E+ V K L R   +  + F  EV ++  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           ++     I EY+   +L   +   +   Q  W +R+S    IA G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 472 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           DL + N L+    N  ++DFG+AR+    +++    R
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 20  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 79  -VSEEPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 169

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 78  PHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKG 130
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 131 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 20  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 79  -VSEEPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTAR 169

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/147 (33%), Positives = 73/147 (49%), Gaps = 7/147 (4%)
Query: 351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG V+ G+L AD   +AVK    T    L+ +F  E  ++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C Q+    ++ E +       FL   T   +L  K  + ++   A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMAR 495
           IHRDL   N L+  +   KISDFGM+R
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTAR 172

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 78  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 130
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 131 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/147 (33%), Positives = 73/147 (49%), Gaps = 7/147 (4%)
Query: 351 NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLLG 408
            ++G G FG V+ G+L AD   +AVK    T    L+ +F  E  ++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C Q+    ++ E +       FL   T   +L  K  + ++   A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMAR 495
           IHRDL   N L+  +   KISDFGM+R
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 80  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 132
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 133 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 81  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 133
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 134 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 177

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 71  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 123
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 124 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 77  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 130 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 79  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 132 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 14  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 73  -VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 127
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 163

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 12  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 71  -VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 125
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 161

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 37  KHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C  E    ++ EYMP  +L  +L +  R  ++     + +   I+  + YL + +    
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLRECNRE-EVTAVVLLYMATQISSAMEYLEKKN---F 151
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           IHRDL   N L+      K++DFG++R+  G+   A+
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAH 188

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 130 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 78/156 (50%), Gaps = 6/156 (3%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            ++G G FG V+ G   +  ++A+K + R      ++F  E  ++ KL H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L++    L+ E+M +  L+ +L   T+      +  + +   +  G+ YL E     +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           RDL   N L+      K+SDFGM R    +Q  ++T
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 89/168 (52%), Gaps = 20/168 (11%)
Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQ 399
            F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIAR 455
           + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+
Sbjct: 76  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 79  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 132 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 83  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 135
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 136 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 179

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 89/168 (52%), Gaps = 20/168 (11%)
Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQ 399
            F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIAR 455
           + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+
Sbjct: 83  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 130 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 80  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 132
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 133 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
             +E   ++I EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  VSEEPIYIVI-EYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 172

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 172

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 80  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 132
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 133 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 87  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 139
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 140 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 183

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 89/168 (52%), Gaps = 20/168 (11%)
Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQ 399
            F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIAR 455
           + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+
Sbjct: 101 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 153
Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 154 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 198

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 80  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 132
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 133 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 84/167 (50%), Gaps = 10/167 (5%)
Query: 350 ENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G FG V  G  KL   +EI V   +  SG   +  ++F +E +++ +  H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L G   +    ++I E+M N SL+ FL       Q    + + ++ GIA G+ YL +  
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLAD-- 127
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVG 511
            +  +HR L   N+L++  +  K+SDFG++R    + S+      +G
Sbjct: 128 -MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 172

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 16/180 (8%)
Query: 336 PLHLAVEATQHFSDENKLGEGGFGPVYKGKLAD-----GKEIAVKRLSRTSG-QGLQEFK 389
           P H      +   D   LGEG FG V   +        G+++AVK L   SG   + + K
Sbjct: 15  PTHFEKRFLKRIRD---LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK 71
Query: 390 NEVTLIAKLQHKNLVRLLGCCLQE--NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI 447
            E+ ++  L H+N+V+  G C ++  N   LI E++P+ SL  +L  +   + L  K+++
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQL 129
Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
                I +G+ YL   SR + +HRDL   NVL++ E   KI DFG+ +    ++     K
Sbjct: 130 KYAVQICKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVK 186

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 16/180 (8%)
Query: 336 PLHLAVEATQHFSDENKLGEGGFGPVYKGKLAD-----GKEIAVKRLSRTSG-QGLQEFK 389
           P H      +   D   LGEG FG V   +        G+++AVK L   SG   + + K
Sbjct: 3   PTHFEKRFLKRIRD---LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK 59
Query: 390 NEVTLIAKLQHKNLVRLLGCCLQE--NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI 447
            E+ ++  L H+N+V+  G C ++  N   LI E++P+ SL  +L  +   + L  K+++
Sbjct: 60  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQL 117
Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
                I +G+ YL   SR + +HRDL   NVL++ E   KI DFG+ +    ++     K
Sbjct: 118 KYAVQICKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVK 174

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 88/167 (52%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A G
Sbjct: 74  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AEG 126
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 127 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 170

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 6/155 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 190 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLY-A 247
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 248 VVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 303
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           HRDL+ +N+L+   +  K++DFG+ R+   N+  A
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTA 338

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/149 (35%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           +G+G FG VY G+  D  +     A+K LSR T  Q ++ F  E  L+  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 408 GCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
           G  L  E    ++  YM +  L  F+    R+  +  K  IS    +ARG+ YL E    
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYLAEQ--- 143
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           K +HRDL   N +LD     K++DFG+AR
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 88/167 (52%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 81  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 133
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG A++ G  + E
Sbjct: 134 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 177

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ K++H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 172

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL  +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIEDNEYTAR 172

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG---- 408
           +G G +G VYKG L D + +AVK  S  + Q     KN +  +  ++H N+ R +     
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIARFIVGDER 78
Query: 409 -CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH------ 461
                  E LL+ EY PN SL  +L   T     DW     + + + RGL YLH      
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
           +  +  I HRDL + NVL+ ++    ISDFG++    GN+
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 88/167 (52%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 79  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG A++ G  + E
Sbjct: 132 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 88/167 (52%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 79  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG A++ G  + E
Sbjct: 132 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G FG VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 16  KHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +    
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---F 130
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 168

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 88/167 (52%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG A++ G  + E
Sbjct: 130 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 173

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 137
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 175

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 137
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 175

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 88/168 (52%), Gaps = 20/168 (11%)
Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQ 399
            F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIAR 455
           + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+
Sbjct: 83  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++ G  + E
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 180

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 78/156 (50%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM    L  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 172

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 88/167 (52%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 79  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG A++ G  + E
Sbjct: 132 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 132
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 133
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 171

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 132
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 137
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 175

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/149 (35%), Positives = 80/149 (53%), Gaps = 12/149 (8%)
Query: 351 NKLGEGGFGPVYKGK--LADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           +KLGEG +  VYKGK  L D   +A+K  RL    G      + EV+L+  L+H N+V L
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 65
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
                 E    L++EY+ +K L  +L D    + +   +    +  + RGL Y H   R 
Sbjct: 66  HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCH---RQ 119
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           K++HRDLK  N+L++     K++DFG+AR
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 78/156 (50%), Gaps = 6/156 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
            + E    ++ EYM    L  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 172

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 136
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 88/157 (56%), Gaps = 9/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           Q +    K+GEG +G V+K K  +  EI A+KR+      +G+      E+ L+ +L+HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+VRL      + +  L++E+  ++ L  + FDS     LD +   S +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNG-DLDPEIVKSFLFQLLKGLGFCH 118
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
             SR  ++HRDLK  N+L++     K++DFG+AR FG
Sbjct: 119 --SR-NVLHRDLKPQNLLINRNGELKLADFGLARAFG 152

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 350 ENKLGEGGFGPVYKG--KLADGKEIAVK----RLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           E  +G G FG V  G  KL   +++AV     ++  T  Q  ++F  E +++ +  H N+
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ-RRDFLCEASIMGQFDHPNV 106
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           V L G   +    +++ E+M N +L+ FL       Q    + + ++ GIA G+ YL + 
Sbjct: 107 VHLEGVVTRGKPVMIVIEFMENGALDAFL--RKHDGQFTVIQLVGMLRGIAAGMRYLAD- 163
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
             +  +HRDL   N+L++  +  K+SDFG++R+ 
Sbjct: 164 --MGYVHRDLAARNILVNSNLVCKVSDFGLSRVI 195

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +    
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---F 130
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 168

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 145
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 183

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 134
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 172

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 137
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 175

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 88/168 (52%), Gaps = 20/168 (11%)
Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQ 399
            F     L  G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIAR 455
           + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+
Sbjct: 83  NPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 134
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 172

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 88/167 (52%), Gaps = 20/167 (11%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     L  G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIARG 456
            ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+G
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           + YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 130 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 8/159 (5%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V  GK     ++AVK +   S     EF  E   + KL H  LV+  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            +E    ++ EY+ N  L  +L    +   L+  + + +   +  G+ +L      + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQ--SEANTK 507
           RDL   N L+D ++  K+SDFGM R    +Q  S   TK
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK 166

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 87/168 (51%), Gaps = 20/168 (11%)
Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQ 399
            F     LG G FG VYKG  + +G+++    A+  L   TS +  +E  +E  ++A + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIAR 455
           + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W         IA+
Sbjct: 110 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 162
Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 163 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 207

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 88/168 (52%), Gaps = 20/168 (11%)
Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEI----AVKRLSR-TSGQGLQEFKNEVTLIAKLQ 399
            F     L  G FG VYKG  + +G+++    A+K L   TS +  +E  +E  ++A + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ----LDWKRRISIINGIAR 455
           + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +I      A+
Sbjct: 83  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + E
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 83/152 (54%), Gaps = 6/152 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 134
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
           IHRDL   N L+      K++DFG++R+  G+
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 83/152 (54%), Gaps = 6/152 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 133
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
           IHRDL   N L+      K++DFG++R+  G+
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +    
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---F 132
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +    
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---F 132
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +    
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---F 132
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 6/155 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG G FG V+        ++AVK + +     ++ F  E  ++  LQH  LV+L   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
             +E    +I E+M   SL  FL     S Q    + I     IA G+ ++ + +    I
Sbjct: 79  VTKE-PIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRN---YI 133
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           HRDL+ +N+L+   +  KI+DFG+AR+   N+  A
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 168

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +    
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---F 132
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +    
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---F 137
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 175

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 21/164 (12%)
Query: 350 ENKLGEGGFGPVYKGKLA-DG--KEIAVKRLSR-TSGQGLQEFKNEVTLIAKL-QHKNLV 404
           ++ +GEG FG V K ++  DG   + A+KR+    S    ++F  E+ ++ KL  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDS-------------TRSVQLDWKRRISIIN 451
            LLG C       L  EY P+ +L  FL  S             + +  L  ++ +    
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +ARG+ YL   S+ + IHRDL   N+L+      KI+DFG++R
Sbjct: 140 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 6/155 (3%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG G FG V+        ++AVK + +     ++ F  E  ++  LQH  LV+L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
             +E    +I E+M   SL  FL     S Q    + I     IA G+ ++ + +    I
Sbjct: 252 VTKE-PIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEA 504
           HRDL+ +N+L+   +  KI+DFG+AR+   N+  A
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 80/145 (55%), Gaps = 8/145 (5%)
Query: 352 KLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           +LG+G FG VYK K  + G   A K +   S + L+++  E+ ++A   H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKII 469
             + +  ++ E+ P  +++  + +  R +    + +I ++   +   L +LH     +II
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK---RII 131
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMA 494
           HRDLK  NVL+  E + +++DFG++
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVS 156

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 80/145 (55%), Gaps = 8/145 (5%)
Query: 352 KLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           +LG+G FG VYK K  + G   A K +   S + L+++  E+ ++A   H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKII 469
             + +  ++ E+ P  +++  + +  R +    + +I ++   +   L +LH     +II
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK---RII 139
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMA 494
           HRDLK  NVL+  E + +++DFG++
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVS 164

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +    
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---F 130
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHA 168

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 21/164 (12%)
Query: 350 ENKLGEGGFGPVYKGKLA-DG--KEIAVKRLSR-TSGQGLQEFKNEVTLIAKL-QHKNLV 404
           ++ +GEG FG V K ++  DG   + A+KR+    S    ++F  E+ ++ KL  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDS-------------TRSVQLDWKRRISIIN 451
            LLG C       L  EY P+ +L  FL  S             + +  L  ++ +    
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +ARG+ YL   S+ + IHRDL   N+L+      KI+DFG++R
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 80/145 (55%), Gaps = 8/145 (5%)
Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           +LG+G FG VYK +  +   +A  ++  T S + L+++  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKII 469
             EN   ++ E+    +++  + +  R +    + +I ++       L YLH++   KII
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMA 494
           HRDLK  N+L   + + K++DFG++
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 80/145 (55%), Gaps = 8/145 (5%)
Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           +LG+G FG VYK +  +   +A  ++  T S + L+++  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKII 469
             EN   ++ E+    +++  + +  R +    + +I ++       L YLH++   KII
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMA 494
           HRDLK  N+L   + + K++DFG++
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 80/145 (55%), Gaps = 8/145 (5%)
Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           +LG+G FG VYK +  +   +A  ++  T S + L+++  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKII 469
             EN   ++ E+    +++  + +  R +    + +I ++       L YLH++   KII
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMA 494
           HRDLK  N+L   + + K++DFG++
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           +G+G F  V   + +  GKE+AVK + +T  +   LQ+   EV ++  L H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
              E    L+ EY     +  +L    R  + + + +      I   + Y H+     I+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---IV 135
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSEA 504
           HRDLK  N+LLD +MN KI+DFG +  F  GN+ +A
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA 171

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 94/179 (52%), Gaps = 15/179 (8%)
Query: 338 HLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRLS-RTSGQGLQEFKNEVTLI 395
           H  V+  + F+  +++G+G FG VYKG     KE+ A+K +    +   +++ + E+T++
Sbjct: 12  HSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVL 71
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
           ++     + R  G  L+  +  +I EY+   S      D  +   L+     +I+  I +
Sbjct: 72  SQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILK 127
Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR--IVGT 512
           GL YLH + +   IHRD+K +NVLL  + + K++DFG+A    G  ++   KR   VGT
Sbjct: 128 GLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNXFVGT 179

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQ---EFKNEVTLIAKLQHK 401
           H+   + LG G FG V  GK    G ++AVK L+R   + L    + + E+  +   +H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           ++++L       ++  ++ EY+    L  ++  + R   LD K    +   I  G+ Y H
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCH 133
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
              R  ++HRDLK  NVLLD  MN KI+DFG++ +    +
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+KL H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 173 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 206

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 88/157 (56%), Gaps = 9/157 (5%)
Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRLS-RTSGQGLQEFK-NEVTLIAKLQHK 401
           Q +    K+GEG +G V+K K  +  EI A+KR+      +G+      E+ L+ +L+HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+VRL      + +  L++E+  ++ L  + FDS     LD +   S +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNG-DLDPEIVKSFLFQLLKGLGFCH 118
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
             SR  ++HRDLK  N+L++     K+++FG+AR FG
Sbjct: 119 --SR-NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+KL H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 159 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 192

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 11/165 (6%)
Query: 339 LAVEATQHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQE--FKNEVTLI 395
           L  ++ + + +   +GEG +G V K +  D G+ +A+K+   +    + +     E+ L+
Sbjct: 19  LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLL 78
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL-NVFLFDSTRSVQLDWKRRISIINGIA 454
            +L+H+NLV LL  C ++    L++E++ +  L ++ LF +    Q+  K    IINGI 
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI- 137
Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG 499
            G  + H      IIHRD+K  N+L+      K+ DFG AR    
Sbjct: 138 -GFCHSH-----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           +G+G F  V   + +  G+E+A+K + +T  +   LQ+   EV ++  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
              E    LI EY     +  +L    R   +  K   S    I   + Y H+    +I+
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQK---RIV 136
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIF 497
           HRDLK  N+LLD +MN KI+DFG +  F
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEF 164

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 17/168 (10%)
Query: 356 GGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ--- 412
           G FG V+K +L + + +AVK       Q  Q  + EV  +  ++H+N+++ +G   +   
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 413 -ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-------S 464
            + +  LI  +    SL+ FL    ++  + W     I   +ARGL YLHED        
Sbjct: 93  VDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +  I HRD+K+ NVLL + +   I+DFG+A  F   +S  +T   VGT
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 6/147 (4%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG G FG V+        ++AVK + +     ++ F  E  ++  LQH  LV+L   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
             +E    +I E+M   SL  FL     S Q    + I     IA G+ ++ + +    I
Sbjct: 246 VTKE-PIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRN---YI 300
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARI 496
           HRDL+ +N+L+   +  KI+DFG+AR+
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARV 327

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 86/163 (52%), Gaps = 18/163 (11%)
Query: 353 LGEGGFGPVYKGKLA--DGK--EIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LGEG FG V +G L   DG   ++AVK  +L  +S + ++EF +E   +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 407 LGCCLQEN-----ESLLIYEYMPNKSLNVFLFDS---TRSVQLDWKRRISIINGIARGLL 458
           LG C++ +     + ++I  +M    L+ +L  S   T    +  +  +  +  IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGN 500
           YL   S    +HRDL   N +L  +M   ++DFG++ +I+ G+
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           +G+G F  V   + +  G+E+A+K + +T  +   LQ+   EV ++  L H N+V+L   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
              E    LI EY     +  +L    R   +  K   S    I   + Y H+    +I+
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQK---RIV 133
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIF 497
           HRDLK  N+LLD +MN KI+DFG +  F
Sbjct: 134 HRDLKAENLLLDADMNIKIADFGFSNEF 161

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           +G+G F  V   + +  GKE+AVK + +T  +   LQ+   EV ++  L H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
              E    L+ EY     +  +L    R  + + + +      I   + Y H+     I+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---IV 135
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIF 497
           HRDLK  N+LLD +MN KI+DFG +  F
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 158 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 191

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           +G+G F  V   + +  GKE+AVK + +T  +   LQ+   EV ++  L H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
              E    L+ EY     +  +L    R  + + + +      I   + Y H+     I+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---IV 135
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIF 497
           HRDLK  N+LLD +MN KI+DFG +  F
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 173 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 206

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 158 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 191

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 21/164 (12%)
Query: 350 ENKLGEGGFGPVYKGKLA-DG--KEIAVKRLSR-TSGQGLQEFKNEVTLIAKL-QHKNLV 404
           ++ +GEG FG V K ++  DG   + A+KR+    S    ++F  E+ ++ KL  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDS-------------TRSVQLDWKRRISIIN 451
            LLG C       L  EY P+ +L  FL  S             + +  L  ++ +    
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +ARG+ YL   S+ + IHR+L   N+L+      KI+DFG++R
Sbjct: 147 DVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 159 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 192

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 199 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 232

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 165 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 198

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 150 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 183

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 175 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 208

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 322
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +    
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 378
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHR+L   N L+      K++DFG++R+  G+   A+ 
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 416

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V  GK     ++A+K +   S     EF  E  ++  L H+ LV+L G C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            ++    +I EYM N  L  +L +     Q   ++ + +   +   + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 127
Query: 471 RDLKTSNVLLDHEMNPKISDFGMAR 495
           RDL   N L++ +   K+SDFG++R
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSR 152

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 85/155 (54%), Gaps = 20/155 (12%)
Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHKNLVRLLGC 409
           K+GEG +G VYK +   G+  A+K++      +G+      E++++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 410 CLQENESLLIYEYMPNKSLNVFL------FDSTRSVQLDWKRRISIINGIARGLLYLHED 463
              +   +L++E++ ++ L   L       +S  +        + ++NGIA    Y H+ 
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF----LLQLLNGIA----YCHDR 119
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
              +++HRDLK  N+L++ E   KI+DFG+AR FG
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 173 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 206

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 85/155 (54%), Gaps = 20/155 (12%)
Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHKNLVRLLGC 409
           K+GEG +G VYK +   G+  A+K++      +G+      E++++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 410 CLQENESLLIYEYMPNKSLNVFL------FDSTRSVQLDWKRRISIINGIARGLLYLHED 463
              +   +L++E++ ++ L   L       +S  +        + ++NGIA    Y H+ 
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF----LLQLLNGIA----YCHDR 119
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
              +++HRDLK  N+L++ E   KI+DFG+AR FG
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V  GK     ++A+K +   S     EF  E  ++  L H+ LV+L G C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            ++    +I EYM N  L  +L +     Q   ++ + +   +   + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 134
Query: 471 RDLKTSNVLLDHEMNPKISDFGMAR 495
           RDL   N L++ +   K+SDFG++R
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSR 159

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +    
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---F 339
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           IHR+L   N L+      K++DFG++R+  G+   A+ 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 176 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 209

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V  GK     ++A+K +   S     EF  E  ++  L H+ LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            ++    +I EYM N  L  +L +     Q   ++ + +   +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 471 RDLKTSNVLLDHEMNPKISDFGMAR 495
           RDL   N L++ +   K+SDFG++R
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 353 LGEGGFGPVY-----KGKLADGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRL 406
           LGEG FG V            G+ +AVK L   +G Q    +K E+ ++  L H+++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 407 LGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            GCC     +   L+ EY+P  SL  +L     S+ L   + +     I  G+ YLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGL--AQLLLFAQQICEGMAYLHAQH 154
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               IHRDL   NVLLD++   KI DFG+A+
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 85/155 (54%), Gaps = 20/155 (12%)
Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHKNLVRLLGC 409
           K+GEG +G VYK +   G+  A+K++      +G+      E++++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 410 CLQENESLLIYEYMPNKSLNVFL------FDSTRSVQLDWKRRISIINGIARGLLYLHED 463
              +   +L++E++ ++ L   L       +S  +        + ++NGIA    Y H+ 
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF----LLQLLNGIA----YCHDR 119
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
              +++HRDLK  N+L++ E   KI+DFG+AR FG
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 343 ATQHFSDENKLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLI 395
           A +  +   +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWK----------- 444
            +    ++VRLLG   Q   +L+I E M    L  +L    RS++ + +           
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 131
Query: 445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 343 ATQHFSDENKLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLI 395
           A +  +   +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWK----------- 444
            +    ++VRLLG   Q   +L+I E M    L  +L    RS++ + +           
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 131
Query: 445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 353 LGEGGFGPVY-----KGKLADGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRL 406
           LGEG FG V            G+ +AVK L    G Q    +K E+ ++  L H+++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 407 LGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            GCC  + E    L+ EY+P  SL  +L     S+ L   + +     I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGL--AQLLLFAQQICEGMAYLHSQH 137
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               IHR+L   NVLLD++   KI DFG+A+
Sbjct: 138 ---YIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 92/177 (51%), Gaps = 14/177 (7%)
Query: 339 LAVEATQHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAK 397
           L  +  + F    KLGEG +G VYK    + G+ +A+K++   S   LQE   E++++ +
Sbjct: 23  LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQ 80
Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
               ++V+  G   +  +  ++ EY    S++  +    R+  L      +I+    +GL
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGL 138
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR--IVGT 512
            YLH    ++ IHRD+K  N+LL+ E + K++DFG+A    G  ++   KR  ++GT
Sbjct: 139 EYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDXMAKRNXVIGT 188

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V  GK     ++A+K +   S     EF  E  ++  L H+ LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            ++    +I EYM N  L  +L +     Q   ++ + +   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 471 RDLKTSNVLLDHEMNPKISDFGMAR 495
           RDL   N L++ +   K+SDFG++R
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR 168

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMAR
Sbjct: 185 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 218

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V  GK     ++A+K +   S     EF  E  ++  L H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            ++    +I EYM N  L  +L +     Q   ++ + +   +   + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 471 RDLKTSNVLLDHEMNPKISDFGMAR 495
           RDL   N L++ +   K+SDFG++R
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSR 148

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V  GK     ++A+K +   S     EF  E  ++  L H+ LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            ++    +I EYM N  L  +L +     Q   ++ + +   +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 471 RDLKTSNVLLDHEMNPKISDFGMAR 495
           RDL   N L++ +   K+SDFG++R
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 343 ATQHFSDENKLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLI 395
           A +  +   +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWK----------- 444
            +    ++VRLLG   Q   +L+I E M    L  +L    RS++ + +           
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 129
Query: 445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R
Sbjct: 130 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 43/200 (21%)
Query: 336 PLHLAVEATQHFSDEN------------KLGEGGFGPVYKGKL------ADGKEIAVKRL 377
           PL L+V+A +   D               LGEG FG V K         A    +AVK L
Sbjct: 2   PLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML 61
Query: 378 SR-TSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDST 436
               S   L++  +E  ++ ++ H ++++L G C Q+   LLI EY    SL  FL +S 
Sbjct: 62  KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 437 R-------------SVQLDWKRRISIING--------IARGLLYLHEDSRLKIIHRDLKT 475
           +             S  LD     ++  G        I++G+ YL E   +K++HRDL  
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178
Query: 476 SNVLLDHEMNPKISDFGMAR 495
            N+L+      KISDFG++R
Sbjct: 179 RNILVAEGRKMKISDFGLSR 198

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            +LG G FG V  GK     ++A+K +   S     EF  E  ++  L H+ LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            ++    +I EYM N  L  +L +     Q   ++ + +   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 471 RDLKTSNVLLDHEMNPKISDFGMAR 495
           RDL   N L++ +   K+SDFG++R
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR 168

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 343 ATQHFSDENKLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLI 395
           A +  +   +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWK----------- 444
            +    ++VRLLG   Q   +L+I E M    L  +L    RS++ + +           
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 132
Query: 445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 353 LGEGGFGPVY-----KGKLADGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRL 406
           LGEG FG V            G+ +AVK L    G Q    +K E+ ++  L H+++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 407 LGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            GCC  + E    L+ EY+P  SL  +L     S+ L   + +     I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGL--AQLLLFAQQICEGMAYLHAQH 137
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               IHR+L   NVLLD++   KI DFG+A+
Sbjct: 138 ---YIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 343 ATQHFSDENKLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLI 395
           A +  +   +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWK----------- 444
            +    ++VRLLG   Q   +L+I E M    L  +L    RS++ + +           
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 160
Query: 445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R
Sbjct: 161 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      +I+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 343 ATQHFSDENKLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLI 395
           A +  +   +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWK----------- 444
            +    ++VRLLG   Q   +L+I E M    L  +L    RS++ + +           
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 132
Query: 445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 343 ATQHFSDENKLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLI 395
           A +  +   +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWK----------- 444
            +    ++VRLLG   Q   +L+I E M    L  +L    RS++ + +           
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 138
Query: 445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 83/158 (52%), Gaps = 11/158 (6%)
Query: 349 DENK----LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           DEN     LG+G +G VY G+ L++   IA+K +     +  Q    E+ L   L+HKN+
Sbjct: 8   DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 404 VRLLGCCLQENESLLIY-EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           V+ LG    EN  + I+ E +P  SL+  L      ++ + +        I  GL YLH+
Sbjct: 68  VQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 126
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGG 499
           +   +I+HRD+K  NVL++ +    KISDFG ++   G
Sbjct: 127 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 161

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 83/158 (52%), Gaps = 11/158 (6%)
Query: 349 DENK----LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           DEN     LG+G +G VY G+ L++   IA+K +     +  Q    E+ L   L+HKN+
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 404 VRLLGCCLQENESLLIY-EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           V+ LG    EN  + I+ E +P  SL+  L      ++ + +        I  GL YLH+
Sbjct: 82  VQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGG 499
           +   +I+HRD+K  NVL++ +    KISDFG ++   G
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 343 ATQHFSDENKLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLI 395
           A +  +   +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWK----------- 444
            +    ++VRLLG   Q   +L+I E M    L  +L    RS++ + +           
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 125
Query: 445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 43/200 (21%)
Query: 336 PLHLAVEATQHFSDEN------------KLGEGGFGPVYKGKL------ADGKEIAVKRL 377
           PL L+V+A +   D               LGEG FG V K         A    +AVK L
Sbjct: 2   PLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML 61
Query: 378 SR-TSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDST 436
               S   L++  +E  ++ ++ H ++++L G C Q+   LLI EY    SL  FL +S 
Sbjct: 62  KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 437 R-------------SVQLDWKRRISIING--------IARGLLYLHEDSRLKIIHRDLKT 475
           +             S  LD     ++  G        I++G+ YL E   +K++HRDL  
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178
Query: 476 SNVLLDHEMNPKISDFGMAR 495
            N+L+      KISDFG++R
Sbjct: 179 RNILVAEGRKMKISDFGLSR 198

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 87/166 (52%), Gaps = 16/166 (9%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQ-GLQ-EFKNEVTLIAKLQ 399
           AT  +    ++G G +G VYK +    G  +A+K +   +G+ GL      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 400 ---HKNLVRLLGCCL-----QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIIN 451
              H N+VRL+  C      +E +  L++E++ ++ L  +L D      L  +    ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
              RGL +LH +    I+HRDLK  N+L+      K++DFG+ARI+
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 343 ATQHFSDENKLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLI 395
           A +  +   +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD--------WKRRI 447
            +    ++VRLLG   Q   +L+I E M    L  +L  S R    +          + I
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMI 141
Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           +G+G F  V   + +  GKE+AV+ + +T  +   LQ+   EV ++  L H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
              E    L+ EY     +  +L    R  + + + +      I   + Y H+     I+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---IV 135
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIF 497
           HRDLK  N+LLD +MN KI+DFG +  F
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 343 ATQHFSDENKLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLI 395
           A +  +   +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD--------WKRRI 447
            +    ++VRLLG   Q   +L+I E M    L  +L  S R    +          + I
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMI 131
Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           +G+G F  V   + +  GKE+AV+ + +T  +   LQ+   EV ++  L H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
              E    L+ EY     +  +L    R  + + + +      I   + Y H+     I+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---IV 135
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIF 497
           HRDLK  N+LLD +MN KI+DFG +  F
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 87/166 (52%), Gaps = 16/166 (9%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQ-GLQ-EFKNEVTLIAKLQ 399
           AT  +    ++G G +G VYK +    G  +A+K +   +G+ GL      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 400 ---HKNLVRLLGCCL-----QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIIN 451
              H N+VRL+  C      +E +  L++E++ ++ L  +L D      L  +    ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
              RGL +LH +    I+HRDLK  N+L+      K++DFG+ARI+
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 87/166 (52%), Gaps = 16/166 (9%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQ-GLQ-EFKNEVTLIAKLQ 399
           AT  +    ++G G +G VYK +    G  +A+K +   +G+ GL      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 400 ---HKNLVRLLGCCL-----QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIIN 451
              H N+VRL+  C      +E +  L++E++ ++ L  +L D      L  +    ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
              RGL +LH +    I+HRDLK  N+L+      K++DFG+ARI+
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 343 ATQHFSDENKLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLI 395
           A +  +   +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWK----------- 444
            +    ++VRLLG   Q   +L+I E M    L  +L    RS++ + +           
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 123
Query: 445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 84/159 (52%), Gaps = 16/159 (10%)
Query: 353 LGEGGFGPVYKGK-LADGK----EIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG G FG VYKG  + DG+     +A+K L   TS +  +E  +E  ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRS--VQLDWKRRISIINGIARGLLYLHEDS 464
           LG CL     L + + MP   L     D  R    +L  +  ++    IA+G+ YL ED 
Sbjct: 85  LGICLTSTVQL-VTQLMPYGCL----LDHVRENRGRLGSQDLLNWCMQIAKGMSYL-EDV 138
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           RL  +HRDL   NVL+    + KI+DFG+AR+   +++E
Sbjct: 139 RL--VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 175

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/166 (33%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K     ++AVK L S  + + L +  +E+ ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTRSV--QLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           F+ + +   QL  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 90/169 (53%), Gaps = 17/169 (10%)
Query: 351 NKLGEGGFGPVYKGKLADGK----EIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHKNL 403
           +KLG GG   VY   LA+      ++A+K +    R   + L+ F+ EV   ++L H+N+
Sbjct: 17  DKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           V ++    +++   L+ EY+   +L+ ++ +S   + +D    I+  N I  G+ + H+ 
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTA--INFTNQILDGIKHAHD- 129
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             ++I+HRD+K  N+L+D     KI DFG+A+      S   T  ++GT
Sbjct: 130 --MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGT 175

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 12/160 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H    ++LG+G FG V   +   L D  G  +AVK+L  +     ++F+ E+ ++  L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 400 HKNLVRLLGCCLQEN-ESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
              +V+  G       +SL L+ EY+P+  L  FL       +LD  R +   + I +G+
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            YL   SR + +HRDL   N+L++ E + KI+DFG+A++ 
Sbjct: 141 EYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLL 177

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 87/167 (52%), Gaps = 17/167 (10%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLAD--GKEIAVKRLSRTSGQGLQEFKN--EVTLIAKL 398
           A Q +    ++GEG +G V+K +     G+ +A+KR+   +G+         EV ++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 399 Q---HKNLVRLLGCCL-----QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII 450
           +   H N+VRL   C      +E +  L++E++ ++ L  +L D      +  +    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
             + RGL +LH     +++HRDLK  N+L+      K++DFG+ARI+
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 83/160 (51%), Gaps = 12/160 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H    ++LG+G FG V   +   L D  G  +AVK+L  +     ++F+ E+ ++  L 
Sbjct: 7   RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 66
Query: 400 HKNLVRLLGCCLQEN--ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
              +V+  G        E  L+ EY+P+  L  FL       +LD  R +   + I +G+
Sbjct: 67  SDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 124
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            YL   SR + +HRDL   N+L++ E + KI+DFG+A++ 
Sbjct: 125 EYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLL 161

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 82/154 (53%), Gaps = 21/154 (13%)
Query: 353 LGEGGFGPVYKGKLA----DGKEIAVK-----RLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           LGEG FG V   KLA     G+++A+K      L+++  QG    + E++ +  L+H ++
Sbjct: 22  LGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHI 76
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           ++L      ++E +++ EY  N+  +  +     S Q   +    II+ +     Y H  
Sbjct: 77  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE----YCH-- 130
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            R KI+HRDLK  N+LLD  +N KI+DFG++ I 
Sbjct: 131 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 163

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 87/167 (52%), Gaps = 17/167 (10%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLAD--GKEIAVKRLSRTSGQGLQEFKN--EVTLIAKL 398
           A Q +    ++GEG +G V+K +     G+ +A+KR+   +G+         EV ++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 399 Q---HKNLVRLLGCCL-----QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII 450
           +   H N+VRL   C      +E +  L++E++ ++ L  +L D      +  +    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
             + RGL +LH     +++HRDLK  N+L+      K++DFG+ARI+
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 347 FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           F +   LG+G FG V K + A D +  A+K++ R + + L    +EV L+A L H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 406 LLGCCLQ------------ENESLLI-YEYMPNKSLNVFLFDSTRSVQLD--WKRRISII 450
                L+            +  +L I  EY  N++L   +     + Q D  W+    + 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR----LF 122
Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             I   L Y+H      IIHRDLK  N+ +D   N KI DFG+A+
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 82/154 (53%), Gaps = 21/154 (13%)
Query: 353 LGEGGFGPVYKGKLA----DGKEIAVK-----RLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           LGEG FG V   KLA     G+++A+K      L+++  QG    + E++ +  L+H ++
Sbjct: 21  LGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHI 75
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           ++L      ++E +++ EY  N+  +  +     S Q   +    II+ +     Y H  
Sbjct: 76  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE----YCH-- 129
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            R KI+HRDLK  N+LLD  +N KI+DFG++ I 
Sbjct: 130 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 82/154 (53%), Gaps = 21/154 (13%)
Query: 353 LGEGGFGPVYKGKLA----DGKEIAVK-----RLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           LGEG FG V   KLA     G+++A+K      L+++  QG    + E++ +  L+H ++
Sbjct: 12  LGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHI 66
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           ++L      ++E +++ EY  N+  +  +     S Q   +    II+ +     Y H  
Sbjct: 67  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE----YCH-- 120
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            R KI+HRDLK  N+LLD  +N KI+DFG++ I 
Sbjct: 121 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 153

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 12/160 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H    ++LG+G FG V   +   L D  G  +AVK+L  +     ++F+ E+ ++  L 
Sbjct: 10  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 69
Query: 400 HKNLVRLLGCCLQEN-ESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
              +V+  G       +SL L+ EY+P+  L  FL       +LD  R +   + I +G+
Sbjct: 70  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 127
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            YL   SR + +HRDL   N+L++ E + KI+DFG+A++ 
Sbjct: 128 EYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLL 164

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 12/160 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGK---LAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ 399
           +H    ++LG+G FG V   +   L D  G  +AVK+L  +     ++F+ E+ ++  L 
Sbjct: 11  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 70
Query: 400 HKNLVRLLGCCLQEN-ESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
              +V+  G       +SL L+ EY+P+  L  FL       +LD  R +   + I +G+
Sbjct: 71  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 128
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            YL   SR + +HRDL   N+L++ E + KI+DFG+A++ 
Sbjct: 129 EYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLL 165

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 82/154 (53%), Gaps = 21/154 (13%)
Query: 353 LGEGGFGPVYKGKLA----DGKEIAVK-----RLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           LGEG FG V   KLA     G+++A+K      L+++  QG    + E++ +  L+H ++
Sbjct: 16  LGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHI 70
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           ++L      ++E +++ EY  N+  +  +     S Q   +    II+ +     Y H  
Sbjct: 71  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE----YCH-- 124
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            R KI+HRDLK  N+LLD  +N KI+DFG++ I 
Sbjct: 125 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 157

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 87/167 (52%), Gaps = 17/167 (10%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLAD--GKEIAVKRLSRTSGQGLQEFKN--EVTLIAKL 398
           A Q +    ++GEG +G V+K +     G+ +A+KR+   +G+         EV ++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 399 Q---HKNLVRLLGCCL-----QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII 450
           +   H N+VRL   C      +E +  L++E++ ++ L  +L D      +  +    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
             + RGL +LH     +++HRDLK  N+L+      K++DFG+ARI+
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 353 LGEGGFGPVY-----KGKLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRL 406
           LGEG FG V            G+ +AVK L    G  L+  ++ E+ ++  L H+++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 407 LGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            GCC  + E    L+ EY+P  SL  +L      V L   + +     I  G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGL--AQLLLFAQQICEGMAYLHAQH 132
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               IHR L   NVLLD++   KI DFG+A+
Sbjct: 133 ---YIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 350 ENKLGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRL 406
           +  +G+G F  V   + +  G+E+AVK + +T  +   LQ+   EV ++  L H N+V+L
Sbjct: 20  QKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
                 E    L+ EY     +  +L    R  + + + +      I   + Y H+    
Sbjct: 80  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKY-- 134
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            I+HRDLK  N+LLD +MN KI+DFG +  F
Sbjct: 135 -IVHRDLKAENLLLDGDMNIKIADFGFSNEF 164

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 353 LGEGGFGPVY-----KGKLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRL 406
           LGEG FG V            G+ +AVK L    G  L+  ++ E+ ++  L H+++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 407 LGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            GCC  + E    L+ EY+P  SL  +L      V L   + +     I  G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGL--AQLLLFAQQICEGMAYLHAQH 131
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               IHR L   NVLLD++   KI DFG+A+
Sbjct: 132 ---YIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 353 LGEGGFGPVYKGKLADGK------EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVR 405
           LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS----TRSVQLDWKRRISIINGIARGLLYLH 461
            +G  LQ     ++ E M    L  FL ++    ++   L     + +   IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR 495
           E+     IHRD+   N LL     P    KI DFGMA+
Sbjct: 159 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAQ 192

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I  Y    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           +G+G F  V   + +  GKE+AVK + +T  +   LQ+   EV +   L H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
              E    L+ EY     +  +L    R  + + + +      I   + Y H+     I+
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF---RQIVSAVQYCHQKF---IV 135
Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSEA 504
           HRDLK  N+LLD + N KI+DFG +  F  GN+ +A
Sbjct: 136 HRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA 171

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K     ++AVK L S  + + L +  +E+ ++  + +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTRSV--QLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           ++ + +   QL  K  +S 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 191

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 25/171 (14%)
Query: 343 ATQHFSDENKLGEGGFGPVY----KGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLI 395
           A +  +   +LG+G FG VY    KG + D  E  +A+K ++  +    + EF NE +++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWK----------- 444
            +    ++VRLLG   Q   +L+I E M    L  +L    RS++ + +           
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 125
Query: 445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + I +   IA G+ YL+ +   K +HRDL   N  +  +   KI DFGM R
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K     ++AVK L S  + + L +  +E+ ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTRSV--QLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           ++ + +   QL  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K     ++AVK L S  + + L +  +E+ ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTRSV--QLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           ++ + +   QL  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K     ++AVK L S  + + L +  +E+ ++  + +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTRSV--QLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           ++ + +   QL  K  +S 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 187

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K     ++AVK L S  + + L +  +E+ ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTRSV--QLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           ++ + +   QL  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K     ++AVK L S  + + L +  +E+ ++  + +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTRSV--QLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           ++ + +   QL  K  +S 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K     ++AVK L S  + + L +  +E+ ++  + +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTRSV--QLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           ++ + +   QL  K  +S 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K     ++AVK L S  + + L +  +E+ ++  + +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTRSV--QLDWKRRISI 449
           ++ LLG C Q+    +I EY    +L  +L           ++ + +   QL  K  +S 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 190

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           +G+G F  V   + +  GKE+AVK + +T  +   LQ+   EV ++  L H N+V+L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDW---KRRISIINGIARGLLYLHEDSRL 466
              E    L+ EY     +  +L      V   W   K   +    I   + Y H+    
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYL------VAHGWMKEKEARAKFRQIVSAVQYCHQKF-- 126
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            I+HRDLK  N+LLD +MN KI+DFG +  F
Sbjct: 127 -IVHRDLKAENLLLDADMNIKIADFGFSNEF 156

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGPVY--------KGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
           LGEG FG V         K K  +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-----------FDSTR--SVQLDWKRRISI 449
           ++ LLG C Q+    +I  Y    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ 412
           +G+G FG VY G+      I +  + R +   L+ FK EV    + +H+N+V  +G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 413 ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRD 472
                +I      ++L   + D+   + LD  +   I   I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 473 LKTSNVLLDHEMNPK--ISDFGMARIFGGNQS 502
           LK+ NV  D   N K  I+DFG+  I G  Q+
Sbjct: 156 LKSKNVFYD---NGKVVITDFGLFSISGVLQA 184

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 339 LAVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLS-RTSGQGLQEFKNEVTLIA 396
           ++++  + F+   K+G+G FG V+KG      K +A+K +    +   +++ + E+T+++
Sbjct: 1   MSLDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 397 KLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARG 456
           +     + +  G  L++ +  +I EY+   S      D      LD  +  +I+  I +G
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKG 116
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           L YLH + +   IHRD+K +NVLL      K++DFG+A      Q + NT   VGT
Sbjct: 117 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 167

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 43/200 (21%)
Query: 336 PLHLAVEATQHFSDEN------------KLGEGGFGPVYKGKL------ADGKEIAVKRL 377
           PL L+V+A +   D               LGEG FG V K         A    +AVK L
Sbjct: 2   PLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML 61
Query: 378 SR-TSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDST 436
               S   L++  +E  ++ ++ H ++++L G C Q+   LLI EY    SL  FL +S 
Sbjct: 62  KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 437 R-------------SVQLDWKRRISIING--------IARGLLYLHEDSRLKIIHRDLKT 475
           +             S  LD     ++  G        I++G+ YL E   + ++HRDL  
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MSLVHRDLAA 178
Query: 476 SNVLLDHEMNPKISDFGMAR 495
            N+L+      KISDFG++R
Sbjct: 179 RNILVAEGRKMKISDFGLSR 198

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 10/160 (6%)
Query: 346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQ---EFKNEVTLIAKLQHK 401
           H+   + LG G FG V  G+    G ++AVK L+R   + L    + K E+  +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           ++++L        +  ++ EY+    L  ++    R  +++ +R   +   I   + Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSAVDYCH 128
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
              R  ++HRDLK  NVLLD  MN KI+DFG++ +    +
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 10/160 (6%)
Query: 346 HFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQ---EFKNEVTLIAKLQHK 401
           H+   + LG G FG V  G+    G ++AVK L+R   + L    + K E+  +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           ++++L        +  ++ EY+    L  ++    R  +++ +R   +   I   + Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSAVDYCH 128
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
              R  ++HRDLK  NVLLD  MN KI+DFG++ +    +
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 25/162 (15%)
Query: 352 KLGEGGFGPVYKGKLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLV 404
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD-----------WKRRISIINGI 453
           RLLG   +   +L++ E M +  L  +L    RS++ +            +  I +   I
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           A G+ YL+     K +HRDL   N ++ H+   KI DFGM R
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 25/162 (15%)
Query: 352 KLGEGGFGPVYKGKLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLV 404
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD-----------WKRRISIINGI 453
           RLLG   +   +L++ E M +  L  +L    RS++ +            +  I +   I
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           A G+ YL+     K +HRDL   N ++ H+   KI DFGM R
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 25/162 (15%)
Query: 352 KLGEGGFGPVYKGKLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLV 404
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD-----------WKRRISIINGI 453
           RLLG   +   +L++ E M +  L  +L    RS++ +            +  I +   I
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           A G+ YL+     K +HRDL   N ++ H+   KI DFGM R
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 80/176 (45%), Gaps = 8/176 (4%)
Query: 339 LAVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIA 396
           +AV   + +     LGEG +G V         + +AVK +         E  K E+ + A
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINA 60
Query: 397 KLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARG 456
            L H+N+V+  G   + N   L  EY     L   +       + D +R     + +  G
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAG 117
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           ++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 24/159 (15%)
Query: 353 LGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           LG+G FG V K + A D +  A+K++ R + + L    +EV L+A L H+ +VR     L
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 412 Q------------ENESLLI-YEYMPNKSLNVFLFDSTRSVQLD--WKRRISIINGIARG 456
           +            +  +L I  EY  N++L   +     + Q D  W+    +   I   
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR----LFRQILEA 128
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           L Y+H      IIHR+LK  N+ +D   N KI DFG+A+
Sbjct: 129 LSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 86/201 (42%), Gaps = 30/201 (14%)
Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG-KLADGKE 371
           GN Y++         E  EFP   L               LG G FG V +      GKE
Sbjct: 24  GNSYTFIDPTQLPYNEKWEFPRNNLQFG----------KTLGAGAFGKVVEATAFGLGKE 73
Query: 372 -----IAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
                +AVK L  T+    +E   +E+ +++ L QH+N+V LLG C      L+I EY  
Sbjct: 74  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL----------KIIHRDLK 474
              L  FL   +R ++ D     +I N  A     LH  S++            IHRD+ 
Sbjct: 134 YGDLLNFLRRKSRVLETD--PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA 191
Query: 475 TSNVLLDHEMNPKISDFGMAR 495
             NVLL +    KI DFG+AR
Sbjct: 192 ARNVLLTNGHVAKIGDFGLAR 212

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +  + K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     K+IHRD+K  N+LL      KI+DFG +
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 25/162 (15%)
Query: 352 KLGEGGFGPVYKGKLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLV 404
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD-----------WKRRISIINGI 453
           RLLG   +   +L++ E M +  L  +L    RS++ +            +  I +   I
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           A G+ YL+     K +HRDL   N ++ H+   KI DFGM R
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 78/165 (47%), Gaps = 24/165 (14%)
Query: 347 FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           F +   LG+G FG V K + A D +  A+K++ R + + L    +EV L+A L H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 406 LLGCCLQ------------ENESLLI-YEYMPNKSLNVFLFDSTRSVQLD--WKRRISII 450
                L+            +  +L I  EY  N +L   +     + Q D  W+    + 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR----LF 122
Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             I   L Y+H      IIHRDLK  N+ +D   N KI DFG+A+
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 90/175 (51%), Gaps = 11/175 (6%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLS-RTSGQGLQEFKNEVTLIAK 397
           +++  + F+   K+G+G FG V+KG      K +A+K +    +   +++ + E+T++++
Sbjct: 22  SMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 81
Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
                + +  G  L++ +  +I EY+   S      D      LD  +  +I+  I +GL
Sbjct: 82  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGL 137
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            YLH + +   IHRD+K +NVLL      K++DFG+A      Q + NT   VGT
Sbjct: 138 DYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 187

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 25/162 (15%)
Query: 352 KLGEGGFGPVYKGKLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLV 404
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLD-----------WKRRISIINGI 453
           RLLG   +   +L++ E M +  L  +L    RS++ +            +  I +   I
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 136
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           A G+ YL+     K +HRDL   N ++ H+   KI DFGM R
Sbjct: 137 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 17/158 (10%)
Query: 352 KLGEGGFGPVYKGKLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLV 404
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKR-------RISIINGIARGL 457
           RLLG   +   +L++ E M +  L  +L       + +  R        I +   IA G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            YL+     K +HRDL   N ++ H+   KI DFGM R
Sbjct: 143 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 81/169 (47%), Gaps = 12/169 (7%)
Query: 353 LGEGGFGPVYK-GKLADGKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           +G G +G   K  + +DGK +  K L   S T  +  Q   +EV L+ +L+H N+VR   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYD 72
Query: 409 CCLQENESLL--IYEYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHE--D 463
             +    + L  + EY     L   +   T+  Q LD +  + ++  +   L   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
               ++HRDLK +NV LD + N K+ DFG+ARI   N  E   K  VGT
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEFVGT 179

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 352 KLGEGGFGPVYKGKLADGK---EIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           +LG G FG V +G     K   ++A+K L + T     +E   E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G C Q    +L+ E      L+ FL      + +       +++ ++ G+ YL E +   
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKN--- 130
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
            +HRDL   NVLL +    KISDFG+++  G + S
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 92/178 (51%), Gaps = 15/178 (8%)
Query: 339 LAVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLS-RTSGQGLQEFKNEVTLIA 396
           ++++  + F+   K+G+G FG V+KG      K +A+K +    +   +++ + E+T+++
Sbjct: 1   MSLDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 397 KLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARG 456
           +     + +  G  L++ +  +I EY+   S      D      LD  +  +I+  I +G
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKG 116
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR--IVGT 512
           L YLH + +   IHRD+K +NVLL      K++DFG+A    G  ++   KR   VGT
Sbjct: 117 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNXFVGT 167

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ 412
           +G+G FG V  G    G ++AVK +   +    Q F  E +++ +L+H NLV+LLG  ++
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 413 ENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           E   L ++ EYM   SL  +L    RSV L     +     +   + YL  ++    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 472 DLKTSNVLLDHEMNPKISDFGMAR 495
           DL   NVL+  +   K+SDFG+ +
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK 337

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 15/179 (8%)
Query: 338 HLAVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLS-RTSGQGLQEFKNEVTLI 395
           +L  +  + F+   K+G+G FG V+KG      K +A+K +    +   +++ + E+T++
Sbjct: 15  NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 396 AKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
           ++     + +  G  L++ +  +I EY+   S      D      LD  +  +I+  I +
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILK 130
Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR--IVGT 512
           GL YLH + +   IHRD+K +NVLL      K++DFG+A    G  ++   KR   VGT
Sbjct: 131 GLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNXFVGT 182

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 86/198 (43%), Gaps = 28/198 (14%)
Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG-KLADGKE 371
           GN Y++         E  EFP   L               LG G FG V +      GKE
Sbjct: 16  GNSYTFIDPTQLPYNEKWEFPRNNLQFG----------KTLGAGAFGKVVEATAFGLGKE 65
Query: 372 -----IAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
                +AVK L  T+    +E   +E+ +++ L QH+N+V LLG C      L+I EY  
Sbjct: 66  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 125
Query: 425 NKSLNVFL-------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
              L  FL        D      L+ +  +   + +A+G+ +L   +    IHRD+   N
Sbjct: 126 YGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 182
Query: 478 VLLDHEMNPKISDFGMAR 495
           VLL +    KI DFG+AR
Sbjct: 183 VLLTNGHVAKIGDFGLAR 200

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 88/202 (43%), Gaps = 32/202 (15%)
Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG-KLADGKE 371
           GN Y++         E  EFP   L               LG G FG V +      GKE
Sbjct: 24  GNSYTFIDPTQLPYNEKWEFPRNNLQFG----------KTLGAGAFGKVVEATAFGLGKE 73
Query: 372 -----IAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
                +AVK L  T+    +E   +E+ +++ L QH+N+V LLG C      L+I EY  
Sbjct: 74  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 425 NKSLNVFLFDSTRSVQLDWKRRIS-----------IINGIARGLLYLHEDSRLKIIHRDL 473
              L  FL   +R ++ D    I+             + +A+G+ +L   +    IHRD+
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN---CIHRDV 190
Query: 474 KTSNVLLDHEMNPKISDFGMAR 495
              NVLL +    KI DFG+AR
Sbjct: 191 AARNVLLTNGHVAKIGDFGLAR 212

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
           Y H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
           Y H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 79/176 (44%), Gaps = 8/176 (4%)
Query: 339 LAVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIA 396
           +AV   + +     LGEG +G V         + +AVK +         E  K E+ +  
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 60
Query: 397 KLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARG 456
            L H+N+V+  G   + N   L  EY     L   +       + D +R     + +  G
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAG 117
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           ++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ 412
           +G+G FG V  G    G ++AVK +   +    Q F  E +++ +L+H NLV+LLG  ++
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 413 ENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           E   L ++ EYM   SL  +L    RSV L     +     +   + YL  ++    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 472 DLKTSNVLLDHEMNPKISDFGMAR 495
           DL   NVL+  +   K+SDFG+ +
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK 156

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
           Y H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 17/158 (10%)
Query: 352 KLGEGGFGPVYKGKLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLV 404
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKR-------RISIINGIARGL 457
           RLLG   +   +L++ E M +  L  +L       + +  R        I +   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            YL+     K +HR+L   N ++ H+   KI DFGM R
Sbjct: 144 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
           Y H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 157

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ 412
           +G+G FG V  G    G ++AVK +   +    Q F  E +++ +L+H NLV+LLG  ++
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 413 ENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           E   L ++ EYM   SL  +L    RSV L     +     +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 472 DLKTSNVLLDHEMNPKISDFGMAR 495
           DL   NVL+  +   K+SDFG+ +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 12/169 (7%)
Query: 353 LGEGGFGPVYK-GKLADGKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           +G G +G   K  + +DGK +  K L   S T  +  Q   +EV L+ +L+H N+VR   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYD 72
Query: 409 CCLQENESLL--IYEYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHE--D 463
             +    + L  + EY     L   +   T+  Q LD +  + ++  +   L   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
               ++HRDLK +NV LD + N K+ DFG+ARI   + S A T   VGT
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ 412
           +G+G FG V  G    G ++AVK +   +    Q F  E +++ +L+H NLV+LLG  ++
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 413 ENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
           E   L ++ EYM   SL  +L    RSV L     +     +   + YL  ++    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 472 DLKTSNVLLDHEMNPKISDFGMAR 495
           DL   NVL+  +   K+SDFG+ +
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK 165

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 18/185 (9%)
Query: 314 NDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEI- 372
           N+   ++   QK EES++           A + F     LG+G FG VY  +    K I 
Sbjct: 2   NNPEEELASKQKNEESKKRQW--------ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL 53
Query: 373 AVKRL--SRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           A+K L  ++    G++ + + EV + + L+H N++RL G         LI EY P   L 
Sbjct: 54  ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LG 110
Query: 430 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 489
               +  +  + D +R  + I  +A  L Y H     ++IHRD+K  N+LL      KI+
Sbjct: 111 TVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 167
Query: 490 DFGMA 494
           DFG +
Sbjct: 168 DFGWS 172

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 154

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 10/147 (6%)
Query: 353 LGEGGFGPVYK-GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           LG G FG V+K  + A G ++A K +     +  +E KNE++++ +L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 412 QENESLLIYEYMPNKSLNVFLFDSTRSV-QLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            +N+ +L+ EY+    L   + D + ++ +LD    I  +  I  G+ ++H+   + I+H
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMHQ---MYILH 210
Query: 471 RDLKTSNVL-LDHEMNP-KISDFGMAR 495
            DLK  N+L ++ +    KI DFG+AR
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 18/185 (9%)
Query: 314 NDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEI- 372
           N+   ++   QK EES++           A + F     LG+G FG VY  +    K I 
Sbjct: 11  NNPEEELASKQKNEESKKRQW--------ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL 62
Query: 373 AVKRL--SRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           A+K L  ++    G++ + + EV + + L+H N++RL G         LI EY P   L 
Sbjct: 63  ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LG 119
Query: 430 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 489
               +  +  + D +R  + I  +A  L Y H     ++IHRD+K  N+LL      KI+
Sbjct: 120 TVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 176
Query: 490 DFGMA 494
           DFG +
Sbjct: 177 DFGWS 181

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 157

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 6/146 (4%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E  +G G FG V K K    K++A+K++   S +  + F  E+  ++++ H N+V+L G 
Sbjct: 14  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 70
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
           CL  N   L+ EY    SL   L  +           +S     ++G+ YLH      +I
Sbjct: 71  CL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 470 HRDLKTSNVLLDHEMNP-KISDFGMA 494
           HRDLK  N+LL       KI DFG A
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 17/158 (10%)
Query: 352 KLGEGGFGPVYKGKLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLV 404
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKR-------RISIINGIARGL 457
           RLLG   +   +L++ E M +  L  +L       + +  R        I +   IA G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            YL+     K +HR+L   N ++ H+   KI DFGM R
Sbjct: 145 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQ--GLQ-EFKNEVTLIAKLQH 400
           + F     LG+G FG VY  +    K I A+K L +T  +  G++ + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
            N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 86/198 (43%), Gaps = 28/198 (14%)
Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG-KLADGKE 371
           GN Y++         E  EFP   L               LG G FG V +      GKE
Sbjct: 24  GNSYTFIDPTQLPYNEKWEFPRNNLQFG----------KTLGAGAFGKVVEATAFGLGKE 73
Query: 372 -----IAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
                +AVK L  T+    +E   +E+ +++ L QH+N+V LLG C      L+I EY  
Sbjct: 74  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 425 NKSLNVFL-------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
              L  FL        D      L+ +  +   + +A+G+ +L   +    IHRD+   N
Sbjct: 134 YGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 190
Query: 478 VLLDHEMNPKISDFGMAR 495
           VLL +    KI DFG+AR
Sbjct: 191 VLLTNGHVAKIGDFGLAR 208

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 6/146 (4%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E  +G G FG V K K    K++A+K++   S +  + F  E+  ++++ H N+V+L G 
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
           CL  N   L+ EY    SL   L  +           +S     ++G+ YLH      +I
Sbjct: 70  CL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 470 HRDLKTSNVLLDHEMNP-KISDFGMA 494
           HRDLK  N+LL       KI DFG A
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 79/176 (44%), Gaps = 8/176 (4%)
Query: 339 LAVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIA 396
           +AV   + +     LGEG +G V         + +AVK +         E  K E+ +  
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 60
Query: 397 KLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARG 456
            L H+N+V+  G   + N   L  EY     L   +       + D +R     + +  G
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAG 117
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           ++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQ--GLQ-EFKNEVTLIAKLQH 400
           + F     LG+G FG VY  +    K I A+K L +T  +  G++ + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
            N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 36/171 (21%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC- 410
           +G GGFG V+K K   DGK   ++R+   +    ++ + EV  +AKL H N+V   GC  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 75
Query: 411 ------LQENESLLIYEYMPNKSLN--------VFL-------------FDSTRSVQLDW 443
                    ++SL   +Y P  S N        +F+              +  R  +LD 
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 444 KRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
              + +   I +G+ Y+H     K+IHRDLK SN+ L      KI DFG+ 
Sbjct: 136 VLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLV 183

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 85/162 (52%), Gaps = 10/162 (6%)
Query: 352 KLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+G+G  G VY    +A G+E+A+++++       +   NE+ ++ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ EY+   SL     D      +D  +  ++     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RD+K+ N+LL  + + K++DFG        QS+ +T  +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 11/149 (7%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCL 411
           +G G +G VYKG+     ++A  ++   +G   +E K E+ ++ K   H+N+    G  +
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 412 QENES------LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           ++N         L+ E+    S+   L  +T+   L  +    I   I RGL +LH+   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 148
Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
            K+IHRD+K  NVLL      K+ DFG++
Sbjct: 149 -KVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 82/179 (45%), Gaps = 14/179 (7%)
Query: 339 LAVEATQHFSDENKLGEGGFGPVYKGKLADGK----EIAVKRLSRTSGQGLQE-FKNEVT 393
           +AV   + +     LGEG +G V   +LA  +     +AVK +         E  K E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIX 57
Query: 394 LIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +   L H+N+V+  G   + N   L  EY     L   +       + D +R     + +
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQL 114
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 115 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 82/179 (45%), Gaps = 14/179 (7%)
Query: 339 LAVEATQHFSDENKLGEGGFGPVYKGKLADGK----EIAVKRLSRTSGQGLQE-FKNEVT 393
           +AV   + +     LGEG +G V   +LA  +     +AVK +         E  K E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 394 LIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +   L H+N+V+  G   + N   L  EY     L   +       + D +R     + +
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQL 114
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 115 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 82/179 (45%), Gaps = 14/179 (7%)
Query: 339 LAVEATQHFSDENKLGEGGFGPVYKGKLADGK----EIAVKRLSRTSGQGLQE-FKNEVT 393
           +AV   + +     LGEG +G V   +LA  +     +AVK +         E  K E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 394 LIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +   L H+N+V+  G   + N   L  EY     L   +       + D +R     + +
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQL 114
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 115 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 82/179 (45%), Gaps = 14/179 (7%)
Query: 339 LAVEATQHFSDENKLGEGGFGPVYKGKLADGK----EIAVKRLSRTSGQGLQE-FKNEVT 393
           +AV   + +     LGEG +G V   +LA  +     +AVK +         E  K E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 394 LIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +   L H+N+V+  G   + N   L  EY     L   +       + D +R     + +
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQL 114
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 115 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 82/179 (45%), Gaps = 14/179 (7%)
Query: 339 LAVEATQHFSDENKLGEGGFGPVYKGKLADGK----EIAVKRLSRTSGQGLQE-FKNEVT 393
           +AV   + +     LGEG +G V   +LA  +     +AVK +         E  K E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 394 LIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +   L H+N+V+  G   + N   L  EY     L   +       + D +R     + +
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQL 114
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 115 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 81/152 (53%), Gaps = 12/152 (7%)
Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKN-----EVTLIAKLQHKNLVRL 406
           LGEG F  VYK +  +  +I A+K++        ++  N     E+ L+ +L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
           L     ++   L++++M    L V + D++  +     +   ++    +GL YLH+    
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMT--LQGLEYLHQHW-- 132
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            I+HRDLK +N+LLD     K++DFG+A+ FG
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 18/185 (9%)
Query: 314 NDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEI- 372
           N+   ++   QK EES++           A + F     LG+G FG VY  +    K I 
Sbjct: 11  NNPEEELASKQKNEESKKRQW--------ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL 62
Query: 373 AVKRL--SRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           A+K L  ++    G++ + + EV + + L+H N++RL G         LI EY P   L 
Sbjct: 63  ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LG 119
Query: 430 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 489
               +  +  + D +R  + I  +A  L Y H     ++IHRD+K  N+LL      KI+
Sbjct: 120 TVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 176
Query: 490 DFGMA 494
           DFG +
Sbjct: 177 DFGWS 181

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 8/175 (4%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAK 397
           AV   + +     LGEG +G V         + +AVK +         E  K E+ +   
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           L H+N+V+  G   + N   L  EY     L   +       + D +R     + +  G+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGV 117
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 118 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 152

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 12/169 (7%)
Query: 353 LGEGGFGPVYK-GKLADGKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           +G G +G   K  + +DGK +  K L   S T  +  Q   +EV L+ +L+H N+VR   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYD 72
Query: 409 CCLQENESLL--IYEYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHE--D 463
             +    + L  + EY     L   +   T+  Q LD +  + ++  +   L   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
               ++HRDLK +NV LD + N K+ DFG+ARI   + S A  K  VGT
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGT 179

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 8/175 (4%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAK 397
           AV   + +     LGEG +G V         + +AVK +         E  K E+ +   
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           L H+N+V+  G   + N   L  EY     L   +       + D +R     + +  G+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGV 117
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 118 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 8/175 (4%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAK 397
           AV   + +     LGEG +G V         + +AVK +         E  K E+ +   
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           L H+N+V+  G   + N   L  EY     L   +       + D +R     + +  G+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGV 117
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 118 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 83/161 (51%), Gaps = 21/161 (13%)
Query: 344 TQHFSDEN-----KLGEGGFGPVYKGKLADGKE----IAVKRL--SRTSGQGLQ-EFKNE 391
           T+HF+ ++      LG+G FG VY   LA  K+    +A+K L  S+   +G++ + + E
Sbjct: 17  TRHFTIDDFEIGRPLGKGKFGNVY---LAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 392 VTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIIN 451
           + + A L H N++RL           LI EY P   L   L    +S   D +R  +I+ 
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIME 130
Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
            +A  L+Y H     K+IHRD+K  N+LL  +   KI+DFG
Sbjct: 131 ELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG 168

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 8/175 (4%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAK 397
           AV   + +     LGEG +G V         + +AVK +         E  K E+ +   
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           L H+N+V+  G   + N   L  EY     L   +       + D +R     + +  G+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGV 117
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 118 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 83/174 (47%), Gaps = 35/174 (20%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAV----KRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRL 406
           LG G FG V+KG  + +G+ I +    K +   SG Q  Q   + +  I  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 407 LGCCLQENESL-LIYEYMPNKSLNVFLFDSTRS--------VQLDWKRRISIINGIARGL 457
           LG C     SL L+ +Y+P  SL     D  R         + L+W  +I      A+G+
Sbjct: 81  LGLC--PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQI------AKGM 128
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ-----SEANT 506
            YL E     ++HR+L   NVLL      +++DFG+A +   +      SEA T
Sbjct: 129 YYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 90/168 (53%), Gaps = 11/168 (6%)
Query: 347 FSDENKLGEGGFGPVYKGKLADGKEI-AVKRLS-RTSGQGLQEFKNEVTLIAKLQHKNLV 404
           F+   ++G+G FG V+KG     +++ A+K +    +   +++ + E+T++++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           +  G  L+ ++  +I EY+   S      D  R+   D  +  +++  I +GL YLH + 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 140
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +   IHRD+K +NVLL  + + K++DFG+A      Q + NT   VGT
Sbjct: 141 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 183

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 8/175 (4%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAK 397
           AV   + +     LGEG +G V         + +AVK +         E  K E+ +   
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           L H+N+V+  G   + N   L  EY     L   +       + D +R     + +  G+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGV 117
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 118 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 8/175 (4%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAK 397
           AV   + +     LGEG +G V         + +AVK +         E  K E+ +   
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           L H+N+V+  G   + N   L  EY     L   +       + D +R     + +  G+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGV 117
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 118 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 14/178 (7%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKGKLADGK----EIAVKRLSRTSGQGLQE-FKNEVTL 394
           AV   + +     LGEG +G V   +LA  +     +AVK +         E  K E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXI 57
Query: 395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIA 454
              L H+N+V+  G   + N   L  EY     L   +       + D +R     + + 
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLM 114
Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 115 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   +   L    +  + D +R  + I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 15/156 (9%)
Query: 351 NKLGEGGFGPVYKG-KLADGKEIAVKRLS-RTSGQGLQEFK-NEVTLIAKLQHKNLVRLL 407
            KLGEG +G VYK       + +A+KR+      +G+      EV+L+ +LQH+N++ L 
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
                 +   LI+EY  N        +   S+++       +ING+     + H  SR +
Sbjct: 100 SVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN----FCH--SR-R 152
Query: 468 IIHRDLKTSNVLL---DHEMNP--KISDFGMARIFG 498
            +HRDLK  N+LL   D    P  KI DFG+AR FG
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 14/178 (7%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKGKLADGK----EIAVKRLSRTSGQGLQE-FKNEVTL 394
           AV   + +     LGEG +G V   +LA  +     +AVK +         E  K E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXI 57
Query: 395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIA 454
              L H+N+V+  G   + N   L  EY     L   +       + D +R     + + 
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLM 114
Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 115 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 83/174 (47%), Gaps = 35/174 (20%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAV----KRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRL 406
           LG G FG V+KG  + +G+ I +    K +   SG Q  Q   + +  I  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 407 LGCCLQENESL-LIYEYMPNKSLNVFLFDSTRS--------VQLDWKRRISIINGIARGL 457
           LG C     SL L+ +Y+P  SL     D  R         + L+W  +I      A+G+
Sbjct: 99  LGLC--PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQI------AKGM 146
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ-----SEANT 506
            YL E     ++HR+L   NVLL      +++DFG+A +   +      SEA T
Sbjct: 147 YYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 197

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 352 KLGEGGFGPVYKGKLADGK---EIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           +LG G FG V +G     K   ++A+K L + T     +E   E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G C Q    +L+ E      L+ FL      + +       +++ ++ G+ YL E +   
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKN--- 456
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
            +HR+L   NVLL +    KISDFG+++  G + S
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 14/178 (7%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKGKLADGK----EIAVKRLSRTSGQGLQE-FKNEVTL 394
           AV   + +     LGEG +G V   +LA  +     +AVK +         E  K E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIA 454
              L H+N+V+  G   + N   L  EY     L   +       + D +R     + + 
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLM 114
Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 115 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 24/172 (13%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           + D   LG GG G V+     D  K +A+K++  T  Q ++    E+ +I +L H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 406 L--------------LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIIN 451
           +              +G   + N   ++ EYM     NV      +   L+   R+ +  
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL----EQGPLLEEHARLFMYQ 128
Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQS 502
            + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI   + S
Sbjct: 129 -LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 14/178 (7%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKGKLADGK----EIAVKRLSRTSGQGLQE-FKNEVTL 394
           AV   + +     LGEG +G V   +LA  +     +AVK +         E  K E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIA 454
              L H+N+V+  G   + N   L  EY     L   +       + D +R     + + 
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLM 114
Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 345 QHFSDENKLGEGGFGPVYKGKLA--DGK--EIAVKRLSR--TSGQGLQEFKNEVTLIAKL 398
           Q F+    LG+G FG V + +L   DG   ++AVK L     +   ++EF  E   + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 399 QHKNLVRLLGCCLQENES------LLIYEYMPNKSLNVFLFDS---TRSVQLDWKRRISI 449
            H ++ +L+G  L+          ++I  +M +  L+ FL  S        L  +  +  
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGN 500
           +  IA G+ YL   S    IHRDL   N +L  +M   ++DFG++R I+ G+
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 74/162 (45%), Gaps = 8/162 (4%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCC 410
           LGEG +G V         + +AVK +         E  K E+ +   L H+N+V+  G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            + N   L  EY     L   +       + D +R     + +  G++YLH    + I H
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 126
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   +   L    +  + D +R  + I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
           Y H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 352 KLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+GEG  G V   +    G+++AVK +     Q  +   NEV ++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L   E  ++ E++   +L     D    V+L+ ++  ++   + + L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 471 RDLKTSNVLLDHEMNPKISDFGM-ARIFGGNQSEANTKRIVGT 512
           RD+K+ ++LL  +   K+SDFG  A+I   ++     K +VGT
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKXLVGT 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 14/178 (7%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKGKLADGK----EIAVKRLSRTSGQGLQE-FKNEVTL 394
           AV   + +     LGEG +G V   +LA  +     +AVK +         E  K E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIA 454
              L H+N+V+  G   + N   L  EY     L   +       + D +R     + + 
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLM 114
Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 115 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 343 ATQHFSDENKLGEGGFGPVYK------GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIA 396
           AT  +    ++G G +G VYK      G     K + V       G        EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 397 KLQ---HKNLVRLLGCCL-----QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS 448
           +L+   H N+VRL+  C      +E +  L++E++ ++ L  +L D      L  +    
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 449 IINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
           ++    RGL +LH +    I+HRDLK  N+L+      K++DFG+ARI+
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 170

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 335 FPLHLAVEATQHFSDENKLGEGGFGPV-YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVT 393
           F  H+ +   +H+    KLGEGGF  V     L DG   A+KR+     Q  +E + E  
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREAD 78
Query: 394 LIAKLQHKNLVRLLGCCLQE----NESLLIYEYMPNKSL-NVFLFDSTRSVQLDWKRRIS 448
           +     H N++RL+  CL+E    +E+ L+  +    +L N       +   L   + + 
Sbjct: 79  MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 449 IINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
           ++ GI RGL  +H        HRDLK +N+LL  E  P + D G
Sbjct: 139 LLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI++FG +
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS 157

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 84/162 (51%), Gaps = 10/162 (6%)
Query: 352 KLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+G+G  G VY    +A G+E+A+++++       +   NE+ ++ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ EY+   SL     D      +D  +  ++     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RD+K+ N+LL  + + K++DFG        QS+ +   +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--EMVGT 179

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 88/171 (51%), Gaps = 23/171 (13%)
Query: 338 HLAVEATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRL--SRTSGQGLQEFKNEVTL 394
           +L  ++ + +    K+GEG FG     K   DG++  +K +  SR S +  +E + EV +
Sbjct: 17  NLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV 76
Query: 395 IAKLQHKNLVRLLGCCLQENESL-LIYEYMPN----KSLNV---FLFDSTRSVQLDWKRR 446
           +A ++H N+V+      +EN SL ++ +Y       K +N     LF   +   LDW  +
Sbjct: 77  LANMKHPNIVQYRES-FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI--LDWFVQ 133
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
           I +       L ++H+    KI+HRD+K+ N+ L  +   ++ DFG+AR+ 
Sbjct: 134 ICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKL 398
           A + F     LG+G FG VY  +    K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++RL G         LI EY P   L     +  +  + D +R  + I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           Y H     ++IHRD+K  N+LL      KI++FG +
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS 158

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 84/162 (51%), Gaps = 10/162 (6%)
Query: 352 KLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+G+G  G VY    +A G+E+A+++++       +   NE+ ++ + ++ N+V  L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ EY+   SL     D      +D  +  ++     + L +LH +   ++IH
Sbjct: 88  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RD+K+ N+LL  + + K++DFG        QS+ +   +VGT
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGT 180

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 84/162 (51%), Gaps = 10/162 (6%)
Query: 352 KLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+G+G  G VY    +A G+E+A+++++       +   NE+ ++ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ EY+   SL     D      +D  +  ++     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RD+K+ N+LL  + + K++DFG        QS+ +   +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGT 179

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 14/164 (8%)
Query: 352 KLGEGGFGPV-YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+GEG  G V    +   GK++AVK++     Q  +   NEV ++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ E++   +L     D     +++ ++  ++   + R L YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR--IVGT 512
           RD+K+ ++LL  +   K+SDFG    F    S+   KR  +VGT
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKXLVGT 204

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 352 KLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+GEG  G V    + + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ E++   +L     D     +++ ++  ++   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 471 RDLKTSNVLLDHEMNPKISDFGM-ARIFGGNQSEANTKRIVGT 512
           RD+K+ ++LL H+   K+SDFG  A++   ++     K +VGT
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGT 179

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 18/169 (10%)
Query: 356 GGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ--- 412
           G FG V+K +L +   +AVK       Q  Q  + E+     ++H+NL++ +    +   
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 413 -ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-------- 463
            E E  LI  +    SL  +L  +     + W     +   ++RGL YLHED        
Sbjct: 84  LEVELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            +  I HRD K+ NVLL  ++   ++DFG+A  F   +   +T   VGT
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGT 188

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 85/162 (52%), Gaps = 10/162 (6%)
Query: 352 KLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+G+G  G VY    +A G+E+A+++++       +   NE+ ++ + ++ N+V  L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ EY+   SL     D      +D  +  ++     + L +LH +   ++IH
Sbjct: 88  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           R++K+ N+LL  + + K++DFG        QS+ +T  +VGT
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 180

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 84/153 (54%), Gaps = 16/153 (10%)
Query: 352 KLGEGGFGPVYKG-KLADGKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQ-HKNLVRL 406
           KLG+G +G V+K      G+ +AVK++    + S    + F+ E+ ++ +L  H+N+V L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 407 LGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           L     +N+    L+++YM        L    R+  L+   +  ++  + + + YLH   
Sbjct: 75  LNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
              ++HRD+K SN+LL+ E + K++DFG++R F
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 352 KLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+GEG  G V    + + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ E++   +L     D     +++ ++  ++   + + L  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 471 RDLKTSNVLLDHEMNPKISDFGM-ARIFGGNQSEANTKRIVGT 512
           RD+K+ ++LL H+   K+SDFG  A++   ++     K +VGT
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGT 183

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 10/144 (6%)
Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLLG 408
           LG+G FG VY  +    K I A+K L  S+   +G++ + + E+ + + L+H N++R+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
                    L+ E+ P   L   L    R    D +R  + +  +A  L Y HE    K+
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCHER---KV 135
Query: 469 IHRDLKTSNVLLDHEMNPKISDFG 492
           IHRD+K  N+L+ ++   KI+DFG
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFG 159

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 352 KLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+GEG  G V    + + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ E++   +L     D     +++ ++  ++   + + L  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 150
Query: 471 RDLKTSNVLLDHEMNPKISDFGM-ARIFGGNQSEANTKRIVGT 512
           RD+K+ ++LL H+   K+SDFG  A++   ++     K +VGT
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGT 190

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 10/144 (6%)
Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLLG 408
           LG+G FG VY  +    K I A+K L  S+   +G++ + + E+ + + L+H N++R+  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
                    L+ E+ P   L   L    R    D +R  + +  +A  L Y HE    K+
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCHER---KV 136
Query: 469 IHRDLKTSNVLLDHEMNPKISDFG 492
           IHRD+K  N+L+ ++   KI+DFG
Sbjct: 137 IHRDIKPENLLMGYKGELKIADFG 160

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 83/164 (50%), Gaps = 14/164 (8%)
Query: 352 KLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+GEG  G V    + + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ E++   +L     D     +++ ++  ++   + + L  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR--IVGT 512
           RD+K+ ++LL H+   K+SDFG    F    S+   +R  +VGT
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGT 188

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 76/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 103
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
            C Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 104 FCFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 151
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 152 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 22/189 (11%)
Query: 336 PLHLAVEATQHFSDENK----LGEGGFGPVY--KGKLADGKEIAVKRLSRTSGQ---GLQ 386
           P      +T  FSD  K    LG+G FG V   K K+  G+E AVK +S+   +     +
Sbjct: 19  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKE 77
Query: 387 EFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR 446
               EV L+ +L H N+++L      +    L+ E      L   +    R  ++D  R 
Sbjct: 78  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 136
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSE 503
             II  +  G+ Y+H++   KI+HRDLK  N+LL+    + N +I DFG++  F   ++ 
Sbjct: 137 --IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EAS 188
Query: 504 ANTKRIVGT 512
              K  +GT
Sbjct: 189 KKMKDKIGT 197

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 353 LGEGGFGPVYKGKLADG----KEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVR 405
           LGEG FG V   KLA      +++A+K +SR            + E++ +  L+H ++++
Sbjct: 17  LGEGSFGKV---KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L        + +++ EY   +  + ++ +  R  + + +R       I   + Y H   R
Sbjct: 74  LYDVITTPTDIVMVIEYAGGELFD-YIVEKKRMTEDEGRR---FFQQIICAIEYCH---R 126
Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            KI+HRDLK  N+LLD  +N KI+DFG++ I 
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 77/175 (44%), Gaps = 8/175 (4%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAK 397
           AV   + +     LGEG  G V         + +AVK +         E  K E+ +   
Sbjct: 1   AVPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           L H+N+V+  G   + N   L  EY     L   +       + D +R     + +  G+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGV 117
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 89/189 (47%), Gaps = 22/189 (11%)
Query: 336 PLHLAVEATQHFSDENK----LGEGGFGPVY--KGKLADGKEIAVKRLSR---TSGQGLQ 386
           P      +T  FSD  K    LG+G FG V   K K+  G+E AVK +S+         +
Sbjct: 13  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKE 71
Query: 387 EFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR 446
               EV L+ +L H N+++L      +    L+ E      L   +    R  ++D  R 
Sbjct: 72  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 130
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSE 503
             II  +  G+ Y+H++   KI+HRDLK  N+LL+    + N +I DFG++  F   ++ 
Sbjct: 131 --IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EAS 182
Query: 504 ANTKRIVGT 512
              K  +GT
Sbjct: 183 KKMKDKIGT 191

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 74/151 (49%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKL------QHKNLVR 405
           LG+G FG V   ++ + G   AVK L +     LQ+   E T+  K        H  L +
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 406 LLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           L  CC Q  + L  + E++    L   +F   +S + D  R       I   L++LH+  
Sbjct: 89  LF-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              II+RDLK  NVLLDHE + K++DFGM +
Sbjct: 145 ---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 23/158 (14%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC-- 409
           +G GGFG V+K K   DGK   +KR+   +    ++ + EV  +AKL H N+V   GC  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 410 -------------CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARG 456
                           + + L I     +K       +  R  +LD    + +   I +G
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKG 134
Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           + Y+H     K+I+RDLK SN+ L      KI DFG+ 
Sbjct: 135 VDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLV 169

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 82/158 (51%), Gaps = 19/158 (12%)
Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           K+G+G FG V+K +    G+++A+K++   +   G  +   + E+ ++  L+H+N+V L+
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 83
Query: 408 GCCLQENESL--------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
             C  +            L++++  +    +    S   V+        ++  +  GL Y
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
           +H   R KI+HRD+K +NVL+  +   K++DFG+AR F
Sbjct: 141 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAF 175

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 352 KLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+GEG  G V    + + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ E++   +L     D     +++ ++  ++   + + L  LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 193
Query: 471 RDLKTSNVLLDHEMNPKISDFGM-ARIFGGNQSEANTKRIVGT 512
           RD+K+ ++LL H+   K+SDFG  A++   ++     K +VGT
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGT 233

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 89/189 (47%), Gaps = 22/189 (11%)
Query: 336 PLHLAVEATQHFSDENK----LGEGGFGPVY--KGKLADGKEIAVKRLSR---TSGQGLQ 386
           P      +T  FSD  K    LG+G FG V   K K+  G+E AVK +S+         +
Sbjct: 37  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKE 95
Query: 387 EFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR 446
               EV L+ +L H N+++L      +    L+ E      L   +    R  ++D  R 
Sbjct: 96  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 154
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSE 503
             II  +  G+ Y+H++   KI+HRDLK  N+LL+    + N +I DFG++  F   ++ 
Sbjct: 155 --IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EAS 206
Query: 504 ANTKRIVGT 512
              K  +GT
Sbjct: 207 KKMKDKIGT 215

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 89/189 (47%), Gaps = 22/189 (11%)
Query: 336 PLHLAVEATQHFSDENK----LGEGGFGPVY--KGKLADGKEIAVKRLSR---TSGQGLQ 386
           P      +T  FSD  K    LG+G FG V   K K+  G+E AVK +S+         +
Sbjct: 36  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKE 94
Query: 387 EFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR 446
               EV L+ +L H N+++L      +    L+ E      L   +    R  ++D  R 
Sbjct: 95  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 153
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSE 503
             II  +  G+ Y+H++   KI+HRDLK  N+LL+    + N +I DFG++  F   ++ 
Sbjct: 154 --IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EAS 205
Query: 504 ANTKRIVGT 512
              K  +GT
Sbjct: 206 KKMKDKIGT 214

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 90/185 (48%), Gaps = 25/185 (13%)
Query: 325 KQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRL---SRT 380
           KQ +S E P        +    +    K+G+G FG V+K +    G+++A+K++   +  
Sbjct: 4   KQYDSVECPF------CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK 57
Query: 381 SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL--------LIYEYMPNKSLNVFL 432
            G  +   + E+ ++  L+H+N+V L+  C  +            L++++  +    +  
Sbjct: 58  EGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLL- 115
Query: 433 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
             S   V+        ++  +  GL Y+H   R KI+HRD+K +NVL+  +   K++DFG
Sbjct: 116 --SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 170
Query: 493 MARIF 497
           +AR F
Sbjct: 171 LARAF 175

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHKN 402
           F  E K+G G F  VY+   L DG  +A+K++        +   +   E+ L+ +L H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI-SIINGIARGLLYLH 461
           +++     +++NE  ++ E      L+  +    +  +L  +R +      +   L ++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             SR +++HRD+K +NV +      K+ D G+ R F    + A++  +VGT
Sbjct: 154 --SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 90/185 (48%), Gaps = 25/185 (13%)
Query: 325 KQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRL---SRT 380
           KQ +S E P        +    +    K+G+G FG V+K +    G+++A+K++   +  
Sbjct: 4   KQYDSVECPF------CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK 57
Query: 381 SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL--------LIYEYMPNKSLNVFL 432
            G  +   + E+ ++  L+H+N+V L+  C  +            L++++  +    +  
Sbjct: 58  EGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL- 115
Query: 433 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
             S   V+        ++  +  GL Y+H   R KI+HRD+K +NVL+  +   K++DFG
Sbjct: 116 --SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 170
Query: 493 MARIF 497
           +AR F
Sbjct: 171 LARAF 175

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 90/185 (48%), Gaps = 25/185 (13%)
Query: 325 KQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRL---SRT 380
           KQ +S E P        +    +    K+G+G FG V+K +    G+++A+K++   +  
Sbjct: 3   KQYDSVECPF------CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK 56
Query: 381 SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL--------LIYEYMPNKSLNVFL 432
            G  +   + E+ ++  L+H+N+V L+  C  +            L++++  +    +  
Sbjct: 57  EGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL- 114
Query: 433 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
             S   V+        ++  +  GL Y+H   R KI+HRD+K +NVL+  +   K++DFG
Sbjct: 115 --SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 169
Query: 493 MARIF 497
           +AR F
Sbjct: 170 LARAF 174

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 74/142 (52%), Gaps = 8/142 (5%)
Query: 352 KLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           K+GEG  G V    + + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L  +E  ++ E++   +L     D     +++ ++  ++   + + L  LH      +IH
Sbjct: 218 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 471 RDLKTSNVLLDHEMNPKISDFG 492
           RD+K+ ++LL H+   K+SDFG
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFG 292

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 34/204 (16%)
Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG-KLADGKE 371
           GN Y++         E  EFP   L               LG G FG V +      GKE
Sbjct: 24  GNSYTFIDPTQLPYNEKWEFPRNNLQFG----------KTLGAGAFGKVVEATAFGLGKE 73
Query: 372 -----IAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
                +AVK L  T+    +E   +E+ +++ L QH+N+V LLG C      L+I EY  
Sbjct: 74  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 425 NKSLNVFL-----------FDSTRSV--QLDWKRRISIINGIARGLLYLHEDSRLKIIHR 471
              L  FL           ++ + +   QL  +  +   + +A+G+ +L   +    IHR
Sbjct: 134 YGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKN---CIHR 190
Query: 472 DLKTSNVLLDHEMNPKISDFGMAR 495
           D+   NVLL +    KI DFG+AR
Sbjct: 191 DVAARNVLLTNGHVAKIGDFGLAR 214

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 342 EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN--EVTLIAKL 398
           E  + + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 399 QHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +H+N++ LL        L+E   + +  ++    LN    +  +  +L       +I  I
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCAKLTDDHVQFLIYQI 130
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQG--LQEFKNEVTLIAKLQHKNLVRLLGC 409
           LG+G FG V K K     +E AVK +++ S +         EV L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
               +   ++ E      L   +    R  + D  R   II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 470 HRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           HRDLK  N+LL   + + + KI DFG++  F   Q     K  +GT
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGT 186

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 86/211 (40%), Gaps = 41/211 (19%)
Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG-KLADGKE 371
           GN Y++         E  EFP   L               LG G FG V +      GKE
Sbjct: 9   GNSYTFIDPTQLPYNEKWEFPRNNLQFG----------KTLGAGAFGKVVEATAFGLGKE 58
Query: 372 -----IAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
                +AVK L  T+    +E   +E+ +++ L QH+N+V LLG C      L+I EY  
Sbjct: 59  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 118
Query: 425 NKSLNVFL--------------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
              L  FL                     D      L+ +  +   + +A+G+ +L   +
Sbjct: 119 YGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN 178
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               IHRD+   NVLL +    KI DFG+AR
Sbjct: 179 ---CIHRDVAARNVLLTNGHVAKIGDFGLAR 206

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQG--LQEFKNEVTLIAKLQHKNLVRLLGC 409
           LG+G FG V K K     +E AVK +++ S +         EV L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
               +   ++ E      L   +    R  + D  R   II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 470 HRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           HRDLK  N+LL   + + + KI DFG++  F   Q     K  +GT
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGT 186

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 15/162 (9%)
Query: 342 EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN--EVTLIAKL 398
           E  + +   + +G G +G V     +  G +IAVK+LSR     +   +   E+ L+  +
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHM 107
Query: 399 QHKNLVRLL-----GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +H+N++ LL        L+E   + +  ++    LN    +  +  +L       +I  I
Sbjct: 108 KHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQI 163
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 164 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 76/158 (48%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++     QG + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIV 76
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 327 EESQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTS 381
           E SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR  
Sbjct: 5   EMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 64
Query: 382 GQGLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFD 434
              +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +
Sbjct: 65  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----N 120
Query: 435 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
             +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+A
Sbjct: 121 IVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 177
Query: 495 R 495
           R
Sbjct: 178 R 178

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 8/160 (5%)
Query: 346 HFSDENKLGEGGFGPVYK-GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           H+    +LG G FG V++  + A G   A K +        +  + E+  ++ L+H  LV
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      +NE ++IYE+M    L   + D    +  D    +  +  + +GL ++HE++
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENN 275
Query: 465 RLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQS 502
               +H DLK  N++   + +   K+ DFG+       QS
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 76/158 (48%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++     QG + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIV 76
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 87/189 (46%), Gaps = 22/189 (11%)
Query: 336 PLHLAVEATQHFSDENK----LGEGGFGPVY--KGKLADGKEIAVKRLSR---TSGQGLQ 386
           P      +T  FSD  K    LG+G FG V   K K+  G+E AVK +S+         +
Sbjct: 13  PGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKE 71
Query: 387 EFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR 446
               EV L+ +L H N+ +L      +    L+ E      L   +    R  ++D  R 
Sbjct: 72  SLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 130
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSE 503
             II  +  G+ Y H++   KI+HRDLK  N+LL+    + N +I DFG++  F   ++ 
Sbjct: 131 --IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EAS 182
Query: 504 ANTKRIVGT 512
              K  +GT
Sbjct: 183 KKXKDKIGT 191

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 90/189 (47%), Gaps = 20/189 (10%)
Query: 320 VLRGQKQ-EESQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIA 373
           V RG    E SQE P F    L+  + E  + + + + +G G +G V        G  +A
Sbjct: 15  VPRGSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVA 74
Query: 374 VKRLSRTSGQGLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNK 426
           VK+LSR     +   +   E+ L+  ++H+N++ LL        L+E   + +  ++   
Sbjct: 75  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 134
Query: 427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP 486
            LN    +  +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   
Sbjct: 135 DLN----NIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 187
Query: 487 KISDFGMAR 495
           KI DFG+AR
Sbjct: 188 KILDFGLAR 196

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 19/185 (10%)
Query: 323 GQKQEESQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRL 377
                 SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+L
Sbjct: 2   AHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL 61
Query: 378 SRTSGQGLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNV 430
           SR     +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN 
Sbjct: 62  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN- 120
Query: 431 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD 490
              +  +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D
Sbjct: 121 ---NIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 174
Query: 491 FGMAR 495
           FG+AR
Sbjct: 175 FGLAR 179

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 327 EESQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTS 381
           E SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR  
Sbjct: 6   EMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 65
Query: 382 GQGLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFD 434
              +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +
Sbjct: 66  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----N 121
Query: 435 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
             +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+A
Sbjct: 122 IVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLA 178
Query: 495 R 495
           R
Sbjct: 179 R 179

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 327 EESQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTS 381
           E SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR  
Sbjct: 6   EMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 65
Query: 382 GQGLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFD 434
              +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +
Sbjct: 66  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----N 121
Query: 435 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
             +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+A
Sbjct: 122 IVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 178
Query: 495 R 495
           R
Sbjct: 179 R 179

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 8/160 (5%)
Query: 346 HFSDENKLGEGGFGPVYK-GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           H+    +LG G FG V++  + A G   A K +        +  + E+  ++ L+H  LV
Sbjct: 52  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 111
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      +NE ++IYE+M    L   + D    +  D    +  +  + +GL ++HE++
Sbjct: 112 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENN 169
Query: 465 RLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQS 502
               +H DLK  N++   + +   K+ DFG+       QS
Sbjct: 170 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 206

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KXQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 7   SQERPTFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 67  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 122
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 123 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 104
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 165 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 199

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 342 EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN--EVTLIAKL 398
           E  + + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 399 QHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +H+N++ LL        L+E   + +  ++    LN    +  +  +L       +I  I
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQI 130
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 81
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 142 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 176

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 342 EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN--EVTLIAKL 398
           E  + + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 399 QHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +H+N++ LL        L+E   + +  ++    LN    +  +  +L       +I  I
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQI 130
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLV 404
           F  +  LG G F  V   +  A GK  AVK + + + +G +   +NE+ ++ K++H+N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDW---KRRISIINGIARGLLYLH 461
            L       N   L+ + +        LFD  R V+  +   K   ++I  +   + YLH
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGE----LFD--RIVEKGFYTEKDASTLIRQVLDAVYYLH 137
Query: 462 EDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFG 498
              R+ I+HRDLK  N+L    D E    ISDFG++++ G
Sbjct: 138 ---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEG 174

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 171 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 112
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 173 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 207

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQG--LQEFKNEVTLIAKLQHKNLVRLLGC 409
           LG+G FG V K K     +E AVK +++ S +         EV L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
               +   ++ E      L   +    R  + D  R   II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 470 HRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           HRDLK  N+LL   + + + KI DFG++  F   Q     K  +GT
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGT 186

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 155
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 216 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 250

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 76/158 (48%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++     QG + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIV 76
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 21  SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 80
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 81  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 136
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 137 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 7   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 67  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 122
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 123 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 22  SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 81
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 82  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 137
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 138 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 89
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 150 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 184

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 88
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 149 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 77
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 138 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 172

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 114
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 175 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 209

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 96  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 143
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 144 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 67/135 (49%), Gaps = 16/135 (11%)
Query: 370 KEIAVKRLSRTSG-----QGLQEFKN----EVTLIAKLQ-HKNLVRLLGCCLQENESLLI 419
           KE AVK +  T G     + +QE +     EV ++ K+  H N+++L           L+
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVL 479
           ++ M    L  +L   T  V L  K    I+  +   +  LH   +L I+HRDLK  N+L
Sbjct: 103 FDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 156
Query: 480 LDHEMNPKISDFGMA 494
           LD +MN K++DFG +
Sbjct: 157 LDDDMNIKLTDFGFS 171

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 84
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 145 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 179

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 171 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 67/135 (49%), Gaps = 16/135 (11%)
Query: 370 KEIAVKRLSRTSG-----QGLQEFKN----EVTLIAKLQ-HKNLVRLLGCCLQENESLLI 419
           KE AVK +  T G     + +QE +     EV ++ K+  H N+++L           L+
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVL 479
           ++ M    L  +L   T  V L  K    I+  +   +  LH   +L I+HRDLK  N+L
Sbjct: 103 FDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 156
Query: 480 LDHEMNPKISDFGMA 494
           LD +MN K++DFG +
Sbjct: 157 LDDDMNIKLTDFGFS 171

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 95
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 156 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 190

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KXQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 13  SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 72
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 73  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 128
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 129 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 88
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 149 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 96  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 143
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 144 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 67/135 (49%), Gaps = 16/135 (11%)
Query: 370 KEIAVKRLSRTSG-----QGLQEFKN----EVTLIAKLQ-HKNLVRLLGCCLQENESLLI 419
           KE AVK +  T G     + +QE +     EV ++ K+  H N+++L           L+
Sbjct: 30  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 89
Query: 420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVL 479
           ++ M    L  +L   T  V L  K    I+  +   +  LH   +L I+HRDLK  N+L
Sbjct: 90  FDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 143
Query: 480 LDHEMNPKISDFGMA 494
           LD +MN K++DFG +
Sbjct: 144 LDDDMNIKLTDFGFS 158

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 80
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 81  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 128
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 129 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLV 404
           ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 80
Query: 405 RLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           RL        E        L+ +Y+P     V    S     L        +  + R L 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR 495
           Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 141 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 175

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 19/185 (10%)
Query: 323 GQKQEESQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRL 377
                 SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+L
Sbjct: 2   AHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 61
Query: 378 SRTSGQGLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNV 430
           SR     +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN 
Sbjct: 62  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN- 120
Query: 431 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD 490
              +  +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D
Sbjct: 121 ---NIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 174
Query: 491 FGMAR 495
           FG+AR
Sbjct: 175 FGLAR 179

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 342 EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN--EVTLIAKL 398
           E  + + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 399 QHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +H+N++ LL        L+E   + +  ++    LN    +  +  +L       +I  I
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQI 130
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 76
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 77  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 124
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 125 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 22  SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 81
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 82  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 137
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 138 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 25  SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 84
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 85  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 140
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 141 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + +   +G G +G V        G  +AVK+LSR    
Sbjct: 12  SQERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 71
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 72  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 127
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 128 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 124
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 342 EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN--EVTLIAKL 398
           E  + + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 399 QHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +H+N++ LL        L+E   + +  ++    LN    +  +  +L       +I  I
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQI 131
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 132 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 73
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 74  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 121
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 122 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 124
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 124
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 75
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 76  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 123
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 124 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 124
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 97  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 144
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 4   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 64  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 119
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 120 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 4   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 64  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 119
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 120 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 7   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 67  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 122
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 123 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 342 EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN--EVTLIAKL 398
           E  + + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 76
Query: 399 QHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +H+N++ LL        L+E   + +  ++    LN    +  +  +L       +I  I
Sbjct: 77  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQI 132
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 133 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 1   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 60
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 61  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 116
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 117 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 14  SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 73
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 74  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 129
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 74
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 75  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 123 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +S +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+ R
Sbjct: 118 KSQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 14  SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 73
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 74  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 129
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 99  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 4   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 64  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 119
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 120 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 97  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 144
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 13  SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 72
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 73  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 128
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 129 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 99  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 97  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 144
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 4   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 64  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 119
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 120 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 101
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 102 FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 149
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 150 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 22  SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 81
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 82  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 137
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 138 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 100 FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 147
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 148 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 342 EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN--EVTLIAKL 398
           E  + + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 399 QHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +H+N++ LL        L+E   + +  ++    LN    +  +  +L       +I  I
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQI 131
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 132 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 21  SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 80
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 81  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 136
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 137 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 100 FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 147
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 148 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 99  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 351 NKLGEGGFGPVYKGKL--ADGK--EIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNL 403
            KLG+G FG V +G+     GK   +AVK L     +  + + +F  EV  +  L H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           +RL G  L     + + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
              + IHRDL   N+LL      KI DFG+ R    N
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 168

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 81/163 (49%), Gaps = 23/163 (14%)
Query: 352 KLGEGGFGPVYKGKLADG-KEIAVKRLSRT---------SGQGLQEFK----NEVTLIAK 397
           KLG G +G V   K  +G  E A+K + ++           + +++F     NE++L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           L H N+++L      +    L+ E+     L   + +  +  + D     +I+  I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD---AANIMKQILSGI 159
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFGMARIF 497
            YLH+ +   I+HRD+K  N+LL+++   +N KI DFG++  F
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 346 HFSDENKLGE----GGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQ---EFKNEVTLIAK 397
           H SD  +LGE    GG   V+  + L D +++AVK L     +       F+ E    A 
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 398 LQHKNLVRLLGCCLQENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           L H  +V +      E  +     ++ EY+   +L   +        +  KR I +I   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADA 125
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSEANTKRIVGT 512
            + L + H++    IIHRD+K +N+L+      K+ DFG+AR I     S   T  ++GT
Sbjct: 126 CQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGT 182

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 99  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 351 NKLGEGGFGPVYKGKL--ADGK--EIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNL 403
            KLG+G FG V +G+     GK   +AVK L     +  + + +F  EV  +  L H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           +RL G  L     + + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
              + IHRDL   N+LL      KI DFG+ R    N
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 351 NKLGEGGFGPVYKGKL--ADGK--EIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNL 403
            KLG+G FG V +G+     GK   +AVK L     +  + + +F  EV  +  L H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           +RL G  L     + + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
              + IHRDL   N+LL      KI DFG+ R    N
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 168

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 99  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 351 NKLGEGGFGPVYKGKL--ADGK--EIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNL 403
            KLG+G FG V +G+     GK   +AVK L     +  + + +F  EV  +  L H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           +RL G  L     + + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
              + IHRDL   N+LL      KI DFG+ R    N
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 351 NKLGEGGFGPVYKGKL--ADGK--EIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNL 403
            KLG+G FG V +G+     GK   +AVK L     +  + + +F  EV  +  L H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           +RL G  L     + + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
              + IHRDL   N+LL      KI DFG+ R    N
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 351 NKLGEGGFGPVYKGKL--ADGK--EIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNL 403
            KLG+G FG V +G+     GK   +AVK L     +  + + +F  EV  +  L H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           +RL G  L     + + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
              + IHRDL   N+LL      KI DFG+ R    N
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGP-VYKGKLADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F   V   +LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 97  FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVSALE 144
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 351 NKLGEGGFGPVYKGKL--ADGK--EIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNL 403
            KLG+G FG V +G+     GK   +AVK L     +  + + +F  EV  +  L H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           +RL G  L     + + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
              + IHRDL   N+LL      KI DFG+ R    N
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   + LA  +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 409 CCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIING---------IARGLL 458
              Q++E L     Y  N  L            L + R+I   +          I   L 
Sbjct: 99  FTFQDDEKLYFGLSYAKNGCL------------LKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 17/165 (10%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           LG GGFG V++ K   D    A+KR+   + +   ++   EV  +AKL+H  +VR     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDW---------KRR---ISIINGIARGLL 458
           L++N +  +    P   L + +    +    DW         + R   + I   IA  + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           +LH      ++HRDLK SN+    +   K+ DFG+      ++ E
Sbjct: 133 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 21/181 (11%)
Query: 346 HFSDENKLGE----GGFGPVYKGK-LADGKEIAVK----RLSRTSGQGLQEFKNEVTLIA 396
           H SD  +LGE    GG   V+  + L D +++AVK     L+R     L+ F+ E    A
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAA 67
Query: 397 KLQHKNLVRLLGCCLQENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING 452
            L H  +V +      E  +     ++ EY+   +L   +        +  KR I +I  
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIAD 124
Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSEANTKRIVG 511
             + L + H++    IIHRD+K +N+++      K+ DFG+AR I     S   T  ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 512 T 512
           T
Sbjct: 182 T 182

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGK----EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           LGEG FG VY+G   + K     +AVK   +  +    ++F +E  ++  L H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  ++E  + +I E  P   L  +L  +  S+++      S+   I + + YL     + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 129
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   N+L+      K+ DFG++R
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSR 157

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 21/181 (11%)
Query: 346 HFSDENKLGE----GGFGPVYKGK-LADGKEIAVK----RLSRTSGQGLQEFKNEVTLIA 396
           H SD  +LGE    GG   V+  + L D +++AVK     L+R     L+ F+ E    A
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAA 67
Query: 397 KLQHKNLVRLLGCCLQENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING 452
            L H  +V +      E  +     ++ EY+   +L   +        +  KR I +I  
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIAD 124
Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSEANTKRIVG 511
             + L + H++    IIHRD+K +N+++      K+ DFG+AR I     S   T  ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 512 T 512
           T
Sbjct: 182 T 182

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGK----EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           LGEG FG VY+G   + K     +AVK   +  +    ++F +E  ++  L H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  ++E  + +I E  P   L  +L  +  S+++      S+   I + + YL     + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 145
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   N+L+      K+ DFG++R
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSR 173

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGK----EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           LGEG FG VY+G   + K     +AVK   +  +    ++F +E  ++  L H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  ++E  + +I E  P   L  +L  +  S+++      S+   I + + YL     + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 133
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   N+L+      K+ DFG++R
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSR 161

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D+G+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LS+    
Sbjct: 14  SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQS 73
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 74  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 129
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 11/160 (6%)
Query: 342 EATQHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKN--EVTLIA 396
           E  Q       +G G +G V   Y  +L   +++AVK+LSR     +   +   E+ L+ 
Sbjct: 25  EVPQRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLK 82
Query: 397 KLQHKNLVRLLGCCLQENESLLIYE-YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
            L+H+N++ LL             E Y+    +   L +  +S  L  +    ++  + R
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLR 142
Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           GL Y+H      IIHRDLK SNV ++ +   +I DFG+AR
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 72/141 (51%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 50  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 430 VF--------LFDSTRS----VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+  S    ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 157 IVVKSDATLKILDFGLARTAG 177

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 68/131 (51%), Gaps = 13/131 (9%)
Query: 385 LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN---VFLFDSTRSVQL 441
           +++   E+ ++ KL H N+V+L+      NE  L   YM  + +N   V    + + +  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YMVFELVNQGPVMEVPTLKPLSE 136
Query: 442 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
           D  R       + +G+ YLH     KIIHRD+K SN+L+  + + KI+DFG++  F G  
Sbjct: 137 DQAR--FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG-- 189
Query: 502 SEANTKRIVGT 512
           S+A     VGT
Sbjct: 190 SDALLSNTVGT 200

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 349 DENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSGQGL---QEFKNEVTLIAKLQHKNL 403
           ++ +LG G FG V KG  ++    +    ++ +          E   E  ++ +L +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           VR++G C  E+  +L+ E      LN +L    R V+   K  I +++ ++ G+ YL E 
Sbjct: 91  VRMIGICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 146
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
           +    +HRDL   NVLL  +   KISDFG+++    +++
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 349 DENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSGQGL---QEFKNEVTLIAKLQHKNL 403
           ++ +LG G FG V KG  ++    +    ++ +          E   E  ++ +L +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           VR++G C  E+  +L+ E      LN +L    R V+   K  I +++ ++ G+ YL E 
Sbjct: 91  VRMIGICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 146
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
           +    +HRDL   NVLL  +   KISDFG+++    +++
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 335 FPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTL 394
            PL +     +      ++G+G +G V+ GK   G+++AVK +  T+ +     + E+  
Sbjct: 27  LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVK-VFFTTEEASWFRETEIYQ 84
Query: 395 IAKLQHKNLVRLLGCCLQENESL----LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII 450
              ++H+N++  +   ++   S     LI +Y  N SL    +D  +S  LD K  + + 
Sbjct: 85  TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLA 140
Query: 451 NGIARGLLYLHED-----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
                GL +LH +      +  I HRDLK+ N+L+       I+D G+A  F  + +E +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 349 DENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQHKNL 403
           ++ +LG G FG V KG  ++    +    ++ +          E   E  ++ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           VR++G C  E+  +L+ E      LN +L    R V+   K  I +++ ++ G+ YL E 
Sbjct: 71  VRMIGICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 126
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
           +    +HRDL   NVLL  +   KISDFG+++    +++
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V           +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   +S QL        +  I RGL Y+H  +   ++H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+L++   + KI DFG+ARI
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARI 193

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 349 DENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSGQGL---QEFKNEVTLIAKLQHKNL 403
           ++ +LG G FG V KG  ++    +    ++ +          E   E  ++ +L +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           VR++G C  E+  +L+ E      LN +L    R V+   K  I +++ ++ G+ YL E 
Sbjct: 89  VRMIGICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 144
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
           +    +HRDL   NVLL  +   KISDFG+++    +++
Sbjct: 145 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 72/141 (51%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 50  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 430 VF--------LFDSTRS----VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+  S    ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG 177

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 349 DENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQHKNL 403
           ++ +LG G FG V KG  ++    +    ++ +          E   E  ++ +L +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           VR++G C  E+  +L+ E      LN +L    R V+   K  I +++ ++ G+ YL E 
Sbjct: 75  VRMIGICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 130
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
           +    +HRDL   NVLL  +   KISDFG+++    +++
Sbjct: 131 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 82/158 (51%), Gaps = 21/158 (13%)
Query: 353 LGEGGFGPVYKG---KLAD-----GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           LG+G F  ++KG   ++ D       E+ +K L +      + F    ++++KL HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
              G C+  +E++L+ E++   SL+ +L  +   + + WK  + +   +A  + +L E++
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFLEENT 133
Query: 465 RLKIIHRDLKTSNVLLDHEM-----NP---KISDFGMA 494
              +IH ++   N+LL  E      NP   K+SD G++
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 349 DENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQHKNL 403
           ++ +LG G FG V KG  ++    +    ++ +          E   E  ++ +L +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           VR++G C  E+  +L+ E      LN +L    R V+   K  I +++ ++ G+ YL E 
Sbjct: 69  VRMIGICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 124
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
           +    +HRDL   NVLL  +   KISDFG+++    +++
Sbjct: 125 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 160

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 349 DENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSGQGL---QEFKNEVTLIAKLQHKNL 403
           ++ +LG G FG V KG  ++    +    ++ +          E   E  ++ +L +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           VR++G C  E+  +L+ E      LN +L    R V+   K  I +++ ++ G+ YL E 
Sbjct: 75  VRMIGICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 130
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
           +    +HRDL   NVLL  +   KISDFG+++    +++
Sbjct: 131 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 30/169 (17%)
Query: 345 QHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK 401
           + + +   +G G  G V   Y   L   + +A+K+LSR        F+N+    AK  ++
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 65
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVF--------LFDSTR----SVQLDWKRRISI 449
            LV L+ C   +N   L+  + P K+L  F        L D+       ++LD +R   +
Sbjct: 66  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 124
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 125 LYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 170

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 349 DENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQHKNL 403
           ++ +LG G FG V KG  ++    +    ++ +          E   E  ++ +L +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           VR++G C  E+  +L+ E      LN +L    R V+   K  I +++ ++ G+ YL E 
Sbjct: 81  VRMIGICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 136
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
           +    +HRDL   NVLL  +   KISDFG+++    +++
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 7/112 (6%)
Query: 386 QEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL-----NVFLFDSTRSVQ 440
            +FKNE+ +I  ++++  +   G     +E  +IYEYM N S+       F+ D   +  
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 441 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
           +  +    II  +     Y+H +    I HRD+K SN+L+D     K+SDFG
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFG 197

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 29/143 (20%)
Query: 370 KEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKS 427
           + +A+K+LSR   +    +    E+ L+  + HKN++ LL              + P KS
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKS 97
Query: 428 LNVF--------LFDSTRS----VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKT 475
           L  F        L D+  S    ++LD +R   ++  +  G+ +LH      IIHRDLK 
Sbjct: 98  LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKP 154
Query: 476 SNVLLDHEMNPKISDFGMARIFG 498
           SN+++  +   KI DFG+AR  G
Sbjct: 155 SNIVVKSDATLKILDFGLARTAG 177

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P K+L 
Sbjct: 50  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLE 99
Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSN 156
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 157 IVVKSDXTLKILDFGLARTAG 177

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 29/143 (20%)
Query: 370 KEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKS 427
           + +A+K+LSR   +    +    E+ L+  + HKN++ LL              + P KS
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKS 97
Query: 428 LNVF--------LFDSTRS----VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKT 475
           L  F        L D+  S    ++LD +R   ++  +  G+ +LH      IIHRDLK 
Sbjct: 98  LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKP 154
Query: 476 SNVLLDHEMNPKISDFGMARIFG 498
           SN+++  +   KI DFG+AR  G
Sbjct: 155 SNIVVKSDATLKILDFGLARTAG 177

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 29/143 (20%)
Query: 370 KEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKS 427
           + +A+K+LSR   +    +    E+ L+  + HKN++ LL              + P KS
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKS 97
Query: 428 LNVF--------LFDSTRS----VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKT 475
           L  F        L D+  S    ++LD +R   ++  +  G+ +LH      IIHRDLK 
Sbjct: 98  LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKP 154
Query: 476 SNVLLDHEMNPKISDFGMARIFG 498
           SN+++  +   KI DFG+AR  G
Sbjct: 155 SNIVVKSDATLKILDFGLARTAG 177

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 41/214 (19%)
Query: 310 GRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG----- 364
           G   N+Y Y   R  + +   EFP   L               LG G FG V        
Sbjct: 20  GSSDNEYFYVDFREYEYDLKWEFPRENLEFG----------KVLGSGAFGKVMNATAYGI 69
Query: 365 -KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYE 421
            K     ++AVK L   +    +E   +E+ ++ +L  H+N+V LLG C       LI+E
Sbjct: 70  SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129
Query: 422 YMPNKSLNVFL-------------FDSTRSVQ-------LDWKRRISIINGIARGLLYLH 461
           Y     L  +L             +++ + ++       L ++  +     +A+G+ +L 
Sbjct: 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 189
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             S    +HRDL   NVL+ H    KI DFG+AR
Sbjct: 190 FKS---CVHRDLAARNVLVTHGKVVKICDFGLAR 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLAR 173

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 83/170 (48%), Gaps = 13/170 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE-IAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           +G G    V     A  KE +A+KR++    Q  + E   E+  +++  H N+V      
Sbjct: 18  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 77
Query: 411 LQENESLLIYEYMPNKSL-----NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           + ++E  L+ + +   S+     ++      +S  LD     +I+  +  GL YLH++ +
Sbjct: 78  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 137
Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSEANTKR-IVGT 512
              IHRD+K  N+LL  + + +I+DFG++     GG+ +    ++  VGT
Sbjct: 138 ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 353 LGEGGFGPVYKG---KLAD-----GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           LG+G F  ++KG   ++ D       E+ +K L +      + F    ++++KL HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
              G C   +E++L+ E++   SL+ +L  +   + + WK  + +   +A  + +L E++
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAWAMHFLEENT 133
Query: 465 RLKIIHRDLKTSNVLLDHEM-----NP---KISDFGMA 494
              +IH ++   N+LL  E      NP   K+SD G++
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 17/137 (12%)
Query: 370 KEIAVKRLSRTSGQGLQEFK--NEVTLIAKLQHKNLVRLLGC-----CLQENESL-LIYE 421
           + +A+K+LSR         +   E+ L+  + HKN++ LL        L+E + + L+ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD 481
            M      V        ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++ 
Sbjct: 110 LMDANLXQVI------QMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 482 HEMNPKISDFGMARIFG 498
            +   KI DFG+AR  G
Sbjct: 161 SDXTLKILDFGLARTAG 177

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 71/144 (49%), Gaps = 25/144 (17%)
Query: 369 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL 428
           G  +AVK+LSR        F+N+    AK  ++ LV LL C   +N   L+  + P K+L
Sbjct: 47  GINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTL 96
Query: 429 NVF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTS 476
             F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK S
Sbjct: 97  EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 153
Query: 477 NVLLDHEMNPKISDFGMARIFGGN 500
           N+++  +   KI DFG+AR    N
Sbjct: 154 NIVVKSDCTLKILDFGLARTASTN 177

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 83/170 (48%), Gaps = 13/170 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE-IAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           +G G    V     A  KE +A+KR++    Q  + E   E+  +++  H N+V      
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 411 LQENESLLIYEYMPNKSL-----NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           + ++E  L+ + +   S+     ++      +S  LD     +I+  +  GL YLH++ +
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 142
Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSEANTKR-IVGT 512
              IHRD+K  N+LL  + + +I+DFG++     GG+ +    ++  VGT
Sbjct: 143 ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI  FG+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLAR 173

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 342 EATQHFSDENKLGEGGFGPVYK------GKLADGKEIAVKRLSRTS-GQGLQEFKNEVTL 394
           +   H+    +LG G F  V K      GK    K I  +RLS +  G   +E + EV +
Sbjct: 9   DVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIA 454
           + +++H N++ L      + + +LI E +    L  FL +      L        +  I 
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQIL 125
Query: 455 RGLLYLHEDSRLKIIHRDLKTSNV-LLDHEM-NPKIS--DFGMA-RIFGGNQSEANTKRI 509
            G+ YLH     +I H DLK  N+ LLD  + NP+I   DFG+A +I  GN+     K I
Sbjct: 126 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNI 178
Query: 510 VGT 512
            GT
Sbjct: 179 FGT 181

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 29/143 (20%)
Query: 370 KEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKS 427
           + +A+K+LSR   +    +    E+ L+  + HKN++ LL              + P KS
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKS 97
Query: 428 LNVF--------LFDSTRS----VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKT 475
           L  F        L D+  S    ++LD +R   ++  +  G+ +LH      IIHRDLK 
Sbjct: 98  LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154
Query: 476 SNVLLDHEMNPKISDFGMARIFG 498
           SN+++  +   KI DFG+AR  G
Sbjct: 155 SNIVVKSDATLKILDFGLARTAG 177

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 30/169 (17%)
Query: 345 QHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK 401
           + + +   +G G  G V   Y   L   + +A+K+LSR        F+N+    AK  ++
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 110
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVF--------LFDSTR----SVQLDWKRRISI 449
            LV L+ C   +N   L+  + P K+L  F        L D+       ++LD +R   +
Sbjct: 111 ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 170 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 349 DENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSGQGL---QEFKNEVTLIAKLQHKNL 403
           ++ +LG G FG V KG  ++    +    ++ +          E   E  ++ +L +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 404 VRLLGCCLQENES-LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           VR++G C  E ES +L+ E      LN +L    R V+   K  I +++ ++ G+ YL E
Sbjct: 433 VRMIGIC--EAESWMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEE 487
Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
            +    +HRDL   NVLL  +   KISDFG+++    +++
Sbjct: 488 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLAR 173

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 349 DENKLGEGGFGPVYKG--KLADGKEIAVKRLSRTSGQGL---QEFKNEVTLIAKLQHKNL 403
           ++ +LG G FG V KG  ++    +    ++ +          E   E  ++ +L +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 404 VRLLGCCLQENES-LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           VR++G C  E ES +L+ E      LN +L    R V+   K  I +++ ++ G+ YL E
Sbjct: 434 VRMIGIC--EAESWMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEE 488
Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
            +    +HRDL   NVLL  +   KISDFG+++    +++
Sbjct: 489 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 525

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 352 KLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 132
Query: 465 RLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
            L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 180

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 346 HFSDENKLGEGGFGPVYK------GKLADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL 398
           H+    +LG G F  V K      GK    K I  +RLS +  G   +E + EV ++ ++
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++ L      + + +LI E +    L  FL +      L        +  I  G+ 
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVH 122
Query: 459 YLHEDSRLKIIHRDLKTSNV-LLDHEM-NPKIS--DFGMA-RIFGGNQSEANTKRIVGT 512
           YLH     +I H DLK  N+ LLD  + NP+I   DFG+A +I  GN+     K I GT
Sbjct: 123 YLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFGT 174

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 52  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 101
Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 102 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 158
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 159 IVVKSDCTLKILDFGLARTAG 179

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 352 KLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 132
Query: 465 RLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
            L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 180

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 50  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG 177

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 22/174 (12%)
Query: 351 NKLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNL 403
            +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N+
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           + L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH  
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH-- 131
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
             L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 180

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 55  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 104
Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 105 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 161
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 162 IVVKSDCTLKILDFGLARTAG 182

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 9/151 (5%)
Query: 352 KLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLVRLLG 408
           K+GEG +G V+K +  D G+ +A+K+   +    +  +    E+ ++ +L+H NLV LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
              ++    L++EY  +  L+  L    R V     + I+     A    + H       
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHE-LDRYQRGVPEHLVKSITWQTLQAVNFCHKH-----NC 123
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGG 499
           IHRD+K  N+L+      K+ DFG AR+  G
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTG 154

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 11/160 (6%)
Query: 342 EATQHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKN--EVTLIA 396
           E  Q       +G G +G V   Y  +L   +++AVK+LSR     +   +   E+ L+ 
Sbjct: 17  EVPQRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLK 74
Query: 397 KLQHKNLVRLLGCCLQENESLLIYE-YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
            L+H+N++ LL             E Y+    +   L +  +   L  +    ++  + R
Sbjct: 75  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR 134
Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           GL Y+H      IIHRDLK SNV ++ +   +I DFG+AR
Sbjct: 135 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 51  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 100
Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 101 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 157
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 158 IVVKSDCTLKILDFGLARTAG 178

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 50  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG 177

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 22/174 (12%)
Query: 351 NKLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNL 403
            +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           + L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH  
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH-- 131
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
             L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 180

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLAR 173

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 44  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 93
Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 94  EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 150
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 151 IVVKSDCTLKILDFGLARTAG 171

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P K+L 
Sbjct: 88  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLE 137
Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 138 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 194
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 195 IVVKSDCTLKILDFGLARTAG 215

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 352 KLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH--- 130
Query: 465 RLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
            L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 179

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 11/160 (6%)
Query: 342 EATQHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKN--EVTLIA 396
           E  Q       +G G +G V   Y  +L   +++AVK+LSR     +   +   E+ L+ 
Sbjct: 25  EVPQRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLK 82
Query: 397 KLQHKNLVRLLGCCLQENESLLIYE-YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
            L+H+N++ LL             E Y+    +   L +  +   L  +    ++  + R
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR 142
Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           GL Y+H      IIHRDLK SNV ++ +   +I DFG+AR
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 50  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG 177

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 25/139 (17%)
Query: 369 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL 428
           G  +AVK+LSR        F+N+    AK  ++ LV LL C   +N   L+  + P K+L
Sbjct: 49  GINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTL 98
Query: 429 NVF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTS 476
             F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK S
Sbjct: 99  EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 155
Query: 477 NVLLDHEMNPKISDFGMAR 495
           N+++  +   KI DFG+AR
Sbjct: 156 NIVVKSDCTLKILDFGLAR 174

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 50  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG 177

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 352 KLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH--- 130
Query: 465 RLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
            L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 179

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 25/141 (17%)
Query: 370 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN 429
           + +A+K+LSR        F+N+    AK  ++ LV L+ C   +N   L+  + P KSL 
Sbjct: 50  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 430 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN 477
            F        L D+       ++LD +R   ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 478 VLLDHEMNPKISDFGMARIFG 498
           +++  +   KI DFG+AR  G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG 177

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 30/169 (17%)
Query: 345 QHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK 401
           + + +   +G G  G V   Y   L   + +A+K+LSR        F+N+    AK  ++
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVF--------LFDSTR----SVQLDWKRRISI 449
            LV L+ C   +N   L+  + P K+L  F        L D+       ++LD +R   +
Sbjct: 73  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 30/169 (17%)
Query: 345 QHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK 401
           + + +   +G G  G V   Y   L   + +A+K+LSR        F+N+    AK  ++
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 73
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVF--------LFDSTR----SVQLDWKRRISI 449
            LV L+ C   +N   L+  + P K+L  F        L D+       ++LD +R   +
Sbjct: 74  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 132
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 133 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 30/169 (17%)
Query: 345 QHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK 401
           + + +   +G G  G V   Y   L   + +A+K+LSR        F+N+    AK  ++
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 71
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVF--------LFDSTR----SVQLDWKRRISI 449
            LV L+ C   +N   L+  + P K+L  F        L D+       ++LD +R   +
Sbjct: 72  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 130
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 131 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 176

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 329 SQEFPLF---PLHLAV-EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ 383
           SQE P F    L+  + E  + + + + +G G +G V        G  +AVK+LSR    
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 384 GLQEFKN--EVTLIAKLQHKNLVRLLGC-----CLQENESLLIYEYMPNKSLNVFLFDST 436
            +   +   E+ L+  ++H+N++ LL        L+E   + +  ++    LN    +  
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIV 117
Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLAR 173

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 30/169 (17%)
Query: 345 QHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK 401
           + + +   +G G  G V   Y   L   + +A+K+LSR        F+N+    AK  ++
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 66
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVF--------LFDSTR----SVQLDWKRRISI 449
            LV L+ C   +N   L+  + P K+L  F        L D+       ++LD +R   +
Sbjct: 67  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 125
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 126 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 171

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL 407
           +GEG FG V++G     +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  + EN   +I E      L  FL    R   LD    I     ++  L YL      +
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   NVL+      K+ DFG++R
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSR 187

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 352 KLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 132
Query: 465 RLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
            L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 180

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 30/169 (17%)
Query: 345 QHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK 401
           + + +   +G G  G V   Y   L   + +A+K+LSR        F+N+    AK  ++
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVF--------LFDSTR----SVQLDWKRRISI 449
            LV L+ C   +N   L+  + P K+L  F        L D+       ++LD +R   +
Sbjct: 73  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 17/174 (9%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLV--R 405
           + +LG GGFG V +    D G+++A+K+  +  S +  + +  E+ ++ KL H N+V  R
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 406 LLGCCLQE----NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
            +   LQ+    +  LL  EY     L  +L        L      ++++ I+  L YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 462 EDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           E+   +IIHRDLK  N++L      +  KI D G A+    +Q E  T+  VGT
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGT 186

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 30/169 (17%)
Query: 345 QHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK 401
           + + +   +G G  G V   Y   L   + +A+K+LSR        F+N+    AK  ++
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 73
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVF--------LFDSTR----SVQLDWKRRISI 449
            LV L+ C   +N   L+  + P K+L  F        L D+       ++LD +R   +
Sbjct: 74  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 132
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 133 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 352 KLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 132
Query: 465 RLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
            L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 180

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 17/174 (9%)
Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLV--R 405
           + +LG GGFG V +    D G+++A+K+  +  S +  + +  E+ ++ KL H N+V  R
Sbjct: 20  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 79
Query: 406 LLGCCLQE----NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
            +   LQ+    +  LL  EY     L  +L        L      ++++ I+  L YLH
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 462 EDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           E+   +IIHRDLK  N++L      +  KI D G A+    +Q E  T+  VGT
Sbjct: 140 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGT 187

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 352 KLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 132
Query: 465 RLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
            L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 180

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 22/165 (13%)
Query: 345 QHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQ 399
           + + +   +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 400 HKNLVRLLGC-----CLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           HKN++ LL        L+E + + L+ E M      V        ++LD +R   ++  +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI------QMELDHERMSYLLYQM 135
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
             G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 22/174 (12%)
Query: 351 NKLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNL 403
            +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N+
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           + L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH  
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS- 132
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
             L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 180

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 352 KLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 132
Query: 465 RLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
            L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 180

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 30/169 (17%)
Query: 345 QHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK 401
           + + +   +G G  G V   Y   L   + +A+K+LSR        F+N+    AK  ++
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 65
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVF--------LFDSTR----SVQLDWKRRISI 449
            LV L+ C   +N   L+  + P K+L  F        L D+       ++LD +R   +
Sbjct: 66  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 125 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 352 KLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 132
Query: 465 RLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
            L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 180

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 30/169 (17%)
Query: 345 QHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK 401
           + + +   +G G  G V   Y   L   + +A+K+LSR        F+N+    AK  ++
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 66
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVF--------LFDSTR----SVQLDWKRRISI 449
            LV L+ C   +N   L+  + P K+L  F        L D+       ++LD +R   +
Sbjct: 67  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 125
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 126 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 171

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL 407
           +GEG FG V++G     +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  + EN   +I E      L  FL    R   LD    I     ++  L YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   NVL+      K+ DFG++R
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL 407
           +GEG FG V++G     +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  + EN   +I E      L  FL    R   LD    I     ++  L YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   NVL+      K+ DFG++R
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR 159

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 34/171 (19%)
Query: 345 QHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQ 399
           + + +   +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVF--------LFDSTR----SVQLDWKRRI 447
           HKN++ LL              + P K+L  F        L D+       ++LD +R  
Sbjct: 82  HKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 129
Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL 407
           +GEG FG V++G     +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  + EN   +I E      L  FL    R   LD    I     ++  L YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   NVL+      K+ DFG++R
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL 407
           +GEG FG V++G     +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  + EN   +I E      L  FL    R   LD    I     ++  L YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   NVL+      K+ DFG++R
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL 407
           +GEG FG V++G     +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  + EN   +I E      L  FL    R   LD    I     ++  L YL      +
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   NVL+      K+ DFG++R
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSR 161

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 346 HFSDENKLGEGGFGPVYK------GKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL 398
           H+    +LG G F  V K      GK    K I  +RL S   G   +E + EV ++ ++
Sbjct: 27  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREI 86
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           +H N++ L      + + +LI E +    L  FL +      L        +  I  G+ 
Sbjct: 87  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVH 143
Query: 459 YLHEDSRLKIIHRDLKTSNV-LLDHEM-NPKIS--DFGMA-RIFGGNQSEANTKRIVGT 512
           YLH     +I H DLK  N+ LLD  + NP+I   DFG+A +I  GN+     K I GT
Sbjct: 144 YLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFGT 195

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL 407
           +GEG FG V++G     +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  + EN   +I E      L  FL    R   LD    I     ++  L YL      +
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   NVL+      K+ DFG++R
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR 164

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 10/171 (5%)
Query: 347 FSDENKLGEGGFGPVYKGKL-ADGKEIA---VKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
           F D   LG GGFG V+  ++ A GK  A   + +      +G Q    E  ++AK+  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFD-STRSVQLDWKRRISIINGIARGLLYLH 461
           +V L      + +  L+   M    +   +++    +      R I     I  GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           + +   II+RDLK  NVLLD + N +ISD G+A      Q++  TK   GT
Sbjct: 307 QRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGT 352

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 346 HFSDENKLGEG-GFGPVYKGKLADG----KEIAVKRLSRTSGQGLQ---EFKNEVTLIAK 397
           H SD  +LGE  GFG + +  LA      +++AVK L     +       F+ E    A 
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 398 LQHKNLVRLLGCCLQENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           L H  +V +      E  +     ++ EY+   +L   +        +  KR I +I   
Sbjct: 69  LNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADA 125
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSEANTKRIVGT 512
            + L + H++    IIHRD+K +N+++      K+ DFG+AR I     S   T  ++GT
Sbjct: 126 CQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 17/159 (10%)
Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFK-NEVTLIAKLQHKNLVRLLGCC 410
           K+G G +G VYK K  DGK+     L +  G G+      E+ L+ +L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 411 LQ--ENESLLIYEYMPNKSLNVFLFD-----STRSVQLDWKRRISIINGIARGLLYLHED 463
           L   + +  L+++Y  +   ++  F      + + VQL      S++  I  G+ YLH +
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP-----KISDFGMARIF 497
               ++HRDLK +N+L+  E  P     KI+D G AR+F
Sbjct: 148 W---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 182

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEI--AVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
           Q+++ EN +G G +G V K  +  G  I  A K++ +   + +  FK E+ ++  L H N
Sbjct: 26  QYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           ++RL        +  L+ E      L   +       + D  R   I+  +   + Y H 
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH- 140
Query: 463 DSRLKIIHRDLKTSNVLL--DHEMNP-KISDFGMARIF 497
             +L + HRDLK  N L   D   +P K+ DFG+A  F
Sbjct: 141 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 176

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARV 173

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL 407
           +GEG FG V++G     +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  + EN   +I E      L  FL    R   LD    I     ++  L YL      +
Sbjct: 75  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   NVL+      K+ DFG++R
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR 156

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 352 KLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH--- 131
Query: 465 RLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
            L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 180

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARV 173

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 74/152 (48%), Gaps = 5/152 (3%)
Query: 347 FSDENKLGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLV 404
           +++ + +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            +           +   Y+    +   L+   ++  L        +  I RGL Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
              ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 165 ---VLHRDLKPSNLLLNTTXDLKICDFGLARV 193

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL 407
           +GEG FG V++G     +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  + EN   +I E      L  FL    R   LD    I     ++  L YL      +
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   NVL+      K+ DFG++R
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSR 162

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 353 LGEGGFGPVY--KGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
           LG G F  V+  K +L  GK  A+K + ++        +NE+ ++ K++H+N+V L    
Sbjct: 17  LGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS-IINGIARGLLYLHEDSRLKII 469
                  L+ + +        LFD      +  ++  S +I  +   + YLHE+    I+
Sbjct: 76  ESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IV 128
Query: 470 HRDLKTSNVL-LDHEMNPK--ISDFGMARI 496
           HRDLK  N+L L  E N K  I+DFG++++
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM 158

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEI--AVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
           Q+++ EN +G G +G V K  +  G  I  A K++ +   + +  FK E+ ++  L H N
Sbjct: 9   QYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           ++RL        +  L+ E      L   +       + D  R   I+  +   + Y H 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH- 123
Query: 463 DSRLKIIHRDLKTSNVLL--DHEMNP-KISDFGMARIF 497
             +L + HRDLK  N L   D   +P K+ DFG+A  F
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 10/171 (5%)
Query: 347 FSDENKLGEGGFGPVYKGKL-ADGKEIA---VKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
           F D   LG GGFG V+  ++ A GK  A   + +      +G Q    E  ++AK+  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFD-STRSVQLDWKRRISIINGIARGLLYLH 461
           +V L      + +  L+   M    +   +++    +      R I     I  GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           + +   II+RDLK  NVLLD + N +ISD G+A      Q++  TK   GT
Sbjct: 307 QRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGT 352

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 16/165 (9%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYK-GKLADGKEIAVKRLS----RTSGQGLQEFKN---- 390
           A E  Q +  ++ +G G    V +    A G E AVK +     R S + L+E +     
Sbjct: 89  AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR 148
Query: 391 EVTLIAKLQ-HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI 449
           E  ++ ++  H +++ L+      +   L+++ M    L  +L   T  V L  K   SI
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSI 205
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           +  +   + +LH ++   I+HRDLK  N+LLD  M  ++SDFG +
Sbjct: 206 MRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS 247

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 10/171 (5%)
Query: 347 FSDENKLGEGGFGPVYKGKL-ADGKEIA---VKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
           F D   LG GGFG V+  ++ A GK  A   + +      +G Q    E  ++AK+  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFD-STRSVQLDWKRRISIINGIARGLLYLH 461
           +V L      + +  L+   M    +   +++    +      R I     I  GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           + +   II+RDLK  NVLLD + N +ISD G+A      Q++  TK   GT
Sbjct: 307 QRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGT 352

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARV 175

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 10/171 (5%)
Query: 347 FSDENKLGEGGFGPVYKGKL-ADGKEIA---VKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
           F D   LG GGFG V+  ++ A GK  A   + +      +G Q    E  ++AK+  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFD-STRSVQLDWKRRISIINGIARGLLYLH 461
           +V L      + +  L+   M    +   +++    +      R I     I  GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           + +   II+RDLK  NVLLD + N +ISD G+A      Q++  TK   GT
Sbjct: 307 QRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGT 352

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARV 173

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 352 KLGEGGFGPVYKGK-----LADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           +LG G F  V K +     L    +   KR +++S +G+  ++ + EV+++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      + + +LI E +    L  FL +      L  +     +  I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILIGELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH--- 131
Query: 465 RLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSEANTKRIVGT 512
            L+I H DLK  N++L     P    KI DFG+A +I  GN+     K I GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGT 180

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARV 173

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARV 177

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL 407
           +GEG FG V++G     +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  + EN   +I E      L  FL    R   LD    I     ++  L YL      +
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   NVL+      K+ DFG++R
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR 539

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLVRLLG 408
           +  +G+G FG V++GK   G+E+AVK  S  S +    F+  E+     L+H+N++  + 
Sbjct: 9   QESIGKGRFGEVWRGKWR-GEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 65
Query: 409 CCLQENESL----LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED- 463
              ++N +     L+ +Y  + SL  +L   T +V+      I +    A GL +LH + 
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEI 121
Query: 464 ----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
                +  I HRDLK+ N+L+       I+D G+A
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLVRLLG 408
           +  +G+G FG V++GK   G+E+AVK  S  S +    F+  E+     L+H+N++  + 
Sbjct: 34  QESIGKGRFGEVWRGKWR-GEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 90
Query: 409 CCLQENESL----LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED- 463
              ++N +     L+ +Y  + SL  +L   T +V+      I +    A GL +LH + 
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEI 146
Query: 464 ----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
                +  I HRDLK+ N+L+       I+D G+A
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARV 178

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 153
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARV 179

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 144
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARV 170

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARV 177

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLVRLLG 408
           +  +G+G FG V++GK   G+E+AVK  S  S +    F+  E+     L+H+N++  + 
Sbjct: 14  QESIGKGRFGEVWRGKWR-GEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 70
Query: 409 CCLQENESL----LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED- 463
              ++N +     L+ +Y  + SL  +L   T +V+      I +    A GL +LH + 
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEI 126
Query: 464 ----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
                +  I HRDLK+ N+L+       I+D G+A
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 83/192 (43%), Gaps = 19/192 (9%)
Query: 334 LFPLHLAVEATQHFSDENKLGEG-GFGPVYKGKLADG----KEIAVKRLSRTSGQGLQ-- 386
           L P    +    H SD  +LGE  GFG + +  LA      +++AVK L     +     
Sbjct: 14  LVPRGSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFY 73
Query: 387 -EFKNEVTLIAKLQHKNLVRLLGCCLQENES----LLIYEYMPNKSLNVFLFDSTRSVQL 441
             F+ E    A L H  +V +      E  +     ++ EY+   +L   +        +
Sbjct: 74  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PM 130
Query: 442 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGN 500
             KR I +I    + L + H++    IIHRD+K +N+++      K+ DFG+AR I    
Sbjct: 131 TPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG 187
Query: 501 QSEANTKRIVGT 512
            S   T  ++GT
Sbjct: 188 NSVTQTAAVIGT 199

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 21/181 (11%)
Query: 346 HFSDENKLGEG-GFGPVYKGKLADG----KEIAVK----RLSRTSGQGLQEFKNEVTLIA 396
           H SD  +LGE  GFG + +  LA      +++AVK     L+R     L+ F+ E    A
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAA 67
Query: 397 KLQHKNLVRLLGCCLQENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING 452
            L H  +V +      E  +     ++ EY+   +L   +        +  KR I +I  
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIAD 124
Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSEANTKRIVG 511
             + L + H++    IIHRD+K +N+++      K+ DFG+AR I     S   T  ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 512 T 512
           T
Sbjct: 182 T 182

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 155
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARV 181

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARV 173

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLVRLLG 408
           +  +G+G FG V++GK   G+E+AVK  S  S +    F+  E+     L+H+N++  + 
Sbjct: 11  QESIGKGRFGEVWRGKWR-GEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 67
Query: 409 CCLQENESL----LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED- 463
              ++N +     L+ +Y  + SL  +L   T +V+      I +    A GL +LH + 
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEI 123
Query: 464 ----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
                +  I HRDLK+ N+L+       I+D G+A
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARV 171

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARV 193

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARV 171

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL 407
           +GEG FG V++G     +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G  + EN   +I E      L  FL    R   LD    I     ++  L YL      +
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +HRD+   NVL+      K+ DFG++R
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSR 539

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 10/151 (6%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCC 410
           L EGGF  VY+ + +  G+E A+KRL     +  +    EV  + KL  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 411 -LQENES------LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
            + + ES       L+   +    L  FL        L     + I     R + ++H  
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
            +  IIHRDLK  N+LL ++   K+ DFG A
Sbjct: 156 -KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARV 178

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLVRLLG 408
           +  +G+G FG V++GK   G+E+AVK  S  S +    F+  E+     L+H+N++  + 
Sbjct: 8   QESIGKGRFGEVWRGKWR-GEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 409 CCLQENESL----LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED- 463
              ++N +     L+ +Y  + SL  +L   T +V+      I +    A GL +LH + 
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEI 120
Query: 464 ----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
                +  I HRDLK+ N+L+       I+D G+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 85/169 (50%), Gaps = 13/169 (7%)
Query: 341 VEATQHFSDENKLGEGGFGPVYKGKLADG-KEIAVKRLSRTSGQGL--QEFKNEVTLIAK 397
           V+   ++  ++ +G G +G VY     +  K +A+K+++R     +  +    E+T++ +
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 398 LQHKNLVRLLGCCLQEN----ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           L+   ++RL    + E+    + L I   + +  L   LF +   + L  +   +I+  +
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKK-LFKT--PIFLTEQHVKTILYNL 140
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
             G  ++HE     IIHRDLK +N LL+ + + KI DFG+AR    ++ 
Sbjct: 141 LLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKD 186

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLVRLLG 408
           +  +G+G FG V++GK   G+E+AVK  S  S +    F+  E+     L+H+N++  + 
Sbjct: 47  QESIGKGRFGEVWRGKWR-GEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 409 CCLQENESL----LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED- 463
              ++N +     L+ +Y  + SL  +L   T +V+      I +    A GL +LH + 
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEI 159
Query: 464 ----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
                +  I HRDLK+ N+L+       I+D G+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 83/207 (40%), Gaps = 38/207 (18%)
Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG------KL 366
           GN+Y Y        +   EFP              S    LG G FG V +       K 
Sbjct: 1   GNNYVYIDPTQLPYDHKWEFP----------RNRLSFGKTLGAGAFGKVVEATAYGLIKS 50
Query: 367 ADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
                +AVK L  ++    +E   +E+ +++ L  H N+V LLG C     +L+I EY  
Sbjct: 51  DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 110
Query: 425 NKSLNVFLFDSTRSVQLDWKRRISIING----------------IARGLLYLHEDSRLKI 468
              L  FL    R   +  K   +I+                  +A+G+ +L   +    
Sbjct: 111 YGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---C 166
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMAR 495
           IHRDL   N+LL H    KI DFG+AR
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLAR 193

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 351 NKLGEGGFGPVYK-GKLADGKEIAVK----RLSRTSGQGL--QEFKNEVTLIAKLQHKNL 403
            +LG G F  V K  + + G E A K    R SR S +G+  +E + EV+++ ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           + L        + +LI E +    L  FL    +   L  +   S I  I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA 494
              KI H DLK  N++L  +  P    K+ DFG+A
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+GGF   ++   AD KE+   ++   S        ++   E+++   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLYL 460
              ++N+ + +          V      RS+    KRR ++    AR        G  YL
Sbjct: 89  F-FEDNDFVFV----------VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 137
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           H   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 138 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 168

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+GGF   ++   AD KE+   ++   S        ++   E+++   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLYL 460
              ++N+ + +          V      RS+    KRR ++    AR        G  YL
Sbjct: 85  F-FEDNDFVFV----------VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 133
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           H   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 134 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 351 NKLGEGGFGPVYKG-KLADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
            +LG+G F  V +  K+  G+E A K ++  + S +  Q+ + E  +   L+H N+VRL 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
               +E    LI++ +    L   +       + D       I  I   +L+ H+   + 
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHCHQ---MG 141
Query: 468 IIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQ 501
           ++HRDLK  N+LL  ++     K++DFG+A    G Q
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 178

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+GGF   ++   AD KE+   ++   S        ++   E+++   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLYL 460
              ++N+ + +          V      RS+    KRR ++    AR        G  YL
Sbjct: 83  F-FEDNDFVFV----------VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           H   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 132 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+GGF   ++   AD KE+   ++   S        ++   E+++   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLYL 460
              ++N+ + +          V      RS+    KRR ++    AR        G  YL
Sbjct: 85  F-FEDNDFVFV----------VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 133
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           H   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 134 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++   +H+N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARV 175

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 351 NKLGEGGFGPVYK-GKLADGKEIAVK----RLSRTSGQGL--QEFKNEVTLIAKLQHKNL 403
            +LG G F  V K  + + G E A K    R SR S +G+  +E + EV+++ ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           + L        + +LI E +    L  FL    +   L  +   S I  I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA 494
              KI H DLK  N++L  +  P    K+ DFG+A
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+GGF   ++   AD KE+   ++   S        ++   E+++   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLYL 460
              ++N+ + +          V      RS+    KRR ++    AR        G  YL
Sbjct: 107 F-FEDNDFVFV----------VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 155
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           H   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 156 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 186

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 26/158 (16%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLVRLLGCCL 411
           +G G FG V++ KL +  E+A+K++ +      + FKN E+ ++  ++H N+V L     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 412 QENESL------LIYEYMPNKSLNVFLFDSTRS-VQLDWKRRISIIN----GIARGLLYL 460
              +        L+ EY+P       ++ ++R   +L     + +I      + R L Y+
Sbjct: 103 SNGDKKDEVFLNLVLEYVPET-----VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIF 497
           H    + I HRD+K  N+LLD      K+ DFG A+I 
Sbjct: 158 HS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+GGF   ++   AD KE+   ++   S        ++   E+++   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLYL 460
              ++N+ + +          V      RS+    KRR ++    AR        G  YL
Sbjct: 109 F-FEDNDFVFV----------VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           H   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 158 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 351 NKLGEGGFGPVYK-GKLADGKEIAVK----RLSRTSGQGL--QEFKNEVTLIAKLQHKNL 403
            +LG G F  V K  + + G E A K    R SR S +G+  +E + EV+++ ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           + L        + +LI E +    L  FL    +   L  +   S I  I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA 494
              KI H DLK  N++L  +  P    K+ DFG+A
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 83/207 (40%), Gaps = 38/207 (18%)
Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG------KL 366
           GN+Y Y        +   EFP              S    LG G FG V +       K 
Sbjct: 19  GNNYVYIDPTQLPYDHKWEFP----------RNRLSFGKTLGAGAFGKVVEATAYGLIKS 68
Query: 367 ADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
                +AVK L  ++    +E   +E+ +++ L  H N+V LLG C     +L+I EY  
Sbjct: 69  DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 128
Query: 425 NKSLNVFLFDSTRSVQLDWKRRISIING----------------IARGLLYLHEDSRLKI 468
              L  FL    R   +  K   +I+                  +A+G+ +L   +    
Sbjct: 129 YGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---C 184
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMAR 495
           IHRDL   N+LL H    KI DFG+AR
Sbjct: 185 IHRDLAARNILLTHGRITKICDFGLAR 211

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 77/162 (47%), Gaps = 12/162 (7%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGL--QEFKNEVTLIA 396
           A E  + +     +G G +G V        G+++A+K+LSR     +  +    E+ L+ 
Sbjct: 37  AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 96
Query: 397 KLQHKNLVRLLGCCLQENESLLIYEY---MPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
            +QH+N++ LL      +     Y++   MP    ++        ++   ++   ++  +
Sbjct: 97  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL---QKIMGMEFSEEKIQYLVYQM 153
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR
Sbjct: 154 LKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 351 NKLGEGGFGPVYK-GKLADGKEIAVK----RLSRTSGQGL--QEFKNEVTLIAKLQHKNL 403
            +LG G F  V K  + + G E A K    R SR S +G+  +E + EV+++ ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           + L        + +LI E +    L  FL    +   L  +   S I  I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA 494
              KI H DLK  N++L  +  P    K+ DFG+A
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 84/194 (43%), Gaps = 22/194 (11%)
Query: 327 EESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGL 385
           E ++E P   + L +E    F     LG+G FG V+  +     +  A+K L +     L
Sbjct: 3   ELNKERPSLQIKLKIED---FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--L 57
Query: 386 QEFKNEVTLIAK------LQHKNLVRLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRS 438
            +   E T++ K       +H  L  +  C  Q  E+L  + EY+    L   ++     
Sbjct: 58  MDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSC 113
Query: 439 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            + D  R       I  GL +LH      I++RDLK  N+LLD + + KI+DFGM +   
Sbjct: 114 HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--E 168
Query: 499 GNQSEANTKRIVGT 512
               +A T    GT
Sbjct: 169 NMLGDAKTNEFCGT 182

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A++++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 351 NKLGEGGFGPVYK-GKLADGKEIAVK----RLSRTSGQGL--QEFKNEVTLIAKLQHKNL 403
            +LG G F  V K  + + G E A K    R SR S +G+  +E + EV+++ ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           + L        + +LI E +    L  FL    +   L  +   S I  I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA 494
              KI H DLK  N++L  +  P    K+ DFG+A
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 5/146 (3%)
Query: 353 LGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCC 410
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++   +H+N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
                  +   Y+    +   L+   ++  L        +  I RGL Y+H  +   ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 471 RDLKTSNVLLDHEMNPKISDFGMARI 496
           RDLK SN+LL+   + KI DFG+AR+
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARV 175

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 16/163 (9%)
Query: 342 EATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSR--------TSGQGLQEFKNEV 392
           E +Q +S  + LG G FG V+        KE+ VK + +             L +   E+
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 393 TLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING 452
            ++++++H N++++L     +    L+ E      L++F F   R  +LD      I   
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAF-IDRHPRLDEPLASYIFRQ 138
Query: 453 IARGLLYLHEDSRLK-IIHRDLKTSNVLLDHEMNPKISDFGMA 494
           +   + YL    RLK IIHRD+K  N+++  +   K+ DFG A
Sbjct: 139 LVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 351 NKLGEGGFGPVYK-GKLADGKEIAVK----RLSRTSGQGL--QEFKNEVTLIAKLQHKNL 403
            +LG G F  V K  + + G E A K    R SR S +G+  +E + EV+++ ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           + L        + +LI E +    L  FL    +   L  +   S I  I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA 494
              KI H DLK  N++L  +  P    K+ DFG+A
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 83/207 (40%), Gaps = 38/207 (18%)
Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG------KL 366
           GN+Y Y        +   EFP              S    LG G FG V +       K 
Sbjct: 24  GNNYVYIDPTQLPYDHKWEFP----------RNRLSFGKTLGAGAFGKVVEATAYGLIKS 73
Query: 367 ADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
                +AVK L  ++    +E   +E+ +++ L  H N+V LLG C     +L+I EY  
Sbjct: 74  DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 133
Query: 425 NKSLNVFLFDSTRSVQLDWKRRISIING----------------IARGLLYLHEDSRLKI 468
              L  FL    R   +  K   +I+                  +A+G+ +L   +    
Sbjct: 134 YGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---C 189
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMAR 495
           IHRDL   N+LL H    KI DFG+AR
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLAR 216

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 83/207 (40%), Gaps = 38/207 (18%)
Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG------KL 366
           GN+Y Y        +   EFP              S    LG G FG V +       K 
Sbjct: 24  GNNYVYIDPTQLPYDHKWEFP----------RNRLSFGKTLGAGAFGKVVEATAYGLIKS 73
Query: 367 ADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
                +AVK L  ++    +E   +E+ +++ L  H N+V LLG C     +L+I EY  
Sbjct: 74  DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 133
Query: 425 NKSLNVFLFDSTRSVQLDWKRRISIING----------------IARGLLYLHEDSRLKI 468
              L  FL    R   +  K   +I+                  +A+G+ +L   +    
Sbjct: 134 YGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---C 189
Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMAR 495
           IHRDL   N+LL H    KI DFG+AR
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLAR 216

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 77/162 (47%), Gaps = 12/162 (7%)
Query: 340 AVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGL--QEFKNEVTLIA 396
           A E  + +     +G G +G V        G+++A+K+LSR     +  +    E+ L+ 
Sbjct: 19  AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78
Query: 397 KLQHKNLVRLLGCCLQENESLLIYEY---MPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
            +QH+N++ LL      +     Y++   MP    ++        ++   ++   ++  +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL---QKIMGLKFSEEKIQYLVYQM 135
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR
Sbjct: 136 LKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 346 HFSDENKLGEGGFGPVY---KGKLAD-GKEIAVKRLSRTSGQGLQEF--KNEVTLIAKLQ 399
           HF     LG+G FG V+   K    D G   A+K L + + +       K E  ++A + 
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN 88
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H  +V+L      E +  LI +++    L   L       + D K  ++    +A GL +
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALGLDH 145
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           LH    L II+RDLK  N+LLD E + K++DFG+++
Sbjct: 146 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 178

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 31/172 (18%)
Query: 340 AVEATQHFSDENKLGEGGFGPV---YKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIA 396
           A E    + D   +G G +G V     G+   G ++A+K+L R        F++E  L A
Sbjct: 20  AWEVRAVYRDLQPVGSGAYGAVCSAVDGRT--GAKVAIKKLYRP-------FQSE--LFA 68
Query: 397 KLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVF-------------LFDSTRSVQLDW 443
           K  ++ L RLL     EN   L+  + P+++L+ F             L    +  +L  
Sbjct: 69  KRAYREL-RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 127
Query: 444 KRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            R   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR
Sbjct: 128 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 68/142 (47%), Gaps = 7/142 (4%)
Query: 352 KLGEGGFGPVYKGKLADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           KL E   G ++KG+   G +I VK  ++   S +  ++F  E   +    H N++ +LG 
Sbjct: 17  KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 410 CLQE--NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           C         LI  +MP  SL   L + T  V +D  + +     +ARG+ +LH    L 
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEPL- 133
Query: 468 IIHRDLKTSNVLLDHEMNPKIS 489
           I    L + +V++D +M  +IS
Sbjct: 134 IPRHALNSRSVMIDEDMTARIS 155

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 21/176 (11%)
Query: 344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
           +  F  E++LG G    VY+ K     K  A+K L +T  + +   + E+ ++ +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPN 109
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDW---KRRISIINGIARGLLY 459
           +++L        E  L+ E +    L    FD  R V+  +   +     +  I   + Y
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FD--RIVEKGYYSERDAADAVKQILEAVAY 163
Query: 460 LHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           LHE+    I+HRDLK  N+L      +   KI+DFG+++I    + +   K + GT
Sbjct: 164 LHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGT 213

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 25/174 (14%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLS-RTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           +G+G +G V++G    G+ +AVK  S R      +E   E+     L+H+N++  +   +
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 101
Query: 412 QENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH-----E 462
               S     LI  Y    SL    +D  +   LD    + I+  IA GL +LH      
Sbjct: 102 TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG--------GNQSEANTKR 508
             +  I HRDLK+ N+L+       I+D G+A +          GN     TKR
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 79/149 (53%), Gaps = 11/149 (7%)
Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRT-SGQGLQEFKNEVTL-IAKLQHKNLVRLLG 408
           +LG G +G V K + +  G+ +AVKR+  T + Q  +    ++ + +  +     V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 409 CCLQENESLLIYEYMPNKSLNVF---LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
              +E +  +  E M + SL+ F   + D  +++  D   +I++   I + L +LH  S+
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHLH--SK 128
Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           L +IHRD+K SNVL++     K+ DFG++
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGIS 157

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 351 NKLGEGGFGPVYK-GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
            +LG G FG V++  + A G+    K ++          KNE++++ +L H  L+ L   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 410 CLQENESLLIYEYMPNKSLNVFLFD--STRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
              + E +LI E++        LFD  +    ++     I+ +     GL ++HE S   
Sbjct: 117 FEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--- 169
Query: 468 IIHRDLKTSNVLLDHEM--NPKISDFGMA 494
           I+H D+K  N++ + +   + KI DFG+A
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLA 198

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 79/149 (53%), Gaps = 11/149 (7%)
Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRT-SGQGLQEFKNEVTL-IAKLQHKNLVRLLG 408
           +LG G +G V K + +  G+ +AVKR+  T + Q  +    ++ + +  +     V   G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 409 CCLQENESLLIYEYMPNKSLNVF---LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
              +E +  +  E M + SL+ F   + D  +++  D   +I++   I + L +LH  S+
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHLH--SK 172
Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           L +IHRD+K SNVL++     K+ DFG++
Sbjct: 173 LSVIHRDVKPSNVLINALGQVKMCDFGIS 201

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 23/173 (13%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ 412
           +G+G +G V++G L  G+ +AVK  S    Q     + E+     L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 413 ENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED----- 463
              S     LI  Y  + SL  FL   T    L  +  +S     A GL +LH +     
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSA----ACGLAHLHVEIFGTQ 129
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG--------GNQSEANTKR 508
            +  I HRD K+ NVL+   +   I+D G+A +          GN     TKR
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKR 182

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 27/193 (13%)
Query: 323 GQKQEESQEFPLFPLHLAVEATQHFSD----ENKLGEGGFGPVYKG-KLADGKEIAVKRL 377
           GQ+     EF        + A+  FSD    + +LG+G F  V +      G E A K +
Sbjct: 10  GQQMGRGSEF-------MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 378 S--RTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDS 435
           +  + S +  Q+ + E  +  KLQH N+VRL     +E+   L+++ +        LF+ 
Sbjct: 63  NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFED 118
Query: 436 TRSVQLDWKRRIS-IINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDF 491
             + +   +   S  I  I   + Y H +    I+HR+LK  N+LL  +      K++DF
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 492 GMARIFGGNQSEA 504
           G+A     N SEA
Sbjct: 176 GLA--IEVNDSEA 186

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 25/174 (14%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLS-RTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           +G+G +G V++G    G+ +AVK  S R      +E   E+     L+H+N++  +   +
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 412 QENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH-----E 462
               S     LI  Y    SL    +D  +   LD    + I+  IA GL +LH      
Sbjct: 73  TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG--------GNQSEANTKR 508
             +  I HRDLK+ N+L+       I+D G+A +          GN     TKR
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 25/174 (14%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLS-RTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           +G+G +G V++G    G+ +AVK  S R      +E   E+     L+H+N++  +   +
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 412 QENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH-----E 462
               S     LI  Y    SL    +D  +   LD    + I+  IA GL +LH      
Sbjct: 73  TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG--------GNQSEANTKR 508
             +  I HRDLK+ N+L+       I+D G+A +          GN     TKR
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 26/165 (15%)
Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFK---NEVTLIAKL 398
           + Q F     LG G FG V+  +   +G+  A+K L +     L++ +   +E  +++ +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--- 455
            H  ++R+ G      +  +I +Y+    L   L  S R             N +A+   
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-----------FPNPVAKFYA 112
Query: 456 -----GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                 L YLH      II+RDLK  N+LLD   + KI+DFG A+
Sbjct: 113 AEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK 154

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 84/194 (43%), Gaps = 22/194 (11%)
Query: 327 EESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGL 385
           E ++E P   + L +E    F     LG+G FG V+  +     +  A+K L +     L
Sbjct: 2   ELNKERPSLQIKLKIED---FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--L 56
Query: 386 QEFKNEVTLIAK------LQHKNLVRLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRS 438
            +   E T++ K       +H  L  +  C  Q  E+L  + EY+    L   ++     
Sbjct: 57  MDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSC 112
Query: 439 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            + D  R       I  GL +LH      I++RDLK  N+LLD + + KI+DFGM +   
Sbjct: 113 HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--E 167
Query: 499 GNQSEANTKRIVGT 512
               +A T    GT
Sbjct: 168 NMLGDAKTNXFCGT 181

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 72/145 (49%), Gaps = 7/145 (4%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ 412
           LG G FG V++      K+  + +  +  G      K E++++   +H+N++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 413 ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRD 472
             E ++I+E++    L++F   +T + +L+ +  +S ++ +   L +LH  +   I H D
Sbjct: 73  MEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFD 127
Query: 473 LKTSNVLLDHEMNP--KISDFGMAR 495
           ++  N++     +   KI +FG AR
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQAR 152

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 17/152 (11%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLL 407
           LG G F  V    LA+ K     +A+K +++ + +G +   +NE+ ++ K++H N+V L 
Sbjct: 26  LGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
                     LI + +    L   + +     + D  R   +I  +   + YLH+   L 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LG 136
Query: 468 IIHRDLKTSNVL---LDHEMNPKISDFGMARI 496
           I+HRDLK  N+L   LD +    ISDFG++++
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 27/164 (16%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHK 401
           LG G FG V +       K A  + +AVK L   +        + E K    LI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 402 NLVRLLGCCLQENESLL-IYEYMPNKSLNVFL------FDSTRSVQLDWKRRISIIN--- 451
           N+V LLG C +    L+ I E+    +L+ +L      F   + +  D+     +I    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 27/164 (16%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHK 401
           LG G FG V +       K A  + +AVK L   +        + E K    LI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 402 NLVRLLGCCLQENESLL-IYEYMPNKSLNVFL------FDSTRSVQLDW---KRRISIIN 451
           N+V LLG C +    L+ I E+    +L+ +L      F   + +  D+   +  I    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           F   ++LG G  G V+K        +  ++L     +     +   E+ ++ +     +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHED 463
              G    + E  +  E+M   SL+  L  + R   Q+  K  I++I    +GL YL E 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 122
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
            + KI+HRD+K SN+L++     K+ DFG        MA  F G +S  + +R+ GT
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 17/152 (11%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLL 407
           LG G F  V    LA+ K     +A+K +++ + +G +   +NE+ ++ K++H N+V L 
Sbjct: 26  LGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
                     LI + +    L   + +     + D  R   +I  +   + YLH+   L 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LG 136
Query: 468 IIHRDLKTSNVL---LDHEMNPKISDFGMARI 496
           I+HRDLK  N+L   LD +    ISDFG++++
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+GGF   Y+    D KE+   ++   S        ++   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLYL 460
               ++   ++ E    +SL          ++L  KRR ++    AR        G+ YL
Sbjct: 110 FFEDDDFVYVVLEICRRRSL----------LEL-HKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           H +   ++IHRDLK  N+ L+ +M+ KI DFG+A
Sbjct: 159 HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+GGF   Y+    D KE+   ++   S        ++   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLYL 460
               ++   ++ E    +SL          ++L  KRR ++    AR        G+ YL
Sbjct: 110 FFEDDDFVYVVLEICRRRSL----------LEL-HKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           H +   ++IHRDLK  N+ L+ +M+ KI DFG+A
Sbjct: 159 HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           F   ++LG G  G V+K        +  ++L     +     +   E+ ++ +     +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHED 463
              G    + E  +  E+M   SL+  L  + R   Q+  K  I++I    +GL YL E 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 122
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
            + KI+HRD+K SN+L++     K+ DFG        MA  F G +S  + +R+ GT
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 17/152 (11%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLL 407
           LG G F  V    LA+ K     +A+K +++ + +G +   +NE+ ++ K++H N+V L 
Sbjct: 26  LGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
                     LI + +    L   + +     + D  R   +I  +   + YLH+   L 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LG 136
Query: 468 IIHRDLKTSNVL---LDHEMNPKISDFGMARI 496
           I+HRDLK  N+L   LD +    ISDFG++++
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+GGF   Y+    D KE+   ++   S        ++   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLYL 460
               ++   ++ E    +SL          ++L  KRR ++    AR        G+ YL
Sbjct: 110 FFEDDDFVYVVLEICRRRSL----------LEL-HKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           H +   ++IHRDLK  N+ L+ +M+ KI DFG+A
Sbjct: 159 HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 17/152 (11%)
Query: 353 LGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLL 407
           LG G F  V    LA+ K     +A+K +++ + +G +   +NE+ ++ K++H N+V L 
Sbjct: 26  LGTGAFSEVI---LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
                     LI + +    L   + +     + D  R   +I  +   + YLH+   L 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LG 136
Query: 468 IIHRDLKTSNVL---LDHEMNPKISDFGMARI 496
           I+HRDLK  N+L   LD +    ISDFG++++
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 353 LGEGGFGPVYKGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+GGF   Y+    D KE+   ++   S        ++   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLYL 460
               ++   ++ E    +SL          ++L  KRR ++    AR        G+ YL
Sbjct: 94  FFEDDDFVYVVLEICRRRSL----------LEL-HKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           H +   ++IHRDLK  N+ L+ +M+ KI DFG+A
Sbjct: 143 HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           F   ++LG G  G V+K        +  ++L     +     +   E+ ++ +     +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHED 463
              G    + E  +  E+M   SL+  L  + R   Q+  K  I++I    +GL YL E 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 122
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
            + KI+HRD+K SN+L++     K+ DFG        MA  F G +S  + +R+ GT
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           F   ++LG G  G V+K        +  ++L     +     +   E+ ++ +     +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHED 463
              G    + E  +  E+M   SL+  L  + R   Q+  K  I++I    +GL YL E 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 122
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
            + KI+HRD+K SN+L++     K+ DFG        MA  F G +S  + +R+ GT
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           F   ++LG G  G V+K        +  ++L     +     +   E+ ++ +     +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHED 463
              G    + E  +  E+M   SL+  L  + R   Q+  K  I++I    +GL YL E 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 122
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
            + KI+HRD+K SN+L++     K+ DFG        MA  F G +S  + +R+ GT
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLH 461
           +V   G    + E  +  E+M   SL+  L  + R   Q+  K  I++I    +GL YL 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLR 183
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
           E  + KI+HRD+K SN+L++     K+ DFG        MA  F G +S  + +R+ GT
Sbjct: 184 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 240

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 20/169 (11%)
Query: 347 FSD----ENKLGEGGFGPVYKG-KLADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQ 399
           FSD    + +LG+G F  V +      G E A K ++  + S +  Q+ + E  +  KLQ
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 62
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS-IINGIARGLL 458
           H N+VRL     +E+   L+++ +        LF+   + +   +   S  I  I   + 
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIA 118
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSEA 504
           Y H +    I+HR+LK  N+LL  +      K++DFG+A     N SEA
Sbjct: 119 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA 162

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 20/169 (11%)
Query: 347 FSD----ENKLGEGGFGPVYKG-KLADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQ 399
           FSD    + +LG+G F  V +      G E A K ++  + S +  Q+ + E  +  KLQ
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS-IINGIARGLL 458
           H N+VRL     +E+   L+++ +        LF+   + +   +   S  I  I   + 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIA 119
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSEA 504
           Y H +    I+HR+LK  N+LL  +      K++DFG+A     N SEA
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA 163

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 74/167 (44%), Gaps = 11/167 (6%)
Query: 347 FSDENKLGEGGFGPVY-KGKLADGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLV 404
           F  + KLG G FG V+   + + G E  +K +++   Q  +++ + E+ ++  L H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 405 RLLGCCLQENESLLIYEYMPNKSL-NVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           ++       +   ++ E      L    +    R   L       ++  +   L Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSEANT 506
               ++H+DLK  N+L   + +P    KI DFG+A +F  ++   N 
Sbjct: 144 H---VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNA 186

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           +G+G F  V +  KL  G E A K ++  + S +  Q+ + E  +   L+H N+VRL   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
             +E    L+++ +    L   +       + D       I  I   +L+ H+   + ++
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHCHQ---MGVV 125
Query: 470 HRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQ 501
           HRDLK  N+LL  +      K++DFG+A    G+Q
Sbjct: 126 HRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ 160

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 73/167 (43%), Gaps = 28/167 (16%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLV 404
           LG G FG V +       K      +AVK L  ++    +E   +E+ +++ L  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING------------ 452
            LLG C     +L+I EY     L  FL    R   +  K   +I+              
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 453 ----IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR
Sbjct: 166 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 209

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           F   ++LG G  G V+K        +  ++L     +     +   E+ ++ +     +V
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHED 463
              G    + E  +  E+M   SL+  L  + R   Q+  K  I++I    +GL YL E 
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 125
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
            + KI+HRD+K SN+L++     K+ DFG        MA  F G +S  + +R+ GT
Sbjct: 126 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGT 181

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 20/169 (11%)
Query: 347 FSD----ENKLGEGGFGPVYKG-KLADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQ 399
           FSD    + +LG+G F  V +      G E A K ++  + S +  Q+ + E  +  KLQ
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS-IINGIARGLL 458
           H N+VRL     +E+   L+++ +        LF+   + +   +   S  I  I   + 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIA 119
Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSEA 504
           Y H +    I+HR+LK  N+LL  +      K++DFG+A     N SEA
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA 163

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKRLS-----RTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG+G    V++G+    G   A+K  +     R     ++EF+    ++ KL HKN+V+L
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLNHKNIVKL 72
Query: 407 LGCCLQEN--ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
                +      +LI E+ P  SL   L + + +  L     + ++  +  G+ +L E+ 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 465 RLKIIHRDLKTSNVLL----DHEMNPKISDFGMAR 495
              I+HR++K  N++     D +   K++DFG AR
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLV 404
           F   ++LG G  G V+K        +  ++L     +     +   E+ ++ +     +V
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHED 463
              G    + E  +  E+M   SL+  L  + R   Q+  K  I++I    +GL YL E 
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 141
Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
            + KI+HRD+K SN+L++     K+ DFG        MA  F G +S  + +R+ GT
Sbjct: 142 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 197

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLH 461
           +V   G    + E  +  E+M   SL+  L  + R   Q+  K  I++I    +GL YL 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLR 148
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
           E  + KI+HRD+K SN+L++     K+ DFG        MA  F G +S  + +R+ GT
Sbjct: 149 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 205

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 74/167 (44%), Gaps = 31/167 (18%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHK 401
           LG G FG V +       K A  + +AVK L   +        + E K    LI    H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 93
Query: 402 NLVRLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWKRR------------IS 448
           N+V LLG C +    L+ I E+    +L+ +L  S R+  + +K              I 
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 449 IINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 153 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 30/167 (17%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHK 401
           LG G FG V +       K A  + +AVK L   +        + E K    LI    H 
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 92
Query: 402 NLVRLLGCCLQENESLL-IYEYMPNKSLNVFL------FDSTRSVQLDWKRRISIIN--- 451
           N+V LLG C +    L+ I E+    +L+ +L      F   ++ +  +K  +++ +   
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLIC 152
Query: 452 ---GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 78/157 (49%), Gaps = 23/157 (14%)
Query: 353 LGEGGFGPVYKGKLAD-GKEIAVKRLS-----RTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           LG+G    V++G+    G   A+K  +     R     ++EF+    ++ KL HKN+V+L
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLNHKNIVKL 72
Query: 407 LGCCLQENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
               ++E  +    +LI E+ P  SL   L + + +  L     + ++  +  G+ +L E
Sbjct: 73  F--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 463 DSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMAR 495
           +    I+HR++K  N++     D +   K++DFG AR
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 23/172 (13%)
Query: 339 LAVEATQHFS-------DENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQE--F 388
           L +   QH+        D  ++G G +G V K      G+ +AVKR+  T  +  Q+   
Sbjct: 9   LKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 389 KNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVF------LFDSTRSVQLD 442
            +   ++       +V+  G   +E +  +  E M + S + F      + D     ++ 
Sbjct: 69  MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEIL 127
Query: 443 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
            K  ++ +    + L +L E+  LKIIHRD+K SN+LLD   N K+ DFG++
Sbjct: 128 GKITLATV----KALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGIS 173

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 15/150 (10%)
Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVTLIAK-----LQHKNLVRL 406
           LG+G FG V        +E+ A+K L +     +Q+   E T++ K     L     +  
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVV--IQDDDVECTMVEKRVLALLDKPPFLTQ 84
Query: 407 LGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L  C Q  + L  + EY+    L   ++   +  +    + +     I+ GL +LH   +
Sbjct: 85  LHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISIGLFFLH---K 138
Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             II+RDLK  NV+LD E + KI+DFGM +
Sbjct: 139 RGIIYRDLKLDNVMLDSEGHIKIADFGMCK 168

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 11/147 (7%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCC 410
           LGEG +  V     L +GKE AVK + + +G        EV  + + Q +KN++ L+   
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
             +    L++E +   S+   L    +    + +    ++  +A  L +LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 471 RDLKTSNVLLD--HEMNP-KISDFGMA 494
           RDLK  N+L +   +++P KI DF + 
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLG 161

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 21/165 (12%)
Query: 351 NKLGEGGFGPVY--KGKLADGKEIAVKRLSR-----TSGQGLQEFKNEVTLIAKLQHKNL 403
            KLG G +G V   K KL  G E A+K + +     TS  G     +EV ++ +L H N+
Sbjct: 27  KKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSG--ALLDEVAVLKQLDHPNI 83
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           ++L      +    L+ E      L   +    +  ++D      I+  +  G  YLH+ 
Sbjct: 84  MKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVD---AAVIMKQVLSGTTYLHKH 140
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIF--GGNQSE 503
           +   I+HRDLK  N+LL+ +      KI DFG++  F  GG   E
Sbjct: 141 N---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE 182

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 60/118 (50%), Gaps = 13/118 (11%)
Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           +V   G    + E  +  E+M   SL+  L ++ R +  +   ++SI   + RGL YL E
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSI--AVLRGLAYLRE 132
Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFG--------MARIFGGNQSEANTKRIVGT 512
             + +I+HRD+K SN+L++     K+ DFG        MA  F G +S    +R+ GT
Sbjct: 133 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGT 188

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 353 LGEGGFGPVYKGKLADGKEI----AVKRLSRTSGQGLQEF--KNEVTLIAKLQHKNLVRL 406
           LG+G FG V+  K   G +     A+K L + + +       K E  ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
                 E +  LI +++    L   L       + D K  ++    +A  L +LH    L
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDHLHS---L 145
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            II+RDLK  N+LLD E + K++DFG+++
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 25/162 (15%)
Query: 353 LGEGGFGPVYK------GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           +G+G F  V +      G+    K + V + + + G   ++ K E ++   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFL-------FDSTRSVQLDWKRRISIINGIARGLLY 459
           L     +    +++E+M    L   +       F  + +V   + R+      I   L Y
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ------ILEALRY 145
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFG 498
            H+++   IIHRD+K  NVLL  + N    K+ DFG+A   G
Sbjct: 146 CHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG 184

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 31/168 (18%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHK 401
           LG G FG V +       K A  + +AVK L   +        + E K    LI    H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 93
Query: 402 NLVRLLGCCLQENESLL-IYEYMPNKSLNVFL------FDSTRSVQLDWKRRISIING-- 452
           N+V LLG C +    L+ I E+    +L+ +L      F   +    D  +    +    
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 453 -----IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 154 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 12/164 (7%)
Query: 344 TQHFSDENKLGEGGFGPVYKG-KLADGKEIA--VKRLSRTSGQGLQEFKNEVTLIAKLQH 400
           T+ +    +LG+G F  V +  K+  G+E A  +    + S +  Q+ + E  +   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
            N+VRL     +E    LI++ +    L   +       + D       I  I   +L+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHC 126
Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQ 501
           H+   + ++HR+LK  N+LL  ++     K++DFG+A    G Q
Sbjct: 127 HQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 353 LGEGGFGPVYKGKLADGKEI----AVKRLSRTSGQGLQEF--KNEVTLIAKLQHKNLVRL 406
           LG+G FG V+  K   G +     A+K L + + +       K E  ++ ++ H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
                 E +  LI +++    L   L       + D K  ++    +A  L +LH    L
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDHLHS---L 146
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            II+RDLK  N+LLD E + K++DFG+++
Sbjct: 147 GIIYRDLKPENILLDEEGHIKLTDFGLSK 175

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 353 LGEGGFGPVYKGKLADGKEI----AVKRLSRTSGQGLQEF--KNEVTLIAKLQHKNLVRL 406
           LG+G FG V+  K   G +     A+K L + + +       K E  ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
                 E +  LI +++    L   L       + D K  ++    +A  L +LH    L
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDHLHS---L 145
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            II+RDLK  N+LLD E + K++DFG+++
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 33/169 (19%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHK 401
           LG G FG V +       K A  + +AVK L   +        + E K    LI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 402 NLVRLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWK--------------RR 446
           N+V LLG C +    L+ I E+    +L+ +L  S R+  + +K                
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           I     +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAK-LQHKNLVRLLG 408
           +LG G +G V K + +  G+  AVKR+  T + Q  +    ++ +  + +     V   G
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 409 CCLQENESLLIYEYMPNKSLNVF---LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
              +E +  +  E + + SL+ F   + D  +++  D   +I++   I + L +LH  S+
Sbjct: 101 ALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHLH--SK 155
Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           L +IHRD+K SNVL++     K  DFG++
Sbjct: 156 LSVIHRDVKPSNVLINALGQVKXCDFGIS 184

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 27/166 (16%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLV 404
           LG G FG V +       K A  + +AVK L   +         +E+ ++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 405 RLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWK--------------RRISI 449
            LLG C +    L+ I E+    +L+ +L  S R+  + +K                I  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 33/169 (19%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHK 401
           LG G FG V +       K A  + +AVK L   +        + E K    LI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 402 NLVRLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWK--------------RR 446
           N+V LLG C +    L+ I E+    +L+ +L  S R+  + +K                
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           I     +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 21/165 (12%)
Query: 351 NKLGEGGFGPVY--KGKLADGKEIAVKRLSR-----TSGQGLQEFKNEVTLIAKLQHKNL 403
            KLG G +G V   K KL  G E A+K + +     TS  G     +EV ++ +L H N+
Sbjct: 10  KKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGA--LLDEVAVLKQLDHPNI 66
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           ++L      +    L+ E      L   +    +  ++D      I+  +  G  YLH+ 
Sbjct: 67  MKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVD---AAVIMKQVLSGTTYLHKH 123
Query: 464 SRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIF--GGNQSE 503
           +   I+HRDLK  N+LL+ +      KI DFG++  F  GG   E
Sbjct: 124 N---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE 165

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 33/169 (19%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHK 401
           LG G FG V +       K A  + +AVK L   +        + E K    LI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 402 NLVRLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWK--------------RR 446
           N+V LLG C +    L+ I E+    +L+ +L  S R+  + +K                
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           I     +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 33/169 (19%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHK 401
           LG G FG V +       K A  + +AVK L   +        + E K    LI    H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 82
Query: 402 NLVRLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWK--------------RR 446
           N+V LLG C +    L+ I E+    +L+ +L  S R+  + +K                
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           I     +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 19/185 (10%)
Query: 335 FPLHLAVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ--GLQEFKNE 391
            P  +    +  F  ++ LGEG +G V        G+ +A+K++         L+  + E
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-E 59
Query: 392 VTLIAKLQHKNLVRLLGCCLQE-----NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR 446
           + ++   +H+N++ +      +     NE  +I E M      V    ST+ +  D  + 
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQ- 115
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
              I    R +  LH  +   +IHRDLK SN+L++   + K+ DFG+ARI   ++S A+ 
Sbjct: 116 -YFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADN 169
Query: 507 KRIVG 511
               G
Sbjct: 170 SEPTG 174

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 28/158 (17%)
Query: 353 LGEGGFGPVYKGKLADG----KEIAVKRLSRT----SGQGLQEFKNEVTLIAKLQHKNLV 404
           LG+GG+G V++ +   G    K  A+K L +     + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 405 RLLGCCLQENESLLIYEYMPNKSL-------NVFLFDSTRSVQLDWKRRISIINGIARGL 457
            L+       +  LI EY+    L        +F+ D+              +  I+  L
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA----------CFYLAEISMAL 134
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +LH+     II+RDLK  N++L+H+ + K++DFG+ +
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 28/158 (17%)
Query: 353 LGEGGFGPVYKGKLADG----KEIAVKRLSRT----SGQGLQEFKNEVTLIAKLQHKNLV 404
           LG+GG+G V++ +   G    K  A+K L +     + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 405 RLLGCCLQENESLLIYEYMPNKSL-------NVFLFDSTRSVQLDWKRRISIINGIARGL 457
            L+       +  LI EY+    L        +F+ D+              +  I+  L
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA----------CFYLAEISMAL 134
Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +LH+     II+RDLK  N++L+H+ + K++DFG+ +
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 19/185 (10%)
Query: 335 FPLHLAVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ--GLQEFKNE 391
            P  +    +  F  ++ LGEG +G V        G+ +A+K++         L+  + E
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-E 59
Query: 392 VTLIAKLQHKNLVRLLGCCLQE-----NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR 446
           + ++   +H+N++ +      +     NE  +I E M      V    ST+ +  D  + 
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQ- 115
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
              I    R +  LH  +   +IHRDLK SN+L++   + K+ DFG+ARI   ++S A+ 
Sbjct: 116 -YFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADN 169
Query: 507 KRIVG 511
               G
Sbjct: 170 SEPTG 174

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 19/184 (10%)
Query: 336 PLHLAVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQ--GLQEFKNEV 392
           P  +    +  F  ++ LGEG +G V        G+ +A+K++         L+  + E+
Sbjct: 2   PKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EI 60
Query: 393 TLIAKLQHKNLVRLLGCCLQE-----NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI 447
            ++   +H+N++ +      +     NE  +I E M      V    ST+ +  D  +  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQ-- 115
Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
             I    R +  LH  +   +IHRDLK SN+L++   + K+ DFG+ARI   ++S A+  
Sbjct: 116 YFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNS 170
Query: 508 RIVG 511
              G
Sbjct: 171 EPTG 174

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 33/169 (19%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHK 401
           LG G FG V +       K A  + +AVK L   +        + E K    LI    H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 82
Query: 402 NLVRLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWK--------------RR 446
           N+V LLG C +    L+ I E+    +L+ +L  S R+  + +K                
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           I     +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 33/169 (19%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHK 401
           LG G FG V +       K A  + +AVK L   +        + E K    LI    H 
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 128
Query: 402 NLVRLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWK--------------RR 446
           N+V LLG C +    L+ I E+    +L+ +L  S R+  + +K                
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           I     +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 188 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 233

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 79/180 (43%), Gaps = 38/180 (21%)
Query: 352 KLGEGGFGPVYKGKLADGK------EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           ++G G F  VYKG   +        E+  ++L+++     Q FK E   +  LQH N+VR
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAEXLKGLQHPNIVR 89
Query: 406 LLGC---------CLQENESLLIYEYMPNKSLNVFL--FDSTR-SVQLDWKRRISIINGI 453
                        C+     +L+ E   + +L  +L  F   +  V   W R+      I
Sbjct: 90  FYDSWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------I 138
Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSEANTKRIVGT 512
            +GL +LH  +   IIHRDLK  N+ +       KI D G+A +    +  +  K ++GT
Sbjct: 139 LKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGT 193

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 33/169 (19%)
Query: 353 LGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHK 401
           LG G FG V +       K A  + +AVK L   +        + E K    LI    H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 82
Query: 402 NLVRLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWK--------------RR 446
           N+V LLG C +    L+ I E+    +L+ +L  S R+  + +K                
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           I     +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H  LV L  C   E+    + EY+    L   +F   R  +L  +        I+  L Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           LHE     II+RDLK  NVLLD E + K++D+GM +
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H  LV L  C   E+    + EY+    L   +F   R  +L  +        I+  L Y
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           LHE     II+RDLK  NVLLD E + K++D+GM +
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 169

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 78/157 (49%), Gaps = 13/157 (8%)
Query: 353 LGEGGFGPVYKGKLADG-KEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLVRLLGC 409
           +G G +G VY     +  K +A+K+++R     +  +    E+T++ +L+   ++RL   
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 410 CLQEN----ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
            + ++    + L I   + +  L   LF +   + L  +   +I+  +  G  ++HE   
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKK-LFKT--PIFLTEEHIKTILYNLLLGENFIHESG- 149
Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
             IIHRDLK +N LL+ + + K+ DFG+AR     + 
Sbjct: 150 --IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H  LV L  C   E+    + EY+    L   +F   R  +L  +        I+  L Y
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           LHE     II+RDLK  NVLLD E + K++D+GM +
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 154

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 76/154 (49%), Gaps = 20/154 (12%)
Query: 353 LGEGGFGPVYKGKLA-DGKEIAVKRLSRT------SGQGLQEFKNEVTLIAKLQHKNLVR 405
           +G G +G V   +    G+++A+K++         + + L+E K    ++   +H N++ 
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNIIA 118
Query: 406 L---LGCCLQENESLLIYEYMPNKSLNVF-LFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           +   L   +   E   +Y  +     ++  +  S++ + L+  R    +  + RGL Y+H
Sbjct: 119 IKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVR--YFLYQLLRGLKYMH 176
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                ++IHRDLK SN+L++     KI DFGMAR
Sbjct: 177 S---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 207

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 10/153 (6%)
Query: 346 HFSDENKLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKN---EVTLIAKLQHK 401
           HF     +G+G FG V   +  D K++ A+K +++       E +N   E+ ++  L+H 
Sbjct: 16  HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
            LV L      E +  ++ + +    L   L    ++V    +     I  +   L YL 
Sbjct: 76  FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMALDYLQ 132
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
                +IIHRD+K  N+LLD   +  I+DF +A
Sbjct: 133 NQ---RIIHRDMKPDNILLDEHGHVHITDFNIA 162

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 76/154 (49%), Gaps = 20/154 (12%)
Query: 353 LGEGGFGPVYKGKLA-DGKEIAVKRLSRT------SGQGLQEFKNEVTLIAKLQHKNLVR 405
           +G G +G V   +    G+++A+K++         + + L+E K    ++   +H N++ 
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNIIA 117
Query: 406 L---LGCCLQENESLLIYEYMPNKSLNVF-LFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           +   L   +   E   +Y  +     ++  +  S++ + L+  R    +  + RGL Y+H
Sbjct: 118 IKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVR--YFLYQLLRGLKYMH 175
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                ++IHRDLK SN+L++     KI DFGMAR
Sbjct: 176 S---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H  LV L  C   E+    + EY+    L   +F   R  +L  +        I+  L Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           LHE     II+RDLK  NVLLD E + K++D+GM +
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 158

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQ--HKNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 128
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 129 XG---VLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 352 KLGEGGFGPVY--KGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           KLG G +G V   + K+    + I + R +  S     +   EV ++  L H N+++L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
               +    L+ E      L   +    +  ++D      II  +  G+ YLH+ +   I
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD---AAVIIKQVLSGVTYLHKHN---I 157
Query: 469 IHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSEANTKRIVGT 512
           +HRDLK  N+LL+ +      KI DFG++ +F   +++   K  +GT
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGT 201

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 350 ENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLL 407
           E+ LGEG    V     L   +E AVK + +  G        EV ++ + Q H+N++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
               +E+   L++E M   S+   +       +L+      ++  +A  L +LH      
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHNKG--- 131
Query: 468 IIHRDLKTSNVLLDH--EMNP-KISDFGMA 494
           I HRDLK  N+L +H  +++P KI DFG+ 
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLG 161

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQ--HKNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 128
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 22/185 (11%)
Query: 336 PLHLAVEATQHFSDENKL----GEGGFGPVYKGKLADGKE-IAVKRLSRTSGQGLQE-FK 389
           P+ L +    H SD  +L    G G FG     +     E +AVK + R  G+ + E  K
Sbjct: 9   PMDLPI---MHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIER--GEKIDENVK 63
Query: 390 NEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI 449
            E+     L+H N+VR     L      ++ EY     L   + ++ R  + + +     
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR---FF 120
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSEANTK 507
              +  G+ Y H    +++ HRDLK  N LLD    P  KI+DFG ++    +   +  K
Sbjct: 121 FQQLISGVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPK 174
Query: 508 RIVGT 512
             VGT
Sbjct: 175 SAVGT 179

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCH- 132
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 133 --NCGVLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 147
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 148 ---CGVLHRDIKDENILIDLNRGELKLIDFG 175

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQ--HKNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 128
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQ--HKNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 75  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 131
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 132 ---CGVLHRDIKDENILIDLNRGELKLIDFG 159

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCH- 132
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 133 --NCGVLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 147
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 148 ---CGVLHRDIKDENILIDLNRGELKLIDFG 175

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 148
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 149 ---CGVLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 161
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 162 ---CGVLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 148
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 149 ---CGVLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 175
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 176 ---CGVLHRDIKDENILIDLNRGELKLIDFG 203

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 160
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 161 ---CGVLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 160
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 161 ---CGVLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 161
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 162 ---CGVLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQ--HKNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 133
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 134 ---CGVLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 161
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 162 ---CGVLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 161
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 162 ---CGVLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 160
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 161 ---CGVLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 175
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 176 ---CGVLHRDIKDENILIDLNRGELKLIDFG 203

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 160
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 161 ---CGVLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 148
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 149 ---CGVLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQ--HKNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 132
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 133 ---CGVLHRDIKDENILIDLNRGELKLIDFG 160

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 22/185 (11%)
Query: 336 PLHLAVEATQHFSDE----NKLGEGGFGPVYKGKLADGKE-IAVKRLSRTSGQGLQE-FK 389
           PL + +    H SD       +G G FG     +    KE +AVK + R  G  + E  +
Sbjct: 10  PLDMPI---MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQ 64
Query: 390 NEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI 449
            E+     L+H N+VR     L      +I EY     L   + ++ R  + + +     
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR---FF 121
Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSEANTK 507
              +  G+ Y H    ++I HRDLK  N LLD    P  KI DFG ++    +   +  K
Sbjct: 122 FQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPK 175
Query: 508 RIVGT 512
             VGT
Sbjct: 176 STVGT 180

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 111 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 167
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 168 ---CGVLHRDIKDENILIDLNRGELKLIDFG 195

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQ--HKNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 99  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCH- 154
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 155 --NCGVLHRDIKDENILIDLNRGELKLIDFG 183

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 8/142 (5%)
Query: 344 TQHFSDENKLGEGGFGPVYK-GKLADGKEIAVKRLSRTSGQGLQEFK--NEVTLIAKL-Q 399
           T  F +  K+G G FG V+K  K  DG   A+KR  +     + E     EV   A L Q
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI-SIINGIARGLL 458
           H ++VR      +++  L+  EY    SL   + ++ R +    +  +  ++  + RGL 
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 127
Query: 459 YLHEDSRLKIIHRDLKTSNVLL 480
           Y+H    + ++H D+K SN+ +
Sbjct: 128 YIHS---MSLVHMDIKPSNIFI 146

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQH--KNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E  P    ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 124 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 180
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 181 ---CGVLHRDIKDENILIDLNRGELKLIDFG 208

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 8/142 (5%)
Query: 344 TQHFSDENKLGEGGFGPVYK-GKLADGKEIAVKRLSRTSGQGLQEFK--NEVTLIAKL-Q 399
           T  F +  K+G G FG V+K  K  DG   A+KR  +     + E     EV   A L Q
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI-SIINGIARGLL 458
           H ++VR      +++  L+  EY    SL   + ++ R +    +  +  ++  + RGL 
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 127
Query: 459 YLHEDSRLKIIHRDLKTSNVLL 480
           Y+H    + ++H D+K SN+ +
Sbjct: 128 YIHS---MSLVHMDIKPSNIFI 146

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 8/142 (5%)
Query: 344 TQHFSDENKLGEGGFGPVYK-GKLADGKEIAVKRLSRTSGQGLQEFK--NEVTLIAKL-Q 399
           T  F +  K+G G FG V+K  K  DG   A+KR  +     + E     EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI-SIINGIARGLL 458
           H ++VR      +++  L+  EY    SL   + ++ R +    +  +  ++  + RGL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 459 YLHEDSRLKIIHRDLKTSNVLL 480
           Y+H    + ++H D+K SN+ +
Sbjct: 130 YIHS---MSLVHMDIKPSNIFI 148

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 351 NKLGEGGFGPVYK-GKLADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
            +LG+G F  V +  K+  G+E A K ++  + S +  Q+ + E  +   L+H N+VRL 
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
               +E    L+++ +    L   +       + D       I  I   + + H +    
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILESVNHCHLNG--- 123
Query: 468 IIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQ 501
           I+HRDLK  N+LL  +      K++DFG+A    G+Q
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ 160

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 351 NKLGEGGFGPVYK-GKLADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
            +LG+G F  V +  K+  G+E A K ++  + S +  Q+ + E  +   L+H N+VRL 
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
               +E    L+++ +    L   +       + D       I  I   + + H +    
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILESVNHCHLNG--- 123
Query: 468 IIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQ 501
           I+HRDLK  N+LL  +      K++DFG+A    G+Q
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ 160

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQ--HKNL 403
           LG GGFG VY G +++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHE 462
           +RLL    + +  +LI E M     ++F F + R ++Q +  R  S    +   + + H 
Sbjct: 76  IRLLDWFERPDSFVLILERM-EPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 132
Query: 463 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFG 492
                ++HRD+K  N+L+D +    K+ DFG
Sbjct: 133 ---CGVLHRDIKDENILIDLNRGELKLIDFG 160

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 8/142 (5%)
Query: 344 TQHFSDENKLGEGGFGPVYK-GKLADGKEIAVKRLSRTSGQGLQEFK--NEVTLIAKL-Q 399
           T  F +  K+G G FG V+K  K  DG   A+KR  +     + E     EV   A L Q
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 65
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI-SIINGIARGLL 458
           H ++VR      +++  L+  EY    SL   + ++ R +    +  +  ++  + RGL 
Sbjct: 66  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 125
Query: 459 YLHEDSRLKIIHRDLKTSNVLL 480
           Y+H    + ++H D+K SN+ +
Sbjct: 126 YIHS---MSLVHMDIKPSNIFI 144

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 353 LGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQ----HK 401
           LG+GGFG V+ G +L D  ++A+K + R    G     +      EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
            ++RLL    +  E  ++    P  + ++F + + +    +   R      +   + + H
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156
Query: 462 EDSRLKIIHRDLKTSNVLLDHEMN-PKISDFG 492
             SR  ++HRD+K  N+L+D      K+ DFG
Sbjct: 157 --SR-GVVHRDIKDENILIDLRRGCAKLIDFG 185

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 65/147 (44%), Gaps = 12/147 (8%)
Query: 353 LGEGGFGPVYKGKLADGKE-IAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCC 410
           +G G FG     +     E +AVK + R  G+ + E  K E+     L+H N+VR     
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRSLRHPNIVRFKEVI 83
Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
           L      ++ EY     L   + ++ R  + + +        +  G+ Y H    +++ H
Sbjct: 84  LTPTHLAIVMEYASGGELFERICNAGRFSEDEAR---FFFQQLISGVSYCHA---MQVCH 137
Query: 471 RDLKTSNVLLDHEMNP--KISDFGMAR 495
           RDLK  N LLD    P  KI DFG ++
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSK 164

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 13/145 (8%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE---FKNEVTLIAKLQHKNLVRLLG 408
           +G G FG V   +  A  K  A+K LS+       +   F  E  ++A      +V+L  
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 141
Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           C  Q+++ L ++ EYMP   L   +  S   V   W +  +     A  +L L     + 
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYT-----AEVVLALDAIHSMG 194
Query: 468 IIHRDLKTSNVLLDHEMNPKISDFG 492
           +IHRD+K  N+LLD   + K++DFG
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFG 219

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 76/169 (44%), Gaps = 21/169 (12%)
Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVTLIAK----LQHKN-LVRL 406
           LG+G FG V   +     E+ AVK L +     +Q+   E T++ K    L  K   +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 407 LGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L  C Q  + L  + EY+    L   ++   +  +      +     IA GL +L     
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG- 141
Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSEANTKRIVGT 512
             II+RDLK  NV+LD E + KI+DFGM +  I+ G      TK   GT
Sbjct: 142 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFCGT 184

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 21/169 (12%)
Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVTLIAKL------QHKNLVR 405
           LG+G FG V   +     E+ AVK L +     +Q+   E T++ K       +   L +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L  C    +    + EY+    L   ++   +  +      +     IA GL +L     
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG- 462
Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSEANTKRIVGT 512
             II+RDLK  NV+LD E + KI+DFGM +  I+ G      TK   GT
Sbjct: 463 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFCGT 505

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 16/165 (9%)
Query: 347 FSDE----NKLGEGGFGPVYKG-KLADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQ 399
           F+D+     +LG+G F  V +  K    +E A K ++  + S +  Q+ + E  +   L+
Sbjct: 29  FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLK 88
Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N+VRL     +E    L+++ +    L   +       + D       I+ I   + +
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIHQILESVNH 145
Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQ 501
           +H+     I+HRDLK  N+LL  +      K++DFG+A    G Q
Sbjct: 146 IHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ 187

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 350 ENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLL 407
           E+ LGEG    V     L   +E AVK + +  G        EV ++ + Q H+N++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
               +E+   L++E M   S+   +       +L+      ++  +A  L +LH      
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHNKG--- 131
Query: 468 IIHRDLKTSNVLLDH--EMNP-KISDFGMA 494
           I HRDLK  N+L +H  +++P KI DF + 
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLG 161

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFK---NEVTLIAKLQHKNLVRLLG 408
           +G G FG V   K +  G   A+K L +     L++ +   NE  ++  +    LV+L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL-E 107
Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSV-QLDWKRRISIINGIARGLLYLHEDSRL 466
              ++N +L ++ EYMP   +    F   R + +            I     YLH    L
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---L 160
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG 499
            +I+RDLK  N+L+D +   K++DFG A+   G
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 193

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFK---NEVTLIAKLQHKNLVRLLG 408
           +G G FG V   K +  G   A+K L +     L++ +   NE  ++  +    LV+L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL-E 107
Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSV-QLDWKRRISIINGIARGLLYLHEDSRL 466
              ++N +L ++ EYMP   +    F   R + +            I     YLH    L
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---L 160
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG 499
            +I+RDLK  N+L+D +   K++DFG A+   G
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 193

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFK---NEVTLIAKLQHKNLVRLLG 408
           LG G FG V   K +  G   A+K L +     L+E +   NE  ++  +    LV+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL-E 107
Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSV-QLDWKRRISIINGIARGLLYLHEDSRL 466
              ++N +L ++ EY P   +    F   R + +            I     YLH    L
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---L 160
Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG 499
            +I+RDLK  N+++D +   K++DFG+A+   G
Sbjct: 161 DLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG 193

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	512
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-93
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-89
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-82
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-64
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-54
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-50
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-47
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-47
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-46
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-46
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-46
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-45
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-45
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-43
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-41
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-40
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-39
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-33
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-33
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-33
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-32
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-30
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-30
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-29
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-27
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-27
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-26
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-26
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-24
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-24
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-23
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-22
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	5e-22
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	1e-17
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-22
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-20
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-20
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-19
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-18
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-18
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-16
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-14
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-14
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-11
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-11
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-09
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-09
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  284 bits (730), Expect = 4e-93
 Identities = 74/180 (41%), Positives = 101/180 (56%), Gaps = 14/180 (7%)

Query: 343 ATQHFSDE------NKLGEGGFGPVYKGKLADGKEIAVKRLS----RTSGQGLQEFKNEV 392
            T +F +       NK+GEGGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+
Sbjct: 23  VTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEI 81

Query: 393 TLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING 452
            ++AK QH+NLV LLG     ++  L+Y YMPN SL   L     +  L W  R  I  G
Sbjct: 82  KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG 141

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            A G+ +LHE+     IHRD+K++N+LLD     KISDFG+AR          T RIVGT
Sbjct: 142 AANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGT 198

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  276 bits (708), Expect = 2e-89
 Identities = 78/172 (45%), Positives = 106/172 (61%), Gaps = 3/172 (1%)

Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHK 401
           A+ +FS++N LG GGFG VYKG+LADG  +AVKRL     QG + +F+ EV +I+   H+
Sbjct: 28  ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 87

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRS-VQLDWKRRISIINGIARGLLYL 460
           NL+RL G C+   E LL+Y YM N S+   L +   S   LDW +R  I  G ARGL YL
Sbjct: 88  NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 147

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           H+    KIIHRD+K +N+LLD E    + DFG+A++     +   T  + GT
Sbjct: 148 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  258 bits (662), Expect = 1e-82
 Identities = 74/180 (41%), Positives = 111/180 (61%), Gaps = 6/180 (3%)

Query: 335 FPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTL 394
            PL    EAT +F  +  +G G FG VYKG L DG ++A+KR +  S QG++EF+ E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGI 453
           ++  +H +LV L+G C + NE +LIY+YM N +L   L+ S      + W++R+ I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSEANTKRIVGT 512
           ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++     +Q+  +T  + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  210 bits (537), Expect = 3e-64
 Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 17/201 (8%)

Query: 323 GQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSG 382
           G                    +           G FG V+K +L   + +AVK       
Sbjct: 2   GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK 60

Query: 383 QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN----ESLLIYEYMPNKSLNVFLFDSTRS 438
           Q   + + EV  +  ++H+N+++ +G   +      +  LI  +    SL+ FL  +   
Sbjct: 61  QS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-- 117

Query: 439 VQLDWKRRISIINGIARGLLYLHED-------SRLKIIHRDLKTSNVLLDHEMNPKISDF 491
             + W     I   +ARGL YLHED        +  I HRD+K+ NVLL + +   I+DF
Sbjct: 118 --VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175

Query: 492 GMARIFGGNQSEANTKRIVGT 512
           G+A  F   +S  +T   VGT
Sbjct: 176 GLALKFEAGKSAGDTHGQVGT 196

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  185 bits (470), Expect = 3e-54
 Identities = 55/187 (29%), Positives = 82/187 (43%), Gaps = 23/187 (12%)

Query: 343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
              +      +G G +G VYKG L D + +AVK  S  + Q     K  +  +  ++H N
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68

Query: 403 LVRLLGCCL-----QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           + R +            E LL+ EY PN SL  +L   T     DW     + + + RGL
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124

Query: 458 LYLHED------SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN------QSEAN 505
            YLH +       +  I HRDL + NVL+ ++    ISDFG++    GN      + +  
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 506 TKRIVGT 512
               VGT
Sbjct: 185 AISEVGT 191

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  174 bits (443), Expect = 1e-50
 Identities = 54/165 (32%), Positives = 91/165 (55%), Gaps = 6/165 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           + K+G G FG V++ +   G ++AVK L       + + EF  EV ++ +L+H N+V  +
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G   Q     ++ EY+   SL   L  S    QLD +RR+S+   +A+G+ YLH      
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           I+HR+LK+ N+L+D +   K+ DFG++R+     +  ++K   GT
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGT 202

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  166 bits (422), Expect = 1e-47
 Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 6/160 (3%)

Query: 350 ENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
              LG+G FG   K      G+ + +K L R   +  + F  EV ++  L+H N+++ +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
              ++     I EY+   +L   +       Q  W +R+S    IA G+ YLH    + I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           IHRDL + N L+    N  ++DFG+AR+    +++    R
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  163 bits (415), Expect = 6e-47
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 7/152 (4%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
             KL E   G ++KG+   G +I VK L     S +  ++F  E   +    H N++ +L
Sbjct: 15  LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 408 GCCLQENESLL--IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           G C          I  +MP  SL   L + T  V +D  + +     +ARG+ +LH    
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLH-TLE 131

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
             I    L + +V++D +M  +IS   +   F
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  162 bits (413), Expect = 1e-46
 Identities = 54/169 (31%), Positives = 84/169 (49%), Gaps = 17/169 (10%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRL----SRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           E  +G GGFG VY+     G E+AVK           Q ++  + E  L A L+H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L G CL+E    L+ E+     LN  L       ++     ++    IARG+ YLH+++ 
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 466 LKIIHRDLKTSNVLLDHEMNP--------KISDFGMARIFGGNQSEANT 506
           + IIHRDLK+SN+L+  ++          KI+DFG+AR +      +  
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  162 bits (413), Expect = 2e-46
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 6/151 (3%)

Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
              E  +G G FG V K K    K++A+K++   S    + F  E+  ++++ H N+V+L
Sbjct: 10  IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKL 66

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
            G CL      L+ EY    SL   L  +           +S     ++G+ YLH     
Sbjct: 67  YGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 467 KIIHRDLKTSNVLLDHEMN-PKISDFGMARI 496
            +IHRDLK  N+LL       KI DFG A  
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  161 bits (410), Expect = 5e-46
 Identities = 48/176 (27%), Positives = 90/176 (51%), Gaps = 23/176 (13%)

Query: 350 ENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQG-------LQEFKNEVTLIAKLQHK 401
           E ++G+GGFG V+KG+ + D   +A+K L     +G        QEF+ EV +++ L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V+L G         ++ E++P   L   L D  ++  + W  ++ ++  IA G+ Y+ 
Sbjct: 84  NIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 462 EDSRLKIIHRDLKTSNVLLD-----HEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            +    I+HRDL++ N+ L        +  K++DFG+++      S  +   ++G 
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGN 189

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  159 bits (405), Expect = 2e-45
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 10/165 (6%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
             ++G G FG VYKGK     ++AVK L  +  + Q LQ FKNEV ++ K +H N++  +
Sbjct: 29  GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G       ++ + ++    SL   L       + + K+ I I    ARG+ YLH      
Sbjct: 87  GYSTAPQLAI-VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKS 140

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           IIHRDLK++N+ L  +   KI DFG+A            +++ G+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  155 bits (393), Expect = 3e-43
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 10/161 (6%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
              +G+G FG VY G+     E+A++ +   R +   L+ FK EV    + +H+N+V  +
Sbjct: 38  GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G C+      +I      ++L   + D    + LD  +   I   I +G+ YLH      
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           I+H+DLK+ NV  D      I+DFG+  I G  Q+     +
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  147 bits (374), Expect = 8e-41
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 21/176 (11%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNE--VTLIAKLQHKNLVRLL 407
              +G+G +G V++G    G+ +AVK  S    +  + +  E  +     L+H+N++  +
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68

Query: 408 GCCLQENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
              +    S     LI  Y    SL  +L    +   LD    + I+  IA GL +LH +
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 464 -----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRI--VGT 512
                 +  I HRDLK+ N+L+       I+D G+A +   + ++ +      VGT
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  148 bits (376), Expect = 9e-41
 Identities = 46/176 (26%), Positives = 79/176 (44%), Gaps = 21/176 (11%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNE--VTLIAKLQHKNLVRLL 407
             ++G+G +G V+ GK   G+++AVK            +  E  +     ++H+N++  +
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97

Query: 408 GCCLQENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
              ++   S     LI +Y  N SL  +L    +S  LD K  + +      GL +LH +
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 464 -----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSEANTKRIVGT 512
                 +  I HRDLK+ N+L+       I+D G+A  F    N+ +      VGT
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  144 bits (364), Expect = 6e-39
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 21/176 (11%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNE--VTLIAKLQHKNLVRLL 407
           +  +G+G FG V++GK   G+E+AVK  S    +  + +  E  +     L+H+N++  +
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102

Query: 408 GCCLQENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
               ++N +     L+ +Y  + SL  +L        +  +  I +    A GL +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHME 158

Query: 464 -----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRI--VGT 512
                 +  I HRDLK+ N+L+       I+D G+A          +      VGT
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  140 bits (355), Expect = 9e-38
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 26/209 (12%)

Query: 310 GRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDEN-----KLGEGGFGPVYKG 364
           G +G+  S     G+           P + +     H    +     +LGEG FG V+  
Sbjct: 1   GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLA 60

Query: 365 KLADGKE------IAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL 418
           +  +         +AVK L   S    Q+F+ E  L+  LQH+++VR  G C +    L+
Sbjct: 61  ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120

Query: 419 IYEYMPNKSLNVFL------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
           ++EYM +  LN FL             +      L   + +++ + +A G++YL   + L
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGL 177

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             +HRDL T N L+   +  KI DFGM+R
Sbjct: 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  137 bits (348), Expect = 4e-37
 Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 22/165 (13%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE------IAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           + +LGEG FG V+  +  +         +AVK L   +    ++F+ E  L+  LQH+++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFL-------------FDSTRSVQLDWKRRISII 450
           V+  G C   +  ++++EYM +  LN FL                    +L   + + I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + IA G++YL   +    +HRDL T N L+   +  KI DFGM+R
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  135 bits (343), Expect = 1e-36
 Identities = 55/166 (33%), Positives = 82/166 (49%), Gaps = 23/166 (13%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE------IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKN 402
             +LGE  FG VYKG L           +A+K L  +  G   +EF++E  L A+LQH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL-------------FDSTRSVQLDWKRRISI 449
           +V LLG   ++    +I+ Y  +  L+ FL              D T    L+    + +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  IA G+ YL   S   ++H+DL T NVL+  ++N KISD G+ R
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  136 bits (344), Expect = 2e-36
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 15/160 (9%)

Query: 350 ENKLGEGGFGPVYKGKL---ADGKEI--AVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNL 403
              LGEG FG V         DG     AVK L   +G Q    +K E+ ++  L H+++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 404 VRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           ++  GCC     +   L+ EY+P  SL  +L        +   + +     I  G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
                  IHRDL   NVLLD++   KI DFG+A+      
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  136 bits (344), Expect = 3e-36
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 17/159 (10%)

Query: 351 NKLGEGGFGPVYKGKLADGKE------IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNL 403
            +LG+G FG VY+G      +      +A+K +    S +   EF NE +++ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFL-------FDSTRSVQLDWKRRISIINGIARG 456
           VRLLG   Q   +L+I E M    L  +L        ++         + I +   IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + YL+     K +HRDL   N ++  +   KI DFGM R
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  135 bits (341), Expect = 4e-36
 Identities = 49/159 (30%), Positives = 83/159 (52%), Gaps = 12/159 (7%)

Query: 350 ENKLGEGGFGPVYKGK---LADGKEI--AVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
             +LG+G FG V   +   L D      AVK+L  ++ + L++F+ E+ ++  LQH N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 405 RLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           +  G C         LI EY+P  SL  +L       ++D  + +   + I +G+ YL  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
               + IHRDL T N+L+++E   KI DFG+ ++   ++
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  135 bits (341), Expect = 4e-36
 Identities = 46/162 (28%), Positives = 82/162 (50%), Gaps = 13/162 (8%)

Query: 350 ENKLGEGGFGPVYKGKLA-----DGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNL 403
              LGEG FG V   +        G+++AVK L   + G  + + K E+ ++  L H+N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 404 VRLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           V+  G C ++  +   LI E++P+ SL  +L       +++ K+++     I +G+ YL 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
                + +HRDL   NVL++ E   KI DFG+ +    ++  
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  135 bits (341), Expect = 6e-36
 Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 12/161 (7%)

Query: 350 ENKLGEGGFGPVYKGK---LADGKEI--AVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
             +LG+G FG V   +   L D      AVK+L  ++ + L++F+ E+ ++  LQH N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 405 RLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           +  G C         LI EY+P  SL  +L       ++D  + +   + I +G+ YL  
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
               + IHRDL T N+L+++E   KI DFG+ ++   ++  
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  134 bits (338), Expect = 2e-35
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 12/161 (7%)

Query: 350 ENKLGEGGFGPVYKGK---LADGKEI--AVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
            ++LG+G FG V   +   L D      AVK+L  +     ++F+ E+ ++  L    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 405 RLLGCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           +  G           L+ EY+P+  L  FL       +LD  R +   + I +G+ YL  
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
               + +HRDL   N+L++ E + KI+DFG+A++   ++  
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  132 bits (335), Expect = 7e-35
 Identities = 52/174 (29%), Positives = 75/174 (43%), Gaps = 31/174 (17%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE------IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKN 402
              +GEG FG V++ +            +AVK L    S     +F+ E  L+A+  + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL---------------------FDSTRSVQL 441
           +V+LLG C       L++EYM    LN FL                       S     L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 442 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               ++ I   +A G+ YL   S  K +HRDL T N L+   M  KI+DFG++R
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  132 bits (333), Expect = 8e-35
 Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE----IAVKRLSR--TSGQGLQEFKNEVTLIAKLQHKNL 403
              LGEG FG V +G L         +AVK +    +S + ++EF +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 404 VRLLGCCLQEN-----ESLLIYEYMPNKSLNVFLFDS---TRSVQLDWKRRISIINGIAR 455
           +RLLG C++ +     + ++I  +M    L+ +L  S   T    +  +  +  +  IA 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           G+ YL   S    +HRDL   N +L  +M   ++DFG+++
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  132 bits (333), Expect = 9e-35
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 21/164 (12%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE---IAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKNLV 404
           ++ +GEG FG V K ++         A+KR+    S    ++F  E+ ++ KL  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFL-------------FDSTRSVQLDWKRRISIIN 451
            LLG C       L  EY P+ +L  FL               ++ +  L  ++ +    
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            +ARG+ YL   S+ + IHRDL   N+L+      KI+DFG++R
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  131 bits (332), Expect = 1e-34
 Identities = 52/174 (29%), Positives = 76/174 (43%), Gaps = 31/174 (17%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE------IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKN 402
              LGEG FG V K      K       +AVK L    S   L++  +E  ++ ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL---------------------FDSTRSVQL 441
           +++L G C Q+   LLI EY    SL  FL                      D      L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 442 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                IS    I++G+ YL   + +K++HRDL   N+L+      KISDFG++R
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  133 bits (336), Expect = 1e-34
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 7/149 (4%)

Query: 350 ENKLGEGGFGPVYKGKL-ADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
             ++G G FG V+ G+L AD   +AVK            +F  E  ++ +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
           G C Q+    ++ E +       FL   T   +L  K  + ++   A G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KC 233

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARI 496
            IHRDL   N L+  +   KISDFGM+R 
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSRE 262

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (330), Expect = 1e-34
 Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 11/152 (7%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE----IAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLV 404
           +  +G+G FG VY G+  D  +     A+K LSR T  Q ++ F  E  L+  L H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 405 RLLGCCLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
            L+G  L       +   YM +  L  F+    R+  +  K  IS    +ARG+ YL   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL--- 140

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  K +HRDL   N +LD     K++DFG+AR
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  131 bits (331), Expect = 2e-34
 Identities = 49/164 (29%), Positives = 87/164 (53%), Gaps = 10/164 (6%)

Query: 350 ENKLGEGGFGPVYKGKL--ADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           E  +G G  G V  G+L     +++  A+K L +  + +  ++F +E +++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           RL G   +   ++++ EYM N SL+ FL   T   Q    + + ++ G+  G+ YL   S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
            L  +HRDL   NVL+D  +  K+SDFG++R+   +   A T  
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  131 bits (331), Expect = 2e-34
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 12/163 (7%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE-----IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNL 403
              LG G FG VYKG      E     +A+K L   TS +  +E  +E  ++A + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
            RLLG CL      LI + MP   L  ++ +   ++    +  ++    IA+G+ YL   
Sbjct: 80  CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYL--- 133

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
              +++HRDL   NVL+    + KI+DFG+A++ G  + E + 
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  130 bits (328), Expect = 2e-34
 Identities = 47/159 (29%), Positives = 82/159 (51%), Gaps = 6/159 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGK-EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L +     ++EF  E  ++ +++H NLV+LLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  ++     + +   I+  + YL    +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 132

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
           IHRDL   N L+      K++DFG++R+  G+   A+  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (328), Expect = 2e-34
 Identities = 51/152 (33%), Positives = 73/152 (48%), Gaps = 11/152 (7%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE----IAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLV 404
              +G G FG VY G L D        AVK L+R T    + +F  E  ++    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 405 RLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
            LLG CL+   S L +  YM +  L  F+ + T       K  I     +A+G+ YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLAS- 146

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
              K +HRDL   N +LD +   K++DFG+AR
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  130 bits (329), Expect = 3e-34
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 18/161 (11%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE----IAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNL 403
              LG+G FG V + +L         +AVK L     +   ++EF  E   + +  H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 404 VRLLGCCLQENES------LLIYEYMPNKSLNVFLFDS---TRSVQLDWKRRISIINGIA 454
            +L+G  L+          ++I  +M +  L+ FL  S        L  +  +  +  IA
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
            G+ YL   S    IHRDL   N +L  +M   ++DFG++R
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  130 bits (329), Expect = 4e-34
 Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 26/169 (15%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE--------IAVKRL-SRTSGQGLQEFKNEVTLIAKL-Q 399
              LGEG FG V   +     +        +AVK L    + + L +  +E+ ++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFL-------------FDSTRSVQLDWKRR 446
           HKN++ LLG C Q+    +I EY    +L  +L              +     Q+ +K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +S    +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  128 bits (324), Expect = 5e-34
 Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 8/147 (5%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
              +G+G FG V  G    G ++AVK +   +    Q F  E +++ +L+H NLV+LLG 
Sbjct: 26  LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82

Query: 410 CLQENESLLI-YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            ++E   L I  EYM   SL  +L    RS  L     +     +   + YL        
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 138

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +HRDL   NVL+  +   K+SDFG+ +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK 165

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  128 bits (324), Expect = 6e-34
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 6/152 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
             +LG G FG V  GK     ++A+K + +       EF  E  ++  L H+ LV+L G 
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
           C ++    +I EYM N  L  +L       +   ++ + +   +   + YL      + +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
           HRDL   N L++ +   K+SDFG++R    ++
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  129 bits (326), Expect = 7e-34
 Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 25/167 (14%)

Query: 351 NKLGEGGFGPVYKGKLADGKE------IAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKN 402
             LG G FG V +       +      +AVK L    +    +   +E+ ++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 403 LVRLLGCCLQENESL-LIYEYMPNKSLNVFL-------------FDSTRSVQLDWKRRIS 448
           +V LLG C +    L +I E+    +L+ +L              +      L  +  I 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 449 IINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
               +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  128 bits (323), Expect = 7e-34
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 6/152 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
             ++G G FG V+ G   +  ++A+K + R      ++F  E  ++ KL H  LV+L G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
           CL++    L+ E+M +  L+ +L   T+      +  + +   +  G+ YL       +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
           HRDL   N L+      K+SDFGM R    +Q
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  129 bits (327), Expect = 7e-34
 Identities = 51/160 (31%), Positives = 70/160 (43%), Gaps = 17/160 (10%)

Query: 350 ENKLGEGGFGPVYKGKLADGK------EIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKN 402
              LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL----FDSTRSVQLDWKRRISIINGIARGLL 458
           +VR +G  LQ     ++ E M    L  FL       ++   L     + +   IA G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 459 YLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMAR 495
           YL        IHRD+   N LL         KI DFGMAR
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  130 bits (328), Expect = 9e-34
 Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 10/164 (6%)

Query: 350 ENKLGEGGFGPVYKG--KLADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           +  +G G FG V  G  KL   KEI  A+K L    + +  ++F  E +++ +  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           RL G   +    +++ EYM N SL+ FL       Q    + + ++ GIA G+ YL   S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
            +  +HRDL   N+L++  +  K+SDFG+ R+   +   A T R
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  130 bits (328), Expect = 1e-33
 Identities = 51/160 (31%), Positives = 70/160 (43%), Gaps = 17/160 (10%)

Query: 350 ENKLGEGGFGPVYKGKLADGK------EIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKN 402
              LG G FG VY+G+++         ++AVK L    S Q   +F  E  +I+K  H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFL----FDSTRSVQLDWKRRISIINGIARGLL 458
           +VR +G  LQ     ++ E M    L  FL       ++   L     + +   IA G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 459 YLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMAR 495
           YL        IHRD+   N LL         KI DFGMAR
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  130 bits (328), Expect = 1e-33
 Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 26/169 (15%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE--------IAVKRL-SRTSGQGLQEFKNEVTLIAKL-Q 399
              LGEG FG V   +     +        +AVK L    + + L +  +E+ ++  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFL-------------FDSTRSVQLDWKRR 446
           HKN++ LLG C Q+    +I EY    +L  +L              +     Q+ +K  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +S    +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (322), Expect = 1e-33
 Identities = 38/162 (23%), Positives = 75/162 (46%), Gaps = 21/162 (12%)

Query: 350 ENKLGEGGFGPVYKGKL--------ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK 401
              LG+G F  ++KG              E+ +K L +      + F    ++++KL HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           +LV   G C+  +E++L+ E++   SL+ +L  +   + + WK  + +   +A  + +L 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFL- 129

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP--------KISDFGMAR 495
                 +IH ++   N+LL  E +         K+SD G++ 
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  131 bits (331), Expect = 1e-33
 Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 8/147 (5%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
              +G+G FG V  G    G ++AVK +   +    Q F  E +++ +L+H NLV+LLG 
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 410 CLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            ++E   L ++ EYM   SL  +L    RS  L     +     +   + YL        
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 310

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +HRDL   NVL+  +   K+SDFG+ +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK 337

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  126 bits (320), Expect = 2e-33
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 6/152 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
             +LG G FG V  GK     ++AVK + +       EF  E   + KL H  LV+  G 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
           C +E    ++ EY+ N  L  +L   +    L+  + + +   +  G+ +L      + I
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
           HRDL   N L+D ++  K+SDFGM R    +Q
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  127 bits (322), Expect = 2e-33
 Identities = 48/169 (28%), Positives = 70/169 (41%), Gaps = 26/169 (15%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE------IAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHK 401
              LG G FG V +       +      +AVK L         +   +E+ +++ L  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFL---------------FDSTRSVQLDWKRR 446
           N+V LLG C     +L+I EY     L  FL                     + LD +  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +S    +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  128 bits (324), Expect = 2e-33
 Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 22/165 (13%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE------IAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHK 401
              LG G FG V +       +      +AVK L S       +   +E+ +++ L QH+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ-----------LDWKRRISII 450
           N+V LLG C      L+I EY     L  FL   +R ++              +  +   
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           + +A+G+ +L   +    IHRD+   NVLL +    KI DFG+AR
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  129 bits (326), Expect = 2e-33
 Identities = 53/152 (34%), Positives = 78/152 (51%), Gaps = 11/152 (7%)

Query: 350 ENKLGEGGFGPVYKGKL--ADGKEI--AVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLV 404
              +G G FG VY G L   DGK+I  AVK L+R T    + +F  E  ++    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 405 RLLGCCLQENESLL-IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
            LLG CL+   S L +  YM +  L  F+ + T       K  I     +A+G+ +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFL--- 208

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +  K +HRDL   N +LD +   K++DFG+AR
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  128 bits (323), Expect = 2e-33
 Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 11/165 (6%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE-----IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNL 403
           +  +G G FG VYKG L          +A+K L +  + +   +F  E  ++ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           +RL G   +    ++I EYM N +L+ FL    +  +    + + ++ GIA G+ YL   
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL--- 163

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           + +  +HRDL   N+L++  +  K+SDFG++R+   +     T  
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  127 bits (321), Expect = 4e-33
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 12/163 (7%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE-----IAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNL 403
              LG G FG V+KG      E     + +K +   SG Q  Q   + +  I  L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           VRLLG C       L+ +Y+P  SL   +     ++    +  ++    IA+G+ YL   
Sbjct: 78  VRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYL--- 131

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
               ++HR+L   NVLL      +++DFG+A +   +  +   
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (318), Expect = 5e-33
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 10/158 (6%)

Query: 350 ENKLGEGGFGPVYKGKL-ADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           + +LG G FG V +G      K+I  A+K L   T     +E   E  ++ +L +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L+G C  E   +L+ E      L+ FL    +  ++       +++ ++ G+ YL     
Sbjct: 75  LIGVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
              +HRDL   NVLL +    KISDFG+++  G + S 
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  126 bits (319), Expect = 7e-33
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 12/163 (7%)

Query: 350 ENKLGEGGFGPVYKGKLADGKE-----IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNL 403
              LG G FG VYKG      E     +A+K L   TS +  +E  +E  ++A + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
            RLLG CL      LI + MP   L  ++ +      +  +  ++    IA+G+ YL   
Sbjct: 80  CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYL--- 133

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
              +++HRDL   NVL+    + KI+DFG+A++ G  + E + 
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  125 bits (315), Expect = 1e-32
 Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 6/152 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
             +LG G FG V+ G      ++AVK L +        F  E  L+ +LQH+ LVRL   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
             QE    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++        I
Sbjct: 77  VTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
           HRDL+ +N+L+   ++ KI+DFG+AR+   N+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 163

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  125 bits (315), Expect = 2e-32
 Identities = 52/166 (31%), Positives = 69/166 (41%), Gaps = 13/166 (7%)

Query: 350 ENKLGEGGFGPVYKG--KLADGKEI--AVKRL---SRTSGQGLQEFKNEVTLIAKLQHKN 402
             KLG+G FG V +G      GK +  AVK L     +  + + +F  EV  +  L H+N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           L+RL G  L      ++ E  P  SL   L        L           +A G+ YL E
Sbjct: 83  LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYL-E 138

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
             R   IHRDL   N+LL      KI DFG+ R    N      + 
Sbjct: 139 SKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  127 bits (320), Expect = 2e-32
 Identities = 52/169 (30%), Positives = 78/169 (46%), Gaps = 26/169 (15%)

Query: 350 ENKLGEGGFGPVYKGKLADGK--------EIAVKRL-SRTSGQGLQEFKNEVTLIAKL-Q 399
              LGEG FG V   +             ++AVK L S  + + L +  +E+ ++  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFL-------------FDSTRSVQLDWKRR 446
           HKN++ LLG C Q+    +I EY    +L  +L                    QL  K  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  128 bits (323), Expect = 3e-32
 Identities = 45/153 (29%), Positives = 81/153 (52%), Gaps = 6/153 (3%)

Query: 350 ENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
            C +E    +I E+M   +L  +L +  R  ++     + +   I+  + YL    +   
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 339

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
           IHR+L   N L+      K++DFG++R+  G+ 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  127 bits (322), Expect = 3e-32
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 6/152 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG G FG V+        ++AVK + +     ++ F  E  ++  LQH  LV+L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
             +E    +I E+M   SL  FL     S +    + I     IA G+ ++    +   I
Sbjct: 252 VTKEP-IYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNYI 306

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
           HRDL+ +N+L+   +  KI+DFG+AR+   N+
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE 338

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  123 bits (312), Expect = 4e-32
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 12/164 (7%)

Query: 350 ENKLGEGGFGPVYKGKLADGK---EIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           + +LG G FG V KG     K    +AVK L           E   E  ++ +L +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           R++G C  E+  +L+ E      LN +L    ++  +  K  I +++ ++ G+ YL    
Sbjct: 82  RMIGICEAES-WMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
               +HRDL   NVLL  +   KISDFG+++    +++    + 
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 178

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  124 bits (314), Expect = 5e-32
 Identities = 56/237 (23%), Positives = 88/237 (37%), Gaps = 48/237 (20%)

Query: 287 RRKERVKEEKANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQH 346
           +++ R + +    Q T S         N+Y Y   R  + +   EFP   L         
Sbjct: 4   KKQFRYESQLQMVQVTGSS-------DNEYFYVDFREYEYDLKWEFPRENLEF------- 49

Query: 347 FSDENKLGEGGFGPVYKGKLADGKE------IAVKRL-SRTSGQGLQEFKNEVTLIAKL- 398
                 LG G FG V         +      +AVK L  +      +   +E+ ++ +L 
Sbjct: 50  ---GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 106

Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFL--------------------FDSTRS 438
            H+N+V LLG C       LI+EY     L  +L                     +    
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 439 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             L ++  +     +A+G+ +L        +HRDL   NVL+ H    KI DFG+AR
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  122 bits (309), Expect = 8e-32
 Identities = 40/152 (26%), Positives = 66/152 (43%), Gaps = 11/152 (7%)

Query: 350 ENKLGEGGFGPVYKG--KLADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLV 404
              +GEG FG V++G     +   +  A+K   + TS    ++F  E   + +  H ++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           +L+G   +     +I E      L  FL    R   LD    I     ++  L YL    
Sbjct: 80  KLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---E 133

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
             + +HRD+   NVL+      K+ DFG++R 
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  122 bits (309), Expect = 8e-32
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 11/157 (7%)

Query: 350 ENKLGEGGFGPVYKGKL--ADGKEI--AVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLV 404
              LGEG FG VY+G      G++I  AVK   +  +    ++F +E  ++  L H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           +L+G   +E  + +I E  P   L  +L  +  S+++     +     I + + YL    
Sbjct: 77  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL---E 130

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
            +  +HRD+   N+L+      K+ DFG++R      
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  121 bits (306), Expect = 5e-31
 Identities = 46/163 (28%), Positives = 71/163 (43%), Gaps = 19/163 (11%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
           +H+    KLGEGGF  V   + L DG   A+KR+     Q  +E + E  +     H N+
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 404 VRLLGCCLQENES----LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS------IINGI 453
           +RL+  CL+E  +     L+  +    +L   +         D    ++      ++ GI
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGI 143

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 496
            RGL  +H        HRDLK +N+LL  E  P + D G    
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  125 bits (316), Expect = 5e-31
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 10/158 (6%)

Query: 350 ENKLGEGGFGPVYKGKL-ADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           + +LG G FG V +G      K+I  A+K L   T     +E   E  ++ +L +  +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L+G C  E   +L+ E      L+ FL    +  ++       +++ ++ G+ YL     
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 454

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
              +HR+L   NVLL +    KISDFG+++  G + S 
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  119 bits (301), Expect = 1e-30
 Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 9/163 (5%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 411
           LG+G +G VY G+ L++   IA+K +     +  Q    E+ L   L+HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF- 88

Query: 412 QENESLLIY-EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
            EN  + I+ E +P  SL+  L      ++ + +        I  GL YLH++   +I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 471 RDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RD+K  NVL++ +    KISDFG ++   G      T    GT
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 186

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  118 bits (299), Expect = 3e-30
 Identities = 42/174 (24%), Positives = 80/174 (45%), Gaps = 12/174 (6%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQH 400
            +F  E K+G G F  VY+   L DG  +A+K++        +   +   E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 401 KNLVRLLGCCLQENESLLIY-EYMPNKSLNVFLFDSTRSVQLDWKRRI-SIINGIARGLL 458
            N+++     + E+  L I  E      L+  +    +  +L  +R +      +   L 
Sbjct: 92  PNVIKYYASFI-EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           ++H     +++HRD+K +NV +      K+ D G+ R F    + A++  +VGT
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  118 bits (298), Expect = 4e-30
 Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 17/176 (9%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKN 402
             F     LG GGFG V++ K   D    A+KR+         ++   EV  +AKL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 403 LVRLLGCCLQENE---------SLLIY---EYMPNKSLNVFLFDSTRSVQLDWKRRISII 450
           +VR     L++N           + +Y   +    ++L  ++       + +    + I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
             IA  + +LH      ++HRDLK SN+    +   K+ DFG+      ++ E   
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  123 bits (309), Expect = 5e-30
 Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 11/151 (7%)

Query: 350 ENKLGEGGFGPVYKG--KLADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLV 404
              +GEG FG V++G     +   +  A+K   + TS    ++F  E   + +  H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           +L+G   +     +I E      L  FL    R   LD    I     ++  L YL    
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---E 508

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             + +HRD+   NVL+      K+ DFG++R
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  121 bits (304), Expect = 6e-30
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 6/158 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
             +E    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 302

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A   
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  121 bits (305), Expect = 9e-30
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 6/158 (3%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           E KLG+G FG V+ G       +A+K L   +    + F  E  ++ KL+H+ LV+L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKII 469
             +E    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 385

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A   
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  117 bits (294), Expect = 1e-29
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 16/169 (9%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           ++G G F  VYKG       E+A    +  + +    Q FK E  ++  LQH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 409 CCL---QENESLLIY-EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
                 +  + +++  E M + +L  +L    R   +  K   S    I +GL +LH  +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 465 RLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGGNQSEANTKRIVGT 512
              IIHRDLK  N+ +     + KI D G+A +   +      K ++GT
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGT 193

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  118 bits (297), Expect = 1e-29
 Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 9/164 (5%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           K+GEG FG     K   DG++  +K   +SR S +  +E + EV ++A ++H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
              +     ++ +Y     L   + ++ + V     + +     I   L ++H+    KI
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR---KI 146

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +HRD+K+ N+ L  +   ++ DFG+AR+       A     +GT
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  116 bits (292), Expect = 2e-29
 Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 28/185 (15%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL 403
             F +   +G GGFG V+K K   DGK   +KR+   +    ++ + EV  +AKL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 404 VRLLGC---------------CLQENESLLIY-EYMPNKSLNVFLFDSTRSVQLDWKRRI 447
           V   GC                  + + L I  E+    +L  ++ +  R  +LD    +
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            +   I +G+ Y+H     K+I+RDLK SN+ L      KI DFG+       +++    
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179

Query: 508 RIVGT 512
           R  GT
Sbjct: 180 RSKGT 184

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  115 bits (290), Expect = 4e-29
 Identities = 45/173 (26%), Positives = 90/173 (52%), Gaps = 16/173 (9%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
            + ++   K+G+G  G VY    +A G+E+A+++++       +   NE+ ++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLLYLH 461
           +V  L   L  +E  ++ EY+   SL     D      +D + +I+ +     + L +LH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD-EGQIAAVCRECLQALEFLH 133

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR--IVGT 512
            +   ++IHRD+K+ N+LL  + + K++DFG    F    +   +KR  +VGT
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  115 bits (289), Expect = 9e-29
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 16/173 (9%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
                   K+GEG  G V   +    G+++AVK +     Q  +   NEV ++   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLLYLH 461
           +V +    L   E  ++ E++   +L     D    V+L+ + +I+ +   + + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLN-EEQIATVCEAVLQALAYLH 158

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR--IVGT 512
                 +IHRD+K+ ++LL  +   K+SDFG    F    S+   KR  +VGT
Sbjct: 159 AQ---GVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGT 204

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  114 bits (287), Expect = 1e-28
 Identities = 44/171 (25%), Positives = 85/171 (49%), Gaps = 10/171 (5%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
            + +    +LG+G FG VYK K    G   A K +   S + L+++  E+ ++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLLYLH 461
           +V+LLG    + +  ++ E+ P  +++  + +  R +       I ++   +   L +LH
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLH 134

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
                +IIHRDLK  NVL+  E + +++DFG++        + ++   +GT
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  111 bits (280), Expect = 8e-28
 Identities = 53/169 (31%), Positives = 80/169 (47%), Gaps = 10/169 (5%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            +G G +G   K +  +DGK +  K       +    Q   +EV L+ +L+H N+VR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 409 CCLQE-NESLLIY-EYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHE--D 463
             +   N +L I  EY     L   +   T+  Q LD +  + ++  +   L   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
               ++HRDLK +NV LD + N K+ DFG+ARI   + S A T   VGT
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  110 bits (278), Expect = 2e-27
 Identities = 47/180 (26%), Positives = 75/180 (41%), Gaps = 24/180 (13%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
              F +   LG+G FG V K +   D +  A+K++  T  + L    +EV L+A L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 403 LVRLLGCCLQENESLL----------IY---EYMPNKSLNVFLFD--STRSVQLDWKRRI 447
           +VR     L+    +           ++   EY  N +L    +D   + ++        
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119

Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            +   I   L Y+H      IIHRDLK  N+ +D   N KI DFG+A+    +       
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  109 bits (275), Expect = 6e-27
 Identities = 40/166 (24%), Positives = 71/166 (42%), Gaps = 12/166 (7%)

Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNL--VRL 406
            ++G GG   V++      +  A+K   L     Q L  ++NE+  + KLQ  +   +RL
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
               + +    ++ E   N  LN +L    +   +D   R S    +   +  +H+    
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 146

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            I+H DLK +N L+  +   K+ DFG+A     + +       VGT
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  108 bits (273), Expect = 1e-26
 Identities = 48/161 (29%), Positives = 85/161 (52%), Gaps = 20/161 (12%)

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN--------EVTLIAK 397
           F    K+GEG +G VYK +    G+ +A+K++       L             E++L+ +
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLLKE 58

Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           L H N+V+LL     EN+  L++E++  + L  F+ D++    +      S +  + +GL
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 116

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
            + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  108 bits (272), Expect = 2e-26
 Identities = 46/178 (25%), Positives = 74/178 (41%), Gaps = 20/178 (11%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFK-NEVTLIAKLQ 399
           E     + + ++G G FG V++ K    G + AVK++       L+ F+  E+   A L 
Sbjct: 55  EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLS 108

Query: 400 HKNLVRLLGCCLQENESLLIY-EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
              +V L G    E   + I+ E +   SL   +    +   L   R +  +     GL 
Sbjct: 109 SPRIVPLYGAVR-EGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLE 164

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSEANTKR---IVGT 512
           YLH     +I+H D+K  NVLL  + +   + DFG A     +    +      I GT
Sbjct: 165 YLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  108 bits (272), Expect = 3e-26
 Identities = 40/166 (24%), Positives = 71/166 (42%), Gaps = 12/166 (7%)

Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNL--VRL 406
            ++G GG   V++      +  A+K   L     Q L  ++NE+  + KLQ  +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
               + +    ++ E   N  LN +L    +   +D   R S    +   +  +H+    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            I+H DLK +N L+  +   K+ DFG+A     + +       VGT
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  107 bits (270), Expect = 3e-26
 Identities = 48/171 (28%), Positives = 87/171 (50%), Gaps = 12/171 (7%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
            + F    KLGEG +G VYK      G+ +A+K++       LQE   E++++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLLYLH 461
           +V+  G   +  +  ++ EY    S++  +    +++  D    I+ I     +GL YLH
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE---IATILQSTLKGLEYLH 142

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
                + IHRD+K  N+LL+ E + K++DFG+A       ++ NT  ++GT
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGT 188

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  109 bits (274), Expect = 3e-26
 Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 12/166 (7%)

Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNL--VRL 406
            ++G GG   V++      +  A+K   L     Q L  ++NE+  + KLQ  +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
               + +    ++ E   N  LN +L        +D   R S    +   +  +H+    
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 174

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            I+H DLK +N L+  +   K+ DFG+A     + +       VG 
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (267), Expect = 7e-26
 Identities = 52/172 (30%), Positives = 88/172 (51%), Gaps = 13/172 (7%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHK 401
            + F+   K+G+G FG V+KG      K +A+K +     +  +++ + E+T++++    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLLYL 460
            + +  G  L++ +  +I EY+   S      D      LD + +I+ I   I +GL YL
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLD-ETQIATILREILKGLDYL 135

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           H +   K IHRD+K +NVLL      K++DFG+A      Q + NT   VGT
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  107 bits (269), Expect = 7e-26
 Identities = 44/157 (28%), Positives = 65/157 (41%), Gaps = 10/157 (6%)

Query: 350 ENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLL 407
              L EGGF  VY+ + +  G+E A+KRL     +  +    EV  + KL  H N+V+  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 408 GCCLQENES-------LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
                  E         L+   +    L  FL        L     + I     R + ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
           H   +  IIHRDLK  N+LL ++   K+ DFG A   
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  106 bits (266), Expect = 1e-25
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 20/156 (12%)

Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKN--------EVTLIAKLQHKN 402
            K+GEG +G VYK K + G+ +A+KR+       L             E++L+ +L H N
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPN 80

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           +V L+     E    L++E+M  K L   L        L   +    +  + RG+ + H+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQ 137

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
               +I+HRDLK  N+L++ +   K++DFG+AR FG
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  105 bits (263), Expect = 3e-25
 Identities = 46/197 (23%), Positives = 66/197 (33%), Gaps = 15/197 (7%)

Query: 321 LRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG-KLADGKEIAVK--RL 377
            RG+  E  Q     P        Q F   ++LG G +G V+K     DG+  AVK    
Sbjct: 33  FRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS 92

Query: 378 SRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIY-EYMPNKSLNVFLFDS 435
                +       EV    K+ QH   VRL     +E   L +  E     SL       
Sbjct: 93  PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--E 148

Query: 436 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
                L   +    +      L +LH      ++H D+K +N+ L      K+ DFG+  
Sbjct: 149 AWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205

Query: 496 IFGGNQSEANTKRIVGT 512
              G           G 
Sbjct: 206 EL-GTAGAGEV--QEGD 219

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  104 bits (262), Expect = 3e-25
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 21/157 (13%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN--------EVTLIAKLQHK 401
            K+GEG +G V+K K     + +A+KR+       L +           E+ L+ +L+HK
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHK 61

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+VRL      + +  L++E+   + L  +    + +  LD +   S +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                 ++HRDLK  N+L++     K+++FG+AR FG
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  105 bits (263), Expect = 4e-25
 Identities = 53/174 (30%), Positives = 89/174 (51%), Gaps = 18/174 (10%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQ 399
            + FSD  ++G G FG VY  + + + + +A+K++S   + S +  Q+   EV  + KL+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGLL 458
           H N ++  GC L+E+ + L+ EY    + ++          L  +  I+ + +G  +GL 
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQ-EVEIAAVTHGALQGLA 168

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           YLH      +IHRD+K  N+LL      K+ DFG A       + AN+   VGT
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGT 213

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  103 bits (260), Expect = 5e-25
 Identities = 44/156 (28%), Positives = 81/156 (51%), Gaps = 20/156 (12%)

Query: 351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKN--------EVTLIAKLQHKN 402
            K+GEG +G VYK +   G+  A+K++       L++           E++++ +L+H N
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKELKHSN 61

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           +V+L      +   +L++E++  + L   L        L+     S +  +  G+ Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLD-QDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
               +++HRDLK  N+L++ E   KI+DFG+AR FG
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  102 bits (257), Expect = 9e-25
 Identities = 47/146 (32%), Positives = 78/146 (53%), Gaps = 9/146 (6%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTS--GQGLQE-FKNEVTLIAKLQHKNLVRLLG 408
           LG+G F  VY+ + +  G E+A+K + + +    G+ +  +NEV +  +L+H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
                N   L+ E   N  +N +L +  +    +  R    ++ I  G+LYLH      I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYLH---SHGI 133

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMA 494
           +HRDL  SN+LL   MN KI+DFG+A
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA 159

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  103 bits (259), Expect = 1e-24
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 17/178 (9%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHK 401
              F     +G G +G VYKG+ +  G+  A+K +   +G   +E K E+ ++ K   H+
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHR 81

Query: 402 NLVRLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIA 454
           N+    G  +++N         L+ E+    S+   L  +T+   L  +  I+ I   I 
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLK-EEWIAYICREIL 139

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           RGL +LH+    K+IHRD+K  NVLL      K+ DFG++          NT   +GT
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGT 192

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  103 bits (258), Expect = 1e-24
 Identities = 39/159 (24%), Positives = 72/159 (45%), Gaps = 13/159 (8%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLLGC 409
            LG+G    V++G+    G   A+K  +  S     +    E  ++ KL HKN+V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 410 CLQENESLLIY---EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
             +E  +       E+ P  SL   L + + +  L     + ++  +  G+ +L E    
Sbjct: 76  -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131

Query: 467 KIIHRDLKTSNVLL----DHEMNPKISDFGMARIFGGNQ 501
            I+HR++K  N++     D +   K++DFG AR    ++
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  102 bits (256), Expect = 2e-24
 Identities = 36/152 (23%), Positives = 68/152 (44%), Gaps = 22/152 (14%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTS--GQGLQE-FKNEVTLIAKLQHKNLVRLLG 408
           LG+GGF   ++       +  A K + ++       +E    E+++   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHE 462
                +   ++ E    +SL     +  +      ++ ++       +  I  G  YLH 
Sbjct: 83  FFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH- 132

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
             R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  103 bits (258), Expect = 2e-24
 Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 18/157 (11%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN--------EVTLIAKLQHK 401
           + LGEG F  VYK +     + +A+K++ +   +   E K+        E+ L+ +L H 
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHR--SEAKDGINRTALREIKLLQELSHP 72

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N++ LL     ++   L++++M    L V +     S+ L      + +    +GL YLH
Sbjct: 73  NIIGLLDAFGHKSNISLVFDFME-TDLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +     I+HRDLK +N+LLD     K++DFG+A+ FG
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  102 bits (257), Expect = 3e-24
 Identities = 36/152 (23%), Positives = 68/152 (44%), Gaps = 22/152 (14%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTS--GQGLQE-FKNEVTLIAKLQHKNLVRLLG 408
           LG+GGF   ++       +  A K + ++       +E    E+++   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHE 462
                +   ++ E    +SL     +  +      ++ ++       +  I  G  YLH 
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH- 158

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
             R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  101 bits (255), Expect = 4e-24
 Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 19/158 (12%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHKNLV 404
            KLG G +  VYKG     G  +A+K +   S +G     ++E    ++L+ +L+H+N+V
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIV 66

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIA----RGLLYL 460
           RL      EN+  L++E+M    L  ++ DS           ++++        +GL + 
Sbjct: 67  RLYDVIHTENKLTLVFEFMD-NDLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           HE+   KI+HRDLK  N+L++     K+ DFG+AR FG
Sbjct: 125 HEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  101 bits (253), Expect = 4e-24
 Identities = 50/194 (25%), Positives = 74/194 (38%), Gaps = 35/194 (18%)

Query: 344 TQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKL-Q 399
           T  F +  K+G G FG V+K  K  DG   A+KR           Q    EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 400 HKNLVRLLGCCLQENESLLIY-EYMPNKSLNVFLFDSTRSVQLDWKRRI-SIINGIARGL 457
           H ++VR       E++ +LI  EY    SL   + ++ R +    +  +  ++  + RGL
Sbjct: 70  HSHVVRYFSAWA-EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNP-------------------KISDFGMARIFG 498
            Y+H      ++H D+K SN+ +     P                   KI D G      
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 499 GNQSEANTKRIVGT 512
             Q E       G 
Sbjct: 186 SPQVE------EGD 193

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  102 bits (255), Expect = 9e-24
 Identities = 39/159 (24%), Positives = 72/159 (45%), Gaps = 13/159 (8%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLLGC 409
            LG+G    V++G+    G   A+K  +  S     +    E  ++ KL HKN+V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-A 74

Query: 410 CLQENESLLIY---EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRL 466
             +E  +       E+ P  SL   L + + +  L     + ++  +  G+ +L E    
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131

Query: 467 KIIHRDLKTSNVLL----DHEMNPKISDFGMARIFGGNQ 501
            I+HR++K  N++     D +   K++DFG AR    ++
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (250), Expect = 1e-23
 Identities = 44/178 (24%), Positives = 82/178 (46%), Gaps = 15/178 (8%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNL 403
            +  +  +G G    V         +++A+KR++    Q  + E   E+  +++  H N+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75

Query: 404 VRLLGCCLQENESLLIYEYMPNKSL-----NVFLFDSTRSVQLDWKRRISII-NGIARGL 457
           V      + ++E  L+ + +   S+     ++      +S  LD +  I+ I   +  GL
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEGL 134

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM-ARIFGGNQSEANTKR--IVGT 512
            YLH++     IHRD+K  N+LL  + + +I+DFG+ A +  G     N  R   VGT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  101 bits (254), Expect = 2e-23
 Identities = 39/175 (22%), Positives = 70/175 (40%), Gaps = 20/175 (11%)

Query: 347 FSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVR 405
           F  ++ LG G  G +    + D +++AVKR+     +       EV L+ +  +H N++R
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFD--STRSVQLDWKRRISIINGIARGLLYLHED 463
                       +  E          L +    +         I+++     GL +LH  
Sbjct: 83  YFCTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS- 136

Query: 464 SRLKIIHRDLKTSNVLL-----DHEMNPKISDFGMARIFGGNQSE-ANTKRIVGT 512
             L I+HRDLK  N+L+       ++   ISDFG+ +     +   +    + GT
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 21/157 (13%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN--------EVTLIAKLQHK 401
            K+GEG +G V+K +    G+ +A+K+          E           E+ ++ +L+H 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRMLKQLKHP 62

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           NLV LL    ++    L++EY  + ++   L        +      SI     + + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
              +   IHRD+K  N+L+      K+ DFG AR+  
Sbjct: 120 ---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =   99 bits (249), Expect = 3e-23
 Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 11/194 (5%)

Query: 321 LRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSR 379
           L  Q+++  + F      +       F   ++LG G  G V+K      G  +A K +  
Sbjct: 9   LDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL 68

Query: 380 TSGQGLQEF-KNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRS 438
                ++     E+ ++ +     +V   G    + E  +  E+M   SL+  L      
Sbjct: 69  EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR 127

Query: 439 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           +      ++SI   + +GL YL E    KI+HRD+K SN+L++     K+ DFG++    
Sbjct: 128 IPEQILGKVSI--AVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL- 182

Query: 499 GNQSEANTKRIVGT 512
              S AN+   VGT
Sbjct: 183 -IDSMANS--FVGT 193

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 98.8 bits (247), Expect = 5e-23
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 21/157 (13%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN--------EVTLIAKLQHK 401
             +GEG +G V K +    G+ +A+K+          +           E+ L+ +L+H+
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           NLV LL  C ++    L++E++ + ++   L        LD++     +  I  G+ + H
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFV-DHTILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH 141

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
                 IIHRD+K  N+L+      K+ DFG AR   
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 45/183 (24%), Positives = 83/183 (45%), Gaps = 30/183 (16%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQH 400
           +    +++   +G G FG V++ KL +  E+A+K++ +      + FKN E+ ++  ++H
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKH 91

Query: 401 KNLVRLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING-- 452
            N+V L        +        L+ EY+P +++        +      K+ + ++    
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKL-----KQTMPMLLIKL 145

Query: 453 ----IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSEANTK 507
               + R L Y+H    + I HRD+K  N+LLD      K+ DFG A+I      E N  
Sbjct: 146 YMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200

Query: 508 RIV 510
            I 
Sbjct: 201 YIC 203

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 98.4 bits (246), Expect = 7e-23
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQH 400
           +   +KLGEG +  VYKGK       +A+K +     +G     ++E    V+L+  L+H
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKH 59

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
            N+V L      E    L++EY+ +K L  +L        ++       +  + RGL Y 
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           H     K++HRDLK  N+L++     K++DFG+AR   
Sbjct: 117 HRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 27/162 (16%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN--------EVTLIAKLQHK 401
            KLGEG +G VYK       + +A+KR+       L+  +         EV+L+ +LQH+
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHR 93

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N++ L       +   LI+EY     L  ++ D    V +   +  S +  +  G+ + H
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYA-ENDLKKYM-DKNPDVSMRVIK--SFLYQLINGVNFCH 149

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP-----KISDFGMARIFG 498
                + +HRDLK  N+LL           KI DFG+AR FG
Sbjct: 150 SR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 19/162 (11%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLS-RTSGQGLQEFKN----EVTLIAKLQ---HK 401
            ++G G +G VYK +    G  +A+K +     G G          EV L+ +L+   H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 402 NLVRLLGCCLQENESL-----LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARG 456
           N+VRL+  C            L++E++ ++ L  +L D      L  +    ++    RG
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQFLRG 132

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           L +LH +    I+HRDLK  N+L+      K++DFG+ARI+ 
Sbjct: 133 LDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 29/166 (17%)

Query: 351 NKLGEGGFGPVYKGK--LADGKEIAVKRLSRTSGQGLQEFKN--------EVTLIAKLQ- 399
            ++GEG +G V+K +     G+ +A+KR+       +Q  +         EV ++  L+ 
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLRHLET 70

Query: 400 --HKNLVRLL----GCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING 452
             H N+VRL              L L++E++ ++ L  +L D      +  +    ++  
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQ 128

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
           + RGL +LH     +++HRDLK  N+L+      K++DFG+ARI+ 
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 46/180 (25%), Positives = 87/180 (48%), Gaps = 32/180 (17%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN--------EVTLIAKLQHK 401
            K+G+G FG V+K +    G+++A+K++       ++  K         E+ ++  L+H+
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHE 76

Query: 402 NLVRLLGCCLQENESL--------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           N+V L+  C  +            L++++     L   L  S   V+        ++  +
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLL--SNVLVKFTLSEIKRVMQML 133

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN---TKRIV 510
             GL Y+H +   KI+HRD+K +NVL+  +   K++DFG+AR F   ++      T R+V
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 97.9 bits (244), Expect = 3e-22
 Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 19/161 (11%)

Query: 352 KLGEGGFGPVYKGK---LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           K+G G +G VYK K     D K+ A+K++   +G  +   + E+ L+ +L+H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85

Query: 409 CCLQENE-SL-LIYEYMPN--KSL---NVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
             L   +  + L+++Y  +    +   +     + + VQL      S++  I  G+ YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFG 498
            +    ++HRDLK +N+L+  E       KI+D G AR+F 
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 19/177 (10%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKL-QHK 401
           +   D  ++G G +G V K      G+ +AVKR+  T   +  ++   ++ ++ +     
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS------IINGIAR 455
            +V+  G   +E +  +  E M + S + F     + V       I       I     +
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            L +L E+  LKIIHRD+K SN+LLD   N K+ DFG++     + ++       G 
Sbjct: 137 ALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGC 188

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 97.5 bits (243), Expect = 5e-22
 Identities = 47/188 (25%), Positives = 67/188 (35%), Gaps = 27/188 (14%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNL 403
                E  LG G  G V       G+ +AVKR+             E+ L+ +   H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFL----FDSTRSVQLDWKRRISIINGIARGLLY 459
           +R       +    +  E   N +L   +                  IS++  IA G+ +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNP-------------KISDFGMARIFGGNQS--EA 504
           LH    LKIIHRDLK  N+L+                    ISDFG+ +     QS    
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 505 NTKRIVGT 512
           N     GT
Sbjct: 188 NLNNPSGT 195

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 25/171 (14%)

Query: 352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEF-----------------KNEVTL 394
            L +G F  +   +  D K  A+K+  ++  +  ++F                 KNE+ +
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSL-----NVFLFDSTRSVQLDWKRRISI 449
           I  ++++  +   G     +E  +IYEYM N S+       F+ D   +  +  +    I
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
           I  +     Y+H  +   I HRD+K SN+L+D     K+SDFG +      
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 97.8 bits (243), Expect = 1e-21
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 14/161 (8%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL-- 407
           +LG GGFG V +      G+++A+K+  +      +E +  E+ ++ KL H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 408 ----GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
                     +  LL  EY     L  +L        L      ++++ I+  L YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139

Query: 464 SRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQ 501
              +IIHRDLK  N++L      +  KI D G A+     +
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 96.3 bits (240), Expect = 1e-21
 Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 31/182 (17%)

Query: 344 TQHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHK 401
              ++D   +G G FG VY+ KL D G+ +A+K++ +      + FKN E+ ++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 402 NLVRLLGCCLQENESL------LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING--- 452
           N+VRL        E        L+ +Y+P +++       +R+ Q      + +I     
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQ-----TLPVIYVKLY 161

Query: 453 ---IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSEANTKR 508
              + R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N   
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSY 216

Query: 509 IV 510
           I 
Sbjct: 217 IC 218

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 92.3 bits (230), Expect = 5e-21
 Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 16/154 (10%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLL 407
           LGEG +G V +          AVK L +        G    K E+ L+ +L+HKN+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 408 GCCLQENES--LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI--SIINGIARGLLYLHED 463
                E +    ++ EY       +      +   +         +I+G+     YLH  
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH-- 126

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
               I+H+D+K  N+LL      KIS  G+A   
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 93.8 bits (233), Expect = 6e-21
 Identities = 31/180 (17%), Positives = 65/180 (36%), Gaps = 16/180 (8%)

Query: 344 TQHFSDENKLGEG--GFGPVYKGK-LADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKL 398
              +     +G+G      V   +    G+ + V+R  L   S + +   + E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISII-NGIARGL 457
            H N+V      + +NE  ++  +M   S    L  +     ++ +  I+ I  G+ + L
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMN-ELAIAYILQGVLKAL 141

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT-----KRIVGT 512
            Y+H       +HR +K S++L+  +    +S          +           K  V  
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 42/160 (26%), Positives = 67/160 (41%), Gaps = 23/160 (14%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSG-----QGLQEFKNEVTLIAKL 398
                  +LG G +G V K + +  G+ +AVKR+  T       + L +       +  +
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD---ISMRTV 63

Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS------IING 452
                V   G   +E +  +  E M + SL+ F             + I       I   
Sbjct: 64  DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDK-----GQTIPEDILGKIAVS 117

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 492
           I + L +LH  S+L +IHRD+K SNVL++     K+ DFG
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG 155

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 12/149 (8%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRT----SGQGLQEFKNEVTLIAKLQHKNLVR 405
             LG+G FG VY  +       +A+K L +     +G   Q  + EV + + L+H N++R
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L G         LI EY P  ++   L   ++    D +R  + I  +A  L Y H    
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH---S 127

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
            ++IHRD+K  N+LL      KI+DFG +
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS 156

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 94.5 bits (235), Expect = 9e-21
 Identities = 48/231 (20%), Positives = 90/231 (38%), Gaps = 17/231 (7%)

Query: 287 RRKERVKEEKANSQETRSLHLADGRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQH 346
                 ++ +          +  G+     +YD       ++    P+   H  V    H
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL--DH 158

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           +    +LG G FG V++    A G   A K +        +  + E+  ++ L+H  LV 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFD--STRSVQLDWKRRISIINGIARGLLYLHED 463
           L      +NE ++IYE+M        LF+  +    ++     +  +  + +GL ++HE 
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE- 273

Query: 464 SRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSEANTKRIVGT 512
                +H DLK  N++   + +   K+ DFG+       Q   + K   GT
Sbjct: 274 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGT 319

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 15/174 (8%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
             ++    +LG G FG V++    A G+    K ++          KNE++++ +L H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFD--STRSVQLDWKRRISIINGIARGLLYL 460
           L+ L      + E +LI E++        LFD  +    ++     I+ +     GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSEANTKRIVGT 512
           HE     I+H D+K  N++ + +     KI DFG+A     ++     K    T
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTAT 213

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 19/193 (9%), Positives = 42/193 (21%), Gaps = 36/193 (18%)

Query: 339 LAVEATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRL---SRTSGQGLQEFKNEVTL 394
           L  +  +       L  G    V+  + +   ++ A+K     +  S   L+        
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 395 IAKLQHKNLVRLLGCC--------------------------LQENESLLIYEYMP---N 425
            A+L  ++                                        LL+         
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175

Query: 426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN 485
              +   F               +   + R    L       ++H      N+ +  +  
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGR 232

Query: 486 PKISDFGMARIFG 498
             + D       G
Sbjct: 233 LMLGDVSALWKVG 245

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 15/171 (8%)

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
            S    LG G FG V+K +  A G ++A K +     +  +E KNE++++ +L H NL++
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDS--TRSVQLDWKRRISIINGIARGLLYLHED 463
           L      +N+ +L+ EY+        LFD     S  L     I  +  I  G+ ++H+ 
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ- 205

Query: 464 SRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSEANTKRIVGT 512
             + I+H DLK  N+L  +      KI DFG+AR +   +     K   GT
Sbjct: 206 --MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGT 251

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 51/172 (29%), Positives = 72/172 (41%), Gaps = 28/172 (16%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCC 410
           LGEG +G V         + +AVK +         E  K E+ +   L H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS----------IINGIARGLLYL 460
            + N   L  EY     L    FD  R         +           ++ G+     YL
Sbjct: 75  REGNIQYLFLEYCSGGEL----FD--RIEP---DIGMPEPDAQRFFHQLMAGVV----YL 121

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           H    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 47/186 (25%), Positives = 75/186 (40%), Gaps = 29/186 (15%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRL-------SRTSGQGLQEFKNEVT 393
           +    F  E   G+G FG V  GK    G  +A+K++       +R     LQ  +    
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQ---- 71

Query: 394 LIAKLQHKNLVRLLGCCLQENES-------LLIYEYMPNKSLNVFLFDSTRSVQ-LDWKR 445
            +A L H N+V+L        E         ++ EY+P  +L+    +  R         
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPIL 130

Query: 446 RISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSEA 504
               +  + R +  LH  S + + HRD+K  NVL++      K+ DFG A+    + SE 
Sbjct: 131 IKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEP 187

Query: 505 NTKRIV 510
           N   I 
Sbjct: 188 NVAYIC 193

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 51/172 (29%), Positives = 72/172 (41%), Gaps = 28/172 (16%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCC 410
           LGEG +G V         + +AVK +         E  K E+ +   L H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS----------IINGIARGLLYL 460
            + N   L  EY     L    FD  R         +           ++ G+     YL
Sbjct: 75  REGNIQYLFLEYCSGGEL----FD--RIEP---DIGMPEPDAQRFFHQLMAGVV----YL 121

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           H    + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 42/183 (22%), Positives = 71/183 (38%), Gaps = 23/183 (12%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVK-----RLSRTSGQGLQEFKNEVTLIAK 397
              +     +G+G F  V +      G++ AVK     + + + G   ++ K E ++   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFD-----STRSVQLDWKRRISIING 452
           L+H ++V LL     +    +++E+M        L       +              +  
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQ 138

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSEANTKRI 509
           I   L Y H+     IIHRD+K   VLL  + N    K+  FG+A   G +   A     
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--R 193

Query: 510 VGT 512
           VGT
Sbjct: 194 VGT 196

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 89.2 bits (222), Expect = 9e-20
 Identities = 35/174 (20%), Positives = 75/174 (43%), Gaps = 16/174 (9%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
            + +     LG G FG V++    +  K    K + +  G      K E++++   +H+N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFD--STRSVQLDWKRRISIINGIARGLLYL 460
           ++ L        E ++I+E++        +F+  +T + +L+ +  +S ++ +   L +L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSEANTKRIVGT 512
           H      I H D++  N++     +   KI +FG AR         N + +   
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTA 166

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 90.9 bits (226), Expect = 9e-20
 Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 33/206 (16%)

Query: 324 QKQEESQEFPLFPLHLAVEATQHFSD----ENKLGEGGFGPVYKGK-LADGKEIAVKRLS 378
           +      +    P         H S+      KLG G +G V   +      E A+K + 
Sbjct: 12  ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71

Query: 379 RT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL-LIYEYMPNKSLNVFLFDS 435
           +T  S     +   EV ++  L H N+++L     ++  +  L+ E      L    FD 
Sbjct: 72  KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-EDKRNYYLVMECYKGGEL----FD- 125

Query: 436 TRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNP 486
              +    + + +      II  +  G+ YLH+     I+HRDLK  N+LL   + +   
Sbjct: 126 -EIIH---RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALI 178

Query: 487 KISDFGMARIFGGNQSEANTKRIVGT 512
           KI DFG++ +F   +     K  +GT
Sbjct: 179 KIVDFGLSAVFENQKK---MKERLGT 201

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 49/187 (26%), Positives = 77/187 (41%), Gaps = 39/187 (20%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQH 400
            + ++    LG+G FG V K K     +E AVK +++     +       EV L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI------------S 448
            N+++L       +   ++ E          LFD            I             
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGE----LFD-----------EIIKRKRFSEHDAAR 125

Query: 449 IINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEAN 505
           II  +  G+ Y+H+     I+HRDLK  N+LL   + + + KI DFG++  F  N     
Sbjct: 126 IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--- 179

Query: 506 TKRIVGT 512
            K  +GT
Sbjct: 180 MKDRIGT 186

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 31/207 (14%), Positives = 64/207 (30%), Gaps = 23/207 (11%)

Query: 326 QEESQEFPLFPLHLAVE-ATQHFSDENKLGEGGFGPVYKGK------LADGKEIAVKRLS 378
            E   + P        +  ++     + LGEG F  VY+          + ++  +K   
Sbjct: 45  FEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK 104

Query: 379 RTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLN--VFLFDST 436
             +          +  +        ++     L +N S+L+ E     +L   + L+ +T
Sbjct: 105 PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT 164

Query: 437 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP---------- 486
               +     IS    +   +  +H+    +IIH D+K  N +L +              
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221

Query: 487 -KISDFGMARIFGGNQSEANTKRIVGT 512
             + D G +                 T
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCET 248

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 35/156 (22%), Positives = 64/156 (41%), Gaps = 14/156 (8%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSG-----QGLQEFKNEVTLIAKL 398
               +  ++G G  G V+K +    G  IAVK++ R+       + L +      ++   
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD---VVLKSH 81

Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
               +V+  G  +   +  +  E M               +      ++++   I + L 
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTV--AIVKALY 138

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           YL E     +IHRD+K SN+LLD     K+ DFG++
Sbjct: 139 YLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 39/179 (21%), Positives = 74/179 (41%), Gaps = 20/179 (11%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHK 401
              F  + KLG G FG V+  +  + G E  +K +++   Q  +++ + E+ ++  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR-----ISIINGIARG 456
           N++++       +   ++ E      L     +   S Q   K         ++  +   
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           L Y H      ++H+DLK  N+L          KI DFG+A +F  ++    +    GT
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGT 189

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 39/145 (26%), Positives = 72/145 (49%), Gaps = 12/145 (8%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQE-FKNEVTLIAKLQHKNLVRLLG 408
           LG+G FG VY  +   +   +A+K L ++    +G++   + E+ + + L+H N++R+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHEDSRLK 467
                    L+ E+ P   L    +   +     D +R  + +  +A  L Y H     K
Sbjct: 82  YFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCH---ERK 134

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFG 492
           +IHRD+K  N+L+ ++   KI+DFG
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFG 159

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 29/182 (15%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQH 400
            + ++    LG+G FG V K K     +E AVK +++     +       EV L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 401 KNLVRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS------IINGI 453
            N+++L     +++ S  ++ E          LFD    ++   ++R S      II  +
Sbjct: 81  PNIMKLFEIL-EDSSSFYIVGELYTGGE----LFD--EIIK---RKRFSEHDAARIIKQV 130

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEANTKRIV 510
             G+ Y+H+     I+HRDLK  N+LL   + + + KI DFG++  F  N      K  +
Sbjct: 131 FSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRI 184

Query: 511 GT 512
           GT
Sbjct: 185 GT 186

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 42/185 (22%), Positives = 71/185 (38%), Gaps = 37/185 (20%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
            Q+++ EN +G G +G V            A K++ +   + +  FK E+ ++  L H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI------------SII 450
           ++RL        +  L+ E          LF+           R+             I+
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGE----LFE-----------RVVHKRVFRESDAARIM 112

Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEANTK 507
             +   + Y H+   L + HRDLK  N L      +   K+ DFG+A  F   +     +
Sbjct: 113 KDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMR 166

Query: 508 RIVGT 512
             VGT
Sbjct: 167 TKVGT 171

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 30/183 (16%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQ 399
           +  +  +  LG+G FG V   K    G+E AVK +S+         +    EV L+ +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 400 HKNLVRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS------IING 452
           H N+++L     ++     L+ E      L    FD    +    ++R S      II  
Sbjct: 85  HPNIMKLYEFF-EDKGYFYLVGEVYTGGEL----FD--EIIS---RKRFSEVDAARIIRQ 134

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEANTKRI 509
           +  G+ Y+H+    KI+HRDLK  N+LL     + N +I DFG++  F  ++     K  
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDK 188

Query: 510 VGT 512
           +GT
Sbjct: 189 IGT 191

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 88.6 bits (219), Expect = 3e-19
 Identities = 29/194 (14%), Positives = 57/194 (29%), Gaps = 38/194 (19%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQH-------- 400
           LG+       +      G+   V       R     +++ K EV  +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 401 --------KNLVRLLGCCL--------QENESLLIYEYMPNKSLNVFLF------DSTRS 438
                    +LV+              ++   L  +   P    N+  F       S+  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 439 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
             L    R+ +   + R L  LH      ++H  L+  +++LD      ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261

Query: 499 GNQSEANTKRIVGT 512
           G  + +   R    
Sbjct: 262 GASAVSPIGRGFAP 275

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 49/181 (27%), Positives = 74/181 (40%), Gaps = 22/181 (12%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVK------RLSRTSGQGLQEFKNEVTLIA 396
              +    +LG G F  V K +  + G E A K        +   G   +E + EV+++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 397 KLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIAR 455
           ++ H N++ L        + +LI E +        LFD   +   L  +   S I  I  
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSEANTKRIVG 511
           G+ YLH     KI H DLK  N++L  +  P    K+ DFG+A            K I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180

Query: 512 T 512
           T
Sbjct: 181 T 181

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 44/187 (23%), Positives = 76/187 (40%), Gaps = 39/187 (20%)

Query: 344 TQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQH 400
           + ++  + +LG+G F  V +      G E A K ++    S +  Q+ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI------------S 448
            N+VRL     +E+   L+++ +        LF+            I             
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFE-----------DIVAREFYSEADASH 109

Query: 449 IINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSEAN 505
            I  I   + Y H      I+HR+LK  N+LL  +      K++DFG+A     +++   
Sbjct: 110 CIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--- 163

Query: 506 TKRIVGT 512
                GT
Sbjct: 164 WHGFAGT 170

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 86.5 bits (215), Expect = 6e-19
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 11/165 (6%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           KLG GG   VY  +      ++A+K +    R   + L+ F+ EV   ++L H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
               +++   L+ EY+   +L+ ++        L     I+  N I  G+ + H    ++
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           I+HRD+K  N+L+D     KI DFG+A+      S   T  ++GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGT 175

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 88.8 bits (220), Expect = 8e-19
 Identities = 35/169 (20%), Positives = 64/169 (37%), Gaps = 23/169 (13%)

Query: 352 KLGEGGFGPVYKGK--LADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL- 407
            +  GG G +Y       +G+ + +K L  +     Q     E   +A++ H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 408 -GCCLQENESLLIY---EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
                  +   + Y   EY+  +SL           +L     I+ +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             + +++ DLK  N++L  E   K+ D G                + GT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGT 240

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 49/181 (27%), Positives = 74/181 (40%), Gaps = 22/181 (12%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVK------RLSRTSGQGLQEFKNEVTLIA 396
              +    +LG G F  V K +  + G E A K        +   G   +E + EV+++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 397 KLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIAR 455
           ++ H N++ L        + +LI E +        LFD   +   L  +   S I  I  
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSEANTKRIVG 511
           G+ YLH     KI H DLK  N++L  +  P    K+ DFG+A            K I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180

Query: 512 T 512
           T
Sbjct: 181 T 181

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 50/187 (26%), Positives = 77/187 (41%), Gaps = 26/187 (13%)

Query: 342 EATQHFSDE----NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGL---------QE 387
            +T  F +       LG G    V +       KE AVK +  T G            + 
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 388 FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDS-TRSVQLDWKR 445
              EV ++ K+  H N+++L           L+++ M    L    FD  T  V L  K 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKE 125

Query: 446 RISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
              I+  +   +  LH+   L I+HRDLK  N+LLD +MN K++DFG +      +    
Sbjct: 126 TRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--- 179

Query: 506 TKRIVGT 512
            + + GT
Sbjct: 180 LREVCGT 186

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 84.9 bits (211), Expect = 1e-18
 Identities = 48/183 (26%), Positives = 74/183 (40%), Gaps = 26/183 (14%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVK------RLSRTSGQGLQEFKNEVTLIA 396
             H+    +LG G F  V K +    GKE A K        S   G   +E + EV ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 397 KLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDW---KRRISIINGI 453
           +++H N++ L      + + +LI E +        LFD     + +          +  I
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFD--FLAEKESLTEDEATQFLKQI 117

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSEANTKRI 509
             G+ YLH     +I H DLK  N++L  +  P    K+ DFG+A            K I
Sbjct: 118 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 171

Query: 510 VGT 512
            GT
Sbjct: 172 FGT 174

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 50/156 (32%), Positives = 77/156 (49%), Gaps = 25/156 (16%)

Query: 353 LGEGGFGPVYKGKLAD----GKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRL 406
           +G+G F  V   KLA     G+E+A+K + +T  +   LQ+   EV ++  L H N+V+L
Sbjct: 23  IGKGNFAKV---KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 407 LGCCLQENESLLIYEYMPNKSLNVFLFD---STRSVQLDWKRRI--SIINGIARGLLYLH 461
                 E    LI EY     +    FD   +   ++    R     I++ +     Y H
Sbjct: 80  FEVIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH 131

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
              + +I+HRDLK  N+LLD +MN KI+DFG +  F
Sbjct: 132 ---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 44/187 (23%), Positives = 76/187 (40%), Gaps = 39/187 (20%)

Query: 344 TQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQH 400
           + ++  + +LG+G F  V +      G E A K ++    S +  Q+ + E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI------------S 448
            N+VRL     +E+   L+++ +        LF+            I             
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFE-----------DIVAREFYSEADASH 132

Query: 449 IINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSEAN 505
            I  I   + Y H      I+HR+LK  N+LL  +      K++DFG+A     +++   
Sbjct: 133 CIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--- 186

Query: 506 TKRIVGT 512
                GT
Sbjct: 187 WHGFAGT 193

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 26/183 (14%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRL------SRTSGQGLQEFKNEVTLIA 396
             ++    +LG G F  V K +  + G + A K +      S   G   ++ + EV+++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 397 KLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDW---KRRISIINGI 453
           ++QH N++ L      + + +LI E +        LFD     + +    +     +  I
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGE----LFD--FLAEKESLTEEEATEFLKQI 123

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSEANTKRI 509
             G+ YLH    L+I H DLK  N++L     P    KI DFG+A            K I
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNI 177

Query: 510 VGT 512
            GT
Sbjct: 178 FGT 180

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 27/188 (14%), Positives = 54/188 (28%), Gaps = 37/188 (19%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQ--------- 399
           LG+       +      G+   V     T       +++ K EV  +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 400 ----------------HKNLVRLLGCCLQENES--LLIYEYMPNKSLNVF--LFD-STRS 438
                            K ++R+              +Y  M +        L   S+  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 439 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
             L    R+ +   + R L  LH      ++H  L+  +++LD      ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 499 GNQSEANT 506
                + +
Sbjct: 258 ARVVSSVS 265

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 15/170 (8%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVK--RLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLL 407
            LG GG   V+  + L D +++AVK  R            F+ E    A L H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 408 GCCLQENESLLIY----EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
                E  +  +     EY+   +L   +        +  KR I +I    + L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH-- 133

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE-ANTKRIVGT 512
            +  IIHRD+K +N+++      K+ DFG+AR    + +    T  ++GT
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 44/236 (18%), Positives = 73/236 (30%), Gaps = 50/236 (21%)

Query: 324 QKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVK-----RL 377
                 +E   F     +E  + +  +  +G+G +G V            A+K     ++
Sbjct: 5   HHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKI 64

Query: 378 SRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR 437
            + + + ++  K EV L+ KL H N+ RL      E    L+ E      L   L     
Sbjct: 65  RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFID 124

Query: 438 SVQLDWKRRI-------------------------------------SIINGIARGLLYL 460
                    +                                     +I+  I   L YL
Sbjct: 125 DSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184

Query: 461 HEDSRLKIIHRDLKTSNVLL--DHEMNPKISDFGMARIFGGNQSEANT--KRIVGT 512
           H      I HRD+K  N L   +     K+ DFG+++ F    +          GT
Sbjct: 185 HN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 47/196 (23%), Positives = 74/196 (37%), Gaps = 45/196 (22%)

Query: 344 TQHFSD-----ENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAK 397
           +  F D     E+ LGEG    V     L   +E AVK + +  G        EV ++ +
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 398 LQ-HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI--------- 447
            Q H+N++ L+    +E+   L++E M   S+                  I         
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LS-----------HIHKRRHFNEL 111

Query: 448 ---SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIF--GG 499
               ++  +A  L +LH      I HRDLK  N+L +H       KI DF +       G
Sbjct: 112 EASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168

Query: 500 NQSEANTKR---IVGT 512
           + S  +T       G+
Sbjct: 169 DCSPISTPELLTPCGS 184

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 36/164 (21%), Positives = 67/164 (40%), Gaps = 34/164 (20%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--------SGQGLQEFKNEVTLIAKLQHKNL 403
           LG G FG V+        KE+ VK + +             L +   E+ ++++++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS----------IINGI 453
           +++L   + EN+       M      + LF       +D   R+           +++ +
Sbjct: 92  IKVLD--IFENQGF-FQLVMEKHGSGLDLFA-----FIDRHPRLDEPLASYIFRQLVSAV 143

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
                YL       IIHRD+K  N+++  +   K+ DFG A   
Sbjct: 144 G----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 44/217 (20%), Positives = 80/217 (36%), Gaps = 47/217 (21%)

Query: 322 RGQKQEESQEFPLFPLHLAVEATQHFSDE----NKLGEGGFGPVYKGK-LADGKEIAVKR 376
           +G +    Q            A + F  +    + +G G    V +    A G E AVK 
Sbjct: 67  KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126

Query: 377 LSRTSGQGLQE--------FKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMPNKS 427
           +  T+ +   E         + E  ++ ++  H +++ L+      +   L+++ M    
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186

Query: 428 LNVFLFDSTRSVQLDWKRRI------------SIINGIARGLLYLHEDSRLKIIHRDLKT 475
           L    FD            +            SI+  +   + +LH      I+HRDLK 
Sbjct: 187 L----FD-----------YLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKP 228

Query: 476 SNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            N+LLD  M  ++SDFG +      +     + + GT
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGT 262

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 44/218 (20%)

Query: 323 GQKQEESQEFPLFPLHLAVEATQHFSD----ENKLGEGGFGPVYKGK-LADGKEIAVKRL 377
           G++    Q   + P     +      +      KLG G +G V   K      E A+K +
Sbjct: 10  GRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVI 69

Query: 378 SR-------------TSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL-LIYEYM 423
            +                +  +E  NE++L+  L H N+++L     ++ +   L+ E+ 
Sbjct: 70  KKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFY 128

Query: 424 PNKSLNVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLKTSN 477
               L    F+     Q+  + +        I+  I  G+ YLH+     I+HRD+K  N
Sbjct: 129 EGGEL----FE-----QIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPEN 176

Query: 478 VLL---DHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +LL   +  +N KI DFG++  F  +      +  +GT
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGT 211

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 46/196 (23%), Positives = 80/196 (40%), Gaps = 42/196 (21%)

Query: 339 LAVEATQHFSDE----NKLGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNE 391
           +A      F++E     +LG+G F  V +   +  G+E A   ++    S +  Q+ + E
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60

Query: 392 VTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI---- 447
             +   L+H N+VRL     +E    LI++ +        LF+            I    
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFE-----------DIVARE 105

Query: 448 --------SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARI 496
                     I  I   +L+ H+   + ++HR+LK  N+LL  ++     K++DFG+A  
Sbjct: 106 YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162

Query: 497 FGGNQSEANTKRIVGT 512
             G Q         GT
Sbjct: 163 VEGEQQAWFG--FAGT 176

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 43/179 (24%), Positives = 71/179 (39%), Gaps = 34/179 (18%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSR--------TSGQGLQEFKNEVTLIAKLQHKN 402
            LG G  G V         K++A++ +S+                 + E+ ++ KL H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS------IINGIARG 456
           ++++        +  ++ E M    L    FD  + V     +R+           +   
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGEL----FD--KVVG---NKRLKEATCKLYFYQMLLA 251

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSEANTKRIVGT 512
           + YLHE     IIHRDLK  NVLL  +      KI+DFG ++I G        + + GT
Sbjct: 252 VQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGT 304

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 43/185 (23%), Positives = 71/185 (38%), Gaps = 38/185 (20%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
            + F     LG G F  V+  K    GK  A+K + ++        +NE+ ++ K++H+N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI------------SII 450
           +V L           L+ + +        LFD           RI             +I
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGE----LFD-----------RILERGVYTEKDASLVI 112

Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEANTK 507
             +   + YLHE     I+HRDLK  N+L    +      I+DFG++++           
Sbjct: 113 QQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MS 165

Query: 508 RIVGT 512
              GT
Sbjct: 166 TACGT 170

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 44/179 (24%), Positives = 72/179 (40%), Gaps = 34/179 (18%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE--------FKNEVTLIAKLQHKN 402
            LG G  G V         K++A+K +S+                 + E+ ++ KL H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS------IINGIARG 456
           ++++        +  ++ E M    L    FD  + V     +R+           +   
Sbjct: 77  IIKIKNFF-DAEDYYIVLELMEGGEL----FD--KVVG---NKRLKEATCKLYFYQMLLA 126

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           + YLHE     IIHRDLK  NVLL   + +   KI+DFG ++I G        + + GT
Sbjct: 127 VQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGT 179

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 47/173 (27%), Positives = 69/173 (39%), Gaps = 28/173 (16%)

Query: 353 LGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEF---KNEVTLIAKLQHKNLVRLLG 408
           LGEG F  V   +  A  +E A+K L +       +      E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLY 459
              Q++E L     Y  N      L        +             R         L Y
Sbjct: 98  TF-QDDEKLYFGLSYAKNGE----LLK-----YIRKIGSFD--ETCTRFYTAEIVSALEY 145

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           LH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VGT
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 30/159 (18%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG G FG V  G+    G ++AVK L+R    S   + + K E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS----------IINGIARGLL 458
                 +  ++ EY+    L    FD      +    R+           I++ +     
Sbjct: 79  VISTPTDFFMVMEYVSGGEL----FD-----YICKHGRVEEMEARRLFQQILSAVD---- 125

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
           Y H   R  ++HRDLK  NVLLD  MN KI+DFG++ + 
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 20/154 (12%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG G FG V  GK    G ++AVK L+R    S   + + + E+  +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFD---STRSVQLDWKRRI--SIINGIARGLLYLHED 463
                ++  ++ EY+    L    FD       +     RR+   I++G+     Y H  
Sbjct: 84  VISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCH-- 133

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
            R  ++HRDLK  NVLLD  MN KI+DFG++ + 
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 81.2 bits (201), Expect = 6e-17
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 31/159 (19%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQE-FKNEVTLIAKLQHKNLVRLLG 408
           LGEG FG V         +++A+K +SR       +    + E++ +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS----------IINGIARGLL 458
                 + +++ EY   +     LFD      +  K+R++          II  I     
Sbjct: 77  VITTPTDIVMVIEYAGGE-----LFD-----YIVEKKRMTEDEGRRFFQQIICAIE---- 122

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
           Y H   R KI+HRDLK  N+LLD  +N KI+DFG++ I 
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 39/165 (23%), Positives = 66/165 (40%), Gaps = 35/165 (21%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQHK--NL 403
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS----------IINGI 453
           +RLL    + +  +LI E          LFD      +  +  +           ++  +
Sbjct: 111 IRLLDWFERPDSFVLILERPEP---VQDLFD-----FITERGALQEELARSFFWQVLEAV 162

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIF 497
                + H      ++HRD+K  N+L+D      K+ DFG   + 
Sbjct: 163 R----HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 49/204 (24%), Positives = 82/204 (40%), Gaps = 29/204 (14%)

Query: 326 QEESQEFPLFPLHLAVEATQHFSD-----ENKLGEGGFGPVYKGK-LADGKEIAVK--RL 377
              S    L   +L  ++ ++F++       +LG G F  V +    + G+E A K  + 
Sbjct: 5   HHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK 64

Query: 378 SRTSGQGLQEFKNEVTLIAKLQH-KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDST 436
            R       E  +E+ ++   +    ++ L       +E +LI EY     +    F   
Sbjct: 65  RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FS-- 118

Query: 437 RSVQLDWKRR-----ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKI 488
             +    +       I +I  I  G+ YLH+     I+H DLK  N+LL       + KI
Sbjct: 119 LCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI 175

Query: 489 SDFGMARIFGGNQSEANTKRIVGT 512
            DFGM+R  G        + I+GT
Sbjct: 176 VDFGMSRKIGHACE---LREIMGT 196

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 40/187 (21%), Positives = 67/187 (35%), Gaps = 42/187 (22%)

Query: 344 TQHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHK 401
           T  +  +  +G G +    +    A   E AVK + ++          E+ ++ +  QH 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHP 76

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI------------SI 449
           N++ L           ++ E M    L     D           +I            ++
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGEL----LD-----------KILRQKFFSEREASAV 121

Query: 450 INGIARGLLYLHEDSRLKIIHRDLKTSNVLL-DHEMNP---KISDFGMARIFGGNQSEAN 505
           +  I + + YLH      ++HRDLK SN+L  D   NP   +I DFG A+          
Sbjct: 122 LFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178

Query: 506 TKRIVGT 512
           T     T
Sbjct: 179 T--PCYT 183

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 44/188 (23%), Positives = 75/188 (39%), Gaps = 46/188 (24%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT--------------------------SGQGL 385
           +G+G +G V       D    A+K LS+                               +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 386 QEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY---EYMPNKSLNVFLFDSTRSVQLD 442
           ++   E+ ++ KL H N+V+L+   L +     +Y   E +    +     +      L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 443 WK--RRI--SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
               R     +I GI     YLH     KIIHRD+K SN+L+  + + KI+DFG++  F 
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 499 GNQSEANT 506
           G+ +  + 
Sbjct: 189 GSDALLSN 196

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 34/184 (18%), Positives = 81/184 (44%), Gaps = 35/184 (19%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN---------E 391
           +    +   + +G G +G V +     + + +A+K++ R        F++         E
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILRE 102

Query: 392 VTLIAKLQHKNLVRLLGCCLQENESL-----LIYEYMP---NKSLNVFLFDSTRSVQLDW 443
           + ++ +L H ++V++L   + ++        ++ E       K     LF +   +    
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKK-----LFRTPVYLTELH 157

Query: 444 KRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
            +  +++  +  G+ Y+H      I+HRDLK +N L++ + + K+ DFG+AR     ++ 
Sbjct: 158 IK--TLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212

Query: 504 ANTK 507
            +  
Sbjct: 213 NSQL 216

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 38/172 (22%), Positives = 66/172 (38%), Gaps = 21/172 (12%)

Query: 350 ENKLGEGGFGPVYKGKLAD---GKEIAVKRLSR--TSGQGLQE-FKNEVTLIAKLQHKNL 403
              +G GG G VY+ +  D    + +A+K +S   +S    +   + E     +LQ  ++
Sbjct: 39  RRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 404 VRL--LGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
           V +   G   + +  L +    +    L   L        L   R ++I+  I   L   
Sbjct: 97  VPIHDFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAA 150

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           H        HRD+K  N+L+  +    + DFG+A      +        VGT
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGT 198

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 40/167 (23%), Positives = 64/167 (38%), Gaps = 37/167 (22%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRT------SGQGLQEFKNEVTLIAKL----QHK 401
           LG+GGFG V+ G  L D  ++A+K + R                 EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS----------IIN 451
            ++RLL     +   +L+ E          LFD         K  +           ++ 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLP---AQDLFDYITE-----KGPLGEGPSRCFFGQVVA 150

Query: 452 GIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIF 497
            I     + H      ++HRD+K  N+L+D      K+ DFG   + 
Sbjct: 151 AIQ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 40/180 (22%), Positives = 69/180 (38%), Gaps = 40/180 (22%)

Query: 350 ENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLL 407
           +  LGEG F    K       +  AVK +S+         + E+T +   + H N+V+L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72

Query: 408 GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI------------SIINGIAR 455
                +  + L+ E +    L    F+           RI             I+  +  
Sbjct: 73  EVFHDQLHTFLVMELLNGGEL----FE-----------RIKKKKHFSETEASYIMRKLVS 117

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            + ++H+   + ++HRDLK  N+L    +  +  KI DFG AR+   +     T     T
Sbjct: 118 AVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 77.6 bits (191), Expect = 8e-16
 Identities = 37/221 (16%), Positives = 66/221 (29%), Gaps = 62/221 (28%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADG-----KEIA--------------VKRLSR----- 379
             F     +G GGFG V++ K   D      K I               VK L++     
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 380 ----------------------------------TSGQGLQEFKNEVTLIAKLQHKNLVR 405
                                             +S   +     ++  +     KN V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
            L     +    +  +    ++L  ++         +    + I   IA  + +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
             ++HRDLK SN+    +   K+ DFG+      ++ E   
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 46/214 (21%), Positives = 82/214 (38%), Gaps = 63/214 (29%)

Query: 344 TQHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHK 401
           ++ +S    LG G FG V +    + GK  A+K++ +        +KN E+ ++  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60

Query: 402 NLVRLLGCCLQENESL--------------------------------------LIYEYM 423
           N+++L+       +                                        +I EY+
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 424 PNKSLNVFLFDSTRSVQLDWKRRISIING------IARGLLYLHEDSRLKIIHRDLKTSN 477
           P  +L+  L    RS +      I +         + R + ++H    L I HRD+K  N
Sbjct: 121 P-DTLHKVLKSFIRSGR-----SIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQN 171

Query: 478 VLLDHEMNP-KISDFGMARIFGGNQSEANTKRIV 510
           +L++ + N  K+ DFG A+      SE +   I 
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYIC 203

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 38/176 (21%), Positives = 67/176 (38%), Gaps = 22/176 (12%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQE--FKN--------- 390
                ++ +  +  G +G V  G  ++G  +A+KR+  T   G       +         
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 391 EVTLIAKLQHKNLVRLLGCCLQENESL-----LIYEYMPNKSLNVFLFDSTRSVQLDWKR 445
           E+ L+    H N++ L    +   E       L+ E M    L   +    + + +  + 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQH 135

Query: 446 RISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
               +  I  GL  LHE     ++HRDL   N+LL    +  I DF +AR    + 
Sbjct: 136 IQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 48/185 (25%), Positives = 76/185 (41%), Gaps = 39/185 (21%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
           +  F  E++LG G    VY+ K     K  A+K L +T  +  +  + E+ ++ +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI------------SII 450
           +++L        E  L+ E +    L    FD           RI              +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FD-----------RIVEKGYYSERDAADAV 154

Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSEANTK 507
             I   + YLHE     I+HRDLK  N+L      +   KI+DFG+++I          K
Sbjct: 155 KQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MK 208

Query: 508 RIVGT 512
            + GT
Sbjct: 209 TVCGT 213

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 32/159 (20%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCC 410
           +G G FG     +     + +AVK + R  G  + E  + E+     L+H N+VR     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS----------IINGIARGLLYL 460
           L      +I EY     L    ++  R        R S          +++G++    Y 
Sbjct: 86  LTPTHLAIIMEYASGGEL----YE--RICN---AGRFSEDEARFFFQQLLSGVS----YC 132

Query: 461 HEDSRLKIIHRDLKTSNVLLDH--EMNPKISDFGMARIF 497
           H    ++I HRDLK  N LLD       KI DFG ++  
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 42/178 (23%), Positives = 75/178 (42%), Gaps = 31/178 (17%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN---------E 391
           E    + D   +G G +G V        G ++A+K+L R        F++         E
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRE 74

Query: 392 VTLIAKLQHKNLVRLL------GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKR 445
           + L+  ++H+N++ LL             +  L+  +M    L   +    +  +L   R
Sbjct: 75  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDR 129

Query: 446 RISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
              ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR      + 
Sbjct: 130 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 184

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 75.9 bits (187), Expect = 6e-15
 Identities = 40/202 (19%), Positives = 84/202 (41%), Gaps = 32/202 (15%)

Query: 324 QKQEESQEFPLFPLHLAV-EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTS 381
                S    L+   +       ++  ++ +G G +G VY        K +A+K+++R  
Sbjct: 4   HHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM- 62

Query: 382 GQGLQEFKN---------EVTLIAKLQHKNLVRLLGCCLQENESL-----LIYEYMPNKS 427
                 F++         E+T++ +L+   ++RL    + ++        ++ E   +  
Sbjct: 63  ------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDL 116

Query: 428 LNVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP 486
             +F     ++   L  +   +I+  +  G  ++HE     IIHRDLK +N LL+ + + 
Sbjct: 117 KKLF-----KTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSV 168

Query: 487 KISDFGMARIFGGNQSEANTKR 508
           K+ DFG+AR     +       
Sbjct: 169 KVCDFGLARTINSEKDTNIVND 190

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 38/179 (21%), Positives = 78/179 (43%), Gaps = 31/179 (17%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN---------E 391
           +    +++ + +GEG +G V       +   +A+K++S         F++         E
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLRE 75

Query: 392 VTLIAKLQHKNLVRLLGCCLQE-----NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR 446
           + ++ + +H+N++ +             +  ++ + M    L   L    ++  L     
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHI 130

Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
              +  I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+   +     
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 12/166 (7%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG GGFG V+  ++    ++ A K+L++      +G Q    E  ++AK+  + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRL 466
              +    L L+   M    +   +++    +      R I     I  GL +LH+    
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308

Query: 467 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            II+RDLK  NVLLD + N +ISD G+A      Q++       GT
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGT 352

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 38/193 (19%), Positives = 64/193 (33%), Gaps = 62/193 (32%)

Query: 349 DENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRL 406
            +  LG G  G V +      G++ A+K L  +      + + EV    +     ++V +
Sbjct: 33  SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87

Query: 407 LGCCLQENESLLIYEYMPNKSLNVF----------LFDSTRSVQLDWKRRI--------- 447
           L           +YE M +    +           LF            RI         
Sbjct: 88  LD----------VYENMHHGKRCLLIIMECMEGGELFS-----------RIQERGDQAFT 126

Query: 448 -----SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGG 499
                 I+  I   + +LH      I HRD+K  N+L    + +   K++DFG A+    
Sbjct: 127 EREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183

Query: 500 NQSEANTKRIVGT 512
           N      +    T
Sbjct: 184 NA----LQTPCYT 192

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 44/189 (23%), Positives = 74/189 (39%), Gaps = 42/189 (22%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN---------E 391
           +    + D   LG GG G V+        K +A+K++            +         E
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALRE 58

Query: 392 VTLIAKLQHKNLVRLLGCCLQENESL--------------LIYEYMPNKSLNVFLFDSTR 437
           + +I +L H N+V++          L              ++ EYM    L   L     
Sbjct: 59  IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL----E 113

Query: 438 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARI 496
              L  +     +  + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARI 170

Query: 497 FGGNQSEAN 505
              + S   
Sbjct: 171 MDPHYSHKG 179

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 36/167 (21%), Positives = 70/167 (41%), Gaps = 19/167 (11%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ- 399
                +    KLG G +  V++   + + +++ VK L        ++ K E+ ++  L+ 
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRG 89

Query: 400 HKNLVRLLGCCL--QENESLLIYEYMPNKSLNVFLFDSTRS-VQLDWKRRISIINGIARG 456
             N++ L             L++E++ N          T   ++         +  I + 
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR-------FYMYEILKA 142

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQS 502
           L Y H  S   I+HRD+K  NV++DHE    ++ D+G+A  +   Q 
Sbjct: 143 LDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 39/178 (21%), Positives = 77/178 (43%), Gaps = 32/178 (17%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN---------E 391
           E  + +     +G G +G V        G+++A+K+LSR        F++         E
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRE 73

Query: 392 VTLIAKLQHKNLVRLL------GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKR 445
           + L+  +QH+N++ LL             +  L+  +M    L   +      ++   ++
Sbjct: 74  LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM-----GLKFSEEK 127

Query: 446 RISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
              ++  + +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR      + 
Sbjct: 128 IQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 38/197 (19%), Positives = 62/197 (31%), Gaps = 61/197 (30%)

Query: 345 QHFSDENKLGEGGFGPVYKG-KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKN 402
            +      LG G  G V +       ++ A+K L         + + EV L  +     +
Sbjct: 62  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 116

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVF----------LFDSTRSVQLDWKRRI----- 447
           +VR++           +YE +      +           LF            RI     
Sbjct: 117 IVRIVD----------VYENLYAGRKCLLIVMECLDGGELFS-----------RIQDRGD 155

Query: 448 ---------SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMAR 495
                     I+  I   + YLH    + I HRD+K  N+L          K++DFG A+
Sbjct: 156 QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212

Query: 496 IFGGNQSEANTKRIVGT 512
               + S         T
Sbjct: 213 ETTSHNS---LTTPCYT 226

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 13/165 (7%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
           LG+GGFG V   ++    ++ A K+L +      +G     NE  ++ K+  + +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
              +  ++L L+   M    L   ++   ++      R +     I  GL  LH     +
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDLHR---ER 306

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           I++RDLK  N+LLD   + +ISD G+A      Q+    K  VGT
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 31/178 (17%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN---------E 391
           E  + + + + +G G +G V        G  +AVK+LSR        F++         E
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRE 78

Query: 392 VTLIAKLQHKNLVRLL------GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKR 445
           + L+  ++H+N++ LL          + N+  L+   M    LN  +    +  +L    
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV----KCQKLTDDH 133

Query: 446 RISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
              +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      + 
Sbjct: 134 VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 32/176 (18%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN---------E 391
              + + +   +G G  G V         + +A+K+LSR        F+N         E
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRE 74

Query: 392 VTLIAKLQHKNLVRLL------GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKR 445
           + L+  + HKN++ LL          +  +  ++ E M   +L   +    +  +LD +R
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QM-ELDHER 128

Query: 446 RISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
              ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G + 
Sbjct: 129 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 19/153 (12%), Positives = 46/153 (30%), Gaps = 22/153 (14%)

Query: 352 KLGEGGFGPVYKGKLAD---GKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVR 405
             G       ++    D    +++A+  +          LQE  +    ++++    + R
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSV---QLDWKRRISIINGIARGLLYLHE 462
           +L         L++ E++   SL        + V          I  +  +A      H 
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSL--------QEVADTSPSPVGAIRAMQSLAAAADAAH- 146

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
             R  +       S V +  + +  ++      
Sbjct: 147 --RAGVALSIDHPSRVRVSIDGDVVLAYPATMP 177

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 47/180 (26%), Positives = 89/180 (49%), Gaps = 28/180 (15%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN---------E 391
              + +    KLG+G +G V+K      G+ +AVK++          F+N         E
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFRE 58

Query: 392 VTLIAKLQ-HKNLVRLLGCCLQEN--ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRIS 448
           + ++ +L  H+N+V LL     +N  +  L+++YM    L+  +    R+  L+   +  
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI----RANILEPVHKQY 113

Query: 449 IINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           ++  + + + YLH  S   ++HRD+K SN+LL+ E + K++DFG++R F   +   N   
Sbjct: 114 VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 32/176 (18%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN---------E 391
              + + +   +G G  G V         + +A+K+LSR        F+N         E
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRE 111

Query: 392 VTLIAKLQHKNLVRLL------GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKR 445
           + L+  + HKN++ LL          +  +  L+ E M    L   +      ++LD +R
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-----QMELDHER 165

Query: 446 RISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
              ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G + 
Sbjct: 166 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 70.7 bits (172), Expect = 2e-13
 Identities = 34/216 (15%), Positives = 64/216 (29%), Gaps = 52/216 (24%)

Query: 326 QEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS---- 381
           Q+    F           T+      K+GEG FG V++   AD   +A+K ++       
Sbjct: 7   QKGPVPFSHCL------PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLV 59

Query: 382 ----GQGLQEFKNEVTLIAKLQ---------HKNLVRLLGCCL----------------- 411
                +  +E   E+ +  +L           +  + L                      
Sbjct: 60  NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119

Query: 412 --QENESLLIYEYMPNKSLNVFLF-------DSTRSVQLDWKRRISIINGIARGLLYLHE 462
             + + +     +  ++   V  F       +  R+         SI++ +   L     
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA 179

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 498
              L+  HRDL   NVLL      K+      +   
Sbjct: 180 --SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 24/202 (11%)

Query: 324 QKQEESQEFPLFPLHLAVEATQHFSDEN-----KLGEGGFGPVYKGKLADGKEI-AVKRL 377
           QK  ES +F  F     VE   H +  +      +G GGFG VY  + AD  ++ A+K L
Sbjct: 163 QKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 222

Query: 378 SRT---SGQGLQEFKNE---VTLIAKLQHKNLVRLLGCCLQENESL-LIYEYMPNKSLNV 430
            +      QG     NE   ++L++      +V +        + L  I + M    L  
Sbjct: 223 DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL-- 279

Query: 431 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD 490
             +  ++               I  GL ++H      +++RDLK +N+LLD   + +ISD
Sbjct: 280 -HYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISD 335

Query: 491 FGMARIFGGNQSEANTKRIVGT 512
            G+A  F   +        VGT
Sbjct: 336 LGLACDFSKKK----PHASVGT 353

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 37/179 (20%), Positives = 60/179 (33%), Gaps = 58/179 (32%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKN 402
            +      LG G  G V +       ++ A+K L         + + EV L  +  Q  +
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 72

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVF----------LFDSTRSVQLDWKRRI----- 447
           +VR++           +YE +      +           LF            RI     
Sbjct: 73  IVRIVD----------VYENLYAGRKCLLIVMECLDGGELFS-----------RIQDRGD 111

Query: 448 ---------SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFGMA 494
                     I+  I   + YLH    + I HRD+K  N+L   +      K++DFG A
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 33/163 (20%), Positives = 59/163 (36%), Gaps = 19/163 (11%)

Query: 350 ENKLGEGGFGPVYKGKL------ADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHK 401
              LG G FG V +         A  + +AVK L    +    +   +E+ ++  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 402 NLVRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
           N+V LLG C +    L +I E+    +L+ +L            +R   +    +G  + 
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
                +  I  DLK     +    +   S F   +     + E
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 495
           +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 41/180 (22%), Positives = 75/180 (41%), Gaps = 31/180 (17%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKN---------E 391
             +  F  ++ LGEG +G V        G+ +A+K++          F           E
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLRE 59

Query: 392 VTLIAKLQHKNLVRLL-----GCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR 446
           + ++   +H+N++ +            NE  +I E M    L+  +     +  L     
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHI 114

Query: 447 ISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
              I    R +  LH  +   +IHRDLK SN+L++   + K+ DFG+ARI   + ++ + 
Sbjct: 115 QYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 28/155 (18%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEF---KNEVTLIAKLQHKNLVRLLG 408
           LG G FG V+  +        A+K L +     L++     +E  +++ + H  ++R+ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLY 459
              Q+ + + +I +Y+    L  F         L   +R    N +A+         L Y
Sbjct: 74  TF-QDAQQIFMIMDYIEGGEL--FS-------LLRKSQRFP--NPVAKFYAAEVCLALEY 121

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           LH      II+RDLK  N+LLD   + KI+DFG A
Sbjct: 122 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFA 153

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 28/161 (17%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEF---KNEVTLIAKLQHKNLVRLLG 408
           LG G FG V   K  +     A+K L +     L++     NE  ++  +    LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLY 459
              ++N +L ++ EY+    +  F         L    R S     AR           Y
Sbjct: 109 SF-KDNSNLYMVMEYVAGGEM--FS-------HLRRIGRFS--EPHARFYAAQIVLTFEY 156

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 500
           LH    L +I+RDLK  N+L+D +   +++DFG A+   G 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 43/173 (24%), Positives = 67/173 (38%), Gaps = 30/173 (17%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQE---FKNEVTLIAKLQHKNLVRLLG 408
           +G G FG V   +    +++ A+K LS+       +   F  E  ++A      +V+L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR--------GLLY 459
              Q++  L ++ EYMP   L          V L     +      AR         L  
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVP--EKWARFYTAEVVLALDA 183

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +H    +  IHRD+K  N+LLD   + K++DFG                 VGT
Sbjct: 184 IHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGT 232

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 41/170 (24%), Positives = 69/170 (40%), Gaps = 28/170 (16%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKN---EVTLIAKLQH 400
            HF     +G+G FG V   +  D K++ A+K +++       E +N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 401 KNLVRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR---- 455
             LV L     Q+ E + ++ + +    L        R   L             +    
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDL--------RY-HLQQNVHFK--EETVKLFIC 122

Query: 456 ----GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 501
                L YL      +IIHRD+K  N+LLD   +  I+DF +A +     
Sbjct: 123 ELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 36/165 (21%), Positives = 66/165 (40%), Gaps = 12/165 (7%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQE---FKNEVTLIAKLQHKNLVRLLG 408
           +G G F  V   K+    ++ A+K +++       E   F+ E  ++     + + +L  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
              Q+   L L+ EY     L   L      +  +  R    +  I   +  +H    L 
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR--FYLAEIVMAIDSVHR---LG 182

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            +HRD+K  N+LLD   + +++DFG       +     +   VGT
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGT 226

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 62.9 bits (153), Expect = 8e-11
 Identities = 37/165 (22%), Positives = 70/165 (42%), Gaps = 12/165 (7%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQE---FKNEVTLIAKLQHKNLVRLLG 408
           +G G FG V   KL +  ++ A+K L++       E   F+ E  ++     K +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 467
              Q++ +L L+ +Y     L   L      +  +  R    +  +   +  +H+   L 
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR--FYLAEMVIAIDSVHQ---LH 195

Query: 468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            +HRD+K  N+L+D   + +++DFG       +     +   VGT
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGT 239

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 43/165 (26%), Positives = 65/165 (39%), Gaps = 23/165 (13%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEF---KNEVTLIAKLQHKNLVRLLG 408
           LG+G FG V   K        A+K L +       E      E  ++   +H  L  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214

Query: 409 CCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI------INGIARGLLYLH 461
              Q ++ L  + EY     L  F         L  +R  S          I   L YLH
Sbjct: 215 YSFQTHDRLCFVMEYANGGEL--FF-------HLSRERVFSEDRARFYGAEIVSALDYLH 265

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
             S   +++RDLK  N++LD + + KI+DFG+ +    + +   T
Sbjct: 266 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 21/164 (12%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVT--------LIAKLQHKNL 403
           LG+G FG V+  +     +  A+K L +     +    ++V         L    +H  L
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKK----DVVLMDDDVECTMVEKRVLSLAWEHPFL 80

Query: 404 VRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
             +  C  Q  E+L  + EY+    L   ++      + D  R       I  GL +LH 
Sbjct: 81  THMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
                I++RDLK  N+LLD + + KI+DFGM +      ++ NT
Sbjct: 137 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 177

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 21/152 (13%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVT--------LIAKLQHKNL 403
           LG+G FG V   +     E+ AVK L +     +    ++V         L    +   L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKK----DVVIQDDDVECTMVEKRVLALPGKPPFL 404

Query: 404 VRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
            +L   C Q  + L  + EY+    L   ++   +  +      +     IA GL +L  
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
                II+RDLK  NV+LD E + KI+DFGM 
Sbjct: 461 ---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 489

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 21/164 (12%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVT--------LIAKLQHKNL 403
           LG+G FG V   ++ +  ++ AVK L +     + +  ++V         L     H  L
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKK---DVILQ-DDDVECTMTEKRILSLARNHPFL 86

Query: 404 VRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
            +L  CC Q  + L  + E++    L   +F   +S + D  R       I   L++LH+
Sbjct: 87  TQLF-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISALMFLHD 142

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
                II+RDLK  NVLLDHE + K++DFGM +    N     T
Sbjct: 143 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 39/157 (24%), Positives = 63/157 (40%), Gaps = 32/157 (20%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVT-------LIAKLQHKNLV 404
           LG+G FG V   +        A+K L +     +   K+EV        ++   +H  L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEV---IIA-KDEVAHTVTESRVLQNTRHPFLT 68

Query: 405 RLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI------INGIARGL 457
            L     Q ++ L  + EY     L  F         L  +R  +          I   L
Sbjct: 69  ALK-YAFQTHDRLCFVMEYANGGEL--FF-------HLSRERVFTEERARFYGAEIVSAL 118

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
            YLH      +++RD+K  N++LD + + KI+DFG+ 
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLC 152

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 59.9 bits (146), Expect = 6e-10
 Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 21/152 (13%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVT--------LIAKLQHKNL 403
           LG+G FG V   +     E+ AVK L +     + +  ++V         L    +   L
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKPPFL 83

Query: 404 VRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
            +L   C Q  + L  + EY+    L   ++   +  +      +     IA GL +L  
Sbjct: 84  TQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
                II+RDLK  NV+LD E + KI+DFGM 
Sbjct: 140 ---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 168

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 43/158 (27%), Positives = 65/158 (41%), Gaps = 33/158 (20%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVT--------LIAKLQHKNL 403
           +G+G FG V   +    +   AVK L +     L+  K E          L+  ++H  L
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQK--KAILK--KKEEKHIMSERNVLLKNVKHPFL 101

Query: 404 VRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI------INGIARG 456
           V L     Q  + L  + +Y+    L  F         L  +R             IA  
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGEL--FY-------HLQRERCFLEPRARFYAAEIASA 151

Query: 457 LLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
           L YLH    L I++RDLK  N+LLD + +  ++DFG+ 
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLC 186

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 59.1 bits (144), Expect = 8e-10
 Identities = 43/172 (25%), Positives = 80/172 (46%), Gaps = 34/172 (19%)

Query: 353 LGEGGFGPVY---KGKLADGKEI-AVKRLSRTSGQGLQEFKNEVT-------LIAKLQHK 401
           LG+GG+G V+   K   A+  +I A+K L +     +     +         ++ +++H 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKDTAHTKAERNILEEVKHP 81

Query: 402 NLVRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI------INGIA 454
            +V L+    Q    L LI EY+    L  F+       QL+ +           +  I+
Sbjct: 82  FIVDLI-YAFQTGGKLYLILEYLSGGEL--FM-------QLEREGIFMEDTACFYLAEIS 131

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
             L +LH+     II+RDLK  N++L+H+ + K++DFG+ +    + +  +T
Sbjct: 132 MALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 43/164 (26%), Positives = 65/164 (39%), Gaps = 21/164 (12%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVT--------LIAKLQHKNL 403
           +G G +  V   +L     I A++ + +     L     ++               H  L
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKK----ELVNDDEDIDWVQTEKHVFEQASNHPFL 115

Query: 404 VRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           V L   C Q    L  + EY+    L   +F   R  +L  +        I+  L YLHE
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHE 171

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
                II+RDLK  NVLLD E + K++D+GM +         +T
Sbjct: 172 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 58.3 bits (142), Expect = 2e-09
 Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 40/174 (22%)

Query: 353 LGEGGFGPVY---KGKLADGKEI-AVKRLSRTSGQGLQEFKNEV-TLI-----AKLQHKN 402
           LG+G FG V+   K   +D +++ A+K L + +   L+  ++ V T +      ++ H  
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT---LKV-RDRVRTKMERDILVEVNHPF 87

Query: 403 LVRLLGCCLQENESL-LIYEYMPNKSL-----NVFLFDSTRSV----QLDWKRRISIING 452
           +V+L     Q    L LI +++    L        +F          +            
Sbjct: 88  IVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE------------ 134

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           +A  L +LH    L II+RDLK  N+LLD E + K++DFG+++    ++ +A +
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 44/164 (26%), Positives = 65/164 (39%), Gaps = 21/164 (12%)

Query: 353 LGEGGFGPVYKGKLADGKEI-AVKRLSRTSGQGLQEFKNEVT--------LIAKLQHKNL 403
           +G G +  V   +L     I A+K + +     L     ++               H  L
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKK----ELVNDDEDIDWVQTEKHVFEQASNHPFL 72

Query: 404 VRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           V L   C Q    L  + EY+    L   +F   R  +L  +        I+  L YLHE
Sbjct: 73  VGLH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHE 128

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
                II+RDLK  NVLLD E + K++D+GM +         +T
Sbjct: 129 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 42/161 (26%), Positives = 68/161 (42%), Gaps = 35/161 (21%)

Query: 353 LGEGGFGPVY---KGKLADGKEI-AVKRLSRTSGQGLQEFKNEV--TLIAK--LQHKN-- 402
           LG G +G V+   K    D  ++ A+K L + +   + +       T   +  L+H    
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT---IVQKAKTTEHTRTERQVLEHIRQS 118

Query: 403 --LVRLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI------INGI 453
             LV L     Q    L LI +Y+    L  F         L  + R +       +  I
Sbjct: 119 PFLVTLH-YAFQTETKLHLILDYINGGEL--FT-------HLSQRERFTEHEVQIYVGEI 168

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 494
              L +LH+   L II+RD+K  N+LLD   +  ++DFG++
Sbjct: 169 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 206

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 37/157 (23%), Positives = 70/157 (44%), Gaps = 25/157 (15%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV-RLLGC 409
           K+G G FG +Y G  +A G+E+A+K     +     +   E  +   +Q    +  +  C
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI--INGIARGLL----YLHED 463
             + + ++++ E +   SL   LF+          R+ S+  +  +A  ++    Y+H  
Sbjct: 74  GAEGDYNVMVMELL-GPSLE-DLFNFC-------SRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPK---ISDFGMARIF 497
           +    IHRD+K  N L+          I DFG+A+ +
Sbjct: 125 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 38/165 (23%), Positives = 65/165 (39%), Gaps = 27/165 (16%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH-KNL 403
           +F    K+G G FG +  GK L   + +A+K     S     +   E     +L     +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI--INGIARGLL--- 458
            ++         + ++ E +   SL   LFD          R  S+  +  IA  L+   
Sbjct: 68  PQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLC-------DRTFSLKTVLMIAIQLISRM 118

Query: 459 -YLHEDSRLKIIHRDLKTSNVLLDHEMNPK-----ISDFGMARIF 497
            Y+H  +   +I+RD+K  N L+    N       I DF +A+ +
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 40/164 (24%), Positives = 60/164 (36%), Gaps = 35/164 (21%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVK---RLSRTSGQGLQEFKNEVTLIAKLQH------ 400
           + +G+G FG V K     + + +A+K          Q       EV L+  +        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115

Query: 401 KNLVRLLGC-------CL-QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING 452
             +V L          CL  E  S  +Y+ + N +      + TR               
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK----------FAQQ 165

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMA 494
           +   LL+L     L IIH DLK  N+LL +      KI DFG +
Sbjct: 166 MCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 34/159 (21%), Positives = 70/159 (44%), Gaps = 27/159 (16%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV-RLLGC 409
           ++GEG FG +++G  L + +++A+K   R S     + ++E      L     +  +   
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISI--INGIARGLL----YLHED 463
             +   ++L+ + +   SL   L D          R+ S+  +   A+ +L     +HE 
Sbjct: 75  GQEGLHNVLVIDLLG-PSLE-DLLDLC-------GRKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPK-----ISDFGMARIF 497
           S   +++RD+K  N L+    +       + DFGM + +
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.2 bits (124), Expect = 3e-07
 Identities = 90/586 (15%), Positives = 153/586 (26%), Gaps = 214/586 (36%)

Query: 1   LLQSSSAAAK------LDSNY--LYHFCVRESNTSSLF--MYNVGTLFYGKLYNEGGRYL 50
           LL       +      L  NY  L      E    S+   MY        +LYN+   + 
Sbjct: 71  LLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE---QRDRLYNDNQVFA 127

Query: 51  YYN------------ATEGDDPNK---VYGLYHCYFGVS---IEVCQ------------- 79
            YN            A     P K   + G+     G +   ++VC              
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS--GKTWVALDVCLSYKVQCKMDFKIF 185

Query: 80  -------NCIKALINTLVTNCT-----------GSKGAIIWYDQCMLRFSNISFVSTLGL 121
                  N  + ++  L                 S    +           +     L  
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-----LKS 240

Query: 122 APY----VILSQVTNFTDPDKVTN---ILVQSINDLIQNVTSRD-SNSKYAAAAQMVNAS 173
            PY    ++L  V N    +       IL+          T+R    + + +AA   + S
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSCKILL----------TTRFKQVTDFLSAATTTHIS 290

Query: 174 SIDKIWTL------------VQCIPY-LSKSDCNI----------CLRQTVSRIS-SRYY 209
                 TL            + C P  L +                +R  ++     ++ 
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV 350

Query: 210 G--------RQSVRALSPSCIIR--YEMYPFFEEPTAPISPPNKKSGSSNDSGKKKTKES 259
                      S+  L P+   R  ++    F   +A I                     
Sbjct: 351 NCDKLTTIIESSLNVLEPA-EYRKMFDRLSVFPP-SAHIPT--------------ILLS- 393

Query: 260 RTWIAIGAAASSIIVLALSCFLLWCMKRRKERVK-------EEKANSQETRSLH------ 306
             W  +  +   ++V  L  + L   K+ KE          E K   +   +LH      
Sbjct: 394 LIWFDVIKSDVMVVVNKLHKYSL-VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH 452

Query: 307 --LADGRIGNDYSYDVLRG----------QKQEESQEFPLFPLHLAVEATQHFSD----E 350
             +      +D     L            +  E  +   LF           F D    E
Sbjct: 453 YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR--------MVFLDFRFLE 504

Query: 351 NKL--------GEGGFGPV------YKGKLADGKEIAVKRLSRTSGQGLQEF--KNEVTL 394
            K+          G           YK  + D  +   +RL       + +F  K E  L
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICD-NDPKYERLVNA----ILDFLPKIEENL 559

Query: 395 IAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQ 440
           I   ++ +L+R+    L   E   I+E            ++ + VQ
Sbjct: 560 I-CSKYTDLLRI---ALM-AEDEAIFE------------EAHKQVQ 588

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.0 bits (108), Expect = 3e-05
 Identities = 34/246 (13%), Positives = 67/246 (27%), Gaps = 83/246 (33%)

Query: 280 FLLWCMKRRKERV---------------------KEEKANSQETRSLHLADGRIGNDYS- 317
            L W +  ++E +                      E++  S  TR       R+ ND   
Sbjct: 66  RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125

Query: 318 ---YDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKL---GEGGFGPVYKGKLADGKE 371
              Y+V R Q   + ++           A         +   G  G G   K  +A    
Sbjct: 126 FAKYNVSRLQPYLKLRQ-----------ALLELRPAKNVLIDGVLGSG---KTWVA---- 167

Query: 372 IAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL-----LIYEYMPNK 426
           + V    +       +   ++  +           L  C      L     L+Y+  PN 
Sbjct: 168 LDVCLSYKV----QCKMDFKIFWLN----------LKNCNSPETVLEMLQKLLYQIDPNW 213

Query: 427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP 486
           +       + +      +  +                 RL +  +  +   ++L +  N 
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELR----------------RL-LKSKPYENCLLVLLNVQNA 256

Query: 487 KISD-F 491
           K  + F
Sbjct: 257 KAWNAF 262

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 35/173 (20%), Positives = 63/173 (36%), Gaps = 43/173 (24%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ----------- 399
           KLG G F  V+  K + +   +A+K + R      +  ++E+ L+ ++            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 400 HKNLVRLLG------------CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI 447
             ++++LL               + E     +   +             +          
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--------- 135

Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP------KISDFGMA 494
            I   +  GL Y+H   R  IIH D+K  NVL++   +P      KI+D G A
Sbjct: 136 -ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 34/157 (21%), Positives = 69/157 (43%), Gaps = 25/157 (15%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV-RLLGC 409
           K+G G FG +Y G  +   +E+A+K  +  +     +   E  +   LQ    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71

Query: 410 CLQENESLLIYEYMPNKSLNVFLFD------STRSVQLDWKRRISIINGIARGLLYLHED 463
            ++ + ++L+ + +   SL   LF+      S ++V +   + I+ +        ++H  
Sbjct: 72  GVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVE-------FVHSK 122

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPK---ISDFGMARIF 497
           S    +HRD+K  N L+          I DFG+A+ +
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 33/179 (18%), Positives = 67/179 (37%), Gaps = 49/179 (27%)

Query: 352 KLGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQGLQEFK-----NEVTLIAKLQH 400
            +G+GGFG +Y         +       VK     +G    E K      +   I K   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 401 KNLVRLLG-----CCLQENESLLIYEYMPNKSLNVF---------LFDSTRSVQLDWKRR 446
              ++ LG          +++   Y +M      +          ++++         +R
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFM------IMDRFGSDLQKIYEAN-------AKR 148

Query: 447 ISI--INGIARGLL----YLHEDSRLKIIHRDLKTSNVLLDHEMNPKI--SDFGMARIF 497
            S   +  ++  +L    Y+HE      +H D+K SN+LL+++   ++   D+G+A  +
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 37/162 (22%)

Query: 353 LGEGGFGPVYKGK-LADGKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHK------N 402
           +G+G FG V K       + +A+K +    R   Q       E+ ++  L+ +      N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTMN 160

Query: 403 LVRLLGC-------CL-QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIA 454
           ++ +L         C+  E  S+ +YE +       F   S   V+          + I 
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGF---SLPLVR-------KFAHSIL 210

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMA 494
           + L  LH   + +IIH DLK  N+LL  +     K+ DFG +
Sbjct: 211 QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 47.0 bits (112), Expect = 8e-06
 Identities = 28/187 (14%), Positives = 61/187 (32%), Gaps = 51/187 (27%)

Query: 345 QHFSDENKLGEGGFGPVYKGK---------LADGKEIAVKRLSRTSGQGLQEFK------ 389
           + +  ++       G +Y+               ++ ++K L    G+   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 390 --NEVTLIAKLQHKNLV---RLLGCCLQENE------SLL------IYEYMPNKSLNVFL 432
              +V    KL    L+     +G  + +++        L        +  P   L    
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVL---- 156

Query: 433 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI--SD 490
             S RSV     R +  +        +LHE+     +H ++   N+ +D E   ++  + 
Sbjct: 157 --SERSVLQVACRLLDALE-------FLHENE---YVHGNVTAENIFVDPEDQSQVTLAG 204

Query: 491 FGMARIF 497
           +G A  +
Sbjct: 205 YGFAFRY 211

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 30/164 (18%), Positives = 59/164 (35%), Gaps = 22/164 (13%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIA---VKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLL 407
           K+G GGFG +Y        ++ A   VK   + +G    E K    + AK          
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV-AKKDCIKKWIER 102

Query: 408 GCCLQENESLLIY---EYMPNKSLNVFLFDS-TRSVQ--LDWKRRISI--INGIARGLL- 458
                    L           +S    + +     +Q             +  +   +L 
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLD 162

Query: 459 ---YLHEDSRLKIIHRDLKTSNVLLDHEMNPKI--SDFGMARIF 497
              Y+HE+     +H D+K +N+LL ++   ++  +D+G++  +
Sbjct: 163 VLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.2 bits (105), Expect = 7e-05
 Identities = 40/174 (22%), Positives = 64/174 (36%), Gaps = 34/174 (19%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVK---RLSRTSGQGLQEFKNEVTLIAKLQH-----KN 402
           K+G+G FG V   + + + K  AVK    + + +       K E  ++ K+Q+      N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97

Query: 403 LVRLLGC-------CL-QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIA 454
           +V+  G        CL  E     +YE +   + N F       ++            I 
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGF---HIEDIK-------LYCIEIL 147

Query: 455 RGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           + L YL +   + + H DLK  N+LLD     K          G       TK 
Sbjct: 148 KALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 36/180 (20%), Positives = 74/180 (41%), Gaps = 34/180 (18%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ--------HKN 402
           KLG G F  V+    +   K +A+K + +++    +   +E+ L+  ++         + 
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 403 LVRLLGC-----------CLQENESLLIYEYMPNKSLNVFLFDS-TRSVQLDWKRRISII 450
           +V+LL             C+       ++E +    L  ++  S  + + L   ++I  I
Sbjct: 103 VVQLLDDFKISGVNGTHICM-------VFEVL-GHHLLKWIIKSNYQGLPLPCVKKI--I 152

Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIV 510
             + +GL YLH  ++ +IIH D+K  N+LL             A  +  + +   +   V
Sbjct: 153 QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	512
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.98
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.98
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.97
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.97
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.96
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.96
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.96
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.96
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.95
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.95
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.95
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.95
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.94
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.94
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.94
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.94
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.94
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.94
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.94
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.94
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.94
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.94
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.94
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.94
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.93
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.93
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.93
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.93
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.93
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.93
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.93
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.93
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.93
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.93
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.93
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.93
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.93
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.93
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.93
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.93
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.93
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.93
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.93
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.93
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.93
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.93
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.93
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.93
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.93
3niz_A	311	Rhodanese family protein; structural genomics, str	99.93
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.93
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.93
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.93
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.93
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.93
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.93
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.93
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.93
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.93
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.93
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.93
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.93
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.93
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.93
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.93
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.93
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.93
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.93
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.93
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.93
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.92
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.92
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.92
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.92
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.92
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.92
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.92
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.92
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.92
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.92
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.92
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.92
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.92
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.92
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.92
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.92
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.92
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.92
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.92
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.92
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.92
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.92
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.92
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.92
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.92
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.92
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.92
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.92
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.92
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.92
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.92
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.92
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.92
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.92
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.92
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.92
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.92
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.92
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.92
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.92
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.92
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.92
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.92
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.92
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.92
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.92
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.92
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.92
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.92
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.92
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.92
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.91
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.91
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.91
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.91
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.91
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.91
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.91
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.91
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.91
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.91
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.91
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.91
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.91
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.91
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.91
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.91
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.91
3bhy_A	283	Death-associated protein kinase 3; death associate	99.91
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.91
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.91
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.91
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.91
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.91
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.91
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.91
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.91
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.91
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.91
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.91
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.91
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.91
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.91
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.91
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.91
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.91
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.91
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.91
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.91
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.91
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.91
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.91
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.91
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.91
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.91
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.91
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.91
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.91
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.91
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.91
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.91
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.91
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.91
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.91
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.91
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.91
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.91
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.91
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.91
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.91
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.91
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.91
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.91
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.91
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.91
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.91
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.91
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.9
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.9
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.9
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.9
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.9
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.9
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.9
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.9
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.9
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.9
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.9
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.9
3uqc_A	286	Probable conserved transmembrane protein; structur	99.9
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.9
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.9
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.9
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.9
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.9
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.9
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.9
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.9
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.9
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.9
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.9
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.9
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.9
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.9
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.89
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.89
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.89
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.89
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.89
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.89
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.89
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.89
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.89
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.89
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.89
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.89
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.89
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.89
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.89
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.89
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.88
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.88
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.88
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.88
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.88
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.88
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.88
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.87
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.87
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.87
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.86
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.86
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.82
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.97
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.52
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.48
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.42
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.28
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.2
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.14
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.09
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.85
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.84
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.8
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.63
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.43
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.01
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.91
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.91
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.77
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.69
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.34
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.31
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.02
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.95
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.05
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	92.95
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	92.25
3mes_A	424	Choline kinase; malaria, structural genomics, stru	91.67
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.69
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.06
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.73

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.3e-36  Score=294.52  Aligned_cols=165  Identities=30%  Similarity=0.524  Sum_probs=140.8

Q ss_pred             cCCccccccccccceeEEEEEeC------CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ++|...++||+|+||.||+|++.      ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45677889999999999999864      467899999988777778899999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcC----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          419 IYEYMPNKSLNVFLFDS----------TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                      |||||++|+|.++|+..          .....++|..++.|+.||++||.|||+++   ||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            99999999999999753          23457999999999999999999999974   999999999999999999999


Q ss_pred             eccCcccccCCCCCCcCccccccC
Q 043262          489 SDFGMARIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       489 ~DFGla~~~~~~~~~~~~~~~~Gt  512 (512)
                      +|||+|+..........+....||
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt  193 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLP  193 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEEC
T ss_pred             CCcccceecCCCCceeecCceecC
Confidence            999999987655433333334444

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.2e-36  Score=296.05  Aligned_cols=165  Identities=32%  Similarity=0.502  Sum_probs=133.9

Q ss_pred             cCCccccccccccceeEEEEEeC------CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ++|...++||+|+||.||+|++.      ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45666789999999999999864      477899999988777778899999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCce
Q 043262          419 IYEYMPNKSLNVFLFDSTR------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP  486 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~  486 (512)
                      |||||++|+|.++|+....            ..+++|..++.|+.|||.||.|||+.+   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999975422            346999999999999999999999974   9999999999999999999


Q ss_pred             EEeccCcccccCCCCCCcCccccccC
Q 043262          487 KISDFGMARIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       487 kl~DFGla~~~~~~~~~~~~~~~~Gt  512 (512)
                      ||+|||+++.+........++..+||
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt  223 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLP  223 (329)
T ss_dssp             EECCCC----------------CCCC
T ss_pred             EEcccccceeccCCCcceecCccccc
Confidence            99999999987655444334445554

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-35  Score=290.21  Aligned_cols=163  Identities=32%  Similarity=0.472  Sum_probs=138.1

Q ss_pred             CccccccccccceeEEEEEeC------CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          347 FSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      +...++||+|+||.||+|++.      +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+.+..+||
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            455678999999999999873      4678999999754 334568899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCce
Q 043262          420 YEYMPNKSLNVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP  486 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~  486 (512)
                      ||||++|+|.++|.....             ...++|..++.|+.|||.||.|||+++   ||||||||+||||++++++
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence            999999999999965321             246999999999999999999999974   9999999999999999999


Q ss_pred             EEeccCcccccCCCCCCcCccccccC
Q 043262          487 KISDFGMARIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       487 kl~DFGla~~~~~~~~~~~~~~~~Gt  512 (512)
                      ||+|||+++.+........++..+||
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt  210 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLP  210 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred             EECCcccceeccCCCceeEecccccC
Confidence            99999999987655443344445554

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=283.60  Aligned_cols=160  Identities=29%  Similarity=0.522  Sum_probs=131.2

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      +++...++||+|+||.||+|++.+  .||||.++..  +....++|.+|+.++++++|||||+++|++.+ +..+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            456778899999999999999853  6999998743  34456789999999999999999999998864 568999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  502 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~  502 (512)
                      |++|+|.++|+..  ...++|..++.|+.|||.||.|||+++   ||||||||+||||++++++||+|||+|+.......
T Consensus       113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            9999999999653  346999999999999999999999974   99999999999999999999999999998765544


Q ss_pred             CcCccccccC
Q 043262          503 EANTKRIVGT  512 (512)
Q Consensus       503 ~~~~~~~~Gt  512 (512)
                      ...++..+||
T Consensus       188 ~~~~~~~~GT  197 (307)
T 3omv_A          188 SQQVEQPTGS  197 (307)
T ss_dssp             ------CCCC
T ss_pred             ceeecccccC
Confidence            4444456676

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.3e-34  Score=279.19  Aligned_cols=162  Identities=28%  Similarity=0.427  Sum_probs=144.9

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+++. .+++.||||.+.+.   .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4688899999999999999986 56899999999643   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|.+++..   ...+++.....++.||+.||.|||+++   |+||||||+||||++++.+||+|||+|+.+..+
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999954   346999999999999999999999985   999999999999999999999999999998776


Q ss_pred             CCCcCccccccC
Q 043262          501 QSEANTKRIVGT  512 (512)
Q Consensus       501 ~~~~~~~~~~Gt  512 (512)
                      .....+..++||
T Consensus       186 ~~~~~~~~~~GT  197 (311)
T 4aw0_A          186 SKQARANSFVGT  197 (311)
T ss_dssp             TTCCCBCCCCSC
T ss_pred             CCcccccCcccC
Confidence            655556667887

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.6e-34  Score=282.50  Aligned_cols=159  Identities=27%  Similarity=0.451  Sum_probs=141.5

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ..|+..++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            4578888999999999999997 469999999997655555677899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE  503 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~  503 (512)
                      ++|+|.+++..    ..+++.....++.||+.||.|||+++   ||||||||+||||++++.+||+|||+|+.+..+...
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999999854    35999999999999999999999985   999999999999999999999999999988655432


Q ss_pred             cCccccccC
Q 043262          504 ANTKRIVGT  512 (512)
Q Consensus       504 ~~~~~~~Gt  512 (512)
                        ++.++||
T Consensus       227 --~~~~~GT  233 (346)
T 4fih_A          227 --RKSLVGT  233 (346)
T ss_dssp             --BCCCCSC
T ss_pred             --ccccccC
Confidence              3346776

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.3e-34  Score=282.58  Aligned_cols=152  Identities=24%  Similarity=0.447  Sum_probs=131.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...++||+|+||.||+++. .+|+.||||++...  .....+.|.+|+.+|++++|||||++++++.+.+..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5788899999999999999986 56999999999644  33456789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+++|+|.++|... +...+++...+.|+.||+.||.|||+++   ||||||||+||||++++.+||+|||+|+.+...
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999653 3446789999999999999999999985   999999999999999999999999999987643

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.1e-33  Score=283.92  Aligned_cols=159  Identities=27%  Similarity=0.451  Sum_probs=142.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      +.|...++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            5688889999999999999996 569999999998666666677999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE  503 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~  503 (512)
                      ++|+|.+++..    ..+++.....|+.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+......
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~  303 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  303 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence            99999999854    34899999999999999999999985   999999999999999999999999999988655432


Q ss_pred             cCccccccC
Q 043262          504 ANTKRIVGT  512 (512)
Q Consensus       504 ~~~~~~~Gt  512 (512)
                        .+.++||
T Consensus       304 --~~~~~GT  310 (423)
T 4fie_A          304 --RKSLVGT  310 (423)
T ss_dssp             --BCCCEEC
T ss_pred             --ccccccC
Confidence              3346776

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.1e-33  Score=274.02  Aligned_cols=161  Identities=27%  Similarity=0.400  Sum_probs=129.6

Q ss_pred             CCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCC----eeEEEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN----ESLLIYE  421 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lv~E  421 (512)
                      ++...++||+|+||.||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|++.+.+    ..+||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            456678999999999999998 5899999999654321 122345666677899999999999998764    5799999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ||++|+|.++|+.    ..++|..+++|+.|++.||.|||++     ..++||||||||+||||++++++||+|||+|+.
T Consensus        82 y~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            9999999999964    3589999999999999999999986     235799999999999999999999999999998


Q ss_pred             cCCCCCC--cCccccccC
Q 043262          497 FGGNQSE--ANTKRIVGT  512 (512)
Q Consensus       497 ~~~~~~~--~~~~~~~Gt  512 (512)
                      .......  ..+...+||
T Consensus       158 ~~~~~~~~~~~~~~~~GT  175 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGT  175 (303)
T ss_dssp             EETTTTEESCC-----CC
T ss_pred             ccCCCCceeeeccccccc
Confidence            8654432  223345665

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.6e-33  Score=268.85  Aligned_cols=157  Identities=31%  Similarity=0.436  Sum_probs=132.7

Q ss_pred             ccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEe----CCeeEEEE
Q 043262          348 SDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ----ENESLLIY  420 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~  420 (512)
                      ...++||+|+||.||+|+. .++..||||++...  .....+.|.+|+.++++++|||||++++++..    .+..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4567899999999999986 46889999999643  34456789999999999999999999999865    34579999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-CCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DFGla~~~~~  499 (512)
                      |||++|+|.+++..   ...+++..+..++.||+.||.|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999964   346999999999999999999999974 46999999999999974 78999999999987544


Q ss_pred             CCCCcCccccccC
Q 043262          500 NQSEANTKRIVGT  512 (512)
Q Consensus       500 ~~~~~~~~~~~Gt  512 (512)
                      ..    ++.++||
T Consensus       185 ~~----~~~~~GT  193 (290)
T 3fpq_A          185 SF----AKAVIGT  193 (290)
T ss_dssp             TS----BEESCSS
T ss_pred             Cc----cCCcccC
Confidence            32    3345676

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.2e-33  Score=270.74  Aligned_cols=154  Identities=26%  Similarity=0.443  Sum_probs=127.5

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCe-------
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE-------  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-------  415 (512)
                      ++|+..+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            3578889999999999999986 578999999997543 3445689999999999999999999999976543       


Q ss_pred             -----eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEec
Q 043262          416 -----SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD  490 (512)
Q Consensus       416 -----~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~D  490 (512)
                           .++||||+++|+|.+++.........++...+.|+.||+.||+|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                 6899999999999999976554455778888999999999999999985   99999999999999999999999


Q ss_pred             cCcccccCCCC
Q 043262          491 FGMARIFGGNQ  501 (512)
Q Consensus       491 FGla~~~~~~~  501 (512)
                      ||+|+.+..+.
T Consensus       162 FGla~~~~~~~  172 (299)
T 4g31_A          162 FGLVTAMDQDE  172 (299)
T ss_dssp             CCCC-------
T ss_pred             CccceecCCCc
Confidence            99999886654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.98  E-value=6.8e-33  Score=276.94  Aligned_cols=170  Identities=25%  Similarity=0.356  Sum_probs=141.9

Q ss_pred             HHHHhcCCccccccccccceeEEEEEeCC------CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCC-CccccceeeEE
Q 043262          340 AVEATQHFSDENKLGEGGFGPVYKGKLAD------GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQH-KNLVRLLGCCL  411 (512)
Q Consensus       340 ~~~~~~~~~~~~~lg~G~fG~Vy~~~~~~------g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~  411 (512)
                      ++...++|...++||+|+||.||+|++..      ++.||||++.... ....++|.+|+.+|.+++| ||||+++|+|.
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            33445778889999999999999998632      3579999997644 3446789999999999965 89999999997


Q ss_pred             eC-CeeEEEEEecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCC
Q 043262          412 QE-NESLLIYEYMPNKSLNVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN  477 (512)
Q Consensus       412 ~~-~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N  477 (512)
                      +. +..++|||||++|+|.++|+....             ...++|..++.|+.|||+||.|||+++   ||||||||+|
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~N  215 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN  215 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccc
Confidence            75 568999999999999999975321             345899999999999999999999984   9999999999


Q ss_pred             eeecCCCceEEeccCcccccCCCCCCcCccccccC
Q 043262          478 VLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       478 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt  512 (512)
                      |||++++.+||+|||+|+.+..+.....++...||
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt  250 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  250 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence            99999999999999999988766554444445554

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.98  E-value=3.8e-32  Score=261.66  Aligned_cols=150  Identities=25%  Similarity=0.489  Sum_probs=125.5

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++. .+|+.||||.+...   .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5788999999999999999986 56999999999643   2334567999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+ +|+|.+++..   ...+++.....++.||+.||+|||+++   |+||||||+||||++++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6899998854   346999999999999999999999985   999999999999999999999999999987654


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       166 ~  166 (275)
T 3hyh_A          166 N  166 (275)
T ss_dssp             -
T ss_pred             C
Confidence            3

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.97  E-value=1.9e-32  Score=270.78  Aligned_cols=157  Identities=26%  Similarity=0.331  Sum_probs=131.5

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      +.|...++||+|+||.||+|+. .+|+.||||+++....     +.+|+.+++.++|||||++++++.+.+..+|||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            4567778999999999999996 5689999999975432     246999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-ceEEeccCcccccCCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGGNQS  502 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DFGla~~~~~~~~  502 (512)
                      ++|+|.++|..   ...+++.....++.||+.||.|||+++   ||||||||+||||+.++ .+||+|||+|+.+..+..
T Consensus       133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999964   346999999999999999999999975   99999999999999987 699999999998865432


Q ss_pred             C---cCccccccC
Q 043262          503 E---ANTKRIVGT  512 (512)
Q Consensus       503 ~---~~~~~~~Gt  512 (512)
                      .   .....++||
T Consensus       207 ~~~~~~~~~~~GT  219 (336)
T 4g3f_A          207 GKSLLTGDYIPGT  219 (336)
T ss_dssp             -------CCCCCC
T ss_pred             ccceecCCccccC
Confidence            1   122335676

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.97  E-value=7.9e-33  Score=270.14  Aligned_cols=160  Identities=27%  Similarity=0.334  Sum_probs=130.0

Q ss_pred             cCCccccccccccceeEEEEEe----CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL----ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~----~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ++|+..++||+|+||.||+++.    ..++.||||.++...  ......+.+|+.++.+++|||||++++++.+.+..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4688899999999999999985    246789999996532  2234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++|+|.+++..   ...+++.....++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999964   346999999999999999999999985   9999999999999999999999999999775


Q ss_pred             CCCCCcCccccccC
Q 043262          499 GNQSEANTKRIVGT  512 (512)
Q Consensus       499 ~~~~~~~~~~~~Gt  512 (512)
                      .....  +..++||
T Consensus       178 ~~~~~--~~~~~GT  189 (304)
T 3ubd_A          178 DHEKK--AYSFCGT  189 (304)
T ss_dssp             ---CC--CCSCCCC
T ss_pred             CCCcc--ccccccC
Confidence            54332  2235676

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.96  E-value=8.8e-30  Score=258.75  Aligned_cols=161  Identities=24%  Similarity=0.420  Sum_probs=134.2

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEe------CCe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ------ENE  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~  415 (512)
                      ++|...++||+|+||.||+|+. .+|+.||||+++...  ....+.+.+|+.+|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5688899999999999999986 579999999997543  3345678999999999999999999998764      356


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .+||||||+ |+|.+++..   ...+++.....++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 789999853   456999999999999999999999985   9999999999999999999999999999


Q ss_pred             ccCCCC--CCcCccccccC
Q 043262          496 IFGGNQ--SEANTKRIVGT  512 (512)
Q Consensus       496 ~~~~~~--~~~~~~~~~Gt  512 (512)
                      .+....  .....+..+||
T Consensus       207 ~~~~~~~~~~~~~~~~~GT  225 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVAT  225 (398)
T ss_dssp             CC-------CCCCCSSCCC
T ss_pred             ecccCccccccccccceeC
Confidence            875432  22233446776

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.96  E-value=7.5e-29  Score=249.13  Aligned_cols=147  Identities=24%  Similarity=0.379  Sum_probs=130.6

Q ss_pred             HhcCCccccccccccceeEEEEEeC----CCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA----DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~----~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  417 (512)
                      ..++|...++||+|+||.||+|+.+    .++.||||++....  ....+.+|++++..+ +|||||++++++.+.+..+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4578999999999999999999752    46789999986543  345788999999998 6999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC-CceEEeccCcccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARI  496 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~-~~~kl~DFGla~~  496 (512)
                      +||||+++|+|.+++.      .+++.....++.||+.||.|||+++   |+||||||+||||+.+ +.+||+|||+|+.
T Consensus        97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999983      3899999999999999999999985   9999999999999877 7999999999997


Q ss_pred             cCCC
Q 043262          497 FGGN  500 (512)
Q Consensus       497 ~~~~  500 (512)
                      ....
T Consensus       168 ~~~~  171 (361)
T 4f9c_A          168 THDT  171 (361)
T ss_dssp             CTTC
T ss_pred             cCCc
Confidence            6543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.96  E-value=5.9e-29  Score=263.94  Aligned_cols=158  Identities=27%  Similarity=0.347  Sum_probs=134.7

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHH---HHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQ---EFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~---~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++|...++||+|+||.||+++. .+|+.||||++.+..   .....   +...++.++..++|||||++++++.+.+..+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            5688889999999999999996 468999999996421   12222   3344567788899999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |||||+++|+|.++|..   ...+++.....++.||+.||.|||+++   ||||||||+||||+.++++||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999964   345999999999999999999999985   999999999999999999999999999988


Q ss_pred             CCCCCCcCccccccC
Q 043262          498 GGNQSEANTKRIVGT  512 (512)
Q Consensus       498 ~~~~~~~~~~~~~Gt  512 (512)
                      ..+..    ...+||
T Consensus       343 ~~~~~----~t~~GT  353 (689)
T 3v5w_A          343 SKKKP----HASVGT  353 (689)
T ss_dssp             SSCCC----CSCCSC
T ss_pred             CCCCC----CCccCC
Confidence            76542    335776

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.96  E-value=1.2e-28  Score=262.34  Aligned_cols=152  Identities=26%  Similarity=0.453  Sum_probs=137.8

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ++|...+.||+|+||.||+++. .+|+.||||.+........+.+.+|+.+|+.++|||||++++++.+.+..+||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            5788899999999999999986 569999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC--CceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE--MNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~--~~~kl~DFGla~~~~~~~  501 (512)
                      ++|+|.++|.+  +...+++.....++.||+.||.|||+++   |+||||||+||||+.+  +.+||+|||+|+.+..+.
T Consensus       237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            99999999854  2346899999999999999999999985   9999999999999854  789999999999987654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.95  E-value=4.5e-28  Score=240.40  Aligned_cols=161  Identities=43%  Similarity=0.736  Sum_probs=144.2

Q ss_pred             hhHHHHHhcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          337 LHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       337 ~~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      +.++...+++|...+.||+|+||.||+|+..+++.||||++........+.+.+|+.++..++||||+++++++...+..
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            33344567899999999999999999999988999999999877666778899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      ++||||+++|+|.+++..... ...++|..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999999865432 346999999999999999999999975   9999999999999999999999999998


Q ss_pred             ccCCC
Q 043262          496 IFGGN  500 (512)
Q Consensus       496 ~~~~~  500 (512)
                      .....
T Consensus       188 ~~~~~  192 (321)
T 2qkw_B          188 KGTEL  192 (321)
T ss_dssp             ECSSS
T ss_pred             ccccc
Confidence            76543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.95  E-value=6.2e-27  Score=230.47  Aligned_cols=167  Identities=41%  Similarity=0.663  Sum_probs=148.3

Q ss_pred             CCCCcChhHHHHHhcCCccc------cccccccceeEEEEEeCCCCEEEEEEcccC----CcccHHHHHHHHHHHhcCCC
Q 043262          331 EFPLFPLHLAVEATQHFSDE------NKLGEGGFGPVYKGKLADGKEIAVKRLSRT----SGQGLQEFKNEVTLIAKLQH  400 (512)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~----~~~~~~~~~~E~~~l~~l~H  400 (512)
                      ....+.+.++..++++|...      ++||+|+||.||+|.. ++..||||++...    .....+.+.+|+.++..++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45667888999999999877      8899999999999997 5889999998643    23346789999999999999


Q ss_pred             CccccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee
Q 043262          401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL  480 (512)
Q Consensus       401 ~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl  480 (512)
                      |||+++++++...+..++||||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999975444567999999999999999999999985   9999999999999


Q ss_pred             cCCCceEEeccCcccccCCCC
Q 043262          481 DHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       481 ~~~~~~kl~DFGla~~~~~~~  501 (512)
                      ++++.+||+|||+++......
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFA  187 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCS
T ss_pred             cCCCcEEEeeccccccccccc
Confidence            999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.95  E-value=8.5e-27  Score=231.30  Aligned_cols=162  Identities=25%  Similarity=0.400  Sum_probs=142.3

Q ss_pred             CCcChhHHHHHhcC----------CccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCC
Q 043262          333 PLFPLHLAVEATQH----------FSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK  401 (512)
Q Consensus       333 ~~~~~~~~~~~~~~----------~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~  401 (512)
                      +.++++++..+++.          |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++.+++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34556666655543          556678999999999999975 7999999999877666778899999999999999


Q ss_pred             ccccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec
Q 043262          402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD  481 (512)
Q Consensus       402 nIv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~  481 (512)
                      ||+++++++...+..++||||+++++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            999999999999999999999999999999843    35899999999999999999999975   99999999999999


Q ss_pred             CCCceEEeccCcccccCCCC
Q 043262          482 HEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       482 ~~~~~kl~DFGla~~~~~~~  501 (512)
                      .++.+||+|||+++.+..+.
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDV  195 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSS
T ss_pred             CCCcEEEeeeeeeeecccCc
Confidence            99999999999999876543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.95  E-value=2.8e-27  Score=235.11  Aligned_cols=170  Identities=44%  Similarity=0.755  Sum_probs=148.7

Q ss_pred             CCCcChhHHHHHhcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCc-ccHHHHHHHHHHHhcCCCCccccceeeE
Q 043262          332 FPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCC  410 (512)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~  410 (512)
                      ...+++.++....++|...+.||+|+||.||+++..++..||||++..... .....+.+|+.++..++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            455778888889999999999999999999999988899999999975432 2234689999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEe
Q 043262          411 LQENESLLIYEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  489 (512)
Q Consensus       411 ~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~  489 (512)
                      ...+..++||||+++|+|.+++.... ....++|..+..++.|++.||.|||+....+|+||||||+|||+++++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999997643 33459999999999999999999999844459999999999999999999999


Q ss_pred             ccCcccccCCCC
Q 043262          490 DFGMARIFGGNQ  501 (512)
Q Consensus       490 DFGla~~~~~~~  501 (512)
                      |||+++.+....
T Consensus       177 Dfg~~~~~~~~~  188 (326)
T 3uim_A          177 DFGLAKLMDYKD  188 (326)
T ss_dssp             CCSSCEECCSSS
T ss_pred             cCccccccCccc
Confidence            999999876443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.94  E-value=8.2e-27  Score=230.06  Aligned_cols=152  Identities=30%  Similarity=0.534  Sum_probs=137.2

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ++|...++||+|+||.||+++. .++..||+|.+........+.|.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            5677889999999999999997 468999999998777777889999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      ++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+....
T Consensus        90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999653  345899999999999999999999985   9999999999999999999999999999875443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.94  E-value=1e-26  Score=228.08  Aligned_cols=152  Identities=26%  Similarity=0.458  Sum_probs=138.1

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .++|...++||+|+||.||++.. .+++.||||.+........+.+.+|+.++..++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            35788889999999999999985 67899999999766666678899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  502 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~  502 (512)
                      +++|+|.+++...    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999999542    4899999999999999999999985   99999999999999999999999999998765543

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.94  E-value=2.2e-27  Score=194.03  Aligned_cols=104  Identities=21%  Similarity=0.444  Sum_probs=93.9

Q ss_pred             CcccccccCCCCCC-CCchHHHHHHHHHhhhhhhcCC-CCCccccccCC-CCCcEEEEEeccCCCChhhhHHHHHHHHHH
Q 043262           12 DSNYLYHFCVRESN-TSSLFMYNVGTLFYGKLYNEGG-RYLYYNATEGD-DPNKVYGLYHCYFGVSIEVCQNCIKALINT   88 (512)
Q Consensus        12 ~~~~~~~~c~~~~~-~~~~f~~~l~~l~~~l~~~~~~-~~~~~~~~~g~-~~~~vy~~~~C~~d~~~~~C~~C~~~a~~~   88 (512)
                      ++.++++.|++.+. ++++|++||+.||++|+++++. +.+|+++..|. ++++||||+|||||+++++|..||+.|+.+
T Consensus         2 ~t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~   81 (108)
T 3a2e_A            2 NTAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNR   81 (108)
T ss_dssp             CCCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTT
T ss_pred             CcceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHH
Confidence            56799999987766 8999999999999999998854 34577776664 569999999999999999999999999999


Q ss_pred             HHhhCCCCCcEEEEeceeEEEEccccc
Q 043262           89 LVTNCTGSKGAIIWYDQCMLRFSNISF  115 (512)
Q Consensus        89 ~~~~c~~~~~~~~~~~~C~~ry~~~~f  115 (512)
                      +.++||++++|+||++.|+||||+++|
T Consensus        82 ~~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           82 IFSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHHCCCCceEEEECCCEEEEEeCCcC
Confidence            999999999999999999999999998

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.94  E-value=9.2e-27  Score=231.47  Aligned_cols=154  Identities=25%  Similarity=0.416  Sum_probs=135.5

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCe------
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE------  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------  415 (512)
                      .++|...++||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++.+++||||+++++++.+.+.      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            456888899999999999999975 79999999997433 3456789999999999999999999999876542      


Q ss_pred             ---------------------------------------------------eEEEEEecCCCChhHHhhcCCCCCCCCHH
Q 043262          416 ---------------------------------------------------SLLIYEYMPNKSLNVFLFDSTRSVQLDWK  444 (512)
Q Consensus       416 ---------------------------------------------------~~lv~E~~~~gsL~~~l~~~~~~~~l~~~  444 (512)
                                                                         .++||||+++|+|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               79999999999999999876655667888


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          445 RRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       445 ~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      .++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  217 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  217 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence            89999999999999999985   999999999999999999999999999988665

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.94  E-value=7e-27  Score=232.50  Aligned_cols=151  Identities=31%  Similarity=0.490  Sum_probs=136.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .+|...+.||+|+||.||+++. .+|+.||||++...  .....+.+.+|+.++..++||||+++++++...+..++|||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            5788889999999999999997 67999999999653  33456778999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      |+++|+|.+++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+.
T Consensus        95 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           95 YASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             CCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            99999999998543   35899999999999999999999985   9999999999999999999999999999876543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.94  E-value=9.2e-27  Score=235.67  Aligned_cols=154  Identities=32%  Similarity=0.528  Sum_probs=135.2

Q ss_pred             cCCccccccccccceeEEEEEeC--------CCCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeCC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA--------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQEN  414 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~--------~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  414 (512)
                      ++|...+.||+|+||.||+++..        ++..||||.++... ....+.+.+|+.++..+ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            56888899999999999999852        34579999997543 34467899999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD  481 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~  481 (512)
                      ..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+++   |+||||||+||||+
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEEC
Confidence            99999999999999999975431             235899999999999999999999985   99999999999999


Q ss_pred             CCCceEEeccCcccccCCCC
Q 043262          482 HEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       482 ~~~~~kl~DFGla~~~~~~~  501 (512)
                      +++.+||+|||+++.+....
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~  257 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNID  257 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCC
T ss_pred             CCCCEEEccccCCcccCccc
Confidence            99999999999999876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.94  E-value=1e-26  Score=230.88  Aligned_cols=152  Identities=29%  Similarity=0.419  Sum_probs=132.6

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .++|...++||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367888999999999999999875 78999999986433 2334678999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+.
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999999843   345999999999999999999999975   9999999999999999999999999999775443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.94  E-value=6.3e-27  Score=241.28  Aligned_cols=155  Identities=21%  Similarity=0.266  Sum_probs=135.9

Q ss_pred             HHhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ...++|...++||+|+||.||+++.. +++.||||++....   ......+.+|..++..++||||+++++++.+.+..+
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            34578889999999999999999975 47889999986421   122334889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +||||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+
T Consensus       151 lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~  225 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL  225 (437)
T ss_dssp             EEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence            999999999999999652  345999999999999999999999975   999999999999999999999999999887


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ..+.
T Consensus       226 ~~~~  229 (437)
T 4aw2_A          226 MEDG  229 (437)
T ss_dssp             CTTS
T ss_pred             ccCC
Confidence            6554

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.94  E-value=1.9e-26  Score=230.14  Aligned_cols=149  Identities=24%  Similarity=0.306  Sum_probs=133.7

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++.. +++.||+|.++..   .......+.+|+.++..++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            56788899999999999999874 6899999999653   2345678899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++|+|..++..   ...+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999854   245899999999999999999999985   99999999999999999999999999987543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.94  E-value=1.5e-26  Score=234.41  Aligned_cols=152  Identities=30%  Similarity=0.582  Sum_probs=127.8

Q ss_pred             cCCccccccccccceeEEEEEeC----CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA----DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~----~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...+.||+|+||.||+|+..    ++..||||.++.. .....++|.+|+.++.+++||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            56888899999999999999864    5778999999754 344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       125 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          125 TEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999643  346899999999999999999999975   99999999999999999999999999998765


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      +.
T Consensus       200 ~~  201 (373)
T 2qol_A          200 DP  201 (373)
T ss_dssp             --
T ss_pred             CC
Confidence            43

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.94  E-value=7.9e-26  Score=227.74  Aligned_cols=152  Identities=28%  Similarity=0.402  Sum_probs=135.1

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc------ccHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG------QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      .++|...+.||+|+||.||+++.. +|..||||.+.....      ...+.+.+|+.++..++||||+++++++...+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            357888899999999999999974 689999999975432      2367899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC----ceEEeccC
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM----NPKISDFG  492 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~----~~kl~DFG  492 (512)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999943   346999999999999999999999985   99999999999998876    79999999


Q ss_pred             cccccCCCC
Q 043262          493 MARIFGGNQ  501 (512)
Q Consensus       493 la~~~~~~~  501 (512)
                      +++.+..+.
T Consensus       165 ~a~~~~~~~  173 (361)
T 2yab_A          165 LAHEIEDGV  173 (361)
T ss_dssp             SCEECCTTC
T ss_pred             CceEcCCCC
Confidence            999876543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.93  E-value=2.9e-26  Score=227.90  Aligned_cols=151  Identities=29%  Similarity=0.551  Sum_probs=133.7

Q ss_pred             cCCccccccccccceeEEEEEeC----CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA----DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~----~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...++||+|+||.||+|+..    .+..||||.++.. .....+.|.+|+.++..++||||+++++++...+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56778899999999999999974    3456999999754 344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       129 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             eeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            9999999999999643  345999999999999999999999985   99999999999999999999999999998765


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      +
T Consensus       204 ~  204 (325)
T 3kul_A          204 D  204 (325)
T ss_dssp             -
T ss_pred             C
Confidence            4

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.93  E-value=2.1e-26  Score=228.60  Aligned_cols=162  Identities=31%  Similarity=0.477  Sum_probs=135.3

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCC----eeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN----ESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lv~  420 (512)
                      ++|...++||+|+||.||+|+.. ++.||||++..... ....+..|+.++.+++||||+++++++....    ..++||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            57888899999999999999986 78999999965432 2345667899999999999999999998754    369999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------CCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-------SRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      ||+++|+|.+++..    ..+++..++.++.||+.||.|||+.       ...+|+||||||+|||++.++.+||+|||+
T Consensus       102 e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          102 AFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            99999999999954    2489999999999999999999987       011499999999999999999999999999


Q ss_pred             ccccCCCCCCcCccccccC
Q 043262          494 ARIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       494 a~~~~~~~~~~~~~~~~Gt  512 (512)
                      ++.+.............||
T Consensus       178 a~~~~~~~~~~~~~~~~gt  196 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGT  196 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCC
T ss_pred             ccccccccCccccccCccC
Confidence            9988765543333334444

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.93  E-value=2.5e-26  Score=230.73  Aligned_cols=150  Identities=29%  Similarity=0.428  Sum_probs=133.2

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .++|...++||+|+||.||+++.. +++.||||+++..   .....+.+..|..++..+ +||||+++++++...+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            467888999999999999999964 5899999999753   233456788999999988 79999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++|+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999998543   45899999999999999999999985   9999999999999999999999999998654


Q ss_pred             C
Q 043262          499 G  499 (512)
Q Consensus       499 ~  499 (512)
                      .
T Consensus       176 ~  176 (353)
T 3txo_A          176 C  176 (353)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.93  E-value=1.9e-26  Score=227.57  Aligned_cols=155  Identities=33%  Similarity=0.587  Sum_probs=131.0

Q ss_pred             hcCCccccccccccceeEEEEEeCCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ..+|...++||+|+||.||+++. ++..||||.+....  ....++|.+|+.++.+++||||+++++++...+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            35688889999999999999987 58899999987543  3345689999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+++|+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            9999999999975443345899999999999999999999974 34999999999999999999999999999876543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.93  E-value=5.5e-26  Score=222.58  Aligned_cols=151  Identities=27%  Similarity=0.461  Sum_probs=133.5

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .++|...+.||+|+||.||+++. .++..||+|.+....   ....+.|.+|+.++.+++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            35788889999999999999986 468899999985432   33456899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++++|.+++...   ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999999543   35899999999999999999999985   99999999999999999999999999998754


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       164 ~  164 (294)
T 4eqm_A          164 T  164 (294)
T ss_dssp             -
T ss_pred             c
Confidence            4

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.93  E-value=1.4e-26  Score=233.05  Aligned_cols=162  Identities=27%  Similarity=0.400  Sum_probs=137.0

Q ss_pred             hhHHHHHhcCCccccccccccceeEEEEEe------CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCcccccee
Q 043262          337 LHLAVEATQHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLG  408 (512)
Q Consensus       337 ~~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~------~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g  408 (512)
                      ........++|...++||+|+||.||++++      .+++.||||+++... ....+.+.+|+.++.++ +||||+++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            333444567889999999999999999974      345789999997543 33456799999999999 7999999999


Q ss_pred             eEEeCCe-eEEEEEecCCCChhHHhhcCCC--------------------------------------------------
Q 043262          409 CCLQENE-SLLIYEYMPNKSLNVFLFDSTR--------------------------------------------------  437 (512)
Q Consensus       409 ~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------  437 (512)
                      ++.+.+. .++||||+++|+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            9988655 8999999999999999975432                                                  


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          438 -------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       438 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                                   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..+.
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                         122899999999999999999999985   9999999999999999999999999999875543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.93  E-value=1.9e-26  Score=232.87  Aligned_cols=150  Identities=21%  Similarity=0.250  Sum_probs=130.5

Q ss_pred             HhcCCccccccccccceeEEEEE------eCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC---CCccccceeeEEeC
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGK------LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLQE  413 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~------~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~  413 (512)
                      ..++|...++||+|+||.||+|+      ..+++.||||++....   ..++..|+.++..++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            34678888999999999999994      4568899999997543   457788888888886   99999999999999


Q ss_pred             CeeEEEEEecCCCChhHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC---------
Q 043262          414 NESLLIYEYMPNKSLNVFLFDS--TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH---------  482 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~---------  482 (512)
                      +..++||||+++|+|.+++...  .....+++..++.|+.||+.||.|||+.+   |+||||||+||||+.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            9999999999999999999642  13456999999999999999999999975   999999999999998         


Q ss_pred             --CCceEEeccCcccccC
Q 043262          483 --EMNPKISDFGMARIFG  498 (512)
Q Consensus       483 --~~~~kl~DFGla~~~~  498 (512)
                        ++.+||+|||+++.+.
T Consensus       217 ~~~~~~kl~DFG~a~~~~  234 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMK  234 (365)
T ss_dssp             --CTTEEECCCTTCEEGG
T ss_pred             cccCCEEEeeCchhhhhh
Confidence              8999999999998764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.93  E-value=1.9e-26  Score=235.97  Aligned_cols=154  Identities=21%  Similarity=0.278  Sum_probs=136.0

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ..++|...++||+|+||.||+++. .+++.||||++.+..   ....+.+.+|..++..++||||+++++++.+.+..++
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            457888899999999999999997 468999999996432   2223458899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++++||+|||+++.+.
T Consensus       139 VmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             EECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheecc
Confidence            99999999999999643  235899999999999999999999975   9999999999999999999999999999886


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      .+.
T Consensus       214 ~~~  216 (412)
T 2vd5_A          214 ADG  216 (412)
T ss_dssp             TTS
T ss_pred             CCC
Confidence            544

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.93  E-value=7.6e-26  Score=224.12  Aligned_cols=154  Identities=26%  Similarity=0.434  Sum_probs=136.0

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCC--eeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN--ESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lv~  420 (512)
                      ++|...++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56788899999999999999975 58999999997543 344678899999999999999999999998765  679999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee----cCCCceEEeccCcccc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMARI  496 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl----~~~~~~kl~DFGla~~  496 (512)
                      ||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999976555555999999999999999999999985   9999999999999    7888899999999998


Q ss_pred             cCCCC
Q 043262          497 FGGNQ  501 (512)
Q Consensus       497 ~~~~~  501 (512)
                      +..+.
T Consensus       166 ~~~~~  170 (319)
T 4euu_A          166 LEDDE  170 (319)
T ss_dssp             CCTTC
T ss_pred             cCCCC
Confidence            76554

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.93  E-value=4.7e-26  Score=230.93  Aligned_cols=150  Identities=25%  Similarity=0.400  Sum_probs=134.8

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...   .....+.+.+|+.++..++||||+++++++...+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888899999999999999864 5889999998643   2344678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+..+
T Consensus        95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999954   345999999999999999999999985   999999999999999999999999999987654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.93  E-value=1.7e-26  Score=234.41  Aligned_cols=151  Identities=30%  Similarity=0.511  Sum_probs=134.4

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|+||.||+|++. ++..||||.++... ....++|.+|+.++.+++||||+++++++...+..++||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            56778899999999999999985 78999999997543 23345789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++....+
T Consensus       194 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          194 VQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            9999999999642  235899999999999999999999985   999999999999999999999999999876543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.93  E-value=3.7e-26  Score=232.57  Aligned_cols=148  Identities=27%  Similarity=0.368  Sum_probs=130.0

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...++||+|+||.||+++.. +++.||||+++...   ....+.+..|..++.++ +||||+++++++...+..++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            56888899999999999999975 57889999997542   22334678899998876 899999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |||+++|+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       132 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999998642   45999999999999999999999985   9999999999999999999999999998743

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.93  E-value=2.7e-26  Score=224.64  Aligned_cols=151  Identities=32%  Similarity=0.616  Sum_probs=131.9

Q ss_pred             cCCccccccccccceeEEEEEe-----CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-----ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~  417 (512)
                      ++|...++||+|+||.||++++     .+++.||||++........+.|.+|+.++.+++||||+++++++...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            5678889999999999999984     36889999999877767778899999999999999999999998654  4589


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +||||+++|+|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        90 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999999999996532  35899999999999999999999975   999999999999999999999999999987


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      ..+
T Consensus       165 ~~~  167 (295)
T 3ugc_A          165 PQD  167 (295)
T ss_dssp             ---
T ss_pred             cCC
Confidence            654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.93  E-value=2e-26  Score=235.77  Aligned_cols=152  Identities=24%  Similarity=0.299  Sum_probs=134.1

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ..++|...++||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l  146 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  146 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            3567888999999999999999975 58899999986421   1223458899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++|+|.+++..    ..+++.....++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       147 V~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          147 VMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             EECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            9999999999999854    24899999999999999999999985   9999999999999999999999999999876


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      ...
T Consensus       220 ~~~  222 (410)
T 3v8s_A          220 KEG  222 (410)
T ss_dssp             TTS
T ss_pred             cCC
Confidence            543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.93  E-value=5.5e-26  Score=227.45  Aligned_cols=151  Identities=25%  Similarity=0.390  Sum_probs=133.3

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  417 (512)
                      ..++|...+.||+|+||.||+++.. +++.||||.++...   ....+.+..|..++..+ +||||+++++++...+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4477888999999999999999974 68899999997532   33456788899998876 9999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        95 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999999999999542   35899999999999999999999985   999999999999999999999999999875


Q ss_pred             CC
Q 043262          498 GG  499 (512)
Q Consensus       498 ~~  499 (512)
                      ..
T Consensus       169 ~~  170 (345)
T 1xjd_A          169 ML  170 (345)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.93  E-value=5.5e-26  Score=226.07  Aligned_cols=149  Identities=27%  Similarity=0.378  Sum_probs=124.3

Q ss_pred             cCCccccccccccceeEEEEEe----CCCCEEEEEEcccCC----cccHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL----ADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~----~~g~~vaVK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      ++|...++||+|+||.||+++.    .+++.||+|.++...    ......+.+|+.++..++||||+++++++...+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            5688889999999999999986    478999999997542    23355688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++||||+++|+|.+++...   ..+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           97 YLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            9999999999999998542   35889999999999999999999985   99999999999999999999999999987


Q ss_pred             cCC
Q 043262          497 FGG  499 (512)
Q Consensus       497 ~~~  499 (512)
                      ...
T Consensus       171 ~~~  173 (327)
T 3a62_A          171 SIH  173 (327)
T ss_dssp             ---
T ss_pred             ccc
Confidence            543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.93  E-value=7.6e-26  Score=229.98  Aligned_cols=155  Identities=32%  Similarity=0.499  Sum_probs=135.6

Q ss_pred             hcCCccccccccccceeEEEEEeC--------CCCEEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeC
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA--------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQE  413 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~--------~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  413 (512)
                      .++|...++||+|+||.||+++..        .+..||||++... .....+.+.+|++++.++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            367888899999999999999852        2357999999754 334467899999999999 999999999999999


Q ss_pred             CeeEEEEEecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee
Q 043262          414 NESLLIYEYMPNKSLNVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL  480 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl  480 (512)
                      +..++||||+++|+|.+++.....             ...+++..++.|+.||+.||.|||+.+   |+||||||+||||
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999975431             245999999999999999999999985   9999999999999


Q ss_pred             cCCCceEEeccCcccccCCCC
Q 043262          481 DHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       481 ~~~~~~kl~DFGla~~~~~~~  501 (512)
                      ++++.+||+|||+++.+....
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~  245 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHID  245 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCC
T ss_pred             cCCCcEEEcccCccccccccc
Confidence            999999999999999876543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.93  E-value=4.4e-26  Score=227.91  Aligned_cols=154  Identities=32%  Similarity=0.549  Sum_probs=135.7

Q ss_pred             HhcCCccccccccccceeEEEEEeC------CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCe
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE  415 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  415 (512)
                      ..++|...+.||+|+||.||+++..      ++..||||.++... ....+.|.+|+.++.+++||||+++++++...+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            3467888999999999999999874      34789999997543 3346789999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCC
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTR---------------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK  474 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk  474 (512)
                      .++||||+++|+|.+++.....                     ...+++..++.++.||+.||.|||+++   |+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            9999999999999999975321                     256899999999999999999999985   9999999


Q ss_pred             CCCeeecCCCceEEeccCcccccCC
Q 043262          475 TSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       475 ~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |+|||+++++.+||+|||+++.+..
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~  226 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYS  226 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTG
T ss_pred             cceEEECCCCeEEEeecCCCccccc
Confidence            9999999999999999999987643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.93  E-value=7.4e-26  Score=226.71  Aligned_cols=148  Identities=28%  Similarity=0.370  Sum_probs=131.8

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...+.||+|+||.||+++.. +++.||+|.+....   ....+.+.+|..++.++ +||||+++++++...+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46788899999999999999974 58899999997542   33456788999999987 899999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999998542   35899999999999999999999985   9999999999999999999999999998753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.93  E-value=1.7e-25  Score=222.49  Aligned_cols=150  Identities=27%  Similarity=0.408  Sum_probs=134.1

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc------ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG------QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++|...+.||+|+||.||+++.. ++..||||.+.....      ...+.+.+|+.++..++||||+++++++...+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            56788899999999999999974 689999999865322      24678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC----ceEEeccCc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM----NPKISDFGM  493 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~----~~kl~DFGl  493 (512)
                      +||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            99999999999999953   346999999999999999999999975   99999999999999887    799999999


Q ss_pred             ccccCCC
Q 043262          494 ARIFGGN  500 (512)
Q Consensus       494 a~~~~~~  500 (512)
                      ++.+..+
T Consensus       165 a~~~~~~  171 (326)
T 2y0a_A          165 AHKIDFG  171 (326)
T ss_dssp             CEECCTT
T ss_pred             CeECCCC
Confidence            9987644

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.93  E-value=7.2e-26  Score=224.19  Aligned_cols=149  Identities=28%  Similarity=0.408  Sum_probs=133.9

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++.. +|+.||+|.++..   .....+.+.+|..++..++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56788899999999999999874 6899999999653   2234677889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++|+|.+++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999643   45899999999999999999999975   99999999999999999999999999997654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=9.7e-26  Score=217.64  Aligned_cols=150  Identities=28%  Similarity=0.509  Sum_probs=135.3

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...+.||+|+||.||+++..++..||||++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            4677789999999999999999889999999997543 335789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....+
T Consensus        89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence            99999999643  345899999999999999999999985   999999999999999999999999999876543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.93  E-value=4.8e-26  Score=236.80  Aligned_cols=150  Identities=30%  Similarity=0.510  Sum_probs=134.3

Q ss_pred             hcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .++|...++||+|+||.||+|.+.++..||||+++... ...++|.+|+.++..++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            46678889999999999999999888999999997644 45788999999999999999999999986 66789999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||||++++.+||+|||+++.+..
T Consensus       265 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          265 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             TTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            999999999642 2235889999999999999999999985   99999999999999999999999999998754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.93  E-value=5.6e-26  Score=238.69  Aligned_cols=152  Identities=29%  Similarity=0.538  Sum_probs=136.4

Q ss_pred             hcCCccccccccccceeEEEEEeCC-CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ..+|...++||+|+||.||+|++.. +..||||.++... ...++|.+|+.+|.+++||||+++++++...+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            3567778899999999999999864 7899999997543 3468899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++|+|.+++.... ...+++..++.|+.||+.||.|||+++   |+||||||+||||++++.+||+|||+++.+..+
T Consensus       298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            99999999996532 345899999999999999999999985   999999999999999999999999999987654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.93  E-value=1.3e-25  Score=221.74  Aligned_cols=151  Identities=30%  Similarity=0.504  Sum_probs=132.1

Q ss_pred             hcCCccccccccccceeEEEEEeCCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .++|...++||+|+||.||+++..+++.||||++....  ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            36788889999999999999999889999999996432  2335678999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+++ +|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       100 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9984 787777542  345899999999999999999999985   999999999999999999999999999987543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.93  E-value=1e-25  Score=220.99  Aligned_cols=149  Identities=26%  Similarity=0.445  Sum_probs=127.3

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc--------------------------ccHHHHHHHHHHHhc
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG--------------------------QGLQEFKNEVTLIAK  397 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~--------------------------~~~~~~~~E~~~l~~  397 (512)
                      ++|...+.||+|+||.||+++. .+++.||||.+.....                          ...+.+.+|+.++.+
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            5788889999999999999986 4688999999864321                          123568999999999


Q ss_pred             CCCCccccceeeEEe--CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCC
Q 043262          398 LQHKNLVRLLGCCLQ--ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKT  475 (512)
Q Consensus       398 l~H~nIv~l~g~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~  475 (512)
                      ++||||+++++++..  .+..++||||+++++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp  165 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP  165 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence            999999999999987  567899999999999987652    346999999999999999999999985   99999999


Q ss_pred             CCeeecCCCceEEeccCcccccCCC
Q 043262          476 SNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       476 ~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +|||++.++.+||+|||+++.+...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~  190 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGS  190 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSS
T ss_pred             HHEEECCCCCEEEecCCCccccccc
Confidence            9999999999999999999987644

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.93  E-value=8.4e-26  Score=222.90  Aligned_cols=155  Identities=34%  Similarity=0.509  Sum_probs=135.7

Q ss_pred             hcCCccccccccccceeEEEEEe------CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~------~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      .++|...+.||+|+||.||+++.      .++..||||.+... .....+.+.+|+.++..++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            35688889999999999999985      34578999999754 334567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCC
Q 043262          417 LLIYEYMPNKSLNVFLFDSTR---------------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKT  475 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~  475 (512)
                      ++||||+++|+|.+++.....                     ...+++..++.++.||+.||.|||+++   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999975432                     234899999999999999999999985   99999999


Q ss_pred             CCeeecCCCceEEeccCcccccCCCC
Q 043262          476 SNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       476 ~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +|||+++++.+||+|||+++.+....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~  204 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEED  204 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTS
T ss_pred             heEEEcCCCCEEEccccccccccccc
Confidence            99999999999999999999875543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=2.1e-25  Score=221.25  Aligned_cols=152  Identities=20%  Similarity=0.345  Sum_probs=134.7

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .++|...+.||+|+||.||+++.. ++..+|+|.+.... .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            367888899999999999999874 57889999987543 3456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC--CCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH--EMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~--~~~~kl~DFGla~~~~~~  500 (512)
                      +++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.+..+
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999954  2346899999999999999999999985   999999999999987  789999999999988654


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       158 ~  158 (321)
T 1tki_A          158 D  158 (321)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.93  E-value=1.5e-25  Score=226.97  Aligned_cols=149  Identities=32%  Similarity=0.467  Sum_probs=128.2

Q ss_pred             ccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCC
Q 043262          348 SDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNK  426 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~g  426 (512)
                      ...+.||+|+||.||+++. .+|..||||.++.......+++.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            3356899999999999986 568999999998766666788999999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee--cCCCceEEeccCcccccCCCC
Q 043262          427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL--DHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl--~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||+  ++++.+||+|||+++.+....
T Consensus       172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            999988643  245899999999999999999999985   9999999999999  567899999999999886543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.93  E-value=2.3e-25  Score=224.65  Aligned_cols=153  Identities=26%  Similarity=0.413  Sum_probs=134.7

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ..++|...+.||+|+||.||++.. .++..||||.+...  .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            456788899999999999999987 46899999999654  334456799999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC---CceEEeccCcccc
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFGMARI  496 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~---~~~kl~DFGla~~  496 (512)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+|||+++.
T Consensus       107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999998853   346899999999999999999999985   9999999999999865   4599999999998


Q ss_pred             cCCCC
Q 043262          497 FGGNQ  501 (512)
Q Consensus       497 ~~~~~  501 (512)
                      +....
T Consensus       181 ~~~~~  185 (362)
T 2bdw_A          181 VNDSE  185 (362)
T ss_dssp             CTTCC
T ss_pred             ecCCc
Confidence            76543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.93  E-value=1.3e-25  Score=225.49  Aligned_cols=149  Identities=28%  Similarity=0.344  Sum_probs=133.0

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .++|...+.||+|+||.||+++.. +++.||||.++..   .....+.+..|..++..+ +||||+++++++...+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            367888999999999999999975 4788999999753   234467788999999988 79999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999999642   35899999999999999999999985   9999999999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.93  E-value=4.3e-26  Score=230.54  Aligned_cols=151  Identities=34%  Similarity=0.534  Sum_probs=131.5

Q ss_pred             cCCccccccccccceeEEEEEeC------CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++|...++||+|+||.||+|++.      ++..||||+++.. .......+.+|+.++.+++||||+++++++...+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56788899999999999999853      4668999999754 3444567999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC---ceEEec
Q 043262          418 LIYEYMPNKSLNVFLFDST----RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKISD  490 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~---~~kl~D  490 (512)
                      +||||+++|+|.+++....    ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999996532    2245899999999999999999999985   99999999999999544   599999


Q ss_pred             cCcccccC
Q 043262          491 FGMARIFG  498 (512)
Q Consensus       491 FGla~~~~  498 (512)
                      ||+++.+.
T Consensus       228 FG~a~~~~  235 (367)
T 3l9p_A          228 FGMARDIY  235 (367)
T ss_dssp             CHHHHHHH
T ss_pred             Cccccccc
Confidence            99998653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.93  E-value=1.1e-25  Score=223.15  Aligned_cols=154  Identities=29%  Similarity=0.535  Sum_probs=121.8

Q ss_pred             hcCCccccccccccceeEEEEEeCCC----CEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCee-
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADG----KEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES-  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g----~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~-  416 (512)
                      .++|...+.||+|+||.||+++....    ..||||.++..  .....+.+.+|+.++.+++||||+++++++...+.. 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            36788899999999999999987543    27999999754  344567899999999999999999999999887665 


Q ss_pred             -----EEEEEecCCCChhHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          417 -----LLIYEYMPNKSLNVFLFDST---RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       417 -----~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                           ++||||+++|+|.+++....   ....+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 99999999999999986432   2235899999999999999999999985   999999999999999999999


Q ss_pred             eccCcccccCCC
Q 043262          489 SDFGMARIFGGN  500 (512)
Q Consensus       489 ~DFGla~~~~~~  500 (512)
                      +|||+++.+..+
T Consensus       179 ~Dfg~a~~~~~~  190 (323)
T 3qup_A          179 ADFGLSRKIYSG  190 (323)
T ss_dssp             CCCCC-------
T ss_pred             eecccccccccc
Confidence            999999887544

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.93  E-value=2.9e-25  Score=225.65  Aligned_cols=153  Identities=24%  Similarity=0.380  Sum_probs=136.4

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .++|...++||+|+||.||+|... +++.||+|.+..........+.+|+.++..++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            367888999999999999999874 6889999999876655667899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC--CCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH--EMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~--~~~~kl~DFGla~~~~~~  500 (512)
                      +++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.+..+
T Consensus       130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            9999999998542  345899999999999999999999985   999999999999974  477999999999988654


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       205 ~  205 (387)
T 1kob_A          205 E  205 (387)
T ss_dssp             S
T ss_pred             c
Confidence            3

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.93  E-value=2.6e-25  Score=217.39  Aligned_cols=150  Identities=29%  Similarity=0.493  Sum_probs=130.4

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...++||+|+||.||+++.. +++.||||++....  ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46788899999999999999974 68899999997433  3335788999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+++ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9986 55555433  2345999999999999999999999985   999999999999999999999999999987543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.93  E-value=1.9e-25  Score=217.24  Aligned_cols=150  Identities=28%  Similarity=0.490  Sum_probs=132.7

Q ss_pred             hcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .++|...++||+|+||.||++...++..||||++..... ..+++.+|++++.+++||||+++++++...+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            356788899999999999999999888999999975433 3578999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A          102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            999999999652  345999999999999999999999985   99999999999999999999999999987644

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.93  E-value=1.4e-25  Score=216.25  Aligned_cols=151  Identities=31%  Similarity=0.506  Sum_probs=136.1

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...+.||+|+||.||++...++..||||.+..... ..+++.+|+.++.+++||||+++++++...+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            56788899999999999999998888999999975443 35779999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....+.
T Consensus        87 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           87 NGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             TCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             CCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999653  235899999999999999999999985   9999999999999999999999999999775543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.93  E-value=1.3e-25  Score=225.33  Aligned_cols=150  Identities=25%  Similarity=0.342  Sum_probs=134.6

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++.. +++.||||.+...   .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            56788899999999999999974 6899999998643   2244678899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999999643   35899999999999999999999985   999999999999999999999999999987543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.93  E-value=1.4e-25  Score=223.19  Aligned_cols=152  Identities=32%  Similarity=0.573  Sum_probs=127.7

Q ss_pred             cCCccccccccccceeEEEEEeC-CCC----EEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGK----EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~----~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ++|...++||+|+||.||+|+.. ++.    .||+|.+... .....++|.+|+.++.+++||||+++++++...+ .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            56788899999999999999863 444    3688888643 3455788999999999999999999999998754 789


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+||+++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            999999999999996533  45899999999999999999999985   9999999999999999999999999999886


Q ss_pred             CCCC
Q 043262          499 GNQS  502 (512)
Q Consensus       499 ~~~~  502 (512)
                      ....
T Consensus       169 ~~~~  172 (327)
T 3poz_A          169 AEEK  172 (327)
T ss_dssp             TTCC
T ss_pred             CCcc
Confidence            5543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.93  E-value=1.2e-25  Score=224.06  Aligned_cols=150  Identities=25%  Similarity=0.461  Sum_probs=132.8

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++. .+++.||||.+...   .......+.+|+.++..++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5688889999999999999996 67899999998643   1223467899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+ +|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..+
T Consensus        89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 78998888542   35899999999999999999999985   999999999999999999999999999987654


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       162 ~  162 (336)
T 3h4j_B          162 N  162 (336)
T ss_dssp             B
T ss_pred             c
Confidence            3

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.93  E-value=2.4e-25  Score=231.80  Aligned_cols=151  Identities=30%  Similarity=0.527  Sum_probs=135.3

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+|+.. +|+.||||.+....   ....+.+.+|+.++..++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56788899999999999999974 79999999996432   234568999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus        96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999953   346999999999999999999999975   999999999999999999999999999987654


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       170 ~  170 (476)
T 2y94_A          170 E  170 (476)
T ss_dssp             C
T ss_pred             c
Confidence            3

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1e-25  Score=225.49  Aligned_cols=155  Identities=29%  Similarity=0.474  Sum_probs=132.8

Q ss_pred             hcCCccccccccccceeEEEEEe------CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENE  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~------~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  415 (512)
                      .++|...+.||+|+||.||+++.      .++..||||.+... .....+.+.+|+.++.++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            46788889999999999999985      24568999999754 333457899999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCC
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRS--------------------VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKT  475 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~  475 (512)
                      .++||||+++|+|.+++......                    ..+++..++.++.||+.||.|||+.+   |+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence            99999999999999999754321                    34899999999999999999999985   99999999


Q ss_pred             CCeeecCCCceEEeccCcccccCCCC
Q 043262          476 SNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       476 ~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +|||++.++.+||+|||+++.+..+.
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~  226 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDS  226 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCc
Confidence            99999999999999999999876544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.93  E-value=6.4e-26  Score=235.37  Aligned_cols=151  Identities=26%  Similarity=0.306  Sum_probs=124.6

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .++|...++||+|+||.||+++. .+++.||||.+...   .......+.+|+.++..++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            35688899999999999999986 56899999999743   334456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||+ .   +|+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999999999998542   458999999999999999999998 6   49999999999999999999999999998754


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      ..
T Consensus       301 ~~  302 (446)
T 4ejn_A          301 KD  302 (446)
T ss_dssp             C-
T ss_pred             CC
Confidence            43

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.93  E-value=2.3e-25  Score=235.54  Aligned_cols=153  Identities=28%  Similarity=0.399  Sum_probs=136.0

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+++.. +|+.||||++...   .......+.+|+.++..++||||+++++++...+..++||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56788899999999999999974 6899999999643   2334567899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+..+
T Consensus       264 Ey~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             CCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            9999999999986532 345899999999999999999999985   999999999999999999999999999988654


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       340 ~  340 (576)
T 2acx_A          340 Q  340 (576)
T ss_dssp             C
T ss_pred             c
Confidence            4

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.93  E-value=1.6e-25  Score=224.98  Aligned_cols=155  Identities=25%  Similarity=0.389  Sum_probs=134.0

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC-----CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT-----SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      .++|...+.||+|+||.||+++. .+++.||||.+...     .....+.+.+|+.++..++||||+++++++...+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            35688889999999999999986 46899999998532     2234678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc---eEEeccCc
Q 043262          418 LIYEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN---PKISDFGM  493 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~---~kl~DFGl  493 (512)
                      +||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988875432 2345899999999999999999999985   999999999999987654   99999999


Q ss_pred             ccccCCCC
Q 043262          494 ARIFGGNQ  501 (512)
Q Consensus       494 a~~~~~~~  501 (512)
                      ++.+....
T Consensus       180 a~~~~~~~  187 (351)
T 3c0i_A          180 AIQLGESG  187 (351)
T ss_dssp             CEECCTTS
T ss_pred             eeEecCCC
Confidence            99886543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.92  E-value=2.2e-25  Score=217.42  Aligned_cols=149  Identities=29%  Similarity=0.501  Sum_probs=132.5

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|+||.||+++..+++.||||++....  ....+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4678889999999999999999889999999996443  23346789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +++ +|.+++...  ...+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            985 898888543  245899999999999999999999985   99999999999999999999999999987754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.92  E-value=2e-25  Score=231.71  Aligned_cols=148  Identities=29%  Similarity=0.495  Sum_probs=131.5

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCC-eeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN-ESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lv~E~~  423 (512)
                      ++|...++||+|+||.||+|.+. +..||||.++...  ..+.|.+|+.+|.+++||||+++++++...+ ..++||||+
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            56777899999999999999985 7799999997643  4578999999999999999999999988765 789999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++|+|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       270 ~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          270 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             TTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999997532 234799999999999999999999985   99999999999999999999999999986643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.92  E-value=2.6e-25  Score=221.79  Aligned_cols=155  Identities=32%  Similarity=0.530  Sum_probs=134.5

Q ss_pred             hcCCccccccccccceeEEEEEeC--------CCCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeC
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA--------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQE  413 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~--------~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  413 (512)
                      .++|...+.||+|+||.||+++..        ++..||||.+.... ....+.+.+|+.++..+ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            367888899999999999999863        46789999997543 34467899999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee
Q 043262          414 NESLLIYEYMPNKSLNVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL  480 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl  480 (512)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999975432             234899999999999999999999985   9999999999999


Q ss_pred             cCCCceEEeccCcccccCCCC
Q 043262          481 DHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       481 ~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +.++.+||+|||+++.+....
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~  211 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNID  211 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTS
T ss_pred             cCCCCEEEccccccccccccc
Confidence            999999999999999876543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.92  E-value=5.8e-26  Score=224.18  Aligned_cols=151  Identities=26%  Similarity=0.408  Sum_probs=128.9

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCe----
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE----  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----  415 (512)
                      .++|...++||+|+||.||+++. .+++.||||++....   ......+.+|+.++.+++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36788899999999999999996 678899999997543   2335678999999999999999999999876654    


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            39999999999999999642   35899999999999999999999985   9999999999999999999999999999


Q ss_pred             ccCCC
Q 043262          496 IFGGN  500 (512)
Q Consensus       496 ~~~~~  500 (512)
                      .+...
T Consensus       165 ~~~~~  169 (311)
T 3ork_A          165 AIADS  169 (311)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            87544

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.92  E-value=3.2e-25  Score=214.86  Aligned_cols=152  Identities=24%  Similarity=0.380  Sum_probs=137.1

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .++|...++||+|+||.||+++.. ++..||+|++........+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            456888899999999999999974 4778999999876666678999999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee---cCCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl---~~~~~~kl~DFGla~~~~~  499 (512)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        88 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            9999999988542   35899999999999999999999985   9999999999999   7889999999999998765


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      ..
T Consensus       162 ~~  163 (277)
T 3f3z_A          162 GK  163 (277)
T ss_dssp             TS
T ss_pred             cc
Confidence            43

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.92  E-value=1.7e-25  Score=220.65  Aligned_cols=156  Identities=31%  Similarity=0.492  Sum_probs=136.5

Q ss_pred             hcCCccccccccccceeEEEEEe------CCCCEEEEEEcccCCc-ccHHHHHHHHHHHhcC-CCCccccceeeEEeCCe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENE  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~------~~g~~vaVK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  415 (512)
                      .++|...+.||+|+||.||+++.      .++..||||.++.... ...+.+.+|+.++.++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            35688889999999999999984      3467899999975433 3457899999999999 99999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTR---------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL  480 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl  480 (512)
                      .++||||+++|+|.+++.....               ...+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999975432               225899999999999999999999985   9999999999999


Q ss_pred             cCCCceEEeccCcccccCCCCC
Q 043262          481 DHEMNPKISDFGMARIFGGNQS  502 (512)
Q Consensus       481 ~~~~~~kl~DFGla~~~~~~~~  502 (512)
                      ++++.+||+|||+++.+.....
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~  200 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSN  200 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTT
T ss_pred             cCCCCEEEcccccccccccccc
Confidence            9999999999999998866543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.92  E-value=9.1e-26  Score=234.51  Aligned_cols=151  Identities=30%  Similarity=0.518  Sum_probs=131.0

Q ss_pred             hcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .++|...++||+|+||.||+|.+.++..||||.++... ...++|.+|+.+|.+++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            35677889999999999999999888889999997644 346789999999999999999999999876 7789999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.+..+
T Consensus       261 ~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          261 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             cCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            999999999542 2245899999999999999999999985   999999999999999999999999999987643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.92  E-value=2.5e-25  Score=219.71  Aligned_cols=153  Identities=26%  Similarity=0.286  Sum_probs=128.6

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ..++|...++||+|+||.||+|+.. +++.||||++....  ......+..|+..+.++ +||||+++++++.+.+..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            3467888999999999999999975 79999999986532  23344556666655555 89999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+ +++|.+++...  ...++|..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       135 v~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99999 67898888653  245999999999999999999999975   9999999999999999999999999998876


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      ...
T Consensus       209 ~~~  211 (311)
T 3p1a_A          209 TAG  211 (311)
T ss_dssp             ---
T ss_pred             cCC
Confidence            543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.92  E-value=3.4e-25  Score=223.39  Aligned_cols=148  Identities=25%  Similarity=0.331  Sum_probs=129.5

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .++|...++||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++..++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            367888999999999999999975 789999999975433 236788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc--eEEeccCcccccC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN--PKISDFGMARIFG  498 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~--~kl~DFGla~~~~  498 (512)
                      +++|+|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.  +||+|||+++...
T Consensus        98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            9999999998542   35899999999999999999999985   999999999999987765  9999999998543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.92  E-value=2e-25  Score=225.69  Aligned_cols=149  Identities=25%  Similarity=0.303  Sum_probs=123.0

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHH-HhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTL-IAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...+.||+|+||.||+++.. ++..||||.+....   ......+..|..+ +..++||||+++++++...+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            56888899999999999999974 57889999997543   2234556777776 5778999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++..   ...+++.....++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999854   235889999999999999999999985   99999999999999999999999999997543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.92  E-value=1.7e-25  Score=222.26  Aligned_cols=152  Identities=30%  Similarity=0.489  Sum_probs=129.9

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCE----EEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKE----IAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~----vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ++|...++||+|+||.||+|+.. ++..    |++|.+.... ....+.+.+|+.++.+++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            56778899999999999999864 4443    7888875432 333456789999999999999999999885 567899


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999653  346889999999999999999999985   9999999999999999999999999999886


Q ss_pred             CCCC
Q 043262          499 GNQS  502 (512)
Q Consensus       499 ~~~~  502 (512)
                      .+..
T Consensus       167 ~~~~  170 (325)
T 3kex_A          167 PDDK  170 (325)
T ss_dssp             CCTT
T ss_pred             cccc
Confidence            6543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.92  E-value=8.4e-25  Score=213.75  Aligned_cols=151  Identities=31%  Similarity=0.476  Sum_probs=133.5

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      .+.....||+|+||.||+|+. .++..||||.+........+.+.+|+.++..++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            345556899999999999996 5688999999987666667889999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-CCceEEeccCcccccCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGG  499 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DFGla~~~~~  499 (512)
                      +++|.+++........+++..+..++.||+.||.|||+.+   |+|+||||+|||++. ++.+||+|||+++.+..
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999976555556789999999999999999999985   999999999999987 89999999999988754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.92  E-value=4.4e-25  Score=228.25  Aligned_cols=153  Identities=25%  Similarity=0.363  Sum_probs=133.3

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ..++|...++||+|+||.||++.. .+|+.+|+|.+....  ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            456788899999999999999986 578899999986543  33456789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec---CCCceEEeccCcccc
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARI  496 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~---~~~~~kl~DFGla~~  496 (512)
                      |||+++|+|.+++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++   +++.+||+|||+++.
T Consensus        89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999999988643   45899999999999999999999985   99999999999998   467899999999988


Q ss_pred             cCCCC
Q 043262          497 FGGNQ  501 (512)
Q Consensus       497 ~~~~~  501 (512)
                      +....
T Consensus       163 ~~~~~  167 (444)
T 3soa_A          163 VEGEQ  167 (444)
T ss_dssp             CCTTC
T ss_pred             ecCCC
Confidence            76543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.92  E-value=2.7e-25  Score=227.01  Aligned_cols=154  Identities=26%  Similarity=0.434  Sum_probs=135.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCC--eeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN--ESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lv~  420 (512)
                      ++|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56788899999999999999975 58999999997543 344678899999999999999999999998765  679999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee----cCCCceEEeccCcccc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMARI  496 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl----~~~~~~kl~DFGla~~  496 (512)
                      ||+++|+|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999976544455999999999999999999999985   9999999999999    7788899999999998


Q ss_pred             cCCCC
Q 043262          497 FGGNQ  501 (512)
Q Consensus       497 ~~~~~  501 (512)
                      +..+.
T Consensus       166 ~~~~~  170 (396)
T 4eut_A          166 LEDDE  170 (396)
T ss_dssp             CCCGG
T ss_pred             ccCCC
Confidence            76543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.92  E-value=2.5e-25  Score=231.74  Aligned_cols=149  Identities=22%  Similarity=0.449  Sum_probs=122.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC-----Cee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE-----NES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~  416 (512)
                      ++|...++||+|+||.||+++. .+++.||||++...  .....+.+.+|+.++..++||||+++++++...     +..
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            6788899999999999999986 46899999999653  334467899999999999999999999998543     568


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++||||+ +|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus       133 ~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence            9999998 5789888854   345999999999999999999999985   99999999999999999999999999998


Q ss_pred             cCCC
Q 043262          497 FGGN  500 (512)
Q Consensus       497 ~~~~  500 (512)
                      +...
T Consensus       206 ~~~~  209 (458)
T 3rp9_A          206 VDYP  209 (458)
T ss_dssp             TTSC
T ss_pred             ccCc
Confidence            7543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.92  E-value=6.2e-25  Score=217.44  Aligned_cols=153  Identities=31%  Similarity=0.524  Sum_probs=120.6

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .++|...++||+|+||.||+|.. .+++.||||.++... ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            35688889999999999999986 468999999997543 3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          422 YMPNKSLNVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       422 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |++ |+|.+++...   .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 6999888542   12245899999999999999999999975   9999999999999999999999999999875


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      ..
T Consensus       160 ~~  161 (317)
T 2pmi_A          160 IP  161 (317)
T ss_dssp             SC
T ss_pred             CC
Confidence            43

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.92  E-value=3.6e-25  Score=217.24  Aligned_cols=152  Identities=31%  Similarity=0.590  Sum_probs=131.7

Q ss_pred             cCCccccccccccceeEEEEEe-----CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeC--Cee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-----ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-----~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  416 (512)
                      +.|...++||+|+||.||++++     .+++.||||++... .....+.+.+|+.++..++||||+++++++...  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4577889999999999999983     46889999999743 344567899999999999999999999999877  668


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            99999999999999995432  35899999999999999999999985   99999999999999999999999999998


Q ss_pred             cCCCC
Q 043262          497 FGGNQ  501 (512)
Q Consensus       497 ~~~~~  501 (512)
                      +..+.
T Consensus       176 ~~~~~  180 (302)
T 4e5w_A          176 IETDK  180 (302)
T ss_dssp             CCTTC
T ss_pred             ccCCC
Confidence            76543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.92  E-value=2.8e-26  Score=228.93  Aligned_cols=147  Identities=20%  Similarity=0.278  Sum_probs=122.7

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCC--------cccHHHHHHHHHHHhcCC---------CCccccce
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS--------GQGLQEFKNEVTLIAKLQ---------HKNLVRLL  407 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~l~  407 (512)
                      ++|...++||+|+||.||+|+. +|+.||||++....        ....+.+.+|+.++++++         ||||+++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            5677889999999999999998 68999999997542        234578899999988886         66666665


Q ss_pred             eeE-----------------Ee-------------CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 043262          408 GCC-----------------LQ-------------ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL  457 (512)
Q Consensus       408 g~~-----------------~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL  457 (512)
                      +++                 ..             .+..++||||+++|++.+.+.+    ..+++..+..++.||+.||
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence            554                 32             6789999999999977666632    4589999999999999999


Q ss_pred             HHHH-cCCCCCcccCCCCCCCeeecCCC--------------------ceEEeccCcccccCC
Q 043262          458 LYLH-EDSRLKIIHRDLKTSNVLLDHEM--------------------NPKISDFGMARIFGG  499 (512)
Q Consensus       458 ~yLH-~~~~~~ivH~dlk~~NiLl~~~~--------------------~~kl~DFGla~~~~~  499 (512)
                      .||| +.+   |+||||||+||||+.++                    .+||+|||+++.+..
T Consensus       175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~  234 (336)
T 2vuw_A          175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD  234 (336)
T ss_dssp             HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred             HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence            9999 764   99999999999999887                    899999999998754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.92  E-value=3.1e-25  Score=216.29  Aligned_cols=150  Identities=25%  Similarity=0.457  Sum_probs=134.0

Q ss_pred             cCCccccccccccceeEEEEEeCC-C-------CEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-G-------KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g-------~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      ++|...+.||+|+||.||+++... +       ..||+|.+........+.+.+|+.++.+++||||+++++++...+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            567788999999999999998643 3       47999999877667778999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc--------eEE
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN--------PKI  488 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~--------~kl  488 (512)
                      ++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.        +||
T Consensus        88 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             EEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence            9999999999999999653  234899999999999999999999985   999999999999998887        999


Q ss_pred             eccCcccccCC
Q 043262          489 SDFGMARIFGG  499 (512)
Q Consensus       489 ~DFGla~~~~~  499 (512)
                      +|||+++....
T Consensus       163 ~Dfg~~~~~~~  173 (289)
T 4fvq_A          163 SDPGISITVLP  173 (289)
T ss_dssp             CCCCSCTTTSC
T ss_pred             ccCcccccccC
Confidence            99999976643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.92  E-value=1.3e-25  Score=238.08  Aligned_cols=150  Identities=29%  Similarity=0.513  Sum_probs=133.5

Q ss_pred             hcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .++|...++||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|.+++||||+++++++.+ +..++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            35677889999999999999999888889999997644 346789999999999999999999999876 6789999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++|+|.++|... ....+++..++.|+.||+.||.|||+++   |+||||||+||||++++.+||+|||+++.+..
T Consensus       344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            999999999542 2235899999999999999999999985   99999999999999999999999999998754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.92  E-value=5.7e-25  Score=231.79  Aligned_cols=154  Identities=31%  Similarity=0.449  Sum_probs=136.6

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++.. +|+.||+|++....   ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56777889999999999999974 68999999996432   234678899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++|+|..++.... ....+++.....++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999986543 2346999999999999999999999985   99999999999999999999999999998765


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      +.
T Consensus       342 ~~  343 (543)
T 3c4z_A          342 GQ  343 (543)
T ss_dssp             TC
T ss_pred             CC
Confidence            54

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.92  E-value=4.2e-25  Score=219.90  Aligned_cols=149  Identities=21%  Similarity=0.276  Sum_probs=131.6

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...+.||+|+||.||+|+. .+++.||||.+.....  .+.+.+|+.++..+ +||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            5688889999999999999995 6789999999865432  24688999999999 999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc-----eEEeccCccccc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN-----PKISDFGMARIF  497 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~-----~kl~DFGla~~~  497 (512)
                      + +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||+|||+++.+
T Consensus        87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           87 L-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             C-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            9 99999999653  346999999999999999999999985   999999999999999887     999999999987


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ....
T Consensus       161 ~~~~  164 (330)
T 2izr_A          161 IDPE  164 (330)
T ss_dssp             BCTT
T ss_pred             ecCC
Confidence            5543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.92  E-value=9.6e-26  Score=223.49  Aligned_cols=155  Identities=29%  Similarity=0.496  Sum_probs=135.2

Q ss_pred             HhcCCccccccccccceeEEEEEeC------CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCe
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE  415 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  415 (512)
                      ..++|...+.||+|+||.||+|+..      ++..||||.+.... ......+.+|+.++..++||||+++++++...+.
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  102 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP  102 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence            4567888999999999999999864      36789999997543 3345679999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          416 SLLIYEYMPNKSLNVFLFDST-------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                      .++||||+++|+|.+++....       ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||
T Consensus       103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence            999999999999999986421       1245799999999999999999999985   999999999999999999999


Q ss_pred             eccCcccccCCC
Q 043262          489 SDFGMARIFGGN  500 (512)
Q Consensus       489 ~DFGla~~~~~~  500 (512)
                      +|||+++.+...
T Consensus       180 ~Dfg~~~~~~~~  191 (322)
T 1p4o_A          180 GDFGMTRDIYET  191 (322)
T ss_dssp             CCTTCCCGGGGG
T ss_pred             CcCccccccccc
Confidence            999999876543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.92  E-value=4.4e-25  Score=213.57  Aligned_cols=150  Identities=29%  Similarity=0.415  Sum_probs=134.2

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .++|...+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.++..++||||+++++++.+.+..++|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            456888899999999999999974 68999999986433 3345789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            9999999999843   345899999999999999999999985   99999999999999999999999999987643

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.92  E-value=6.3e-25  Score=215.27  Aligned_cols=147  Identities=29%  Similarity=0.445  Sum_probs=126.3

Q ss_pred             hcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhc--CCCCccccceeeEEeC----CeeE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAK--LQHKNLVRLLGCCLQE----NESL  417 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~----~~~~  417 (512)
                      .++|...++||+|+||.||+|+. +++.||||++...   ....+..|.+++..  ++||||+++++++...    +..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46788899999999999999998 6889999998643   34556667766665  8999999999997653    4579


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCcccCCCCCCCeeecCCCceEEe
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH--------EDSRLKIIHRDLKTSNVLLDHEMNPKIS  489 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~dlk~~NiLl~~~~~~kl~  489 (512)
                      +||||+++|+|.+++..    ..+++..++.++.||+.||.|||        +.   +|+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence            99999999999999943    35899999999999999999999        55   59999999999999999999999


Q ss_pred             ccCcccccCCCC
Q 043262          490 DFGMARIFGGNQ  501 (512)
Q Consensus       490 DFGla~~~~~~~  501 (512)
                      |||+++......
T Consensus       156 Dfg~a~~~~~~~  167 (301)
T 3q4u_A          156 DLGLAVMHSQST  167 (301)
T ss_dssp             CCTTCEEEETTT
T ss_pred             eCCCeeeccccc
Confidence            999998775543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.92  E-value=4.6e-25  Score=221.39  Aligned_cols=149  Identities=28%  Similarity=0.432  Sum_probs=120.9

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .++|...+.||+|+||.||+++.. +++.||||.++...  ..+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            467888899999999999999975 57899999997543  346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC---CCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~---~~~~kl~DFGla~~~~~  499 (512)
                      +++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++....
T Consensus       130 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          130 VTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            999999999854   345899999999999999999999985   999999999999975   88999999999997754


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       204 ~  204 (349)
T 2w4o_A          204 Q  204 (349)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.92  E-value=3.3e-25  Score=221.95  Aligned_cols=150  Identities=25%  Similarity=0.387  Sum_probs=130.0

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCC--CccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQH--KNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||++...+++.||||++...  .....+.+.+|+.++..++|  |||+++++++...+..++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            568888999999999999999988999999998643  33445789999999999987  99999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      | +.+++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+..+
T Consensus        89 e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           89 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             C-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             e-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            9 5688999999653   45899999999999999999999985   99999999999997 568999999999988655


Q ss_pred             CC
Q 043262          501 QS  502 (512)
Q Consensus       501 ~~  502 (512)
                      ..
T Consensus       161 ~~  162 (343)
T 3dbq_A          161 TT  162 (343)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.92  E-value=4.8e-25  Score=221.10  Aligned_cols=150  Identities=33%  Similarity=0.546  Sum_probs=131.9

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      +.|...+.||+|+||.||+|+. .+++.||||++....   ....+++.+|+.++.+++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4578889999999999999986 678999999997543   233467899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+. |+|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 6888777532  246899999999999999999999985   999999999999999999999999999887643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.92  E-value=1.2e-24  Score=215.06  Aligned_cols=149  Identities=26%  Similarity=0.371  Sum_probs=130.2

Q ss_pred             cCCcc-ccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSD-ENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~-~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      +.|.. .+.||+|+||.||+++. .+++.||||++........+.+.+|+.++.++ +||||+++++++...+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            45665 46899999999999985 57899999999876666678899999999885 79999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc---eEEeccCcccccC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN---PKISDFGMARIFG  498 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~---~kl~DFGla~~~~  498 (512)
                      |+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||+++.+.
T Consensus        92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            99999999999653   35899999999999999999999985   999999999999998776   9999999998764


Q ss_pred             C
Q 043262          499 G  499 (512)
Q Consensus       499 ~  499 (512)
                      .
T Consensus       166 ~  166 (316)
T 2ac3_A          166 L  166 (316)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.92  E-value=7.9e-25  Score=223.01  Aligned_cols=149  Identities=17%  Similarity=0.277  Sum_probs=133.8

Q ss_pred             cCCccccccccc--cceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEG--GFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G--~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...++||+|  +||.||+++.. +++.||||++....  ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            568888999999  99999999975 68999999997432  34456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++..+
T Consensus       105 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          105 TSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999653 2345899999999999999999999985   999999999999999999999999998765

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.92  E-value=4.4e-25  Score=228.02  Aligned_cols=150  Identities=25%  Similarity=0.472  Sum_probs=130.8

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC-----Ce
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE-----NE  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~  415 (512)
                      .++|...+.||+|+||.||+++. .+++.||||++...  .....+.+.+|+.++..++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            36788899999999999999986 45788999999753  334467899999999999999999999999876     56


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++||||+. |+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 699999854   345999999999999999999999985   9999999999999999999999999999


Q ss_pred             ccCCC
Q 043262          496 IFGGN  500 (512)
Q Consensus       496 ~~~~~  500 (512)
                      .+...
T Consensus       178 ~~~~~  182 (432)
T 3n9x_A          178 TINSE  182 (432)
T ss_dssp             EC---
T ss_pred             ccccc
Confidence            87654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.92  E-value=6.8e-25  Score=213.70  Aligned_cols=155  Identities=23%  Similarity=0.420  Sum_probs=132.7

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .++|...++||+|+||.||+++. .++..||+|++.... ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            35688889999999999999986 468899999986543 3457889999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee---cCCCceEEeccCccccc
Q 043262          422 YMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIF  497 (512)
Q Consensus       422 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl---~~~~~~kl~DFGla~~~  497 (512)
                      |+++|+|.+++... .....+++..+..++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.+
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988543 12356999999999999999999999985   9999999999999   45678999999999887


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ..+.
T Consensus       178 ~~~~  181 (285)
T 3is5_A          178 KSDE  181 (285)
T ss_dssp             ----
T ss_pred             CCcc
Confidence            6543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.92  E-value=2.7e-25  Score=221.75  Aligned_cols=153  Identities=25%  Similarity=0.395  Sum_probs=134.6

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc--------ccHHHHHHHHHHHhcCCCCccccceeeEEeC
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG--------QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE  413 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  413 (512)
                      ..++|...++||+|+||.||+++. .++..||||.+.....        ...+.+.+|+.++.+++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            456788999999999999999985 5688999999975421        1334678899999999999999999999999


Q ss_pred             CeeEEEEEecCCC-ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccC
Q 043262          414 NESLLIYEYMPNK-SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  492 (512)
Q Consensus       414 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFG  492 (512)
                      +..++||||+..| +|.+++..   ...+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999877 99999854   235999999999999999999999985   9999999999999999999999999


Q ss_pred             cccccCCCC
Q 043262          493 MARIFGGNQ  501 (512)
Q Consensus       493 la~~~~~~~  501 (512)
                      +++.+..+.
T Consensus       176 ~a~~~~~~~  184 (335)
T 3dls_A          176 SAAYLERGK  184 (335)
T ss_dssp             TCEECCTTC
T ss_pred             cceECCCCC
Confidence            999876544

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.92  E-value=7e-25  Score=211.65  Aligned_cols=151  Identities=36%  Similarity=0.576  Sum_probs=124.5

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCC----cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||++... +..||||.++...    ....+.+.+|+.++..++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            56788899999999999999985 8899999986542    233578999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC--------CCceEEeccC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH--------EMNPKISDFG  492 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~--------~~~~kl~DFG  492 (512)
                      ||+++++|.+++.    ...+++..++.++.|++.||.|||+++..+|+||||||+|||++.        ++.+||+|||
T Consensus        86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999984    246899999999999999999999986555999999999999986        6789999999


Q ss_pred             cccccCCC
Q 043262          493 MARIFGGN  500 (512)
Q Consensus       493 la~~~~~~  500 (512)
                      +++.+...
T Consensus       162 ~~~~~~~~  169 (271)
T 3dtc_A          162 LAREWHRT  169 (271)
T ss_dssp             C-------
T ss_pred             cccccccc
Confidence            99877544

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=6.7e-25  Score=211.25  Aligned_cols=149  Identities=28%  Similarity=0.486  Sum_probs=134.9

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...+.||+|+||.||++...++..||+|.+..... ..+.+.+|+.++..++||||+++++++...+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            46777889999999999999998889999999976543 35789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence            99999999653  245899999999999999999999985   99999999999999999999999999987643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.92  E-value=4.1e-25  Score=218.11  Aligned_cols=155  Identities=28%  Similarity=0.535  Sum_probs=125.1

Q ss_pred             HhcCCccccccccccceeEEEEEeC----CCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCe-
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA----DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE-  415 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~----~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-  415 (512)
                      ..++|...+.||+|+||.||+|...    .+..||||.++..  .....+.+.+|+.++.+++||||+++++++...+. 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3467888899999999999999863    3457999999744  33445789999999999999999999999987654 


Q ss_pred             ----eEEEEEecCCCChhHHhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          416 ----SLLIYEYMPNKSLNVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       416 ----~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                          .++||||+++|+|.+++...   .....+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence                49999999999999998543   23456999999999999999999999975   999999999999999999999


Q ss_pred             eccCcccccCCC
Q 043262          489 SDFGMARIFGGN  500 (512)
Q Consensus       489 ~DFGla~~~~~~  500 (512)
                      +|||+++.+...
T Consensus       189 ~Dfg~~~~~~~~  200 (313)
T 3brb_A          189 ADFGLSKKIYSG  200 (313)
T ss_dssp             CSCSCC------
T ss_pred             eecCcceecccc
Confidence            999999877543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.92  E-value=8.3e-25  Score=212.68  Aligned_cols=157  Identities=29%  Similarity=0.406  Sum_probs=135.4

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC--CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ..++|...++||+|+||.||+++.. +++.||||.+...  ......++.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467888899999999999999975 7899999999753  233456788999999999 99999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC---------------
Q 043262          419 IYEYMPNKSLNVFLFDSTR-SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH---------------  482 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~---------------  482 (512)
                      ||||+++++|.+++..... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999965321 245899999999999999999999985   999999999999984               


Q ss_pred             ----CCceEEeccCcccccCCCCC
Q 043262          483 ----EMNPKISDFGMARIFGGNQS  502 (512)
Q Consensus       483 ----~~~~kl~DFGla~~~~~~~~  502 (512)
                          ...+||+|||+++.......
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~~  189 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQV  189 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSCC
T ss_pred             ccCCceEEEEcccccccccCCccc
Confidence                44799999999998865543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.92  E-value=8.9e-25  Score=215.42  Aligned_cols=150  Identities=26%  Similarity=0.419  Sum_probs=133.0

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...++||+|+||.||+++.. +++.||||++.....  ...+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888899999999999999974 589999999865432  235678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+++++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999998853   345899999999999999999999985   999999999999999999999999999887643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.92  E-value=1e-24  Score=216.28  Aligned_cols=152  Identities=28%  Similarity=0.408  Sum_probs=135.0

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc------ccHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG------QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      .++|...+.||+|+||.||+++.. ++..||||.+.....      ...+++.+|+.++..++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356888899999999999999974 689999999865432      2467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC----ceEEeccC
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM----NPKISDFG  492 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~----~~kl~DFG  492 (512)
                      ++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999954   345899999999999999999999985   99999999999999887    79999999


Q ss_pred             cccccCCCC
Q 043262          493 MARIFGGNQ  501 (512)
Q Consensus       493 la~~~~~~~  501 (512)
                      +++.+..+.
T Consensus       165 ~~~~~~~~~  173 (321)
T 2a2a_A          165 LAHEIEDGV  173 (321)
T ss_dssp             TCEECCTTC
T ss_pred             cceecCccc
Confidence            999876543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.92  E-value=7.9e-25  Score=225.17  Aligned_cols=152  Identities=25%  Similarity=0.383  Sum_probs=128.0

Q ss_pred             HHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--------cccHHHHHHHHHHHhcCCCCccccceeeEEe
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--------GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ  412 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  412 (512)
                      ...++|...++||+|+||.||+|.. .+++.||||.+....        ......+.+|+.++.+++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4567899999999999999999986 468899999986431        112235889999999999999999999974 


Q ss_pred             CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC---CceEEe
Q 043262          413 ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKIS  489 (512)
Q Consensus       413 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~---~~~kl~  489 (512)
                      .+..++||||+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.+   ..+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            5568999999999999998843   346999999999999999999999985   9999999999999654   459999


Q ss_pred             ccCcccccCCC
Q 043262          490 DFGMARIFGGN  500 (512)
Q Consensus       490 DFGla~~~~~~  500 (512)
                      |||+++.+...
T Consensus       285 DFG~a~~~~~~  295 (419)
T 3i6u_A          285 DFGHSKILGET  295 (419)
T ss_dssp             CSSTTTSCC--
T ss_pred             ecccceecCCC
Confidence            99999987644

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.92  E-value=6.2e-25  Score=218.31  Aligned_cols=152  Identities=29%  Similarity=0.527  Sum_probs=135.2

Q ss_pred             cCCccccccccccceeEEEEEe-----CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEE--eCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-----ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL--QENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~  417 (512)
                      ++|...++||+|+||.||++++     .++..||||++........+.+.+|+.++.+++||||+++++++.  ..+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5678889999999999999984     467899999998777666788999999999999999999999987  445689


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +||||+++++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            9999999999999996422  35899999999999999999999975   999999999999999999999999999987


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ....
T Consensus       178 ~~~~  181 (327)
T 3lxl_A          178 PLDK  181 (327)
T ss_dssp             CTTC
T ss_pred             ccCC
Confidence            6443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.9e-25  Score=224.79  Aligned_cols=150  Identities=26%  Similarity=0.366  Sum_probs=132.9

Q ss_pred             cCCccccccccccceeEEEEEe----CCCCEEEEEEcccCC----cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL----ADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENE  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~----~~g~~vaVK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  415 (512)
                      ++|...++||+|+||.||+++.    .+++.||||+++...    ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5788889999999999999987    478999999986432    23345678899999999 69999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999999643   35899999999999999999999975   9999999999999999999999999999


Q ss_pred             ccCCC
Q 043262          496 IFGGN  500 (512)
Q Consensus       496 ~~~~~  500 (512)
                      .+..+
T Consensus       208 ~~~~~  212 (355)
T 1vzo_A          208 EFVAD  212 (355)
T ss_dssp             ECCGG
T ss_pred             ecccC
Confidence            77543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.92  E-value=4.2e-25  Score=221.07  Aligned_cols=156  Identities=26%  Similarity=0.347  Sum_probs=132.4

Q ss_pred             HHHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC-----CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC
Q 043262          341 VEATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT-----SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN  414 (512)
Q Consensus       341 ~~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  414 (512)
                      ....++|...++||+|+||.||+++. .++..||+|.+...     .....+.+.+|+.++.+++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            35567899999999999999999987 56889999998643     3445678999999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhHHhhcCC-------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 043262          415 ESLLIYEYMPNKSLNVFLFDST-------------------------------------RSVQLDWKRRISIINGIARGL  457 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~gL  457 (512)
                      ..++||||+++|+|.+++....                                     ....+++..+..++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            9999999999999999984210                                     011235677888999999999


Q ss_pred             HHHHcCCCCCcccCCCCCCCeeecCCC--ceEEeccCcccccCC
Q 043262          458 LYLHEDSRLKIIHRDLKTSNVLLDHEM--NPKISDFGMARIFGG  499 (512)
Q Consensus       458 ~yLH~~~~~~ivH~dlk~~NiLl~~~~--~~kl~DFGla~~~~~  499 (512)
                      .|||+.+   |+||||||+|||++.++  .+||+|||+++.+..
T Consensus       182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~  222 (345)
T 3hko_A          182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK  222 (345)
T ss_dssp             HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred             HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence            9999985   99999999999998776  899999999997643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.92  E-value=7.2e-25  Score=223.34  Aligned_cols=160  Identities=24%  Similarity=0.375  Sum_probs=131.7

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCC--CCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQ--HKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      .+|...++||+|+||.||++...+++.||||.+...  .....+.+.+|+.++.+++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458888999999999999999888999999998643  3345678999999999996  599999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      | +.+++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+ ++.+||+|||+++.+..+
T Consensus       136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 6788999999653   36899999999999999999999975   99999999999996 578999999999988655


Q ss_pred             CCCcCccccccC
Q 043262          501 QSEANTKRIVGT  512 (512)
Q Consensus       501 ~~~~~~~~~~Gt  512 (512)
                      .........+||
T Consensus       208 ~~~~~~~~~~gt  219 (390)
T 2zmd_A          208 TTSVVKDSQVGA  219 (390)
T ss_dssp             ------CCSCCC
T ss_pred             CccccCCCCCcC
Confidence            433222333444

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.92  E-value=7.6e-25  Score=213.75  Aligned_cols=148  Identities=37%  Similarity=0.597  Sum_probs=122.7

Q ss_pred             hcCCccccccccccceeEEEEEeCCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .++|...++||+|+||.||+++..+  .||||.++..  .....+.|.+|+.++..++||||++++++. ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            3578888999999999999998753  6999998644  334467899999999999999999999965 5567899999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A          100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999998543  346899999999999999999999985   99999999999999999999999999987654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.92  E-value=1.2e-24  Score=211.00  Aligned_cols=150  Identities=32%  Similarity=0.523  Sum_probs=133.8

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++. .+++.||||.+....   ....+.+.+|+.++..++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5678889999999999999986 578999999986432   233578999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           91 EMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             ECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999643  346899999999999999999999985   99999999999999999999999999988753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.92  E-value=1.2e-24  Score=217.09  Aligned_cols=150  Identities=24%  Similarity=0.375  Sum_probs=133.8

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++.. +++.+|+|.+...   .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            56788899999999999999975 5788999998643   2344677899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       121 e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          121 ELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             CCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            999999999988542   45899999999999999999999985   999999999999999999999999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.92  E-value=1.5e-24  Score=212.06  Aligned_cols=150  Identities=24%  Similarity=0.375  Sum_probs=133.6

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||++... +++.+|+|.+...   .....+.+.+|+.++..++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            56788899999999999999975 5788999998643   2334567899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        95 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           95 ELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             ECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            999999999988542   35899999999999999999999985   999999999999999999999999999887543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.92  E-value=1.1e-24  Score=219.91  Aligned_cols=157  Identities=26%  Similarity=0.427  Sum_probs=137.6

Q ss_pred             HHHHHhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--------ccHHHHHHHHHHHhcC-CCCcccccee
Q 043262          339 LAVEATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--------QGLQEFKNEVTLIAKL-QHKNLVRLLG  408 (512)
Q Consensus       339 ~~~~~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~nIv~l~g  408 (512)
                      ......++|...+.||+|+||.||+++.. +|+.||||++.....        ...+.+.+|+.++.++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34455677888999999999999999985 799999999865431        1145688999999999 7999999999


Q ss_pred             eEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       409 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                      ++...+..++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999964   245899999999999999999999985   999999999999999999999


Q ss_pred             eccCcccccCCCC
Q 043262          489 SDFGMARIFGGNQ  501 (512)
Q Consensus       489 ~DFGla~~~~~~~  501 (512)
                      +|||+++.+..+.
T Consensus       242 ~DfG~~~~~~~~~  254 (365)
T 2y7j_A          242 SDFGFSCHLEPGE  254 (365)
T ss_dssp             CCCTTCEECCTTC
T ss_pred             EecCcccccCCCc
Confidence            9999999876543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.92  E-value=4.5e-25  Score=217.91  Aligned_cols=157  Identities=27%  Similarity=0.433  Sum_probs=134.5

Q ss_pred             HHhcCCccccccccccceeEEEEEe------CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeC
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQE  413 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~------~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  413 (512)
                      ...++|...+.||+|+||.||+++.      .+++.||||.+.... ....+.+.+|+.++.++ +||||+++++++...
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            3457888899999999999999984      356789999997543 33456799999999999 799999999999876


Q ss_pred             C-eeEEEEEecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCee
Q 043262          414 N-ESLLIYEYMPNKSLNVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVL  479 (512)
Q Consensus       414 ~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiL  479 (512)
                      + ..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil  180 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL  180 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence            5 48999999999999999965432             123889999999999999999999985   999999999999


Q ss_pred             ecCCCceEEeccCcccccCCCC
Q 043262          480 LDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       480 l~~~~~~kl~DFGla~~~~~~~  501 (512)
                      ++.++.+||+|||+++.+..+.
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~  202 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDP  202 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCT
T ss_pred             ECCCCCEEECCCccccccccCc
Confidence            9999999999999999876544

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.91  E-value=9.1e-25  Score=211.89  Aligned_cols=150  Identities=34%  Similarity=0.578  Sum_probs=132.7

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...+.||+|+||.||+|...++..||||.+.... ...+.+.+|+.++..++||||+++++++. .+..++||||++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence            5677889999999999999999888899999997543 34678999999999999999999999876 456899999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        91 ~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             CCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999998532 1235899999999999999999999985   999999999999999999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.91  E-value=8.1e-25  Score=212.63  Aligned_cols=150  Identities=26%  Similarity=0.421  Sum_probs=122.9

Q ss_pred             cCCccccccccccceeEEEEEeCC----CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD----GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~----g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...+.||+|+||.||+|+...    +..||+|.+.... ....+.+.+|+.++.+++||||+++++++ ..+..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEE
Confidence            567888999999999999998743    4569999987543 34466899999999999999999999997 45678999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        94 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           94 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence            9999999999999643  345899999999999999999999985   99999999999999999999999999998754


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       169 ~  169 (281)
T 1mp8_A          169 S  169 (281)
T ss_dssp             -
T ss_pred             c
Confidence            4

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.91  E-value=1.1e-24  Score=234.54  Aligned_cols=144  Identities=28%  Similarity=0.547  Sum_probs=126.7

Q ss_pred             ccccccceeEEEEEeC---CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCCCC
Q 043262          352 KLGEGGFGPVYKGKLA---DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKS  427 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~---~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~gs  427 (512)
                      +||+|+||.||+|.+.   ++..||||+++... ....++|.+|+.+|.+++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999863   46679999997643 3457889999999999999999999999876 56899999999999


Q ss_pred             hhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          428 LNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      |.+++...  ...+++..++.|+.||+.||.|||+++   |+||||||+||||++++.+||+|||+++.+..+.
T Consensus       422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            99999543  346999999999999999999999985   9999999999999999999999999999876543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.91  E-value=1.2e-24  Score=216.19  Aligned_cols=152  Identities=32%  Similarity=0.615  Sum_probs=134.4

Q ss_pred             cCCccccccccccceeEEEEEe-----CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCC--eeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-----ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN--ESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~  417 (512)
                      ++|...++||+|+||.||++++     .+++.||||++........+.+.+|+.++.+++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            4577889999999999999984     468899999998776666788999999999999999999999987654  679


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +||||+++++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+
T Consensus       121 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            9999999999999996532  35899999999999999999999975   999999999999999999999999999987


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ..+.
T Consensus       196 ~~~~  199 (326)
T 2w1i_A          196 PQDK  199 (326)
T ss_dssp             CSSC
T ss_pred             cccc
Confidence            6543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.91  E-value=1.7e-24  Score=215.04  Aligned_cols=142  Identities=25%  Similarity=0.362  Sum_probs=125.4

Q ss_pred             ccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEEecCCCC
Q 043262          350 ENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYEYMPNKS  427 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E~~~~gs  427 (512)
                      .++||+|+||.||+++.. +++.||||.+...   ....+.+|+.++..++ ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999974 6899999999643   3467889999999997 9999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC---ceEEeccCcccccCCC
Q 043262          428 LNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKISDFGMARIFGGN  500 (512)
Q Consensus       428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~---~~kl~DFGla~~~~~~  500 (512)
                      |.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||+++....+
T Consensus        93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            99999653   46999999999999999999999985   99999999999997765   8999999999977544

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.91  E-value=1.8e-24  Score=215.05  Aligned_cols=151  Identities=32%  Similarity=0.581  Sum_probs=125.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCE----EEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKE----IAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~----vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ++|...++||+|+||.||+|+.. ++..    |++|.+... .....+++.+|+.++..++||||+++++++...+ .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            56888899999999999999863 4443    577877543 4456788999999999999999999999998765 789


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        94 v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            99999999999999653  245899999999999999999999985   9999999999999999999999999999875


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      ...
T Consensus       169 ~~~  171 (327)
T 3lzb_A          169 AEE  171 (327)
T ss_dssp             ---
T ss_pred             Ccc
Confidence            543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.91  E-value=4.2e-24  Score=210.42  Aligned_cols=154  Identities=31%  Similarity=0.534  Sum_probs=127.5

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-----cccHHHHHHHHHHHhcC---CCCccccceeeEEeC
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-----GQGLQEFKNEVTLIAKL---QHKNLVRLLGCCLQE  413 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-----~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~  413 (512)
                      ..++|...++||+|+||.||+++. .+++.||||.+....     ......+.+|+.++..+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999996 568999999986322     12234567777777666   499999999999876


Q ss_pred             C-----eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEE
Q 043262          414 N-----ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  488 (512)
Q Consensus       414 ~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl  488 (512)
                      .     ..++||||+. |+|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4799999997 69999986532 334999999999999999999999985   999999999999999999999


Q ss_pred             eccCcccccCCCC
Q 043262          489 SDFGMARIFGGNQ  501 (512)
Q Consensus       489 ~DFGla~~~~~~~  501 (512)
                      +|||+++.+....
T Consensus       162 ~Dfg~a~~~~~~~  174 (308)
T 3g33_A          162 ADFGLARIYSYQM  174 (308)
T ss_dssp             CSCSCTTTSTTCC
T ss_pred             eeCccccccCCCc
Confidence            9999999876443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.91  E-value=1e-24  Score=212.50  Aligned_cols=153  Identities=29%  Similarity=0.533  Sum_probs=136.5

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .++|...++||+|+||.||++... ++..||||.+.... ...+.+.+|+.++..++||||+++++++...+..++||||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            456788899999999999999975 47889999997543 3467899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++....+.
T Consensus        91 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           91 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             CCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            9999999999653 3356899999999999999999999985   9999999999999999999999999999876543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.91  E-value=3.5e-25  Score=220.58  Aligned_cols=155  Identities=30%  Similarity=0.465  Sum_probs=134.2

Q ss_pred             hcCCccccccccccceeEEEEEeCC------CCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLAD------GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENE  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~------g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  415 (512)
                      .++|...+.||+|+||.||++....      ...||||.+.... ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            4678888999999999999998642      2479999997543 34467799999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC
Q 043262          416 SLLIYEYMPNKSLNVFLFDST-----------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM  484 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~  484 (512)
                      .++||||+++|+|.+++....           ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence            999999999999999986421           1345899999999999999999999985   99999999999999999


Q ss_pred             ceEEeccCcccccCCCC
Q 043262          485 NPKISDFGMARIFGGNQ  501 (512)
Q Consensus       485 ~~kl~DFGla~~~~~~~  501 (512)
                      .+||+|||+++.+..+.
T Consensus       202 ~~kl~Dfg~~~~~~~~~  218 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDS  218 (333)
T ss_dssp             EEEBCCCGGGCCGGGCT
T ss_pred             eEEECcccccccccccc
Confidence            99999999999775443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.91  E-value=1.6e-24  Score=214.20  Aligned_cols=152  Identities=30%  Similarity=0.420  Sum_probs=132.9

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEe----CCeeEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ----ENESLL  418 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~l  418 (512)
                      .++|...+.||+|+||.||+++. .+++.||||++........+.+.+|+.++..++||||+++++++..    .+..++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            35788899999999999999996 6789999999977666677889999999999999999999999973    346899


Q ss_pred             EEEecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          419 IYEYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      |+||+++|+|.+++... .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999998642 12356899999999999999999999985   999999999999999999999999998765


Q ss_pred             C
Q 043262          498 G  498 (512)
Q Consensus       498 ~  498 (512)
                      .
T Consensus       185 ~  185 (317)
T 2buj_A          185 C  185 (317)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.91  E-value=9.9e-25  Score=214.98  Aligned_cols=150  Identities=31%  Similarity=0.461  Sum_probs=125.9

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...+.||+|+||.||+++.. +..||||.+...  ...+.|.+|+.++.+++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            46777889999999999999985 788999999643  34578999999999999999999999876  45899999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc-eEEeccCcccccCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN-PKISDFGMARIFGG  499 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~-~kl~DFGla~~~~~  499 (512)
                      +|+|.+++........+++..++.++.|+++||.|||+....+|+||||||+|||++.++. +||+|||+++.+..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            9999999976544445889999999999999999999943336999999999999998876 79999999987654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.91  E-value=4.2e-24  Score=209.87  Aligned_cols=150  Identities=29%  Similarity=0.500  Sum_probs=135.2

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .+.|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.++..++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            35688889999999999999986 568899999997543 3457889999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+++++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            9999999999843    45899999999999999999999985   999999999999999999999999999887654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.91  E-value=1.3e-24  Score=236.11  Aligned_cols=151  Identities=27%  Similarity=0.335  Sum_probs=133.2

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .++|...++||+|+||.||+++.. +++.||||+++..   .....+.+..|..++..+ +||+|+++++++...+..+|
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            467888899999999999999964 5788999999743   233456788999999988 79999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++|+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       420 V~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999999643   35899999999999999999999985   9999999999999999999999999999754


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      .+
T Consensus       494 ~~  495 (674)
T 3pfq_A          494 WD  495 (674)
T ss_dssp             CT
T ss_pred             cC
Confidence            33

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=2e-24  Score=211.38  Aligned_cols=150  Identities=32%  Similarity=0.484  Sum_probs=129.4

Q ss_pred             CCccccccccccceeEEEEEeC-CC---CEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCee-EEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA-DG---KEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES-LLI  419 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~-~g---~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~-~lv  419 (512)
                      .|...++||+|+||.||+|+.. ++   ..+|+|.+.... ....+.+.+|+.++..++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3455688999999999999853 22   379999997543 34467899999999999999999999999877665 999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +||+.+|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            9999999999999652  346899999999999999999999985   99999999999999999999999999987654


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       177 ~  177 (298)
T 3pls_A          177 R  177 (298)
T ss_dssp             G
T ss_pred             C
Confidence            3

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=2.4e-24  Score=214.71  Aligned_cols=158  Identities=27%  Similarity=0.444  Sum_probs=130.9

Q ss_pred             ChhHHHHHhcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcC--CCCccccceeeEEeC
Q 043262          336 PLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL--QHKNLVRLLGCCLQE  413 (512)
Q Consensus       336 ~~~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~g~~~~~  413 (512)
                      +........++|...++||+|+||.||+|+.. +..||||++....   ...+..|.+++..+  +||||+++++++...
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            33444455678999999999999999999985 8999999986432   34455566665554  899999999999987


Q ss_pred             ----CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCcccCCCCCCCeeecCCC
Q 043262          414 ----NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS-----RLKIIHRDLKTSNVLLDHEM  484 (512)
Q Consensus       414 ----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlk~~NiLl~~~~  484 (512)
                          +..++||||+++|+|.+++..    ..+++..++.++.|++.||.|||+..     ..+|+||||||+|||++.++
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence                778999999999999999954    25899999999999999999999871     22599999999999999999


Q ss_pred             ceEEeccCcccccCCCC
Q 043262          485 NPKISDFGMARIFGGNQ  501 (512)
Q Consensus       485 ~~kl~DFGla~~~~~~~  501 (512)
                      .+||+|||+++.+..+.
T Consensus       180 ~~kl~Dfg~a~~~~~~~  196 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDT  196 (337)
T ss_dssp             CEEECCCTTCEECC---
T ss_pred             CEEEEeCCCceeecccc
Confidence            99999999998775543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=1.6e-24  Score=220.76  Aligned_cols=150  Identities=29%  Similarity=0.534  Sum_probs=124.1

Q ss_pred             HHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCC-CCccccceeeEEeCC--e
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQEN--E  415 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~--~  415 (512)
                      ...++|...++||+|+||.||++.. .+++.||||++...  .....+.+.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3457899999999999999999986 56899999998643  3344667889999999997 999999999998654  6


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++||||++ |+|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999998 689988854    35899999999999999999999985   9999999999999999999999999999


Q ss_pred             ccCC
Q 043262          496 IFGG  499 (512)
Q Consensus       496 ~~~~  499 (512)
                      .+..
T Consensus       158 ~~~~  161 (388)
T 3oz6_A          158 SFVN  161 (388)
T ss_dssp             ESSS
T ss_pred             cccc
Confidence            8753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.91  E-value=1e-24  Score=227.01  Aligned_cols=148  Identities=29%  Similarity=0.456  Sum_probs=124.4

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC------C
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE------N  414 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~  414 (512)
                      .++|...++||+|+||.||+++. .+++.||||++...  .....+.+.+|+.++..++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46788899999999999999986 46889999999754  334467889999999999999999999999755      3


Q ss_pred             eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                      ..++||||++++ |.+.+..     .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            569999999865 5555522     3899999999999999999999985   999999999999999999999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +.....
T Consensus       212 ~~~~~~  217 (464)
T 3ttj_A          212 RTAGTS  217 (464)
T ss_dssp             -----C
T ss_pred             eecCCC
Confidence            987654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.91  E-value=2e-24  Score=209.89  Aligned_cols=150  Identities=29%  Similarity=0.460  Sum_probs=132.7

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC------cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS------GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++|...+.||+|+||.||+++.. +++.||||.++...      ....+.+.+|+.++.+++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46788899999999999999975 68999999986432      124678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC----ceEEeccCc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM----NPKISDFGM  493 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~----~~kl~DFGl  493 (512)
                      +||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999954   245899999999999999999999975   99999999999998877    899999999


Q ss_pred             ccccCCC
Q 043262          494 ARIFGGN  500 (512)
Q Consensus       494 a~~~~~~  500 (512)
                      ++.+...
T Consensus       159 ~~~~~~~  165 (283)
T 3bhy_A          159 AHKIEAG  165 (283)
T ss_dssp             CEECC--
T ss_pred             ceeccCC
Confidence            9987544

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.91  E-value=1.9e-24  Score=217.81  Aligned_cols=158  Identities=23%  Similarity=0.363  Sum_probs=131.4

Q ss_pred             hhHHHHHhcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCc-----------ccHHHHHHHHHHHhcCCCCcccc
Q 043262          337 LHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSG-----------QGLQEFKNEVTLIAKLQHKNLVR  405 (512)
Q Consensus       337 ~~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-----------~~~~~~~~E~~~l~~l~H~nIv~  405 (512)
                      +.++....++|...+.||+|+||.||++...++..||||++.....           ...+.+.+|+.++..++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            4455667889999999999999999999988899999999864321           12378999999999999999999


Q ss_pred             ceeeEEeC-----CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee
Q 043262          406 LLGCCLQE-----NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL  480 (512)
Q Consensus       406 l~g~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl  480 (512)
                      +++++...     ...++||||++ |+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            99998653     35799999998 688888764  3346999999999999999999999985   9999999999999


Q ss_pred             cCCCceEEeccCcccccCCC
Q 043262          481 DHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       481 ~~~~~~kl~DFGla~~~~~~  500 (512)
                      +.++.+||+|||+++.....
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~  187 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD  187 (362)
T ss_dssp             CTTCCEEECCTTC-------
T ss_pred             cCCCCEEEEecCcccccccc
Confidence            99999999999999865443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.91  E-value=2.5e-24  Score=209.28  Aligned_cols=152  Identities=26%  Similarity=0.423  Sum_probs=133.9

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      .++|...+.||+|+||.||++.. .++..||+|.+...  .....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46788899999999999999986 45899999998643  3344577899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc---eEEeccCccccc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN---PKISDFGMARIF  497 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~---~kl~DFGla~~~  497 (512)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||+++..
T Consensus        85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            999999998888543   45899999999999999999999985   999999999999986655   999999999887


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ....
T Consensus       159 ~~~~  162 (284)
T 3kk8_A          159 NDSE  162 (284)
T ss_dssp             CSSC
T ss_pred             ccCc
Confidence            6544

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.5e-24  Score=216.20  Aligned_cols=151  Identities=30%  Similarity=0.569  Sum_probs=127.7

Q ss_pred             cCCccccccccccceeEEEEEeCC-----CCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-----GKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-----g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .+|...+.||+|+||.||+|....     +..||||.++.. .......+.+|+.++.+++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456677899999999999998642     235999999754 33445679999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus       124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999999653  346899999999999999999999985   9999999999999999999999999999876


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      .+
T Consensus       199 ~~  200 (333)
T 1mqb_A          199 DD  200 (333)
T ss_dssp             --
T ss_pred             cc
Confidence            54

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1e-24  Score=220.82  Aligned_cols=150  Identities=32%  Similarity=0.545  Sum_probs=122.2

Q ss_pred             CCccccccccccceeEEEEEeC--CC--CEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEe-CCeeEEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKLA--DG--KEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ-ENESLLI  419 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~--~g--~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lv  419 (512)
                      .|...++||+|+||.||+|++.  ++  ..||||.++.. .....++|.+|+.++.+++||||+++++++.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3556789999999999999863  22  36899998753 33456789999999999999999999999865 4578999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            9999999999999643  345889999999999999999999985   99999999999999999999999999997744


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       245 ~  245 (373)
T 3c1x_A          245 K  245 (373)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.91  E-value=1.9e-24  Score=217.72  Aligned_cols=162  Identities=26%  Similarity=0.313  Sum_probs=138.0

Q ss_pred             CCcChhHHHHHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-----CCccccc
Q 043262          333 PLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-----HKNLVRL  406 (512)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l  406 (512)
                      ..+.+.......++|...++||+|+||.||+++. .+++.||||.+... ....+.+..|+.++..++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            3344444445568899999999999999999997 56889999999743 234567788999999986     9999999


Q ss_pred             eeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC----
Q 043262          407 LGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH----  482 (512)
Q Consensus       407 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~----  482 (512)
                      ++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++    
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence            99999999999999999 999999996532 335899999999999999999999985   999999999999975    


Q ss_pred             ---------------------CCceEEeccCcccccCCC
Q 043262          483 ---------------------EMNPKISDFGMARIFGGN  500 (512)
Q Consensus       483 ---------------------~~~~kl~DFGla~~~~~~  500 (512)
                                           ++.+||+|||+++.....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~  215 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY  215 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC
Confidence                                 789999999999876543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.91  E-value=2.3e-24  Score=211.06  Aligned_cols=151  Identities=32%  Similarity=0.529  Sum_probs=129.7

Q ss_pred             cCCccccccccccceeEEEEEeCC----CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEe-CCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD----GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ-ENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~----g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~l  418 (512)
                      .+|...++||+|+||.||+|+..+    ...+|||.+.... ....+.+.+|+.++.+++||||+++++++.. .+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457778899999999999998643    2358999987543 3446789999999999999999999999764 457899


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus       105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence            99999999999999652  345899999999999999999999985   9999999999999999999999999999775


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      ..
T Consensus       180 ~~  181 (298)
T 3f66_A          180 DK  181 (298)
T ss_dssp             CG
T ss_pred             cc
Confidence            43

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.91  E-value=3.6e-24  Score=211.97  Aligned_cols=148  Identities=32%  Similarity=0.542  Sum_probs=131.0

Q ss_pred             CccccccccccceeEEEEEeC-----CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeEE
Q 043262          347 FSDENKLGEGGFGPVYKGKLA-----DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESLL  418 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~~-----~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l  418 (512)
                      |...++||+|+||.||++.+.     +++.||||++.... ....+.+.+|+.++.+++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            477899999999999998752     67889999997543 34467899999999999999999999999884  56899


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++|+|.+++..    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999954    24899999999999999999999985   9999999999999999999999999999886


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      ...
T Consensus       186 ~~~  188 (318)
T 3lxp_A          186 EGH  188 (318)
T ss_dssp             TTC
T ss_pred             ccc
Confidence            543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.91  E-value=2.4e-24  Score=214.44  Aligned_cols=150  Identities=27%  Similarity=0.494  Sum_probs=129.3

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...+.||+|+||.||+++.. +++.||||++.....  ...+.+.+|+.++..++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            56888899999999999999974 589999999864432  335668899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+++++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999988743   235899999999999999999999985   999999999999999999999999999876543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.91  E-value=2e-24  Score=209.81  Aligned_cols=151  Identities=30%  Similarity=0.532  Sum_probs=132.2

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEe---------
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ---------  412 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---------  412 (512)
                      ...+|...+.||+|+||.||+++.. +++.||||.+....    +.+.+|+.++.+++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4467888899999999999999975 78999999997544    356789999999999999999998864         


Q ss_pred             -------CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc
Q 043262          413 -------ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN  485 (512)
Q Consensus       413 -------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~  485 (512)
                             ....++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   44579999999999999999643 2346899999999999999999999985   999999999999999999


Q ss_pred             eEEeccCcccccCCCC
Q 043262          486 PKISDFGMARIFGGNQ  501 (512)
Q Consensus       486 ~kl~DFGla~~~~~~~  501 (512)
                      +||+|||+++.+....
T Consensus       161 ~kl~Dfg~~~~~~~~~  176 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG  176 (284)
T ss_dssp             EEECCCTTCEESSCCS
T ss_pred             EEECcchhheeccccc
Confidence            9999999999876543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.91  E-value=1.9e-24  Score=212.01  Aligned_cols=148  Identities=28%  Similarity=0.508  Sum_probs=131.3

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .++|...+.||+|+||.||+++.. ++..||+|.+........+.+.+|+.++..++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467888999999999999999975 5889999999877667788999999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      +++++|.+++...  ...+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            9999999988642  245899999999999999999999985   99999999999999999999999999764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.91  E-value=4.1e-24  Score=213.51  Aligned_cols=157  Identities=27%  Similarity=0.430  Sum_probs=136.9

Q ss_pred             CcChhHHHHHhcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhc--CCCCccccceeeEE
Q 043262          334 LFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAK--LQHKNLVRLLGCCL  411 (512)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~  411 (512)
                      ..++.......++|...+.||+|+||.||+++. +++.||||.+...   ..+.+.+|.+++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            445555566778899999999999999999998 4899999998643   34677888888877  78999999999998


Q ss_pred             eCC----eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCcccCCCCCCCee
Q 043262          412 QEN----ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH--------EDSRLKIIHRDLKTSNVL  479 (512)
Q Consensus       412 ~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~dlk~~NiL  479 (512)
                      ..+    ..++||||+++|+|.+++..    ..+++..++.++.|++.||.|||        +.   +|+||||||+|||
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl  179 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL  179 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence            876    78999999999999999954    35899999999999999999999        54   5999999999999


Q ss_pred             ecCCCceEEeccCcccccCCCC
Q 043262          480 LDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       480 l~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +++++.+||+|||+++.+....
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~  201 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSAT  201 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTT
T ss_pred             ECCCCCEEEEECCCceeccccc
Confidence            9999999999999998876543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.91  E-value=1.8e-24  Score=214.96  Aligned_cols=152  Identities=34%  Similarity=0.525  Sum_probs=129.7

Q ss_pred             cCCccccccccccceeEEEEEe------CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~------~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++|...+.||+|+||.||+|++      .++..||||.+... ......++.+|+.++.+++||||+++++++...+..+
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            5788889999999999999984      35678999999744 3445668999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC---CCceEEec
Q 043262          418 LIYEYMPNKSLNVFLFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISD  490 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~---~~~~kl~D  490 (512)
                      +||||+++++|.+++.....    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.   +..+||+|
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECc
Confidence            99999999999999975432    245899999999999999999999985   999999999999984   45699999


Q ss_pred             cCcccccCC
Q 043262          491 FGMARIFGG  499 (512)
Q Consensus       491 FGla~~~~~  499 (512)
                      ||+++.+..
T Consensus       187 fg~~~~~~~  195 (327)
T 2yfx_A          187 FGMARDIYR  195 (327)
T ss_dssp             CHHHHHHHC
T ss_pred             ccccccccc
Confidence            999986643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.91  E-value=2.2e-24  Score=217.76  Aligned_cols=151  Identities=21%  Similarity=0.320  Sum_probs=126.1

Q ss_pred             hcCCccccccccccceeEEEEEeCC------CCEEEEEEcccCCccc-----------HHHHHHHHHHHhcCCCCccccc
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLAD------GKEIAVKRLSRTSGQG-----------LQEFKNEVTLIAKLQHKNLVRL  406 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l  406 (512)
                      .++|...++||+|+||.||+|.+.+      ++.||||.+.......           ...+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578889999999999999998754      4789999987554221           1224456667788899999999


Q ss_pred             eeeEEeC----CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec-
Q 043262          407 LGCCLQE----NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD-  481 (512)
Q Consensus       407 ~g~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~-  481 (512)
                      ++++...    ...++||||+ +++|.+++...  ...+++..++.|+.||+.||.|||+.+   |+||||||+||||+ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            9999875    4489999999 99999999653  346999999999999999999999985   99999999999999 


Q ss_pred             -CCCceEEeccCcccccCCC
Q 043262          482 -HEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       482 -~~~~~kl~DFGla~~~~~~  500 (512)
                       .++.+||+|||+++.+..+
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~  207 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPE  207 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGG
T ss_pred             CCCCeEEEEECCcceecccC
Confidence             8899999999999887544

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.91  E-value=3e-24  Score=206.88  Aligned_cols=152  Identities=26%  Similarity=0.431  Sum_probs=133.0

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC--CeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--NESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~  420 (512)
                      ++|...++||+|+||.||+|+.. +..||||.+...  .....+.|.+|+.++.+++||||+++++++...  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56778899999999999999985 889999999754  334466899999999999999999999999887  7789999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ .+|+||||||+|||+++++.+||+|||++.....
T Consensus        89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            999999999999653 3346899999999999999999999863 3599999999999999999999999998866443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.91  E-value=2.5e-24  Score=208.30  Aligned_cols=150  Identities=28%  Similarity=0.489  Sum_probs=134.3

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++.. +++.||||.+...   .....+.+.+|+.++..++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            56888899999999999999975 7899999998643   2234678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||+++....+
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           91 EYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999999643   35899999999999999999999985   999999999999999999999999999887554

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.91  E-value=1.7e-24  Score=210.00  Aligned_cols=151  Identities=30%  Similarity=0.443  Sum_probs=131.6

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .++|...+.||+|+||.||+++.. ++..||||.+....   ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            356888899999999999999864 57789999986432   23356789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999998543   35899999999999999999999875   99999999999999999999999999976644


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       162 ~  162 (279)
T 3fdn_A          162 S  162 (279)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.91  E-value=2.4e-24  Score=226.46  Aligned_cols=152  Identities=27%  Similarity=0.451  Sum_probs=129.5

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      .++|...++||+|+||.||+++.. ++..||||.+....  ......+.+|+.++..++||||+++++++...+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456888899999999999999974 68899999997542  334578999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC---CCceEEeccCccccc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGMARIF  497 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~---~~~~kl~DFGla~~~  497 (512)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++.+
T Consensus       116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            999999999888542   45899999999999999999999985   999999999999976   455999999999987


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ....
T Consensus       190 ~~~~  193 (494)
T 3lij_A          190 ENQK  193 (494)
T ss_dssp             BTTB
T ss_pred             CCCc
Confidence            6543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.91  E-value=4.2e-24  Score=225.15  Aligned_cols=153  Identities=28%  Similarity=0.470  Sum_probs=132.2

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc-------------ccHHHHHHHHHHHhcCCCCcccccee
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG-------------QGLQEFKNEVTLIAKLQHKNLVRLLG  408 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~g  408 (512)
                      ..++|...++||+|+||.||+++.. ++..||||.+.....             ...+.+.+|+.++.+++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3567888999999999999999974 578999999864321             33578999999999999999999999


Q ss_pred             eEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC---c
Q 043262          409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM---N  485 (512)
Q Consensus       409 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~---~  485 (512)
                      ++...+..++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999988542   45999999999999999999999985   99999999999998775   6


Q ss_pred             eEEeccCcccccCCCC
Q 043262          486 PKISDFGMARIFGGNQ  501 (512)
Q Consensus       486 ~kl~DFGla~~~~~~~  501 (512)
                      +||+|||+++.+..+.
T Consensus       188 ~kl~Dfg~a~~~~~~~  203 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY  203 (504)
T ss_dssp             EEECCCTTCEECCTTS
T ss_pred             EEEEECCCCEEcCCCC
Confidence            9999999999886553

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.91  E-value=4e-25  Score=224.25  Aligned_cols=152  Identities=16%  Similarity=0.222  Sum_probs=124.6

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHH---HHHhcCCCCccccce-------ee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEV---TLIAKLQHKNLVRLL-------GC  409 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------g~  409 (512)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...   .....+.|.+|+   .++.+++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35677889999999999999996 56999999999733   334567899999   556666899999998       55


Q ss_pred             EEeCC-----------------eeEEEEEecCCCChhHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCc
Q 043262          410 CLQEN-----------------ESLLIYEYMPNKSLNVFLFDST----RSVQLDWKRRISIINGIARGLLYLHEDSRLKI  468 (512)
Q Consensus       410 ~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  468 (512)
                      +...+                 ..++||||+ +|+|.+++....    ....+++..++.|+.||+.||.|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 278999999 689999996421    1123556888999999999999999985   9


Q ss_pred             ccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       469 vH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +||||||+||||+.++.+||+|||+++..+.
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~  258 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA  258 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC
Confidence            9999999999999999999999999997543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.91  E-value=2e-24  Score=216.45  Aligned_cols=152  Identities=27%  Similarity=0.429  Sum_probs=134.2

Q ss_pred             hcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcc-----------------cHHHHHHHHHHHhcCCCCccccc
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQ-----------------GLQEFKNEVTLIAKLQHKNLVRL  406 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~-----------------~~~~~~~E~~~l~~l~H~nIv~l  406 (512)
                      .++|...+.||+|+||.||+++. +++.||||.+......                 ..+.+.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36788899999999999999999 8999999998643211                 12789999999999999999999


Q ss_pred             eeeEEeCCeeEEEEEecCCCChhHH------hhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCCee
Q 043262          407 LGCCLQENESLLIYEYMPNKSLNVF------LFDSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKTSNVL  479 (512)
Q Consensus       407 ~g~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlk~~NiL  479 (512)
                      ++++...+..++||||+++|+|.++      +.. .....+++..+..++.||+.||.|||+ .   +|+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            9999999999999999999999998      532 224679999999999999999999998 6   4999999999999


Q ss_pred             ecCCCceEEeccCcccccCCC
Q 043262          480 LDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       480 l~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++.++.+||+|||+++.+...
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~  205 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK  205 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT
T ss_pred             EcCCCcEEEeccccccccccc
Confidence            999999999999999986543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.91  E-value=1.2e-24  Score=216.49  Aligned_cols=151  Identities=30%  Similarity=0.483  Sum_probs=126.9

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc--ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ..++|...++||+|+||.||+++. .+++.||||++.....  ...+.+.+|+.++.+++||||+++++++...+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            346789999999999999999985 5788999999975432  2345788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee-----cCCCceEEeccCcc
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL-----DHEMNPKISDFGMA  494 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl-----~~~~~~kl~DFGla  494 (512)
                      |||++ |+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||+     ++++.+||+|||++
T Consensus       112 ~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99998 5999998543   35899999999999999999999985   9999999999999     45556999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +.+...
T Consensus       185 ~~~~~~  190 (329)
T 3gbz_A          185 RAFGIP  190 (329)
T ss_dssp             HHHC--
T ss_pred             cccCCc
Confidence            887543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.91  E-value=2.2e-24  Score=226.18  Aligned_cols=152  Identities=28%  Similarity=0.463  Sum_probs=135.3

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .++|...++||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457888899999999999999974 78999999986432   34577899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee---cCCCceEEeccCcccc
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARI  496 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl---~~~~~~kl~DFGla~~  496 (512)
                      +||+.+|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999998854   345899999999999999999999985   9999999999999   5678999999999998


Q ss_pred             cCCCC
Q 043262          497 FGGNQ  501 (512)
Q Consensus       497 ~~~~~  501 (512)
                      +....
T Consensus       179 ~~~~~  183 (484)
T 3nyv_A          179 FEASK  183 (484)
T ss_dssp             BCCCC
T ss_pred             ccccc
Confidence            76543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.91  E-value=3.9e-24  Score=209.41  Aligned_cols=152  Identities=28%  Similarity=0.393  Sum_probs=134.5

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC---------cccHHHHHHHHHHHhcCC-CCccccceeeEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS---------GQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQ  412 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~  412 (512)
                      .++|...+.||+|+||.||+++.. +++.||||.+....         ....+.+.+|+.++.++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            467888999999999999999974 68899999986442         122456889999999996 9999999999999


Q ss_pred             CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccC
Q 043262          413 ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  492 (512)
Q Consensus       413 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFG  492 (512)
                      .+..++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence            9999999999999999999964   245899999999999999999999985   9999999999999999999999999


Q ss_pred             cccccCCCC
Q 043262          493 MARIFGGNQ  501 (512)
Q Consensus       493 la~~~~~~~  501 (512)
                      +++.+..+.
T Consensus       170 ~~~~~~~~~  178 (298)
T 1phk_A          170 FSCQLDPGE  178 (298)
T ss_dssp             TCEECCTTC
T ss_pred             chhhcCCCc
Confidence            999876543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=4e-24  Score=208.38  Aligned_cols=150  Identities=29%  Similarity=0.546  Sum_probs=130.3

Q ss_pred             CCcccc-ccccccceeEEEEEeC---CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          346 HFSDEN-KLGEGGFGPVYKGKLA---DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       346 ~~~~~~-~lg~G~fG~Vy~~~~~---~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      +|...+ .||+|+||.||+|...   ++..||||.++... ....+.+.+|+.++..++||||+++++++ ..+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            344444 8999999999999853   57789999997643 34567899999999999999999999999 566789999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        89 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           89 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             ECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999954  3345899999999999999999999985   999999999999999999999999999988654


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       164 ~  164 (287)
T 1u59_A          164 D  164 (287)
T ss_dssp             S
T ss_pred             c
Confidence            3

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.91  E-value=1.3e-24  Score=234.44  Aligned_cols=144  Identities=31%  Similarity=0.518  Sum_probs=126.0

Q ss_pred             cccccccceeEEEEEe---CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKL---ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~---~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ++||+|+||.||+|.+   ..+..||||+++...  ....++|.+|+.++.+++|||||++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            4799999999999965   346789999997543  344688999999999999999999999986 4568899999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      |+|.+++..   ...+++..++.|+.||+.||.|||+++   |+||||||+||||++++.+||+|||+++.+..+.
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            999999954   345899999999999999999999985   9999999999999999999999999999886543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.91  E-value=3.4e-24  Score=211.21  Aligned_cols=153  Identities=22%  Similarity=0.420  Sum_probs=126.8

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      .+|...+.||+|+||.||++.. .++..||||++...   .....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5688889999999999999986 57899999999753   2344677999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++++|.+++.... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            9999999999985421 2345899999999999999999999985   99999999999999999999999999987754


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       189 ~  189 (310)
T 2wqm_A          189 K  189 (310)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.91  E-value=1.6e-24  Score=212.45  Aligned_cols=154  Identities=23%  Similarity=0.403  Sum_probs=120.0

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .++|...+.||+|+||.||++.. .++..||||.+.... ....+++.+|+.++.+++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            46788899999999999999986 468899999986433 3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          422 YMPNKSLNVFLFDS-----TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       422 ~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      |+++++|.+++...     .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            99999999998631     22456899999999999999999999985   99999999999999999999999999987


Q ss_pred             cCCC
Q 043262          497 FGGN  500 (512)
Q Consensus       497 ~~~~  500 (512)
                      +...
T Consensus       171 ~~~~  174 (303)
T 2vwi_A          171 LATG  174 (303)
T ss_dssp             CC--
T ss_pred             eccC
Confidence            7543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.91  E-value=4.9e-24  Score=210.57  Aligned_cols=147  Identities=30%  Similarity=0.492  Sum_probs=124.6

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEE------------
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL------------  411 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~------------  411 (512)
                      ++|...+.||+|+||.||+++.. +++.||||++........+.+.+|+.++.+++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            57888899999999999999975 48899999998776667788999999999999999999999873            


Q ss_pred             --eCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec-CCCceEE
Q 043262          412 --QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD-HEMNPKI  488 (512)
Q Consensus       412 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~-~~~~~kl  488 (512)
                        +.+..++||||++ |+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++ +++.+||
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence              3467899999998 699999843    45899999999999999999999985   99999999999997 5779999


Q ss_pred             eccCcccccCC
Q 043262          489 SDFGMARIFGG  499 (512)
Q Consensus       489 ~DFGla~~~~~  499 (512)
                      +|||+++.+..
T Consensus       163 ~Dfg~~~~~~~  173 (320)
T 2i6l_A          163 GDFGLARIMDP  173 (320)
T ss_dssp             CCCTTCBCC--
T ss_pred             ccCccccccCC
Confidence            99999998754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.91  E-value=5.3e-24  Score=209.18  Aligned_cols=151  Identities=26%  Similarity=0.382  Sum_probs=128.8

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC----cccHHHHHHHHHHHhcCCCCccccceeeEE--eCCee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLLGCCL--QENES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~  416 (512)
                      .++|...+.||+|+||.||++.. .++..||||.+....    ....+.+.+|+.++..++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            36788899999999999999997 468899999996432    234678999999999999999999999985  44578


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++||||++++ |.+++... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999887 66666542 3456999999999999999999999985   99999999999999999999999999998


Q ss_pred             cCC
Q 043262          497 FGG  499 (512)
Q Consensus       497 ~~~  499 (512)
                      +..
T Consensus       159 ~~~  161 (305)
T 2wtk_C          159 LHP  161 (305)
T ss_dssp             CCT
T ss_pred             cCc
Confidence            754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=2.8e-24  Score=215.37  Aligned_cols=152  Identities=30%  Similarity=0.499  Sum_probs=126.7

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcc-----cHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQ-----GLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      ..++|...+.||+|+||.||+++.. +|+.||||.+......     ..+.+.+|+.++..++||||+++++++...+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3467888999999999999999974 5899999999743221     124688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++||||+++ +|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 888888542  345888999999999999999999985   99999999999999999999999999998


Q ss_pred             cCCC
Q 043262          497 FGGN  500 (512)
Q Consensus       497 ~~~~  500 (512)
                      +...
T Consensus       162 ~~~~  165 (346)
T 1ua2_A          162 FGSP  165 (346)
T ss_dssp             TTSC
T ss_pred             ccCC
Confidence            7543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=3.4e-24  Score=216.54  Aligned_cols=148  Identities=28%  Similarity=0.480  Sum_probs=124.4

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC------e
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN------E  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~  415 (512)
                      ++|...+.||+|+||.||++.. .+|+.||||++...  .....+.+.+|+.++..++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            5788889999999999999997 56899999999643  3334567899999999999999999999998763      4


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++||||+ +++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            59999999 8899999854    35899999999999999999999985   9999999999999999999999999999


Q ss_pred             ccCCC
Q 043262          496 IFGGN  500 (512)
Q Consensus       496 ~~~~~  500 (512)
                      .....
T Consensus       177 ~~~~~  181 (367)
T 1cm8_A          177 QADSE  181 (367)
T ss_dssp             ECCSS
T ss_pred             ccccc
Confidence            87543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.91  E-value=3.7e-24  Score=211.05  Aligned_cols=151  Identities=21%  Similarity=0.281  Sum_probs=130.1

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc---ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .++|...+.||+|+||.||+++.. +++.||||.+.....   ...+.+.+|+.++.+++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            467888999999999999999974 688999999975432   2357799999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      +||+++++|.+++...   ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            9999999999999643   35899999999999999999999985   99999999999999999999999999987754


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       187 ~  187 (309)
T 2h34_A          187 E  187 (309)
T ss_dssp             -
T ss_pred             c
Confidence            3

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.91  E-value=7.4e-24  Score=206.33  Aligned_cols=150  Identities=31%  Similarity=0.601  Sum_probs=128.9

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCccc-------HHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQG-------LQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      ++|...+.||+|+||.||+++. .+++.||||.+.......       .+.+.+|+.++.+++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            6788889999999999999997 578999999986433221       267999999999999999999999986554  


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc-----eEEecc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN-----PKISDF  491 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~-----~kl~DF  491 (512)
                      ++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+++ .+|+||||||+|||++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            7999999999999888653  346999999999999999999999974 34999999999999988776     999999


Q ss_pred             CcccccCC
Q 043262          492 GMARIFGG  499 (512)
Q Consensus       492 Gla~~~~~  499 (512)
                      |+++....
T Consensus       174 g~~~~~~~  181 (287)
T 4f0f_A          174 GLSQQSVH  181 (287)
T ss_dssp             TTCBCCSS
T ss_pred             Cccccccc
Confidence            99986544

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.91  E-value=2.8e-24  Score=225.49  Aligned_cols=153  Identities=28%  Similarity=0.453  Sum_probs=134.5

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ..++|...++||+|+||.||+++.. +++.||||++...  .......+.+|+.++.+++||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4467888999999999999999974 7899999998642  234567899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec---CCCceEEeccCcccc
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARI  496 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~---~~~~~kl~DFGla~~  496 (512)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999999888543   45899999999999999999999985   99999999999995   566799999999998


Q ss_pred             cCCCC
Q 043262          497 FGGNQ  501 (512)
Q Consensus       497 ~~~~~  501 (512)
                      +..+.
T Consensus       174 ~~~~~  178 (486)
T 3mwu_A          174 FQQNT  178 (486)
T ss_dssp             BCCC-
T ss_pred             CCCCC
Confidence            76543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.91  E-value=8.4e-24  Score=208.71  Aligned_cols=152  Identities=30%  Similarity=0.502  Sum_probs=129.9

Q ss_pred             HHhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ...++|...+.||+|+||.||++... +|+.||||.+....  ..+++.+|+.++..++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34567888999999999999999875 58999999997543  3467899999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++++|.+++..  ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+...
T Consensus       104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999999853  2346899999999999999999999975   999999999999999999999999999887654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.91  E-value=4.2e-24  Score=218.35  Aligned_cols=147  Identities=24%  Similarity=0.312  Sum_probs=122.8

Q ss_pred             cCCccc-cccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHH-hcCCCCccccceeeEEe----CCeeE
Q 043262          345 QHFSDE-NKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLI-AKLQHKNLVRLLGCCLQ----ENESL  417 (512)
Q Consensus       345 ~~~~~~-~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~~  417 (512)
                      ++|... +.||+|+||.||+++.. +++.||||++...     ..+.+|+.++ ...+||||+++++++..    .+..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            345444 68999999999999864 6889999998642     4567888876 45589999999999875    56689


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC---CCceEEeccCcc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGMA  494 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~---~~~~kl~DFGla  494 (512)
                      +||||+++|+|.+++... ....+++..+..|+.||+.||.|||+.+   |+||||||+||||+.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999653 2346999999999999999999999975   999999999999998   789999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +.....
T Consensus       212 ~~~~~~  217 (400)
T 1nxk_A          212 KETTSH  217 (400)
T ss_dssp             EECC--
T ss_pred             cccCCC
Confidence            977543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.91  E-value=7.2e-24  Score=212.74  Aligned_cols=149  Identities=27%  Similarity=0.532  Sum_probs=129.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeC--------
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE--------  413 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--------  413 (512)
                      ++|...++||+|+||.||+++. .+++.||||++....  ......+.+|+.++..++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5788889999999999999997 578999999986433  23356788999999999999999999999873        


Q ss_pred             CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          414 NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      +..++||||+++ +|...+...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            468999999985 777766443  245999999999999999999999985   99999999999999999999999999


Q ss_pred             ccccCC
Q 043262          494 ARIFGG  499 (512)
Q Consensus       494 a~~~~~  499 (512)
                      ++.+..
T Consensus       171 a~~~~~  176 (351)
T 3mi9_A          171 ARAFSL  176 (351)
T ss_dssp             CEECCC
T ss_pred             cccccc
Confidence            998753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.91  E-value=5.9e-24  Score=211.32  Aligned_cols=162  Identities=25%  Similarity=0.373  Sum_probs=136.9

Q ss_pred             cChhHHHHHhcCCccc-cccccccceeEEEEEeC-CCCEEEEEEcccC--CcccHHHHHHHHHHHhcCC-CCccccceee
Q 043262          335 FPLHLAVEATQHFSDE-NKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQ-HKNLVRLLGC  409 (512)
Q Consensus       335 ~~~~~~~~~~~~~~~~-~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~  409 (512)
                      ..+.......++|... ++||+|+||.||+++.. +++.||||.+...  ......++.+|+.++..++ ||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3444455566677766 78999999999999874 6899999998743  3344778999999999995 6999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC---CCce
Q 043262          410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH---EMNP  486 (512)
Q Consensus       410 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~---~~~~  486 (512)
                      +...+..++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence            99999999999999999999998542 3356999999999999999999999985   999999999999998   7899


Q ss_pred             EEeccCcccccCCC
Q 043262          487 KISDFGMARIFGGN  500 (512)
Q Consensus       487 kl~DFGla~~~~~~  500 (512)
                      ||+|||+++.+...
T Consensus       174 kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          174 KIVDFGMSRKIGHA  187 (327)
T ss_dssp             EECCGGGCEEC---
T ss_pred             EEeeCccccccCCc
Confidence            99999999987654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.91  E-value=4.7e-24  Score=208.94  Aligned_cols=150  Identities=31%  Similarity=0.519  Sum_probs=131.9

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEe----------
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ----------  412 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----------  412 (512)
                      .++|...+.||+|+||.||+++. .+++.||||.+... ....+.+.+|+.++..++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            45688889999999999999996 57899999999643 3345789999999999999999999999865          


Q ss_pred             ---CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEe
Q 043262          413 ---ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  489 (512)
Q Consensus       413 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~  489 (512)
                         .+..++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               35679999999999999999653  245788999999999999999999985   9999999999999999999999


Q ss_pred             ccCcccccCC
Q 043262          490 DFGMARIFGG  499 (512)
Q Consensus       490 DFGla~~~~~  499 (512)
                      |||+++.+..
T Consensus       159 dfg~~~~~~~  168 (303)
T 1zy4_A          159 DFGLAKNVHR  168 (303)
T ss_dssp             CCCCCSCTTC
T ss_pred             eCcchhhccc
Confidence            9999987753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.91  E-value=3.1e-24  Score=210.97  Aligned_cols=150  Identities=25%  Similarity=0.407  Sum_probs=131.0

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .++|...+.||+|+||.||+++.. +++.||+|.+........+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            356888899999999999999974 6899999999866555556789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee---cCCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl---~~~~~~kl~DFGla~~~~~  499 (512)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||+   ++++.+||+|||+++....
T Consensus        88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999999988542   35899999999999999999999985   9999999999999   7889999999999986543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.91  E-value=8.5e-24  Score=206.87  Aligned_cols=149  Identities=20%  Similarity=0.343  Sum_probs=131.2

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...+.||+|+||.||+++. .+++.||||.+.....  .+.+.+|+.++..+ +|+|++++++++...+..++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            5688889999999999999995 6789999999864432  24578899999999 799999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc-----eEEeccCccccc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN-----PKISDFGMARIF  497 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~-----~kl~DFGla~~~  497 (512)
                      + +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||+|||+++.+
T Consensus        88 ~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           88 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            9 99999999653  235899999999999999999999875   999999999999987776     999999999987


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ....
T Consensus       162 ~~~~  165 (298)
T 1csn_A          162 RDPV  165 (298)
T ss_dssp             BCTT
T ss_pred             cccc
Confidence            6543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.91  E-value=2.3e-24  Score=217.15  Aligned_cols=148  Identities=25%  Similarity=0.357  Sum_probs=132.7

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|+||.||+++.. ++..||+|.+... .....+.+.+|+.++..++||||+++++++...+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56888899999999999999975 6889999999754 334467899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||+++.+
T Consensus       113 ~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          113 MDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            9999999999643   35899999999999999999999851  3999999999999999999999999999765

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.91  E-value=1.5e-24  Score=215.44  Aligned_cols=149  Identities=32%  Similarity=0.517  Sum_probs=127.3

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCccc-HHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|+||.||+++.. +++.||||++....... ...+.+|+.++..++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46788899999999999999975 68999999996443221 22456799999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++ |+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            97 5888888653  335899999999999999999999985   99999999999999999999999999987653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.91  E-value=2.4e-24  Score=214.39  Aligned_cols=154  Identities=30%  Similarity=0.410  Sum_probs=134.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceeeEEe--------CC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQ--------EN  414 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~--------~~  414 (512)
                      .+|...++||+|+||.||+++. .+++.||||++........+.+.+|+.++.++. ||||+++++++..        ..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            5688889999999999999996 468999999997766666778999999999996 9999999999953        34


Q ss_pred             eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          415 ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                      ..++|+||+. |+|.+++........+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  185 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSA  185 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccc
Confidence            4789999996 799998865444556999999999999999999999873 34999999999999999999999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +.+...
T Consensus       186 ~~~~~~  191 (337)
T 3ll6_A          186 TTISHY  191 (337)
T ss_dssp             BCCSSC
T ss_pred             eecccc
Confidence            987654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.91  E-value=4.4e-24  Score=207.65  Aligned_cols=149  Identities=27%  Similarity=0.435  Sum_probs=132.6

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++.. ++..||||.+...   .....+.+.+|+.++..++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56788899999999999999975 5778999998643   2233567999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999998643   35899999999999999999999975   99999999999999999999999999987654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.91  E-value=3.2e-24  Score=212.93  Aligned_cols=153  Identities=28%  Similarity=0.496  Sum_probs=132.2

Q ss_pred             HHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEe------C
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQ------E  413 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~------~  413 (512)
                      ...++|...+.||+|+||.||+|+. .+++.||||.+.... ...+.+.+|+.++.++ +||||+++++++..      .
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            3467888999999999999999997 578999999986543 2346889999999998 79999999999987      4


Q ss_pred             CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          414 NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      +..++||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||+
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            6789999999999999999653 2346899999999999999999999985   99999999999999999999999999


Q ss_pred             ccccCC
Q 043262          494 ARIFGG  499 (512)
Q Consensus       494 a~~~~~  499 (512)
                      ++.+..
T Consensus       176 ~~~~~~  181 (326)
T 2x7f_A          176 SAQLDR  181 (326)
T ss_dssp             TC----
T ss_pred             ceecCc
Confidence            987654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.91  E-value=1.1e-23  Score=209.32  Aligned_cols=145  Identities=24%  Similarity=0.421  Sum_probs=129.4

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceeeEEe--CCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQ--ENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+++. .+++.||||.++..   ..+.+.+|+.++.+++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            5688889999999999999985 67899999998743   3577899999999997 9999999999988  56789999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-ceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DFGla~~~~~  499 (512)
                      ||+++++|.+++.      .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||+++.+..
T Consensus       113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999999883      3889999999999999999999985   99999999999999776 899999999998765


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      +.
T Consensus       184 ~~  185 (330)
T 3nsz_A          184 GQ  185 (330)
T ss_dssp             TC
T ss_pred             CC
Confidence            43

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.90  E-value=1e-23  Score=206.47  Aligned_cols=151  Identities=31%  Similarity=0.547  Sum_probs=130.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...+.||+|+||.||+++.. +++.||||.+....  ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            56788899999999999999975 68999999986433  2334678999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |++ ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+...
T Consensus        83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  156 (299)
T 2r3i_A           83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  156 (299)
T ss_dssp             CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccCC
Confidence            998 6999998653 2345899999999999999999999985   999999999999999999999999999877543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.90  E-value=6.7e-24  Score=212.24  Aligned_cols=149  Identities=22%  Similarity=0.362  Sum_probs=127.9

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ..++|...+.||+|+||.||+++.. +++.||||.+......    +.+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3467888899999999999999874 6889999999765432    35677888777 7999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC----CceEEeccCcccc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE----MNPKISDFGMARI  496 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~----~~~kl~DFGla~~  496 (512)
                      ||+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+.++    ..+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999854   345899999999999999999999985   9999999999998543    3599999999998


Q ss_pred             cCCCC
Q 043262          497 FGGNQ  501 (512)
Q Consensus       497 ~~~~~  501 (512)
                      +....
T Consensus       170 ~~~~~  174 (342)
T 2qr7_A          170 LRAEN  174 (342)
T ss_dssp             CBCTT
T ss_pred             CcCCC
Confidence            76543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.90  E-value=5.4e-24  Score=211.51  Aligned_cols=150  Identities=33%  Similarity=0.588  Sum_probs=129.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCE--EEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKE--IAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~--vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...+.||+|+||.||+++.. ++..  |+||.+... .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56888899999999999999864 4554  499988743 334456799999999999 899999999999999999999


Q ss_pred             EEecCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCce
Q 043262          420 YEYMPNKSLNVFLFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP  486 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~  486 (512)
                      |||+++|+|.+++....             ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996542             2346899999999999999999999985   9999999999999999999


Q ss_pred             EEeccCccccc
Q 043262          487 KISDFGMARIF  497 (512)
Q Consensus       487 kl~DFGla~~~  497 (512)
                      ||+|||+++..
T Consensus       182 kL~Dfg~~~~~  192 (327)
T 1fvr_A          182 KIADFGLSRGQ  192 (327)
T ss_dssp             EECCTTCEESS
T ss_pred             EEcccCcCccc
Confidence            99999999854

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.90  E-value=9.3e-24  Score=206.01  Aligned_cols=151  Identities=30%  Similarity=0.423  Sum_probs=130.1

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEe----CCeeEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ----ENESLL  418 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~l  418 (512)
                      .|...++||+|+||.||+|.. .++..||+|.+...  .....+.+.+|+.++..++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            466678899999999999986 46788999998643  34456789999999999999999999999875    355899


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec-CCCceEEeccCccccc
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIF  497 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~-~~~~~kl~DFGla~~~  497 (512)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||+++..
T Consensus       107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            99999999999999542   45899999999999999999999873 3499999999999997 7899999999999876


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      ...
T Consensus       183 ~~~  185 (290)
T 1t4h_A          183 RAS  185 (290)
T ss_dssp             CTT
T ss_pred             ccc
Confidence            544

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.90  E-value=5.2e-24  Score=207.99  Aligned_cols=150  Identities=31%  Similarity=0.516  Sum_probs=129.2

Q ss_pred             cCCcccc-ccccccceeEEEEEe---CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDEN-KLGEGGFGPVYKGKL---ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~-~lg~G~fG~Vy~~~~---~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      ++|...+ .||+|+||.||++.+   .++..||||.++...  ....+++.+|+.++..++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4566666 899999999999964   346789999997543  23367899999999999999999999999 6677899


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        95 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            99999999999999653   35899999999999999999999985   9999999999999999999999999999876


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      ...
T Consensus       169 ~~~  171 (291)
T 1xbb_A          169 ADE  171 (291)
T ss_dssp             TTC
T ss_pred             cCC
Confidence            543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.90  E-value=4e-24  Score=213.12  Aligned_cols=148  Identities=36%  Similarity=0.591  Sum_probs=122.4

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHH--HhcCCCCccccceeeEEe-----CCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTL--IAKLQHKNLVRLLGCCLQ-----ENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~g~~~~-----~~~~~  417 (512)
                      ++|...++||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++.+..     ....+
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            5788889999999999999987 68999999996433   3444555554  455899999999986643     23568


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCcccCCCCCCCeeecCCCceEEecc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS------RLKIIHRDLKTSNVLLDHEMNPKISDF  491 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~dlk~~NiLl~~~~~~kl~DF  491 (512)
                      +||||+++|+|.+++...    ..++..+..++.||+.||.|||+..      ..+|+||||||+||||+.++.+||+||
T Consensus        89 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            999999999999999543    3589999999999999999999871      124999999999999999999999999


Q ss_pred             CcccccCCC
Q 043262          492 GMARIFGGN  500 (512)
Q Consensus       492 Gla~~~~~~  500 (512)
                      |+++.+..+
T Consensus       165 G~a~~~~~~  173 (336)
T 3g2f_A          165 GLSMRLTGN  173 (336)
T ss_dssp             TTCEECSSS
T ss_pred             cceeecccc
Confidence            999987543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.90  E-value=4e-24  Score=214.23  Aligned_cols=149  Identities=19%  Similarity=0.286  Sum_probs=123.1

Q ss_pred             cCCccccccccccceeEEEEEeC----CCCEEEEEEcccCCcc-----------cHHHHHHHHHHHhcCCCCccccceee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA----DGKEIAVKRLSRTSGQ-----------GLQEFKNEVTLIAKLQHKNLVRLLGC  409 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~----~g~~vaVK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~g~  409 (512)
                      ++|...++||+|+||.||+|+..    ++..+|||.+......           ....+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            56888899999999999999975    5788999998754321           12346788899999999999999999


Q ss_pred             EEe----CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-
Q 043262          410 CLQ----ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-  484 (512)
Q Consensus       410 ~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-  484 (512)
                      +..    .+..++||||+ +++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence            988    67889999999 99999998543   26999999999999999999999985   99999999999999887 


Q ss_pred             -ceEEeccCcccccCCC
Q 043262          485 -NPKISDFGMARIFGGN  500 (512)
Q Consensus       485 -~~kl~DFGla~~~~~~  500 (512)
                       .+||+|||+++.+..+
T Consensus       190 ~~~kL~Dfg~a~~~~~~  206 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPN  206 (345)
T ss_dssp             TSEEECCCTTCEESSGG
T ss_pred             CcEEEEeCCCceecccc
Confidence             9999999999987543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.90  E-value=7.8e-24  Score=209.90  Aligned_cols=151  Identities=26%  Similarity=0.396  Sum_probs=127.2

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC--------cccHHHHHHHHHHHhcCCCCccccceeeEEeC
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS--------GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE  413 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  413 (512)
                      ..++|...+.||+|+||.||+++.. +++.||||.+....        ......+.+|+.++.+++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467888999999999999999874 57899999986432        12234588999999999999999999998765


Q ss_pred             CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc---eEEec
Q 043262          414 NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN---PKISD  490 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~---~kl~D  490 (512)
                      + .++||||+++++|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 8999999999999998853   346899999999999999999999985   999999999999987654   99999


Q ss_pred             cCcccccCCC
Q 043262          491 FGMARIFGGN  500 (512)
Q Consensus       491 FGla~~~~~~  500 (512)
                      ||+++.+...
T Consensus       161 fg~~~~~~~~  170 (322)
T 2ycf_A          161 FGHSKILGET  170 (322)
T ss_dssp             CTTCEECCCC
T ss_pred             Cccceecccc
Confidence            9999987543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.90  E-value=6.6e-24  Score=206.08  Aligned_cols=151  Identities=25%  Similarity=0.430  Sum_probs=129.1

Q ss_pred             hcCCccccccccccceeEEEEEeCC----CCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLAD----GKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~----g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .++|...+.||+|+||.||+|+..+    +..||||.+... .....+.+.+|+.++..++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            3568888999999999999998643    235999999754 33456789999999999999999999999764 56789


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999999653  245899999999999999999999985   9999999999999999999999999999875


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      ..
T Consensus       165 ~~  166 (281)
T 3cc6_A          165 DE  166 (281)
T ss_dssp             --
T ss_pred             cc
Confidence            44

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.90  E-value=5.5e-24  Score=214.96  Aligned_cols=147  Identities=32%  Similarity=0.476  Sum_probs=114.9

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC------Ce
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE------NE  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~  415 (512)
                      ++|...+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.++..++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            6788889999999999999985 56889999999653  334467889999999999999999999998754      55


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++|+||+ +++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       109 ~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             EEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            79999999 6899888843    45999999999999999999999975   9999999999999999999999999998


Q ss_pred             ccCC
Q 043262          496 IFGG  499 (512)
Q Consensus       496 ~~~~  499 (512)
                      ....
T Consensus       181 ~~~~  184 (367)
T 2fst_X          181 HTAD  184 (367)
T ss_dssp             ----
T ss_pred             cccc
Confidence            7654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.90  E-value=8.4e-24  Score=214.97  Aligned_cols=152  Identities=24%  Similarity=0.384  Sum_probs=125.2

Q ss_pred             HHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCC------
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN------  414 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------  414 (512)
                      ...++|...++||+|+||.||+++. .+++.||||++......    ..+|+.+++.++||||+++++++....      
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            3457889999999999999999986 67899999998654322    247999999999999999999985432      


Q ss_pred             --------------------------------eeEEEEEecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 043262          415 --------------------------------ESLLIYEYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLH  461 (512)
Q Consensus       415 --------------------------------~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH  461 (512)
                                                      ..++||||++ |+|.+.+... .....+++..+..++.||+.||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                            3789999998 5777776531 23356999999999999999999999


Q ss_pred             cCCCCCcccCCCCCCCeeec-CCCceEEeccCcccccCCCC
Q 043262          462 EDSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       462 ~~~~~~ivH~dlk~~NiLl~-~~~~~kl~DFGla~~~~~~~  501 (512)
                      +.+   |+||||||+|||++ +++.+||+|||+++.+....
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  196 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE  196 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence            875   99999999999998 68899999999999875544

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.90  E-value=5e-24  Score=217.41  Aligned_cols=150  Identities=25%  Similarity=0.415  Sum_probs=125.1

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCe------eEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE------SLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~l  418 (512)
                      .+|...++||+|+||.||+++..++..||+|++......    ..+|+.++..++||||+++++++...+.      .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            467888999999999999999977778999998654322    2369999999999999999999976543      789


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec-CCCceEEeccCccccc
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIF  497 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~-~~~~~kl~DFGla~~~  497 (512)
                      ||||++++.+............+++..+..++.||+.||.|||+.+   |+||||||+||||+ .++.+||+|||+++.+
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            9999987655444332223456999999999999999999999985   99999999999999 7999999999999987


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ..+.
T Consensus       193 ~~~~  196 (394)
T 4e7w_A          193 IAGE  196 (394)
T ss_dssp             CTTC
T ss_pred             cCCC
Confidence            5543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.90  E-value=1.5e-23  Score=204.31  Aligned_cols=142  Identities=11%  Similarity=0.033  Sum_probs=125.6

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc---ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+|+.. +++.||||.+.....   ...+.|.+|+..+.+++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56888899999999999999975 489999999975432   33578999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                      ||+++++|.+++..    . ........|+.||+.||.|||+++   |+||||||+||||++++.+||+++|..
T Consensus       111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~  176 (286)
T 3uqc_A          111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM  176 (286)
T ss_dssp             ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred             EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence            99999999999843    1 345578889999999999999985   999999999999999999999987754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.90  E-value=9.7e-24  Score=212.98  Aligned_cols=148  Identities=26%  Similarity=0.448  Sum_probs=130.1

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeC-----CeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE-----NESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~  417 (512)
                      .+|...++||+|+||.||+++. .++..||||++.... ....+.+.+|+.++.+++||||+++++++...     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            5788899999999999999986 468889999997543 33457899999999999999999999999765     3689


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +|+||+. |+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       107 iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            9999997 589988854    34899999999999999999999985   999999999999999999999999999987


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      ...
T Consensus       179 ~~~  181 (364)
T 3qyz_A          179 DPD  181 (364)
T ss_dssp             CGG
T ss_pred             CCC
Confidence            644

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.90  E-value=5.6e-24  Score=206.25  Aligned_cols=156  Identities=28%  Similarity=0.437  Sum_probs=131.0

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEe--CCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ--ENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv  419 (512)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...  .....+.+.+|+.++.+++||||+++++++..  .+..++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            56788899999999999999874 6899999999753  33446789999999999999999999998865  5678999


Q ss_pred             EEecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          420 YEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDS--RLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      |||+++++|.+++.... ....+++..++.++.|++.||.|||+.+  ..+|+||||||+|||+++++.+||+|||+++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~  165 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  165 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence            99999999999986532 2345899999999999999999999874  12399999999999999999999999999988


Q ss_pred             cCCC
Q 043262          497 FGGN  500 (512)
Q Consensus       497 ~~~~  500 (512)
                      +...
T Consensus       166 ~~~~  169 (279)
T 2w5a_A          166 LNHD  169 (279)
T ss_dssp             C---
T ss_pred             eccc
Confidence            7543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.90  E-value=6.1e-24  Score=231.87  Aligned_cols=148  Identities=21%  Similarity=0.357  Sum_probs=128.6

Q ss_pred             hcCCccccccccccceeEEEEEeC--CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCe-----
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA--DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE-----  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~--~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-----  415 (512)
                      .++|...++||+|+||.||+++..  +++.||||.+... .......+.+|+.++.+++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            367889999999999999999974  6899999998643 33445678999999999999999999999988765     


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++||||+++++|.+++..     .++|..++.|+.||+.||.|||+++   |+||||||+|||++++ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            6999999999999887732     5999999999999999999999985   9999999999999986 89999999999


Q ss_pred             ccCCC
Q 043262          496 IFGGN  500 (512)
Q Consensus       496 ~~~~~  500 (512)
                      .+...
T Consensus       230 ~~~~~  234 (681)
T 2pzi_A          230 RINSF  234 (681)
T ss_dssp             ETTCC
T ss_pred             hcccC
Confidence            87654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.90  E-value=1.6e-23  Score=210.89  Aligned_cols=159  Identities=25%  Similarity=0.330  Sum_probs=120.3

Q ss_pred             hHHHHHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCe-
Q 043262          338 HLAVEATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE-  415 (512)
Q Consensus       338 ~~~~~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-  415 (512)
                      .......++|...++||+|+||.||+++. .++..||||++..... ....+.+|+..+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            34456678999999999999999999997 4689999999865432 23456778888899999999999999976544 


Q ss_pred             ------eEEEEEecCCCChhHHhh-cCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCcccCCCCCCCeeecC-CCc
Q 043262          416 ------SLLIYEYMPNKSLNVFLF-DSTRSVQLDWKRRISIINGIARGLLYLH--EDSRLKIIHRDLKTSNVLLDH-EMN  485 (512)
Q Consensus       416 ------~~lv~E~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~dlk~~NiLl~~-~~~  485 (512)
                            .++||||++++ |...+. .......+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence                  78999999875 443332 2234456899999999999999999999  65   5999999999999997 899


Q ss_pred             eEEeccCcccccCCCC
Q 043262          486 PKISDFGMARIFGGNQ  501 (512)
Q Consensus       486 ~kl~DFGla~~~~~~~  501 (512)
                      +||+|||+++.+....
T Consensus       171 ~kl~Dfg~a~~~~~~~  186 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSE  186 (360)
T ss_dssp             EEECCCTTCBCCCTTS
T ss_pred             EEEeeCCCceecCCCC
Confidence            9999999999876554

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.90  E-value=4e-24  Score=207.27  Aligned_cols=149  Identities=29%  Similarity=0.492  Sum_probs=124.6

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeC-CeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE-NESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lv~E~~  423 (512)
                      ++|...+.||+|+||.||++... +..||||.++...  ..+.+.+|+.++.+++||||+++++++.+. +..++||||+
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            56788899999999999999885 8899999997543  457899999999999999999999997655 4689999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        98 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           98 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             CCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999998542 1223789999999999999999999985   999999999999999999999999999876543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.90  E-value=1.5e-23  Score=212.22  Aligned_cols=147  Identities=29%  Similarity=0.464  Sum_probs=123.7

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC------e
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN------E  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~  415 (512)
                      ++|...+.||+|+||.||++.. .+++.||||++...  .....+.+.+|+.++..++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            5788889999999999999986 46889999999753  3334567899999999999999999999998765      6


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++||||+++ +|.+++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             eEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            8999999974 7877774     24889999999999999999999985   9999999999999999999999999999


Q ss_pred             ccCCC
Q 043262          496 IFGGN  500 (512)
Q Consensus       496 ~~~~~  500 (512)
                      .....
T Consensus       176 ~~~~~  180 (371)
T 2xrw_A          176 TAGTS  180 (371)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            77543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.90  E-value=3.3e-24  Score=228.10  Aligned_cols=141  Identities=18%  Similarity=0.243  Sum_probs=110.7

Q ss_pred             ccccccceeEEEEE-eCCCCEEEEEEcccCC----------cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEE
Q 043262          352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTS----------GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~-~~~g~~vaVK~l~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ..+.|.+|.+..++ .--|+.++||.+....          ....++|.+|+++|.++ .|+||+++++++.+++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            34566666655543 3357889999986431          23356799999999999 799999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++++|.++|...   .+++..   +|+.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+.+..
T Consensus       321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999999643   346654   48899999999999986   99999999999999999999999999998866


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      +.
T Consensus       392 ~~  393 (569)
T 4azs_A          392 DC  393 (569)
T ss_dssp             --
T ss_pred             CC
Confidence            54

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.90  E-value=2.6e-23  Score=213.00  Aligned_cols=145  Identities=32%  Similarity=0.515  Sum_probs=113.5

Q ss_pred             ccccccccceeEEEEEeC---CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEe--CCeeEEEEEecC
Q 043262          350 ENKLGEGGFGPVYKGKLA---DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ--ENESLLIYEYMP  424 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~E~~~  424 (512)
                      .++||+|+||.||+++..   ++..||||++.....  ...+.+|+.++.+++||||+++++++..  ....++||||+.
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            458999999999999965   578899999975432  3568899999999999999999999965  667899999997


Q ss_pred             CCChhHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee----cCCCceEEeccCcc
Q 043262          425 NKSLNVFLFDS------TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMA  494 (512)
Q Consensus       425 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl----~~~~~~kl~DFGla  494 (512)
                       |+|.+++...      .....+++..+..|+.||+.||.|||+.+   |+||||||+||||    +.++.+||+|||++
T Consensus       104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence             4777776421      12335999999999999999999999985   9999999999999    77899999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +.+...
T Consensus       180 ~~~~~~  185 (405)
T 3rgf_A          180 RLFNSP  185 (405)
T ss_dssp             C-----
T ss_pred             eecCCC
Confidence            987643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.90  E-value=9.3e-24  Score=217.22  Aligned_cols=149  Identities=29%  Similarity=0.444  Sum_probs=121.6

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCC------eeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN------ESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~  417 (512)
                      .+|...+.||+|+||.||+|+.. +++.||||++.....    .+.+|++++..++||||+++++++....      ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35777899999999999999974 589999999865432    2347999999999999999999986532      267


Q ss_pred             EEEEecCCCChhHHhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC-CceEEeccCccc
Q 043262          418 LIYEYMPNKSLNVFLFD-STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMAR  495 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~-~~~kl~DFGla~  495 (512)
                      +||||+++ +|.+++.. ......+++..+..++.||++||.|||+.+   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 55555432 123456999999999999999999999975   9999999999999965 578999999999


Q ss_pred             ccCCCC
Q 043262          496 IFGGNQ  501 (512)
Q Consensus       496 ~~~~~~  501 (512)
                      .+..+.
T Consensus       206 ~~~~~~  211 (420)
T 1j1b_A          206 QLVRGE  211 (420)
T ss_dssp             ECCTTC
T ss_pred             hcccCC
Confidence            875443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.90  E-value=5.5e-24  Score=213.77  Aligned_cols=146  Identities=16%  Similarity=0.262  Sum_probs=126.9

Q ss_pred             cCCccccccccccceeEEEEEeCC---------CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCcccc----------
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD---------GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR----------  405 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~---------g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~----------  405 (512)
                      ++|...+.||+|+||.||+++...         ++.||||.+...     +.+.+|+.++.+++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578888999999999999999753         789999998754     36789999999999999998          


Q ss_pred             -----ceeeEEe-CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCee
Q 043262          406 -----LLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVL  479 (512)
Q Consensus       406 -----l~g~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiL  479 (512)
                           +++++.. .+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl  191 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF  191 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence                 5677776 67889999999 99999999653 2356999999999999999999999985   999999999999


Q ss_pred             ecCCC--ceEEeccCcccccCCC
Q 043262          480 LDHEM--NPKISDFGMARIFGGN  500 (512)
Q Consensus       480 l~~~~--~~kl~DFGla~~~~~~  500 (512)
                      ++.++  .+||+|||+++.+...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~  214 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPS  214 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGG
T ss_pred             EcCCCCceEEEecCcceeeccCC
Confidence            99998  8999999999887544

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.90  E-value=7.6e-24  Score=206.41  Aligned_cols=155  Identities=25%  Similarity=0.336  Sum_probs=120.6

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc-cc-HHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG-QG-LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~-~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      .++|...++||+|+||.||+++. .+++.||||+++.... .. .+.+.++...+..++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            35688889999999999999996 5788999999975422 22 334455556688899999999999999999999999


Q ss_pred             EecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ||++ |+|.+++... .....+++..+..++.|++.||.|||++.  +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            9997 5887776432 23356999999999999999999999861  399999999999999999999999999988755


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      +.
T Consensus       163 ~~  164 (290)
T 3fme_A          163 DV  164 (290)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.90  E-value=3.3e-23  Score=203.17  Aligned_cols=147  Identities=24%  Similarity=0.325  Sum_probs=126.9

Q ss_pred             cCCccc-cccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHH-hcCCCCccccceeeEEe----CCeeE
Q 043262          345 QHFSDE-NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLI-AKLQHKNLVRLLGCCLQ----ENESL  417 (512)
Q Consensus       345 ~~~~~~-~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~~  417 (512)
                      ++|... +.||+|+||.||++.. .+++.||||.+...     ..+.+|+.++ ..++||||+++++++..    .+..+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            445555 6799999999999986 56899999998642     4567888887 66699999999999987    67789


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC---CCceEEeccCcc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGMA  494 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~---~~~~kl~DFGla  494 (512)
                      +||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999999753 2346999999999999999999999985   999999999999998   788999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +...+.
T Consensus       168 ~~~~~~  173 (299)
T 3m2w_A          168 KETTGE  173 (299)
T ss_dssp             EECTTC
T ss_pred             cccccc
Confidence            887653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.90  E-value=2e-23  Score=209.55  Aligned_cols=149  Identities=27%  Similarity=0.435  Sum_probs=129.9

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeC-----Cee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE-----NES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~  416 (512)
                      .++|...+.||+|+||.||+++.. +|+.||||.+.... ......+.+|+.++..++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467888899999999999999974 68899999997433 33456788999999999999999999988764     678


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ++|+||+. |+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 689998854    35899999999999999999999985   99999999999999999999999999998


Q ss_pred             cCCC
Q 043262          497 FGGN  500 (512)
Q Consensus       497 ~~~~  500 (512)
                      +...
T Consensus       162 ~~~~  165 (353)
T 2b9h_A          162 IDES  165 (353)
T ss_dssp             CC--
T ss_pred             cccc
Confidence            7543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.89  E-value=1.1e-23  Score=205.43  Aligned_cols=151  Identities=32%  Similarity=0.466  Sum_probs=123.8

Q ss_pred             cCCccccccccccceeEEEEEeC--CCC--EEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA--DGK--EIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~--~g~--~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++|...++||+|+||.||++++.  ++.  .||||.++..   .....+.+.+|+.++.+++||||+++++++...+ .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            56888899999999999999853  333  6899998653   2344678999999999999999999999998765 88


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +|+||+++++|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence            999999999999998653  245899999999999999999999985   999999999999999999999999999987


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ....
T Consensus       172 ~~~~  175 (291)
T 1u46_A          172 PQND  175 (291)
T ss_dssp             CC-C
T ss_pred             cccc
Confidence            6543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.89  E-value=4.1e-23  Score=201.17  Aligned_cols=155  Identities=28%  Similarity=0.435  Sum_probs=136.0

Q ss_pred             HHHhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          341 VEATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       341 ~~~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ....++|...++||+|+||.||+++.. +++.||||.+...  .....+.+.+|+.++.+++||||+++++++...+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            345578899999999999999999975 6899999998643  2345778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC---CceEEeccCcc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFGMA  494 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~---~~~kl~DFGla  494 (512)
                      +|+||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.+   ..+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            999999999999888542   35899999999999999999999985   9999999999999754   47999999999


Q ss_pred             cccCCCC
Q 043262          495 RIFGGNQ  501 (512)
Q Consensus       495 ~~~~~~~  501 (512)
                      +.+....
T Consensus       172 ~~~~~~~  178 (287)
T 2wei_A          172 TCFQQNT  178 (287)
T ss_dssp             GTBCCCS
T ss_pred             eeecCCC
Confidence            9876543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.89  E-value=1.6e-23  Score=206.73  Aligned_cols=151  Identities=25%  Similarity=0.369  Sum_probs=130.0

Q ss_pred             HhcCCccccccccccceeEEEEEeCCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCC--CCccccceeeEEeCCeeEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQ--HKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~l  418 (512)
                      ..++|...+.||+|+||.||++...+++.||||.+...  .....+.+.+|+.++.+++  ||||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            34678888999999999999999988999999998643  3345678999999999997  5999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||| +.+++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||+++ +.+||+|||+++.+.
T Consensus       106 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             EEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            999 6788999999653   36899999999999999999999985   999999999999975 799999999999876


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      ...
T Consensus       178 ~~~  180 (313)
T 3cek_A          178 PDT  180 (313)
T ss_dssp             ---
T ss_pred             Ccc
Confidence            543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.89  E-value=2.4e-23  Score=206.48  Aligned_cols=152  Identities=30%  Similarity=0.521  Sum_probs=126.9

Q ss_pred             HhcCCccccccccccceeEEEEEe--CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcC---CCCccccceeeEE----
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL--ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKL---QHKNLVRLLGCCL----  411 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~--~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~----  411 (512)
                      ..++|...+.||+|+||.||+++.  .+++.||||++....  ......+.+|+.++..+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            346788899999999999999997  467899999986432  12223456677666655   8999999999997    


Q ss_pred             -eCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEec
Q 043262          412 -QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD  490 (512)
Q Consensus       412 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~D  490 (512)
                       .....++||||+. |+|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999998 69999986532 335899999999999999999999985   99999999999999999999999


Q ss_pred             cCcccccCC
Q 043262          491 FGMARIFGG  499 (512)
Q Consensus       491 FGla~~~~~  499 (512)
                      ||+++.+..
T Consensus       164 fg~~~~~~~  172 (326)
T 1blx_A          164 FGLARIYSF  172 (326)
T ss_dssp             CCSCCCCCG
T ss_pred             CcccccccC
Confidence            999987754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.89  E-value=2.6e-23  Score=225.18  Aligned_cols=151  Identities=26%  Similarity=0.419  Sum_probs=131.1

Q ss_pred             hcCCccccccccccceeEEEEEeCC----CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLAD----GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~~----g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .++|...+.||+|+||.||+|.+..    +..||||.++... ....+.|.+|+.++.+++||||+++++++. .+..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            4567888999999999999998742    4579999987543 334578999999999999999999999984 567899


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       468 v~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            99999999999999643  345899999999999999999999985   9999999999999999999999999999875


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      ..
T Consensus       543 ~~  544 (656)
T 2j0j_A          543 DS  544 (656)
T ss_dssp             C-
T ss_pred             CC
Confidence            54

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.89  E-value=5.7e-23  Score=200.67  Aligned_cols=151  Identities=23%  Similarity=0.399  Sum_probs=126.0

Q ss_pred             HhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeE-EeCCeeEEEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC-LQENESLLIY  420 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lv~  420 (512)
                      ..++|...+.||+|+||.||+++. .+++.||||.+......  ..+.+|+.++..++|++++..++.+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999996 67889999987543322  3578899999999999888777766 5567789999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee---cCCCceEEeccCccccc
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIF  497 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl---~~~~~~kl~DFGla~~~  497 (512)
                      ||+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||+   ++++.+||+|||+++.+
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999998643  235999999999999999999999985   9999999999999   78899999999999987


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ....
T Consensus       159 ~~~~  162 (296)
T 4hgt_A          159 RDAR  162 (296)
T ss_dssp             BCTT
T ss_pred             cCcc
Confidence            6553

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.89  E-value=4.2e-23  Score=208.89  Aligned_cols=148  Identities=26%  Similarity=0.478  Sum_probs=125.9

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCee----
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES----  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~----  416 (512)
                      .++|...+.||+|+||.||+++. .+|+.||||++...  .....+.+.+|+.++..++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            36788889999999999999986 46889999999754  333457889999999999999999999999887665    


Q ss_pred             --EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcc
Q 043262          417 --LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  494 (512)
Q Consensus       417 --~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla  494 (512)
                        ++||||+. ++|.+++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 68888772     23899999999999999999999985   999999999999999999999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +.....
T Consensus       192 ~~~~~~  197 (371)
T 4exu_A          192 RHADAE  197 (371)
T ss_dssp             ------
T ss_pred             cccccC
Confidence            876543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.89  E-value=9.3e-24  Score=208.79  Aligned_cols=148  Identities=30%  Similarity=0.551  Sum_probs=126.6

Q ss_pred             HhcCCccccccccccceeEEEEEeCCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ..++|...+.||+|+||.||+|+..+  .+|+|.++..  .....+.+.+|+.++.+++||||+++++++...+..++|+
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            34678889999999999999999853  5999998643  2333456889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++...
T Consensus       109 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             BCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             ecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            999999999999543  345899999999999999999999985   99999999999998 6799999999988764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.89  E-value=1.1e-22  Score=198.73  Aligned_cols=150  Identities=23%  Similarity=0.401  Sum_probs=129.0

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeE-EeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC-LQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lv~E  421 (512)
                      .++|...+.||+|+||.||+++. .+++.||||.+......  +.+.+|+.++..++|++++..+..+ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46788899999999999999996 67899999998654332  4688999999999999877777666 55677899999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee---cCCCceEEeccCcccccC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFG  498 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl---~~~~~~kl~DFGla~~~~  498 (512)
                      |+ +++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||+   ++++.+||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999999643  245999999999999999999999985   9999999999999   588899999999999876


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      ...
T Consensus       160 ~~~  162 (296)
T 3uzp_A          160 DAR  162 (296)
T ss_dssp             CTT
T ss_pred             ccc
Confidence            554

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.89  E-value=1e-22  Score=212.37  Aligned_cols=150  Identities=22%  Similarity=0.375  Sum_probs=127.5

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCC-ccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK-NLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .++|...++||+|+||.||+++. .+++.||||++......  .++..|++++..++|+ +|..+..+....+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            36788899999999999999996 67899999987644322  3578999999999875 55556666677888899999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee---cCCCceEEeccCcccccC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFG  498 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl---~~~~~~kl~DFGla~~~~  498 (512)
                      |+ +++|.+++...  ...+++..++.|+.||+.||.|||+.+   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999999643  245999999999999999999999985   9999999999999   688999999999999886


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      ...
T Consensus       158 ~~~  160 (483)
T 3sv0_A          158 DTS  160 (483)
T ss_dssp             CTT
T ss_pred             CCc
Confidence            554

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.89  E-value=1.1e-23  Score=207.69  Aligned_cols=154  Identities=24%  Similarity=0.401  Sum_probs=124.7

Q ss_pred             HHHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcc------cHHHHHHHHHHHhcC----CCCccccceee
Q 043262          341 VEATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQ------GLQEFKNEVTLIAKL----QHKNLVRLLGC  409 (512)
Q Consensus       341 ~~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~g~  409 (512)
                      ....++|...+.||+|+||.||+++. .+++.||||.+......      ....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34567899999999999999999986 56889999999654321      223466788888888    89999999999


Q ss_pred             EEeCCeeEEEEEe-cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec-CCCceE
Q 043262          410 CLQENESLLIYEY-MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD-HEMNPK  487 (512)
Q Consensus       410 ~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~-~~~~~k  487 (512)
                      +...+..++|+|| +.+++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++ +++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 7899999999652   35899999999999999999999985   99999999999999 889999


Q ss_pred             EeccCcccccCCC
Q 043262          488 ISDFGMARIFGGN  500 (512)
Q Consensus       488 l~DFGla~~~~~~  500 (512)
                      |+|||+++.+...
T Consensus       181 l~dfg~~~~~~~~  193 (312)
T 2iwi_A          181 LIDFGSGALLHDE  193 (312)
T ss_dssp             ECCCSSCEECCSS
T ss_pred             EEEcchhhhcccC
Confidence            9999999987654

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.89  E-value=7.5e-23  Score=167.15  Aligned_cols=103  Identities=22%  Similarity=0.336  Sum_probs=91.3

Q ss_pred             eeEeccCcCCCChHHHHHHHHHHHHHHHHHhhccCccccceeeeeeccCCCcceEEEEeeccCCCCHHhHHHHHHHHHHh
Q 043262          124 YVILSQVTNFTDPDKVTNILVQSINDLIQNVTSRDSNSKYAAAAQMVNASSIDKIWTLVQCIPYLSKSDCNICLRQTVSR  203 (512)
Q Consensus       124 ~~~~~~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~~~~~~a~~~~~~~~~~~~~vy~laQC~~dls~~~C~~CL~~~~~~  203 (512)
                      ....+|..+++++..|+.++..||..|..+++..  ..+|+++.  ....+.++||||+||+|||++++|+.||+.++.+
T Consensus         6 v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s--~~~~~t~~--~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~   81 (108)
T 3a2e_A            6 VSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFS--GYDYKTSR--AGSGGAPTAYGRATCKQSISQSDCTACLSNLVNR   81 (108)
T ss_dssp             EEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGT--TSEEEEEE--CCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTT
T ss_pred             eeeecCCCccCCCChHHHHHHHHHHHHHhhCccc--cCCceEee--ccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHH
Confidence            4456788888888999999999999999888764  35677765  4445568999999999999999999999999999


Q ss_pred             hhhcccCCCCceeeccccceeeecCCC
Q 043262          204 ISSRYYGRQSVRALSPSCIIRYEMYPF  230 (512)
Q Consensus       204 ~~~~~~~~~g~~~~~~~C~lrye~~pf  230 (512)
                      ++++|++++||+|+.++|++|||.++|
T Consensus        82 ~~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           82 IFSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHHCCCCceEEEECCCEEEEEeCCcC
Confidence            999999999999999999999999997

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.89  E-value=2e-23  Score=211.17  Aligned_cols=149  Identities=11%  Similarity=0.122  Sum_probs=111.8

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc---ccHHHHHHHH---HHHhcCCCCccccce-------eeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG---QGLQEFKNEV---TLIAKLQHKNLVRLL-------GCC  410 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~---~~~~~~~~E~---~~l~~l~H~nIv~l~-------g~~  410 (512)
                      ..|...++||+|+||.||+++. .+++.||||++.....   ...+.+.+|+   ..+.. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            3477889999999999999996 4789999999976442   3355677884   45555 799977754       444


Q ss_pred             EeC-----------------CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCC
Q 043262          411 LQE-----------------NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRR------ISIINGIARGLLYLHEDSRLK  467 (512)
Q Consensus       411 ~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~  467 (512)
                      ...                 ...++||||++ |+|.+++....  ..+++..+      +.++.||+.||.|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            433                 33799999999 89999996532  23455555      788899999999999985   


Q ss_pred             cccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          468 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       468 ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+||||||+||||+.++.+||+|||+++..+..
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~  247 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR  247 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence            999999999999999999999999999987543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.89  E-value=5.8e-23  Score=206.33  Aligned_cols=146  Identities=26%  Similarity=0.481  Sum_probs=126.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCe------
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE------  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------  415 (512)
                      ++|...+.||+|+||.||+++. .+|+.||||.+...  .....+.+.+|+.++..++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            5677889999999999999986 46899999999653  23335678999999999999999999999987654      


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++||||+. ++|.+++.     ..+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++
T Consensus       104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence            499999997 68887763     24899999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCC
Q 043262          496 IFGG  499 (512)
Q Consensus       496 ~~~~  499 (512)
                      ....
T Consensus       175 ~~~~  178 (353)
T 3coi_A          175 HADA  178 (353)
T ss_dssp             C---
T ss_pred             CCCC
Confidence            7654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.89  E-value=7.3e-23  Score=203.29  Aligned_cols=152  Identities=26%  Similarity=0.386  Sum_probs=125.8

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHH-HHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVT-LIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...+.||+|+||.||++.. .+++.||||.+.... .....++..|+. ++..++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            5677889999999999999997 468899999997543 333455666666 7788899999999999999999999999


Q ss_pred             ecCCCChhHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          422 YMPNKSLNVFLFDS--TRSVQLDWKRRISIINGIARGLLYLHED-SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       422 ~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      |+++ +|.+++...  .....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9985 777776421  1235689999999999999999999996 5   9999999999999999999999999998875


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      ..
T Consensus       178 ~~  179 (327)
T 3aln_A          178 DS  179 (327)
T ss_dssp             --
T ss_pred             cc
Confidence            44

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.88  E-value=1.2e-22  Score=209.56  Aligned_cols=151  Identities=21%  Similarity=0.292  Sum_probs=129.1

Q ss_pred             hcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcC------CCCccccceeeEEeCCee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL------QHKNLVRLLGCCLQENES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~g~~~~~~~~  416 (512)
                      ..+|...++||+|+||.||+|... +++.||||++... ....+.+.+|+.++..+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457888999999999999999864 5889999999753 23345677888887776      577999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc--eEEeccCcc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN--PKISDFGMA  494 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~--~kl~DFGla  494 (512)
                      ++||||+. ++|.+++... ....+++..+..|+.||+.||.|||+.+   |+||||||+||||+.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 6898888653 2345899999999999999999999985   999999999999999887  999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +.....
T Consensus       250 ~~~~~~  255 (429)
T 3kvw_A          250 CYEHQR  255 (429)
T ss_dssp             EETTCC
T ss_pred             eecCCc
Confidence            876543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.88  E-value=2.8e-23  Score=221.95  Aligned_cols=154  Identities=29%  Similarity=0.432  Sum_probs=132.8

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEe------CCee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ------ENES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~  416 (512)
                      ++|...++||+|+||.||++.. .+|+.||||++... .....+.+.+|+.++.+++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6788999999999999999987 56899999998754 34446789999999999999999999998765      6678


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc---eEEeccCc
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN---PKISDFGM  493 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~---~kl~DFGl  493 (512)
                      ++||||+++|+|.+++........+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999976555556899999999999999999999975   999999999999997665   99999999


Q ss_pred             ccccCCCC
Q 043262          494 ARIFGGNQ  501 (512)
Q Consensus       494 a~~~~~~~  501 (512)
                      ++.+..+.
T Consensus       171 a~~~~~~~  178 (676)
T 3qa8_A          171 AKELDQGE  178 (676)
T ss_dssp             CCBTTSCC
T ss_pred             cccccccc
Confidence            99876543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.88  E-value=8.7e-23  Score=207.99  Aligned_cols=136  Identities=24%  Similarity=0.343  Sum_probs=113.6

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC--------CCccccceeeEE---
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ--------HKNLVRLLGCCL---  411 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~g~~~---  411 (512)
                      .++|...++||+|+||.||+++. .+++.||||++... ....+.+.+|+.++..++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            46789999999999999999986 56889999999743 334567899999999885        788999999988   


Q ss_pred             -eCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC
Q 043262          412 -QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM  484 (512)
Q Consensus       412 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~  484 (512)
                       .....++||||+ +++|.+++... ....+++..+..++.||+.||.|||++.  +|+||||||+||||+.++
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~  184 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence             456789999999 55666665442 2346999999999999999999999972  399999999999998775

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.88  E-value=2e-22  Score=200.56  Aligned_cols=151  Identities=22%  Similarity=0.376  Sum_probs=130.1

Q ss_pred             hcCCccccccccccceeEEEEEe--CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCc------cccceeeEEeCCe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL--ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN------LVRLLGCCLQENE  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~--~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~  415 (512)
                      .++|...++||+|+||.||++..  .+++.||||.++... ...+.+.+|+.++..++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35788899999999999999986  368899999997542 34567889999998887654      9999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-------------
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-------------  482 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-------------  482 (512)
                      .++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 89999998653 2346899999999999999999999985   999999999999987             


Q ss_pred             ------CCceEEeccCcccccCCC
Q 043262          483 ------EMNPKISDFGMARIFGGN  500 (512)
Q Consensus       483 ------~~~~kl~DFGla~~~~~~  500 (512)
                            ++.+||+|||+++.....
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~  190 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH  190 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC
T ss_pred             ccccccCCCceEeeCcccccCccc
Confidence                  668999999999876543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.88  E-value=3.1e-23  Score=205.52  Aligned_cols=153  Identities=25%  Similarity=0.380  Sum_probs=132.2

Q ss_pred             HHhcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcc------cHHHHHHHHHHHhcCC--CCccccceeeEEe
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQ------GLQEFKNEVTLIAKLQ--HKNLVRLLGCCLQ  412 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~  412 (512)
                      ...++|...++||+|+||.||+|+. .+++.||||.+......      ..+.+.+|+.++.+++  |+||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3457788999999999999999985 56889999998654221      2245778999999996  5999999999999


Q ss_pred             CCeeEEEEEecCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec-CCCceEEec
Q 043262          413 ENESLLIYEYMPN-KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD-HEMNPKISD  490 (512)
Q Consensus       413 ~~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~-~~~~~kl~D  490 (512)
                      .+..++|+|++.. ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++ +++.+||+|
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence            9999999999986 899999864   245899999999999999999999975   99999999999999 789999999


Q ss_pred             cCcccccCCC
Q 043262          491 FGMARIFGGN  500 (512)
Q Consensus       491 FGla~~~~~~  500 (512)
                      ||+++.+...
T Consensus       194 fg~~~~~~~~  203 (320)
T 3a99_A          194 FGSGALLKDT  203 (320)
T ss_dssp             CTTCEECCSS
T ss_pred             Cccccccccc
Confidence            9999987644

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.88  E-value=6.9e-23  Score=211.64  Aligned_cols=149  Identities=28%  Similarity=0.326  Sum_probs=120.0

Q ss_pred             CCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEEecC
Q 043262          346 HFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+.++.++ +||||+++++++...+..++||||+.
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            44556889999999998776678999999998643   245678999999876 89999999999999999999999995


Q ss_pred             CCChhHHhhcCCCCC-C---CCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC-------------CceE
Q 043262          425 NKSLNVFLFDSTRSV-Q---LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE-------------MNPK  487 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~-~---l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~-------------~~~k  487 (512)
                       |+|.+++....... .   ..+..++.++.||+.||.|||+.+   |+||||||+||||+.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999996532211 1   133345789999999999999985   9999999999999754             5899


Q ss_pred             EeccCcccccCCCC
Q 043262          488 ISDFGMARIFGGNQ  501 (512)
Q Consensus       488 l~DFGla~~~~~~~  501 (512)
                      |+|||+++.+..+.
T Consensus       169 L~DFG~a~~~~~~~  182 (434)
T 2rio_A          169 ISDFGLCKKLDSGQ  182 (434)
T ss_dssp             ECCCTTCEECCC--
T ss_pred             EcccccceecCCCC
Confidence            99999999886654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.88  E-value=1.1e-22  Score=209.81  Aligned_cols=147  Identities=24%  Similarity=0.377  Sum_probs=120.3

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .+|...++||+|+||.||.....+++.||||++......   .+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            457788899999999976555567999999999654322   356899999999 7999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-----CCceEEeccCcccccC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-----EMNPKISDFGMARIFG  498 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-----~~~~kl~DFGla~~~~  498 (512)
                      . |+|.+++....  ..+.+...+.++.||+.||.|||+.+   |+||||||+||||+.     ...+||+|||+++.+.
T Consensus       101 ~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          101 A-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             S-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             C-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            6 69999986533  23444556789999999999999985   999999999999943     3468899999999876


Q ss_pred             CC
Q 043262          499 GN  500 (512)
Q Consensus       499 ~~  500 (512)
                      .+
T Consensus       175 ~~  176 (432)
T 3p23_A          175 VG  176 (432)
T ss_dssp             --
T ss_pred             CC
Confidence            44

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.87  E-value=3.8e-22  Score=199.03  Aligned_cols=149  Identities=23%  Similarity=0.287  Sum_probs=120.4

Q ss_pred             hcCCccc-cccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEe----CCeeE
Q 043262          344 TQHFSDE-NKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ----ENESL  417 (512)
Q Consensus       344 ~~~~~~~-~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~  417 (512)
                      .++|... +.||+|+||.||+++.. +++.||||++....    .........+..++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            4667774 46999999999999975 68999999986532    222223334667799999999999876    44589


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC---CCceEEeccCcc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGMA  494 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~---~~~~kl~DFGla  494 (512)
                      +||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            999999999999999653 2346999999999999999999999985   999999999999976   455999999999


Q ss_pred             cccCCC
Q 043262          495 RIFGGN  500 (512)
Q Consensus       495 ~~~~~~  500 (512)
                      +.....
T Consensus       179 ~~~~~~  184 (336)
T 3fhr_A          179 KETTQN  184 (336)
T ss_dssp             EEC---
T ss_pred             eecccc
Confidence            877543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.87  E-value=3e-22  Score=197.70  Aligned_cols=151  Identities=23%  Similarity=0.377  Sum_probs=115.1

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCc-cc-HHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG-QG-LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...+.||+|+||.||+++.. +++.||||.+..... .. .+.+.++..++..++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            56777889999999999999974 689999999975432 22 3344555567888999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      |+ ++.+..+...  ....+++..+..++.||+.||.|||+..  +|+||||||+|||++.++.+||+|||+++.+...
T Consensus       105 ~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          105 LM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             CC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             cc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            99 4555555432  2346899999999999999999999841  3999999999999999999999999999877544

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.87  E-value=4.6e-22  Score=202.07  Aligned_cols=154  Identities=25%  Similarity=0.358  Sum_probs=129.0

Q ss_pred             HhcCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CC-----ccccceeeEEeCCe
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HK-----NLVRLLGCCLQENE  415 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~g~~~~~~~  415 (512)
                      ..++|...++||+|+||.||+|+.. +++.||||+++.. .....++..|+.++..++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4578899999999999999999864 6788999999743 233567788888888775 44     49999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec--CCCceEEeccCc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD--HEMNPKISDFGM  493 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~--~~~~~kl~DFGl  493 (512)
                      .++||||++ |+|.+++.... ...+++..+..++.||+.||.|||++ ..+|+||||||+||||+  .++.+||+|||+
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999996 59999986532 24589999999999999999999964 23699999999999994  578899999999


Q ss_pred             ccccCCC
Q 043262          494 ARIFGGN  500 (512)
Q Consensus       494 a~~~~~~  500 (512)
                      ++.+...
T Consensus       208 a~~~~~~  214 (382)
T 2vx3_A          208 SCQLGQR  214 (382)
T ss_dssp             CEETTCC
T ss_pred             ceecccc
Confidence            9987643

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.86  E-value=6e-22  Score=209.55  Aligned_cols=136  Identities=19%  Similarity=0.258  Sum_probs=109.8

Q ss_pred             ccccccccccceeEEEEEeCCCCEEEEEEcccCCc--------ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          348 SDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSG--------QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ...++||+|+||.||++.. .+..+++|+......        ...+.|.+|++++.+++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999965 478889998643211        1134589999999999999999888888888889999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++++|.+++..           +..++.|+++||.|||+++   |+||||||+|||+++  ++||+|||+++.+..
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           4689999999999999985   999999999999999  999999999998865


Q ss_pred             C
Q 043262          500 N  500 (512)
Q Consensus       500 ~  500 (512)
                      .
T Consensus       482 ~  482 (540)
T 3en9_A          482 D  482 (540)
T ss_dssp             H
T ss_pred             c
Confidence            4

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.86  E-value=1.1e-21  Score=196.49  Aligned_cols=151  Identities=22%  Similarity=0.348  Sum_probs=127.4

Q ss_pred             hcCCccccccccccceeEEEEEeC-CC-CEEEEEEcccCCcccHHHHHHHHHHHhcCCCCc------cccceeeEEeCCe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA-DG-KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN------LVRLLGCCLQENE  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~-~g-~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~  415 (512)
                      .++|...+.||+|+||.||++... ++ ..||||.++.. ....+.+.+|+.++..++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            467888999999999999999864 34 68999999753 234567889999999987766      8999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeee---------------
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLL---------------  480 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl---------------  480 (512)
                      .++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 66776766542 2346899999999999999999999975   9999999999999               


Q ss_pred             ----cCCCceEEeccCcccccCCC
Q 043262          481 ----DHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       481 ----~~~~~~kl~DFGla~~~~~~  500 (512)
                          +.++.+||+|||+++.....
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~  195 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH  195 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC
T ss_pred             cccccCCCcEEEeecCcccccccc
Confidence                67889999999999876543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=5.3e-22  Score=192.73  Aligned_cols=141  Identities=20%  Similarity=0.180  Sum_probs=114.5

Q ss_pred             HHhcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCc------------------ccHHHHHHHHHHHhcCCCCcc
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSG------------------QGLQEFKNEVTLIAKLQHKNL  403 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~nI  403 (512)
                      .....|...+.||+|+||.||+|...+|+.||||.++....                  .....+.+|+.++.+++  | 
T Consensus        87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-  163 (282)
T 1zar_A           87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-  163 (282)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred             hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence            34455667799999999999999997799999999964321                  13457899999999999  5 


Q ss_pred             ccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC
Q 043262          404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE  483 (512)
Q Consensus       404 v~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~  483 (512)
                      +++.+++ +.+..++||||+++|+|.+ +..         .....++.|++.||.|||+.+   |+||||||+|||++ +
T Consensus       164 ~~v~~~~-~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~  228 (282)
T 1zar_A          164 LAVPKVY-AWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             SSSCCEE-EEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T
T ss_pred             CCcCeEE-eccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C
Confidence            6677754 3456799999999999987 421         123469999999999999975   99999999999999 9


Q ss_pred             CceEEeccCcccccCCC
Q 043262          484 MNPKISDFGMARIFGGN  500 (512)
Q Consensus       484 ~~~kl~DFGla~~~~~~  500 (512)
                      +.+||+|||+++.....
T Consensus       229 ~~vkl~DFG~a~~~~~~  245 (282)
T 1zar_A          229 EGIWIIDFPQSVEVGEE  245 (282)
T ss_dssp             TEEEECCCTTCEETTST
T ss_pred             CcEEEEECCCCeECCCC
Confidence            99999999999977543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.86  E-value=5.3e-22  Score=200.57  Aligned_cols=151  Identities=22%  Similarity=0.363  Sum_probs=128.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-----------CCccccceeeEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-----------HKNLVRLLGCCLQ  412 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~~  412 (512)
                      .+|...++||+|+||.||+++. .+++.||||.+... ....+.+.+|+.++.+++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5788889999999999999996 57889999999743 234567889999998886           8999999999987


Q ss_pred             CC----eeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec------C
Q 043262          413 EN----ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD------H  482 (512)
Q Consensus       413 ~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~------~  482 (512)
                      .+    ..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++.  +|+||||||+|||++      .
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence            54    689999999 899999986532 345899999999999999999999971  399999999999994      4


Q ss_pred             CCceEEeccCcccccCCC
Q 043262          483 EMNPKISDFGMARIFGGN  500 (512)
Q Consensus       483 ~~~~kl~DFGla~~~~~~  500 (512)
                      .+.+||+|||+++.+...
T Consensus       174 ~~~~kl~Dfg~a~~~~~~  191 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH  191 (373)
T ss_dssp             EEEEEECCCTTCEETTBC
T ss_pred             cceEEEcccccccccCCC
Confidence            458999999999887543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.82  E-value=5.8e-21  Score=195.90  Aligned_cols=152  Identities=18%  Similarity=0.211  Sum_probs=114.8

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCC-Cccccc---------eeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQH-KNLVRL---------LGCC  410 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H-~nIv~l---------~g~~  410 (512)
                      ..|...+.||+|+||.||+|+. .+|+.||||++....   ....+.|.+|+.++..++| +|....         +...
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            3466778999999999999995 579999999987332   2336789999999999987 322111         1111


Q ss_pred             ------------Ee-----CCeeEEEEEecCCCChhHHhhc----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcc
Q 043262          411 ------------LQ-----ENESLLIYEYMPNKSLNVFLFD----STRSVQLDWKRRISIINGIARGLLYLHEDSRLKII  469 (512)
Q Consensus       411 ------------~~-----~~~~~lv~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  469 (512)
                                  ..     ....+++|++ ..++|.+++..    ......+++..++.|+.||+.||.|||+++   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                        11     1224566665 46899988841    123446888999999999999999999985   99


Q ss_pred             cCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       470 H~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||||||+||||+.++.+||+|||+++..+..
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~  264 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS  264 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc
Confidence            9999999999999999999999999876543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=8.3e-20  Score=175.01  Aligned_cols=141  Identities=17%  Similarity=0.177  Sum_probs=106.9

Q ss_pred             CccccccccccceeEEEEEe-CCCCE--EEEEEcccCCcc------------------------cHHHHHHHHHHHhcCC
Q 043262          347 FSDENKLGEGGFGPVYKGKL-ADGKE--IAVKRLSRTSGQ------------------------GLQEFKNEVTLIAKLQ  399 (512)
Q Consensus       347 ~~~~~~lg~G~fG~Vy~~~~-~~g~~--vaVK~l~~~~~~------------------------~~~~~~~E~~~l~~l~  399 (512)
                      |...+.||+|+||.||+|.. .+|..  ||||.++.....                        ....+.+|+..+..++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45678899999999999998 78888  999987543111                        1136889999999998


Q ss_pred             CCccccceeeEEeCCeeEEEEEecCC-C----ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCcccCCC
Q 043262          400 HKNLVRLLGCCLQENESLLIYEYMPN-K----SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH-EDSRLKIIHRDL  473 (512)
Q Consensus       400 H~nIv~l~g~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~dl  473 (512)
                      |+++.....+..  +..+|||||+.+ |    +|.++...      .++.....++.|++.+|.||| +.   +|+||||
T Consensus       129 ~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred             hCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence            886532222221  457899999942 4    66665422      224456789999999999999 76   4999999


Q ss_pred             CCCCeeecCCCceEEeccCcccccCCC
Q 043262          474 KTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       474 k~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||.|||+++  .+||+|||+|......
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEETTST
T ss_pred             CHHHEEEcC--cEEEEECcccccCCCc
Confidence            999999998  9999999999877543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=6.5e-17  Score=161.47  Aligned_cols=141  Identities=15%  Similarity=0.152  Sum_probs=97.7

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCc--------------ccHHHHHHHHHHHhcCCCCccccceeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSG--------------QGLQEFKNEVTLIAKLQHKNLVRLLGCC  410 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv~l~g~~  410 (512)
                      .-|....+||+|+||.||+|...+|++||||.++....              ........+.++.....|+|+++++...
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34788899999999999999999999999998753210              1112223333333333344444433221


Q ss_pred             E------eCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC
Q 043262          411 L------QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM  484 (512)
Q Consensus       411 ~------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~  484 (512)
                      .      .....+|||||++++.|..+..       .  .....++.|++.+|.|||..+   ||||||||.||||++++
T Consensus       175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          175 FPVPEPIAQSRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK  242 (397)
T ss_dssp             CSCCCEEEEETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred             CCCCeeeeccCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence            1      1123379999999988865431       1  123467899999999999975   99999999999998876


Q ss_pred             ----------ceEEeccCccccc
Q 043262          485 ----------NPKISDFGMARIF  497 (512)
Q Consensus       485 ----------~~kl~DFGla~~~  497 (512)
                                .+.|+||+-+-..
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEET
T ss_pred             CcccccccccceEEEEeCCcccC
Confidence                      3899999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=9.8e-12  Score=118.79  Aligned_cols=145  Identities=15%  Similarity=0.076  Sum_probs=112.0

Q ss_pred             HhcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEE
Q 043262          343 ATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       343 ~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ....|.....++.|+.+.||+.... +..+++|............+.+|..++..+. |..+.+++++....+..++|||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            3356777777888888999999864 6889999986532222346888999998884 6778899999998889999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS-------------------------------------  464 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------  464 (512)
                      |+++.+|.+.+..        ......++.+++++|..||+..                                     
T Consensus        91 ~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           91 EADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             ecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            9999999776411        1123468889999999999811                                     


Q ss_pred             -------------------CCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          465 -------------------RLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       465 -------------------~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                                         ...++|+|++|.|||++++..+.|.||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                               13489999999999998876678999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=5.4e-11  Score=113.14  Aligned_cols=130  Identities=16%  Similarity=0.164  Sum_probs=98.0

Q ss_pred             ccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCc--cccceeeEEeCCeeEEEEEecCCCChhHH
Q 043262          354 GEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN--LVRLLGCCLQENESLLIYEYMPNKSLNVF  431 (512)
Q Consensus       354 g~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lv~E~~~~gsL~~~  431 (512)
                      +.|..+.||+....+|..+++|.....   ....+..|+.++..+.+.+  +.+++++....+..++||||+++.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            355569999998877888999987643   2245778888888886544  456888888777889999999998884  


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------------
Q 043262          432 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDS-----------------------------------------------  464 (512)
Q Consensus       432 l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----------------------------------------------  464 (512)
                      ...      .+   ...++.++++.|..||+..                                               
T Consensus       104 ~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          104 SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence            211      11   2356778888888888642                                               


Q ss_pred             --------CCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          465 --------RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       465 --------~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                              ...++|+|++|.|||++++..++|.|||.+...
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                    112999999999999988766789999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.97  E-value=1.5e-09  Score=108.59  Aligned_cols=141  Identities=13%  Similarity=0.251  Sum_probs=105.1

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEEcc--cCC-cccHHHHHHHHHHHhcCC--CCccccceeeEEeC---CeeEEEEE
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKRLS--RTS-GQGLQEFKNEVTLIAKLQ--HKNLVRLLGCCLQE---NESLLIYE  421 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~---~~~~lv~E  421 (512)
                      .+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|..++..+.  +..+.+++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4678999999999998764 678888775  322 122456788999998887  45678888888766   44899999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS-------------------------------------  464 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------  464 (512)
                      |+++..+.+..     ...++...+..++.++++.|..||...                                     
T Consensus       122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99988774321     123678888899999999999999731                                     


Q ss_pred             ------------------CCCcccCCCCCCCeeecCCCc--eEEeccCcccc
Q 043262          465 ------------------RLKIIHRDLKTSNVLLDHEMN--PKISDFGMARI  496 (512)
Q Consensus       465 ------------------~~~ivH~dlk~~NiLl~~~~~--~kl~DFGla~~  496 (512)
                                        ...++|+|+++.|||++.+..  +.|.||+++..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              245899999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.42  E-value=4.4e-07  Score=88.34  Aligned_cols=136  Identities=21%  Similarity=0.257  Sum_probs=95.9

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCc--cccceeeEEeCC---eeEEEEEecC
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKN--LVRLLGCCLQEN---ESLLIYEYMP  424 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~g~~~~~~---~~~lv~E~~~  424 (512)
                      +.++.|....||+..    ..+++|.....  .....+.+|..++..+. +..  +.+++......+   ..|+|||+++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            458889999999763    46888875432  33567889999998873 433  334444332332   3488999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------------------
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-----------------------------------------  463 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------------  463 (512)
                      +..|.....     ..++...+..++.++++.|..||..                                         
T Consensus       100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            988865332     1356677777888888888888851                                         


Q ss_pred             --------------CCCCcccCCCCCCCeeecC--CCceEEeccCccccc
Q 043262          464 --------------SRLKIIHRDLKTSNVLLDH--EMNPKISDFGMARIF  497 (512)
Q Consensus       464 --------------~~~~ivH~dlk~~NiLl~~--~~~~kl~DFGla~~~  497 (512)
                                    ..+.++|+|++|.||++++  +..+.|.||+.+..-
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                          1134799999999999998  556889999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.28  E-value=5.2e-06  Score=80.80  Aligned_cols=136  Identities=21%  Similarity=0.170  Sum_probs=90.7

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCC---ccccceeeEE-eCCeeEEEEEecCCC
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK---NLVRLLGCCL-QENESLLIYEYMPNK  426 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~-~~~~~~lv~E~~~~g  426 (512)
                      +.++.|....||+.    +..+++|.-.  .......+..|..+|..+.+.   .+.+.+.+.. ..+..++||||+++.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            45777888889887    5677888742  223356789999999998753   3556666664 345578999999998


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------------------------------------------
Q 043262          427 SLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-------------------------------------------  463 (512)
Q Consensus       427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------  463 (512)
                      .|......     .++...+..++.++++.|..||..                                           
T Consensus        99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            87653211     123344444444444444444432                                           


Q ss_pred             --------------CCCCcccCCCCCCCeeecC---CCc-eEEeccCccccc
Q 043262          464 --------------SRLKIIHRDLKTSNVLLDH---EMN-PKISDFGMARIF  497 (512)
Q Consensus       464 --------------~~~~ivH~dlk~~NiLl~~---~~~-~kl~DFGla~~~  497 (512)
                                    ..+.++|+|+++.|||++.   ++. +.|.||+.+..-
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                          2234699999999999987   455 589999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.20  E-value=5.9e-06  Score=78.62  Aligned_cols=134  Identities=18%  Similarity=0.169  Sum_probs=92.2

Q ss_pred             cccccce-eEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEEEecCCCChh
Q 043262          353 LGEGGFG-PVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIYEYMPNKSLN  429 (512)
Q Consensus       353 lg~G~fG-~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~  429 (512)
                      +..|..| .||+.... ++..+.+|+-...   ...++.+|...|..+. +--+.++++++...+..++|||++++.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4445544 58987754 4667888876533   3457888998888774 344678889999999999999999998876


Q ss_pred             HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------------
Q 043262          430 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHED----------------------------------------------  463 (512)
Q Consensus       430 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------  463 (512)
                      +.....       ......+..+++..|.-||..                                              
T Consensus       109 ~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          109 QVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            654211       111223444555555555532                                              


Q ss_pred             ---------CCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          464 ---------SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       464 ---------~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                               ..+-++|+|+.+.|||++++..+-|.||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                     111279999999999999887777999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.09  E-value=3.5e-06  Score=83.82  Aligned_cols=79  Identities=5%  Similarity=-0.003  Sum_probs=52.9

Q ss_pred             ccc-ccccceeEEEEEeC-------CCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCC---CccccceeeEEeC---
Q 043262          351 NKL-GEGGFGPVYKGKLA-------DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQH---KNLVRLLGCCLQE---  413 (512)
Q Consensus       351 ~~l-g~G~fG~Vy~~~~~-------~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~~---  413 (512)
                      +.| +.|....+|+....       ++..+++|......   ......+..|..++..+..   ..+.+++.++...   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 77888899988764       26678888765322   1012456778887777742   3466777776554   


Q ss_pred             CeeEEEEEecCCCChh
Q 043262          414 NESLLIYEYMPNKSLN  429 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~  429 (512)
                      +..++||||+++..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3468999999887654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.85  E-value=5.4e-05  Score=72.79  Aligned_cols=79  Identities=19%  Similarity=0.232  Sum_probs=57.6

Q ss_pred             CCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCC---ccccceeeEEeCCeeEEEEEe
Q 043262          346 HFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK---NLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .+...+.+|.|..+.||+.++.||+.+.||+-..........|..|...|..|.-.   -+.+.+++    +..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            34556789999999999999999999999987655444455688899888877422   23344443    234789999


Q ss_pred             cCCCCh
Q 043262          423 MPNKSL  428 (512)
Q Consensus       423 ~~~gsL  428 (512)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.84  E-value=7.1e-05  Score=73.54  Aligned_cols=141  Identities=14%  Similarity=0.194  Sum_probs=79.3

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcC-----CCCccccce-e--eEEeCCeeEEEEEe
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-----QHKNLVRLL-G--CCLQENESLLIYEY  422 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~-g--~~~~~~~~~lv~E~  422 (512)
                      +.|+.|..+.||+....+| .+++|+....    ..++..|..++..|     ..|.++... |  +....+..++++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4565567889999987655 4888888652    23333444444443     234443311 1  12346678999999


Q ss_pred             cCCCChh-----------H---HhhcCCC----C-------CCCCHHHHH------------------------------
Q 043262          423 MPNKSLN-----------V---FLFDSTR----S-------VQLDWKRRI------------------------------  447 (512)
Q Consensus       423 ~~~gsL~-----------~---~l~~~~~----~-------~~l~~~~~~------------------------------  447 (512)
                      +++..+.           .   -++....    .       ..-.|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542           0   1111000    0       112343211                              


Q ss_pred             -HHHHHHHHHHHHHHc----------CCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          448 -SIINGIARGLLYLHE----------DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       448 -~i~~~ia~gL~yLH~----------~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                       .+...+..++.+|+.          .....++|+|+++.|||++.+..+.|.||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             111224446667763          1234699999999999998888899999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.80  E-value=6e-05  Score=75.99  Aligned_cols=75  Identities=9%  Similarity=0.182  Sum_probs=48.7

Q ss_pred             ccccccccceeEEEEEeC-CCCEEEEEEcccCCc-------ccHHHHHHHHHHHhcCCC--Cc-cccceeeEEeCCeeEE
Q 043262          350 ENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSG-------QGLQEFKNEVTLIAKLQH--KN-LVRLLGCCLQENESLL  418 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~n-Iv~l~g~~~~~~~~~l  418 (512)
                      .+.||.|..+.||++... ++..++||.......       .....+..|.+++..+.+  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999764 468899997643211       123456778888877642  33 3345433  4556789


Q ss_pred             EEEecCCC
Q 043262          419 IYEYMPNK  426 (512)
Q Consensus       419 v~E~~~~g  426 (512)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.63  E-value=0.00026  Score=68.80  Aligned_cols=139  Identities=18%  Similarity=0.170  Sum_probs=92.8

Q ss_pred             cccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC---CCccccceeeEEeCCeeEEEEEecCC
Q 043262          349 DENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       349 ~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ..+.|+.|....+|+... ++..++||.....   ....|..|...|..|.   ...+.+++.+....+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            345788999999999887 4678888876543   3567888988888774   35688888888888889999999998


Q ss_pred             CChhH-----------HhhcCCC-C------------------CCCCHHHHH---HHHH----------------HHHHH
Q 043262          426 KSLNV-----------FLFDSTR-S------------------VQLDWKRRI---SIIN----------------GIARG  456 (512)
Q Consensus       426 gsL~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~g  456 (512)
                      ..+..           -|+.... .                  ..-+|....   ++..                .+..-
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            76521           1222111 0                  012565432   1111                11222


Q ss_pred             H-HHHHc-CCCCCcccCCCCCCCeeecCCCceEEeccC
Q 043262          457 L-LYLHE-DSRLKIIHRDLKTSNVLLDHEMNPKISDFG  492 (512)
Q Consensus       457 L-~yLH~-~~~~~ivH~dlk~~NiLl~~~~~~kl~DFG  492 (512)
                      + ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            2 23432 2346799999999999999887 8899984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.43  E-value=0.0005  Score=69.83  Aligned_cols=73  Identities=12%  Similarity=0.164  Sum_probs=44.7

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEEcccC-----C--c--ccHHHHHHHHHHHh-cCCCCccccceeeEEeCCeeEEE
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRT-----S--G--QGLQEFKNEVTLIA-KLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~-----~--~--~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      .+.||.|....||+... ++..++||.....     .  .  .....+..|+..+. ...+..+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            45688899999999965 4678999943211     0  1  12334444443332 22234455666554  5667999


Q ss_pred             EEec-CC
Q 043262          420 YEYM-PN  425 (512)
Q Consensus       420 ~E~~-~~  425 (512)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.01  E-value=0.0017  Score=62.54  Aligned_cols=71  Identities=8%  Similarity=0.154  Sum_probs=41.2

Q ss_pred             ccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccc-cceeeEEeCCeeEEEEEec-CCCC
Q 043262          350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV-RLLGCCLQENESLLIYEYM-PNKS  427 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~E~~-~~gs  427 (512)
                      .+.|+.|....+|+.     ..+++|+........ .+..+|..++..+...++. ++++.  ..+.-++++||+ ++..
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            467888888999988     557788765432111 1224566666665432333 44433  444467899999 5444


Q ss_pred             h
Q 043262          428 L  428 (512)
Q Consensus       428 L  428 (512)
                      |
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.91  E-value=0.0044  Score=60.50  Aligned_cols=31  Identities=29%  Similarity=0.485  Sum_probs=27.0

Q ss_pred             CCcccCCCCCCCeeecCC----CceEEeccCcccc
Q 043262          466 LKIIHRDLKTSNVLLDHE----MNPKISDFGMARI  496 (512)
Q Consensus       466 ~~ivH~dlk~~NiLl~~~----~~~kl~DFGla~~  496 (512)
                      ..++|+|+.+.|||++.+    ..+.|.||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            459999999999999875    6799999998765

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.91  E-value=0.0087  Score=58.12  Aligned_cols=141  Identities=12%  Similarity=0.151  Sum_probs=79.5

Q ss_pred             ccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCC--ccccceee-----EEeCCeeEEEEEecC
Q 043262          352 KLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK--NLVRLLGC-----CLQENESLLIYEYMP  424 (512)
Q Consensus       352 ~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~-----~~~~~~~~lv~E~~~  424 (512)
                      .++ |....||+....+|..+++|...... .....+..|..++..+...  .+.+++..     ....+..++++||++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            455 66778998887778789999986331 1345666777777766422  23444443     223456688999998


Q ss_pred             CCChh-----HH---------hhc----CC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHc---
Q 043262          425 NKSLN-----VF---------LFD----ST--RSVQLDWKRR----ISI---------------INGIARGLLYLHE---  462 (512)
Q Consensus       425 ~gsL~-----~~---------l~~----~~--~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~---  462 (512)
                      +..+.     .+         ++.    ..  ....+++...    ..+               ...+...+..+..   
T Consensus       111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  190 (328)
T 1zyl_A          111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  190 (328)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence            75432     11         111    00  0111222211    000               0111122223321   


Q ss_pred             -CCCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          463 -DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       463 -~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                       .....++|+|+++.|||++ + .+.|.||+.+..
T Consensus       191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence             1233589999999999999 4 899999987754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.77  E-value=0.011  Score=57.32  Aligned_cols=143  Identities=15%  Similarity=0.118  Sum_probs=77.8

Q ss_pred             cccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCc--cccceee------EEeCCeeEEEEEe
Q 043262          351 NKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN--LVRLLGC------CLQENESLLIYEY  422 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~------~~~~~~~~lv~E~  422 (512)
                      +.|+.|....+|+....+| .+++|.......  ..++..|..++..+...+  +.+++..      ....+..++++||
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            4566677788999987666 577888765211  123455666666553212  2333321      1234567899999


Q ss_pred             cCCCChhH--------------HhhcCCC----C--CC---CCHHHHHH------------HHHHHHHHHHHHHcC----
Q 043262          423 MPNKSLNV--------------FLFDSTR----S--VQ---LDWKRRIS------------IINGIARGLLYLHED----  463 (512)
Q Consensus       423 ~~~gsL~~--------------~l~~~~~----~--~~---l~~~~~~~------------i~~~ia~gL~yLH~~----  463 (512)
                      +++..+..              -++....    .  ..   ..|...+.            +...+...+.+|+..    
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            98765321              0111100    0  00   12332111            011244455566532    


Q ss_pred             CCCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       464 ~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ....++|+|+++.|||++++..+.|.||+.+..
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            123589999999999999876668999987653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.69  E-value=0.002  Score=65.49  Aligned_cols=72  Identities=15%  Similarity=0.303  Sum_probs=46.9

Q ss_pred             cccccccceeEEEEEeCC--------CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCcc-ccceeeEEeCCeeEEEEE
Q 043262          351 NKLGEGGFGPVYKGKLAD--------GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL-VRLLGCCLQENESLLIYE  421 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~--------g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~E  421 (512)
                      +.|+.|-...+|+....+        +..+++|+....  .....+..|..++..+...++ .++++.+.  +  .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence            457778788999998753        478888887432  112455678888887753344 45565442  2  38999


Q ss_pred             ecCCCCh
Q 043262          422 YMPNKSL  428 (512)
Q Consensus       422 ~~~~gsL  428 (512)
                      |+++..|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9975333

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.34  E-value=0.02  Score=58.48  Aligned_cols=73  Identities=16%  Similarity=0.110  Sum_probs=44.9

Q ss_pred             cccccccceeEEEEEeCC-CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCcc-ccceeeEEeCCeeEEEEEecCCCCh
Q 043262          351 NKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL-VRLLGCCLQENESLLIYEYMPNKSL  428 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~E~~~~gsL  428 (512)
                      +.|+.|-...+|+....+ +..+++|+........ -+-..|..++..|...++ .++++.+  .+  .+|+||+++..|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence            467778788999998865 4678888764322111 112578888888765555 4566655  23  259999987444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.31  E-value=0.012  Score=58.63  Aligned_cols=141  Identities=18%  Similarity=0.277  Sum_probs=79.6

Q ss_pred             cccccccceeEEEEEeCC--------CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCcc-ccceeeEEeCCeeEEEEE
Q 043262          351 NKLGEGGFGPVYKGKLAD--------GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL-VRLLGCCLQENESLLIYE  421 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~--------g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~E  421 (512)
                      +.|..|-...+|+....+        +..+++|+.-.. ......+.+|..++..+.-.++ .++++.+.  +.  +|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~g--~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--EG--RLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--TE--EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--Cc--cEEE
Confidence            346567677899988742        467888875322 2345667789888887743333 45555543  32  9999


Q ss_pred             ecCCCChhHH-----------------hhcCCC--CCCCC--HHHHHHHHHHHH-------------------HHHHHH-
Q 043262          422 YMPNKSLNVF-----------------LFDSTR--SVQLD--WKRRISIINGIA-------------------RGLLYL-  460 (512)
Q Consensus       422 ~~~~gsL~~~-----------------l~~~~~--~~~l~--~~~~~~i~~~ia-------------------~gL~yL-  460 (512)
                      |+++..|..-                 |+....  .....  |.+..++..++.                   ..+.+| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9987554311                 111110  11122  344444443332                   123333 


Q ss_pred             ---HcC-CCCCcccCCCCCCCeeecCC----CceEEeccCcccc
Q 043262          461 ---HED-SRLKIIHRDLKTSNVLLDHE----MNPKISDFGMARI  496 (512)
Q Consensus       461 ---H~~-~~~~ivH~dlk~~NiLl~~~----~~~kl~DFGla~~  496 (512)
                         ... ....++|+|+.+.|||++.+    ..+.|.||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               221 23458999999999999876    6899999988764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.02  E-value=0.0077  Score=59.72  Aligned_cols=73  Identities=12%  Similarity=0.190  Sum_probs=41.3

Q ss_pred             cccccccceeEEEEEeCC---------CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCcc-ccceeeEEeCCeeEEEE
Q 043262          351 NKLGEGGFGPVYKGKLAD---------GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL-VRLLGCCLQENESLLIY  420 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~---------g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~  420 (512)
                      +.|+.|-.-.+|+....+         +..+++|........ ..+...|..++..+...++ .++++..  .  -++|+
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            456677778899988754         267888876543221 1123567777776643333 3555443  2  37899


Q ss_pred             EecCCCCh
Q 043262          421 EYMPNKSL  428 (512)
Q Consensus       421 E~~~~gsL  428 (512)
                      ||+++..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.95  E-value=0.059  Score=52.66  Aligned_cols=31  Identities=26%  Similarity=0.399  Sum_probs=27.3

Q ss_pred             CCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       466 ~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ..++|+|+.+.||++++++.+.|.||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4589999999999999888899999987654

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=92.95  E-value=0.045  Score=35.50  Aligned_cols=26  Identities=27%  Similarity=0.415  Sum_probs=10.3

Q ss_pred             eeehhhHHHHHHHHHHHHHhhhhhhh
Q 043262          263 IAIGAAASSIIVLALSCFLLWCMKRR  288 (512)
Q Consensus       263 i~i~i~v~~vlll~l~~~i~~~~rrr  288 (512)
                      |+.+++.++++++++++.+++++|||
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr   38 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRR   38 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhh
Confidence            44444444444433333333333333

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=92.25  E-value=0.045  Score=35.41  Aligned_cols=16  Identities=25%  Similarity=0.424  Sum_probs=6.4

Q ss_pred             eeehhhHHHHHHHHHH
Q 043262          263 IAIGAAASSIIVLALS  278 (512)
Q Consensus       263 i~i~i~v~~vlll~l~  278 (512)
                      |+.+++.+++++++++
T Consensus        12 IA~gVVgGv~~v~ii~   27 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVG   27 (44)
T ss_dssp             HHHHHHHHHHHHHHHH
T ss_pred             EEEeehHHHHHHHHHH
Confidence            4444444344433333

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=91.67  E-value=0.42  Score=48.10  Aligned_cols=73  Identities=14%  Similarity=0.216  Sum_probs=44.0

Q ss_pred             cccccccceeEEEEEeCC--------CCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCcc-ccceeeEEeCCeeEEEEE
Q 043262          351 NKLGEGGFGPVYKGKLAD--------GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL-VRLLGCCLQENESLLIYE  421 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~--------g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~E  421 (512)
                      +.|..|-...+|+....+        +..+++++....... .-+-.+|..++..+...++ .++++.+  .  -++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence            456667778899988753        577888876443221 1123467777766643233 3445422  2  378999


Q ss_pred             ecCCCCh
Q 043262          422 YMPNKSL  428 (512)
Q Consensus       422 ~~~~gsL  428 (512)
                      |+++..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.69  E-value=1.2  Score=40.03  Aligned_cols=89  Identities=8%  Similarity=0.032  Sum_probs=60.5

Q ss_pred             CCCccccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCcccCCCCCCC
Q 043262          399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL-YLHEDSRLKIIHRDLKTSN  477 (512)
Q Consensus       399 ~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivH~dlk~~N  477 (512)
                      .||.+  -...-.+.+...+.++.-+++.=...+      ..++...+++++..|+.-.. +++.     -+|--|.|.|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            56766  233334555655555554333222223      23778889998888877666 5543     5888899999


Q ss_pred             eeecCCCceEEeccCcccccCCC
Q 043262          478 VLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       478 iLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++++.++.++|.-.|+-..+.+-
T Consensus       115 L~f~~~~~p~i~hRGi~~~lpP~  137 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESLPPD  137 (219)
T ss_dssp             EEECTTCCEEESCCEETTTBSSC
T ss_pred             EEEeCCCcEEEEEcCCcccCCCC
Confidence            99999999999999987766443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.06  E-value=0.11  Score=52.94  Aligned_cols=60  Identities=10%  Similarity=0.112  Sum_probs=18.0

Q ss_pred             ccccccccceeEEEEEeCC-CCEEEE------EEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEe
Q 043262          350 ENKLGEGGFGPVYKGKLAD-GKEIAV------KRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ  412 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~-g~~vaV------K~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  412 (512)
                      .++||   ||.||+|.+.. ..+|||      |..+..  +......|.+|..++..++|||+++.+++...
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            35566   99999999854 367888      776542  23344678899999999999999999988754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.73  E-value=1.2  Score=39.85  Aligned_cols=91  Identities=7%  Similarity=0.008  Sum_probs=63.3

Q ss_pred             CCCCccccceeeEEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCC
Q 043262          398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSN  477 (512)
Q Consensus       398 l~H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N  477 (512)
                      ..||+++.. ..-...+...+.++.-  .+...|-    .-..++...+++++..|+.-..+++.     -+|--|.|.|
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcC--cccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            357877765 3444455544444443  3333322    12347888999999999988866654     4788899999


Q ss_pred             eeecCCCceEEeccCcccccCCC
Q 043262          478 VLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       478 iLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ++++.++.++|.-.|+-..+.+-
T Consensus       110 L~f~~~~~p~i~~RGik~~l~P~  132 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVVDPL  132 (215)
T ss_dssp             EEECTTSCEEESCCEETTTBSCC
T ss_pred             EEEcCCCCEEEEEccCccCCCCC
Confidence            99999999999999987666544

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	512
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-48
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-44
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-42
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-42
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-42
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-42
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-42
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-42
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-40
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-40
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-40
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-40
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-40
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-39
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-39
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-38
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-37
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-37
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-37
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-36
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-36
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-36
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-33
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-33
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-33
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-31
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-31
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-28
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-27
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-27
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-27
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-27
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-26
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-25
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-24
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-23
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-23
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-18

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 2e-48
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 6/167 (3%)

Query: 346 HFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
             +   ++G G FG VYKGK      + +  ++  + Q LQ FKNEV ++ K +H N++ 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
            +G      +  ++ ++    SL   L       + +  + I I    A+G+ YLH    
Sbjct: 69  FMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK-- 123

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             IIHRDLK++N+ L  ++  KI DFG+A +          +++ G+
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 2e-46
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 7/168 (4%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           +      +LG G FG V+ G      ++AVK L + S      F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           RL      +    +I EYM N SL  FL      ++L   + + +   IA G+ ++ E  
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-- 127

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
               IHRDL+ +N+L+   ++ KI+DFG+AR+   N+  A        
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFP 173

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (407), Expect = 5e-46
 Identities = 52/173 (30%), Positives = 84/173 (48%), Gaps = 16/173 (9%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQ 399
            + FSD  ++G G FG VY  + + + + +A+K++S +  Q     Q+   EV  + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H N ++  GC L+E+ + L+ EY    + ++          L      ++ +G  +GL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           LH      +IHRD+K  N+LL      K+ DFG A I       A     VGT
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGT 174

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-44
 Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 6/162 (3%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
            +    +LG+G FG VYK +        A K +   S + L+++  E+ ++A   H N+V
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           +LL     EN   ++ E+    +++  + +  R   L   +   +       L YLH+  
Sbjct: 73  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD-- 128

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
             KIIHRDLK  N+L   + + K++DFG++          ++
Sbjct: 129 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-44
 Identities = 40/172 (23%), Positives = 72/172 (41%), Gaps = 11/172 (6%)

Query: 343 ATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGL-QEFKNEVTLIAKLQH 400
               F   ++LG G  G V+K      G  +A K +       +  +   E+ ++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
             +V   G    + E  +  E+M   SL+  L  + R   +  +    +   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
               + KI+HRD+K SN+L++     K+ DFG++     +         VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGT 166

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (381), Expect = 2e-42
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 6/162 (3%)

Query: 346 HFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
             + ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           +LLG C +E    +I E+M   +L  +L +  R  ++     + +   I+  + YL    
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE--- 132

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           +   IHRDL   N L+      K++DFG++R+  G+   A+ 
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 2e-42
 Identities = 44/167 (26%), Positives = 77/167 (46%), Gaps = 7/167 (4%)

Query: 346 HFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
             +   ++G G FG V+ G   +  ++A+K + R      ++F  E  ++ KL H  LV+
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 406 LLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 465
           L G CL++    L++E+M +  L    +  T+      +  + +   +  G+ YL E   
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119

Query: 466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             +IHRDL   N L+      K+SDFGM R    +Q   ++      
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  149 bits (378), Expect = 5e-42
 Identities = 50/184 (27%), Positives = 90/184 (48%), Gaps = 19/184 (10%)

Query: 342 EATQHFSDE---------NKLGEGGFGPVYKGKLADGKE----IAVKRL-SRTSGQGLQE 387
           EA + F+ E           +G G FG V  G L    +    +A+K L S  + +  ++
Sbjct: 14  EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD 73

Query: 388 FKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRI 447
           F +E +++ +  H N++ L G   +    ++I E+M N SL+ FL  +    Q    + +
Sbjct: 74  FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLV 131

Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK 507
            ++ GIA G+ YL     +  +HRDL   N+L++  +  K+SDFG++R    + S+    
Sbjct: 132 GMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188

Query: 508 RIVG 511
             +G
Sbjct: 189 SALG 192

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (376), Expect = 6e-42
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 8/168 (4%)

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNL 403
           +     +G G +G   K +  +DGK +  K L   S      Q   +EV L+ +L+H N+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 404 VRLLGCCLQENESLL--IYEYMPNKSLNVFLFDSTRSVQ-LDWKRRISIINGIARGLLYL 460
           VR     +    + L  + EY     L   +   T+  Q LD +  + ++  +   L   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 461 HE--DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           H   D    ++HRDLK +NV LD + N K+ DFG+ARI   + S A  
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 7e-42
 Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 8/159 (5%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           +       +G+G FG V  G    G ++AVK +   +    Q F  E +++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 405 RLLGCCLQENESL-LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           +LLG  ++E   L ++ EYM   SL  +L    RSV L     +     +   + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE-- 120

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
                +HRDL   NVL+  +   K+SDFG+ +     Q 
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 7e-42
 Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 8/170 (4%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKN 402
           + +     LGEG +G V         + +AVK +         E  K E+ +   L H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           +V+  G   + N   L  EY     L   +        +         + +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
              + I HRD+K  N+LLD   N KISDFG+A +F  N  E    ++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 9e-42
 Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 7/168 (4%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           +  +   +LG G FG V  GK     ++A+K +   S     EF  E  ++  L H+ LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           +L G C ++    +I EYM N  L    +      +   ++ + +   +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
             + +HRDL   N L++ +   K+SDFG++R    ++  ++       
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 164

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 1e-40
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 6/162 (3%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           +    E KLG+G FG V+ G       +A+K L   +    + F  E  ++ KL+H+ LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           +L      E    ++ EYM   SL  FL   T        + + +   IA G+ Y+    
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE--- 130

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           R+  +HRDL+ +N+L+   +  K++DFG+AR+   N+  A  
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 1e-40
 Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 11/169 (6%)

Query: 349 DENKLGEGGFGPVYKGKLA---DGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLV 404
            + +LG G FG V +G         ++A+K L + + +   +E   E  ++ +L +  +V
Sbjct: 13  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
           RL+G C Q    +L+ E      L+ FL    +  ++       +++ ++ G+ YL    
Sbjct: 73  RLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE--- 126

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR-IVGT 512
               +HRDL   NVLL +    KISDFG+++  G + S    +      
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-40
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 17/174 (9%)

Query: 350 ENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 409
           +  +G+G FG V++GK   G+E+AVK  S    +     + E+     L+H+N++  +  
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65

Query: 410 CLQENESL----LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-- 463
             ++N +     L+ +Y  + SL  +L        +  +  I +    A GL +LH +  
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 464 ---SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSEANTKRIVGT 512
               +  I HRDLK+ N+L+       I+D G+A       +  +      VGT
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 2e-40
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 13/170 (7%)

Query: 349 DENKLGEGGFGPVYKGKLAD---GKEIAVKRLSRTSGQG--LQEFKNEVTLIAKLQHKNL 403
           ++ +LG G FG V KG        K +AVK L   +       E   E  ++ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 404 VRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
           VR++G C  E+  +L+ E      LN +L  +     +  K  I +++ ++ G+ YL   
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE-- 124

Query: 464 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTK-RIVGT 512
                +HRDL   NVLL  +   KISDFG+++    +++    +      
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (365), Expect = 4e-40
 Identities = 51/195 (26%), Positives = 78/195 (40%), Gaps = 31/195 (15%)

Query: 346 HFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKL 398
           +      +GEG FG V++ +            +AVK L   +   +Q +F+ E  L+A+ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTR--------------------- 437
            + N+V+LLG C       L++EYM    LN FL   +                      
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 438 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 497
              L    ++ I   +A G+ YL E    K +HRDL T N L+   M  KI+DFG++R  
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 498 GGNQSEANTKRIVGT 512
                          
Sbjct: 191 YSADYYKADGNDAIP 205

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 7e-40
 Identities = 57/223 (25%), Positives = 83/223 (37%), Gaps = 36/223 (16%)

Query: 313 GNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGKLA----- 367
           GN+Y Y        +   EFP              S    LG G FG V +         
Sbjct: 1   GNNYVYIDPTQLPYDHKWEFPR----------NRLSFGKTLGAGAFGKVVEATAYGLIKS 50

Query: 368 -DGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYEYMP 424
                +AVK L  ++     +   +E+ +++ L  H N+V LLG C     +L+I EY  
Sbjct: 51  DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 110

Query: 425 NKSLNVFLFDSTRS---------------VQLDWKRRISIINGIARGLLYLHEDSRLKII 469
              L  FL     S               + LD +  +S    +A+G+ +L        I
Sbjct: 111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCI 167

Query: 470 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           HRDL   N+LL H    KI DFG+AR    + +          
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-39
 Identities = 44/170 (25%), Positives = 87/170 (51%), Gaps = 10/170 (5%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN 402
            + ++   K+G+G  G VY    +A G+E+A+++++       +   NE+ ++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           +V  L   L  +E  ++ EY+   S    L D      +D  +  ++     + L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
               ++IHRD+K+ N+LL  + + K++DFG        QS+ +T  +VGT
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-39
 Identities = 53/231 (22%), Positives = 83/231 (35%), Gaps = 41/231 (17%)

Query: 310 GRIGNDYSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKG----- 364
           G   N+Y Y   R  + +   EFP           ++      LG G FG V        
Sbjct: 12  GSSDNEYFYVDFREYEYDLKWEFPR----------ENLEFGKVLGSGAFGKVMNATAYGI 61

Query: 365 -KLADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLIYE 421
            K     ++AVK L   +     +   +E+ ++ +L  H+N+V LLG C       LI+E
Sbjct: 62  SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121

Query: 422 YMPNKSLNVFLFDSTRSVQ--------------------LDWKRRISIINGIARGLLYLH 461
           Y     L  +L                            L ++  +     +A+G+ +L 
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
                  +HRDL   NVL+ H    KI DFG+AR    + +          
Sbjct: 182 F---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 4e-39
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 16/171 (9%)

Query: 350 ENKLGEGGFGPVYKGKLAD-GKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQHKNLVRL 406
           + ++G G F  VYKG   +   E+A   L   + +    Q FK E  ++  LQH N+VR 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 407 LGCCL----QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
                     +   +L+ E M + +L  +L    R   +  K   S    I +GL +LH 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 463 DSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSEANTKRIVGT 512
            +   IIHRDLK  N+ +     + KI D G+A +   +      K ++GT
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGT 176

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 3e-38
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 14/172 (8%)

Query: 345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQH 400
           + F     LG+G FG VY  +       +A+K L +          + + EV + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
            N++RL G         LI EY P  ++   L   ++    D +R  + I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           H     ++IHRD+K  N+LL      KI+DFG +     ++       + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  140 bits (353), Expect = 6e-38
 Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 15/199 (7%)

Query: 316 YSYDVLRGQKQEESQEFPLFPLHLAVEATQHFSDENKLGEGGFGPVYKGK-LADGKEIAV 374
           Y +D+    KQ   Q   +   H+      H+    +LG G FG V++    A G   A 
Sbjct: 4   YVFDIW---KQYYPQPVEIKHDHVL----DHYDIHEELGTGAFGVVHRVTERATGNNFAA 56

Query: 375 KRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFD 434
           K +        +  + E+  ++ L+H  LV L      +NE ++IYE+M    L   + D
Sbjct: 57  KFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 116

Query: 435 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFG 492
                ++     +  +  + +GL ++HE      +H DLK  N++   + +   K+ DFG
Sbjct: 117 --EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFG 171

Query: 493 MARIFGGNQSEANTKRIVG 511
           +       QS   T     
Sbjct: 172 LTAHLDPKQSVKVTTGTAE 190

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 2e-37
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 13/169 (7%)

Query: 346 HFSDENKLGEGGFGPVYKGKLADGK----EIAVKRLSRTSGQG-LQEFKNEVTLIAKLQH 400
           HF     +G G FG VY G L D        AVK L+R +  G + +F  E  ++    H
Sbjct: 30  HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 401 KNLVRLLGCCLQ-ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
            N++ LLG CL+ E   L++  YM +  L  F+ + T +  +       +          
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
           +   +  K +HRDL   N +LD +   K++DFG+AR     + ++   +
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 2e-37
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 12/172 (6%)

Query: 347 FSDENKLGEGGFGPVYKGK-LADGKE----IAVKRLSR-TSGQGLQEFKNEVTLIAKLQH 400
           F     LG G FG VYKG  + +G++    +A+K L   TS +  +E  +E  ++A + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
            ++ RLLG C   +   LI + MP   L    +       +  +  ++    IA+G+ YL
Sbjct: 71  PHVCRLLGIC-LTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
                 +++HRDL   NVL+    + KI+DFG+A++ G  + E + +     
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-37
 Identities = 48/175 (27%), Positives = 70/175 (40%), Gaps = 13/175 (7%)

Query: 345 QHFSDENKLGEGGFGPVYKGKL----ADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAK 397
           +      KLG+G FG V +G+          +AVK L     +  + + +F  EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGL 457
           L H+NL+RL G         ++ E  P  SL   L        L    R ++   +A G+
Sbjct: 68  LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124

Query: 458 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
            YL      + IHRDL   N+LL      KI DFG+ R    N      +     
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 9e-37
 Identities = 38/167 (22%), Positives = 75/167 (44%), Gaps = 5/167 (2%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQ 399
           +    +++ + +GEG +G V       +   +A+K++S    Q   Q    E+ ++ + +
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H+N++ +           +   Y+    +   L+   ++  L        +  I RGL Y
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           +H      ++HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-36
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 24/184 (13%)

Query: 347 FSDENKLGEGGFGPVYKGKLADG---KEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHK 401
              ++ +GEG FG V K ++       + A+KR+    S    ++F  E+ ++ KL  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFL-------------FDSTRSVQLDWKRRIS 448
           N++ LLG C       L  EY P+ +L  FL               ++ +  L  ++ + 
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 449 IINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR 508
               +ARG+ YL +    + IHRDL   N+L+      KI+DFG++R   G +       
Sbjct: 132 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 185

Query: 509 IVGT 512
               
Sbjct: 186 GRLP 189

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-36
 Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 11/168 (6%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKE-----IAVKRLSRTSGQG-LQEFKNEVTLIAKL 398
              + +  +G G FG VYKG L          +A+K L     +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
            H N++RL G   +    ++I EYM N +L+ FL +  +  +    + + ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           YL     +  +HRDL   N+L++  +  K+SDFG++R+   +     T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  135 bits (342), Expect = 2e-36
 Identities = 38/159 (23%), Positives = 72/159 (45%), Gaps = 8/159 (5%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           ++    +LG G FG V++    A G+    K ++          KNE++++ +L H  L+
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            L      + E +LI E++    L  F   +    ++     I+ +     GL ++HE  
Sbjct: 90  NLHDAFEDKYEMVLILEFLSGGEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-- 145

Query: 465 RLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQ 501
              I+H D+K  N++ + +     KI DFG+A     ++
Sbjct: 146 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-36
 Identities = 46/170 (27%), Positives = 69/170 (40%), Gaps = 10/170 (5%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHK 401
            F     LGEG F  V   + LA  +E A+K L +        +     E  ++++L H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
             V+L      + +      Y  N  L  ++         D          I   L YLH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVG 511
                 IIHRDLK  N+LL+ +M+ +I+DFG A++      +A     VG
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-36
 Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 17/182 (9%)

Query: 345 QHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSR-TSGQGLQEFKNEVTLIAK 397
           +  +   +LG+G FG VY+G             +A+K ++   S +   EF NE +++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 398 LQHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLF-------DSTRSVQLDWKRRISII 450
               ++VRLLG   Q   +L+I E M    L  +L        ++         + I + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 451 NGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIV 510
             IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R            + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 511 GT 512
             
Sbjct: 197 LP 198

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 6e-36
 Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 12/173 (6%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLADGKE----IAVKRLSRTSGQGLQE-FKNEVTLIAKLQ 399
           +       +GEG FG V++G     +     +A+K     +   ++E F  E   + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H ++V+L+G    EN   +I E      L    F   R   LD    I     ++  L Y
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           L      + +HRD+   NVL+      K+ DFG++R    +     + +    
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLP 172

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  133 bits (335), Expect = 3e-35
 Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 13/164 (7%)

Query: 346 HFSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQ-- 399
            FS    +G GGFG VY  + AD GK  A+K L +      QG     NE  +++ +   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 400 -HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
               +V +       ++   I + M    L+  L       + D +        I  GL 
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF---YAAEIILGLE 121

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
           ++H      +++RDLK +N+LLD   + +ISD G+A  F   + 
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 3e-34
 Identities = 45/189 (23%), Positives = 72/189 (38%), Gaps = 25/189 (13%)

Query: 346 HFSDENKLGEGGFGPVYKG------KLADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAK- 397
                  LG G FG V +       K A  + +AVK L   +     +   +E+ ++   
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 398 LQHKNLVRLLGCCLQENESLLI-YEYMPNKSLNVFLF-------------DSTRSVQLDW 443
             H N+V LLG C +    L++  E+    +L+ +L              +      L  
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 444 KRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
           +  I     +A+G+ +L      K IHRDL   N+LL  +   KI DFG+AR    +   
Sbjct: 134 EHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 504 ANTKRIVGT 512
                    
Sbjct: 191 VRKGDARLP 199

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  126 bits (318), Expect = 2e-33
 Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 10/162 (6%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQH 400
           Q F     LG G FG V+  +   +G+  A+K L +      + ++   +E  +++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
             ++R+ G      +  +I +Y+    L   L  S R      K   + +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
                  II+RDLK  N+LLD   + KI+DFG A+       
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 3e-33
 Identities = 33/154 (21%), Positives = 70/154 (45%), Gaps = 9/154 (5%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 410
            LG G FG V++    +  K    K + +  G      K E++++   +H+N++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 411 LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 470
               E ++I+E++    +   +  +T + +L+ +  +S ++ +   L +LH      I H
Sbjct: 71  ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125

Query: 471 RDLKTSNVLLDHEMNP--KISDFGMARIFGGNQS 502
            D++  N++     +   KI +FG AR      +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 3e-33
 Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 15/168 (8%)

Query: 347 FSDENKLGEGGFGPVYKGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR 405
           ++D   +G G FG VY+ KL D G+ +A+K++ +      +    E+ ++ KL H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 406 LLGCCLQENES------LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           L        E        L+ +Y+P     V    S     L        +  + R L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSEANT 506
           +H      I HRD+K  N+LLD +    K+ DFG A+     +   + 
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  124 bits (312), Expect = 7e-33
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 20/179 (11%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGL---------QEFKNEVTL 394
           +++  +  LG G    V +       KE AVK +  T G            +    EV +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 395 IAKLQ-HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           + K+  H N+++L           L+++ M    L  +L   T  V L  K    I+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
              +  LH+   L I+HRDLK  N+LLD +MN K++DFG +      +     + + GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 172

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 9e-33
 Identities = 52/190 (27%), Positives = 77/190 (40%), Gaps = 26/190 (13%)

Query: 346 HFSDENKLGEGGFGPVYKGKL--------ADGKEIAVKRLSR-TSGQGLQEFKNEVTLIA 396
                  LGEG FG V   +             ++AVK L    + + L +  +E+ ++ 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 397 KL-QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLF-------------DSTRSVQLD 442
            + +HKN++ LLG C Q+    +I EY    +L  +L                    QL 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 443 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
            K  +S    +ARG+ YL      K IHRDL   NVL+  +   KI+DFG+AR       
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 503 EANTKRIVGT 512
              T      
Sbjct: 191 YKKTTNGRLP 200

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  124 bits (311), Expect = 1e-32
 Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 8/158 (5%)

Query: 351 NKLGEGGFGPVYKGKLADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
            K+GEG +G VYK +   G+  A+K  RL +           E++++ +L+H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 409 CCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKI 468
               +   +L++E++      +          L+     S +  +  G+ Y H+    ++
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD---RRV 121

Query: 469 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
           +HRDLK  N+L++ E   KI+DFG+AR FG    +   
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  119 bits (300), Expect = 3e-31
 Identities = 46/186 (24%), Positives = 77/186 (41%), Gaps = 19/186 (10%)

Query: 336 PLHLAVEATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQG---LQEFKNE 391
           P HL    +  +     LG GG   V+  + L   +++AVK L     +       F+ E
Sbjct: 2   PSHL----SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRRE 57

Query: 392 VTLIAKLQHKNLVRLLGCCLQENESL----LIYEYMPNKSLNVFLFDSTRSVQLDWKRRI 447
               A L H  +V +      E  +     ++ EY+   +L   +        +  KR I
Sbjct: 58  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAI 114

Query: 448 SIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSEANT 506
            +I    + L + H+     IIHRD+K +N+++      K+ DFG+AR       S   T
Sbjct: 115 EVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171

Query: 507 KRIVGT 512
             ++GT
Sbjct: 172 AAVIGT 177

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (299), Expect = 8e-31
 Identities = 32/171 (18%), Positives = 66/171 (38%), Gaps = 8/171 (4%)

Query: 344 TQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHK 401
              +   + LG G F  V   +     K +A+K +++ + +G +   +NE+ ++ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+V L           LI + +    L   + +         +    +I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           +   +    +        LD +    ISDFG++++              GT
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGT 172

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-30
 Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 12/158 (7%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE-----FKNEVTLIAKLQHKNLV 404
           + LGEG F  VYK +     + +A+K++        ++        E+ L+ +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
            LL     ++   L++++M        +     S+ L      + +    +GL YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 465 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
              I+HRDLK +N+LLD     K++DFG+A+ FG    
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-30
 Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 8/164 (4%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKN 402
           +F    K+GEG +G VYK +    G+ +A+K  RL   +         E++L+ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           +V+LL     EN+  L++E++          D++    +      S +  + +GL + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 463 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANT 506
               +++HRDLK  N+L++ E   K++DFG+AR FG        
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 1e-29
 Identities = 43/173 (24%), Positives = 69/173 (39%), Gaps = 13/173 (7%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEV-TLIAKLQ 399
           + F     LG+G FG V+  +     +  A+K L +        ++    E   L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 400 HKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
           H  L  +      +     + EY+    L   +    +    D  R       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           LH      I++RDLK  N+LLD + + KI+DFGM +      ++ NT    GT
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 8e-29
 Identities = 41/175 (23%), Positives = 84/175 (48%), Gaps = 19/175 (10%)

Query: 351 NKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQG--LQEFKNEVTLIAKLQHKNLVRLL 407
            K+G+G FG V+K +    G+++A+K++   + +         E+ ++  L+H+N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 408 GCCLQ--------ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLY 459
             C          +    L++++  +    +      +    + KR + ++      L  
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML------LNG 129

Query: 460 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKR--IVGT 512
           L+   R KI+HRD+K +NVL+  +   K++DFG+AR F   ++    +    V T
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 3e-28
 Identities = 44/180 (24%), Positives = 81/180 (45%), Gaps = 16/180 (8%)

Query: 343 ATQHFSDENKLGEGGFGPVYKGK--LADGKEIAVKRLSRTSGQG--LQEFKNEVTLIAKL 398
           A Q +    ++GEG +G V+K +     G+ +A+KR+   +G+         EV ++  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 399 ---QHKNLVRLLGCCLQENESLLIYEYMPNKSLN---VFLFDSTRSVQLDWKRRISIING 452
              +H N+VRL   C            +  + ++       D      +  +    ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           + RGL +LH     +++HRDLK  N+L+      K++DFG+ARI+    +      +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 178

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 8e-28
 Identities = 43/171 (25%), Positives = 68/171 (39%), Gaps = 12/171 (7%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHK 401
            F     LG+G FG V   +  A G+  A+K L +    +   +     E  ++   +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
            L  L       +    + EY     L   L   +R      +R       I   L YLH
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH 122

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
                 +++RD+K  N++LD + + KI+DFG+ +   G    A  K   GT
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 168

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 3e-27
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 9/164 (5%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHK 401
           Q +    K+GEG +G V+K K     + +A+K  RL             E+ L+ +L+HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           N+VRL      + +  L++E+        F   +      D +   S +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEAN 505
                 ++HRDLK  N+L++     K+++FG+AR FG      +
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  109 bits (272), Expect = 3e-27
 Identities = 37/176 (21%), Positives = 70/176 (39%), Gaps = 16/176 (9%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
            +    K+G G FG +Y G  +A G+E+A+K     +     +   E  +   +Q    +
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGI 65

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
             +  C  E +  ++   +   SL      +  S +   K  + + + +   + Y+H   
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-- 121

Query: 465 RLKIIHRDLKTSNVL---LDHEMNPKISDFGMARIFGGNQSEAN-----TKRIVGT 512
               IHRD+K  N L           I DFG+A+ +   ++  +      K + GT
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 5e-27
 Identities = 40/171 (23%), Positives = 65/171 (38%), Gaps = 19/171 (11%)

Query: 352 KLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQE------FKNEVTLIAKLQ--HKN 402
            LG GGFG VY G  ++D   +A+K + +       E         EV L+ K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 403 LVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 462
           ++RLL    + +  +LI E              T    L  +   S    +   + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128

Query: 463 DSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSEANTKRIVGT 512
                ++HRD+K  N+L+D      K+ DFG   +      +       GT
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGT 172

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 8e-27
 Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 17/170 (10%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKL 398
           E    + D   +G G +G V        G ++A+K+L R   S    +    E+ L+  +
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74

Query: 399 QHKNLVRLLGCCLQEN------ESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIING 452
           +H+N++ LL     +       +  L+  +M      +      +  +L   R   ++  
Sbjct: 75  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQ 129

Query: 453 IARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
           + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR      +
Sbjct: 130 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  107 bits (269), Expect = 8e-27
 Identities = 35/178 (19%), Positives = 71/178 (39%), Gaps = 18/178 (10%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV 404
           H+    ++GEG FG +++G  L + +++A+K   R S     + ++E      L     +
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGI 63

Query: 405 RLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS 464
             +    QE    ++   +   SL   L    R  +   K        +   +  +HE  
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE-- 119

Query: 465 RLKIIHRDLKTSNVLLDHEMNP-----KISDFGMARIFGGNQSEAN-----TKRIVGT 512
              +++RD+K  N L+    +       + DFGM + +    ++ +      K + GT
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 1e-26
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 20/178 (11%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTS------GQGLQEFKNEVTLIAKL 398
           ++    +LG G F  V K +  + G + A K + +        G   ++ + EV+++ ++
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 399 QHKNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLL 458
           QH N++ L      + + +LI E +    L  FL +      L  +     +  I  G+ 
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVY 127

Query: 459 YLHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSEANTKRIVGT 512
           YLH    L+I H DLK  N++L     P    KI DFG+A            K I GT
Sbjct: 128 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 2e-26
 Identities = 36/162 (22%), Positives = 62/162 (38%), Gaps = 18/162 (11%)

Query: 350 ENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLL 407
              LG G  G V +       ++ A+K L         + + EV L  +  Q  ++VR++
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71

Query: 408 GCC----LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 463
                        L++ E +    L   + D         +    I+  I   + YLH  
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS- 129

Query: 464 SRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQS 502
             + I HRD+K  N+L   +      K++DFG A+    + S
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  107 bits (269), Expect = 2e-26
 Identities = 39/161 (24%), Positives = 62/161 (38%), Gaps = 10/161 (6%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHK 401
            F     LG G FG V   K    G   A+K L +      + ++   NE  ++  +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 402 NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
            LV+L       +   ++ EY+    +   L    R               I     YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH 158

Query: 462 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 502
               L +I+RDLK  N+L+D +   +++DFG A+   G   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 99.5 bits (247), Expect = 8e-25
 Identities = 33/170 (19%), Positives = 55/170 (32%), Gaps = 20/170 (11%)

Query: 351 NKLGEGGFGPVYKGKLADGKEIAVK--RLSRTSGQ--------GLQEFKNEVTLIAKLQH 400
             +GEG    V+        E  VK  ++  TS +        G   F       A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 401 KNLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYL 460
           + L +L G  + +      Y +  N  L   +                +++ I   +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 461 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIV 510
           +      I+H DL   NVL+  E    I DF  +   G        +R V
Sbjct: 120 YHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDV 165

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 1e-24
 Identities = 39/168 (23%), Positives = 75/168 (44%), Gaps = 15/168 (8%)

Query: 345 QHFSDENKLGEGGFGPVYKGKLA----DGKEIAVKRLSRTS----GQGLQEFKNEVTLIA 396
           ++F     LG G +G V+  +       GK  A+K L + +     +  +  + E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 397 KLQHK-NLVRLLGCCLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
            ++    LV L      E +  LI +Y+    L   L    R  + + +  +        
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSE 503
            +L L    +L II+RD+K  N+LLD   +  ++DFG+++ F  +++E
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 9e-24
 Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 15/176 (8%)

Query: 342 EATQHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKL 398
           E  + + + + +G G +G V        G  +AVK+LSR   S    +    E+ L+  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 399 QHKNLVRLLGCC-----LQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGI 453
           +H+N++ LL        L+E   + +  ++        L +  +  +L       +I  I
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD----LNNIVKCQKLTDDHVQFLIYQI 130

Query: 454 ARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRI 509
            RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +     R 
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW 183

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 99.5 bits (247), Expect = 1e-23
 Identities = 36/172 (20%), Positives = 70/172 (40%), Gaps = 20/172 (11%)

Query: 346 HFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNL 403
            +    KLG G +  V++   + + +++ VK L        ++ K E+ ++  L+   N+
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNI 92

Query: 404 VRLLGCCLQENESL--LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLH 461
           + L             L++E++ N               L        +  I + L Y H
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH 146

Query: 462 EDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSEANTKRIVGT 512
               + I+HRD+K  NV++DHE    ++ D+G+A  +   Q        V +
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVAS 192

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.2 bits (246), Expect = 2e-23
 Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 21/177 (11%)

Query: 345 QHFSDENKLGEGGFGPVYKGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHK 401
           + + +   +G G  G V         + +A+K+LSR   +    +    E+ L+  + HK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 402 NLVRLLGCCLQE------NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
           N++ LL     +       +  L+ E M      V         +LD +R   ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLC 130

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT 512
           G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G +         V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVT 181

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 83.5 bits (205), Expect = 5e-18
 Identities = 34/179 (18%), Positives = 65/179 (36%), Gaps = 23/179 (12%)

Query: 350 ENKLGEGGFGPVYKGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG 408
             KLG G F  V+  K + +   +A+K +        +  ++E+ L+ ++   +  +   
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDS 76

Query: 409 CCL-------------QENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIAR 455
                             N   ++  +       + L        +       I   +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 456 GLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP------KISDFGMARIFGGNQSEANTKR 508
           GL Y+H   R  IIH D+K  NVL++   +P      KI+D G A  +  + + +   R
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	512
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.98
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.98
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.98
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.98
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.98
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.97
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.97
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.97
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.97
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.97
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.97
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.97
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.97
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.97
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.96
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.96
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.96
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.96
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.96
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.96
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.96
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.96
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.96
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.96
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.96
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.96
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.96
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.96
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.96
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.96
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.96
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.95
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.95
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.94
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.94
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.94
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.94
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.94
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.94
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.94
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.93
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.93
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.93
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.92
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.92
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.92
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.83
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.37
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.76
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.28
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.66
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.66
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	92.3

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-33  Score=269.68  Aligned_cols=162  Identities=29%  Similarity=0.423  Sum_probs=139.7

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|+..++||+|+||.||+|+. .+|+.||||++.... ....+++.+|+.++++++|||||++++++.+.+..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            5688889999999999999997 568999999996543 33456799999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  502 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~  502 (512)
                      +++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||++++.+||+|||+|+.+..+..
T Consensus        85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999843   346999999999999999999999975   99999999999999999999999999998866554


Q ss_pred             CcCccccccC
Q 043262          503 EANTKRIVGT  512 (512)
Q Consensus       503 ~~~~~~~~Gt  512 (512)
                      ....+..+||
T Consensus       159 ~~~~~~~~GT  168 (271)
T d1nvra_         159 ERLLNKMCGT  168 (271)
T ss_dssp             ECCBCCCCSC
T ss_pred             cccccceeeC
Confidence            4444556776

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.98  E-value=3e-33  Score=270.50  Aligned_cols=153  Identities=29%  Similarity=0.529  Sum_probs=137.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ++|...++||+|+||.||+|++. +++.||||+++... ...++|.+|+.++++++|||||+++|++.+.+..++||||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            56777889999999999999975 58899999997543 45678999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  502 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~  502 (512)
                      ++|+|.+++... ....++|..++.|+.||+.||.|||+++   |+||||||+||||++++.+||+|||+++.+..+..
T Consensus        96 ~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          96 TYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             TTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             cCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            999999999653 3456999999999999999999999975   99999999999999999999999999998866543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=5.9e-33  Score=265.18  Aligned_cols=151  Identities=28%  Similarity=0.511  Sum_probs=130.3

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...++||+|+||.||+|++.++..||||+++... ...++|.+|+.++.+++|||||+++|++...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4577788999999999999999888999999997543 446789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +|+|.+++...  ...++|..++.|+.||+.||.|||+.+   |+||||||+||||++++.+||+|||+++.+....
T Consensus        84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence            99999998653  345899999999999999999999975   9999999999999999999999999999876543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=9.5e-33  Score=265.26  Aligned_cols=160  Identities=33%  Similarity=0.551  Sum_probs=130.8

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|+||.||+|+++  ..||||+++..  +....++|.+|+.++.+++|||||+++|++.+ +..++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            56777899999999999999875  36999999643  34557889999999999999999999998754 568999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  502 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~  502 (512)
                      +++|+|.+++...  ...+++..++.|+.||++||+|||+++   ||||||||+||||++++.+||+|||+|+.......
T Consensus        85 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          85 CEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             CCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            9999999999653  345999999999999999999999974   99999999999999999999999999998865544


Q ss_pred             CcCccccccC
Q 043262          503 EANTKRIVGT  512 (512)
Q Consensus       503 ~~~~~~~~Gt  512 (512)
                      ....+.+.||
T Consensus       160 ~~~~~~~~gt  169 (276)
T d1uwha_         160 SHQFEQLSGS  169 (276)
T ss_dssp             ------CCCC
T ss_pred             cccccccccC
Confidence            4344445555

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.6e-32  Score=264.15  Aligned_cols=150  Identities=25%  Similarity=0.456  Sum_probs=137.3

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ++|...++||+|+||.||+|+. .+|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4688889999999999999986 569999999997666566788999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      ++|+|.+++.+    ..+++..+..++.||+.||.|||+++   |+||||||+||||+.++++||+|||+++.+..+.
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            99999998854    35899999999999999999999985   9999999999999999999999999999886554

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=9.8e-33  Score=264.90  Aligned_cols=151  Identities=34%  Similarity=0.578  Sum_probs=133.8

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|...++||+|+||.||+|+++++..||||+++... ...++|.+|+.++.+++|||||+++|++. .+..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence            5677788999999999999999888999999997543 34678999999999999999999999875 456799999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +|+|.+++... ....++|..++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+|+.+..+.
T Consensus        91 ~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence            99999987542 2345999999999999999999999974   9999999999999999999999999999886554

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=2.2e-32  Score=265.99  Aligned_cols=152  Identities=30%  Similarity=0.546  Sum_probs=125.6

Q ss_pred             cCCccccccccccceeEEEEEeCC-C---CEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-G---KEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g---~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...++||+|+||+||+|++.. +   ..||||++... .....++|.+|+.+|++++|||||+++|++...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            346667899999999999998742 3   25899998654 445567899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++...  ...++|..++.++.||++||.|||+++   |+||||||+||||++++.+||+|||+++.+..
T Consensus       106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            9999999999988643  345999999999999999999999974   99999999999999999999999999998865


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      +.
T Consensus       181 ~~  182 (299)
T d1jpaa_         181 DT  182 (299)
T ss_dssp             --
T ss_pred             CC
Confidence            54

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-31  Score=254.71  Aligned_cols=151  Identities=28%  Similarity=0.500  Sum_probs=137.2

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|+..++||+|+||.||+|+++++++||||.++... ...++|.+|+.++.+++||||++++|++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            5678889999999999999999988999999997644 346789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +|+|..++...  ...+++..+++++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+....
T Consensus        83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            99999997543  345899999999999999999999975   9999999999999999999999999999876554

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2e-32  Score=264.57  Aligned_cols=150  Identities=27%  Similarity=0.461  Sum_probs=136.4

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      +.|+..++||+|+||.||+|+. .++..||||+++.......+.|.+|++++++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4577788999999999999996 568999999998776677788999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      ++|+|.+++.+.  ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++++||+|||+|+.+..
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            999999987542  345999999999999999999999985   99999999999999999999999999987643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.7e-32  Score=261.15  Aligned_cols=162  Identities=28%  Similarity=0.427  Sum_probs=137.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+|+. .+++.||||.+...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4688889999999999999997 56899999998642   2344678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|.+++..   ...+++.....++.|++.||+|||+.+   |+||||||+||||++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999998854   346999999999999999999999985   999999999999999999999999999998765


Q ss_pred             CCCcCccccccC
Q 043262          501 QSEANTKRIVGT  512 (512)
Q Consensus       501 ~~~~~~~~~~Gt  512 (512)
                      .........+||
T Consensus       162 ~~~~~~~~~~GT  173 (288)
T d1uu3a_         162 SKQARANSFVGT  173 (288)
T ss_dssp             --------CCCC
T ss_pred             CcccccccccCC
Confidence            544444445666

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-31  Score=255.19  Aligned_cols=151  Identities=30%  Similarity=0.449  Sum_probs=135.1

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+|+. .+++.||||.+...   .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4678889999999999999997 46889999998642   2344678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|.+++..   ...+++.....++.||+.||.|||+++   |+||||||+||||++++.+||+|||+|+....+
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999954   345999999999999999999999975   999999999999999999999999999887654


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       160 ~  160 (263)
T d2j4za1         160 R  160 (263)
T ss_dssp             C
T ss_pred             c
Confidence            3

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.7e-32  Score=266.58  Aligned_cols=151  Identities=25%  Similarity=0.342  Sum_probs=135.1

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .++|+..++||+|+||.||+|+. .+|+.||+|+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46788889999999999999996 56899999999754 33445689999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |+++|+|.+++.+.   ..+++..+..++.|++.||.|||+..  +|+||||||+||||++++++||+|||+|+.+..
T Consensus        85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            99999999999643   35899999999999999999999741  499999999999999999999999999998754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.4e-32  Score=258.47  Aligned_cols=157  Identities=28%  Similarity=0.438  Sum_probs=126.5

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEe--CCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ--ENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv  419 (512)
                      ++|+..+.||+|+||.||+|+. .+|+.||||.+...  .....+.|.+|+.++.+++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5688889999999999999986 56899999999754  33446679999999999999999999999975  4557999


Q ss_pred             EEecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          420 YEYMPNKSLNVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDS--RLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      |||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+  ..+|+||||||+||||++++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999986432 2356999999999999999999999864  23599999999999999999999999999998


Q ss_pred             cCCCC
Q 043262          497 FGGNQ  501 (512)
Q Consensus       497 ~~~~~  501 (512)
                      +..+.
T Consensus       164 ~~~~~  168 (269)
T d2java1         164 LNHDT  168 (269)
T ss_dssp             C----
T ss_pred             cccCC
Confidence            86544

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-31  Score=258.74  Aligned_cols=151  Identities=30%  Similarity=0.526  Sum_probs=130.8

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMP  424 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~  424 (512)
                      ++|+..++||+|+||+||+|+++++.+||||+++... ...+.|.+|+.++.+++|||||+++|++. .++.++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            5688899999999999999999888899999997543 44678999999999999999999999985 567899999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          425 NKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +|+|..++... ....++|..++.|+.||+.||.|||+.+   |+||||||+||||++++++||+|||+++.+..+.
T Consensus        95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            99999988653 2345999999999999999999999975   9999999999999999999999999999886554

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.7e-31  Score=253.16  Aligned_cols=150  Identities=30%  Similarity=0.416  Sum_probs=128.9

Q ss_pred             ccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEe----CCeeEEEE
Q 043262          348 SDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ----ENESLLIY  420 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~  420 (512)
                      ...++||+|+||.||+|+. .++..||+|.+...  .....+.|.+|+++|++++|||||++++++..    .+..++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            4556899999999999997 46889999998643  34456789999999999999999999999875    34579999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec-CCCceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~-~~~~~kl~DFGla~~~~~  499 (512)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999954   346899999999999999999999874 4599999999999996 578999999999997654


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      ..
T Consensus       168 ~~  169 (270)
T d1t4ha_         168 SF  169 (270)
T ss_dssp             TS
T ss_pred             Cc
Confidence            43

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3e-31  Score=256.01  Aligned_cols=152  Identities=30%  Similarity=0.568  Sum_probs=127.8

Q ss_pred             cCCccccccccccceeEEEEEeCCC-----CEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADG-----KEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g-----~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      +.|+..++||+|+||.||+|.+++.     ..||||+++.. ......+|.+|+.++.+++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4567788999999999999987542     36999999654 33445679999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ||||+.+|+|.+++...  ...++|..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999888653  346999999999999999999999974   9999999999999999999999999999876


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      .+.
T Consensus       162 ~~~  164 (283)
T d1mqba_         162 DDP  164 (283)
T ss_dssp             ---
T ss_pred             CCC
Confidence            543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.8e-31  Score=255.06  Aligned_cols=150  Identities=28%  Similarity=0.531  Sum_probs=129.6

Q ss_pred             CCcccc-ccccccceeEEEEEeC---CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          346 HFSDEN-KLGEGGFGPVYKGKLA---DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       346 ~~~~~~-~lg~G~fG~Vy~~~~~---~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      +|...+ +||+|+||.||+|.+.   ++..||||.++... ....++|.+|+++|.+++|||||+++|++. .+..++||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-cCeEEEEE
Confidence            444455 4999999999999863   35579999997543 445678999999999999999999999986 45689999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus        88 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          88 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             ECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence            999999999998543  346999999999999999999999974   999999999999999999999999999988655


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       163 ~  163 (285)
T d1u59a_         163 D  163 (285)
T ss_dssp             S
T ss_pred             c
Confidence            4

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.4e-31  Score=261.88  Aligned_cols=165  Identities=27%  Similarity=0.418  Sum_probs=135.3

Q ss_pred             cCCccccccccccceeEEEEEeCC-C-----CEEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-G-----KEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g-----~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  416 (512)
                      ++|...++||+|+||.||+|++.. +     ..||||.+... .......|.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            568888999999999999998642 2     26899998643 334456899999999998 899999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCC
Q 043262          417 LLIYEYMPNKSLNVFLFDSTR--------------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTS  476 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~  476 (512)
                      ++||||+++|+|.++|+....                    ...++|..++.++.||+.||.|||+++   ||||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence            999999999999999965422                    235899999999999999999999974   999999999


Q ss_pred             CeeecCCCceEEeccCcccccCCCCCCcCccccccC
Q 043262          477 NVLLDHEMNPKISDFGMARIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       477 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt  512 (512)
                      |||++.++.+||+|||+|+...............||
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt  229 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP  229 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence            999999999999999999987665543333333443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.97  E-value=9.8e-31  Score=259.37  Aligned_cols=152  Identities=26%  Similarity=0.450  Sum_probs=137.5

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ++|...++||+|+||.||+|+. .+|+.||||++........+.+.+|+.++.+++|||||++++++.+.+..++||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5788899999999999999986 568999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC--CCceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH--EMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~--~~~~kl~DFGla~~~~~~~  501 (512)
                      ++|+|.+++.+.  ...+++..+..|+.||+.||.|||+++   |+||||||+||||+.  ++.+||+|||+++.+....
T Consensus       106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            999999998542  345999999999999999999999985   999999999999954  5789999999999887654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=6e-31  Score=256.56  Aligned_cols=151  Identities=31%  Similarity=0.555  Sum_probs=133.9

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc---ccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ..|+..++||+|+||.||+|+. .+++.||||+++....   ...+.|.+|+.++.+++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3578889999999999999986 5688999999975432   33567999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||++++.+||+|||+|+.....
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            99999999877643   346999999999999999999999985   999999999999999999999999999987654


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       169 ~  169 (309)
T d1u5ra_         169 N  169 (309)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.97  E-value=1.4e-30  Score=258.52  Aligned_cols=152  Identities=25%  Similarity=0.395  Sum_probs=137.3

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      ++|...++||+|+||.||+|+. .+|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5688899999999999999996 579999999998766566678999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec--CCCceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD--HEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~--~~~~~kl~DFGla~~~~~~~  501 (512)
                      ++|+|.+++..  ....+++.....|+.||+.||.|||+.+   |+||||||+||||+  .++.+||+|||+|+.+..+.
T Consensus       109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999887743  3346999999999999999999999975   99999999999998  67899999999999987654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.5e-31  Score=253.10  Aligned_cols=145  Identities=31%  Similarity=0.515  Sum_probs=125.6

Q ss_pred             cccccccceeEEEEEeCC---CCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEecCC
Q 043262          351 NKLGEGGFGPVYKGKLAD---GKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYMPN  425 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~---g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~~~  425 (512)
                      ++||+|+||.||+|.+++   ++.||||+++..  +....++|.+|+.++++++|||||+++|++. .+..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence            579999999999998643   467999999643  2334578999999999999999999999985 4567899999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCCC
Q 043262          426 KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  502 (512)
Q Consensus       426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~  502 (512)
                      |+|.+++...   ..++|..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus        92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            9999999643   45999999999999999999999974   99999999999999999999999999998865543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=3.1e-31  Score=258.37  Aligned_cols=155  Identities=32%  Similarity=0.546  Sum_probs=135.8

Q ss_pred             hcCCccccccccccceeEEEEEeC------CCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      .++|...++||+|+||.||+|++.      +++.||||+++... ....++|.+|+.++++++||||+++++++...+..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            467888999999999999999863      45789999997543 33467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCC
Q 043262          417 LLIYEYMPNKSLNVFLFDST---------------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKT  475 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~  475 (512)
                      +++|||+++|+|.+++....                     ....+++..++.|+.|++.||+|||+.+   ||||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence            99999999999999996422                     1235899999999999999999999974   99999999


Q ss_pred             CCeeecCCCceEEeccCcccccCCCC
Q 043262          476 SNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       476 ~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      +||||+.++.+||+|||+++.+.++.
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~  194 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSAD  194 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred             cceEECCCCcEEEccchhheeccCCc
Confidence            99999999999999999999875544

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=1.3e-30  Score=250.17  Aligned_cols=151  Identities=28%  Similarity=0.418  Sum_probs=135.2

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc---------ccHHHHHHHHHHHhcCC-CCccccceeeEEeC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG---------QGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQE  413 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~---------~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~  413 (512)
                      ++|...+.||+|+||+||+++. .+++.||||+++....         ...+.+.+|+.++.+++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5788899999999999999986 5789999999965421         12346889999999997 99999999999999


Q ss_pred             CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          414 NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      +..+|||||+++|+|.++|..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999964   346999999999999999999999975   99999999999999999999999999


Q ss_pred             ccccCCCC
Q 043262          494 ARIFGGNQ  501 (512)
Q Consensus       494 a~~~~~~~  501 (512)
                      ++.+..+.
T Consensus       157 a~~~~~~~  164 (277)
T d1phka_         157 SCQLDPGE  164 (277)
T ss_dssp             CEECCTTC
T ss_pred             eeEccCCC
Confidence            99887654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-30  Score=256.72  Aligned_cols=160  Identities=25%  Similarity=0.322  Sum_probs=139.6

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...+.||+|+||.||+++. .+|+.||||++++.   .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5688889999999999999996 57999999999643   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|.+++..   ...+++.....++.||+.||.|||+++   |+||||||+||||++++.+||+|||+|+.+...
T Consensus        85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999854   345899999999999999999999985   999999999999999999999999999987544


Q ss_pred             CCCcCccccccC
Q 043262          501 QSEANTKRIVGT  512 (512)
Q Consensus       501 ~~~~~~~~~~Gt  512 (512)
                      ...  ....+||
T Consensus       159 ~~~--~~~~~GT  168 (337)
T d1o6la_         159 GAT--MKTFCGT  168 (337)
T ss_dssp             TCC--BCCCEEC
T ss_pred             Ccc--cccceeC
Confidence            322  2335665

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.3e-30  Score=254.10  Aligned_cols=152  Identities=23%  Similarity=0.338  Sum_probs=122.5

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      .+.|...++||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.++.+++|||||++++++.+.+..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            35688889999999999999997 468999999997543 2334568899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec---CCCceEEeccCcccccC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFG  498 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~---~~~~~kl~DFGla~~~~  498 (512)
                      |+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||+.   +++.+||+|||+++...
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999954   346999999999999999999999985   99999999999994   57899999999999876


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      .+.
T Consensus       162 ~~~  164 (307)
T d1a06a_         162 PGS  164 (307)
T ss_dssp             ---
T ss_pred             CCC
Confidence            554

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.4e-30  Score=248.52  Aligned_cols=152  Identities=27%  Similarity=0.424  Sum_probs=135.2

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC------cccHHHHHHHHHHHhcCCCCccccceeeEEeCCee
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS------GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENES  416 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  416 (512)
                      .++|...++||+|+||.||+|+. .+|+.||||+++...      ....+.|.+|+.+|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            35788899999999999999997 578999999986432      23467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC----ceEEeccC
Q 043262          417 LLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM----NPKISDFG  492 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~----~~kl~DFG  492 (512)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999999542   46999999999999999999999985   99999999999998776    49999999


Q ss_pred             cccccCCCC
Q 043262          493 MARIFGGNQ  501 (512)
Q Consensus       493 la~~~~~~~  501 (512)
                      +++.+..+.
T Consensus       163 ~a~~~~~~~  171 (293)
T d1jksa_         163 LAHKIDFGN  171 (293)
T ss_dssp             TCEECTTSC
T ss_pred             hhhhcCCCc
Confidence            999886543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=3.8e-30  Score=251.74  Aligned_cols=150  Identities=27%  Similarity=0.400  Sum_probs=134.6

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||+||+++. .+|+.||||+++..   .....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4678889999999999999996 56999999999643   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+++|+|..++..   ...+++.....++.||+.||.|||+++   |+||||||+||||++++.+||+|||+|+.+...
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999998854   345788899999999999999999975   999999999999999999999999999987644

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.4e-30  Score=251.93  Aligned_cols=162  Identities=31%  Similarity=0.528  Sum_probs=131.1

Q ss_pred             cCCccccccccccceeEEEEEeC-CCC----EEEEEEccc-CCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGK----EIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~----~vaVK~l~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  418 (512)
                      .+|+..++||+|+||.||+|++. +|+    +||||+++. .+....++|.+|+.++++++|||||+++|++.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35788899999999999999864 443    589999864 3445678899999999999999999999999865 5678


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++||+.+|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            89999999999988653  356999999999999999999999974   9999999999999999999999999999987


Q ss_pred             CCCCCcCccccccC
Q 043262          499 GNQSEANTKRIVGT  512 (512)
Q Consensus       499 ~~~~~~~~~~~~Gt  512 (512)
                      .+.....+....||
T Consensus       163 ~~~~~~~~~~~~gt  176 (317)
T d1xkka_         163 AEEKEYHAEGGKVP  176 (317)
T ss_dssp             TTCC--------CC
T ss_pred             cccccccccccccC
Confidence            66554444444454

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.2e-30  Score=251.83  Aligned_cols=155  Identities=29%  Similarity=0.492  Sum_probs=135.4

Q ss_pred             cCCccccccccccceeEEEEEeC------CCCEEEEEEcccC-CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++|...++||+|+||.||+|.+.      ++..||||+++.. .......|.+|+.++.+++||||++++|++...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            56778899999999999999863      3578999999754 3344567999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEec
Q 043262          418 LIYEYMPNKSLNVFLFDS-------TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD  490 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~D  490 (512)
                      +||||+++|+|.+++...       .....+++..+..++.|+++||.|||++.   |+||||||+||||++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence            999999999999998642       22345799999999999999999999974   99999999999999999999999


Q ss_pred             cCcccccCCCCC
Q 043262          491 FGMARIFGGNQS  502 (512)
Q Consensus       491 FGla~~~~~~~~  502 (512)
                      ||+++.+.....
T Consensus       177 FGla~~~~~~~~  188 (308)
T d1p4oa_         177 FGMTRDIYETDY  188 (308)
T ss_dssp             TTCCCGGGGGGC
T ss_pred             cccceeccCCcc
Confidence            999998765543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.8e-29  Score=244.18  Aligned_cols=147  Identities=32%  Similarity=0.560  Sum_probs=128.2

Q ss_pred             ccccccccceeEEEEEeCCC----CEEEEEEccc-CCcccHHHHHHHHHHHhcCCCCccccceeeEEeC-CeeEEEEEec
Q 043262          350 ENKLGEGGFGPVYKGKLADG----KEIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE-NESLLIYEYM  423 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~~~g----~~vaVK~l~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lv~E~~  423 (512)
                      .++||+|+||+||+|++.+.    ..||||+++. .+....++|.+|++++.+++||||++++|++.+. +..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999997442    2589999974 3445568899999999999999999999998864 5789999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      ++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++......
T Consensus       112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            999999998653  345788999999999999999999974   9999999999999999999999999999876553

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.2e-30  Score=248.10  Aligned_cols=165  Identities=25%  Similarity=0.390  Sum_probs=128.8

Q ss_pred             cCCccccccccccceeEEEEEeC------CCCEEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCC-e
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQEN-E  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~------~g~~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~-~  415 (512)
                      ++|...++||+|+||.||+|+..      +++.||||+++.. .....+.+..|...+.++ +|+||+.+++++.+.+ .
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            56888899999999999999853      3468999999754 334466788888888777 6899999999987654 5


Q ss_pred             eEEEEEecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH  482 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~  482 (512)
                      .++||||+++|+|.++++....             ...+++..++.++.||++||.|||+++   |+||||||+||||++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence            8999999999999999965321             235899999999999999999999974   999999999999999


Q ss_pred             CCceEEeccCcccccCCCCCCcCccccccC
Q 043262          483 EMNPKISDFGMARIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       483 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt  512 (512)
                      ++++||+|||+|+..........++...||
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt  199 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLP  199 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred             CCcEEEccCcchhhccccccccccCceeeC
Confidence            999999999999988766554444445564

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.2e-29  Score=247.76  Aligned_cols=153  Identities=32%  Similarity=0.564  Sum_probs=131.7

Q ss_pred             cCCccccccccccceeEEEEEeCC-CC--EEEEEEcccC-CcccHHHHHHHHHHHhcC-CCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD-GK--EIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~-g~--~vaVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|+..++||+|+||.||+|++.+ +.  .||||+++.. .....++|.+|+++|.++ +|||||+++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            567888999999999999998753 43  5788888643 444567899999999998 799999999999999999999


Q ss_pred             EEecCCCChhHHhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCce
Q 043262          420 YEYMPNKSLNVFLFDS-------------TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNP  486 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~  486 (512)
                      |||+++|+|.++|+..             .....++|..+++++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999653             23457999999999999999999999974   9999999999999999999


Q ss_pred             EEeccCcccccCCC
Q 043262          487 KISDFGMARIFGGN  500 (512)
Q Consensus       487 kl~DFGla~~~~~~  500 (512)
                      ||+|||+++.....
T Consensus       167 kl~DfG~a~~~~~~  180 (309)
T d1fvra_         167 KIADFGLSRGQEVY  180 (309)
T ss_dssp             EECCTTCEESSCEE
T ss_pred             EEcccccccccccc
Confidence            99999999876543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.6e-29  Score=246.22  Aligned_cols=149  Identities=28%  Similarity=0.432  Sum_probs=125.5

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHH--HHHHHHhcCCCCccccceeeEEeCC----eeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFK--NEVTLIAKLQHKNLVRLLGCCLQEN----ESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~--~E~~~l~~l~H~nIv~l~g~~~~~~----~~~l  418 (512)
                      +.|...++||+|+||.||+|++ +|+.||||+++...   .+++.  .|+..+..++|||||+++|++...+    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            3456678899999999999998 58899999986432   23443  4555566789999999999998764    5799


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-----SRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      ||||+++|+|.++|++    ..++|..++.++.|++.||.|||+.     ..++|+||||||+||||++++.+||+|||+
T Consensus        79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            9999999999999965    2589999999999999999999974     124799999999999999999999999999


Q ss_pred             ccccCCCC
Q 043262          494 ARIFGGNQ  501 (512)
Q Consensus       494 a~~~~~~~  501 (512)
                      ++.+....
T Consensus       155 ~~~~~~~~  162 (303)
T d1vjya_         155 AVRHDSAT  162 (303)
T ss_dssp             CEEEETTT
T ss_pred             cccccCCC
Confidence            99885543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.6e-30  Score=244.18  Aligned_cols=152  Identities=32%  Similarity=0.453  Sum_probs=123.9

Q ss_pred             cCCccccccccccceeEEEEEeC--CC--CEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA--DG--KEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~--~g--~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++|+..+.||+|+||.||+|++.  ++  .+||||++...   .....++|.+|+.++.+++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            45778889999999999999863  23  36899998643   33446789999999999999999999999965 5678


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            999999999999887643  345999999999999999999999974   999999999999999999999999999988


Q ss_pred             CCCCC
Q 043262          498 GGNQS  502 (512)
Q Consensus       498 ~~~~~  502 (512)
                      .....
T Consensus       162 ~~~~~  166 (273)
T d1u46a_         162 PQNDD  166 (273)
T ss_dssp             CC-CC
T ss_pred             ccCCC
Confidence            66543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.7e-29  Score=242.51  Aligned_cols=151  Identities=26%  Similarity=0.415  Sum_probs=122.8

Q ss_pred             cCCccccccccccceeEEEEEeCC----CCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD----GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~----g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...++||+|+||.||+|++..    +..||||.++... ....+.|.+|+.++++++|||||+++|++. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            467788999999999999998642    3468999987543 344678999999999999999999999985 5678999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        86 ~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          86 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence            9999999999987543  346899999999999999999999985   99999999999999999999999999998765


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      ..
T Consensus       161 ~~  162 (273)
T d1mp8a_         161 ST  162 (273)
T ss_dssp             --
T ss_pred             Cc
Confidence            43

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=2.1e-29  Score=249.89  Aligned_cols=150  Identities=25%  Similarity=0.343  Sum_probs=135.3

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ++|...++||+|+||.||+++. .+|+.||||++...   .....+.+.+|+.+|+.++|||||++++++...+..++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4688889999999999999987 57999999998642   2344678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      ||+.+|+|..++...   ..+++.....++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+...
T Consensus       121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999998543   35899999999999999999999975   999999999999999999999999999988654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.1e-29  Score=244.36  Aligned_cols=152  Identities=21%  Similarity=0.349  Sum_probs=134.0

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      .++|...+.||+|+||.||+|+. .+++.||||.++.... ....+.+|+.+|..++|||||++++++.+.+..++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            36788899999999999999987 4688999999976432 345688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCC--CceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHE--MNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~--~~~kl~DFGla~~~~~~  500 (512)
                      +++|+|.+++...  ...+++.....|+.||+.||.|||+++   |+||||||+|||++.+  ..+||+|||+++.+..+
T Consensus        83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            9999999999542  346999999999999999999999975   9999999999999854  58999999999987654


Q ss_pred             C
Q 043262          501 Q  501 (512)
Q Consensus       501 ~  501 (512)
                      .
T Consensus       158 ~  158 (321)
T d1tkia_         158 D  158 (321)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=2.7e-29  Score=250.39  Aligned_cols=151  Identities=26%  Similarity=0.334  Sum_probs=130.6

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHH---HHHHHHHhcCCCCccccceeeEEeCCeeE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEF---KNEVTLIAKLQHKNLVRLLGCCLQENESL  417 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~---~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  417 (512)
                      ++|...++||+|+||.||+|+. .+|+.||||++....   ......+   ..|+.++..++|||||++++++...+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5788899999999999999996 469999999985321   1222333   34577888889999999999999999999


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccccc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  497 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~  497 (512)
                      +||||+++|+|.++|...   ..+++..+..++.||+.||.|||+++   |+||||||+||||++++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999999643   45889999999999999999999985   999999999999999999999999999988


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ....
T Consensus       158 ~~~~  161 (364)
T d1omwa3         158 SKKK  161 (364)
T ss_dssp             SSSC
T ss_pred             CCCc
Confidence            6554

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.8e-29  Score=246.84  Aligned_cols=165  Identities=30%  Similarity=0.434  Sum_probs=139.8

Q ss_pred             cCCccccccccccceeEEEEEe------CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeCCee
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQENES  416 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~------~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  416 (512)
                      ++|...++||+|+||.||+|++      .++..||||+++... .....+|.+|+.++.++ +|||||+++|++.+.+..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            5677789999999999999985      345689999997543 34456899999999999 699999999999999999


Q ss_pred             EEEEEecCCCChhHHhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec
Q 043262          417 LLIYEYMPNKSLNVFLFDST---------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD  481 (512)
Q Consensus       417 ~lv~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~  481 (512)
                      ++||||+++|+|.++++...               ....+++..++.++.||+.||.|||+++   ++||||||+|||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence            99999999999999997532               2236899999999999999999999985   99999999999999


Q ss_pred             CCCceEEeccCcccccCCCCCCcCccccccC
Q 043262          482 HEMNPKISDFGMARIFGGNQSEANTKRIVGT  512 (512)
Q Consensus       482 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt  512 (512)
                      .++.+||+|||+++.+.............||
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt  210 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLP  210 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred             ccCcccccccchheeccCCCcceEeeecccC
Confidence            9999999999999988765544433334443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.6e-30  Score=242.46  Aligned_cols=150  Identities=29%  Similarity=0.492  Sum_probs=125.1

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeC-CeeEEEEEec
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE-NESLLIYEYM  423 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lv~E~~  423 (512)
                      ++|+..++||+|+||.||+|+++ |.+||||+++..  ...++|.+|++++++++||||++++|++.+. +..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            45677889999999999999995 789999999754  3457899999999999999999999999764 5689999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      ++|+|.++|... ....++|..++.|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~  157 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  157 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC
Confidence            999999999642 223589999999999999999999997   49999999999999999999999999999875443

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.6e-29  Score=243.29  Aligned_cols=152  Identities=30%  Similarity=0.521  Sum_probs=130.1

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|...++||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5788889999999999999996 678999999996432  2335789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      |+.++.+. ++.. .....+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+....+.
T Consensus        82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99765444 4422 23446999999999999999999999985   9999999999999999999999999999876544

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.2e-29  Score=244.72  Aligned_cols=151  Identities=25%  Similarity=0.399  Sum_probs=132.4

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC---CcccHHHHHHHHHHHh-cCCCCccccceeeEEeCCeeEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIA-KLQHKNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lv  419 (512)
                      ++|...++||+|+||+||+|+. .+++.||||+++..   .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            4678889999999999999987 46899999999643   2344566777777765 68999999999999999999999


Q ss_pred             EEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCC
Q 043262          420 YEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  499 (512)
Q Consensus       420 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~  499 (512)
                      |||+++|+|.+++..   ...+++.....++.||+.||.|||+++   |+||||||+|||+++++++||+|||+++.+..
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999964   345899999999999999999999985   99999999999999999999999999997765


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      ..
T Consensus       156 ~~  157 (320)
T d1xjda_         156 GD  157 (320)
T ss_dssp             TT
T ss_pred             cc
Confidence            43

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.96  E-value=4.3e-29  Score=241.36  Aligned_cols=150  Identities=27%  Similarity=0.479  Sum_probs=134.2

Q ss_pred             cCCccccccccccceeEEEEEeCCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|+||+||+|+.++|+.||||++....  ....+.+.+|+.+|++++||||+++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788889999999999999999999999999996543  33367899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  500 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~  500 (512)
                      +.++.+..+..   ....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++..+...
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            98887777663   3356999999999999999999999974   999999999999999999999999999987644

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.2e-29  Score=243.04  Aligned_cols=146  Identities=29%  Similarity=0.458  Sum_probs=125.1

Q ss_pred             ccccccccceeEEEEEe-CCCCEEEEEEcccCCccc-----HHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEEec
Q 043262          350 ENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQG-----LQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYEYM  423 (512)
Q Consensus       350 ~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E~~  423 (512)
                      .++||+|+||+||+|+. .+|+.||||+++......     .+.+.+|+.++.+++|||||++++++...+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            46899999999999996 568999999996443221     346889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          424 PNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      .++++..+..   ....+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.+....
T Consensus        83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            9988776653   3456888999999999999999999985   9999999999999999999999999999876544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.2e-29  Score=242.81  Aligned_cols=164  Identities=31%  Similarity=0.448  Sum_probs=133.6

Q ss_pred             cCCccccccccccceeEEEEEeCC--------CCEEEEEEcccCC-cccHHHHHHHHHHHhcC-CCCccccceeeEEeCC
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLAD--------GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLQEN  414 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~~--------g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  414 (512)
                      ++|...++||+|+||.||+|+...        +..||||+++... .....++.+|...+.++ +|||||++++++.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            567778999999999999998532        3479999997544 34467899999999888 8999999999999999


Q ss_pred             eeEEEEEecCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec
Q 043262          415 ESLLIYEYMPNKSLNVFLFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD  481 (512)
Q Consensus       415 ~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~  481 (512)
                      ..++||||+++|+|.+++....             ....+++..++.++.||+.||.|||+.+   ||||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence            9999999999999999996532             1246899999999999999999999985   99999999999999


Q ss_pred             CCCceEEeccCcccccCCCCCCcCcccccc
Q 043262          482 HEMNPKISDFGMARIFGGNQSEANTKRIVG  511 (512)
Q Consensus       482 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~G  511 (512)
                      .++.+||+|||+++..........+....|
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  199 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRL  199 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred             CCCCeEeccchhhccccccccccccccCCC
Confidence            999999999999998866554444333444

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.95  E-value=1.3e-28  Score=236.71  Aligned_cols=151  Identities=25%  Similarity=0.389  Sum_probs=131.9

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC---cccHHHHHHHHHHHhcCCCCccccceeeEEeCCe----
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENE----  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----  415 (512)
                      .++|...+.||+|+||.||+|+. .+|+.||||.++...   ....+.|.+|+.+++.++||||+++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36788899999999999999986 578999999997543   2335679999999999999999999999987543    


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++||||+++|+|.+++..   ...+++.....++.||+.||.|||+++   |+||||||+||||+.++..+|+|||+++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999998854   345999999999999999999999975   9999999999999999999999999998


Q ss_pred             ccCCC
Q 043262          496 IFGGN  500 (512)
Q Consensus       496 ~~~~~  500 (512)
                      .....
T Consensus       160 ~~~~~  164 (277)
T d1o6ya_         160 AIADS  164 (277)
T ss_dssp             ECC--
T ss_pred             hhccc
Confidence            76443

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.3e-28  Score=238.32  Aligned_cols=148  Identities=24%  Similarity=0.311  Sum_probs=126.1

Q ss_pred             cCCccc-cccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhc-CCCCccccceeeEEe----CCeeE
Q 043262          345 QHFSDE-NKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAK-LQHKNLVRLLGCCLQ----ENESL  417 (512)
Q Consensus       345 ~~~~~~-~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~----~~~~~  417 (512)
                      ++|... +.||+|+||.||+|+. .+++.||||+++..     ..+.+|+.++.+ .+|||||++++++..    .+..+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            467665 4599999999999986 67899999998643     457789988665 589999999999865    45689


Q ss_pred             EEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC---CCceEEeccCcc
Q 043262          418 LIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGMA  494 (512)
Q Consensus       418 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~---~~~~kl~DFGla  494 (512)
                      +||||+++|+|.+++... ....+++.....|+.||+.||.|||+.+   |+||||||+|||+++   ++.+||+|||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            999999999999999652 2346999999999999999999999985   999999999999986   467999999999


Q ss_pred             cccCCCC
Q 043262          495 RIFGGNQ  501 (512)
Q Consensus       495 ~~~~~~~  501 (512)
                      +.+....
T Consensus       162 ~~~~~~~  168 (335)
T d2ozaa1         162 KETTSHN  168 (335)
T ss_dssp             EECCCCC
T ss_pred             eeccCCC
Confidence            9886654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-27  Score=238.19  Aligned_cols=149  Identities=30%  Similarity=0.442  Sum_probs=124.1

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccccceeeEEeC------CeeEE
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE------NESLL  418 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~l  418 (512)
                      .|...++||+|+||+||+|+. .+|+.||||++......    +.+|+.+|++++||||+++++++...      ...+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            467778999999999999997 46899999999754432    34799999999999999999998653      24689


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-ceEEeccCccccc
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIF  497 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DFGla~~~  497 (512)
                      ||||++++.+..+.........+++..+..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755544432234457999999999999999999999875   99999999999999764 8999999999988


Q ss_pred             CCCC
Q 043262          498 GGNQ  501 (512)
Q Consensus       498 ~~~~  501 (512)
                      ..+.
T Consensus       174 ~~~~  177 (350)
T d1q5ka_         174 VRGE  177 (350)
T ss_dssp             CTTS
T ss_pred             cCCc
Confidence            6554

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.9e-28  Score=233.71  Aligned_cols=150  Identities=25%  Similarity=0.383  Sum_probs=128.2

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCc------ccHHHHHHHHHHHhcCC--CCccccceeeEEeCCe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSG------QGLQEFKNEVTLIAKLQ--HKNLVRLLGCCLQENE  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~  415 (512)
                      ++|...++||+|+||.||+|+. .+|+.||||++.....      ....++.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5788899999999999999996 5789999999864321      11234678999999986  8999999999999999


Q ss_pred             eEEEEEecCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-CCceEEeccCc
Q 043262          416 SLLIYEYMPN-KSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGM  493 (512)
Q Consensus       416 ~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DFGl  493 (512)
                      .++||||+.+ +++.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 677777743   345999999999999999999999975   999999999999985 47999999999


Q ss_pred             ccccCCC
Q 043262          494 ARIFGGN  500 (512)
Q Consensus       494 a~~~~~~  500 (512)
                      |+.....
T Consensus       158 a~~~~~~  164 (273)
T d1xwsa_         158 GALLKDT  164 (273)
T ss_dssp             CEECCSS
T ss_pred             ceecccc
Confidence            9976543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.5e-27  Score=236.50  Aligned_cols=150  Identities=25%  Similarity=0.427  Sum_probs=126.9

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC-cccHHHHHHHHHHHhcCCCCccccceeeEEeCC----eeEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN----ESLL  418 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~l  418 (512)
                      .+|...++||+|+||+||+|+. .+|+.||||++.... ....+.+++|+.+|..++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            5688889999999999999985 679999999997543 344668999999999999999999999997653    2355


Q ss_pred             EEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccC
Q 043262          419 IYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  498 (512)
Q Consensus       419 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~  498 (512)
                      ++||+.+|+|.+++..    ..+++..+..++.||+.||+|||+++   ||||||||+||||++++.+||+|||+++...
T Consensus        88 l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            6677789999999954    35899999999999999999999985   9999999999999999999999999999875


Q ss_pred             CCC
Q 043262          499 GNQ  501 (512)
Q Consensus       499 ~~~  501 (512)
                      ...
T Consensus       161 ~~~  163 (345)
T d1pmea_         161 PDH  163 (345)
T ss_dssp             GGG
T ss_pred             CCC
Confidence            543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.5e-27  Score=228.49  Aligned_cols=151  Identities=29%  Similarity=0.463  Sum_probs=134.9

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeCCeeEEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQENESLLIYE  421 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~E  421 (512)
                      ++|+..++||+|+||+||+|+. .+++.||||+++...  ....+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5788889999999999999996 578899999986432  3346789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCcccccCCCC
Q 043262          422 YMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  501 (512)
Q Consensus       422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~  501 (512)
                      ++.+++|..++..   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            9999999888743   346889999999999999999999975   9999999999999999999999999999876543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.94  E-value=4.5e-27  Score=231.61  Aligned_cols=145  Identities=24%  Similarity=0.422  Sum_probs=127.2

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceeeEEeC--CeeEEEE
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQE--NESLLIY  420 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lv~  420 (512)
                      ++|...++||+|+||+||+|+. .+++.||||+++..   ..+++.+|+.+|..++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5788899999999999999996 57899999998653   3567899999999995 99999999998754  5589999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCC-ceEEeccCcccccCC
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGG  499 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DFGla~~~~~  499 (512)
                      ||+.+++|..+.      ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++.+..
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997764      24899999999999999999999985   99999999999998654 699999999998865


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      +.
T Consensus       183 ~~  184 (328)
T d3bqca1         183 GQ  184 (328)
T ss_dssp             TC
T ss_pred             CC
Confidence            54

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-26  Score=227.71  Aligned_cols=150  Identities=25%  Similarity=0.509  Sum_probs=127.0

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEe--------C
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQ--------E  413 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------~  413 (512)
                      ++|+..++||+|+||+||+|+. .+|+.||||++...  .....+.+.+|+.+|++++||||+++++.+..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6788899999999999999996 57999999998543  33445778999999999999999999999865        3


Q ss_pred             CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCc
Q 043262          414 NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  493 (512)
Q Consensus       414 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGl  493 (512)
                      +..++||||++++.+..+.   .....++......++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            4579999999988776554   23345888999999999999999999975   99999999999999999999999999


Q ss_pred             ccccCCC
Q 043262          494 ARIFGGN  500 (512)
Q Consensus       494 a~~~~~~  500 (512)
                      ++.+...
T Consensus       164 ~~~~~~~  170 (318)
T d3blha1         164 ARAFSLA  170 (318)
T ss_dssp             CEECCC-
T ss_pred             eeecccc
Confidence            9887644

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=9.3e-27  Score=231.07  Aligned_cols=149  Identities=28%  Similarity=0.474  Sum_probs=123.9

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeCC------e
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQEN------E  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~  415 (512)
                      ++|...++||+|+||.||+|+. .+|+.||||+++..  +....+.+.+|+.+|+.++|||||++++++...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            5788889999999999999996 56999999999753  3334567899999999999999999999998665      4


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++||||+ +.+|..+...    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        98 ~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence            69999999 5677776643    35999999999999999999999985   9999999999999999999999999999


Q ss_pred             ccCCCC
Q 043262          496 IFGGNQ  501 (512)
Q Consensus       496 ~~~~~~  501 (512)
                      ......
T Consensus       170 ~~~~~~  175 (346)
T d1cm8a_         170 QADSEM  175 (346)
T ss_dssp             ECCSSC
T ss_pred             ccCCcc
Confidence            876543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.7e-27  Score=229.71  Aligned_cols=151  Identities=25%  Similarity=0.365  Sum_probs=131.9

Q ss_pred             cCCccccccccccceeEEEEEe----CCCCEEEEEEcccC----CcccHHHHHHHHHHHhcCCC-CccccceeeEEeCCe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL----ADGKEIAVKRLSRT----SGQGLQEFKNEVTLIAKLQH-KNLVRLLGCCLQENE  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~----~~g~~vaVK~l~~~----~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~  415 (512)
                      ++|+..++||+|+||+||+|+.    .+|+.||||.++..    .....+.+.+|++++.+++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5688899999999999999985    24789999998643    22335678899999999976 899999999999999


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++++||+.+|+|.+++...   ..+.......++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999998543   34678888999999999999999974   9999999999999999999999999999


Q ss_pred             ccCCCC
Q 043262          496 IFGGNQ  501 (512)
Q Consensus       496 ~~~~~~  501 (512)
                      .+....
T Consensus       178 ~~~~~~  183 (322)
T d1vzoa_         178 EFVADE  183 (322)
T ss_dssp             ECCGGG
T ss_pred             hhcccc
Confidence            875543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.93  E-value=7e-26  Score=219.21  Aligned_cols=148  Identities=20%  Similarity=0.344  Sum_probs=127.4

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCC-CccccceeeEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH-KNLVRLLGCCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lv~E~  422 (512)
                      ++|...++||+|+||.||+|+. .+|+.||||.+.....  ...+.+|++.+..++| +|++.+++++......++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            5788899999999999999996 4689999998864432  2346788888888875 8999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecC-----CCceEEeccCccccc
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDH-----EMNPKISDFGMARIF  497 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~-----~~~~kl~DFGla~~~  497 (512)
                      + +++|.+++...  ...+++.....++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+|+.+
T Consensus        83 ~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          83 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            8 68999888653  345899999999999999999999985   999999999999974     567999999999987


Q ss_pred             CCC
Q 043262          498 GGN  500 (512)
Q Consensus       498 ~~~  500 (512)
                      ...
T Consensus       157 ~~~  159 (293)
T d1csna_         157 RDP  159 (293)
T ss_dssp             BCT
T ss_pred             ccC
Confidence            644

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.6e-26  Score=223.74  Aligned_cols=152  Identities=28%  Similarity=0.466  Sum_probs=123.0

Q ss_pred             hcCCccccccccccceeEEEEEe-CC-CCEEEEEEcccCC--cccHHHHHHHHHHHhcC---CCCccccceeeEEe----
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-AD-GKEIAVKRLSRTS--GQGLQEFKNEVTLIAKL---QHKNLVRLLGCCLQ----  412 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~-g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~----  412 (512)
                      .++|+..++||+|+||.||+|+. .+ ++.||||+++...  ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            36788999999999999999986 34 5679999986432  22233456676666554   89999999999864    


Q ss_pred             -CCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEecc
Q 043262          413 -ENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  491 (512)
Q Consensus       413 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DF  491 (512)
                       ....++++||+.++++......  ....+++.....++.||+.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             2457999999998877655433  3346899999999999999999999985   999999999999999999999999


Q ss_pred             CcccccCCC
Q 043262          492 GMARIFGGN  500 (512)
Q Consensus       492 Gla~~~~~~  500 (512)
                      |+++.....
T Consensus       161 g~~~~~~~~  169 (305)
T d1blxa_         161 GLARIYSFQ  169 (305)
T ss_dssp             CSCCCCCGG
T ss_pred             hhhhhhccc
Confidence            999876544

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=7.5e-26  Score=224.67  Aligned_cols=149  Identities=29%  Similarity=0.423  Sum_probs=125.9

Q ss_pred             hcCCccccccccccceeEEEEEe-CCCCEEEEEEcccCC--cccHHHHHHHHHHHhcCCCCccccceeeEEeC-----Ce
Q 043262          344 TQHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE-----NE  415 (512)
Q Consensus       344 ~~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~  415 (512)
                      .++|...++||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+.+++.++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            35788899999999999999985 579999999997543  33456789999999999999999999998643     34


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++++||+.+|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            5677888899999999843    35999999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCC
Q 043262          496 IFGG  499 (512)
Q Consensus       496 ~~~~  499 (512)
                      ....
T Consensus       170 ~~~~  173 (348)
T d2gfsa1         170 HTDD  173 (348)
T ss_dssp             CCTG
T ss_pred             ccCc
Confidence            7643

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=1.6e-25  Score=217.56  Aligned_cols=149  Identities=23%  Similarity=0.392  Sum_probs=121.9

Q ss_pred             cCCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCcccccee-eEEeCCeeEEEEEe
Q 043262          345 QHFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLLG-CCLQENESLLIYEY  422 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g-~~~~~~~~~lv~E~  422 (512)
                      ++|+..++||+|+||.||+|+. .+|+.||||.+.....  ..++..|++++..++|+|++..++ +..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            4688899999999999999986 5689999998865432  245788999999998887665554 45677788999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeec---CCCceEEeccCcccccCC
Q 043262          423 MPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGG  499 (512)
Q Consensus       423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~---~~~~~kl~DFGla~~~~~  499 (512)
                      +. ++|...+...  ...+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+.+..
T Consensus        85 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cC-Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            84 5665555432  345899999999999999999999985   99999999999875   456799999999998865


Q ss_pred             CC
Q 043262          500 NQ  501 (512)
Q Consensus       500 ~~  501 (512)
                      ..
T Consensus       159 ~~  160 (299)
T d1ckia_         159 AR  160 (299)
T ss_dssp             TT
T ss_pred             cc
Confidence            54

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.8e-25  Score=222.43  Aligned_cols=148  Identities=30%  Similarity=0.466  Sum_probs=120.5

Q ss_pred             cCCccccccccccceeEEEEEeC-CCCEEEEEEcccC--CcccHHHHHHHHHHHhcCCCCccccceeeEEeC------Ce
Q 043262          345 QHFSDENKLGEGGFGPVYKGKLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLQE------NE  415 (512)
Q Consensus       345 ~~~~~~~~lg~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~  415 (512)
                      ++|...++||+|+||+||+|+.. +|+.||||++...  +....+.+.+|+.++++++||||+++++++...      +.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57888999999999999999964 6999999999743  334456789999999999999999999999643      67


Q ss_pred             eEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          416 SLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       416 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .++||||+.++.+..+.      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            89999999766554432      24899999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCC
Q 043262          496 IFGGNQ  501 (512)
Q Consensus       496 ~~~~~~  501 (512)
                      ......
T Consensus       168 ~~~~~~  173 (355)
T d2b1pa1         168 TAGTSF  173 (355)
T ss_dssp             ------
T ss_pred             cccccc
Confidence            876543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=6.3e-22  Score=178.74  Aligned_cols=135  Identities=21%  Similarity=0.216  Sum_probs=106.0

Q ss_pred             ccccccccccceeEEEEEeCCCCEEEEEEcccCCc------------------ccHHHHHHHHHHHhcCCCCccccceee
Q 043262          348 SDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSG------------------QGLQEFKNEVTLIAKLQHKNLVRLLGC  409 (512)
Q Consensus       348 ~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~g~  409 (512)
                      ...++||+|+||.||+|+..+|++||||.++....                  .....+..|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            34678999999999999998999999998753210                  012335678888999999999887755


Q ss_pred             EEeCCeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCceEEe
Q 043262          410 CLQENESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  489 (512)
Q Consensus       410 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~~kl~  489 (512)
                      .    ..+++|||++++.+..          +++.....++.|++.+|.|||+.+   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            2    2379999998866533          233445678999999999999985   9999999999999975 59999


Q ss_pred             ccCcccccCCC
Q 043262          490 DFGMARIFGGN  500 (512)
Q Consensus       490 DFGla~~~~~~  500 (512)
                      |||+|+....+
T Consensus       145 DFG~a~~~~~~  155 (191)
T d1zara2         145 DFPQSVEVGEE  155 (191)
T ss_dssp             CCTTCEETTST
T ss_pred             ECCCcccCCCC
Confidence            99999887644

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.83  E-value=7.3e-21  Score=189.28  Aligned_cols=152  Identities=22%  Similarity=0.295  Sum_probs=120.2

Q ss_pred             CCccccccccccceeEEEEEe-CCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-----------CCccccceeeEEeC
Q 043262          346 HFSDENKLGEGGFGPVYKGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-----------HKNLVRLLGCCLQE  413 (512)
Q Consensus       346 ~~~~~~~lg~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~~~  413 (512)
                      +|...++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++..++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            588899999999999999996 579999999997543 23467788998888775           57899999988653


Q ss_pred             --CeeEEEEEecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCCeeecCCCc------
Q 043262          414 --NESLLIYEYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKTSNVLLDHEMN------  485 (512)
Q Consensus       414 --~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NiLl~~~~~------  485 (512)
                        ...+++++++..+..............+++..+..++.||+.||.|||+..  +|+||||||+||||+.++.      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence              456677777665544333333344566899999999999999999999832  6999999999999986653      


Q ss_pred             eEEeccCcccccCCC
Q 043262          486 PKISDFGMARIFGGN  500 (512)
Q Consensus       486 ~kl~DFGla~~~~~~  500 (512)
                      +||+|||.++.....
T Consensus       171 ~kl~dfg~s~~~~~~  185 (362)
T d1q8ya_         171 IKIADLGNACWYDEH  185 (362)
T ss_dssp             EEECCCTTCEETTBC
T ss_pred             eeEeecccccccccc
Confidence            999999999876543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.37  E-value=1.2e-06  Score=80.84  Aligned_cols=146  Identities=15%  Similarity=0.088  Sum_probs=94.8

Q ss_pred             HHhcCCccccccccccceeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC-CCccccceeeEEeCCeeEEEE
Q 043262          342 EATQHFSDENKLGEGGFGPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLQENESLLIY  420 (512)
Q Consensus       342 ~~~~~~~~~~~lg~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~  420 (512)
                      ..-..|...+..+-+....||+... ++..+.||+...........+.+|...+..+. +--+.+++.+...++..++||
T Consensus        11 ~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~   89 (263)
T d1j7la_          11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence            3334555444433333468998875 45667888876554444445677877776653 444667788888888899999


Q ss_pred             EecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------
Q 043262          421 EYMPNKSLNVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS------------------------------------  464 (512)
Q Consensus       421 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------  464 (512)
                      |++++..+.......     .   ....++.++++.|.-||+..                                    
T Consensus        90 ~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T d1j7la_          90 SEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             ECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred             Eeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence            999998876543211     1   12223444555555555321                                    


Q ss_pred             --------------------CCCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          465 --------------------RLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       465 --------------------~~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                                          ...++|+|+.|.|||++++..+-|.||+.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                11278999999999999877677999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.76  E-value=5.3e-05  Score=68.91  Aligned_cols=141  Identities=16%  Similarity=0.131  Sum_probs=83.4

Q ss_pred             cccccc-eeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCC--CCccccceeeEEeCCeeEEEEEecCCCChh
Q 043262          353 LGEGGF-GPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ--HKNLVRLLGCCLQENESLLIYEYMPNKSLN  429 (512)
Q Consensus       353 lg~G~f-G~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lv~E~~~~gsL~  429 (512)
                      +..|.. ..||+....++..+.+|.-......   .+..|...+..+.  .-.+.+++.+..+.+..++|||++++-.+.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            344443 5789999888888899976654332   3566666666553  333567788888888899999999876553


Q ss_pred             HHh-----------------hcCC-CCCCC--CHHHHHHHH--------------------HHHHHHHHHHHcC----CC
Q 043262          430 VFL-----------------FDST-RSVQL--DWKRRISII--------------------NGIARGLLYLHED----SR  465 (512)
Q Consensus       430 ~~l-----------------~~~~-~~~~l--~~~~~~~i~--------------------~~ia~gL~yLH~~----~~  465 (512)
                      ...                 +... ....+  .+.....-.                    ......+..+...    ..
T Consensus        95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  174 (255)
T d1nd4a_          95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED  174 (255)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred             cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence            210                 0000 00000  010000000                    0011222333222    11


Q ss_pred             CCcccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          466 LKIIHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       466 ~~ivH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      +.++|+|+.|.|||++++..+-|.||+.+..
T Consensus       175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            2379999999999999887778999998765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.28  E-value=0.00036  Score=67.75  Aligned_cols=75  Identities=11%  Similarity=0.194  Sum_probs=46.0

Q ss_pred             cccccccceeEEEEEeCC-CCEEEEEEccc----C---CcccHHHHHHHHHHHhcCC-C--CccccceeeEEeCCeeEEE
Q 043262          351 NKLGEGGFGPVYKGKLAD-GKEIAVKRLSR----T---SGQGLQEFKNEVTLIAKLQ-H--KNLVRLLGCCLQENESLLI  419 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~-g~~vaVK~l~~----~---~~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~~~~~lv  419 (512)
                      +.||.|..-.||+....+ ++.++||.-..    .   -.....+...|.+.|..+. +  ..+.+++.  .+.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence            468999999999998754 67889986431    1   1112334456777666552 2  23444443  456667899


Q ss_pred             EEecCCCC
Q 043262          420 YEYMPNKS  427 (512)
Q Consensus       420 ~E~~~~gs  427 (512)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.66  E-value=0.0064  Score=56.87  Aligned_cols=135  Identities=13%  Similarity=0.160  Sum_probs=76.2

Q ss_pred             eeEEEEEeCCCCEEEEEEcccCCcccHHHHHHHHHHHhcCCCCcc--ccce-----eeEEeCCeeEEEEEecCCCChh--
Q 043262          359 GPVYKGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL--VRLL-----GCCLQENESLLIYEYMPNKSLN--  429 (512)
Q Consensus       359 G~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~-----g~~~~~~~~~lv~E~~~~gsL~--  429 (512)
                      -.||+.+..+|..+++|..+... ...+++..|...+..|....|  +..+     ......+..+.+++++++..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            36999999999999999876432 235667788888777643222  1111     1223456678899998764321  


Q ss_pred             ---HH------h---hc------CCCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HcCCCCCc
Q 043262          430 ---VF------L---FD------STRSVQLDWK----------------------RRISIINGIARGLLYL-HEDSRLKI  468 (512)
Q Consensus       430 ---~~------l---~~------~~~~~~l~~~----------------------~~~~i~~~ia~gL~yL-H~~~~~~i  468 (512)
                         .+      +   +.      ......+++.                      .....+.++...+.-+ .+.....+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               11      0   00      0001111111                      1122222333333222 12223458


Q ss_pred             ccCCCCCCCeeecCCCceEEeccCcccc
Q 043262          469 IHRDLKTSNVLLDHEMNPKISDFGMARI  496 (512)
Q Consensus       469 vH~dlk~~NiLl~~~~~~kl~DFGla~~  496 (512)
                      ||+|+.+.|||++++  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899997764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.66  E-value=0.024  Score=54.34  Aligned_cols=72  Identities=15%  Similarity=0.291  Sum_probs=44.4

Q ss_pred             cccccccceeEEEEEeCCC--------CEEEEEEcccCCcccHHHHHHHHHHHhcCCCCccc-cceeeEEeCCeeEEEEE
Q 043262          351 NKLGEGGFGPVYKGKLADG--------KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV-RLLGCCLQENESLLIYE  421 (512)
Q Consensus       351 ~~lg~G~fG~Vy~~~~~~g--------~~vaVK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~E  421 (512)
                      +.|+.|-.=.+|+....++        ..|.++..- .. .......+|..+++.+.-.+++ ++++++.    -.+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence            4576677778999886543        345554443 22 2334556788888877533444 6666653    268899


Q ss_pred             ecCCCCh
Q 043262          422 YMPNKSL  428 (512)
Q Consensus       422 ~~~~gsL  428 (512)
                      |+++-.|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9976443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=92.30  E-value=0.65  Score=42.01  Aligned_cols=29  Identities=31%  Similarity=0.353  Sum_probs=25.9

Q ss_pred             CcccCCCCCCCeeecCCCceEEeccCccc
Q 043262          467 KIIHRDLKTSNVLLDHEMNPKISDFGMAR  495 (512)
Q Consensus       467 ~ivH~dlk~~NiLl~~~~~~kl~DFGla~  495 (512)
                      .+||+|+.+.||+++.+...-|.||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            48999999999999998777899999764